CTRP Terminology

Preferred Label : CTRP Terminology;

NCIt synonyms : Clinical Trials Reporting Program Terminology;

NCIt definition : Terminology that is used to support NCI's Clinical Trials Reporting Program (CTRP), a database that captures the required reporting data for all NCI-sponsored clinical trials.;

Details

Origin ID

C116977;

UMLS CUI

C3899741;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- (R)-2-Hydroxyglutarate [NCIt concept]
- 1,2-Carbon C 13-labeled Glucose [NCIt concept]
- 1,24,25-Trihydroxyergocalciferol [NCIt concept]
- 1,25-Dihydroxyvitamin D(3) 24-Hydroxylase, Mitochondrial [NCIt concept]
- 1,3-Butadiene [NCIt concept]
- 1-Acyl-Sn-Glycerol-3-Phosphate Acyltransferase Epsilon [NCIt concept]
- 1-Methylhistidine [NCIt concept]
- 1-Phosphatidylinositol 3-Phosphate 5-Kinase [NCIt concept]
- 1-Phosphatidylinositol 4,5-Bisphosphate Phosphodiesterase Beta-4 [NCIt concept]
- 1-Phosphatidylinositol 4,5-Bisphosphate Phosphodiesterase Gamma-1 [NCIt concept]
- 1-Phosphatidylinositol 4,5-Bisphosphate Phosphodiesterase Gamma-2 [NCIt concept]
- 1.5 Tesla Magnetic Resonance Imaging [NCIt concept]
- 10q [NCIt concept]
- 11-Beta-Hydroxysteroid Dehydrogenase 1 [NCIt concept]
- 11-Dehydro-Thromboxane B2 Measurement [NCIt concept]
- 11p15 [NCIt concept]
- 11q [NCIt concept]
- 11q Aberration [NCIt concept]
- 11q Translocation [NCIt concept]
- 11q13 [NCIt concept]
- 11q22 [NCIt concept]
- 11q22.3 [NCIt concept]
- 11q23 [NCIt concept]
- 11q23 Abnormality [NCIt concept]
- 12-(S)-Hydroxy-5,8,10,14-Eicosatetraenoic Acid Receptor [NCIt concept]
- 12-Lipoxygenase Inhibitor VLX-1005 [NCIt concept]
- 12-Methyltetradecanoic Acid [NCIt concept]
- 12S Mitochondrial Ribosomal RNA [NCIt concept]
- 12q13-q14 [NCIt concept]
- 13-Hydroxyoctadecadienoic Acid [NCIt concept]
- 13-Methyltetradecanoic Acid [NCIt concept]
- 13q [NCIt concept]
- 13q14 [NCIt concept]
- 14-3-3 Protein Epsilon [NCIt concept]
- 14-3-3 Protein Sigma [NCIt concept]
- 14-3-3 Protein Zeta/Delta [NCIt concept]
- 14q [NCIt concept]
- 14q32 [NCIt concept]
- 15-Hydroxyprostaglandin Dehydrogenase [NAD+] [NCIt concept]
- 15q [NCIt concept]
- 15q25 [NCIt concept]
- 15q26 [NCIt concept]
- 16,16-Dimethyl Prostaglandin E2 [NCIt concept]
- 16-Hydroxyestrogen [NCIt concept]
- 16alpha-Hydroxyestrone [NCIt concept]
- 16q [NCIt concept]
- 16q23 [NCIt concept]
- 17-Alpha-Hydroxypregnenolone [NCIt concept]
- 17-Beta-Hydroxysteroid Dehydrogenase Type 6 [NCIt concept]
- 17p [NCIt concept]
- 17p13.1 [NCIt concept]
- 17pter-q21 [NCIt concept]
- 17q [NCIt concept]
- 17q13 [NCIt concept]
- 18-F-fluoroacetate [NCIt concept]
- 18F-FHBG [NCIt concept]
- 18F-Fluoromisonidazole [NCIt concept]
- 18F-labeled Mini-PEG Spacered RGD Dimer [NCIt concept]
- 18F-rhPSMA 7.3 PET/CT Scan [NCIt concept]
- 18q [NCIt concept]
- 19q [NCIt concept]
- 1p/19q Codeletion [NCIt concept]
- 1p/19q Codeletion Negative [NCIt concept]
- 1p36 [NCIt concept]
- 1q21 [NCIt concept]
- 1q32 [NCIt concept]
- 2'-5'-Oligoadenylate [NCIt concept]
- 2'-5'-Oligoadenylate Synthase 2 [NCIt concept]
- 2'-F-ara-deoxyuridine [NCIt concept]
- 2,3-Dinor-6-Ketoprostaglandin F1alpha [NCIt concept]
- 2,6-Dimethoxyquinone [NCIt concept]
- 2-5A-Dependent Ribonuclease [NCIt concept]
- 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine [NCIt concept]
- 2-Deoxy-D-glucose [NCIt concept]
- 2-Dimensional Biplane Ultrasound Mode [NCIt concept]
- 2-Fluorofucose [NCIt concept]
- 2-Fluoropropionyl-labeled Pegylated Dimeric RGD Peptide [NCIt concept]
- 2-Hour Postprandial Glucose [NCIt concept]
- 2-Hour Postprandial Insulin [NCIt concept]
- 2-Hydroxyacyl-CoA Lyase 1 [NCIt concept]
- 2-Hydroxyacylsphingosine 1-Beta-Galactosyltransferase [NCIt concept]
- 2-Hydroxybutyrate [NCIt concept]
- 2-Hydroxyestradiol [NCIt concept]
- 2-Hydroxyestrogen [NCIt concept]
- 2-Hydroxyestrone [NCIt concept]
- 2-Hydroxypropylmercapturic Acid [NCIt concept]
- 2-Methoxyestradiol [NCIt concept]
- 2-Methoxyestradiol Nanocrystal Colloidal Dispersion [NCIt concept]
- 2-Methoxyestrone [NCIt concept]
- 2-Methylhippuric Acid [NCIt concept]
- 20S Proteasome [NCIt concept]
- 20q [NCIt concept]
- 20q11 [NCIt concept]
- 20q13 [NCIt concept]
- 21p [NCIt concept]
- 22q [NCIt concept]
- 22q11.22 [NCIt concept]
- 24 Hour Urine for Total Protein [NCIt concept]
- 24,25-Dihydroxycholecalciferol [NCIt concept]
- 24-Hydroxycholesterol 7-Alpha-Hydroxylase [NCIt concept]
- 25-Hydroxyvitamin D Less than 30 ng/ml [NCIt concept]
- 25-Hydroxyvitamin D Less than 32 ng/ml [NCIt concept]
- 25-Hydroxyvitamin D Less than 66 ng/ml [NCIt concept]
- 25-Hydroxyvitamin D-1 Alpha-Hydroxylase, Mitochondrial [NCIt concept]
- 26S ATP-Dependent Proteasome [NCIt concept]
- 26S Proteasome Complex Subunit SEM1 [NCIt concept]
- 26S Proteasome Non-ATPase Regulatory Subunit 10 [NCIt concept]
- 26S Proteasome Non-ATPase Regulatory Subunit 4 [NCIt concept]
- 27-Hydroxycholesterol [NCIt concept]
- 2H-labeled Acetate [NCIt concept]
- 2Morrow Smoking and Tobacco Cessation Program [NCIt concept]
- 2X-121 DRP [NCIt concept]
- 3 Beta-Hydroxysteroid Dehydrogenase/Delta 5->4-Isomerase Type 1 [NCIt concept]
- 3 Beta-Hydroxysteroid Dehydrogenase/Delta 5->4-Isomerase Type 2 [NCIt concept]
- 3 Tesla Magnetic Resonance Imaging [NCIt concept]
- 3'-Aminomethyl Nicotine-P. aeruginosa r-Exoprotein A Conjugate Vaccine [NCIt concept]
- 3'-C-ethynylcytidine [NCIt concept]
- 3-Aminoisobutyric Acid [NCIt concept]
- 3-Beta-Hydroxysteroid-Delta(8),Delta(7)-Isomerase [NCIt concept]
- 3-Dimensional Conformal Accelerated Partial Breast Irradiation [NCIt concept]
- 3-Dimensional Conformal Radiation Therapy [NCIt concept]
- 3-Dimensional Medical Modeling [NCIt concept]
- 3-Dimensional Printed Anatomic Modeling [NCIt concept]
- 3-Dimensional T1-Weighted Magnetic Resonance Imaging [NCIt concept]
- 3-Dimensional Ultrasound-Guided Radiation Therapy [NCIt concept]
- 3-Hydroxy-3-Methylglutaryl-Coenzyme A [NCIt concept]
- 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase [NCIt concept]
- 3-Hydroxyacyl-CoA Dehydrogenase [NCIt concept]
- 3-Hydroxybutyrate [NCIt concept]
- 3-Hydroxycotinine [NCIt concept]
- 3-Hydroxypropylmercapturic Acid [NCIt concept]
- 3-Ketodihydrosphingosine Reductase [NCIt concept]
- 3-Methylhippuric Acid [NCIt concept]
- 3-Methylhistidine [NCIt concept]
- 3-Nitrotyrosine [NCIt concept]
- 3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 1 [NCIt concept]
- 3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2 [NCIt concept]
- 3D-expanded Placenta-derived Cells PLX-R18 [NCIt concept]
- 3p14 [NCIt concept]
- 3p14 Loss of Heterozygosity [NCIt concept]
- 3q27 [NCIt concept]
- 4'-Iodo-4'-Deoxydoxorubicin [NCIt concept]
- 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol [NCIt concept]
- 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronide [NCIt concept]
- 4-Beta-Hydroxycholesterol Measurement [NCIt concept]
- 4-Beta-Hydroxycholesterol to Total Cholesterol Ratio Measurement [NCIt concept]
- 4-Dimensional Computed Tomography [NCIt concept]
- 4-Dimensional Conformal Radiation Therapy [NCIt concept]
- 4-Dimensional Magnetic Resonance Imaging [NCIt concept]
- 4-Hydroxy-1-(3-Pyridyl)-1-Butanone [NCIt concept]
- 4-Hydroxybut-2-Ylmercapturic Acid [NCIt concept]
- 4-Hydroxyestradiol [NCIt concept]
- 4-Hydroxyestrone [NCIt concept]
- 4-Methoxyestradiol [NCIt concept]
- 4-Methoxyestrone [NCIt concept]
- 4-Methylhippuric Acid [NCIt concept]
- 4-Methylnitrosamino-1,3-pyridyl-1-butanone [NCIt concept]
- 4-OH-DiPT Prodrug RE104 [NCIt concept]
- 4-Peptide Melanoma Vaccine [NCIt concept]
- 4-Thio-2-deoxycytidine [NCIt concept]
- 40S Ribosomal Protein S14 [NCIt concept]
- 40S Ribosomal Protein S2 [NCIt concept]
- 40S Ribosomal Protein S20 [NCIt concept]
- 40S Ribosomal Protein S6 [NCIt concept]
- 40S Ribosomal Protein SA [NCIt concept]
- 4D PET Scan [NCIt concept]
- 4H11-28z/fIL-12/EGFRt-expressing Autologous T-lymphocytes [NCIt concept]
- 4p16 [NCIt concept]
- 4p16.3 [NCIt concept]
- 5'-3' Exoribonuclease 2 [NCIt concept]
- 5'-AMP-Activated Protein Kinase [NCIt concept]
- 5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha [NCIt concept]
- 5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-1 [NCIt concept]
- 5'-Nucleotidase [NCIt concept]
- 5,6-Dihydroxyindole-2-Carboxylic Acid Oxidase [NCIt concept]
- 5-Aminolevulinate Synthase, Nonspecific, Mitochondrial [NCIt concept]
- 5-Aza-4'-thio-2'-deoxycytidine [NCIt concept]
- 5-Carbon C 13-labeled Glutamine [NCIt concept]
- 5-Dimensional Computed Tomography [NCIt concept]
- 5-Fluoro-2-Deoxycytidine [NCIt concept]
- 5-HT3 Receptor [NCIt concept]
- 5-HT3 Receptor Antagonist [NCIt concept]
- 5-Hydroxyindoleacetic Acid [NCIt concept]
- 5-Hydroxylysine [NCIt concept]
- 5-Hydroxytryptamine Receptor 1A [NCIt concept]
- 5-Hydroxytryptamine Receptor 1B [NCIt concept]
- 5-Hydroxytryptamine Receptor 2A [NCIt concept]
- 5-Hydroxytryptamine Receptor 3A [NCIt concept]
- 5-Iodo-2-pyrimidinone [NCIt concept]
- 5-Iodouracil [NCIt concept]
- 5-Methylcytosine [NCIt concept]
- 5p15 [NCIt concept]
- 5q31.1 [NCIt concept]
- 6 Melanoma Helper Peptide Vaccine [NCIt concept]
- 6 Minute Walk Functional Test [NCIt concept]
- 6-Channel Balloon Repositioning, Multichannel Applicator [NCIt concept]
- 6-Hydroxymelatonin [NCIt concept]
- 6-Ketoprostaglandin F1alpha [NCIt concept]
- 6-Phosphofructokinase, Muscle Type [NCIt concept]
- 6-Sulfatoxymelatonin [NCIt concept]
- 60 kDa Heat Shock Protein, Mitochondrial [NCIt concept]
- 60S Acidic Ribosomal Protein P0 [NCIt concept]
- 60S Ribosomal Protein L13a [NCIt concept]
- 60S Ribosomal Protein L22 [NCIt concept]
- 60S Ribosomal Protein L5 [NCIt concept]
- 65 kDa Phosphoprotein [NCIt concept]
- 65 kDa Phosphoprotein Antibody [NCIt concept]
- 66 kDa Phosphoprotein Antibody Positive [NCIt concept]
- 67 kDa Laminin Receptor [NCIt concept]
- 68Ga-PSMA-cyclotron PET Scan [NCIt concept]
- 68Ga-PSMA-generator PET Scan [NCIt concept]
- 6p21 [NCIt concept]
- 6q11-q27 [NCIt concept]
- 6q21 [NCIt concept]
- 7 Tesla Magnetic Resonance Imaging [NCIt concept]
- 7-Aminoactinomycin D [NCIt concept]
- 7-Hydroxystaurosporine [NCIt concept]
- 7-alpha-Hydroxy-4-cholesten-3-one Measurement [NCIt concept]
- 72 kDa Type IV Collagenase [NCIt concept]
- 78 kDa Glucose-Regulated Protein [NCIt concept]
- 7q34 [NCIt concept]
- 8-Chloroadenosine [NCIt concept]
- 8-Hydroxy-2'-deoxyguanosine [NCIt concept]
- 8-Methyl-IQX [NCIt concept]
- 8-Oxoguanine [NCIt concept]
- 8-iso Prostaglandin F2alpha [NCIt concept]
- 8q22 [NCIt concept]
- 8q24 [NCIt concept]
- 99mTc-based PSMA Imaging and Surgery Agent [NCIt concept]
- 9alpha,11beta-Prostaglandin F2alpha [NCIt concept]
- 9p21 [NCIt concept]
- 9p21 Loss of Heterozygosity [NCIt concept]
- 9p24.1 [NCIt concept]
- 9q22 [NCIt concept]
- A Disintegrin and Metalloproteinase with Thrombospondin Motifs 13 [NCIt concept]
- A-Kinase Anchor Protein 10, Mitochondrial [NCIt concept]
- A-Kinase Anchor Protein 12 [NCIt concept]
- A-Kinase Anchor Protein 4 [NCIt concept]
- A-Kinase Anchor Protein 9 [NCIt concept]
- A-Kinase Anchor Protein SPHKAP [NCIt concept]
- A2A/A2B Adenosine Receptor Antagonist INCB106385 [NCIt concept]
- A2M Gene [NCIt concept]
- A2M wt Allele [NCIt concept]
- ABCA1 Gene [NCIt concept]
- ABCA1 wt Allele [NCIt concept]
- ABCA5 Gene [NCIt concept]
- ABCA5 wt Allele [NCIt concept]
- ABCB1 2 Allele [NCIt concept]
- ABCB1 Gene [NCIt concept]
- ABCB1 wt Allele [NCIt concept]
- ABCB11 Gene [NCIt concept]
- ABCB11 Positive [NCIt concept]
- ABCB11 wt Allele [NCIt concept]
- ABCB4 Gene [NCIt concept]
- ABCB4 Positive [NCIt concept]
- ABCB4 wt Allele [NCIt concept]
- ABCB5 Gene [NCIt concept]
- ABCB5 wt Allele [NCIt concept]
- ABCC1 Gene [NCIt concept]
- ABCC1 wt Allele [NCIt concept]
- ABCC2 Gene [NCIt concept]
- ABCC2 wt Allele [NCIt concept]
- ABCC3 Gene [NCIt concept]
- ABCC3 wt Allele [NCIt concept]
- ABCC4 Gene [NCIt concept]
- ABCC4 wt Allele [NCIt concept]
- ABCC5 Gene [NCIt concept]
- ABCC5 wt Allele [NCIt concept]
- ABCC6 Gene [NCIt concept]
- ABCC6 wt Allele [NCIt concept]
- ABCD1 Gene [NCIt concept]
- ABCD1 Gene Mutation [NCIt concept]
- ABCD1 wt Allele [NCIt concept]
- ABCF2 Gene [NCIt concept]
- ABCF2 wt Allele [NCIt concept]
- ABCG1 Gene [NCIt concept]
- ABCG1 wt Allele [NCIt concept]
- ABCG2 Gene [NCIt concept]
- ABCG2 Substrate [NCIt concept]
- ABCG2 wt Allele [NCIt concept]
- ABHD12 Gene [NCIt concept]
- ABHD12 wt Allele [NCIt concept]
- ABI1 Gene [NCIt concept]
- ABI1 wt Allele [NCIt concept]
- ABL Class Rearrangement Positive Ph-Like B Acute Lymphoblastic Leukemia [NCIt concept]
- ABL Interactor 1 [NCIt concept]
- ABL Positive [NCIt concept]
- ABL1 Gene [NCIt concept]
- ABL1 Gene Mutation [NCIt concept]
- ABL1 Gene Rearrangement [NCIt concept]
- ABL1 wt Allele [NCIt concept]
- ABL1/BCR Fusion Gene [NCIt concept]
- ABL2 Gene [NCIt concept]
- ABL2 Gene Mutation [NCIt concept]
- ABL2 Gene Rearrangement [NCIt concept]
- ABL2 wt Allele [NCIt concept]
- ABRAXAS1 Gene [NCIt concept]
- ABRAXAS1 Gene Mutation [NCIt concept]
- ABRAXAS1 wt Allele [NCIt concept]
- ABVD Regimen [NCIt concept]
- AC Regimen [NCIt concept]
- ACACA Gene [NCIt concept]
- ACACA wt Allele [NCIt concept]
- ACBD6 Gene [NCIt concept]
- ACBD6 wt Allele [NCIt concept]
- ACD Gene [NCIt concept]
- ACD Gene Mutation [NCIt concept]
- ACD wt Allele [NCIt concept]
- ACE Gene [NCIt concept]
- ACE wt Allele [NCIt concept]
- ACE2 Gene [NCIt concept]
- ACE2 wt Allele [NCIt concept]
- ACER1 Gene [NCIt concept]
- ACER1 wt Allele [NCIt concept]
- ACER2 Gene [NCIt concept]
- ACER2 wt Allele [NCIt concept]
- ACER3 Gene [NCIt concept]
- ACER3 wt Allele [NCIt concept]
- ACHE Gene [NCIt concept]
- ACHE wt Allele [NCIt concept]
- ACKR1 Gene [NCIt concept]
- ACKR1 Gene Mutation [NCIt concept]
- ACKR1 NM_002036.3:c.-67T>C [NCIt concept]
- ACKR1 wt Allele [NCIt concept]
- ACKR3 Gene [NCIt concept]
- ACKR3 wt Allele [NCIt concept]
- ACLY Gene [NCIt concept]
- ACLY wt Allele [NCIt concept]
- ACOX2 Gene [NCIt concept]
- ACOX2 wt Allele [NCIt concept]
- ACP3 Gene [NCIt concept]
- ACP3 wt Allele [NCIt concept]
- ACP5 Gene [NCIt concept]
- ACP5 Gene Product [NCIt concept]
- ACP5 wt Allele [NCIt concept]
- ACPP Antibody [NCIt concept]
- ACSL3 Gene [NCIt concept]
- ACSL3 wt Allele [NCIt concept]
- ACSL6 Gene [NCIt concept]
- ACSL6 wt Allele [NCIt concept]
- ACSL6/ETV6 Fusion Gene [NCIt concept]
- ACSL6/ETV6 Fusion Protein [NCIt concept]
- ACSS2 Gene [NCIt concept]
- ACSS2 wt Allele [NCIt concept]
- ACTA2 Gene [NCIt concept]
- ACTA2 Positive [NCIt concept]
- ACTA2 wt Allele [NCIt concept]
- ACTB Gene [NCIt concept]
- ACTB wt Allele [NCIt concept]
- ACVR1 Gene [NCIt concept]
- ACVR1 wt Allele [NCIt concept]
- ACVR1B Gene [NCIt concept]
- ACVR1B Gene Mutation [NCIt concept]
- ACVR1B wt Allele [NCIt concept]
- ACVR2A Gene [NCIt concept]
- ACVR2A wt Allele [NCIt concept]
- ACVRL1 Gene [NCIt concept]
- ACVRL1 wt Allele [NCIt concept]
- ADA Gene [NCIt concept]
- ADA wt Allele [NCIt concept]
- ADA2 Gene [NCIt concept]
- ADA2 Gene Mutation [NCIt concept]
- ADA2 wt Allele [NCIt concept]
- ADAM10 Gene [NCIt concept]
- ADAM10 wt Allele [NCIt concept]
- ADAM11 Gene [NCIt concept]
- ADAM11 wt Allele [NCIt concept]
- ADAM12 Gene [NCIt concept]
- ADAM12 wt Allele [NCIt concept]
- ADAM17 Gene [NCIt concept]
- ADAM17 wt Allele [NCIt concept]
- ADAM19 Gene [NCIt concept]
- ADAM19 wt Allele [NCIt concept]
- ADAM8 Gene [NCIt concept]
- ADAM8 wt Allele [NCIt concept]
- ADAM9 Gene [NCIt concept]
- ADAM9 wt Allele [NCIt concept]
- ADAMTS13 Activity Less than 10 Percent [NCIt concept]
- ADAMTS13 Gene [NCIt concept]
- ADAMTS13 wt Allele [NCIt concept]
- ADD3 Gene [NCIt concept]
- ADD3 wt Allele [NCIt concept]
- ADD3/NUP98 Fusion Gene [NCIt concept]
- ADGRE1 Gene [NCIt concept]
- ADGRE1 wt Allele [NCIt concept]
- ADGRE2 Gene [NCIt concept]
- ADGRE2 wt Allele [NCIt concept]
- ADGRF1 Gene [NCIt concept]
- ADGRF1 wt Allele [NCIt concept]
- ADH-1 [NCIt concept]
- ADH1C Gene [NCIt concept]
- ADH1C wt Allele [NCIt concept]
- ADH4 Gene [NCIt concept]
- ADH4 wt Allele [NCIt concept]
- ADIPOQ Gene [NCIt concept]
- ADIPOQ wt Allele [NCIt concept]
- ADIPOR1 Gene [NCIt concept]
- ADIPOR1 wt Allele [NCIt concept]
- ADIPOR2 Gene [NCIt concept]
- ADIPOR2 wt Allele [NCIt concept]
- ADORA2A Gene [NCIt concept]
- ADORA2A wt Allele [NCIt concept]
- ADORA2B Gene [NCIt concept]
- ADORA2B wt Allele [NCIt concept]
- ADP Ribosylation [NCIt concept]
- ADP-Ribosyl Cyclase/Cyclic ADP-Ribose Hydrolase 1 [NCIt concept]
- ADRA2C Gene [NCIt concept]
- ADRA2C wt Allele [NCIt concept]
- ADRB1 Gene [NCIt concept]
- ADRB1 wt Allele [NCIt concept]
- ADRB2 Gene [NCIt concept]
- ADRB2 wt Allele [NCIt concept]
- ADRB3 Gene [NCIt concept]
- ADRB3 wt Allele [NCIt concept]
- AE37 Peptide/GM-CSF Vaccine [NCIt concept]
- AF4/FMR2 Family Member 1 [NCIt concept]
- AF4/FMR2 Family Member 3 [NCIt concept]
- AFDN Gene [NCIt concept]
- AFDN wt Allele [NCIt concept]
- AFF1 Gene [NCIt concept]
- AFF1 wt Allele [NCIt concept]
- AFF3 Gene [NCIt concept]
- AFF3 wt Allele [NCIt concept]
- AFP Gene [NCIt concept]
- AFP wt Allele [NCIt concept]
- AG7 Antigen Positive [NCIt concept]
- AGER Gene [NCIt concept]
- AGER wt Allele [NCIt concept]
- AGPAT5 Gene [NCIt concept]
- AGPAT5 wt Allele [NCIt concept]
- AGR2 Gene [NCIt concept]
- AGR2 wt Allele [NCIt concept]
- AGRP Gene [NCIt concept]
- AGRP wt Allele [NCIt concept]
- AGT Gene [NCIt concept]
- AGT wt Allele [NCIt concept]
- AGTRAP Gene [NCIt concept]
- AGTRAP wt Allele [NCIt concept]
- AHCY Gene [NCIt concept]
- AHCY wt Allele [NCIt concept]
- AHR Gene [NCIt concept]
- AHR wt Allele [NCIt concept]
- AHSG Gene [NCIt concept]
- AHSG wt Allele [NCIt concept]
- AICA-Ribotide [NCIt concept]
- AICDA Gene [NCIt concept]
- AICDA wt Allele [NCIt concept]
- AIDS-Related Anal Canal Carcinoma [NCIt concept]
- AIDS-Related Burkitt Lymphoma [NCIt concept]
- AIDS-Related Cervical Carcinoma [NCIt concept]
- AIDS-Related Diffuse Large Cell Lymphoma [NCIt concept]
- AIDS-Related Diffuse Mixed Cell Lymphoma [NCIt concept]
- AIDS-Related Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- AIDS-Related Hodgkin Lymphoma [NCIt concept]
- AIDS-Related Immunoblastic Lymphoma [NCIt concept]
- AIDS-Related Kaposi Sarcoma [NCIt concept]
- AIDS-Related Lymphoblastic Lymphoma [NCIt concept]
- AIDS-Related Lymphoma [NCIt concept]
- AIDS-Related Malignant Neoplasm [NCIt concept]
- AIDS-Related Primary Central Nervous System Lymphoma [NCIt concept]
- AIFM1 Gene [NCIt concept]
- AIFM1 wt Allele [NCIt concept]
- AIM2 Gene [NCIt concept]
- AIM2 wt Allele [NCIt concept]
- AIRE Gene [NCIt concept]
- AIRE wt Allele [NCIt concept]
- AJUBA Gene [NCIt concept]
- AJUBA wt Allele [NCIt concept]
- AKAP10 Gene [NCIt concept]
- AKAP10 wt Allele [NCIt concept]
- AKAP12 Gene [NCIt concept]
- AKAP12 wt Allele [NCIt concept]
- AKAP4 Gene [NCIt concept]
- AKAP4 Positive [NCIt concept]
- AKAP4 wt Allele [NCIt concept]
- AKAP9 Gene [NCIt concept]
- AKAP9 wt Allele [NCIt concept]
- AKAP9/BRAF Fusion Gene [NCIt concept]
- AKAP9/BRAF Fusion Protein [NCIt concept]
- AKR1A1 Gene [NCIt concept]
- AKR1A1 wt Allele [NCIt concept]
- AKR1C1 Gene [NCIt concept]
- AKR1C1 wt Allele [NCIt concept]
- AKR1C2 Gene [NCIt concept]
- AKR1C2 wt Allele [NCIt concept]
- AKR1C3 Gene [NCIt concept]
- AKR1C3 wt Allele [NCIt concept]
- AKR1C3-activated Prodrug AST-3424 [NCIt concept]
- AKT 1/2 Inhibitor BAY1125976 [NCIt concept]
- AKT Family Gene Alteration Positive [NCIt concept]
- AKT Family Gene Mutation [NCIt concept]
- AKT Inhibitor [NCIt concept]
- AKT/RSK/S6K Inhibitor TAS0612 [NCIt concept]
- AKT1 E17K Inhibitor ALTA2618 [NCIt concept]
- AKT1 Gene [NCIt concept]
- AKT1 Gene Alteration Positive [NCIt concept]
- AKT1 Gene Mutation [NCIt concept]
- AKT1 Gene Rearrangement [NCIt concept]
- AKT1 NM_001014431.1:c.49G>A [NCIt concept]
- AKT1 NP_001014431.1:p.E17K [NCIt concept]
- AKT1 Protein Variant [NCIt concept]
- AKT1 wt Allele [NCIt concept]
- AKT1S1 Gene [NCIt concept]
- AKT1S1 wt Allele [NCIt concept]
- AKT2 Gene [NCIt concept]
- AKT2 Gene Alteration Positive [NCIt concept]
- AKT2 Gene Mutation [NCIt concept]
- AKT2 wt Allele [NCIt concept]
- AKT3 Gene [NCIt concept]
- AKT3 Gene Alteration Positive [NCIt concept]
- AKT3 Gene Amplification [NCIt concept]
- AKT3 Gene Mutation [NCIt concept]
- AKT3 wt Allele [NCIt concept]
- ALAS1 Gene [NCIt concept]
- ALAS1 wt Allele [NCIt concept]
- ALC1 Inhibitor EIS-12656 [NCIt concept]
- ALCAM Gene [NCIt concept]
- ALCAM Positive [NCIt concept]
- ALCAM wt Allele [NCIt concept]
- ALDH1A1 Gene [NCIt concept]
- ALDH1A1 wt Allele [NCIt concept]
- ALDH1A2 Gene [NCIt concept]
- ALDH1A2 wt Allele [NCIt concept]
- ALDH2 Gene [NCIt concept]
- ALDH2 Gene Mutation [NCIt concept]
- ALDH2 Gene Mutation Negative [NCIt concept]
- ALDH2 NM_000690.4:c.1510G>A [NCIt concept]
- ALDH2 NP_000681.2:p.E504K [NCIt concept]
- ALDH2 Protein Variant [NCIt concept]
- ALDH2 wt Allele [NCIt concept]
- ALDH2*1/*2 Genotype Positive [NCIt concept]
- ALK Driver Mutation Negative [NCIt concept]
- ALK Fusion Negative [NCIt concept]
- ALK Fusion Positive [NCIt concept]
- ALK Fusion Protein Expression [NCIt concept]
- ALK Gene [NCIt concept]
- ALK Gene Alteration Negative [NCIt concept]
- ALK Gene Alteration Positive [NCIt concept]
- ALK Gene Amplification [NCIt concept]
- ALK Gene Fusion Negative [NCIt concept]
- ALK Gene Fusion Positive [NCIt concept]
- ALK Gene Mutation [NCIt concept]
- ALK Gene Mutation Negative [NCIt concept]
- ALK Gene Product [NCIt concept]
- ALK Gene Rearrangement [NCIt concept]
- ALK Gene Rearrangement Negative [NCIt concept]
- ALK Gene Translocation [NCIt concept]
- ALK Gene Translocation Negative [NCIt concept]
- ALK Inhibitor ASP3026 [NCIt concept]
- ALK Kinase Domain [NCIt concept]
- ALK Kinase Overexpression [NCIt concept]
- ALK NM_004304.4:c.3512T>A [NCIt concept]
- ALK NM_004304.4:c.3512_3513delinsAT [NCIt concept]
- ALK NM_004304.4:c.3586C>A [NCIt concept]
- ALK NM_004304.5:c.3512T>C [NCIt concept]
- ALK NM_004304.5:c.3512T>G [NCIt concept]
- ALK NM_004304.5:c.3604G>A [NCIt concept]
- ALK NM_004304.5:c.3604G>C [NCIt concept]
- ALK NM_004304.5:c.3607G>A [NCIt concept]
- ALK NM_004304.5:c.3628G>A [NCIt concept]
- ALK NP_004295.2:p.D1203N [NCIt concept]
- ALK NP_004295.2:p.E1210K [NCIt concept]
- ALK NP_004295.2:p.G1202R [NCIt concept]
- ALK NP_004295.2:p.I1171N [NCIt concept]
- ALK NP_004295.2:p.I1171S [NCIt concept]
- ALK NP_004295.2:p.I1171T [NCIt concept]
- ALK NP_004295.2:p.L1196M [NCIt concept]
- ALK Negative [NCIt concept]
- ALK Peptide Vaccine [NCIt concept]
- ALK Positive [NCIt concept]
- ALK Tyrosine Kinase Receptor [NCIt concept]
- ALK wt Allele [NCIt concept]
- ALK-FAK Inhibitor CEP-37440 [NCIt concept]
- ALK-Positive Lung Non-Small Cell Carcinoma [NCIt concept]
- ALKATI Allele [NCIt concept]
- ALKATI Positive [NCIt concept]
- ALKATI Protein [NCIt concept]
- ALOX12 Gene [NCIt concept]
- ALOX12 wt Allele [NCIt concept]
- ALOX15 Gene [NCIt concept]
- ALOX15 wt Allele [NCIt concept]
- ALOX15B Gene [NCIt concept]
- ALOX15B wt Allele [NCIt concept]
- ALOX5 Gene [NCIt concept]
- ALOX5 wt Allele [NCIt concept]
- ALPG Gene [NCIt concept]
- ALPG wt Allele [NCIt concept]
- ALPL Gene [NCIt concept]
- ALPL wt Allele [NCIt concept]
- ALPP Gene [NCIt concept]
- ALPP wt Allele [NCIt concept]
- ALVAC gp100 Vaccine [NCIt concept]
- ALVAC(2) Melanoma Multi-antigen Vaccine [NCIt concept]
- ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine [NCIt concept]
- ALVAC-hB7.1 [NCIt concept]
- AMACR Gene [NCIt concept]
- AMACR wt Allele [NCIt concept]
- AMFR Gene [NCIt concept]
- AMFR wt Allele [NCIt concept]
- AMH Gene [NCIt concept]
- AMH wt Allele [NCIt concept]
- AMP KRAS Vaccine ELI-002 [NCIt concept]
- AMP-Activated Protein Kinase Beta [NCIt concept]
- ANG Gene [NCIt concept]
- ANG wt Allele [NCIt concept]
- ANGPT1 Gene [NCIt concept]
- ANGPT1 wt Allele [NCIt concept]
- ANGPT2 Gene [NCIt concept]
- ANGPT2 wt Allele [NCIt concept]
- ANGPT4 Gene [NCIt concept]
- ANGPT4 wt Allele [NCIt concept]
- ANGPTL1 Gene [NCIt concept]
- ANGPTL1 wt Allele [NCIt concept]
- ANGPTL4 Gene [NCIt concept]
- ANGPTL4 wt Allele [NCIt concept]
- ANK1 Gene [NCIt concept]
- ANK1 wt Allele [NCIt concept]
- ANKRD26 Gene [NCIt concept]
- ANKRD26 Gene Mutation [NCIt concept]
- ANKRD26 wt Allele [NCIt concept]
- ANLN Gene [NCIt concept]
- ANLN wt Allele [NCIt concept]
- ANO1 Gene [NCIt concept]
- ANO1 wt Allele [NCIt concept]
- ANPEP Gene [NCIt concept]
- ANPEP wt Allele [NCIt concept]
- ANTXR1 Gene [NCIt concept]
- ANTXR1 wt Allele [NCIt concept]
- ANXA2 Gene [NCIt concept]
- ANXA2 wt Allele [NCIt concept]
- AP-1 Complex [NCIt concept]
- APAF1 Gene [NCIt concept]
- APAF1 wt Allele [NCIt concept]
- APBA1 Gene [NCIt concept]
- APBA1 wt Allele [NCIt concept]
- APBA2 Gene [NCIt concept]
- APBA2 wt Allele [NCIt concept]
- APBA3 Gene [NCIt concept]
- APBA3 wt Allele [NCIt concept]
- APC Gene [NCIt concept]
- APC Gene Mutation [NCIt concept]
- APC NM_000038.6:c.3920T>A [NCIt concept]
- APC NP_000029.2:p.I1307K [NCIt concept]
- APC Promoter 1B [NCIt concept]
- APC Promoter 1B Variant [NCIt concept]
- APC wt Allele [NCIt concept]
- APC8015F [NCIt concept]
- APE1/Ref-1 Redox Inhibitor APX3330 [NCIt concept]
- APEX1 Gene [NCIt concept]
- APEX1 wt Allele [NCIt concept]
- APIM-containing Peptide ATX-101 [NCIt concept]
- APLN Gene [NCIt concept]
- APLN wt Allele [NCIt concept]
- APOA1 Gene [NCIt concept]
- APOA1 wt Allele [NCIt concept]
- APOA1/APOC3 Fusion Gene [NCIt concept]
- APOA4 Gene [NCIt concept]
- APOA4 wt Allele [NCIt concept]
- APOB Gene [NCIt concept]
- APOB wt Allele [NCIt concept]
- APOBEC Family Protein [NCIt concept]
- APOBEC3G Gene [NCIt concept]
- APOBEC3G wt Allele [NCIt concept]
- APOC3 Gene [NCIt concept]
- APOC3 wt Allele [NCIt concept]
- APOE Gene [NCIt concept]
- APOE Gene Product [NCIt concept]
- APOE wt Allele [NCIt concept]
- APOE*2 Allele [NCIt concept]
- APOE*4 Allele [NCIt concept]
- APP Gene [NCIt concept]
- APP wt Allele [NCIt concept]
- APPSPIRE [NCIt concept]
- AR Antagonist BMS-641988 [NCIt concept]
- AR Gene [NCIt concept]
- AR Gene Product [NCIt concept]
- AR wt Allele [NCIt concept]
- ARAF Gene [NCIt concept]
- ARAF Gene Mutation [NCIt concept]
- ARAF wt Allele [NCIt concept]
- ARC Fusion Protein SL-279252 [NCIt concept]
- ARF GTPase-Activating Protein GIT1 [NCIt concept]
- ARFIP1 Gene [NCIt concept]
- ARFIP1 wt Allele [NCIt concept]
- ARG1 Gene [NCIt concept]
- ARG1 wt Allele [NCIt concept]
- ARG2 Gene [NCIt concept]
- ARG2 wt Allele [NCIt concept]
- ARHGAP26 Gene [NCIt concept]
- ARHGAP26 wt Allele [NCIt concept]
- ARHGAP45 Gene [NCIt concept]
- ARHGAP45 Gene Mutation [NCIt concept]
- ARHGAP45 NM_012292.4:c.416G>A [NCIt concept]
- ARHGAP45 NP_036424.2:p.R139H [NCIt concept]
- ARHGAP45 Protein Variant [NCIt concept]
- ARHGAP45 wt Allele [NCIt concept]
- ARHGEF12 Gene [NCIt concept]
- ARHGEF12 wt Allele [NCIt concept]
- ARHGEF2 Gene [NCIt concept]
- ARHGEF2 wt Allele [NCIt concept]
- ARID1A Gene [NCIt concept]
- ARID1A Gene Mutation [NCIt concept]
- ARID1A Gene Mutation Negative [NCIt concept]
- ARID1A Negative [NCIt concept]
- ARID1A Positive [NCIt concept]
- ARID1A wt Allele [NCIt concept]
- ARID1B Gene [NCIt concept]
- ARID1B Gene Mutation [NCIt concept]
- ARID1B wt Allele [NCIt concept]
- ARID2 Gene [NCIt concept]
- ARID2 Gene Mutation [NCIt concept]
- ARID2 wt Allele [NCIt concept]
- ARID5B Gene [NCIt concept]
- ARID5B wt Allele [NCIt concept]
- ARNT Gene [NCIt concept]
- ARNT wt Allele [NCIt concept]
- ARRB2 Gene [NCIt concept]
- ARRB2 wt Allele [NCIt concept]
- ARRDC3 Gene [NCIt concept]
- ARRDC3 wt Allele [NCIt concept]
- ARSA Gene [NCIt concept]
- ARSA Gene Mutation [NCIt concept]
- ARSA wt Allele [NCIt concept]
- ASAH1 Gene [NCIt concept]
- ASAH1 wt Allele [NCIt concept]
- ASAH2 Gene [NCIt concept]
- ASAH2 wt Allele [NCIt concept]
- ASAH2B Gene [NCIt concept]
- ASAH2B wt Allele [NCIt concept]
- ASAH2C Gene [NCIt concept]
- ASAH2C wt Allele [NCIt concept]
- ASAP1 Gene [NCIt concept]
- ASAP1 wt Allele [NCIt concept]
- ASCL1 Gene [NCIt concept]
- ASCL1 wt Allele [NCIt concept]
- ASIC2 Gene [NCIt concept]
- ASIC2 wt Allele [NCIt concept]
- ASNS Gene [NCIt concept]
- ASNS wt Allele [NCIt concept]
- ASPH Gene [NCIt concept]
- ASPH Positive [NCIt concept]
- ASPH wt Allele [NCIt concept]
- ASPH-Positive Head and Neck Squamous Cell Carcinoma [NCIt concept]
- ASPH-Positive Neoplastic Cells Present [NCIt concept]
- ASPM Gene [NCIt concept]
- ASPM wt Allele [NCIt concept]
- ASPSCR1 Gene [NCIt concept]
- ASPSCR1 wt Allele [NCIt concept]
- ASPSCR1/TFE3 Fusion Gene [NCIt concept]
- ASPSCR1/TFE3 Fusion Protein [NCIt concept]
- ASS1 Gene [NCIt concept]
- ASS1 Gene Deficiency [NCIt concept]
- ASS1 wt Allele [NCIt concept]
- ASXL1 Gene [NCIt concept]
- ASXL1 Gene Mutation [NCIt concept]
- ASXL1 wt Allele [NCIt concept]
- AT-Rich Interactive Domain-Containing Protein 1A [NCIt concept]
- AT-Rich Interactive Domain-Containing Protein 1B [NCIt concept]
- AT-Rich Interactive Domain-Containing Protein 2 [NCIt concept]
- AT-Rich Interactive Domain-Containing Protein 5B [NCIt concept]
- ATAD1 Gene [NCIt concept]
- ATAD1 wt Allele [NCIt concept]
- ATAD5 Gene [NCIt concept]
- ATAD5 wt Allele [NCIt concept]
- ATF1 Gene [NCIt concept]
- ATF1 wt Allele [NCIt concept]
- ATF3 Gene [NCIt concept]
- ATF3 wt Allele [NCIt concept]
- ATF4 Gene [NCIt concept]
- ATF4 wt Allele [NCIt concept]
- ATF5 Gene [NCIt concept]
- ATF5 wt Allele [NCIt concept]
- ATF6 Gene [NCIt concept]
- ATF6 wt Allele [NCIt concept]
- ATG13 Gene [NCIt concept]
- ATG13 wt Allele [NCIt concept]
- ATG4C Gene [NCIt concept]
- ATG4C wt Allele [NCIt concept]
- ATG5 Gene [NCIt concept]
- ATG5 wt Allele [NCIt concept]
- ATG7 Gene [NCIt concept]
- ATG7 wt Allele [NCIt concept]
- ATIC Gene [NCIt concept]
- ATIC wt Allele [NCIt concept]
- ATM Biallelic Inactivation [NCIt concept]
- ATM Deficient Tumor [NCIt concept]
- ATM Gene [NCIt concept]
- ATM Gene Deletion [NCIt concept]
- ATM Gene Mutation [NCIt concept]
- ATM Gene Mutation Negative [NCIt concept]
- ATM Inhibitor M 3541 [NCIt concept]
- ATM Kinase Inhibitor AZD1390 [NCIt concept]
- ATM Kinase Inhibitor WSD-0628 [NCIt concept]
- ATM Kinase/DNA-PK Inhibitor XRD-0394 [NCIt concept]
- ATM Monoallelic Inactivation [NCIt concept]
- ATM Proficient Tumor [NCIt concept]
- ATM Protein Variant [NCIt concept]
- ATM wt Allele [NCIt concept]
- ATOH1 Gene [NCIt concept]
- ATOH1 wt Allele [NCIt concept]
- ATP Synthase Subunit Beta, Mitochondrial [NCIt concept]
- ATP Synthase Subunit Epsilon, Mitochondrial [NCIt concept]
- ATP-Binding Cassette Sub-Family B Member 5 [NCIt concept]
- ATP-Binding Cassette Sub-Family D Member 1 [NCIt concept]
- ATP-Binding Cassette Sub-Family F Member 2 [NCIt concept]
- ATP-Binding Cassette Sub-Family G Member 1 [NCIt concept]
- ATP-Citrate Synthase [NCIt concept]
- ATP-Dependent Clp Protease Proteolytic Subunit, Mitochondrial [NCIt concept]
- ATP-Dependent DNA Helicase Q1 [NCIt concept]
- ATP-Dependent DNA Helicase Q4 [NCIt concept]
- ATP-Dependent RNA Helicase A [NCIt concept]
- ATP-Dependent RNA Helicase DDX1 [NCIt concept]
- ATP-Dependent RNA Helicase DDX3X [NCIt concept]
- ATP1A1 Gene [NCIt concept]
- ATP1A1 wt Allele [NCIt concept]
- ATP1A2 Gene [NCIt concept]
- ATP1A2 wt Allele [NCIt concept]
- ATP1A3 Gene [NCIt concept]
- ATP1A3 wt Allele [NCIt concept]
- ATP2B3 Gene [NCIt concept]
- ATP2B3 wt Allele [NCIt concept]
- ATP5F1B Gene [NCIt concept]
- ATP5F1B wt Allele [NCIt concept]
- ATP5F1E Gene [NCIt concept]
- ATP5F1E wt Allele [NCIt concept]
- ATP6AP1 Gene [NCIt concept]
- ATP6AP1 wt Allele [NCIt concept]
- ATP7A Gene [NCIt concept]
- ATP7A wt Allele [NCIt concept]
- ATP8B2 Gene [NCIt concept]
- ATP8B2 wt Allele [NCIt concept]
- ATPase Family AAA Domain-Containing Protein 5 [NCIt concept]
- ATPase WRNIP1 [NCIt concept]
- ATR Gene [NCIt concept]
- ATR Gene Mutation [NCIt concept]
- ATR Inhibitor [NCIt concept]
- ATR Inhibitor ATRN-119 [NCIt concept]
- ATR Inhibitor IMP9064 [NCIt concept]
- ATR wt Allele [NCIt concept]
- ATRN Gene [NCIt concept]
- ATRN wt Allele [NCIt concept]
- ATRX Gene [NCIt concept]
- ATRX Gene Mutation [NCIt concept]
- ATRX Gene Mutation Negative [NCIt concept]
- ATRX Negative [NCIt concept]
- ATRX wt Allele [NCIt concept]
- ATTR Amyloidosis [NCIt concept]
- ATXN1 Gene [NCIt concept]
- ATXN1 wt Allele [NCIt concept]
- AURKA Gene [NCIt concept]
- AURKA wt Allele [NCIt concept]
- AURKB Gene [NCIt concept]
- AURKB wt Allele [NCIt concept]
- AURKC Gene [NCIt concept]
- AURKC wt Allele [NCIt concept]
- AVATAR [NCIt concept]
- AVPR2 Gene [NCIt concept]
- AVPR2 wt Allele [NCIt concept]
- AXIN1 Gene [NCIt concept]
- AXIN1 Gene Mutation [NCIt concept]
- AXIN1 wt Allele [NCIt concept]
- AXIN2 Gene [NCIt concept]
- AXIN2 Gene Mutation [NCIt concept]
- AXIN2 wt Allele [NCIt concept]
- AXL Gene [NCIt concept]
- AXL Gene Alteration Positive [NCIt concept]
- AXL Gene Amplification [NCIt concept]
- AXL Gene Mutation [NCIt concept]
- AXL Inhibitor [NCIt concept]
- AXL Inhibitor AB801 [NCIt concept]
- AXL Inhibitor DS-1205c [NCIt concept]
- AXL Inhibitor SLC-391 [NCIt concept]
- AXL Overexpression Positive [NCIt concept]
- AXL wt Allele [NCIt concept]
- AYA NA-SB Questionnaire [NCIt concept]
- Abacavir [NCIt concept]
- Abagovomab [NCIt concept]
- Abarelix [NCIt concept]
- Abatacept [NCIt concept]
- Abbreviated Breast MRI Protocol [NCIt concept]
- Abbreviated Magnetic Resonance Imaging [NCIt concept]
- Abdominal Neoplasm, Excluding Pancreas Neoplasm [NCIt concept]
- Abdominal Radiation Therapy [NCIt concept]
- Abdominal Rhabdomyosarcoma [NCIt concept]
- Abdominal Sarcoma [NCIt concept]
- Abdominal Surgery Patient [NCIt concept]
- Abdominal Surgical Procedure [NCIt concept]
- Abdominal Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Abelacimab [NCIt concept]
- Aberrant DNA Methylation of MGMT Gene [NCIt concept]
- Aberrant HOXA Family Gene Expression [NCIt concept]
- Abexinostat [NCIt concept]
- Abexinostat Tosylate [NCIt concept]
- Abipapogene Suvaplasmid [NCIt concept]
- Abiraterone [NCIt concept]
- Abiraterone Acetate [NCIt concept]
- Abiraterone Acetate/Niraparib [NCIt concept]
- Abiraterone Decanoate Depot [NCIt concept]
- Abiraterone/Prednisone Regimen [NCIt concept]
- Abituzumab [NCIt concept]
- Abivertinib [NCIt concept]
- Ablation Therapy [NCIt concept]
- Abnormal DNA Repair [NCIt concept]
- Abnormal PAP Smear [NCIt concept]
- Abnormal Spindle-Like Microcephaly-Associated Protein [NCIt concept]
- Absence of Biallelic TCRgamma Deletion [NCIt concept]
- Absence of MYCN Gene Amplification [NCIt concept]
- Absolute Activated T Lymphocyte Count [NCIt concept]
- Absolute Blood Lymphocyte Count [NCIt concept]
- Absolute Neutrophil Count 500/mm3 [NCIt concept]
- Absolute Neutrophil Count Greater than 2.0x10^9/L [NCIt concept]
- Absolute Neutrophil Count Greater than or Equal to 100/mm3 [NCIt concept]
- Absolute Neutrophil Count Greater than or Equal to 1000/mm3 [NCIt concept]
- Absolute Neutrophil Count Greater than or Equal to 500/mm3 [NCIt concept]
- Absolute Reticulocyte Count [NCIt concept]
- Absolute T Lymphocyte Count [NCIt concept]
- Absorbable Fibrin Sealant Patch [NCIt concept]
- Absorbable Gelatin Sponge [NCIt concept]
- Acalabrutinib [NCIt concept]
- Acalabrutinib Maleate Monohydrate [NCIt concept]
- Acasunlimab [NCIt concept]
- Acazicolcept [NCIt concept]
- Accelerated Hypofractionated Radiation Therapy [NCIt concept]
- Accelerated Partial Breast Irradiation [NCIt concept]
- Accelerated Phase [NCIt concept]
- Accelerated Phase Primary Myelofibrosis [NCIt concept]
- Accelerated Radiation Therapy [NCIt concept]
- Accelerometer [NCIt concept]
- Accelerometry [NCIt concept]
- Acceptance and Commitment Therapy [NCIt concept]
- Acellular Cadaveric Dermal Matrix [NCIt concept]
- Acellular Dermal Matrix [NCIt concept]
- Acetaminophen [NCIt concept]
- Acetaminophen-Cysteine Protein Adduct [NCIt concept]
- Acetazolamide [NCIt concept]
- Acetazolamide Sodium [NCIt concept]
- Acetoacetic Acid Measurement [NCIt concept]
- Acetyl-CoA Carboxylase 1 [NCIt concept]
- Acetyl-Coenzyme A Synthetase, Cytoplasmic [NCIt concept]
- Acetyl-L-Carnitine Hydrochloride [NCIt concept]
- Acetylcholinesterase [NCIt concept]
- Acetylcysteine [NCIt concept]
- AchR Autoantibody [NCIt concept]
- Achaete-Scute Homolog 1 [NCIt concept]
- Acid Ceramidase [NCIt concept]
- Acid Phosphatase [NCIt concept]
- Acid-Sensing Ion Channel 2 [NCIt concept]
- Acimtamig [NCIt concept]
- Acinar Cell Carcinoma [NCIt concept]
- Acinterferon Alfa [NCIt concept]
- Acolbifene Hydrochloride [NCIt concept]
- Acoramidis [NCIt concept]
- Acoustic Angiography [NCIt concept]
- Acoustic Radiation Force Impulse Imaging [NCIt concept]
- Acquired Absence of Limb [NCIt concept]
- Acquired Amegakaryocytic Thrombocytopenia [NCIt concept]
- Acral Lentiginous Melanoma [NCIt concept]
- Acromegaly [NCIt concept]
- Acrylonitrile [NCIt concept]
- Actigraph [NCIt concept]
- Actigraphy [NCIt concept]
- Actin Nucleation-Promoting Factor WAS [NCIt concept]
- Actin, Aortic Smooth Muscle [NCIt concept]
- Actin, Cytoplasmic 1 [NCIt concept]
- Actinic Keratosis [NCIt concept]
- Actinium Ac 225 FPI-2059 [NCIt concept]
- Actinium Ac 225 FPI-2068 [NCIt concept]
- Actinium Ac 225 GPC3-targeted Peptide RYZ801 [NCIt concept]
- Actinium Ac 225 PSMA-R2 [NCIt concept]
- Actinium Ac 225 Rosopatamab Tetraxetan [NCIt concept]
- Actinium Ac 225 Satoreotide Tetraxetan [NCIt concept]
- Actinium Ac 225 Vofatamab [NCIt concept]
- Actinium Ac 225 Zadavotide Guraxetan [NCIt concept]
- Actinium Ac 225-ABD147 [NCIt concept]
- Actinium Ac 225-DOTA-Daratumumab [NCIt concept]
- Actinium Ac 225-DOTA-MTI-201 [NCIt concept]
- Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Actinium Ac 225-DOTA-h11B6 JNJ-69086420 [NCIt concept]
- Actinium Ac 225-FL-020 [NCIt concept]
- Actinium Ac 225-FPI-1434 [NCIt concept]
- Actinium Ac-225 [NCIt concept]
- Action Research Arm Test [NCIt concept]
- Activated B-Cell Positive [NCIt concept]
- Activated Caspase-3 [NCIt concept]
- Activated Caspase-9 [NCIt concept]
- Activated Charcoal [NCIt concept]
- Activated Marrow Infiltrating Lymphocytes [NCIt concept]
- Activated PI3K-Positive Cells Present [NCIt concept]
- Activated Polyethylene Glycol/Polyethyleneimine-based Surgical Sealant [NCIt concept]
- Activating AKT1 Gene Mutation [NCIt concept]
- Activating AKT2 Gene Mutation [NCIt concept]
- Activating AKT3 Gene Mutation [NCIt concept]
- Activating ALK Gene Mutation [NCIt concept]
- Activating ALK Gene Mutation Negative [NCIt concept]
- Activating AXL Gene Mutation [NCIt concept]
- Activating BRAF Mutation [NCIt concept]
- Activating BRAF NP_004324.2:p.V600X [NCIt concept]
- Activating CBL Gene Mutation [NCIt concept]
- Activating CD79A Gene Mutation [NCIt concept]
- Activating CD79B Gene Mutation [NCIt concept]
- Activating EGFR Exon 18 Mutation [NCIt concept]
- Activating EGFR Exon 19 Deletion Mutation [NCIt concept]
- Activating EGFR Exon 19 Mutation [NCIt concept]
- Activating EGFR Exon 20 Mutation [NCIt concept]
- Activating EGFR Exon 21 Mutation [NCIt concept]
- Activating EGFR Gene Mutation [NCIt concept]
- Activating EGFR Gene Mutation Negative [NCIt concept]
- Activating EML4/ALK Gene Mutation [NCIt concept]
- Activating ERBB2 Mutation [NCIt concept]
- Activating ERBB2 Point Mutation [NCIt concept]
- Activating ERBB3 Mutation [NCIt concept]
- Activating ERK Family Gene Mutation [NCIt concept]
- Activating ESR1 Gene Mutation [NCIt concept]
- Activating EZH2 Gene Mutation [NCIt concept]
- Activating FGFR Gene Mutation [NCIt concept]
- Activating FGFR1 Gene Mutation [NCIt concept]
- Activating FGFR2 Gene Mutation [NCIt concept]
- Activating FGFR3 Gene Mutation [NCIt concept]
- Activating FGFR4 Gene Mutation [NCIt concept]
- Activating FLT1 Gene Mutation [NCIt concept]
- Activating FLT3 Gene Mutation [NCIt concept]
- Activating FLT4 Gene Mutation [NCIt concept]
- Activating FOXR2 Gene Mutation [NCIt concept]
- Activating GNA11 Gene Mutation [NCIt concept]
- Activating GNAQ Gene Mutation [NCIt concept]
- Activating GSK3B Gene Mutation [NCIt concept]
- Activating HRAS Mutation [NCIt concept]
- Activating Histone Family Gene Mutation [NCIt concept]
- Activating IRAK1 Gene Mutation [NCIt concept]
- Activating JAK1 Gene Mutation [NCIt concept]
- Activating JAK2 Gene Mutation [NCIt concept]
- Activating JAK3 Gene Mutation [NCIt concept]
- Activating KDR Gene Mutation [NCIt concept]
- Activating KIT Gene Mutation [NCIt concept]
- Activating KRAS Exon 2 Mutation [NCIt concept]
- Activating KRAS Exon 3 Mutation [NCIt concept]
- Activating KRAS Exon 4 Mutation [NCIt concept]
- Activating KRAS Gene Mutation Negative [NCIt concept]
- Activating LGR5 Gene Mutation [NCIt concept]
- Activating LRP6 Gene Mutation [NCIt concept]
- Activating MAP2K1 Gene Mutation [NCIt concept]
- Activating MAP2K2 Gene Mutation [NCIt concept]
- Activating MET Exon 14 Gene Mutation [NCIt concept]
- Activating MET Exon 14 Skipping Mutation [NCIt concept]
- Activating MET Gene Mutation [NCIt concept]
- Activating MTOR Gene Mutation [NCIt concept]
- Activating MYD88 Gene Mutation [NCIt concept]
- Activating NOTCH1 Mutation [NCIt concept]
- Activating NOTCH2 Mutation [NCIt concept]
- Activating NOTCH3 Mutation [NCIt concept]
- Activating NOTCH4 Mutation [NCIt concept]
- Activating NRAS Mutation [NCIt concept]
- Activating NTRK Family Fusion Gene Mutation [NCIt concept]
- Activating NTRK Family Gene Mutation [NCIt concept]
- Activating NTRK Family Point Mutation [NCIt concept]
- Activating NTRK2 Gene Mutation [NCIt concept]
- Activating Non-V600 BRAF Mutation [NCIt concept]
- Activating PI3K Gene Mutation [NCIt concept]
- Activating PIK3CA Gene Mutation [NCIt concept]
- Activating PIK3CB Gene Mutation [NCIt concept]
- Activating PIK3R1 Gene Mutation [NCIt concept]
- Activating PIK3R2 Gene Mutation [NCIt concept]
- Activating PPM1D Gene Mutation [NCIt concept]
- Activating PTEN Gene Mutation [NCIt concept]
- Activating PTPN11 Gene Mutation [NCIt concept]
- Activating RAF Family Alteration Positive [NCIt concept]
- Activating RAF Family Gene Fusion Positive [NCIt concept]
- Activating RAF Mutation [NCIt concept]
- Activating RAS Mutation [NCIt concept]
- Activating RAS Q61X [NCIt concept]
- Activating RET Gene Fusion Mutation Positive [NCIt concept]
- Activating RET Gene Mutation [NCIt concept]
- Activating ROS1 Gene Mutation [NCIt concept]
- Activating ROS1 Gene Mutation Negative [NCIt concept]
- Activating STAT3 Gene Mutation [NCIt concept]
- Activating STAT5B Gene Mutation [NCIt concept]
- Activating STAT6 Gene Mutation [NCIt concept]
- Activating TEK Gene Mutation [NCIt concept]
- Activating TYK2 Gene Mutation [NCIt concept]
- Activating WNT Pathway Gene Mutation Positive [NCIt concept]
- Activating XPO1 Gene Mutation [NCIt concept]
- Activator of Apoptosis Harakiri [NCIt concept]
- Active Breathing Control [NCIt concept]
- Active Breathing Coordinator-Mediated Radiation Therapy [NCIt concept]
- Active Comparator Drug [NCIt concept]
- Activin Receptor Type-1 [NCIt concept]
- Activin Receptor Type-1B [NCIt concept]
- Activin Receptor Type-2A [NCIt concept]
- Activin Type 2B Receptor Fc Fusion Protein STM 434 [NCIt concept]
- Activity Monitor [NCIt concept]
- Acupressure Therapy [NCIt concept]
- Acupuncture Point Injection [NCIt concept]
- Acupuncture Therapy [NCIt concept]
- Acute Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Acute Bilineal Leukemia [NCIt concept]
- Acute Bilineal Leukemia in Remission [NCIt concept]
- Acute Biphenotypic Leukemia [NCIt concept]
- Acute Erythroid Leukemia [NCIt concept]
- Acute Leukemia [NCIt concept]
- Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Acute Lymphoblastic Leukemia [NCIt concept]
- Acute Megakaryoblastic Leukemia [NCIt concept]
- Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 [NCIt concept]
- Acute Myeloid Leukemia [NCIt concept]
- Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Chronic Myelomonocytic Leukemia [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged [NCIt concept]
- Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia [NCIt concept]
- Acute Myeloid Leukemia with FLT3/ITD Mutation [NCIt concept]
- Acute Myeloid Leukemia with KMT2A Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with Trisomy 8 [NCIt concept]
- Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A [NCIt concept]
- Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 [NCIt concept]
- Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Acute Normovolemic Hemodilution [NCIt concept]
- Acute Pancreatitis [NCIt concept]
- Acute Panmyelosis with Myelofibrosis [NCIt concept]
- Acute Promyelocytic Leukemia in Remission [NCIt concept]
- Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Acute Radiation Skin Toxicity [NCIt concept]
- Acute Respiratory Distress Syndrome [NCIt concept]
- Acute Stress Disorder [NCIt concept]
- Acute Undifferentiated Leukemia [NCIt concept]
- Acyclovir [NCIt concept]
- Acyclovir Sodium [NCIt concept]
- Acyl-CoA-Binding Domain-Containing Protein 6 [NCIt concept]
- Acyl-Protein Thioesterase 1 [NCIt concept]
- Acylation Stimulating Protein [NCIt concept]
- Acylfulvene-derived Prodrug LP-184 [NCIt concept]
- Ad-RTS-hIL-12 [NCIt concept]
- Ad-hCMV-Flt3L [NCIt concept]
- Ad-hCMV-TK [NCIt concept]
- Ad5-CMV-NIS [NCIt concept]
- Ad5-SGE-REIC/Dkk-3 MTG-201 [NCIt concept]
- Ad5-survivin-transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Ad5-yCD/mutTK(SR39)rep-ADP [NCIt concept]
- Ad5.SSTR/TK.RGD [NCIt concept]
- AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992 [NCIt concept]
- AdGMCAIX-transduced Autologous Dendritic Cells [NCIt concept]
- AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine [NCIt concept]
- Adagloxad Simolenin [NCIt concept]
- Adagrasib [NCIt concept]
- Adakitug [NCIt concept]
- Adalimumab [NCIt concept]
- Adavosertib [NCIt concept]
- Adenine DNA Glycosylase [NCIt concept]
- Adeno-associated Virus Encoding Anti-CD19/Anti-CD3 Bispecific Diabody VNX-101 [NCIt concept]
- Adenocarcinoma [NCIt concept]
- Adenocarcinoma In Situ in Tubulovillous Adenoma [NCIt concept]
- Adenocarcinoma of Unknown Primary [NCIt concept]
- Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Adenomatous Polyp [NCIt concept]
- Adenomatous Polyposis Coli Protein [NCIt concept]
- Adenosarcoma [NCIt concept]
- Adenosine 3'-phospho 5'-phosphosulfate Transporter 1 [NCIt concept]
- Adenosine A2A Receptor Antagonist [NCIt concept]
- Adenosine A2A Receptor Antagonist DZD2269 [NCIt concept]
- Adenosine A2A Receptor Antagonist JNJ-86974680 [NCIt concept]
- Adenosine A2A Receptor Antagonist NIR178 [NCIt concept]
- Adenosine A2A Receptor Antagonist TT-10 [NCIt concept]
- Adenosine A2B Receptor Antagonist PBF-1129 [NCIt concept]
- Adenosine Axis Inhibitor [NCIt concept]
- Adenosine Deaminase [NCIt concept]
- Adenosine Deaminase 2 [NCIt concept]
- Adenosine Deaminase 2 Deficiency [NCIt concept]
- Adenosine Receptor A2a [NCIt concept]
- Adenosine Receptor A2b [NCIt concept]
- Adenosine Triphosphate Level Finding [NCIt concept]
- Adenosylhomocysteinase [NCIt concept]
- Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 [NCIt concept]
- Adenoviral Brachyury Vaccine ETBX-051 [NCIt concept]
- Adenoviral Cancer Vaccine PF-06936308 [NCIt concept]
- Adenoviral MUC1 Vaccine ETBX-061 [NCIt concept]
- Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001 [NCIt concept]
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP [NCIt concept]
- Adenoviral Vector Ad5-CEA(6D) Vaccine [NCIt concept]
- Adenoviridae [NCIt concept]
- Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine [NCIt concept]
- Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE [NCIt concept]
- Adenovirus Antibody [NCIt concept]
- Adenovirus DNA Viremia [NCIt concept]
- Adenovirus Encoding Human Aquaporin-1 [NCIt concept]
- Adenovirus Encoding Recombinant Human Endostatin [NCIt concept]
- Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Adenovirus Expressing Mutant HPV E6/E7 [NCIt concept]
- Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Adenovirus Infection [NCIt concept]
- Adenovirus Positive [NCIt concept]
- Adenovirus RSV-TK [NCIt concept]
- Adenovirus Reactivation [NCIt concept]
- Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918 [NCIt concept]
- Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 [NCIt concept]
- Adenovirus Serotype 5-based Therapeutic Agent [NCIt concept]
- Adenovirus Type 5 Antibody [NCIt concept]
- Adenovirus-Encoding E.coli PNP [NCIt concept]
- Adenovirus-PSA Prostate Cancer Vaccine [NCIt concept]
- Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001 [NCIt concept]
- Adenovirus-p53 Transduced Dendritic Cell Vaccine [NCIt concept]
- Adenovirus/Cytomegalovirus/Epstein-Barr Virus-specific Allogeneic Cytotoxic T Lymphocytes [NCIt concept]
- Aderbasib [NCIt concept]
- Adhesion G Protein-Coupled Receptor E1 [NCIt concept]
- Adhesion G Protein-Coupled Receptor E2 [NCIt concept]
- Adhesion G Protein-Coupled Receptor F1 [NCIt concept]
- Adipokine [NCIt concept]
- Adiponectin [NCIt concept]
- Adiponectin Measurement [NCIt concept]
- Adiponectin Receptor Protein 1 [NCIt concept]
- Adiponectin Receptor Protein 2 [NCIt concept]
- Adjustment Disorder [NCIt concept]
- Adjuvant Radiation Therapy [NCIt concept]
- Adjuvant Therapy [NCIt concept]
- Adoptive Cell Therapy Agent [NCIt concept]
- Adoptive Immunotherapy [NCIt concept]
- Adoptive T-cell Immunotherapy [NCIt concept]
- Adrenal Cortical Carcinoma [NCIt concept]
- Adrenal Cortical Low Grade Carcinoma [NCIt concept]
- Adrenal Cortical Sarcomatoid Carcinoma [NCIt concept]
- Adrenal Gland Pheochromocytoma [NCIt concept]
- Adrenal Gland Sarcoma [NCIt concept]
- Adrenal-Permissive HSD3B1 Genotype [NCIt concept]
- Adrenal-Restrictive HSD3B1 Genotype [NCIt concept]
- Adrenalectomy [NCIt concept]
- Adrenergic Receptor [NCIt concept]
- Adrenocortical Dysplasia Protein Homolog [NCIt concept]
- Adrenoleukodystrophy [NCIt concept]
- Adrixetinib [NCIt concept]
- Adult Acute Basophilic Leukemia [NCIt concept]
- Adult Acute Eosinophilic Leukemia [NCIt concept]
- Adult Acute Erythroid Leukemia [NCIt concept]
- Adult Acute Leukemia in Remission [NCIt concept]
- Adult Acute Lymphoblastic Leukemia [NCIt concept]
- Adult Acute Lymphoblastic Leukemia in Complete Remission [NCIt concept]
- Adult Acute Lymphoblastic Leukemia in Partial Remission [NCIt concept]
- Adult Acute Lymphoblastic Leukemia in Remission [NCIt concept]
- Adult Acute Megakaryoblastic Leukemia [NCIt concept]
- Adult Acute Monoblastic Leukemia [NCIt concept]
- Adult Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Adult Acute Monocytic Leukemia [NCIt concept]
- Adult Acute Myeloid Leukemia [NCIt concept]
- Adult Acute Myeloid Leukemia in Remission [NCIt concept]
- Adult Acute Myeloid Leukemia with Maturation [NCIt concept]
- Adult Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities [NCIt concept]
- Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 [NCIt concept]
- Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Adult Acute Myeloid Leukemia without Maturation [NCIt concept]
- Adult Acute Myelomonocytic Leukemia [NCIt concept]
- Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Adult Alveolar Soft Part Sarcoma [NCIt concept]
- Adult Anaplastic (Malignant) Meningioma [NCIt concept]
- Adult Anaplastic Astrocytoma [NCIt concept]
- Adult Anaplastic Ependymoma [NCIt concept]
- Adult Anaplastic Large Cell Lymphoma [NCIt concept]
- Adult Anaplastic Oligodendroglioma [NCIt concept]
- Adult Angiosarcoma [NCIt concept]
- Adult Astrocytic Tumor [NCIt concept]
- Adult Atypical Meningioma [NCIt concept]
- Adult B Acute Lymphoblastic Leukemia [NCIt concept]
- Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Adult B Lymphoblastic Lymphoma [NCIt concept]
- Adult Brain Ependymoma [NCIt concept]
- Adult Brain Glioblastoma [NCIt concept]
- Adult Brain Neoplasm [NCIt concept]
- Adult Brain Oligodendroglioma [NCIt concept]
- Adult Brain Stem Glioma [NCIt concept]
- Adult Burkitt Leukemia [NCIt concept]
- Adult Burkitt Lymphoma [NCIt concept]
- Adult Central Nervous System Choriocarcinoma [NCIt concept]
- Adult Central Nervous System Embryonal Carcinoma [NCIt concept]
- Adult Central Nervous System Germ Cell Tumor [NCIt concept]
- Adult Central Nervous System Germinoma [NCIt concept]
- Adult Central Nervous System Melanocytic Neoplasm [NCIt concept]
- Adult Central Nervous System Mixed Germ Cell Tumor [NCIt concept]
- Adult Central Nervous System Neoplasm [NCIt concept]
- Adult Central Nervous System Solitary Fibrous Tumor, Grade 3 [NCIt concept]
- Adult Central Nervous System Teratoma [NCIt concept]
- Adult Cholangiocarcinoma [NCIt concept]
- Adult Choroid Plexus Neoplasm [NCIt concept]
- Adult Classic Hodgkin Lymphoma [NCIt concept]
- Adult Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Adult Craniopharyngioma [NCIt concept]
- Adult Cystic Nephroma [NCIt concept]
- Adult Desmoplastic Small Round Cell Tumor [NCIt concept]
- Adult Diffuse Astrocytoma [NCIt concept]
- Adult Diffuse Large B-Cell Lymphoma [NCIt concept]
- Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered [NCIt concept]
- Adult Ependymal Tumor [NCIt concept]
- Adult Ependymoma [NCIt concept]
- Adult Epithelioid Hemangioendothelioma [NCIt concept]
- Adult Epithelioid Sarcoma [NCIt concept]
- Adult Erythroleukemia [NCIt concept]
- Adult Extraskeletal Myxoid Chondrosarcoma [NCIt concept]
- Adult Extraskeletal Osteosarcoma [NCIt concept]
- Adult Favorable Prognosis Hodgkin Lymphoma [NCIt concept]
- Adult Fibrolamellar Carcinoma [NCIt concept]
- Adult Fibrosarcoma [NCIt concept]
- Adult Germ Cell Tumor [NCIt concept]
- Adult Giant Cell Glioblastoma [NCIt concept]
- Adult Glioblastoma [NCIt concept]
- Adult Gliosarcoma [NCIt concept]
- Adult Grade 1 Meningioma [NCIt concept]
- Adult Grade 2 Meningioma [NCIt concept]
- Adult Grade 3 Meningioma [NCIt concept]
- Adult Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Adult Hepatocellular Carcinoma [NCIt concept]
- Adult Hepatocellular Pleomorphic Carcinoma [NCIt concept]
- Adult Hodgkin Lymphoma [NCIt concept]
- Adult Immunoblastic Lymphoma [NCIt concept]
- Adult Intracranial Germ Cell Tumor [NCIt concept]
- Adult L1 Acute Lymphoblastic Leukemia [NCIt concept]
- Adult L2 Acute Lymphoblastic Leukemia [NCIt concept]
- Adult Langerhans Cell Histiocytosis [NCIt concept]
- Adult Leiomyosarcoma [NCIt concept]
- Adult Liposarcoma [NCIt concept]
- Adult Liver Carcinoma [NCIt concept]
- Adult Lymphoblastic Lymphoma [NCIt concept]
- Adult Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Adult Lymphocyte-Rich Classic Hodgkin Lymphoma [NCIt concept]
- Adult Lymphoma [NCIt concept]
- Adult Malignant Brain Neoplasm [NCIt concept]
- Adult Malignant Mesenchymoma [NCIt concept]
- Adult Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Adult Medulloblastoma [NCIt concept]
- Adult Meningioma [NCIt concept]
- Adult Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Adult Mixed Glioma [NCIt concept]
- Adult Myelodysplastic Syndrome [NCIt concept]
- Adult Myxopapillary Ependymoma [NCIt concept]
- Adult Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Adult Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Adult Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Adult Non-Hodgkin Lymphoma [NCIt concept]
- Adult Non-T Non-B Acute Lymphoblastic Leukemia [NCIt concept]
- Adult Oligodendroglial Tumor [NCIt concept]
- Adult Oligodendroglioma [NCIt concept]
- Adult Ovarian Granulosa Cell Tumor [NCIt concept]
- Adult Papillary Meningioma [NCIt concept]
- Adult Penile Carcinoma [NCIt concept]
- Adult Pilocytic Astrocytoma [NCIt concept]
- Adult Pineal Gland Astrocytoma [NCIt concept]
- Adult Pineal Parenchymal Cell Neoplasm [NCIt concept]
- Adult Pineoblastoma [NCIt concept]
- Adult Pineocytoma [NCIt concept]
- Adult Pre-B Acute Lymphoblastic Leukemia [NCIt concept]
- Adult Primary Cutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Adult Pure Erythroid Leukemia [NCIt concept]
- Adult Rhabdomyosarcoma [NCIt concept]
- Adult Soft Tissue Sarcoma [NCIt concept]
- Adult Solid Neoplasm [NCIt concept]
- Adult Spinal Cord Ependymoma [NCIt concept]
- Adult Spinal Cord Neoplasm [NCIt concept]
- Adult Subependymal Giant Cell Astrocytoma [NCIt concept]
- Adult Subependymoma [NCIt concept]
- Adult Supratentorial Embryonal Tumor, Not Otherwise Specified [NCIt concept]
- Adult Synovial Sarcoma [NCIt concept]
- Adult Systemic Anaplastic Large Cell Lymphoma [NCIt concept]
- Adult T Acute Lymphoblastic Leukemia [NCIt concept]
- Adult T Lymphoblastic Lymphoma [NCIt concept]
- Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Adult TdT Negative Acute Lymphoblastic Leukemia [NCIt concept]
- Adult TdT Positive Acute Lymphoblastic Leukemia [NCIt concept]
- Adult Teratoma [NCIt concept]
- Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Adult Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Adult Unfavorable Prognosis Hodgkin Lymphoma [NCIt concept]
- Adult Yolk Sac Tumor [NCIt concept]
- Advance Care Planning [NCIt concept]
- Advanced Acral Melanoma [NCIt concept]
- Advanced Adenocarcinoma [NCIt concept]
- Advanced Adenoid Cystic Carcinoma [NCIt concept]
- Advanced Adnexal Carcinoma [NCIt concept]
- Advanced Adrenal Cortical Carcinoma [NCIt concept]
- Advanced Adrenal Gland Pheochromocytoma [NCIt concept]
- Advanced Adult Hepatocellular Carcinoma [NCIt concept]
- Advanced Alveolar Soft Part Sarcoma [NCIt concept]
- Advanced Ampulla of Vater Carcinoma [NCIt concept]
- Advanced Anal Canal Squamous Cell Carcinoma [NCIt concept]
- Advanced Anal Carcinoma [NCIt concept]
- Advanced Anal Squamous Cell Carcinoma [NCIt concept]
- Advanced Anaplastic Large Cell Lymphoma [NCIt concept]
- Advanced Angiosarcoma [NCIt concept]
- Advanced Appendix Adenocarcinoma [NCIt concept]
- Advanced B-Cell Malignant Neoplasm [NCIt concept]
- Advanced B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Advanced Basal Cell Carcinoma [NCIt concept]
- Advanced Bladder Carcinoma [NCIt concept]
- Advanced Bladder Urothelial Carcinoma [NCIt concept]
- Advanced Breast Adenocarcinoma [NCIt concept]
- Advanced Breast Carcinoma [NCIt concept]
- Advanced Breast Lobular Carcinoma [NCIt concept]
- Advanced Bronchogenic Carcinoma [NCIt concept]
- Advanced Carcinoma [NCIt concept]
- Advanced Cervical Adenocarcinoma [NCIt concept]
- Advanced Cervical Adenosquamous Carcinoma [NCIt concept]
- Advanced Cervical Carcinoma [NCIt concept]
- Advanced Cervical Squamous Cell Carcinoma [NCIt concept]
- Advanced Childhood Malignant Solid Neoplasm [NCIt concept]
- Advanced Childhood Primary Malignant Brain Neoplasm [NCIt concept]
- Advanced Cholangiocarcinoma [NCIt concept]
- Advanced Chordoma [NCIt concept]
- Advanced Chromophobe Renal Cell Carcinoma [NCIt concept]
- Advanced Clear Cell Renal Cell Carcinoma [NCIt concept]
- Advanced Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Advanced Colon Adenocarcinoma [NCIt concept]
- Advanced Colon Carcinoma [NCIt concept]
- Advanced Colorectal Adenocarcinoma [NCIt concept]
- Advanced Colorectal Carcinoma [NCIt concept]
- Advanced Cutaneous Melanoma [NCIt concept]
- Advanced Cutaneous Melanoma of the Extremity [NCIt concept]
- Advanced Dedifferentiated Liposarcoma [NCIt concept]
- Advanced Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Advanced Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Advanced Diffuse Large B-Cell Lymphoma [NCIt concept]
- Advanced Digestive System Carcinoma [NCIt concept]
- Advanced Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Advanced Digestive System Neuroendocrine Tumor [NCIt concept]
- Advanced Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Advanced Digestive System Neuroendocrine Tumor G2 [NCIt concept]
- Advanced Distal Cholangiocarcinoma [NCIt concept]
- Advanced Endometrial Adenocarcinoma [NCIt concept]
- Advanced Endometrial Carcinoma [NCIt concept]
- Advanced Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Endometrial Serous Adenocarcinoma [NCIt concept]
- Advanced Endometrial Undifferentiated Carcinoma [NCIt concept]
- Advanced Ependymoma [NCIt concept]
- Advanced Epithelioid Hemangioendothelioma [NCIt concept]
- Advanced Epithelioid Mesothelioma [NCIt concept]
- Advanced Epithelioid Sarcoma [NCIt concept]
- Advanced Esophageal Adenocarcinoma [NCIt concept]
- Advanced Esophageal Carcinoma [NCIt concept]
- Advanced Esophageal Squamous Cell Carcinoma [NCIt concept]
- Advanced Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Advanced Extracranial Malignant Solid Neoplasm [NCIt concept]
- Advanced Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Advanced Extrahepatic Cholangiocarcinoma [NCIt concept]
- Advanced Extramammary Paget Disease [NCIt concept]
- Advanced Extrapulmonary Neuroendocrine Carcinoma [NCIt concept]
- Advanced Fallopian Tube Carcinoma [NCIt concept]
- Advanced Fallopian Tube Carcinosarcoma [NCIt concept]
- Advanced Fallopian Tube Clear Cell Adenocarcinoma [NCIt concept]
- Advanced Fallopian Tube Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Advanced Fibrolamellar Carcinoma [NCIt concept]
- Advanced Fibrosarcoma [NCIt concept]
- Advanced Follicular Lymphoma [NCIt concept]
- Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma [NCIt concept]
- Advanced Gallbladder Carcinoma [NCIt concept]
- Advanced Gastric Adenocarcinoma [NCIt concept]
- Advanced Gastric Carcinoma [NCIt concept]
- Advanced Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Advanced Gastrointestinal Stromal Tumor [NCIt concept]
- Advanced Glioblastoma [NCIt concept]
- Advanced Glioma [NCIt concept]
- Advanced Glycation End Product [NCIt concept]
- Advanced Glycosylation End Product-Specific Receptor [NCIt concept]
- Advanced HER2-Low Breast Carcinoma [NCIt concept]
- Advanced HER2-Negative Breast Carcinoma [NCIt concept]
- Advanced HER2-Positive Breast Carcinoma [NCIt concept]
- Advanced Head and Neck Carcinoma [NCIt concept]
- Advanced Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Advanced Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Advanced Hepatoblastoma [NCIt concept]
- Advanced Hepatocellular Carcinoma [NCIt concept]
- Advanced Hilar Cholangiocarcinoma [NCIt concept]
- Advanced Hodgkin Lymphoma [NCIt concept]
- Advanced Hormone Receptor-Negative Breast Carcinoma [NCIt concept]
- Advanced Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Advanced Human Papillomavirus-Related Malignant Neoplasm [NCIt concept]
- Advanced Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Advanced Intrahepatic Cholangiocarcinoma [NCIt concept]
- Advanced Kaposi Sarcoma [NCIt concept]
- Advanced Kidney Medullary Carcinoma [NCIt concept]
- Advanced Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Advanced Leiomyosarcoma [NCIt concept]
- Advanced Liver Carcinoma [NCIt concept]
- Advanced Liver Fibrosis [NCIt concept]
- Advanced Low Grade Glioma [NCIt concept]
- Advanced Lung Adenocarcinoma [NCIt concept]
- Advanced Lung Adenosquamous Carcinoma [NCIt concept]
- Advanced Lung Large Cell Carcinoma [NCIt concept]
- Advanced Lung Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Advanced Lung Neuroendocrine Neoplasm [NCIt concept]
- Advanced Lung Neuroendocrine Tumor [NCIt concept]
- Advanced Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Advanced Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Advanced Lung Small Cell Carcinoma [NCIt concept]
- Advanced Lung Squamous Cell Carcinoma [NCIt concept]
- Advanced Lymphoma [NCIt concept]
- Advanced Magnetic Resonance Imaging [NCIt concept]
- Advanced Malignant Abdominal Neoplasm [NCIt concept]
- Advanced Malignant Digestive System Neoplasm [NCIt concept]
- Advanced Malignant Female Reproductive System Neoplasm [NCIt concept]
- Advanced Malignant Genitourinary System Neoplasm [NCIt concept]
- Advanced Malignant Mesothelioma [NCIt concept]
- Advanced Malignant PEComa [NCIt concept]
- Advanced Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Advanced Malignant Skin Neoplasm [NCIt concept]
- Advanced Malignant Small Intestinal Neoplasm [NCIt concept]
- Advanced Malignant Solid Neoplasm [NCIt concept]
- Advanced Malignant Testicular Germ Cell Tumor [NCIt concept]
- Advanced Malignant Testicular Neoplasm [NCIt concept]
- Advanced Malignant Thoracic Neoplasm [NCIt concept]
- Advanced Malignant Thymoma [NCIt concept]
- Advanced Malignant Uterine Corpus Neoplasm [NCIt concept]
- Advanced Mantle Cell Lymphoma [NCIt concept]
- Advanced Marginal Zone Lymphoma [NCIt concept]
- Advanced Merkel Cell Carcinoma [NCIt concept]
- Advanced Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Advanced Microsatellite Stable Ovarian Carcinoma [NCIt concept]
- Advanced Mixed Neuroendocrine Non-Neuroendocrine Neoplasm [NCIt concept]
- Advanced Mucosal Melanoma [NCIt concept]
- Advanced Myxofibrosarcoma [NCIt concept]
- Advanced NUT Carcinoma [NCIt concept]
- Advanced Nasopharyngeal Carcinoma [NCIt concept]
- Advanced Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Advanced Neuroendocrine Carcinoma [NCIt concept]
- Advanced Neuroendocrine Neoplasm [NCIt concept]
- Advanced Neuroendocrine Tumor [NCIt concept]
- Advanced Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Advanced Oropharyngeal Carcinoma [NCIt concept]
- Advanced Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Advanced Osteosarcoma [NCIt concept]
- Advanced Ovarian Carcinoma [NCIt concept]
- Advanced Ovarian Carcinosarcoma [NCIt concept]
- Advanced Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Advanced Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Ovarian High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Advanced Ovarian Serous Adenocarcinoma [NCIt concept]
- Advanced Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Advanced Pancreatic Adenocarcinoma [NCIt concept]
- Advanced Pancreatic Adenosquamous Carcinoma [NCIt concept]
- Advanced Pancreatic Carcinoma [NCIt concept]
- Advanced Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Advanced Pancreatic Neuroendocrine Neoplasm [NCIt concept]
- Advanced Pancreatic Neuroendocrine Tumor [NCIt concept]
- Advanced Pancreatic Neuroendocrine Tumor G1 [NCIt concept]
- Advanced Pancreatic Neuroendocrine Tumor G2 [NCIt concept]
- Advanced Paraganglioma [NCIt concept]
- Advanced Penile Carcinoma [NCIt concept]
- Advanced Penile Squamous Cell Carcinoma [NCIt concept]
- Advanced Peritoneal Malignant Mesothelioma [NCIt concept]
- Advanced Pharyngeal Squamous Cell Carcinoma [NCIt concept]
- Advanced Phase Myeloproliferative Neoplasm [NCIt concept]
- Advanced Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Advanced Platinum-Resistant Fallopian Tube Carcinoma [NCIt concept]
- Advanced Platinum-Resistant Malignant Germ Cell Tumor [NCIt concept]
- Advanced Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Advanced Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Advanced Platinum-Resistant Primary Peritoneal Carcinoma [NCIt concept]
- Advanced Pleomorphic Liposarcoma [NCIt concept]
- Advanced Pleural Malignant Mesothelioma [NCIt concept]
- Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Advanced Primary Malignant Brain Neoplasm [NCIt concept]
- Advanced Primary Peritoneal Carcinoma [NCIt concept]
- Advanced Primary Peritoneal Carcinosarcoma [NCIt concept]
- Advanced Primary Peritoneal Clear Cell Adenocarcinoma [NCIt concept]
- Advanced Primary Peritoneal Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Advanced Progesterone Receptor-Positive Breast Carcinoma [NCIt concept]
- Advanced Prostate Adenocarcinoma [NCIt concept]
- Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Advanced Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Advanced Rare Malignant Solid Neoplasm [NCIt concept]
- Advanced Rectal Adenocarcinoma [NCIt concept]
- Advanced Rectal Squamous Cell Carcinoma [NCIt concept]
- Advanced Renal Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Advanced Renal Pelvis Carcinoma [NCIt concept]
- Advanced Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Advanced Rhabdoid Tumor [NCIt concept]
- Advanced Rhabdomyosarcoma [NCIt concept]
- Advanced Round Cell Liposarcoma [NCIt concept]
- Advanced Salivary Gland Carcinoma [NCIt concept]
- Advanced Sarcoma of the Extremity [NCIt concept]
- Advanced Sarcomatoid Renal Cell Carcinoma [NCIt concept]
- Advanced Sebaceous Carcinoma [NCIt concept]
- Advanced Skin Sarcoma [NCIt concept]
- Advanced Skin Squamous Cell Carcinoma [NCIt concept]
- Advanced Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Advanced Small Lymphocytic Lymphoma [NCIt concept]
- Advanced Soft Tissue Leiomyosarcoma [NCIt concept]
- Advanced Soft Tissue Sarcoma [NCIt concept]
- Advanced Squamous Cell Carcinoma [NCIt concept]
- Advanced Succinate Dehydrogenase-Deficient Renal Cell Carcinoma [NCIt concept]
- Advanced Thymus Carcinoma [NCIt concept]
- Advanced Thymus Neuroendocrine Neoplasm [NCIt concept]
- Advanced Thyroid Gland Anaplastic Carcinoma [NCIt concept]
- Advanced Thyroid Gland Carcinoma [NCIt concept]
- Advanced Thyroid Gland Medullary Carcinoma [NCIt concept]
- Advanced Transformed Non-Hodgkin Lymphoma [NCIt concept]
- Advanced Transitional Cell Carcinoma [NCIt concept]
- Advanced Triple-Negative Breast Carcinoma [NCIt concept]
- Advanced Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Advanced Unresectable Malignant Solid Neoplasm [NCIt concept]
- Advanced Ureter Urothelial Carcinoma [NCIt concept]
- Advanced Urethral Carcinoma [NCIt concept]
- Advanced Urethral Urothelial Carcinoma [NCIt concept]
- Advanced Urothelial Carcinoma [NCIt concept]
- Advanced Uterine Corpus Carcinosarcoma [NCIt concept]
- Advanced Uveal Melanoma [NCIt concept]
- Advanced Vaginal Adenocarcinoma [NCIt concept]
- Advanced Vaginal Adenosquamous Carcinoma [NCIt concept]
- Advanced Vaginal Carcinoma [NCIt concept]
- Advanced Vaginal Squamous Cell Carcinoma [NCIt concept]
- Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Advanced Vulvar Carcinoma [NCIt concept]
- Advanced Vulvar Squamous Cell Carcinoma [NCIt concept]
- Advising [NCIt concept]
- Aerobic Exercise [NCIt concept]
- Aerodigestive Invasive Malignancy [NCIt concept]
- Aerosol Gemcitabine [NCIt concept]
- Aerosol Sargramostim [NCIt concept]
- Aerosolized Aldesleukin [NCIt concept]
- Afadin [NCIt concept]
- Afamitresgene Autoleucel [NCIt concept]
- Afatinib [NCIt concept]
- Afatinib Dimaleate [NCIt concept]
- Afimoxifene [NCIt concept]
- Aflatoxin B1 [NCIt concept]
- Aflatoxins-Related Hepatocellular Carcinoma [NCIt concept]
- Afuresertib [NCIt concept]
- Agatolimod Sodium [NCIt concept]
- Age-Related Clonal Hematopoiesis [NCIt concept]
- Agerafenib [NCIt concept]
- Aggresome [NCIt concept]
- Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Aggressive NK-Cell Leukemia [NCIt concept]
- Aggressive Prostate Adenocarcinoma [NCIt concept]
- Aggressive Systemic Mastocytosis [NCIt concept]
- Aglatimagene Besadenovec [NCIt concept]
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 [NCIt concept]
- Agouti-Related Protein [NCIt concept]
- Airway Tumor Mass [NCIt concept]
- Akt Inhibitor MK2206 [NCIt concept]
- Akt Inhibitor SR13668 [NCIt concept]
- Akt-1/2 Inhibitor-treated Tumor Infiltrating Lymphocytes [NCIt concept]
- Alanine Aminotransferase [NCIt concept]
- Alanylglutamine [NCIt concept]
- Albumin [NCIt concept]
- Albumin-binding Cisplatin Prodrug BTP-114 [NCIt concept]
- Albuterol [NCIt concept]
- Albuterol Sulfate [NCIt concept]
- Alcestobart [NCIt concept]
- Alcohol [NCIt concept]
- Alcohol Dehydrogenase 1C [NCIt concept]
- Alcohol Dehydrogenase [NADP(+)] [NCIt concept]
- Alcohol-Related Esophageal Squamous Cell Carcinoma [NCIt concept]
- Alcohol-Related Hepatocellular Carcinoma [NCIt concept]
- Alcohol-Related Laryngeal Carcinoma [NCIt concept]
- Aldastotug [NCIt concept]
- Aldehyde [NCIt concept]
- Aldehyde Dehydrogenase [NCIt concept]
- Aldehyde Dehydrogenase 1 Family [NCIt concept]
- Aldehyde Dehydrogenase 3 Family [NCIt concept]
- Aldehyde Dehydrogenase, Mitochondrial [NCIt concept]
- Aldesleukin [NCIt concept]
- Aldo-Keto Reductase Family 1 Member C1 [NCIt concept]
- Aldo-Keto Reductase Family 1 Member C2 [NCIt concept]
- Aldo-Keto Reductase Family 1 Member C3 [NCIt concept]
- Aldolase [NCIt concept]
- Aldosterone [NCIt concept]
- Aldoxorubicin [NCIt concept]
- Alectinib [NCIt concept]
- Alefacept [NCIt concept]
- Alemtuzumab [NCIt concept]
- Alextatug [NCIt concept]
- Algenpantucel-L [NCIt concept]
- Alintegimod [NCIt concept]
- Alirocumab [NCIt concept]
- Alisertib [NCIt concept]
- Alisertib Sodium [NCIt concept]
- Alkaline Ceramidase 1 [NCIt concept]
- Alkaline Ceramidase 2 [NCIt concept]
- Alkaline Ceramidase 3 [NCIt concept]
- Alkaline DNase [NCIt concept]
- Alkaline Phosphatase [NCIt concept]
- Alkaline Phosphatase, Germ Cell Type [NCIt concept]
- Alkaline Phosphatase, Placental Type [NCIt concept]
- Alkaline Phosphatase, Tissue-Nonspecific Isozyme [NCIt concept]
- Alkaline Water [NCIt concept]
- Alkylating Agent-Related Acute Myeloid Leukemia [NCIt concept]
- All-Trans-Retinol Dehydrogenase [NAD(+)] ADH4 [NCIt concept]
- Allele [NCIt concept]
- Allele-Specific Oligonucleotide Real-Time Quantitative Polymerase Chain Reaction [NCIt concept]
- Allelic Imbalance [NCIt concept]
- Alloantigen-specific Allogeneic Type 1 Regulatory T Cells T-allo10 [NCIt concept]
- Allodepleted Haploidentical T Cells-expressing Inducible Caspase 9 [NCIt concept]
- Allodepleted T Cell Immunotherapeutic ATIR101 [NCIt concept]
- Allogeneic AML Antigen-expressing Dendritic Cell Vaccine [NCIt concept]
- Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes [NCIt concept]
- Allogeneic Adipose-derived Mesenchymal Stem Cells [NCIt concept]
- Allogeneic Anti-BCMA CAR T Cells ALLO-605 [NCIt concept]
- Allogeneic Anti-BCMA CAR T Cells P-BCMA-ALLO1 [NCIt concept]
- Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715 [NCIt concept]
- Allogeneic Anti-BCMA-CAR T-cells PBCAR269A [NCIt concept]
- Allogeneic Anti-CD19 CAR T-cells ATA3219 [NCIt concept]
- Allogeneic Anti-CD19 CAR T-cells PBCAR19B [NCIt concept]
- Allogeneic Anti-CD19-CAR-CD28-IL-15-expressing Natural Killer T-cells [NCIt concept]
- Allogeneic Anti-CD19/CD22 CAR-BBz T-cells [NCIt concept]
- Allogeneic Anti-CD20-CAR T-cells PBCAR20A [NCIt concept]
- Allogeneic Anti-CD20/CD22 Universal CAR-expressing T-lymphocytes UCART20x22 [NCIt concept]
- Allogeneic Anti-CD30 CAR-Epstein-Barr Virus-specific T-lymphocytes [NCIt concept]
- Allogeneic Anti-CD33 CAR T-cells VCAR33 [NCIt concept]
- Allogeneic Anti-CD38 DAR-T Cells STI-1492 [NCIt concept]
- Allogeneic Anti-CD5 CAR-CD28zeta T-lymphocytes [NCIt concept]
- Allogeneic Anti-CD6 CAR T-regulatory Cells [NCIt concept]
- Allogeneic Anti-CD7 CAR-T Cells BEAM-201 [NCIt concept]
- Allogeneic Anti-CD7 CAR-T Cells WU-CART-007 [NCIt concept]
- Allogeneic Anti-CD70 CAR/dnTGF-BRII-expressing Gamma Delta T-cells ADI-270 [NCIt concept]
- Allogeneic Anti-CD70-CAR T-cells ALLO-316 [NCIt concept]
- Allogeneic Anti-CD70-CAR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Allogeneic Anti-EGFR Antibody-conjugated Gamma Delta 2 T-cells ACE2016 [NCIt concept]
- Allogeneic Anti-EGFR CAR/HLA-A*02-gated Inhibitory Receptor-expressing T-lymphocytes A2B395 [NCIt concept]
- Allogeneic Anti-HA-1 TCR-engineered T-cells TSC-100 [NCIt concept]
- Allogeneic Anti-HA-2 TCR-engineered T-cells TSC-101 [NCIt concept]
- Allogeneic Anti-NY-ESO-1-TCR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Allogeneic Autophagosome-enriched Vaccine DPV-001 [NCIt concept]
- Allogeneic BKV-specific Cytotoxic T-lymphocytes [NCIt concept]
- Allogeneic Bone Marrow Transplantation [NCIt concept]
- Allogeneic Bone Marrow Transplantation Recipient [NCIt concept]
- Allogeneic CAR-T Cells [NCIt concept]
- Allogeneic CD123-specific Universal CAR123-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD16-expressing Natural Killer Cells CYNK-101 [NCIt concept]
- Allogeneic CD19-CAR CD45RA-negative T-cells [NCIt concept]
- Allogeneic CD19-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX019 [NCIt concept]
- Allogeneic CD19-specific Universal CAR19-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD19/CD20-specific CAR-T Cells P-CD19CD20-ALLO1 [NCIt concept]
- Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22 [NCIt concept]
- Allogeneic CD25/Treg-depleted Donor Lymphocytes [NCIt concept]
- Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100 [NCIt concept]
- Allogeneic CD3- CD19- Selected Natural Killer Cells [NCIt concept]
- Allogeneic CD33CAR-CD3zeta-4-1BB-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD34+-enriched and CD45RA-depleted PBSCs [NCIt concept]
- Allogeneic CD34-positive E-rosetted T-cell Depleted Peripheral Blood Stem Cells [NCIt concept]
- Allogeneic CD34-positive Enriched Peripheral Blood Stem Cells [NCIt concept]
- Allogeneic CD56-positive CD3-negative Natural Killer Cells [NCIt concept]
- Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001 [NCIt concept]
- Allogeneic CD8+ Memory T-cells [NCIt concept]
- Allogeneic CMV Antigen-specific CD4+/CD8+ T-lymphocytes [NCIt concept]
- Allogeneic CMV/AdV-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD19 CAR T Cells CTX110 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD19 CAR T-cells CTX112 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX131 [NCIt concept]
- Allogeneic CRISPR-edited Anti-BCMA CAR-T Cells CB-011 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CD19 CAR-T Cells CB-010 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CLL-1 CAR-T Cells CB-012 [NCIt concept]
- Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A [NCIt concept]
- Allogeneic Calibrated Release IL-15-expressing Logic-Gated Gene Circuit Anti-CD33/FLT3 CAR-NK Cells SENTI-202 [NCIt concept]
- Allogeneic Cellular Vaccine 1650-G [NCIt concept]
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes [NCIt concept]
- Allogeneic Epstein-Barr Virus-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Allogeneic GM-CSF-Based Myeloma Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-Secreting Breast Cancer Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Myeloma Vaccine [NCIt concept]
- Allogeneic Gamma-delta T-lymphocytes KB-GDT-01 [NCIt concept]
- Allogeneic Gene-edited CD33-knockout Hematopoietic Stem and Progenitor Cells [NCIt concept]
- Allogeneic Gene-modified Gamma Delta T-cells [NCIt concept]
- Allogeneic HAdV Antigen-specific T-lymphocytes [NCIt concept]
- Allogeneic HPV-specific CD4+ T-lymphocytes [NCIt concept]
- Allogeneic Hematopoietic Stem Cell Transplant Recipient [NCIt concept]
- Allogeneic Hematopoietic Stem Cell Transplantation [NCIt concept]
- Allogeneic Hematopoietic Stem Cell Transplantation with Donor Pretreatment [NCIt concept]
- Allogeneic Human Stem Cell-derived Pancreatic Islet Cells VX-880 [NCIt concept]
- Allogeneic Human T Cell Progenitors SMART 101 [NCIt concept]
- Allogeneic Hypoimmune Anti-CD19 CAR T-cells SC291 [NCIt concept]
- Allogeneic Hypoimmune Anti-CD22 CAR T-cells SC262 [NCIt concept]
- Allogeneic Invariant Natural Killer T-cells agenT-797 [NCIt concept]
- Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine [NCIt concept]
- Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 [NCIt concept]
- Allogeneic Most Closely HLA-matched Adenovirus-specific Cytotoxic T Lymphocytes [NCIt concept]
- Allogeneic Multipotent Adult Progenitor Cells [NCIt concept]
- Allogeneic NKG2D-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX101 [NCIt concept]
- Allogeneic Natural Killer Cell Line NK-92 [NCIt concept]
- Allogeneic Natural Killer Cells CHM 0201 [NCIt concept]
- Allogeneic Natural Killer Cells DVX201 [NCIt concept]
- Allogeneic Natural Killer Cells IDP-023 [NCIt concept]
- Allogeneic Natural Killer Cells SAR445419 [NCIt concept]
- Allogeneic Nicotinamide-expanded Natural Killer Cells [NCIt concept]
- Allogeneic Organ Transplantation [NCIt concept]
- Allogeneic PD-L1 Tumor-targeted High-affinity Natural Killer Cells [NCIt concept]
- Allogeneic Polymer-encapsulated IL-2-secreting Retinal Pigmented Epithelial Cells AVB-001 [NCIt concept]
- Allogeneic Regulatory T-cells TRX103 [NCIt concept]
- Allogeneic Rituximab Conjugated Gamma Delta T-cells ACE1831 [NCIt concept]
- Allogeneic SARS-CoV-2 Specific T Cells [NCIt concept]
- Allogeneic Skin-derived ABCB5-positive MSCs allo-APZ2-OTS [NCIt concept]
- Allogeneic Stem Cell Transplant Recipient [NCIt concept]
- Allogeneic TCR-CD3 complex/CD16/IL-15-expressing Natural Killer Cells [NCIt concept]
- Allogeneic TCRa/b-depleted HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified RQR8-expressing T Cells BSB-1001 [NCIt concept]
- Allogeneic TGFBR2 KO CAR27/IL-15-expressing NK Cells [NCIt concept]
- Allogeneic Tumor Cell Vaccine [NCIt concept]
- Allogeneic Umbilical Cord Blood-derived CXCR4-enriched T-regulatory Cells CK0804 [NCIt concept]
- Allogeneic Variable Delta 1 Gamma-delta T-lymphocytes GDX012 [NCIt concept]
- Allogeneic Virus-specific T-lymphocytes [NCIt concept]
- Allogeneic Virus-specific T-lymphocytes R-MVST [NCIt concept]
- Allogeneic iPSC-derived Anti-CD19-CAR/IL-15-expressing NK Cells CNTY-101 [NCIt concept]
- Allogeneic iPSC-derived Anti-MICA/B CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT536 [NCIt concept]
- Allogeneic shRNA-based Anti-BCMA CAR T-cells CYAD-211 [NCIt concept]
- Allografting [NCIt concept]
- Alloisoleucine [NCIt concept]
- Allopurinol [NCIt concept]
- Allovectin-7 [NCIt concept]
- Almond Oil [NCIt concept]
- Alnodesertib [NCIt concept]
- Alnuctamab [NCIt concept]
- Alobresib [NCIt concept]
- Alomfilimab [NCIt concept]
- Alopecia [NCIt concept]
- Alpelisib [NCIt concept]
- Alpha Adrenergic Receptor [NCIt concept]
- Alpha Chemokine [NCIt concept]
- Alpha Fetoprotein Adenoviral Vector Vaccine [NCIt concept]
- Alpha Fetoprotein L3 Measurement [NCIt concept]
- Alpha Galactosylceramide [NCIt concept]
- Alpha Tubulin [NCIt concept]
- Alpha V Beta 8 Antagonist PF-06940434 [NCIt concept]
- Alpha-(1,3)-Fucosyltransferase 4 [NCIt concept]
- Alpha-1-Acid Glycoprotein 1 [NCIt concept]
- Alpha-1-Antichymotrypsin [NCIt concept]
- Alpha-1-Antitrypsin [NCIt concept]
- Alpha-1-Proteinase Inhibitor Human [NCIt concept]
- Alpha-2-Antiplasmin [NCIt concept]
- Alpha-2-HS-Glycoprotein [NCIt concept]
- Alpha-2-Macroglobulin [NCIt concept]
- Alpha-2C Adrenergic Receptor [NCIt concept]
- Alpha-Aminoadipic Acid [NCIt concept]
- Alpha-Aminobutyric Acid [NCIt concept]
- Alpha-Amylase [NCIt concept]
- Alpha-Beta T-Cell Depletion [NCIt concept]
- Alpha-Crystallin B Chain [NCIt concept]
- Alpha-Enolase [NCIt concept]
- Alpha-Fetoprotein [NCIt concept]
- Alpha-Fetoprotein Positive [NCIt concept]
- Alpha-Gal Antibody [NCIt concept]
- Alpha-Hydroxyglutarate [NCIt concept]
- Alpha-Internexin [NCIt concept]
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO [NCIt concept]
- Alpha-L-Iduronidase [NCIt concept]
- Alpha-Lactalbumin [NCIt concept]
- Alpha-Lipoic Acid [NCIt concept]
- Alpha-Mannosidosis [NCIt concept]
- Alpha-Methylacyl-CoA Racemase [NCIt concept]
- Alpha-Methylacyl-CoA Racemase Deficiency [NCIt concept]
- Alpha-Soluble NSF Attachment Protein [NCIt concept]
- Alpha-Tectorin [NCIt concept]
- Alpha-Tocopherol [NCIt concept]
- Alpha-fetoprotein Measurement [NCIt concept]
- Alpha-lactalbumin Breast Cancer Vaccine [NCIt concept]
- Alpha-type-1 Polarized Dendritic Cells [NCIt concept]
- Alpha/Beta T-Lymphocyte [NCIt concept]
- Alpha/beta T-cell/CD19+ B-cell-depleted Unrelated or Partially Matched Donor-derived Allogeneic Peripheral Blood Stem Cells [NCIt concept]
- AlphaVbeta1/8 Inhibitor PLN-101095 [NCIt concept]
- Alprostadil [NCIt concept]
- Alsevalimab [NCIt concept]
- Altered Mental Status [NCIt concept]
- Alu Element [NCIt concept]
- Aluminum [NCIt concept]
- Aluminum Acetate/Strontium Chloride Hexahydrate Topical Hydrogel [NCIt concept]
- Alvelestat [NCIt concept]
- Alveolar Rhabdomyosarcoma [NCIt concept]
- Alveolar Soft Part Sarcoma [NCIt concept]
- Alvespimycin Hydrochloride [NCIt concept]
- Alvimopan [NCIt concept]
- Alvocidib [NCIt concept]
- Alvocidib Hydrochloride [NCIt concept]
- Alvocidib Prodrug TP-1287 [NCIt concept]
- Amantadine Hydrochloride [NCIt concept]
- Amatuximab [NCIt concept]
- Amcasertib [NCIt concept]
- Amcenestrant [NCIt concept]
- Amdizalisib [NCIt concept]
- Ameloblastoma [NCIt concept]
- American Ginseng [NCIt concept]
- Amezalpat [NCIt concept]
- Amifampridine [NCIt concept]
- Amifostine [NCIt concept]
- Amikacin Inhalation Solution [NCIt concept]
- Amine Oxidase [Flavin-Containing] A [NCIt concept]
- Amino Acid Measurement [NCIt concept]
- Amino Acid Metabolism Disorder [NCIt concept]
- Amino Acid Transporter Heavy Chain SLC3A2 [NCIt concept]
- Amino Acid/Electrolyte Mixture-based Dietary Supplement [NCIt concept]
- Aminoadipic Semialdehyde [NCIt concept]
- Aminoflavone Prodrug AFP464 [NCIt concept]
- Aminolevulinic Acid Hydrochloride [NCIt concept]
- Aminolevulinic Acid Intravenous Formulation SONALA-001 [NCIt concept]
- Aminopeptidase N [NCIt concept]
- Aminophylline [NCIt concept]
- Amivantamab [NCIt concept]
- Amivantamab and Recombinant Human Hyaluronidase [NCIt concept]
- Ammonia N-13 [NCIt concept]
- Amolimogene Bepiplasmid [NCIt concept]
- Amonafide L-Malate [NCIt concept]
- Amplitude-Modulated Electromagnetic Field Therapy [NCIt concept]
- Ampulla of Vater Carcinoma [NCIt concept]
- Ampulla of Vater Intestinal-Type Adenocarcinoma [NCIt concept]
- Ampulla of Vater Neuroendocrine Carcinoma [NCIt concept]
- Amrecibart [NCIt concept]
- Amredobresib [NCIt concept]
- Amrubicin [NCIt concept]
- Amrubicin Hydrochloride [NCIt concept]
- Amsulostat [NCIt concept]
- Amuvatinib [NCIt concept]
- Amyloid [NCIt concept]
- Amyloid Beta A4 Precursor Protein-Binding Family A Member 1 [NCIt concept]
- Amyloid Beta A4 Precursor Protein-Binding Family A Member 2 [NCIt concept]
- Amyloid Beta A4 Precursor Protein-Binding Family A Member 3 [NCIt concept]
- Amyloid-Beta Precursor Protein [NCIt concept]
- Amyloidosis [NCIt concept]
- Anabasine [NCIt concept]
- Anagrelide [NCIt concept]
- Anakinra [NCIt concept]
- Anal Adenocarcinoma [NCIt concept]
- Anal Basaloid Carcinoma [NCIt concept]
- Anal Canal Carcinoma [NCIt concept]
- Anal Canal Cloacogenic Carcinoma [NCIt concept]
- Anal Carcinoma [NCIt concept]
- Anal High Risk HPV DNA Positive [NCIt concept]
- Anal Intraepithelial Neoplasia [NCIt concept]
- Anal Intraepithelial Neoplasia 2 [NCIt concept]
- Anal Intraepithelial Neoplasia 3 [NCIt concept]
- Anal Margin Carcinoma [NCIt concept]
- Anal Neoplasm [NCIt concept]
- Anal Non-Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Anal Squamous Cell Carcinoma [NCIt concept]
- Analytic Treatment Interruption [NCIt concept]
- Anamorelin Hydrochloride [NCIt concept]
- Anaplastic [NCIt concept]
- Anaplastic (Malignant) Meningioma [NCIt concept]
- Anaplastic Large Cell Lymphoma [NCIt concept]
- Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Anastomosis [NCIt concept]
- Anastrozole [NCIt concept]
- Anatabine [NCIt concept]
- Anatomic Stage 0 Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage I Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IA Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IB Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage II Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IIA Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IIB Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage III Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IIIA Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IIIB Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IIIC Breast Cancer AJCC v8 [NCIt concept]
- Anatomic Stage IV Breast Cancer AJCC v8 [NCIt concept]
- Anatomically Adaptive Image Receiver Coil [NCIt concept]
- Anbenitamab [NCIt concept]
- Ancestry-Informative Marker [NCIt concept]
- Andamertinib [NCIt concept]
- Andecaliximab [NCIt concept]
- Androgen [NCIt concept]
- Androgen Antagonist APC-100 [NCIt concept]
- Androgen Receptor [NCIt concept]
- Androgen Receptor Antagonist TRC253 [NCIt concept]
- Androgen Receptor Antisense Oligonucleotide AZD5312 [NCIt concept]
- Androgen Receptor Degrader [NCIt concept]
- Androgen Receptor Degrader AC176 [NCIt concept]
- Androgen Receptor Degrader CC1083610 [NCIt concept]
- Androgen Receptor Degrader RO7656594 [NCIt concept]
- Androgen Receptor Downregulator AZD3514 [NCIt concept]
- Androgen Receptor Inhibitor [NCIt concept]
- Androgen Receptor Inhibitor ONCT-534 [NCIt concept]
- Androgen Receptor Negative [NCIt concept]
- Androgen Receptor Pathway Inhibitor [NCIt concept]
- Androgen Receptor Positive [NCIt concept]
- Androgen Receptor Splice Variant 3 [NCIt concept]
- Androgen Receptor Splice Variant 5,6,7es [NCIt concept]
- Androgen Receptor Splice Variant 7 Positive [NCIt concept]
- Androgen Receptor-Dependent Gene Signature [NCIt concept]
- Androgen Receptor-directed Therapy [NCIt concept]
- Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10 [NCIt concept]
- Androgen-sensitive [NCIt concept]
- Androstane Steroid HE3235 [NCIt concept]
- Androstane-3,17-Diol Glucuronide [NCIt concept]
- Androstanedione [NCIt concept]
- Androstenediol [NCIt concept]
- Androstenedione [NCIt concept]
- Androsterone [NCIt concept]
- Androsterone Glucuronide [NCIt concept]
- Androsterone Sulfate [NCIt concept]
- Anemia [NCIt concept]
- Anemia due to Chronic Disorder [NCIt concept]
- Anesthesia Procedure [NCIt concept]
- Anesthetic Agent [NCIt concept]
- Anetumab Ravtansine [NCIt concept]
- Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241 [NCIt concept]
- Angiogenesis Inhibitor [NCIt concept]
- Angiogenesis Inhibitor JI-101 [NCIt concept]
- Angiogenin [NCIt concept]
- Angiogram [NCIt concept]
- Angiokine [NCIt concept]
- Angiome [NCIt concept]
- Angiomyolipoma [NCIt concept]
- Angiomyosarcoma [NCIt concept]
- Angiopoietin-1 [NCIt concept]
- Angiopoietin-1 Receptor [NCIt concept]
- Angiopoietin-2 [NCIt concept]
- Angiopoietin-2-specific Fusion Protein PF-04856884 [NCIt concept]
- Angiopoietin-4 [NCIt concept]
- Angiopoietin-Related Protein 1 [NCIt concept]
- Angiopoietin-Related Protein 4 [NCIt concept]
- Angiosarcoma [NCIt concept]
- Angiostatin [NCIt concept]
- Angiotensin-2 [NCIt concept]
- Angiotensin-Converting Enzyme [NCIt concept]
- Angiotensin-Converting Enzyme 2 [NCIt concept]
- Angle-Resolved Low-Coherence Interferometry [NCIt concept]
- Anhydrous Enol-oxaloacetate [NCIt concept]
- Anidulafungin [NCIt concept]
- Anillin [NCIt concept]
- Animal-Assisted Therapy [NCIt concept]
- Anion Exchange Protein 3 [NCIt concept]
- Ankyrin Repeat Domain-Containing Protein 26 [NCIt concept]
- Ankyrin-1 [NCIt concept]
- Ann Arbor Clinical Stage I [NCIt concept]
- Ann Arbor Clinical Stage II [NCIt concept]
- Ann Arbor Clinical Stage III [NCIt concept]
- Ann Arbor Clinical Stage IV [NCIt concept]
- Ann Arbor Stage I AIDS-Related Lymphoma [NCIt concept]
- Ann Arbor Stage I Adult Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage I Adult Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Adult Immunoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage I Adult Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage I Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I B Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage I Centroblastic Lymphoma [NCIt concept]
- Ann Arbor Stage I Childhood Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage I Childhood Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Childhood Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage I Diffuse Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage I Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Ann Arbor Stage I Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage I Grade 1 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage I Grade 2 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage I Grade 3 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage I Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Lymphoma [NCIt concept]
- Ann Arbor Stage I Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage I Mantle Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Nasal Type NK/T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage I Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Noncutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Noncutaneous Childhood Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Small Lymphocytic Lymphoma [NCIt concept]
- Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage I Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II AIDS-Related Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Immunoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II B Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage II Centroblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Childhood Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage II Childhood Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Childhood Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Contiguous Mantle Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Diffuse Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage II Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Ann Arbor Stage II Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 1 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 2 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 3 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage II Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Lymphoma [NCIt concept]
- Ann Arbor Stage II Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage II Mantle Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Nasal Type NK/T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage II Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Small Lymphocytic Lymphoma [NCIt concept]
- Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III AIDS-Related Lymphoma [NCIt concept]
- Ann Arbor Stage III Adult Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage III Adult Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Adult Immunoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage III Adult Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage III Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III B Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage III Centroblastic Lymphoma [NCIt concept]
- Ann Arbor Stage III Childhood Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage III Childhood Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Childhood Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Diffuse Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage III Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Ann Arbor Stage III Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage III Grade 1 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage III Grade 2 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage III Grade 3 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage III Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Lymphoma [NCIt concept]
- Ann Arbor Stage III Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage III Mantle Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Nasal Type NK/T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage III Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage III Small Lymphocytic Lymphoma [NCIt concept]
- Ann Arbor Stage IV AIDS-Related Lymphoma [NCIt concept]
- Ann Arbor Stage IV Adult Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage IV Adult Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Adult Immunoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage IV Adult Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage IV Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV B Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage IV Centroblastic Lymphoma [NCIt concept]
- Ann Arbor Stage IV Childhood Burkitt Lymphoma [NCIt concept]
- Ann Arbor Stage IV Childhood Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma [NCIt concept]
- Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Ann Arbor Stage IV Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Ann Arbor Stage IV Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage IV Grade 1 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage IV Grade 2 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage IV Grade 3 Follicular Lymphoma [NCIt concept]
- Ann Arbor Stage IV Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Lymphoma [NCIt concept]
- Ann Arbor Stage IV Lymphoplasmacytic Lymphoma [NCIt concept]
- Ann Arbor Stage IV Mantle Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Nasal Type NK/T-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Nodal Marginal Zone Lymphoma [NCIt concept]
- Ann Arbor Stage IV Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Ann Arbor Stage IV Small Lymphocytic Lymphoma [NCIt concept]
- Annamycin Liposomal [NCIt concept]
- Annexin A2 [NCIt concept]
- Annexin Family Protein [NCIt concept]
- Anoctamin-1 [NCIt concept]
- Anorectal Dysfunction [NCIt concept]
- Anorectal Melanoma [NCIt concept]
- Anorexia [NCIt concept]
- Anoscopy [NCIt concept]
- Anserine [NCIt concept]
- Antepartum Obstetric Thromboembolism [NCIt concept]
- Anterior Gradient Protein 2 Homolog [NCIt concept]
- Anterior Tongue Squamous Cell Carcinoma [NCIt concept]
- Anthocyanin [NCIt concept]
- Anthracycline Antineoplastic Antibiotic [NCIt concept]
- Anthrax Toxin Receptor 1 [NCIt concept]
- Anti-4-1BB/5T4 Bispecific Antibody ALG.APV-527 [NCIt concept]
- Anti-4-1BB/PD-L1 Bispecific Antibody BH3120 [NCIt concept]
- Anti-5T4 Antibody-drug Conjugate ASN004 [NCIt concept]
- Anti-5T4 Antibody-drug Conjugate PF-06263507 [NCIt concept]
- Anti-5T4/Exatecan Antibody-drug Conjugate TUB-030 [NCIt concept]
- Anti-5T4/MMAE Antibody-drug Conjugate XB010 [NCIt concept]
- Anti-A33 Monoclonal Antibody KRN330 [NCIt concept]
- Anti-A5B1 Integrin Monoclonal Antibody PF-04605412 [NCIt concept]
- Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 [NCIt concept]
- Anti-ADAM9/Exatecan Antibody-drug Conjugate MGC028 [NCIt concept]
- Anti-AG7 Antibody-drug Conjugate AbGn-107 [NCIt concept]
- Anti-AGS-16 Monoclonal Antibody AGS-16M18 [NCIt concept]
- Anti-AGS-5 Antibody-drug Conjugate ASG-5ME [NCIt concept]
- Anti-AGS-8 Monoclonal Antibody AGS-8M4 [NCIt concept]
- Anti-ALPP/ALPPL2/MMAE ADC SGN-ALPV [NCIt concept]
- Anti-ANG2 Monoclonal Antibody MEDI-3617 [NCIt concept]
- Anti-ASCT2 Antibody-drug Conjugate MEDI7247 [NCIt concept]
- Anti-Androgen [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate DB-1311 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate HS-20093 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate MGC026 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate YL201 [NCIt concept]
- Anti-B7-H3 CAR T-cells [NCIt concept]
- Anti-B7-H3/CD28 Bispecific Antibody XmAb808 [NCIt concept]
- Anti-B7-H3/PD-L1-P1003 Bispecific Antibody-drug Conjugate DB-1419 [NCIt concept]
- Anti-B7-H3/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BGB-C354 [NCIt concept]
- Anti-B7-H4 Antibody Drug Conjugate BG-C9074 [NCIt concept]
- Anti-B7-H4 Monoclonal Antibody [NCIt concept]
- Anti-B7-H4 Monoclonal Antibody NC762 [NCIt concept]
- Anti-B7-H4/Anti-4-1BB Bispecific Antibody ABL103 [NCIt concept]
- Anti-B7-H4/Anti-4-1BB Bispecific Antibody CLN-418 [NCIt concept]
- Anti-B7-H4/Anti-CD3 Bispecific Antibody GEN1047 [NCIt concept]
- Anti-B7-H4/Anti-CD3 Bispecific Antibody PF-07260437 [NCIt concept]
- Anti-B7-H4/MMAE ADC LNCB74 [NCIt concept]
- Anti-B7-H4/TOP1i Antibody-drug Conjugate GSK5733584 [NCIt concept]
- Anti-B7-H6/Anti-CD3 Bispecific Antibody BI 765049 [NCIt concept]
- Anti-B7H7 Monoclonal Antibody [NCIt concept]
- Anti-BCMA Antibody SEA-BCMA [NCIt concept]
- Anti-BCMA Antibody-drug Conjugate AMG 224 [NCIt concept]
- Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody WVT078 [NCIt concept]
- Anti-BCMA/Anti-GPRC5D CAR-T Cells BMS-986453 [NCIt concept]
- Anti-BCMA/CD38/CD3 Trispecific Antibody ISB 2001 [NCIt concept]
- Anti-BCMA/GPRC5D/CD3 Trispecific Antibody SIM0500 [NCIt concept]
- Anti-BCMA/PBD ADC MEDI2228 [NCIt concept]
- Anti-BTLA Monoclonal Antibody HFB200603 [NCIt concept]
- Anti-BTN3A Agonistic Monoclonal Antibody ICT01 [NCIt concept]
- Anti-CA19-9 Antibody hu5B1/TCO Immunoconjugate [NCIt concept]
- Anti-CA19-9 Monoclonal Antibody BNT321 [NCIt concept]
- Anti-CALRmut/Anti-CD3 Bispecific Antibody JNJ-88549968 [NCIt concept]
- Anti-CCR7 Antibody-drug Conjugate JBH492 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody ABBV-514 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody AMG 355 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody BGB-A3055 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody RO7502175 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody S-531011 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody ZL-1218 [NCIt concept]
- Anti-CD117/Amanitin Antibody-drug Conjugate MGTA-117 [NCIt concept]
- Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1 [NCIt concept]
- Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A [NCIt concept]
- Anti-CD123/CD3 BiTE Antibody SAR440234 [NCIt concept]
- Anti-CD123/CD3 Bispecific Antibody JNJ-63709178 [NCIt concept]
- Anti-CD123/Kinesin Spindle Protein Inhibitor Antibody-drug Conjugate VIP943 [NCIt concept]
- Anti-CD123/TOP1i Antibody-drug Conjugate AZD9829 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody ADG106 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody AGEN2373 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody CTX-471 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody EU101 [NCIt concept]
- Anti-CD137 Monoclonal Antibody [NCIt concept]
- Anti-CD137/Anti-FAP Bispecific Antibody BI 765179 [NCIt concept]
- Anti-CD138 Antibody-IFNalpha Fusion Protein QXL138AM [NCIt concept]
- Anti-CD16/IL-15/Anti-CD33 Trispecific Natural Killer Cell Engager GTB-3650 [NCIt concept]
- Anti-CD19 Antibody-drug Conjugate IKS03 [NCIt concept]
- Anti-CD19 Antibody-drug Conjugate SGN-CD19B [NCIt concept]
- Anti-CD19 CAR T Cells Preparation [NCIt concept]
- Anti-CD19 CAR-IL-18-expressing Autologous T-lymphocytes [NCIt concept]
- Anti-CD19 Monoclonal Antibody MDX-1342 [NCIt concept]
- Anti-CD19-CAR CMV-specific T-lymphocytes [NCIt concept]
- Anti-CD19-CAR FMC63-28Z Retroviral Vector-transduced Allogeneic T-lymphocytes [NCIt concept]
- Anti-CD19-CAR Retroviral Vector-Transduced Autologous T Cells [NCIt concept]
- Anti-CD19-CAR-CD28/CD20-CAR-4-1BB-expressing Autologous T-lymphocytes Hu1928-Hu20BB [NCIt concept]
- Anti-CD19-Glucosteroid Receptor Modulator ADC ABBV-31 [NCIt concept]
- Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL [NCIt concept]
- Anti-CD19/Anti-CD3/Anti-CD2 Trispecific Antibody PIT565 [NCIt concept]
- Anti-CD19/CD20 Bicistronic CAR T-cells [NCIt concept]
- Anti-CD19/CD20/CD22 CAR T-Cells [NCIt concept]
- Anti-CD19/CD28 Bispecific Antibody RO7443904 [NCIt concept]
- Anti-CD19/CD3 BiTE Antibody AMG 562 [NCIt concept]
- Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978 [NCIt concept]
- Anti-CD20 Antibody [NCIt concept]
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein [NCIt concept]
- Anti-CD20 Monoclonal Antibody PRO131921 [NCIt concept]
- Anti-CD20-engineered Toxin Body MT-3724 [NCIt concept]
- Anti-CD20/Anti-CD3 Bispecific Antibody [NCIt concept]
- Anti-CD20/Anti-CD3/Anti-CD8 Trispecific Antibody AZD5492 [NCIt concept]
- Anti-CD20/CD37 Monoclonal Antibody Combination PSB202 [NCIt concept]
- Anti-CD22 ADC TRPH-222 [NCIt concept]
- Anti-CD22 CAR T Cells Preparation [NCIt concept]
- Anti-CD22 CAR-expressing T Lymphocytes [NCIt concept]
- Anti-CD22 scFv TCRz:41BB-CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-CD22-CAR m971-BBz Lentiviral Vector-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-CD22/Anti-CD28 Bispecific Antibody REGN5837 [NCIt concept]
- Anti-CD226 Agonist Antibody LY3435151 [NCIt concept]
- Anti-CD228/4-1BB Bispecific Agent SGN-BB228 [NCIt concept]
- Anti-CD228/MMAE Antibody-drug Conjugate PF-08046031 [NCIt concept]
- Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A [NCIt concept]
- Anti-CD24 Monoclonal Antibody [NCIt concept]
- Anti-CD24 Monoclonal Antibody ATG-031 [NCIt concept]
- Anti-CD24 Monoclonal Antibody PHST001 [NCIt concept]
- Anti-CD25 Antibody-drug Conjugate PF-08046032 [NCIt concept]
- Anti-CD27 Monoclonal Antibody [NCIt concept]
- Anti-CD27L Antibody-drug Conjugate AMG 172 [NCIt concept]
- Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1) [NCIt concept]
- Anti-CD3 Monoclonal Antibody [NCIt concept]
- Anti-CD3 OKT3/Anti-EGFR Bispecific Antibody Armed Activated T Lymphocytes [NCIt concept]
- Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells [NCIt concept]
- Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044 [NCIt concept]
- Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119 [NCIt concept]
- Anti-CD3/CD19/CD20 Trispecific Antibody 1A46 [NCIt concept]
- Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424 [NCIt concept]
- Anti-CD3/CD38 Bispecific Monoclonal Antibody IGM-2644 [NCIt concept]
- Anti-CD3/CD7-Ricin Toxin A Immunotoxin [NCIt concept]
- Anti-CD30 Antibody-drug Conjugate SGN-35C [NCIt concept]
- Anti-CD30 Antibody-drug Conjugate SGN-35T [NCIt concept]
- Anti-CD30 Monoclonal Antibody MDX-1401 [NCIt concept]
- Anti-CD30 Monoclonal Antibody XmAb2513 [NCIt concept]
- Anti-CD30/CD3 Bispecific Antibody GEN3017 [NCIt concept]
- Anti-CD32B Monoclonal Antibody BI-1206 [NCIt concept]
- Anti-CD33 Antibody-drug Conjugate BL-M11D1 [NCIt concept]
- Anti-CD33 Antibody-drug Conjugate IMGN779 [NCIt concept]
- Anti-CD33 CAR T Cells Preparation [NCIt concept]
- Anti-CD33 CAR T-cells [NCIt concept]
- Anti-CD33 GSPT1 Degrader BMS-986497 [NCIt concept]
- Anti-CD33 Monoclonal Antibody [NCIt concept]
- Anti-CD33 Monoclonal Antibody BI 836858 [NCIt concept]
- Anti-CD33/BET Degrader ADC ABBV-787 [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 [NCIt concept]
- Anti-CD352 Antibody-drug Conjugate SGN-CD352A [NCIt concept]
- Anti-CD37 MMAE Antibody-drug Conjugate AGS67E [NCIt concept]
- Anti-CD37 Monoclonal Antibody BI 836826 [NCIt concept]
- Anti-CD37-CAR-expressing T-lymphocytes [NCIt concept]
- Anti-CD37/DM1 Derivative Antibody-drug Conjugate Debio 1562M [NCIt concept]
- Anti-CD38 Antibody-drug Conjugate STI-6129 [NCIt concept]
- Anti-CD38 Monoclonal Antibody [NCIt concept]
- Anti-CD38 Monoclonal Antibody SAR442085 [NCIt concept]
- Anti-CD38-CAR-TCRz/4-1BB-expressing T-lymphocytes [NCIt concept]
- Anti-CD38/Anti-CD47 Bispecific Antibody ISB 1442 [NCIt concept]
- Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257 [NCIt concept]
- Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342 [NCIt concept]
- Anti-CD38/CD3 Bispecific Monoclonal Antibody XmAb18968 [NCIt concept]
- Anti-CD39 Monoclonal Antibody AB598 [NCIt concept]
- Anti-CD39 Monoclonal Antibody IPH5201 [NCIt concept]
- Anti-CD39 Monoclonal Antibody PUR001 [NCIt concept]
- Anti-CD4 CAR T-cells [NCIt concept]
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140 [NCIt concept]
- Anti-CD40/Anti-mesothelin Bispecific Antibody ABBV-428 [NCIt concept]
- Anti-CD44 Monoclonal Antibody RO5429083 [NCIt concept]
- Anti-CD45 Monoclonal Antibody [NCIt concept]
- Anti-CD45 Monoclonal Antibody AHN-12 [NCIt concept]
- Anti-CD46 Antibody-drug Conjugate FOR46 [NCIt concept]
- Anti-CD46 Monoclonal Antibody YS5 [NCIt concept]
- Anti-CD47 ADC SGN-CD47M [NCIt concept]
- Anti-CD47 Monoclonal Antibody AO-176 [NCIt concept]
- Anti-CD47 Monoclonal Antibody CC-90002 [NCIt concept]
- Anti-CD47 Monoclonal Antibody IMC-002 [NCIt concept]
- Anti-CD47 Monoclonal Antibody ZL-1201 [NCIt concept]
- Anti-CD47/Anti-HER2 Bispecific Antibody D3L-001 [NCIt concept]
- Anti-CD47/Anti-PD-L1 Bispecific Antibody PF-07257876 [NCIt concept]
- Anti-CD47/CD20 Bispecific Antibody CC-96673 [NCIt concept]
- Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A [NCIt concept]
- Anti-CD5 CAR T Cells Preparation [NCIt concept]
- Anti-CD52 Monoclonal Antibody ALLO-647 [NCIt concept]
- Anti-CD7 CAR T Cells Preparation [NCIt concept]
- Anti-CD7 Immunotoxin [NCIt concept]
- Anti-CD70 Antibody-Ddrug Conjugate MDX-1203 [NCIt concept]
- Anti-CD70 CAR-expressing T Lymphocytes [NCIt concept]
- Anti-CD70 Monoclonal Antibody MDX-1411 [NCIt concept]
- Anti-CD70 Monoclonal Antibody SEA-CD70 [NCIt concept]
- Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 [NCIt concept]
- Anti-CD73 Monoclonal Antibody BMS-986179 [NCIt concept]
- Anti-CD73 Monoclonal Antibody HB0045 [NCIt concept]
- Anti-CD73 Monoclonal Antibody NZV930 [NCIt concept]
- Anti-CD73 Monoclonal Antibody S095024 [NCIt concept]
- Anti-CD74 Antibody-drug Conjugate STRO-001 [NCIt concept]
- Anti-CD79b CAR T Cells [NCIt concept]
- Anti-CD93 Monoclonal Antibody DCBY02 [NCIt concept]
- Anti-CD93 Monoclonal Antibody DCSZ11 [NCIt concept]
- Anti-CDH17 Monoclonal Antibody [NCIt concept]
- Anti-CDH3/MMAE Antibody-drug Conjugate BC3195 [NCIt concept]
- Anti-CDH3/MSLN BiTE Antibody AMG 305 [NCIt concept]
- Anti-CDH6 Antibody-drug Conjugate [NCIt concept]
- Anti-CDH6 Antibody-drug Conjugate HKT288 [NCIt concept]
- Anti-CDH6/Exatecan ADC CUSP06 [NCIt concept]
- Anti-CEA BiTE Monoclonal Antibody AMG211 [NCIt concept]
- Anti-CEA-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody BGB-B167 [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody LM-24C5 [NCIt concept]
- Anti-CEA/Anti-CEACAM6 Antibody-drug Conjugate EBC-129 [NCIt concept]
- Anti-CEACAM1 Monoclonal Antibody CM-24 [NCIt concept]
- Anti-CEACAM5 ADC SGN-CEACAM5C [NCIt concept]
- Anti-CEACAM5 Antibody-drug Conjugate BG-C477 [NCIt concept]
- Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47 [NCIt concept]
- Anti-CFH Monoclonal Antibody GT103 [NCIt concept]
- Anti-CLDN1 Antibody-drug Conjugate ALE.P02 [NCIt concept]
- Anti-CLDN18.2 Monoclonal Antibody ZL-1211 [NCIt concept]
- Anti-CLDN18.2/Anti-CD3 Bispecific Antibody ASP2138 [NCIt concept]
- Anti-CLDN4/Anti-CD137 Bispecific Antibody ASP1002 [NCIt concept]
- Anti-CLDN6 Antibody-drug Conjugate DS-9606a [NCIt concept]
- Anti-CLDN6 CAR T-cells [NCIt concept]
- Anti-CLDN6 Monoclonal Antibody ASP1650 [NCIt concept]
- Anti-CLDN6/9 Antibody-drug Conjugate SC-004 [NCIt concept]
- Anti-CLDN6/Anti-CD3 Bispecific Antibody BGB-B455 [NCIt concept]
- Anti-CLDN6/CD3 Bispecific Antibody CTIM-76 [NCIt concept]
- Anti-CLDN6/CD3 Bispecific Antibody XmAb541 [NCIt concept]
- Anti-CLL1-PBD ADC DCLL9718S [NCIt concept]
- Anti-CSF1 Monoclonal Antibody PD-0360324 [NCIt concept]
- Anti-CSF1R Monoclonal Antibody AMB-05X [NCIt concept]
- Anti-CSF1R Monoclonal Antibody IMC-CS4 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody REGN4659 [NCIt concept]
- Anti-CTLA-4 Probody BMS-986288 [NCIt concept]
- Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine [NCIt concept]
- Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine [NCIt concept]
- Anti-CTLA4 Monoclonal Antibody BMS-986218 [NCIt concept]
- Anti-CXCR4 Monoclonal Antibody PF-06747143 [NCIt concept]
- Anti-Caprin-1 Monoclonal Antibody TRK-950 [NCIt concept]
- Anti-Chimeric Antigen Receptor Antibody [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate EO-3021 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SKB315 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SOT102 [NCIt concept]
- Anti-Claudin-18.2 Monoclonal Antibody SPX-101 [NCIt concept]
- Anti-Claudin18.2 Monoclonal Antibody TORL-2-307-MAB [NCIt concept]
- Anti-Claudin18.2/Anti-CD3 Bispecific Antibody AZD5863 [NCIt concept]
- Anti-Claudin18.2/MMAE Antibody-drug Conjugate TORL-2-307-ADC [NCIt concept]
- Anti-DDR1 Monoclonal Antibody PRTH-101 [NCIt concept]
- Anti-DKK1 Monoclonal Antibody [NCIt concept]
- Anti-DKK1 Monoclonal Antibody BHQ880 [NCIt concept]
- Anti-DLK-1 Antibody-drug Conjugate ADCT-701 [NCIt concept]
- Anti-DLK-1/MMAE Antibody-drug Conjugate TORL-4-500 [NCIt concept]
- Anti-DLL3 ADC ZL-1310 [NCIt concept]
- Anti-DLL3 Antibody-drug Conjugate SC-002 [NCIt concept]
- Anti-DLL4 Monoclonal Antibody MEDI0639 [NCIt concept]
- Anti-DNA Antibody [NCIt concept]
- Anti-DR5 Agonistic Antibody DS-8273a [NCIt concept]
- Anti-Drug Antibody [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate ABBV-637 [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate CPO301 [NCIt concept]
- Anti-EGFR CAR T Cells Preparation [NCIt concept]
- Anti-EGFR Gamma Delta T-cell Engaging Bispecific Antibody SGN-EGFRd2 [NCIt concept]
- Anti-EGFR Monoclonal Antibody Mixture MM-151 [NCIt concept]
- Anti-EGFR Monoclonal Antibody SYN004 [NCIt concept]
- Anti-EGFR Monoclonal Antibody ZZ06 [NCIt concept]
- Anti-EGFR/Anti-c-Met Monoclonal Antibody FPI-2053 [NCIt concept]
- Anti-EGFR/CD16A Bispecific Antibody AFM24 [NCIt concept]
- Anti-EGFR/DM1 Antibody-drug Conjugate AVID100 [NCIt concept]
- Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013 [NCIt concept]
- Anti-EGFR/anti-CD3 Tumor Protease-activated T-cell Engager JANX008 [NCIt concept]
- Anti-EGFR/c-Met/c-Met Trispecific Antibody BG-T187 [NCIt concept]
- Anti-EGFRvIII Antibody Drug Conjugate AMG 595 [NCIt concept]
- Anti-EGFRvIII CAR-transduced Allogeneic T-lymphocytes [NCIt concept]
- Anti-EGFRvIII Immunotoxin MR1-1 [NCIt concept]
- Anti-EGFRvIII-CAR-CD3/EGFR BiTE-transduced Autologous T-lymphocytes CARv3-TEAM-E [NCIt concept]
- Anti-EGFRvIII/CD3 Bispecific Antibody RO7428731 [NCIt concept]
- Anti-ENPP3 Antibody-drug Conjugate AGS-16C3F [NCIt concept]
- Anti-ENPP3/Anti-CD3 Bispecific Antibody XmAb819 [NCIt concept]
- Anti-ENPP3/MMAF Antibody-drug Conjugate AGS-16M8F [NCIt concept]
- Anti-ENTPD2 Monoclonal Antibody KAZ954 [NCIt concept]
- Anti-ETBR/MMAE Antibody-drug Conjugate DEDN6526A [NCIt concept]
- Anti-EpCAM/Anti-4-1BB Bispecific Antibody BNT314 [NCIt concept]
- Anti-EpCAM/Anti-CD3 Bispecific Antibody BA3182 [NCIt concept]
- Anti-EpCAM/Anti-CD40 Bispecific Antibody KK2269 [NCIt concept]
- Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310 [NCIt concept]
- Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547 [NCIt concept]
- Anti-EphA5/MMAE Antibody-drug Conjugate MBRC-101 [NCIt concept]
- Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody AV-203 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody CDX-3379 [NCIt concept]
- Anti-FAP Antibody-drug Conjugate OMTX705 [NCIt concept]
- Anti-FGFR2b/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BG-C137 [NCIt concept]
- Anti-FGFR3 Antibody-drug Conjugate LY3076226 [NCIt concept]
- Anti-FL(FITC-E2) CAR T Cells [NCIt concept]
- Anti-FLT3 Antibody-drug Conjugate AGS62P1 [NCIt concept]
- Anti-FLT3 Monoclonal Antibody [NCIt concept]
- Anti-FLT3 Monoclonal Antibody IMC-EB10 [NCIt concept]
- Anti-FLT3/CD3 Bispecific Antibody CLN-049 [NCIt concept]
- Anti-FOLR1 Antibody-drug Conjugate [NCIt concept]
- Anti-FOLR1 CAR T-cells [NCIt concept]
- Anti-FOLR1 CoStAR-expressing Autologous Tumor-infiltrating Lymphocytes ITIL-306 [NCIt concept]
- Anti-FOXP3 Antisense Oligonucleotide AZD8701 [NCIt concept]
- Anti-FRalpha Antibody-drug Conjugate ZW191 [NCIt concept]
- Anti-FRalpha/Exatecan ADC LY4170156 [NCIt concept]
- Anti-FcRH5 Antibody-drug Conjugate DFRF4539A [NCIt concept]
- Anti-GARP Chimeric Antigen Receptor-T Cells [NCIt concept]
- Anti-GARP Monoclonal Antibody DS-1055a [NCIt concept]
- Anti-GARP Monoclonal Antibody PBA-0111 [NCIt concept]
- Anti-GCC Antibody-Drug Conjugate TAK-164 [NCIt concept]
- Anti-GD2 Antibody-drug Conjugate M3554 [NCIt concept]
- Anti-GD2 Monoclonal Antibody hu14.18K322A [NCIt concept]
- Anti-GD2 scFv/Anti-DOTA scFv Fusion Protein GD2-SADA [NCIt concept]
- Anti-GD3 Antibody-drug Conjugate PF-06688992 [NCIt concept]
- Anti-GDF-15 Monoclonal Antibody AZD8853 [NCIt concept]
- Anti-GFRAL Monoclonal Antibody NGM120 [NCIt concept]
- Anti-GITR Agonistic Monoclonal Antibody ASP1951 [NCIt concept]
- Anti-GITR Agonistic Monoclonal Antibody BMS-986156 [NCIt concept]
- Anti-GITR Monoclonal Antibody GWN 323 [NCIt concept]
- Anti-GPC3 T Cell-engaging Antibody AZD9793 [NCIt concept]
- Anti-GPC3-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-GPC3/Anti-4-1BB Bispecific Antibody BGB-B2033 [NCIt concept]
- Anti-GPC3/TCR Nanobody SAR444200 [NCIt concept]
- Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a [NCIt concept]
- Anti-GPRC5D Monoclonal Antibody SAR446523 [NCIt concept]
- Anti-GPRC5D/MMAE Antibody-drug Conjugate AZD0305 [NCIt concept]
- Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962 [NCIt concept]
- Anti-Globo H Monoclonal Antibody OBI-888 [NCIt concept]
- Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999 [NCIt concept]
- Anti-Glypican 3-scFvGC33-CAR-expressing T Lymphocytes [NCIt concept]
- Anti-Glypican 3/CD3 Bispecific Antibody ERY974 [NCIt concept]
- Anti-HA Epitope Monoclonal Antibody MEDI8852 [NCIt concept]
- Anti-HB-EGF Monoclonal Antibody KHK2866 [NCIt concept]
- Anti-HBEGF Monoclonal Antibody U3-1565 [NCIt concept]
- Anti-HER2 ADC BB-1701 [NCIt concept]
- Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate BL-M07D1 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate MEDI4276 [NCIt concept]
- Anti-HER2 Dendritic Cell Vaccine [NCIt concept]
- Anti-HER2 GSPT1 Degrader ORM-5029 [NCIt concept]
- Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 [NCIt concept]
- Anti-HER2 Monoclonal Antibody [NCIt concept]
- Anti-HER2 Monoclonal Antibody BAY2701438 [NCIt concept]
- Anti-HER2 Monoclonal Antibody HLX22 [NCIt concept]
- Anti-HER2-CAR Autologous CMV-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 [NCIt concept]
- Anti-HER2-vc0101 ADC PF-06804103 [NCIt concept]
- Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302 [NCIt concept]
- Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522 [NCIt concept]
- Anti-HER2/CD3/CD28 Tri-specific Antibody SAR443216 [NCIt concept]
- Anti-HER2/HER3 Dendritic Cell Vaccine [NCIt concept]
- Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A [NCIt concept]
- Anti-HER3 Antibody-drug Conjugate YL202 [NCIt concept]
- Anti-HER3 Dendritic Cell Vaccine [NCIt concept]
- Anti-HER3 Monoclonal Antibody GSK2849330 [NCIt concept]
- Anti-HER3/Anti-MUC1 Bispecific Antibody-drug Conjugate DM002 [NCIt concept]
- Anti-HER3/Exatecan Antibody-drug Conjugate ENV-501 [NCIt concept]
- Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate [NCIt concept]
- Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate DB-1310 [NCIt concept]
- Anti-HGF Monoclonal Antibody [NCIt concept]
- Anti-HHLA2 Monoclonal Antibody NPX887 [NCIt concept]
- Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968 [NCIt concept]
- Anti-HJV Monoclonal Antibody DISC-0974 [NCIt concept]
- Anti-HLA Class I Antibody Positive [NCIt concept]
- Anti-HLA-A*02/NY-ESO-1 Bispecific T-cell Engager DS-2243a [NCIt concept]
- Anti-HLA-A*02:01/p53 R175H Bispecific T-cell Engager CLSP-1025 [NCIt concept]
- Anti-HLA-A2-MAGE-A4/Anti-CD3 Bispecific Antibody RO7444973 [NCIt concept]
- Anti-HLA-A2-WT1/Anti-CD3 T-cell Engaging Bispecific Antibody RO7283420 [NCIt concept]
- Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-HLA-DR Monoclonal Antibody IMMU-114 [NCIt concept]
- Anti-HLA-G Antibody TTX-080 [NCIt concept]
- Anti-HLA-G Monoclonal Antibody [NCIt concept]
- Anti-HLA-G/CD3 Bispecific Antibody RO7515629 [NCIt concept]
- Anti-Hairy Cell Leukemia Antibody DBA.44 [NCIt concept]
- Anti-ICOS Agonist Monoclonal Antibody BMS-986226 [NCIt concept]
- Anti-ICOS Monoclonal Antibody MEDI-570 [NCIt concept]
- Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022 [NCIt concept]
- Anti-IL-18BP Monoclonal Antibody GS-0321 [NCIt concept]
- Anti-IL-4/IL-13 Combination Agent QBX258 [NCIt concept]
- Anti-IL-6 Monoclonal Antibody [NCIt concept]
- Anti-IL-6R Monoclonal Antibody [NCIt concept]
- Anti-IL17A Monoclonal Antibody CJM112 [NCIt concept]
- Anti-ILT2 Monoclonal Antibody [NCIt concept]
- Anti-ILT2 Monoclonal Antibody AGEN1571 [NCIt concept]
- Anti-ILT2 Monoclonal Antibody SAR444881 [NCIt concept]
- Anti-ILT2/Anti-ILT4 Bispecific Antibody PF-07826390 [NCIt concept]
- Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707 [NCIt concept]
- Anti-ILT4 Monoclonal Antibody [NCIt concept]
- Anti-ILT4 Monoclonal Antibody MK-4830 [NCIt concept]
- Anti-ILT4/Anti-PD-L1 Bispecific Antibody SPX-303 [NCIt concept]
- Anti-Inhibitor Coagulant Complex [NCIt concept]
- Anti-K-RAS G12D mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-K-RAS G12V mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-KIR Monoclonal Antibody IPH 2101 [NCIt concept]
- Anti-KIR3DL3 Monoclonal Antibody NPX267 [NCIt concept]
- Anti-KSP/Anti-VEGF siRNAs ALN-VSP02 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody Sym022 [NCIt concept]
- Anti-LAG-3/PD-1 Bispecific Antibody INCA32459 [NCIt concept]
- Anti-LAG-3/PD-L1 Bispecific Antibody FS118 [NCIt concept]
- Anti-LAIR1 Monoclonal Antibody NC525 [NCIt concept]
- Anti-LAIR1 Monoclonal Antibody NGM438 [NCIt concept]
- Anti-LILRB Monoclonal Antibody ADA-011 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody BMS-986406 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody IO-108 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody OR502 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody BND-35 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody IO-202 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody MK-0482 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody NGM831 [NCIt concept]
- Anti-LLT1 Monoclonal Antibody ZM008 [NCIt concept]
- Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102 [NCIt concept]
- Anti-Ly6E Antibody-Drug Conjugate RG 7841 [NCIt concept]
- Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C [NCIt concept]
- Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL [NCIt concept]
- Anti-MSLN/Anti-CD3 Bispecific Antibody ZW171 [NCIt concept]
- Anti-MUC1/EGFR Bispecific Antibody-drug Conjugate M1231 [NCIt concept]
- Anti-MUC16 CAR T-cells 27T51 [NCIt concept]
- Anti-MUC16/CD28 Bispecific Antibody REGN5668 [NCIt concept]
- Anti-MUC16/MMAE Antibody-drug Conjugate DMUC4064A [NCIt concept]
- Anti-Met Monoclonal Antibody Mixture Sym015 [NCIt concept]
- Anti-Mullerian Hormone Measurement [NCIt concept]
- Anti-NKG2A Monoclonal Antibody Sym025 [NCIt concept]
- Anti-NRP1 Antibody ASP1948 [NCIt concept]
- Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A [NCIt concept]
- Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso [NCIt concept]
- Anti-NaPi2b Antibody-drug Conjugate XMT-1592 [NCIt concept]
- Anti-Notch1 Monoclonal Antibody [NCIt concept]
- Anti-Nucleolin Aptamer AS1411 [NCIt concept]
- Anti-OFA Immunotherapeutic BB-MPI-03 [NCIt concept]
- Anti-OX40 Agonist Monoclonal Antibody GEN1055 [NCIt concept]
- Anti-OX40 Antibody BMS 986178 [NCIt concept]
- Anti-OX40 Monoclonal Antibody GSK3174998 [NCIt concept]
- Anti-OX40/CD137 Bispecific Antibody FS120 [NCIt concept]
- Anti-PD-1 Antibody/Anti-CTLA-4 Antibody/CD40 Agonist/TLR9 Agonist SV-102 [NCIt concept]
- Anti-PD-1 Antibody/IL-18 Variant Immunocytokine BPT567 [NCIt concept]
- Anti-PD-1 Fusion Protein AMP-224 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody MEDI0680 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody Sym021 [NCIt concept]
- Anti-PD-1/Anti-ILT4 Bispecific Antibody CDX-585 [NCIt concept]
- Anti-PD-1/Anti-PD-L1 Bispecific Antibody CTX-8371 [NCIt concept]
- Anti-PD-1/Anti-TGFbRII Bispecific Antibody INCA33890 [NCIt concept]
- Anti-PD-1/Anti-TIM-3 Bispecific Antibody AZD7789 [NCIt concept]
- Anti-PD-1/Anti-VEGF Bispecific Antibody AI-081 [NCIt concept]
- Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363 [NCIt concept]
- Anti-PD-1/IL-2 Fusion Protein TEV-56278 [NCIt concept]
- Anti-PD-1/IL-2Ra/IL-2 Fusion Protein REGN10597 [NCIt concept]
- Anti-PD-L1 Antibody-drug Conjugate SGN-PDL1V [NCIt concept]
- Anti-PD-L1 Antibody/IL-15 Fusion Protein IGM-7354 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody FAZ053 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody MDX-1105 [NCIt concept]
- Anti-PD-L1/Anti-4-1BB Bispecific Antibody ABL503 [NCIt concept]
- Anti-PD-L1/Anti-VEGF Bispecific Antibody [NCIt concept]
- Anti-PD-L1/Anti-VEGF-A Bispecific Antibody BNT327 [NCIt concept]
- Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 [NCIt concept]
- Anti-PD-L1/CD27 Bispecific Antibody CDX-527 [NCIt concept]
- Anti-PD-L1/IL-15 Fusion Protein KD033 [NCIt concept]
- Anti-PD-L1/PD-L2 Bispecific Antibody IMGS-001 [NCIt concept]
- Anti-PD-L1/TGFbetaRII Fusion Protein BJ-005 [NCIt concept]
- Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244 [NCIt concept]
- Anti-PD-L2 Monoclonal Antibody [NCIt concept]
- Anti-PD1/IL-15 Fusion Protein SAR445877 [NCIt concept]
- Anti-PLVAP CSR02-Fab-Tissue Factor [NCIt concept]
- Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4 [NCIt concept]
- Anti-PRAME Immunotherapeutic GSK2302032A [NCIt concept]
- Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C [NCIt concept]
- Anti-PSCA Monoclonal Antibody AGS-1C4D4 [NCIt concept]
- Anti-PSMA Antibody-drug Conjugate ABBV-969 [NCIt concept]
- Anti-PSMA Gamma Delta T-cell Engaging Bispecific Antibody LAVA-1207 [NCIt concept]
- Anti-PSMA Monoclonal Antibody-MMAE Conjugate [NCIt concept]
- Anti-PSMA/Anti-CD28 Bispecific Antibody JNJ-87189401 [NCIt concept]
- Anti-PSMA/CD3 Bispecific Antibody CCW702 [NCIt concept]
- Anti-PSMA/CD3 Bispecific Antibody REGN4336 [NCIt concept]
- Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414 [NCIt concept]
- Anti-PSMA/CD3 Protease-activated T-cell Engager JANX007 [NCIt concept]
- Anti-PSMA/PBD ADC MEDI3726 [NCIt concept]
- Anti-PTK7 Antibody-drug Conjugate [NCIt concept]
- Anti-PTK7/Exatecan Antibody-drug Conjugate DAY301 [NCIt concept]
- Anti-PTK7/MMAE ADC PRO1107 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody [NCIt concept]
- Anti-PVRIG Monoclonal Antibody COM701 [NCIt concept]
- Anti-Poliovirus Antibody [NCIt concept]
- Anti-Poliovirus Antibody Positive [NCIt concept]
- Anti-Progranulin Monoclonal Antibody AG01 [NCIt concept]
- Anti-RNF43 Antibody-drug Conjugate SC-006 [NCIt concept]
- Anti-ROR1 Antibody-drug Conjugate IM-1021 [NCIt concept]
- Anti-ROR1/Anti-CD3/Anti-HSA Trispecific Antibody NM32-2668 [NCIt concept]
- Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002 [NCIt concept]
- Anti-Reovirus Antibody [NCIt concept]
- Anti-S15 Monoclonal Antibody NC318 [NCIt concept]
- Anti-SARS-CoV-2 Monoclonal Antibodies AZD5156 [NCIt concept]
- Anti-SEZ6 Antibody-drug Conjugate ABBV-011 [NCIt concept]
- Anti-SIRP Monoclonal Antibody ELA026 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody ADU-1805 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody BI 765063 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody BI 770371 [NCIt concept]
- Anti-STEAP1 Antibody-drug Conjugate ADRX-0405 [NCIt concept]
- Anti-STEAP1 CAR T-cells [NCIt concept]
- Anti-STn Antibody-drug Conjugate SGN-STNV [NCIt concept]
- Anti-Siglec-10 Monoclonal Antibody ONC-841 [NCIt concept]
- Anti-Smith Antibody [NCIt concept]
- Anti-Smith Antibody Positive [NCIt concept]
- Anti-TA-MUC1/DXd Antibody-drug Conjugate DS-3939a [NCIt concept]
- Anti-TAA Monoclonal Antibody-chelator Conjugate BAY3547922 [NCIt concept]
- Anti-TCR Vb6/Vb10/IL-2 Antibody Fusion Protein STAR0602 [NCIt concept]
- Anti-TF Monoclonal Antibody ALT-836 [NCIt concept]
- Anti-TF/Exatecan Antibody-drug Conjugate ADCE-T02 [NCIt concept]
- Anti-TGF-beta 1/Anti-COX-2 siRNAs STP707 [NCIt concept]
- Anti-TGF-beta Monoclonal Antibody SAR-439459 [NCIt concept]
- Anti-TGF-beta RII Monoclonal Antibody IMC-TR1 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody [NCIt concept]
- Anti-TIGIT Monoclonal Antibody ASP8374 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody COM902 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody SGN-TGT [NCIt concept]
- Anti-TIGIT Monoclonal Antibody TAB006 [NCIt concept]
- Anti-TIGIT/Anti-CD96 Bispecific Antibody BMS-986442 [NCIt concept]
- Anti-TIM-3 Antibody BMS-986258 [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody S095018 [NCIt concept]
- Anti-TIM3 Monoclonal Antibody LY3321367 [NCIt concept]
- Anti-TMEFF2/Anti-CD3 Bispecific Antibody JNJ-70218902 [NCIt concept]
- Anti-TMPRSS6 Monoclonal Antibody DISC-3405 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody BI-1910 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody SIM1811-03 [NCIt concept]
- Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711 [NCIt concept]
- Anti-TREM1 Agonistic Monoclonal Antibody PY159 [NCIt concept]
- Anti-TREM2 Monoclonal Antibody EOS006215 [NCIt concept]
- Anti-TREM2 Monoclonal Antibody PY314 [NCIt concept]
- Anti-TROP-2 Antibody-drug Conjugate DB-1305 [NCIt concept]
- Anti-TROP-2 Antibody-drug Conjugate PBI-410 [NCIt concept]
- Anti-TROP-2 Antibody-drug Conjugate PF-06664178 [NCIt concept]
- Anti-TROP-2/MMAE Antibody-drug Conjugate LCB84 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate BIO-106 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate OBI-992 [NCIt concept]
- Anti-TROP2-CAR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Anti-TROP2/EGFR Bispecific Antibody-drug Conjugate DM001 [NCIt concept]
- Anti-TSPAN8/Anti-CD3 Bispecific Antibody ASP2074 [NCIt concept]
- Anti-TYRP1/CD3 T-cell Engager RO7293583 [NCIt concept]
- Anti-Thymocyte Globulin [NCIt concept]
- Anti-Tissue Factor Monoclonal Antibody MORAb-066 [NCIt concept]
- Anti-ULBP6 Monoclonal Antibody 23ME-01473 [NCIt concept]
- Anti-VEGF/ANG2 Nanobody BI 836880 [NCIt concept]
- Anti-VEGFC Monoclonal Antibody VGX-100 [NCIt concept]
- Anti-VEGFR2-CAR Retroviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-VEGFR3 Monoclonal Antibody IMC-3C5 [NCIt concept]
- Anti-VISTA Monoclonal Antibody HMBD-002 [NCIt concept]
- Anti-Vector Antibody [NCIt concept]
- Anti-Yeast Antibody [NCIt concept]
- Anti-alpha5beta1 Integrin Antibody MINT1526A [NCIt concept]
- Anti-angiopoietin Monoclonal Antibody AMG 780 [NCIt concept]
- Anti-c-KIT Monoclonal Antibody CDX 0158 [NCIt concept]
- Anti-c-Kit/MMAE Antibody-Drug Conjugate NN3201 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate HTI-1066 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate TR1801 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate YL211 [NCIt concept]
- Anti-c-Met/Anti-TROP2/Anti-CD3/Anti-CD28 Tetra-specific Antibody MDX2001 [NCIt concept]
- Anti-c-Met/EGFR/VEGF Trispecific Antibody TAVO412 [NCIt concept]
- Anti-c-Met/MMAE ADC MYTX-011 [NCIt concept]
- Anti-dectin-2 Agonist Monoclonal Antibody BDC-3042 [NCIt concept]
- Anti-ds DNA Antibody [NCIt concept]
- Anti-ds DNA Antibody Positive [NCIt concept]
- Anti-galectin-9 Monoclonal Antibody LYT-200 [NCIt concept]
- Anti-gpA33/CD3 Monoclonal Antibody MGD007 [NCIt concept]
- Anti-gremlin-1 Monoclonal Antibody TST003 [NCIt concept]
- Anti-hCD70-CAR Retroviral Vector-transduced Autologous PBLs [NCIt concept]
- Anti-hepcidin Monoclonal Antibody LY2787106 [NCIt concept]
- Anti-human Cytomegalovirus Monoclonal Antibody Combination CSJ-148 [NCIt concept]
- Anti-human GITR Monoclonal Antibody AMG 228 [NCIt concept]
- Anti-human GITR Monoclonal Antibody TRX518 [NCIt concept]
- Anti-integrin AlphaV/Beta8 Monoclonal Antibody CRB-601 [NCIt concept]
- Anti-integrin Beta-1 Monoclonal Antibody OS2966 [NCIt concept]
- Anti-interleukin-1 Beta Monoclonal Antibody [NCIt concept]
- Anti-interleukin-2 Receptor Subunit Gamma Monoclonal Antibody REGN7257 [NCIt concept]
- Anti-latent TGFb1 Monoclonal Antibody RO7496353 [NCIt concept]
- Anti-mesothelin Antibody-drug Conjugate BMS-986148 [NCIt concept]
- Anti-mesothelin Antibody-drug Conjugate SGN-MesoC2 [NCIt concept]
- Anti-mesothelin CAR Vector-transduced T-lymphocytes [NCIt concept]
- Anti-mesothelin CIR mRNA-electroporated Autologous T Cells [NCIt concept]
- Anti-mesothelin iCasp9M28z CAR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100 [NCIt concept]
- Anti-mesothelin/MMAE Antibody-drug Conjugate DMOT4039A [NCIt concept]
- Anti-mucin-1/CD16A Bispecific Antibody BGB-B3227 [NCIt concept]
- Anti-mutant Calreticulin Monoclonal Antibody INCA033989 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate ADRX-0706 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate IPH4502 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate LY4052031 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate LY4101174 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate MK-3120 [NCIt concept]
- Anti-nectin-4/MMAE Antibody-drug Conjugate CRB-701 [NCIt concept]
- Anti-prolactin Receptor Antibody LFA102 [NCIt concept]
- Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-uPARAP ADC ADCE-D01 [NCIt concept]
- Anti-von Willebrand Factor Nanobody [NCIt concept]
- Antiandrogen Therapy [NCIt concept]
- Antibiotic [NCIt concept]
- Antibiotic Therapy [NCIt concept]
- Antibody [NCIt concept]
- Antibody MIB-1 Staining Method [NCIt concept]
- Antibody ROSE12 [NCIt concept]
- Antibody Repertoire [NCIt concept]
- Antibody STING Drug Conjugate TAK-500 [NCIt concept]
- Antibody-Dependent Cellular Cytotoxicity [NCIt concept]
- Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014 [NCIt concept]
- Antibody-drug Conjugate PF-06647263 [NCIt concept]
- Antibody-drug Conjugate PHN-010 [NCIt concept]
- Antibody-drug Conjugate SC-007 [NCIt concept]
- Antibody/PNE-based Biologic Agent ABBV-461 [NCIt concept]
- Anticardiolipin Antibody [NCIt concept]
- Anticoagulant Agent [NCIt concept]
- Anticoagulation Therapy [NCIt concept]
- Anticonvulsant Agent [NCIt concept]
- Antiestrogen [NCIt concept]
- Antiestrogen Therapy [NCIt concept]
- Antifungal Agent VL-2397 [NCIt concept]
- Antigen KI-67 [NCIt concept]
- Antigen Peptide Transporter 1 [NCIt concept]
- Antigen Peptide Transporter 2 [NCIt concept]
- Antigen Presenting Cell [NCIt concept]
- Antigen-Presentation Machinery Expression Profile [NCIt concept]
- Antigen-Presenting Glycoprotein CD1d [NCIt concept]
- Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV [NCIt concept]
- Antigen-presenting Cells-expressing HPV16 E6/E7/CD86/mbIL-2/mbIL-12 SQZ-eAPC-HPV [NCIt concept]
- Antihemophilic Factor, Human Recombinant [NCIt concept]
- Antihormone Therapy [NCIt concept]
- Antihypertensive Therapy [NCIt concept]
- Antileukemic Agent [NCIt concept]
- Antileukoproteinase [NCIt concept]
- Antimetabolite FF-10502 [NCIt concept]
- Antimicrobial Peptide [NCIt concept]
- Antineoplastic Biological Agent [NCIt concept]
- Antineoplastic Immunomodulating Agent [NCIt concept]
- Antineoplastic Radiopharmaceutical Agent [NCIt concept]
- Antineutrophil Cytoplasmic Antibody [NCIt concept]
- Antineutrophil Cytoplasmic Antibody-Associated Vasculitis [NCIt concept]
- Antinuclear Antibody [NCIt concept]
- Antioxidants Therapy [NCIt concept]
- Antisense Oligonucleotide GTI-2040 [NCIt concept]
- Antisense Oligonucleotide QR-313 [NCIt concept]
- Antisense Therapy [NCIt concept]
- Antithrombin-III [NCIt concept]
- Antitumor Drug Screening Assay [NCIt concept]
- Antiviral Agent TGN-S11 [NCIt concept]
- Antiviral Innate Immune Response Receptor RIG-I [NCIt concept]
- Antiviral Therapy [NCIt concept]
- Antroquinonol Capsule [NCIt concept]
- Anvatabart Opadotin [NCIt concept]
- Anvumetostat [NCIt concept]
- Anxiety [NCIt concept]
- Anzurstobart [NCIt concept]
- Apadamtase Alfa [NCIt concept]
- Apalutamide [NCIt concept]
- Apatorsen [NCIt concept]
- Apaziquone [NCIt concept]
- Apelin [NCIt concept]
- Apilimod Dimesylate Capsule [NCIt concept]
- Apitolisib [NCIt concept]
- Apixaban [NCIt concept]
- Aplastic Anemia [NCIt concept]
- Aplitabart [NCIt concept]
- Apolipoprotein A [NCIt concept]
- Apolipoprotein A-I [NCIt concept]
- Apolipoprotein A-IV [NCIt concept]
- Apolipoprotein B-100 [NCIt concept]
- Apolipoprotein C-III [NCIt concept]
- Apolipoprotein E [NCIt concept]
- Apolipoprotein E4 [NCIt concept]
- Apolizumab [NCIt concept]
- Apomab [NCIt concept]
- Apoptosis Inducer BZL101 [NCIt concept]
- Apoptosis Inducer GCS-100 [NCIt concept]
- Apoptosis Inhibitor UL38 [NCIt concept]
- Apoptosis Marker [NCIt concept]
- Apoptosis Regulator BAX [NCIt concept]
- Apoptosis Regulator Bcl-2 [NCIt concept]
- Apoptosis-Associated Speck-Like Protein Containing A CARD [NCIt concept]
- Apoptosis-Inducing Factor 1, Mitochondrial [NCIt concept]
- Apoptotic Index [NCIt concept]
- Apoptotic Protease-Activating Factor 1 [NCIt concept]
- Appendix Carcinoma [NCIt concept]
- Appendix Mucinous Neoplasm [NCIt concept]
- Appendix Neuroendocrine Tumor [NCIt concept]
- Appetite-Regulating Hormone [NCIt concept]
- Apple Juice [NCIt concept]
- Apraglutide [NCIt concept]
- Apremilast [NCIt concept]
- Aprepitant [NCIt concept]
- ApricityRx [NCIt concept]
- Apricoxib [NCIt concept]
- Aprotinin [NCIt concept]
- Aprutumab Ixadotin [NCIt concept]
- Aqueous Volumeter [NCIt concept]
- Arabinofuranosylcytosine Triphosphate [NCIt concept]
- Arachidonate 12-Lipoxygenase, 12R-Type [NCIt concept]
- Arachidonate 12-Lipoxygenase, 12S-Type [NCIt concept]
- Arachidonate 15-Lipoxygenase [NCIt concept]
- Arachidonate 15-Lipoxygenase B [NCIt concept]
- Arachidonate 5-Lipoxygenase [NCIt concept]
- Arachidonic Acid [NCIt concept]
- Archive Sample Retrieval [NCIt concept]
- Arf-GAP with SH3 Domain, Ankyrin Repeat and PH Domain-Containing 1 [NCIt concept]
- Arfaptin-1 [NCIt concept]
- Arfolitixorin [NCIt concept]
- Argatroban [NCIt concept]
- Arginase-1 [NCIt concept]
- Arginase-2, Mitochondrial [NCIt concept]
- Arginase-based Agent [NCIt concept]
- Arginine [NCIt concept]
- Arginine Butyrate [NCIt concept]
- Argininosuccinate Synthase [NCIt concept]
- Argininosuccinic Acid [NCIt concept]
- Arlocabtagene Autoleucel [NCIt concept]
- Armodafinil [NCIt concept]
- Arnebia Indigo Jade Pearl Topical Cream [NCIt concept]
- Aromatase [NCIt concept]
- Aromatase Inhibition Therapy [NCIt concept]
- Aromatase Inhibitor [NCIt concept]
- Aromatherapy and Essential Oils [NCIt concept]
- Aromatic-L-Amino-Acid Decarboxylase [NCIt concept]
- Arrestin Domain-Containing Protein 3 [NCIt concept]
- Arsenic [NCIt concept]
- Arsenic Trioxide [NCIt concept]
- Arsenic Trioxide Capsule Formulation ORH 2014 [NCIt concept]
- Art Therapy [NCIt concept]
- Artemisia annua Decaffeinated Coffee [NCIt concept]
- Arterial Embolization [NCIt concept]
- Arterial Spin Labeling Magnetic Resonance Imaging [NCIt concept]
- Arteriography [NCIt concept]
- Artesunate [NCIt concept]
- Arthralgia [NCIt concept]
- Artificial Urinary Sphincter Implantation [NCIt concept]
- Aryl Hydrocarbon Receptor [NCIt concept]
- Aryl Hydrocarbon Receptor Inhibitor IK-175 [NCIt concept]
- Aryl Hydrocarbon Receptor Nuclear Translocator [NCIt concept]
- Arylamine N-Acetyltransferase 1 [NCIt concept]
- Arylamine N-Acetyltransferase 2 [NCIt concept]
- Arylsulfatase A [NCIt concept]
- Asbestos-Related Lung Carcinoma [NCIt concept]
- Ascorbic Acid [NCIt concept]
- Ascrinvacumab [NCIt concept]
- Asimov Imaging Platform [NCIt concept]
- Askin Tumor [NCIt concept]
- Aspacytarabine [NCIt concept]
- Asparaginase [NCIt concept]
- Asparaginase Antibody [NCIt concept]
- Asparaginase Erwinia chrysanthemi [NCIt concept]
- Asparagine [NCIt concept]
- Asparagine Synthetase [Glutamine-Hydrolyzing] [NCIt concept]
- Aspartate Aminotransferase [NCIt concept]
- Aspartic Acid [NCIt concept]
- Aspartyl/Asparaginyl Beta-Hydroxylase [NCIt concept]
- Aspartylglycosaminuria [NCIt concept]
- Aspira Indwelling Catheter [NCIt concept]
- Aspiration of Breast [NCIt concept]
- Aspirin [NCIt concept]
- Assessment [NCIt concept]
- Assessment of Therapy Complications [NCIt concept]
- Assistance [NCIt concept]
- AssureMDx [NCIt concept]
- Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10 [NCIt concept]
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 [NCIt concept]
- Astrocytic Phosphoprotein PEA-15 [NCIt concept]
- Astrocytoma [NCIt concept]
- Astuprotimut-R [NCIt concept]
- Asymmetric Dimethylarginine [NCIt concept]
- Asymptomatic COVID-19 Infection Laboratory-Confirmed [NCIt concept]
- Asymptomatic HIV Infection [NCIt concept]
- Atamparib [NCIt concept]
- Ataxia Telangiectasia Syndrome [NCIt concept]
- Ataxin-1 [NCIt concept]
- Atazanavir/Ritonavir [NCIt concept]
- Atenolol [NCIt concept]
- Atezolizumab [NCIt concept]
- Atezolizumab and Recombinant Human Hyaluronidase [NCIt concept]
- Atherosclerotic Plaque [NCIt concept]
- Atibuclimab [NCIt concept]
- Atigotatug [NCIt concept]
- Atigotatug/Nivolumab [NCIt concept]
- Atiprimod [NCIt concept]
- Atirmociclib [NCIt concept]
- Atopic Dermatitis [NCIt concept]
- Atopobium [NCIt concept]
- Atorvastatin Calcium [NCIt concept]
- Atrasentan Hydrochloride [NCIt concept]
- Attenuated Live Listeria monocytogenes Encoding KRAS G12D [NCIt concept]
- Attenuated S. typhimurium Carrying IL-15/IL-15Ra and Engineered STING-encoding DNA Plasmid ACTM-838 [NCIt concept]
- Attractin [NCIt concept]
- Atuveciclib [NCIt concept]
- Atypical Chemokine Receptor 1 [NCIt concept]
- Atypical Chemokine Receptor 3 [NCIt concept]
- Atypical Chronic Myeloid Leukemia [NCIt concept]
- Atypical Endocervical Glandular Cell of Undetermined Significance [NCIt concept]
- Atypical Glandular Cell of Undetermined Significance [NCIt concept]
- Atypical Lymph Node [NCIt concept]
- Atypical Small Acinar Proliferation of the Prostate Gland [NCIt concept]
- Atypical Squamous Cell of Undetermined Significance [NCIt concept]
- Audio Acquisition [NCIt concept]
- Audiovisual Material [NCIt concept]
- Augmentation Mammoplasty [NCIt concept]
- Augmented Reality [NCIt concept]
- Augmented Reality Intervention [NCIt concept]
- Aumolertinib [NCIt concept]
- Auranofin [NCIt concept]
- AuroLase Therapy [NCIt concept]
- Aurora A Kinase Inhibitor JAB-2485 [NCIt concept]
- Aurora A Kinase Inhibitor LY3295668 [NCIt concept]
- Aurora A Kinase Inhibitor LY3295668 Erbumine [NCIt concept]
- Aurora A Kinase Inhibitor MK5108 [NCIt concept]
- Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076 [NCIt concept]
- Aurora B Serine/Threonine Kinase Inhibitor TAK-901 [NCIt concept]
- Aurora B/VEGFR/FGFR Inhibitor AL8326 [NCIt concept]
- Aurora Kinase A [NCIt concept]
- Aurora Kinase A Inhibitor [NCIt concept]
- Aurora Kinase B [NCIt concept]
- Aurora Kinase C [NCIt concept]
- Aurora Kinase Inhibitor AMG 900 [NCIt concept]
- Aurora Kinase Inhibitor SNS-314 [NCIt concept]
- Aurora Kinase/VEGFR2 Inhibitor CYC116 [NCIt concept]
- Autoantibody [NCIt concept]
- Autogene Cevumeran [NCIt concept]
- Autoimmune Disease [NCIt concept]
- Autoimmune Lymphoproliferative Syndrome [NCIt concept]
- Autoimmune Polyglandular Syndrome [NCIt concept]
- Autoimmune Regulator [NCIt concept]
- Autologous 19-28z/IL-18 CAR T-lymphocytes [NCIt concept]
- Autologous 4-1BB Selected Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 [NCIt concept]
- Autologous ALPG/ALPP-targeted Anti-MSLN CAR-Fas/PTPN2 shRNA-miR-expressing T-lymphocytes AB-1015 [NCIt concept]
- Autologous AML/Dendritic Cell Fusion Vaccine [NCIt concept]
- Autologous Active IL-7 Receptor Co-expressing GD2-specific CAR T-cells [NCIt concept]
- Autologous Ad-CD154-Transduced CLL B Cells [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 and CD19-specific Adapter Molecule SWI019 [NCIt concept]
- Autologous Anti-ALK CAR T-cells [NCIt concept]
- Autologous Anti-B7-H3 CAR T-cells TX103 [NCIt concept]
- Autologous Anti-B7-H3 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-B7-H3/CD19 CAR T-cells SCRI-CARB7H3(s)x19 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells MCARH125 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells PHE885 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells UF-KURE-BCMA [NCIt concept]
- Autologous Anti-BCMA CAR-transduced T-cells KITE-585 [NCIt concept]
- Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 [NCIt concept]
- Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-expressing T-cells NXC-201 [NCIt concept]
- Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA [NCIt concept]
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 [NCIt concept]
- Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes [NCIt concept]
- Autologous Anti-BCMA/CS1 Bispecific CAR-T Cells [NCIt concept]
- Autologous Anti-CD123 CAR TCR/4-1BB-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-CD123 CAR-T Cells [NCIt concept]
- Autologous Anti-CD19 AbTCR-expressing T-lymphocytes EB103 [NCIt concept]
- Autologous Anti-CD19 CAR T Cells KITE-197 [NCIt concept]
- Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx [NCIt concept]
- Autologous Anti-CD19 CAR T-cells GLPG5101 [NCIt concept]
- Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 [NCIt concept]
- Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-CD19 CAR-CD8alpha-CD28-CD3zeta T Cells KYV 101 [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells CABA-201 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes UF-KURE19 [NCIt concept]
- Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 [NCIt concept]
- Autologous Anti-CD19 KIR-CAR-transduced T-cells SynKIR-310 [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor Fusion Construct T-cells TC-110 [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor T cells ET190L1 [NCIt concept]
- Autologous Anti-CD19/Anti-CD20-CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing Tn/mem Cells [NCIt concept]
- Autologous Anti-CD19/Anti-CD79b CAR-expressing Bispecific T-cells [NCIt concept]
- Autologous Anti-CD19/CD20 CAR-T Cells KITE-363 [NCIt concept]
- Autologous Anti-CD19/CD20/CD22 CAR T-cells [NCIt concept]
- Autologous Anti-CD19/CD22 CAR T-cells AUTO3 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T-lymphocytes SCRI-huCAR19v2 [NCIt concept]
- Autologous Anti-CD19CAR-CD28tm/4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T-lymphocytes SCRI-huCAR19v1 [NCIt concept]
- Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-CD20 CAR T-cells C-CAR066 [NCIt concept]
- Autologous Anti-CD20CAR-CD28-4-1BB-CD3zeta T-lymphocytes MB-106 [NCIt concept]
- Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s [NCIt concept]
- Autologous Anti-CD22 CAR-expressing T-cells SCRI-CAR22v2 [NCIt concept]
- Autologous Anti-CD3/Anti-EGFR Bispecific Antibody Armed Peripheral Blood Mononuclear Cells [NCIt concept]
- Autologous Anti-CD3/Anti-SLAMF7 Bispecific Antibody-armed Activated T-lymphocytes [NCIt concept]
- Autologous Anti-CD33 CAR-mbIL15-Safety Switch T-cells PRGN-3006 [NCIt concept]
- Autologous Anti-CD38 A2 CAR2-expressing T-cells [NCIt concept]
- Autologous Anti-CD4 CAR T-cells LB1901 [NCIt concept]
- Autologous Anti-CD5 CAR Monocytes MT-101 [NCIt concept]
- Autologous Anti-CD5 CAR T-lymphocytes MB-105 [NCIt concept]
- Autologous Anti-CD7-CAR-CD28zeta T-cells [NCIt concept]
- Autologous Anti-CD79a/anti-CD20 CAR T-cells bbT369 [NCIt concept]
- Autologous Anti-CD83 CAR T-cells [NCIt concept]
- Autologous Anti-CEA CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B530 [NCIt concept]
- Autologous Anti-CLDN18.2 TAC T-cells TAC01-CLDN18.2 [NCIt concept]
- Autologous Anti-CLL-1-CAR T-lymphocytes KITE-222 [NCIt concept]
- Autologous Anti-CSPG4 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-Claudin18.2 CAR T-cells LB1908 [NCIt concept]
- Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells [NCIt concept]
- Autologous Anti-EGFRvIII synNotch Receptor-induced Anti-EphA2/IL-13Ralpha2 CAR-T Cells [NCIt concept]
- Autologous Anti-FGFR4 CAR T-cells [NCIt concept]
- Autologous Anti-FLT3 CAR-T Cells HG-CT-1 [NCIt concept]
- Autologous Anti-FSHR CER-4-1BB/CD3zeta-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-GD2-CAR-BBz-iCasp9 Retroviral Vector-transduced T Lymphocytes [NCIt concept]
- Autologous Anti-GD2CAR-CD28-CD3zeta-IL-15-expressing Natural Killer T-cells [NCIt concept]
- Autologous Anti-GFRa4 CAR-TCR-zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-GPC2-CAR T-cells [NCIt concept]
- Autologous Anti-GPRC5D CAR-T Cells OriCAR-017 [NCIt concept]
- Autologous Anti-GPRC5D-CAR-4-1BB-expressing T-cells MCARH109 [NCIt concept]
- Autologous Anti-H3.3K27M TCR-expressing T-cells [NCIt concept]
- Autologous Anti-HER2 CAR Macrophages CT-0508 [NCIt concept]
- Autologous Anti-HER2 CAR Monocytes CT-0525 [NCIt concept]
- Autologous Anti-HER2 CAR-CD28 T Cells [NCIt concept]
- Autologous Anti-HER2 CAR-T Cells [NCIt concept]
- Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 [NCIt concept]
- Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140203 [NCIt concept]
- Autologous Anti-HLA-G CAR-T Cells IVS-3001 [NCIt concept]
- Autologous Anti-HPV-16 E6 T-cell Receptor Gene-engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 [NCIt concept]
- Autologous Anti-KK-LC-1 TCR-expressing T-cells [NCIt concept]
- Autologous Anti-L1CAM-CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-A0201 [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-C0702 [NCIt concept]
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-MART-1 F5 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-MSLN CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B694 [NCIt concept]
- Autologous Anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-MUC16 CAR-mbIL15-Safety Switch T-cells PRGN-3005 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/dnTGF-BRII-expressing T-cells GSK3845097 [NCIt concept]
- Autologous Anti-NY-ESO-1 mTCR Retroviral Vector Transduced PBLs [NCIt concept]
- Autologous Anti-PRAME TCR/CD8alphabeta-expressing T-cells IMA203CD8 [NCIt concept]
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-PSMA CAR-T Cells P-PSMA-101 [NCIt concept]
- Autologous Anti-PSMA Gene-Modified T-Lymphocytes [NCIt concept]
- Autologous Anti-ROR1 CAR T-cells LYL797 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells BMS-986403 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells ONCT-808 [NCIt concept]
- Autologous Anti-ROR1 CAR-mbIL15-Safety Switch/Intrinsic PD-1 Blockade T-cells PRGN-3007 [NCIt concept]
- Autologous Anti-SLAMF7 CAR-expressing T-cells [NCIt concept]
- Autologous Anti-glypican-3 CAR-IL-15-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T-cells [NCIt concept]
- Autologous Anti-mesothelin KIR-CAR-transduced T-cells SynKIR-110 [NCIt concept]
- Autologous Anti-mesothelin M28z1XXPD1DNR CAR-expressing T-cells [NCIt concept]
- Autologous Anti-mesothelin TCR-expressing T-cells FH-TCR TMSLN [NCIt concept]
- Autologous Anti-mesothelin TNhYP218 CAR T-cells [NCIt concept]
- Autologous BAFF-expressing CAR T Cells LMY-920 [NCIt concept]
- Autologous BAFFR-targeting CAR T Cells [NCIt concept]
- Autologous BCL11A-disrupted Human Hematopoietic Stem and Progenitor Cells HIX763 [NCIt concept]
- Autologous BCMA-targeted CAR T Cells CC-98633 [NCIt concept]
- Autologous Base Edited CD34+ HSPCs BEAM-101 [NCIt concept]
- Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F [NCIt concept]
- Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells [NCIt concept]
- Autologous Blood Patch Pleurodesis [NCIt concept]
- Autologous Bone Marrow Transplantation [NCIt concept]
- Autologous Bone Marrow Transplantation Recipient [NCIt concept]
- Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 [NCIt concept]
- Autologous CAR-T Cells [NCIt concept]
- Autologous CAR-engineered Regulatory T-cells SBT777101 [NCIt concept]
- Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes [NCIt concept]
- Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes MB-102 [NCIt concept]
- Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Autologous CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous CD19 CAR+ EGFRt + CD4+ and CD8+ T Cells [NCIt concept]
- Autologous CD19-28z Chimeric Antigen Receptor-expressing T-lymphocytes [NCIt concept]
- Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells [NCIt concept]
- Autologous CD19/CD22 Chimeric Antigen Receptor T-cells CT120 [NCIt concept]
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T Cells [NCIt concept]
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes [NCIt concept]
- Autologous CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes [NCIt concept]
- Autologous CD34+ enriched Alpha-L-iduronidase-expressing Hematopoietic Stem Cells OTL-203 [NCIt concept]
- Autologous CD34+-enriched HSPCs Transduced with LV Vector Carrying TCIRG1 Gene RP-L401 [NCIt concept]
- Autologous CD34-positive BCL11A-disrupted Hematopoietic Progenitor Cells BIVV003 [NCIt concept]
- Autologous CD34-positive BCL11A-disrupted Hematopoietic Progenitor Cells ST-400 [NCIt concept]
- Autologous CD34-positive Peripheral Blood Stem Cells [NCIt concept]
- Autologous CD4 and CD8 Positive Truncated CD19-expressing Antigen Presenting T-cells [NCIt concept]
- Autologous CD4+/CD8+ 4-1BB-CD3zeta-EGFR806-CAR-EGFRt/4-1BB-CD3zeta-CD19-CAR-HER2tG-expressing CARs T Cells [NCIt concept]
- Autologous CD4+/CD8+ EGFR806 Specific 4-1BB-CD3zeta-EGFRt-expressing CAR T Cells [NCIt concept]
- Autologous CD40L-expressing B-CLL Vaccine [NCIt concept]
- Autologous CD5-specific CAR-28 zeta CAR T-cells [NCIt concept]
- Autologous CD5KO Anti-CD5 CAR 4-1BB-expressing T-lymphocytes and Autologous CD5KO T-lymphocytes [NCIt concept]
- Autologous CD8 Positive PBL Sensitized to Drosophila Cell-Presented Melanoma Peptides [NCIt concept]
- Autologous CD8+ SLC45A2-specific T Lymphocytes [NCIt concept]
- Autologous CISH-inactivated TILs [NCIt concept]
- Autologous CLTX-targeted CAR T-lymphocytes CHM 1101 [NCIt concept]
- Autologous CMV pp65/Total Tumor mRNA-loaded Lipid Particle Vaccine [NCIt concept]
- Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine [NCIt concept]
- Autologous CMV-pp65-shLAMP-1 mRNA Loaded Dendritic Cell Vaccine [NCIt concept]
- Autologous CRISPR-Cas9 Engineered Regnase-1/SOCS1 Dual-edited Tumor Infiltrating Lymphocytes KSQ-004EX [NCIt concept]
- Autologous CRISPR-Cas9 Engineered Tumor Infiltrating Lymphocytes KSQ-001EX [NCIt concept]
- Autologous CRISPR-Cas9 Modified/BCL11A Gene-disrupted Human Hematopoietic Stem and Progenitor Cells OTQ923 [NCIt concept]
- Autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T-cells [NCIt concept]
- Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells [NCIt concept]
- Autologous Cell Immunotherapy [NCIt concept]
- Autologous Cryopreserved Cell Infusion [NCIt concept]
- Autologous Cultured Acute Myeloid Leukemia-specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous Cytokine-induced Killer Cells/Vaccinia Virus DD-CDSR CRX100 [NCIt concept]
- Autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous Deep IL-15 Primed T-cells TRQ15-01 [NCIt concept]
- Autologous Dendritic Cell-Adenovirus CCL21 Vaccine [NCIt concept]
- Autologous Dendritic Cell-Adenovirus P53 Vaccine [NCIt concept]
- Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine [NCIt concept]
- Autologous Dendritic Cell-Tumor Fusion Vaccine [NCIt concept]
- Autologous Dendritic Cell/Myeloma Fusion Vaccine [NCIt concept]
- Autologous Dendritic Cells Pulsed with MART-1 (26-35) Peptide [NCIt concept]
- Autologous Dendritic Cells Transduced with Wild-type p53 Adenovirus Vaccine [NCIt concept]
- Autologous Desmoglein-3 Chimeric Autoantibody Receptor T-cells DSG3-CAART [NCIt concept]
- Autologous E6 T Cell Receptor Genetically-modified T Cells [NCIt concept]
- Autologous EBV-CTL CD19CAR zeta [NCIt concept]
- Autologous EGFRt/19-28z/4-1BBL CAR T-Lymphocytes [NCIt concept]
- Autologous Enhanced NY-ESO-1 TCR Engineered T-cells GSK4427296 [NCIt concept]
- Autologous Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous Fat Graft [NCIt concept]
- Autologous Fecal Microbiota Transplantation [NCIt concept]
- Autologous Follicular Lymphoma-Derived Idiotype Vaccine [NCIt concept]
- Autologous GCC-targeting CAR T Cells GCC19CART [NCIt concept]
- Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine [NCIt concept]
- Autologous GM-CSF-secreting Lethally Irradiated Leukemia Cell Vaccine [NCIt concept]
- Autologous GM-CSF-secreting Lethally Irradiated Pancreatic Cancer Vaccine [NCIt concept]
- Autologous Gamma Delta T-cell Receptor-expressing T-cells TEG002 [NCIt concept]
- Autologous Gamma-retroviral MSGV1 139 scFv EGFRvIII CAR Gene-modified T Cells [NCIt concept]
- Autologous Gene-modified Gamma Delta T-cells [NCIt concept]
- Autologous HBV-specific TCR-expressing T-lymphocytes SCG101 [NCIt concept]
- Autologous HER2-CAR-modified Adenovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous HER2-targeted Dual-switch CAR-T Cells BPX-603 [NCIt concept]
- Autologous HIV Gag-specific CD4+ T-cells AGT103-T [NCIt concept]
- Autologous HLA-A*11:01 KRASG12V-specific TCR-expressing CD8- and CD4-positive T-lymphocytes AFNT-211 [NCIt concept]
- Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 [NCIt concept]
- Autologous Hematopoietic Stem Cell Transplant Recipient [NCIt concept]
- Autologous Hematopoietic Stem Cell Transplantation [NCIt concept]
- Autologous IL-12/Multi-targeted Primed T-cells RPTR 168 [NCIt concept]
- Autologous IL-15-expanded HER2-specific CD4+ T-cells [NCIt concept]
- Autologous IL-15/IL-21-armored Anti-glypican-3 CAR T-cells [NCIt concept]
- Autologous IL-2-expressing B-CLL Vaccine [NCIt concept]
- Autologous IL-7-expanded HER2-specific CD4+ T-cells [NCIt concept]
- Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine [NCIt concept]
- Autologous Islet Cell Transplantation [NCIt concept]
- Autologous KRAS G12D Mutant-specific HLA-C*08:02-/KRAS G12D Mutant-specific HLA-A*11:01-/KRAS G12V Mutant-specific HLA-C*01:02-/TP53 R175H Mutant-specific HLA-A*02:01-restricted TCR Genes Engineered T-lymphocytes [NCIt concept]
- Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR Gene Engineered T-lymphocytes NT-112 [NCIt concept]
- Autologous KRAS Mutant-specific TCRs Gene Engineered PBLs [NCIt concept]
- Autologous LMP1-/LMP2- Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Autologous Lymphocyte [NCIt concept]
- Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine [NCIt concept]
- Autologous MAGE-A10-specific HLA-A2-restricted TCR c796 Gene-engineered Lymphocytes [NCIt concept]
- Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 [NCIt concept]
- Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR [NCIt concept]
- Autologous MGMTP140K Lentiviral Vector-transduced HSCs [NCIt concept]
- Autologous MUC1-activated T-cells [NCIt concept]
- Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Autologous Memory Cytokine-enriched Natural Killer Cells [NCIt concept]
- Autologous Mesothelin-specific CAR-T Cells [NCIt concept]
- Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 [NCIt concept]
- Autologous Monocytes [NCIt concept]
- Autologous Muscle-derived Cells for Gastrointestinal Repair [NCIt concept]
- Autologous NKG2D CAR T-cells CYAD-02 [NCIt concept]
- Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 [NCIt concept]
- Autologous NY-ESO-1 TCR-targeted T Lymphocytes [NCIt concept]
- Autologous NY-ESO-1-Melanoma-Specific CD8+ T-lymphocytes [NCIt concept]
- Autologous NY-ESO-1-specific CD8-positive T Lymphocytes [NCIt concept]
- Autologous NY-ESO-1/LAGE-1a-specific HLA-A*02:01-restricted TCR-expressing T-lymphocytes MDG1015 [NCIt concept]
- Autologous Native ESR1-pulsed DC1 Vaccine Alternating with Autologous Mutated ESR1-pulsed DC1 Vaccine [NCIt concept]
- Autologous Natural Killer Cell-like CTLs [NCIt concept]
- Autologous Natural Killer Cells SNK01 [NCIt concept]
- Autologous Neoantigen-specific T-lymphocytes GEN-011 [NCIt concept]
- Autologous Neuroblastoma Lysate/KLH-pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous Orthogonal IL-2Rbeta-expressing Anti-CD19 CAR T-cells SYNCAR-001 [NCIt concept]
- Autologous Ovarian Tissue Transplantation [NCIt concept]
- Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous PBLs Retrovirally-transduced with TCRs Targeting Neoantigens [NCIt concept]
- Autologous PBMCs in GM-CSF [NCIt concept]
- Autologous PBTL CD19CAR-28 zeta [NCIt concept]
- Autologous PD-1-knockout Tumor-infiltrating Lymphocytes IOV-4001 [NCIt concept]
- Autologous PRAME-targeting TCR-engineered T-cells IMA203 [NCIt concept]
- Autologous PSMA-inducible Anti-CA9 CAR T-cells AB-2100 [NCIt concept]
- Autologous Peripheral Blood Lymphocytes Cotransduced with Retroviral Vectors Encoding Inducible IL-12 and Anti-NY-ESO-1 TCR [NCIt concept]
- Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 [NCIt concept]
- Autologous Peripheral Blood Mononuclear Cells [NCIt concept]
- Autologous Pluripotent ALDHbr Stem Cells ALD-451 [NCIt concept]
- Autologous Polyclonal Tumor Infiltrating Lymphocytes LYL845 [NCIt concept]
- Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 [NCIt concept]
- Autologous Retroviral Vector MSGV1-transduced Anti-PSCA-8T28Z CAR Gamma Delta T-cells [NCIt concept]
- Autologous SIRPa-depleted Activated Macrophages SI-101 [NCIt concept]
- Autologous Sarcoma Cell Lysate [NCIt concept]
- Autologous Stem Cell Transplant Recipient [NCIt concept]
- Autologous TBX-4000-treated Peripheral Blood Mononuclear Cells TBX-3400 [NCIt concept]
- Autologous TCR-engineered T-cells IMA201 [NCIt concept]
- Autologous TCR-engineered T-cells IMA202 [NCIt concept]
- Autologous TGFbRII-4-1BB CSR-armored HPV16/52 E7-specific HLA-A*02:01-restricted TCR T-lymphocytes SCG142 [NCIt concept]
- Autologous TGFbRII-knockout Anti-interleukin-13 Receptor Alpha 2 CAR T-cells [NCIt concept]
- Autologous TGFbeta-Resistant HER2/EBV-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous TIM-4 Chimeric Engulfment Receptor T-cells CER-1236 [NCIt concept]
- Autologous TNS9.3.55-transduced CD34-positive Cells [NCIt concept]
- Autologous TP53 R175H Mutant-specific HLA-A*02:01-restricted TCR Gene Engineered T-lymphocytes NT-175 [NCIt concept]
- Autologous Tn-MUC1-specific CAR T-lymphocytes [NCIt concept]
- Autologous Tolerogenic Proinsulin Peptide-loaded Dendritic Cells PIpepTolDC [NCIt concept]
- Autologous Total Tumor mRNA Loaded Liposome Vaccine [NCIt concept]
- Autologous Tumor Cell Vaccine [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes C-TIL051 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes ITIL-168 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145-S1 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes TBio-4101 [NCIt concept]
- Autologous Tumor Membrane Vesicles Vaccine [NCIt concept]
- Autologous UCD19 CAR T Cells [NCIt concept]
- Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes [NCIt concept]
- Autologous WT1-directed CRISPR/Cas9-engineered TCR-T Cells NTLA-5001 [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-GPC3 CAR T-cells AZD5851 [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-STEAP2 CAR T-cells AZD0754 [NCIt concept]
- Autologous gamma-globinG16D/sh RNA734 Gene-transduced CD34-positive Cells CSL200 [NCIt concept]
- Autologous iC9-GD2-CAR-expressing VZV-specific T Lymphocytes [NCIt concept]
- Autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T-lymphocytes [NCIt concept]
- Autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T-lymphocytes [NCIt concept]
- Autologous iCASP9-CD19-expressing T-Lymphocytes [NCIt concept]
- Autologous iCasp9-deltaNGFR-CD19CAR-expressing T Cells [NCIt concept]
- Autologous mDC3 Vaccine [NCIt concept]
- Autologous mDC3/8-KRAS Vaccine [NCIt concept]
- Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation [NCIt concept]
- Autologous-Autologous Tandem Hematopoietic Stem Cell Transplantation [NCIt concept]
- Automated Breast Ultrasound [NCIt concept]
- Automated Video-Assisted Smoking Treatment [NCIt concept]
- Autophagy [NCIt concept]
- Autophagy Protein 5 [NCIt concept]
- Autophagy-Related Protein 13 [NCIt concept]
- Autopsy [NCIt concept]
- Autoradiography [NCIt concept]
- Autosomal Dominant Pathogenic Germline Variant [NCIt concept]
- Autosomal Recessive Osteopetrosis 8 [NCIt concept]
- Avadomide [NCIt concept]
- Avadomide Hydrochloride [NCIt concept]
- Avanafil [NCIt concept]
- Avapritinib [NCIt concept]
- Avdoralimab [NCIt concept]
- Avelumab [NCIt concept]
- Avena sativa [NCIt concept]
- Avipendekin Pegol [NCIt concept]
- Aviptadil [NCIt concept]
- Avutometinib [NCIt concept]
- Axalimogene Filolisbac [NCIt concept]
- Axatilimab [NCIt concept]
- Axicabtagene Ciloleucel [NCIt concept]
- Axillary Lymph Node Biopsy [NCIt concept]
- Axillary Lymph Node Dissection [NCIt concept]
- Axillary Radiation Therapy [NCIt concept]
- Axillary Reverse Mapping [NCIt concept]
- Axin-1 [NCIt concept]
- Axin-2 [NCIt concept]
- Axitinib [NCIt concept]
- Axl/Mer Inhibitor INCB081776 [NCIt concept]
- Axl/Mer Inhibitor PF-07265807 [NCIt concept]
- Azacitidine [NCIt concept]
- Azadirachta indica [NCIt concept]
- Azeliragon [NCIt concept]
- Azenosertib [NCIt concept]
- Azercabtagene Zapreleucel [NCIt concept]
- Azerutamig [NCIt concept]
- Azintuxizumab Vedotin [NCIt concept]
- Azithromycin [NCIt concept]
- Azithromycin Monohydrate [NCIt concept]
- Aztreonam [NCIt concept]
- Azurin:50-77 Cell Penetrating Peptide p28 [NCIt concept]
- B Acute Lymphoblastic Leukemia [NCIt concept]
- B Acute Lymphoblastic Leukemia Associated with Down Syndrome [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1 [NCIt concept]
- B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified [NCIt concept]
- B Lymphoblastic Lymphoma [NCIt concept]
- B Melanoma Antigen 1 [NCIt concept]
- B- and T-Lymphocyte Attenuator [NCIt concept]
- B-Cell Antigen Receptor Complex-Associated Protein Alpha Chain [NCIt concept]
- B-Cell Antigen Receptor Complex-Associated Protein Beta Chain [NCIt concept]
- B-Cell CLL/Lymphoma 9-Like Protein [NCIt concept]
- B-Cell Lymphoma 6 Protein [NCIt concept]
- B-Cell Lymphoma Protein 3 [NCIt concept]
- B-Cell Lymphoma/Leukemia 11A [NCIt concept]
- B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- B-Cell Prolymphocytic Leukemia [NCIt concept]
- B-Cell Receptor CD22 [NCIt concept]
- B-Cell Receptor Complex [NCIt concept]
- B-Cell Receptor Complex Profile [NCIt concept]
- B-Cell Receptor-Associated Protein 31 [NCIt concept]
- B-Lymphocyte [NCIt concept]
- B-Lymphocyte Antigen CD19 [NCIt concept]
- B-Lymphocyte Antigen CD20 [NCIt concept]
- B-Mode Ultrasound Imaging [NCIt concept]
- B-Raf/VEGFR-2 Inhibitor RAF265 [NCIt concept]
- B. infantis-based Formulation PBCLN-014 [NCIt concept]
- B16alphaGal Melanoma Vaccine [NCIt concept]
- B2M Gene [NCIt concept]
- B2M wt Allele [NCIt concept]
- B3GAT1 Gene [NCIt concept]
- B3GAT1 wt Allele [NCIt concept]
- B3GAT2 Gene [NCIt concept]
- B3GAT2 wt Allele [NCIt concept]
- B4GALNT1 Gene [NCIt concept]
- B4GALNT1 wt Allele [NCIt concept]
- B4GALT1 Gene [NCIt concept]
- B4GALT1 wt Allele [NCIt concept]
- B4GALT6 Gene [NCIt concept]
- B4GALT6 wt Allele [NCIt concept]
- B7-DC Crosslinking Antibody rHIgM12B7 [NCIt concept]
- B7-H3-targeting Agent [NCIt concept]
- B7-H4-targeting Agent [NCIt concept]
- B7H3/CD3-targeting T-cell Engaging Molecule TAK-280 [NCIt concept]
- BAALC Gene [NCIt concept]
- BAALC wt Allele [NCIt concept]
- BABAM1 Gene [NCIt concept]
- BABAM1 wt Allele [NCIt concept]
- BABAM2 Gene [NCIt concept]
- BABAM2 wt Allele [NCIt concept]
- BACH2 Gene [NCIt concept]
- BACH2 wt Allele [NCIt concept]
- BAG Family Molecular Chaperone Regulator 1 [NCIt concept]
- BAG Family Molecular Chaperone Regulator 3 [NCIt concept]
- BAG1 Gene [NCIt concept]
- BAG1 wt Allele [NCIt concept]
- BAG3 Gene [NCIt concept]
- BAG3 wt Allele [NCIt concept]
- BAGE Gene [NCIt concept]
- BAGE wt Allele [NCIt concept]
- BAIAP2L1 Gene [NCIt concept]
- BAIAP2L1 wt Allele [NCIt concept]
- BAP1 Gene [NCIt concept]
- BAP1 Gene Mutation [NCIt concept]
- BAP1 Loss of Function Gene Mutation [NCIt concept]
- BAP1 Negative [NCIt concept]
- BAP1 wt Allele [NCIt concept]
- BARD1 Gene [NCIt concept]
- BARD1 Gene Mutation [NCIt concept]
- BARD1 wt Allele [NCIt concept]
- BASE47 Gene Signature [NCIt concept]
- BASP1 Gene [NCIt concept]
- BASP1 wt Allele [NCIt concept]
- BAT25 [NCIt concept]
- BAT26 [NCIt concept]
- BAX Gene [NCIt concept]
- BAX wt Allele [NCIt concept]
- BBC3 Gene [NCIt concept]
- BBC3 wt Allele [NCIt concept]
- BBS9 Gene [NCIt concept]
- BBS9 wt Allele [NCIt concept]
- BCAP31 Gene [NCIt concept]
- BCAP31 wt Allele [NCIt concept]
- BCAR1 Gene [NCIt concept]
- BCAR1 wt Allele [NCIt concept]
- BCCIP Gene [NCIt concept]
- BCCIP wt Allele [NCIt concept]
- BCG Antibody [NCIt concept]
- BCG Solution [NCIt concept]
- BCG Tokyo-172 Strain Solution [NCIt concept]
- BCG Tokyo-172 Strain Vaccine [NCIt concept]
- BCG Vaccine [NCIt concept]
- BCHE Gene [NCIt concept]
- BCHE wt Allele [NCIt concept]
- BCL-2 Family Protein [NCIt concept]
- BCL-2 Gene Family [NCIt concept]
- BCL-2-Related Protein A1 [NCIt concept]
- BCL-6 Corepressor [NCIt concept]
- BCL-6 Corepressor-Like Protein 1 [NCIt concept]
- BCL-XL Inhibitor [NCIt concept]
- BCL11A Gene [NCIt concept]
- BCL11A wt Allele [NCIt concept]
- BCL2 Gene [NCIt concept]
- BCL2 Gene Amplification [NCIt concept]
- BCL2 Gene Mutation [NCIt concept]
- BCL2 Gene Rearrangement [NCIt concept]
- BCL2 Gene Translocation [NCIt concept]
- BCL2 Inhibitor VOB560 [NCIt concept]
- BCL2 Overexpression Positive [NCIt concept]
- BCL2 Positive [NCIt concept]
- BCL2 wt Allele [NCIt concept]
- BCL2/Adenovirus E1B 19 kDa Protein-Interacting Protein 3 [NCIt concept]
- BCL2/Adenovirus E1B 19 kDa Protein-Interacting Protein 3-Like [NCIt concept]
- BCL2A1 Gene [NCIt concept]
- BCL2A1 wt Allele [NCIt concept]
- BCL2L1 Gene [NCIt concept]
- BCL2L1 wt Allele [NCIt concept]
- BCL2L10 Gene [NCIt concept]
- BCL2L10 wt Allele [NCIt concept]
- BCL2L12 Gene [NCIt concept]
- BCL2L12 wt Allele [NCIt concept]
- BCL3 Gene [NCIt concept]
- BCL3 wt Allele [NCIt concept]
- BCL5 Gene [NCIt concept]
- BCL6 Degrader ARV-393 [NCIt concept]
- BCL6 Degrader BMS-986458 [NCIt concept]
- BCL6 Gene [NCIt concept]
- BCL6 Gene Amplification [NCIt concept]
- BCL6 Gene Mutation [NCIt concept]
- BCL6 Gene Rearrangement [NCIt concept]
- BCL6 Gene Translocation [NCIt concept]
- BCL6 Overexpression Positive [NCIt concept]
- BCL6 Positive [NCIt concept]
- BCL6 wt Allele [NCIt concept]
- BCL6/LCP1 Fusion Gene [NCIt concept]
- BCL9L Gene [NCIt concept]
- BCL9L wt Allele [NCIt concept]
- BCLC Stage 0 Adult Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage 0 Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage A Adult Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage A Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage B Adult Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage B Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage C Adult Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage C Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage D Adult Hepatocellular Carcinoma [NCIt concept]
- BCLC Stage D Hepatocellular Carcinoma [NCIt concept]
- BCO1 Gene [NCIt concept]
- BCO1 wt Allele [NCIt concept]
- BCOR Gene [NCIt concept]
- BCOR Gene Mutation [NCIt concept]
- BCOR Gene Rearrangement [NCIt concept]
- BCOR Genetic Alteration [NCIt concept]
- BCOR wt Allele [NCIt concept]
- BCOR/CCNB3 Fusion Gene [NCIt concept]
- BCOR/CCNB3 Fusion Protein [NCIt concept]
- BCOR/MAML3 Fusion Gene [NCIt concept]
- BCOR/MAML3 Fusion Protein [NCIt concept]
- BCORL1 Gene [NCIt concept]
- BCORL1 Gene Mutation [NCIt concept]
- BCORL1 wt Allele [NCIt concept]
- BCR Gene [NCIt concept]
- BCR Signaling Pathway Inhibitor DZD8586 [NCIt concept]
- BCR wt Allele [NCIt concept]
- BCR-ABL Inhibitor [NCIt concept]
- BCR-ABL Inhibitor ELVN-001 [NCIt concept]
- BCR-ABL Inhibitor HS-10382 [NCIt concept]
- BCR-ABL Inhibitor TGRX-678 [NCIt concept]
- BCR-ABL TKI-Resistant Mutation [NCIt concept]
- BCR-ABL1 Fusion Protein Expression [NCIt concept]
- BCR-JAK2 Fusion Protein Expression [NCIt concept]
- BCR-JAK2 Fusion in Hematologic Malignancies [NCIt concept]
- BCR/ABL1 Fusion Gene [NCIt concept]
- BCR/ABL1 Fusion Gene p190 [NCIt concept]
- BCR/ABL1 Fusion Gene p210 [NCIt concept]
- BCR/ABL1 Fusion Gene p230 [NCIt concept]
- BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.895G>C Mutation [NCIt concept]
- BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.895G>T Mutation [NCIt concept]
- BCR/ABL1 Fusion Gene with ABL1 NM_005157.4:c.944C>T Mutation [NCIt concept]
- BCR/ABL1 Fusion Negative [NCIt concept]
- BCR/ABL1 Fusion Protein [NCIt concept]
- BCR/ABL1 Fusion Protein Negative [NCIt concept]
- BCR/ABL1 Fusion Protein p190 [NCIt concept]
- BCR/ABL1 Fusion Protein p210 [NCIt concept]
- BCR/ABL1 Fusion Protein p230 [NCIt concept]
- BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315A [NCIt concept]
- BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.T315I [NCIt concept]
- BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.V299L [NCIt concept]
- BCR/FGFR1 Fusion Gene [NCIt concept]
- BCR/FGFR1 Fusion Protein [NCIt concept]
- BCR/JAK2 Fusion Gene [NCIt concept]
- BCR/JAK2 Fusion Protein [NCIt concept]
- BCR/PDGFRA Fusion Gene [NCIt concept]
- BCR/PDGFRA Fusion Protein [NCIt concept]
- BDNF Gene [NCIt concept]
- BDNF wt Allele [NCIt concept]
- BDNF/NT-3 Growth Factors Receptor [NCIt concept]
- BEACOPP Regimen [NCIt concept]
- BECN1 Gene [NCIt concept]
- BECN1 wt Allele [NCIt concept]
- BET Bromodomain Inhibitor ZEN-3694 [NCIt concept]
- BET Inhibitor [NCIt concept]
- BET Inhibitor ABBV-744 [NCIt concept]
- BET Inhibitor BAY1238097 [NCIt concept]
- BET Inhibitor FT-1101 [NCIt concept]
- BET Inhibitor GSK2820151 [NCIt concept]
- BET Inhibitor INCB054329 [NCIt concept]
- BET Inhibitor INCB057643 [NCIt concept]
- BET Inhibitor RO6870810 [NCIt concept]
- BET/CBP/p300 Inhibitor EP31670 [NCIt concept]
- BGLAP Gene [NCIt concept]
- BGLAP wt Allele [NCIt concept]
- BGN Gene [NCIt concept]
- BGN wt Allele [NCIt concept]
- BH3 Domain [NCIt concept]
- BH3-Interacting Domain Death Agonist [NCIt concept]
- BHMT Gene [NCIt concept]
- BHMT wt Allele [NCIt concept]
- BHMT2 Gene [NCIt concept]
- BHMT2 wt Allele [NCIt concept]
- BICC1 Gene [NCIt concept]
- BICC1 wt Allele [NCIt concept]
- BID Gene [NCIt concept]
- BID wt Allele [NCIt concept]
- BIK Gene [NCIt concept]
- BIK wt Allele [NCIt concept]
- BIN1 Gene [NCIt concept]
- BIN1 wt Allele [NCIt concept]
- BIRC2 Gene [NCIt concept]
- BIRC2 wt Allele [NCIt concept]
- BIRC3 Gene [NCIt concept]
- BIRC3 Gene Mutation [NCIt concept]
- BIRC3 wt Allele [NCIt concept]
- BIRC3/MALT1 Fusion Gene [NCIt concept]
- BIRC3/MALT1 Fusion Protein [NCIt concept]
- BIRC5 Antibody [NCIt concept]
- BIRC5 Gene [NCIt concept]
- BIRC5 wt Allele [NCIt concept]
- BIRC7 Gene [NCIt concept]
- BIRC7 wt Allele [NCIt concept]
- BK Virus [NCIt concept]
- BK Virus Infection [NCIt concept]
- BK Virus Positive [NCIt concept]
- BK Virus Reactivation [NCIt concept]
- BLM Gene [NCIt concept]
- BLM Gene Mutation [NCIt concept]
- BLM NM_000057.3:c.2207_2212delinsTAGATTC [NCIt concept]
- BLM NP_000048.1:p.Y736fs*4 [NCIt concept]
- BLM Protein Variant [NCIt concept]
- BLM wt Allele [NCIt concept]
- BMF Gene [NCIt concept]
- BMF wt Allele [NCIt concept]
- BMI1 Gene [NCIt concept]
- BMI1 wt Allele [NCIt concept]
- BMP10 Gene [NCIt concept]
- BMP10 wt Allele [NCIt concept]
- BMP2 Gene [NCIt concept]
- BMP2 wt Allele [NCIt concept]
- BMP3 Gene [NCIt concept]
- BMP3 wt Allele [NCIt concept]
- BMP4 Gene [NCIt concept]
- BMP4 wt Allele [NCIt concept]
- BMP6 Gene [NCIt concept]
- BMP6 wt Allele [NCIt concept]
- BMP7 Gene [NCIt concept]
- BMP7 wt Allele [NCIt concept]
- BMPR1A Gene [NCIt concept]
- BMPR1A Gene Mutation [NCIt concept]
- BMPR1A wt Allele [NCIt concept]
- BMPR1B Gene [NCIt concept]
- BMPR1B wt Allele [NCIt concept]
- BMPR2 Gene [NCIt concept]
- BMPR2 wt Allele [NCIt concept]
- BMS-214662 [NCIt concept]
- BMX Gene [NCIt concept]
- BMX Inhibitor [NCIt concept]
- BMX wt Allele [NCIt concept]
- BNIP3 Gene [NCIt concept]
- BNIP3 wt Allele [NCIt concept]
- BNIP3L Gene [NCIt concept]
- BNIP3L wt Allele [NCIt concept]
- BPI Fold-Containing Family A Member 1 [NCIt concept]
- BPI Gene [NCIt concept]
- BPI wt Allele [NCIt concept]
- BPIFA1 Gene [NCIt concept]
- BPIFA1 wt Allele [NCIt concept]
- BRAF Fusion Positive [NCIt concept]
- BRAF Gene [NCIt concept]
- BRAF Gene Alteration Negative [NCIt concept]
- BRAF Gene Alteration Positive [NCIt concept]
- BRAF Gene Amplification [NCIt concept]
- BRAF Gene Mutation [NCIt concept]
- BRAF Gene Mutation Negative [NCIt concept]
- BRAF Gene Rearrangement [NCIt concept]
- BRAF Inhibitor [NCIt concept]
- BRAF Inhibitor ARQ 736 [NCIt concept]
- BRAF Inhibitor LUT014 [NCIt concept]
- BRAF NM_004333.4:c.1396G>A [NCIt concept]
- BRAF NM_004333.4:c.1396G>C [NCIt concept]
- BRAF NM_004333.4:c.1397G>A [NCIt concept]
- BRAF NM_004333.4:c.1397G>C [NCIt concept]
- BRAF NM_004333.4:c.1397G>T [NCIt concept]
- BRAF NM_004333.4:c.1405G>A [NCIt concept]
- BRAF NM_004333.4:c.1405G>C [NCIt concept]
- BRAF NM_004333.4:c.1405_1406delinsTC [NCIt concept]
- BRAF NM_004333.4:c.1405_1407delinsAGC [NCIt concept]
- BRAF NM_004333.4:c.1405_1407delinsAGT [NCIt concept]
- BRAF NM_004333.4:c.1406G>A [NCIt concept]
- BRAF NM_004333.4:c.1406G>C [NCIt concept]
- BRAF NM_004333.4:c.1406G>T [NCIt concept]
- BRAF NM_004333.4:c.1789C>G [NCIt concept]
- BRAF NM_004333.4:c.1789_1790delinsTC [NCIt concept]
- BRAF NM_004333.4:c.1790T>A [NCIt concept]
- BRAF NM_004333.4:c.1790T>G [NCIt concept]
- BRAF NM_004333.4:c.1791A>G [NCIt concept]
- BRAF NM_004333.4:c.1796_1797insTAC [NCIt concept]
- BRAF NM_004333.4:c.1797_1798insACA [NCIt concept]
- BRAF NM_004333.4:c.1797_1799delinsGAG [NCIt concept]
- BRAF NM_004333.4:c.1798G>A [NCIt concept]
- BRAF NM_004333.4:c.1798G>T [NCIt concept]
- BRAF NM_004333.4:c.1798_1799delinsAA [NCIt concept]
- BRAF NM_004333.4:c.1798_1799delinsAG [NCIt concept]
- BRAF NM_004333.4:c.1799T>A [NCIt concept]
- BRAF NM_004333.4:c.1799T>C [NCIt concept]
- BRAF NM_004333.4:c.1799T>G [NCIt concept]
- BRAF NM_004333.4:c.1799_1800delinsAA [NCIt concept]
- BRAF NM_004333.4:c.1799_1800delinsAT [NCIt concept]
- BRAF NP_004324.2:p.G466A [NCIt concept]
- BRAF NP_004324.2:p.G466E [NCIt concept]
- BRAF NP_004324.2:p.G466R [NCIt concept]
- BRAF NP_004324.2:p.G466V [NCIt concept]
- BRAF NP_004324.2:p.G469A [NCIt concept]
- BRAF NP_004324.2:p.G469E [NCIt concept]
- BRAF NP_004324.2:p.G469R [NCIt concept]
- BRAF NP_004324.2:p.G469S [NCIt concept]
- BRAF NP_004324.2:p.G469V [NCIt concept]
- BRAF NP_004324.2:p.G469X [NCIt concept]
- BRAF NP_004324.2:p.L485X [NCIt concept]
- BRAF NP_004324.2:p.L597Q [NCIt concept]
- BRAF NP_004324.2:p.L597R [NCIt concept]
- BRAF NP_004324.2:p.L597S [NCIt concept]
- BRAF NP_004324.2:p.L597V [NCIt concept]
- BRAF NP_004324.2:p.L597X [NCIt concept]
- BRAF NP_004324.2:p.T599_V600insT [NCIt concept]
- BRAF NP_004324.2:p.V600A [NCIt concept]
- BRAF NP_004324.2:p.V600D [NCIt concept]
- BRAF NP_004324.2:p.V600E [NCIt concept]
- BRAF NP_004324.2:p.V600G [NCIt concept]
- BRAF NP_004324.2:p.V600K [NCIt concept]
- BRAF NP_004324.2:p.V600L [NCIt concept]
- BRAF NP_004324.2:p.V600M [NCIt concept]
- BRAF NP_004324.2:p.V600R [NCIt concept]
- BRAF NP_004324.2:p.V600X [NCIt concept]
- BRAF Negative [NCIt concept]
- BRAF Protein Variant [NCIt concept]
- BRAF V600 Wild Type [NCIt concept]
- BRAF V600E Degrader CFT1946 [NCIt concept]
- BRAF V600E Mutation Present [NCIt concept]
- BRAF V600E Negative [NCIt concept]
- BRAF wt Allele [NCIt concept]
- BRAF(V600E) Kinase Inhibitor ABM-1310 [NCIt concept]
- BRAF585-614 (V600E) Peptide [NCIt concept]
- BRAFV600/PI3K Inhibitor ASN003 [NCIt concept]
- BRCA Driver Mutation Negative [NCIt concept]
- BRCA Gene Family [NCIt concept]
- BRCA Gene Mutation [NCIt concept]
- BRCA Gene Mutation Negative [NCIt concept]
- BRCA Mutation Analysis [NCIt concept]
- BRCA Rearrangement [NCIt concept]
- BRCA Variant of Unknown Significance [NCIt concept]
- BRCA-Associated Malignant Neoplasm [NCIt concept]
- BRCA1 Biallelic Inactivation [NCIt concept]
- BRCA1 Gene [NCIt concept]
- BRCA1 Gene Mutation [NCIt concept]
- BRCA1 Gene Mutation Negative [NCIt concept]
- BRCA1 Mutation Carrier [NCIt concept]
- BRCA1 NM_007294.3:c.5265_5266insC [NCIt concept]
- BRCA1 NM_007294.3:c.68_69delAG [NCIt concept]
- BRCA1 NP_009225.1:p.E23Vfs*17 [NCIt concept]
- BRCA1 NP_009225.1:p.Q1756Pfs [NCIt concept]
- BRCA1 Polymorphism Positive [NCIt concept]
- BRCA1 Protein Variant [NCIt concept]
- BRCA1 wt Allele [NCIt concept]
- BRCA1-A Complex Subunit Abraxas 1 [NCIt concept]
- BRCA1-A Complex Subunit RAP80 [NCIt concept]
- BRCA1-Associated Hereditary Breast and Ovarian Cancer Syndrome [NCIt concept]
- BRCA1-Associated RING Domain Protein 1 [NCIt concept]
- BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome [NCIt concept]
- BRCA2 Biallelic Inactivation [NCIt concept]
- BRCA2 Gene [NCIt concept]
- BRCA2 Gene Mutation [NCIt concept]
- BRCA2 Gene Mutation Negative [NCIt concept]
- BRCA2 Mutation Carrier [NCIt concept]
- BRCA2 NM_000059.3:c.5946delT [NCIt concept]
- BRCA2 NP_000050.2:p.S1982Rfs*22 [NCIt concept]
- BRCA2 Polymorphism Positive [NCIt concept]
- BRCA2 Protein Variant [NCIt concept]
- BRCA2 and CDKN1A-Interacting Protein [NCIt concept]
- BRCA2 wt Allele [NCIt concept]
- BRCA2-Associated Hereditary Breast and Ovarian Cancer Syndrome [NCIt concept]
- BRCC3 Gene [NCIt concept]
- BRCC3 wt Allele [NCIt concept]
- BRD2 Gene [NCIt concept]
- BRD2 wt Allele [NCIt concept]
- BRD3 Gene [NCIt concept]
- BRD3 Gene Translocation [NCIt concept]
- BRD3 wt Allele [NCIt concept]
- BRD4 Gene [NCIt concept]
- BRD4 Gene Amplification [NCIt concept]
- BRD4 Gene Mutation [NCIt concept]
- BRD4 Gene Translocation [NCIt concept]
- BRD4 Inhibitor PLX2853 [NCIt concept]
- BRD4 Inhibitor PLX51107 [NCIt concept]
- BRD4 Protein Degrader RNK05047 [NCIt concept]
- BRD4 wt Allele [NCIt concept]
- BRD4/NUTM1 Fusion Gene [NCIt concept]
- BRD4/NUTM1 Fusion Negative [NCIt concept]
- BRD4/NUTM1 Fusion Protein [NCIt concept]
- BRD9 Degrader FHD-609 [NCIt concept]
- BRD9 Gene [NCIt concept]
- BRD9 wt Allele [NCIt concept]
- BRDT Gene [NCIt concept]
- BRDT wt Allele [NCIt concept]
- BRIP1 Gene [NCIt concept]
- BRIP1 Gene Mutation [NCIt concept]
- BRIP1 Gene Mutation Negative [NCIt concept]
- BRIP1 wt Allele [NCIt concept]
- BRISC and BRCA1-A Complex Member 1 [NCIt concept]
- BRISC and BRCA1-A Complex Member 2 [NCIt concept]
- BROCA Gene Signature [NCIt concept]
- BROCA-HR Gene Signature [NCIt concept]
- BST2 Gene [NCIt concept]
- BST2 Positive [NCIt concept]
- BST2 wt Allele [NCIt concept]
- BTA Stat Assay [NCIt concept]
- BTB/POZ Domain-Containing Adapter for CUL3-Mediated RhoA Degradation Protein 2 [NCIt concept]
- BTG1 Gene [NCIt concept]
- BTG1 wt Allele [NCIt concept]
- BTK C481 Resistance Mutation [NCIt concept]
- BTK Degrader [NCIt concept]
- BTK Degrader ABBV-101 [NCIt concept]
- BTK Degrader AC0676 [NCIt concept]
- BTK Degrader BGB-16673 [NCIt concept]
- BTK Degrader NX-5948 [NCIt concept]
- BTK Degrader UBX-303061 [NCIt concept]
- BTK Gene [NCIt concept]
- BTK Gene Mutation [NCIt concept]
- BTK Inhibitor DTRMWXHS-12 [NCIt concept]
- BTK Inhibitor GB5121 [NCIt concept]
- BTK Inhibitor HMPL-760 [NCIt concept]
- BTK Inhibitor JNJ-64264681 [NCIt concept]
- BTK Inhibitor Resistant Gene Mutation [NCIt concept]
- BTK Inhibitor TL-895 [NCIt concept]
- BTK Inhibitor TT-01488 [NCIt concept]
- BTK NM_000061.3:c.1441T>A [NCIt concept]
- BTK NM_000061.3:c.1442G>C [NCIt concept]
- BTK NM_000061.3:c.1442_1443delinsCT [NCIt concept]
- BTK NP_000052.1:p.C481S [NCIt concept]
- BTK NP_000052.1:p.C481X [NCIt concept]
- BTK Protein Variant [NCIt concept]
- BTK wt Allele [NCIt concept]
- BTLA Gene [NCIt concept]
- BTLA wt Allele [NCIt concept]
- BTN1A1 Gene [NCIt concept]
- BTN1A1 wt Allele [NCIt concept]
- BUB1 Gene [NCIt concept]
- BUB1 wt Allele [NCIt concept]
- BUB1B Gene [NCIt concept]
- BUB1B wt Allele [NCIt concept]
- BXQ-350 Nanovesicle Formulation [NCIt concept]
- BZLF1 Peptide Vaccine OSU-2131 [NCIt concept]
- Bacillus Calmette-Guerin Unresponsive Disease [NCIt concept]
- Bacterial 16S RNA [NCIt concept]
- Bacterial Infection [NCIt concept]
- Bactericidal Permeability-Increasing Protein [NCIt concept]
- Bacteriophage phi X 174 Vaccine [NCIt concept]
- Bacteroides [NCIt concept]
- Bacteroides fragilis [NCIt concept]
- Baculoviral IAP Repeat-Containing Protein 2 [NCIt concept]
- Baculoviral IAP Repeat-Containing Protein 3 [NCIt concept]
- Baculoviral IAP Repeat-Containing Protein 5 [NCIt concept]
- Baculoviral IAP Repeat-Containing Protein 7 [NCIt concept]
- Bafetinib [NCIt concept]
- Bafisontamab [NCIt concept]
- Balixafortide [NCIt concept]
- Balloon Brachytherapy [NCIt concept]
- Balloon Catheter [NCIt concept]
- Balloon Cell Melanoma [NCIt concept]
- Balloon Device [NCIt concept]
- Balloon-Guided Endoscopic Procedure [NCIt concept]
- Baloramotide [NCIt concept]
- Baloxavir Marboxil [NCIt concept]
- Balstilimab [NCIt concept]
- Baltaleucel-T [NCIt concept]
- Band 3 Anion Transport Protein [NCIt concept]
- Banoxantrone [NCIt concept]
- Bapotulimab [NCIt concept]
- Barasertib [NCIt concept]
- BardPort Titanium Implanted Port with Peritoneal Catheter [NCIt concept]
- Bardoxolone Methyl [NCIt concept]
- Bariatric Surgery [NCIt concept]
- Baricitinib [NCIt concept]
- Barium Enema Injection [NCIt concept]
- Barrett Adenocarcinoma [NCIt concept]
- Barrett Esophagus [NCIt concept]
- Barrier Device [NCIt concept]
- Bartholin Gland Carcinoma [NCIt concept]
- Basal Cell Carcinoma [NCIt concept]
- Basal Ganglia Germinoma [NCIt concept]
- Basal Ganglia Neoplasm [NCIt concept]
- Base Excision Repair Gene Mutation [NCIt concept]
- Basement Membrane [NCIt concept]
- Basement Membrane Coverage Measurement [NCIt concept]
- Basement Membrane Thickness [NCIt concept]
- Basiliximab [NCIt concept]
- Basiliximab-IR700 RM-1995 [NCIt concept]
- Basophil [NCIt concept]
- Basroparib [NCIt concept]
- Batiraxcept [NCIt concept]
- Batoprotafib [NCIt concept]
- Battlefield Acupuncture [NCIt concept]
- Bavdegalutamide [NCIt concept]
- Bavituximab [NCIt concept]
- Bazedoxifene [NCIt concept]
- Bcl-2 Family Protein Inhibitor [NCIt concept]
- Bcl-2 Inhibitor BCL201 [NCIt concept]
- Bcl-2 Inhibitor BGB-21447 [NCIt concept]
- Bcl-2 Inhibitor LOXO-338 [NCIt concept]
- Bcl-2-Binding Component 3 [NCIt concept]
- Bcl-2-Interacting Killer [NCIt concept]
- Bcl-2-Like Protein 1 [NCIt concept]
- Bcl-2-Like Protein 10 [NCIt concept]
- Bcl-2-Like Protein 12 [NCIt concept]
- Bcl-2-Modifying Factor [NCIt concept]
- Bcl-2/Bcl-XL Inhibitor LP-118 [NCIt concept]
- Bcl-X(S) [NCIt concept]
- Bcl-XL Proteolysis Targeting Chimera DT2216 [NCIt concept]
- Bcr-Abl (b2a2)-Derived Peptide Vaccine [NCIt concept]
- Bcr-Abl (b3a2)-Derived Peptide Vaccine [NCIt concept]
- Becatecarin [NCIt concept]
- Beclin-1 [NCIt concept]
- Beclomethasone Dipropionate [NCIt concept]
- Bedaquiline [NCIt concept]
- Begelomab [NCIt concept]
- Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain [NCIt concept]
- Behavioral Activation Therapy [NCIt concept]
- Behavioral Assessment [NCIt concept]
- Behavioral Counseling [NCIt concept]
- Behavioral Dietary Intervention [NCIt concept]
- Behavioral Intervention [NCIt concept]
- Behavioral, Psychological or Informational Intervention [NCIt concept]
- Belagenpumatucel-L [NCIt concept]
- Belantamab [NCIt concept]
- Belantamab Mafodotin [NCIt concept]
- Belapectin [NCIt concept]
- Belimumab [NCIt concept]
- Belinostat [NCIt concept]
- Belumosudil [NCIt concept]
- Belumosudil Mesylate [NCIt concept]
- Belzupacap Sarotalocan [NCIt concept]
- Belzutifan [NCIt concept]
- Bemarituzumab [NCIt concept]
- Bemcentinib [NCIt concept]
- Bemdaneprocel [NCIt concept]
- Bempegaldesleukin [NCIt concept]
- Benazepril Hydrochloride [NCIt concept]
- Bence Jones Protein [NCIt concept]
- Bence Jones Protein Present [NCIt concept]
- Bendamustine Hydrochloride [NCIt concept]
- Bendamustine-containing Nanoparticle-based Formulation RXDX-107 [NCIt concept]
- Benign [NCIt concept]
- Benign Adrenal Gland Neoplasm [NCIt concept]
- Benign Central Nervous System Neoplasm [NCIt concept]
- Benign Cephalic Histiocytosis [NCIt concept]
- Benign Female Reproductive System Neoplasm [NCIt concept]
- Benign Gynecologic Care Patient [NCIt concept]
- Benign Head and Neck Neoplasm [NCIt concept]
- Benign Major Salivary Gland Neoplasm [NCIt concept]
- Benign Neoplasm [NCIt concept]
- Benign Odontogenic Neoplasm [NCIt concept]
- Benign Pancreatic Neoplasm [NCIt concept]
- Benign Parapharyngeal Neoplasm [NCIt concept]
- Benign Periampullary Neoplasm [NCIt concept]
- Benign Pineal Region Neoplasm [NCIt concept]
- Benign Prostatic Hyperplasia [NCIt concept]
- Benign Retropharyngeal Neoplasm [NCIt concept]
- Benign Sigmoid Colon Neoplasm [NCIt concept]
- Benign Skin Neoplasm [NCIt concept]
- Benign Skull Base Neoplasm [NCIt concept]
- Benign Teratoma [NCIt concept]
- Benralizumab [NCIt concept]
- Benzaldehyde Dimethane Sulfonate [NCIt concept]
- Benzene [NCIt concept]
- Benzo(a)pyrene-7,8-diol 9,10-Epoxide [NCIt concept]
- Benzoylphenylurea [NCIt concept]
- Bermekimab [NCIt concept]
- Beroterkib Anhydrous [NCIt concept]
- Bersanlimab [NCIt concept]
- Berubicin Hydrochloride [NCIt concept]
- Berzosertib [NCIt concept]
- Best Practice [NCIt concept]
- Besufetamig [NCIt concept]
- Beta Amyloid Measurement [NCIt concept]
- Beta Isomer of C-Terminal Telopeptide of Type I Collagen [NCIt concept]
- Beta Thalassemia [NCIt concept]
- Beta Tubulin [NCIt concept]
- Beta,Beta-Carotene 15,15'-Dioxygenase [NCIt concept]
- Beta-1 Adrenergic Receptor [NCIt concept]
- Beta-1,4 N-Acetylgalactosaminyltransferase 1 [NCIt concept]
- Beta-1,4-Galactosyltransferase 1 [NCIt concept]
- Beta-1,4-Galactosyltransferase 6 [NCIt concept]
- Beta-2 Adrenergic Receptor [NCIt concept]
- Beta-2-Glycoprotein 1 [NCIt concept]
- Beta-2-Microglobulin [NCIt concept]
- Beta-2-Microglobulin Greater than 3 g/mL [NCIt concept]
- Beta-3 Adrenergic Receptor [NCIt concept]
- Beta-Arrestin-2 [NCIt concept]
- Beta-Chimaerin [NCIt concept]
- Beta-Galactosidase [NCIt concept]
- Beta-Glucan [NCIt concept]
- Beta-Glucan MM-10-001 [NCIt concept]
- Beta-Glucuronidase [NCIt concept]
- Beta-Hydroxybutyrate Measurement [NCIt concept]
- Beta-Klotho [NCIt concept]
- Beta-Lactamase [NCIt concept]
- Beta-Microseminoprotein [NCIt concept]
- Beta-Nerve Growth Factor [NCIt concept]
- Beta-Thromboglobulin [NCIt concept]
- Beta-catenin Antagonist ST316 [NCIt concept]
- Beta-catenin Inhibitor [NCIt concept]
- Beta-catenin Inhibitor FOG-001 [NCIt concept]
- Beta-cryptoxanthin [NCIt concept]
- Beta-glucan/Dexpanthenol/Glutamine in Mucoadhesive Polymer Hydrogel [NCIt concept]
- Beta-lapachone Prodrug ARQ 761 [NCIt concept]
- Betaine-Homocysteine S-Methyltransferase 1 [NCIt concept]
- Bethanechol [NCIt concept]
- Bethanechol Chloride [NCIt concept]
- Betibeglogene Autotemcel [NCIt concept]
- Betifisolimab [NCIt concept]
- Betrixaban [NCIt concept]
- Betulinic Acid [NCIt concept]
- Bevacizumab [NCIt concept]
- Bevifimod [NCIt concept]
- Bevonescein [NCIt concept]
- Bexarotene [NCIt concept]
- Bexirestrant [NCIt concept]
- Bezlotoxumab [NCIt concept]
- Bezuclastinib [NCIt concept]
- Biallelic ADA2 Gene Mutation [NCIt concept]
- Biallelic ATM Gene Mutation [NCIt concept]
- Biallelic CEBPA Gene Mutation [NCIt concept]
- Biallelic IDUA Gene Mutation [NCIt concept]
- Biallelic MUTYH Gene Mutation [NCIt concept]
- Biallelic RB1 Gene Mutation [NCIt concept]
- Biallelic SMARCA4 Gene Mutation [NCIt concept]
- Biallelic SMARCB1 Gene Mutation [NCIt concept]
- Biallelic TP53 Gene Mutation [NCIt concept]
- Bicalutamide [NCIt concept]
- Biclonal Gammopathy [NCIt concept]
- Bictegravir [NCIt concept]
- Bifikafusp Alfa [NCIt concept]
- Bifunctional Expression Vector Plasmid DNA-bi-shRNA EWS/FLI1 Type 1 Lipoplex [NCIt concept]
- Bifunctional Methylenetetrahydrofolate Dehydrogenase/Cyclohydrolase, Mitochondrial [NCIt concept]
- Bifunctional Purine Biosynthesis Protein PURH [NCIt concept]
- Biglycan [NCIt concept]
- Bilateral Breast Carcinoma [NCIt concept]
- Bilateral Hip Replacement [NCIt concept]
- Bilateral Mastectomy [NCIt concept]
- Bilateral Orchiectomy [NCIt concept]
- Bilateral Salpingectomy [NCIt concept]
- Bilateral Salpingectomy with Oophorectomy [NCIt concept]
- Bilateral Synchronous Sporadic Renal Cell Carcinoma [NCIt concept]
- Bilateral Thalamic Glioma [NCIt concept]
- Bile Acid Measurement [NCIt concept]
- Bile Duct Carcinoma [NCIt concept]
- Bile Duct Disorder [NCIt concept]
- Bile Duct Neoplasm [NCIt concept]
- Bile Salt Export Pump [NCIt concept]
- Biliary Stenting [NCIt concept]
- Biliary Tract Carcinoma [NCIt concept]
- Bilirubin [NCIt concept]
- Bilobectomy [NCIt concept]
- Bimagrumab [NCIt concept]
- Bimatoprost Ophthalmic Solution [NCIt concept]
- Binimetinib [NCIt concept]
- Bintrafusp Alfa [NCIt concept]
- Bio-enhanced Curcumin Extract Formulation [NCIt concept]
- Bioadhesive Nanoparticles-encapsulating Avobenzone/Octocrylene Plus Diosmin/Ferulic Acid/Cytisine/Trans-resveratrol Sunscreen [NCIt concept]
- Biochemically Recurrent Prostate Carcinoma [NCIt concept]
- Bioconductance Measurement [NCIt concept]
- Biodynamic Imaging [NCIt concept]
- Bioelectric Field Imaging [NCIt concept]
- Bioelectric Impedance Analysis [NCIt concept]
- Biofeedback [NCIt concept]
- Bioimpedance Spectroscopy [NCIt concept]
- Bioinformatician [NCIt concept]
- Biologic Sample Preservation Procedure [NCIt concept]
- Biological Therapy [NCIt concept]
- Biologically Based Practices [NCIt concept]
- Biology-Guided Radiotherapy [NCIt concept]
- Biomarker Analysis [NCIt concept]
- Biomarker Positive Malignant Neoplasm [NCIt concept]
- Biopsy Patient [NCIt concept]
- Biopsy Procedure [NCIt concept]
- Biopsy Specimen Radiography [NCIt concept]
- Biopsy Twinkling Marker Ultrasound Detection [NCIt concept]
- Biopsy of Bladder [NCIt concept]
- Biopsy of Bone [NCIt concept]
- Biopsy of Prostate [NCIt concept]
- Biopsy of Soft Tissue [NCIt concept]
- Biospecimen Collection [NCIt concept]
- Biparametric Magnetic Resonance Imaging [NCIt concept]
- Biphasic Positive Airway Pressure [NCIt concept]
- Birabresib [NCIt concept]
- Birinapant [NCIt concept]
- Biropepimut-S [NCIt concept]
- Birt-Hogg-Dube Syndrome [NCIt concept]
- Birtamimab [NCIt concept]
- Bispecific Antibody AGEN1223 [NCIt concept]
- Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102 [NCIt concept]
- Bispecific Monoclonal Antibody [NCIt concept]
- Bisphenol A [NCIt concept]
- Bivalent BRD4 Inhibitor AZD5153 [NCIt concept]
- Bizalimogene Ralaplasmid [NCIt concept]
- Black Seed Oil Extract Supplement [NCIt concept]
- Black Tea [NCIt concept]
- Bladder Adenocarcinoma [NCIt concept]
- Bladder Cancer pT1 TNM Finding v8 [NCIt concept]
- Bladder Cancer pTa TNM Finding v8 [NCIt concept]
- Bladder Carcinoma [NCIt concept]
- Bladder Irrigation [NCIt concept]
- Bladder Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Bladder Neck Surgery [NCIt concept]
- Bladder Neoplasm [NCIt concept]
- Bladder Papillary Clear Cell Adenocarcinoma [NCIt concept]
- Bladder Papillary Urothelial Carcinoma [NCIt concept]
- Bladder Radiation Therapy [NCIt concept]
- Bladder Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Bladder Squamous Cell Carcinoma [NCIt concept]
- Bladder Urothelial Carcinoma [NCIt concept]
- Bland Embolization [NCIt concept]
- Blast Cells Present [NCIt concept]
- Blast Phase [NCIt concept]
- Blast Phase Primary Myelofibrosis [NCIt concept]
- Blastema Predominant Kidney Wilms Tumor [NCIt concept]
- Blastic Granulocytic Sarcoma [NCIt concept]
- Blastic Plasmacytoid Dendritic Cell Neoplasm [NCIt concept]
- Blasts 0 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts 0.01 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 1 Percent or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts 1 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 1 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Blasts 10 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 10 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 10 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Blasts 10-19 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 10-19 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts 10-20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 11-20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 15 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 2 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 2 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Blasts 2-4 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts 20 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 20 Percent or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts 20 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 20 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Blasts 20,000 or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts 20-30 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 20-30 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts 21-30 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 25 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 25 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 30 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 30 Percent or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts 30 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 30,000 or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts 5 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5 Percent or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts 5 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Blasts 5-10 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5-19 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5-19 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts 5-20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5-25 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5-30 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 5-9 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 50 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 50 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 6 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 6-19 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 6-24 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 6-25 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 60 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 60 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Blasts 75 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 9 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts 9 Percent or Less of Peripheral Blood White Cells [NCIt concept]
- Blasts Greater than or Equal to 5000 per mL [NCIt concept]
- Blasts Increased by Greater than or Equal to 50 Percent [NCIt concept]
- Blasts Less Than 50 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Less than 0.01 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Less than or Equal to 10000/mm3 [NCIt concept]
- Blasts More Than 5 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts More Than 75 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 10 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 10 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts More than 10000 of Peripheral Blood White Cells [NCIt concept]
- Blasts More than 15 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 20 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts More than 25 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 5 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 60 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts More than 60 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 10 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Under 10 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 10,000 of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 15 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Under 15 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 2 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Under 20 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 20,000 in Peripheral Blood White Cells [NCIt concept]
- Blasts Under 25 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Under 30 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Under 30 Percent of Peripheral Blood White Cells [NCIt concept]
- Blasts Under 5 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Blasts Under 5 Percent of Peripheral Blood White Cells [NCIt concept]
- Bleomycin [NCIt concept]
- Bleomycin Sulfate [NCIt concept]
- Bleximenib [NCIt concept]
- Blinatumomab [NCIt concept]
- Blocking Antibody [NCIt concept]
- Blood [NCIt concept]
- Blood Cell Count [NCIt concept]
- Blood Cell Count Ratio Measurement [NCIt concept]
- Blood Glucose Measurement [NCIt concept]
- Blood Oxygen Level-Dependent Functional MRI [NCIt concept]
- Blood Pressure [NCIt concept]
- Blood Pressure Measurement [NCIt concept]
- Blood Transfusion [NCIt concept]
- Blood Urea Nitrogen Measurement [NCIt concept]
- Blood Vessel [NCIt concept]
- Blood-Brain Barrier Disruption Chemotherapy [NCIt concept]
- Bloom Syndrome Protein [NCIt concept]
- Blueberry Powder Supplement [NCIt concept]
- Bluetooth-enabled Activity Monitor [NCIt concept]
- Boceprevir [NCIt concept]
- Bocodepsin Besylate [NCIt concept]
- BodiMetrics Performance Monitor [NCIt concept]
- Body Cavity Primary Effusion Lymphoma [NCIt concept]
- Body Mass Index 25 or Greater [NCIt concept]
- Body Mass Index Greater Than 25 [NCIt concept]
- Body Mass Index Greater than or Equal to 30 [NCIt concept]
- Body Mass Index Less than or Equal to 30 [NCIt concept]
- Bomedemstat [NCIt concept]
- Bone Cement without Medicinal Substance [NCIt concept]
- Bone Graft [NCIt concept]
- Bone Lesion [NCIt concept]
- Bone Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Bone Marrow Ablation with Stem Cell Support [NCIt concept]
- Bone Marrow Aspiration [NCIt concept]
- Bone Marrow Aspiration and Biopsy [NCIt concept]
- Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level [NCIt concept]
- Bone Marrow Blasts Percentage Decreased by 5 to 25 Percent [NCIt concept]
- Bone Marrow Donation [NCIt concept]
- Bone Marrow Donor [NCIt concept]
- Bone Marrow Failure Syndrome [NCIt concept]
- Bone Marrow Myeloid Stem Cell [NCIt concept]
- Bone Marrow Stem Cell Transplantation [NCIt concept]
- Bone Marrow Stromal Antigen 2 [NCIt concept]
- Bone Marrow Suppression [NCIt concept]
- Bone Marrow Transplant Recipient [NCIt concept]
- Bone Marrow Transplantation [NCIt concept]
- Bone Marrow-Derived Cell [NCIt concept]
- Bone Metastases Prevention [NCIt concept]
- Bone Metastasis Targeting Peptide-11 [NCIt concept]
- Bone Morphogenetic Protein [NCIt concept]
- Bone Morphogenetic Protein 10 [NCIt concept]
- Bone Morphogenetic Protein 2 [NCIt concept]
- Bone Morphogenetic Protein 3 [NCIt concept]
- Bone Morphogenetic Protein 4 [NCIt concept]
- Bone Morphogenetic Protein 6 [NCIt concept]
- Bone Morphogenetic Protein 7 [NCIt concept]
- Bone Morphogenetic Protein Receptor [NCIt concept]
- Bone Morphogenetic Protein Receptor Type-1A [NCIt concept]
- Bone Morphogenetic Protein Receptor Type-1B [NCIt concept]
- Bone Morphogenetic Protein Receptor Type-2 [NCIt concept]
- Bone Necrosis [NCIt concept]
- Bone Neoplasm [NCIt concept]
- Bone Osteosarcoma [NCIt concept]
- Bone Sarcoma [NCIt concept]
- Bone Scan [NCIt concept]
- Bone Specific Alkaline Phosphatase [NCIt concept]
- Borderline [NCIt concept]
- Borderline Ovarian Clear Cell Tumor [NCIt concept]
- Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor [NCIt concept]
- Borderline Ovarian Epithelial Tumor [NCIt concept]
- Borderline Ovarian Mucinous Tumor [NCIt concept]
- Borderline Ovarian Serous Tumor [NCIt concept]
- Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor [NCIt concept]
- Borderline Papillary Serous Cystadenoma [NCIt concept]
- Borderline Resectable Intrahepatic Cholangiocarcinoma [NCIt concept]
- Borderline Resectable Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Borealin [NCIt concept]
- Boron-dipyrromethene-modified Olaparib Fluorescent Imaging Agent [NCIt concept]
- Bortezomib [NCIt concept]
- Bosentan [NCIt concept]
- Boserolimab [NCIt concept]
- Bosutinib [NCIt concept]
- Bosutinib Monohydrate [NCIt concept]
- Boswellia serrata Extract [NCIt concept]
- Botanical Extracts Rinse IZN-6N4 [NCIt concept]
- Botanical-based Agent NBT-NM108 [NCIt concept]
- Botanically-derived Agent RH324 [NCIt concept]
- Botensilimab [NCIt concept]
- Botulinum Toxin E EB-001 [NCIt concept]
- Botulinum Toxin Type A [NCIt concept]
- Bovine Lactoferrin Supplement [NCIt concept]
- Bowel Obstruction [NCIt concept]
- Bowel Obstruction Management [NCIt concept]
- Bowen Disease of the Skin [NCIt concept]
- Bowman-Birk Inhibitor Concentrate [NCIt concept]
- Brachytherapy [NCIt concept]
- Brachyury Protein Antibody [NCIt concept]
- Brachyury-expressing Yeast Vaccine GI-6301 [NCIt concept]
- Brain Acid Soluble Protein 1 [NCIt concept]
- Brain Astrocytoma [NCIt concept]
- Brain Disorder [NCIt concept]
- Brain Ependymoma [NCIt concept]
- Brain Irradiation [NCIt concept]
- Brain Lesion [NCIt concept]
- Brain Metastasis Velocity Greater Than or Equal to 4 per Year [NCIt concept]
- Brain Natriuretic Peptide 32 [NCIt concept]
- Brain Natriuretic Peptide Measurement [NCIt concept]
- Brain Neoplasm [NCIt concept]
- Brain Surgery [NCIt concept]
- Brain Tumor Initiating Cell Vaccine [NCIt concept]
- Brain and Acute Leukemia Cytoplasmic Protein [NCIt concept]
- Brain-Derived Neurotrophic Factor [NCIt concept]
- Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2-Like Protein 1 [NCIt concept]
- BrainCheck Cognitive Assessment [NCIt concept]
- Breakpoint Cluster Region Protein [NCIt concept]
- Breast Adenocarcinoma [NCIt concept]
- Breast Apocrine Carcinoma [NCIt concept]
- Breast Atypical Ductal Hyperplasia [NCIt concept]
- Breast Atypical Lobular Hyperplasia [NCIt concept]
- Breast Atypical Papilloma [NCIt concept]
- Breast Biopsy Procedure [NCIt concept]
- Breast Cancer Anti-Estrogen Resistance Protein 1 [NCIt concept]
- Breast Cancer Index [NCIt concept]
- Breast Cancer Locator [NCIt concept]
- Breast Cancer Risk Reduction Counseling [NCIt concept]
- Breast Cancer Screening [NCIt concept]
- Breast Cancer Type 1 Susceptibility Protein [NCIt concept]
- Breast Cancer Type 2 Susceptibility Protein [NCIt concept]
- Breast Cancer-Related Lymphedema [NCIt concept]
- Breast Carcinoma [NCIt concept]
- Breast Conservation Treatment [NCIt concept]
- Breast Density [NCIt concept]
- Breast Duct Lavage [NCIt concept]
- Breast Ductal Carcinoma [NCIt concept]
- Breast Ductal Carcinoma In Situ [NCIt concept]
- Breast Ductal Carcinoma In Situ, Cribriform Pattern [NCIt concept]
- Breast Ductal Carcinoma In Situ, High Grade [NCIt concept]
- Breast Hyperplasia [NCIt concept]
- Breast Imaging Study [NCIt concept]
- Breast Inflammatory Carcinoma [NCIt concept]
- Breast Irradiation [NCIt concept]
- Breast Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Breast Lesion [NCIt concept]
- Breast Lobular Carcinoma [NCIt concept]
- Breast Lobular Carcinoma In Situ [NCIt concept]
- Breast Lobular Neoplasia [NCIt concept]
- Breast Lump [NCIt concept]
- Breast Measurement [NCIt concept]
- Breast Medullary Carcinoma [NCIt concept]
- Breast Micropapillary Ductal Carcinoma In Situ [NCIt concept]
- Breast Mucinous Carcinoma [NCIt concept]
- Breast Neoplasm [NCIt concept]
- Breast Neuroendocrine Tumor [NCIt concept]
- Breast Paget Disease [NCIt concept]
- Breast Paget Disease and Intraductal Carcinoma [NCIt concept]
- Breast Paget Disease with Invasive Ductal Carcinoma [NCIt concept]
- Breast Papillary Carcinoma [NCIt concept]
- Breast Papillary Ductal Carcinoma In Situ with Invasion [NCIt concept]
- Breast Tubular Carcinoma [NCIt concept]
- Breath Carbon Monoxide Monitor [NCIt concept]
- Breath Test [NCIt concept]
- Breathing-Synchronized Delivery Tomotherapy [NCIt concept]
- Brentuximab [NCIt concept]
- Brentuximab Vedotin [NCIt concept]
- Brepocitinib [NCIt concept]
- Brexucabtagene Autoleucel [NCIt concept]
- Briciclib Sodium [NCIt concept]
- Brief Behavioral Treatment for Insomnia [NCIt concept]
- Brigatinib [NCIt concept]
- Bright White Light Therapy [NCIt concept]
- Brigimadlin [NCIt concept]
- Brilacidin Oral Rinse [NCIt concept]
- Brilanestrant [NCIt concept]
- Brimarafenib [NCIt concept]
- Brimonidine Tartrate [NCIt concept]
- Brimonidine Tartrate Nanoemulsion OCU-300 [NCIt concept]
- Brincidofovir [NCIt concept]
- Briquilimab [NCIt concept]
- Brivanib Alaninate [NCIt concept]
- Brivaracetam [NCIt concept]
- Brivudine [NCIt concept]
- Broad Ligament Papillary Cystadenoma [NCIt concept]
- Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 [NCIt concept]
- Broad-Spectrum Human Papillomavirus Vaccine V505 [NCIt concept]
- Broccoli Sprout Extract [NCIt concept]
- Broccoli Sprout/Broccoli Seed Extract Supplement [NCIt concept]
- Brochure [NCIt concept]
- Bromodomain Testis-Specific Protein [NCIt concept]
- Bromodomain and Extra-Terminal Domain Protein [NCIt concept]
- Bromodomain-Containing Protein 2 [NCIt concept]
- Bromodomain-Containing Protein 3 [NCIt concept]
- Bromodomain-Containing Protein 4 [NCIt concept]
- Bromodomain-Containing Protein 9 [NCIt concept]
- Bronchial Brush Biopsy [NCIt concept]
- Bronchial Epithelial Dysplasia [NCIt concept]
- Bronchial Intraepithelial Neoplasia [NCIt concept]
- Bronchial Papillomatosis [NCIt concept]
- Bronchiolitis Obliterans [NCIt concept]
- Bronchiolitis Obliterans Syndrome [NCIt concept]
- Bronchogenic Carcinoma [NCIt concept]
- Bronchoscopy [NCIt concept]
- Bronchoscopy with Biopsy [NCIt concept]
- Bronchoscopy with Bronchoalveolar Lavage [NCIt concept]
- Brontictuzumab [NCIt concept]
- Brostallicin [NCIt concept]
- Broxuridine [NCIt concept]
- Bryostatin 1 [NCIt concept]
- Budesonide [NCIt concept]
- Budigalimab [NCIt concept]
- Bufalin [NCIt concept]
- Buffered Lidocaine [NCIt concept]
- Bufogenin [NCIt concept]
- Bumetanide [NCIt concept]
- Buparlisib [NCIt concept]
- Bupivacaine [NCIt concept]
- Bupivacaine Hydrochloride [NCIt concept]
- Buprenorphine [NCIt concept]
- Buprenorphine Transdermal Matrix Patch [NCIt concept]
- Bupropion [NCIt concept]
- Bupropion Hydrochloride [NCIt concept]
- Bupropion Hydrochloride Controlled-release [NCIt concept]
- Burixafor Hydrobromide [NCIt concept]
- Burkitt Leukemia [NCIt concept]
- Burkitt Lymphoma [NCIt concept]
- Burosumab [NCIt concept]
- Buserelin [NCIt concept]
- Buspirone Hydrochloride [NCIt concept]
- Busulfan [NCIt concept]
- Buthionine Sulfoximine [NCIt concept]
- Butyrate Level Finding [NCIt concept]
- Butyrate-Producing Bacteria [NCIt concept]
- Butyric Acid [NCIt concept]
- Butyrophilin Subfamily 1 Member A1 [NCIt concept]
- C Peptide [NCIt concept]
- C-1-Tetrahydrofolate Synthase, Cytoplasmic [NCIt concept]
- C-C Chemokine Receptor Type 1 [NCIt concept]
- C-C Chemokine Receptor Type 10 [NCIt concept]
- C-C Chemokine Receptor Type 2 [NCIt concept]
- C-C Chemokine Receptor Type 3 [NCIt concept]
- C-C Chemokine Receptor Type 4 [NCIt concept]
- C-C Chemokine Receptor Type 5 [NCIt concept]
- C-C Chemokine Receptor Type 6 [NCIt concept]
- C-C Chemokine Receptor Type 7 [NCIt concept]
- C-C Chemokine Receptor Type 8 [NCIt concept]
- C-C Chemokine Receptor Type 9 [NCIt concept]
- C-C Motif Chemokine 1 [NCIt concept]
- C-C Motif Chemokine 13 [NCIt concept]
- C-C Motif Chemokine 15 [NCIt concept]
- C-C Motif Chemokine 17 [NCIt concept]
- C-C Motif Chemokine 18 [NCIt concept]
- C-C Motif Chemokine 19 [NCIt concept]
- C-C Motif Chemokine 2 [NCIt concept]
- C-C Motif Chemokine 20 [NCIt concept]
- C-C Motif Chemokine 21 [NCIt concept]
- C-C Motif Chemokine 22 [NCIt concept]
- C-C Motif Chemokine 24 [NCIt concept]
- C-C Motif Chemokine 26 [NCIt concept]
- C-C Motif Chemokine 27 [NCIt concept]
- C-C Motif Chemokine 3 [NCIt concept]
- C-C Motif Chemokine 4 [NCIt concept]
- C-C Motif Chemokine 7 [NCIt concept]
- C-C Motif Chemokine 8 [NCIt concept]
- C-Circle [NCIt concept]
- C-KIT Somatic Point Mutation [NCIt concept]
- C-KIT Tyrosine Kinase Protein Overexpression [NCIt concept]
- C-Myc Translocation [NCIt concept]
- C-Reactive Protein [NCIt concept]
- C-Scan System [NCIt concept]
- C-Telopeptide of Type I Collagen Generated by Matrix Metalloproteinases [NCIt concept]
- C-Type Lectin Domain Family 10 Member A [NCIt concept]
- C-Type Lectin Domain Family 11 Member A [NCIt concept]
- C-Type Lectin Domain Family 12 Member A [NCIt concept]
- C-Type Lectin Domain Family 2 Member A [NCIt concept]
- C-Type Lectin Domain Family 2 Member D [NCIt concept]
- C-Type Lectin Domain Family 4 Member C [NCIt concept]
- C-Type Lectin Domain Family 6 Member A [NCIt concept]
- C-Type Lectin Domain Family 7 Member A [NCIt concept]
- C-Type Mannose Receptor 2 [NCIt concept]
- C-VISA BikDD:Liposome [NCIt concept]
- C-X-C Chemokine Receptor Type 1 [NCIt concept]
- C-X-C Chemokine Receptor Type 2 [NCIt concept]
- C-X-C Chemokine Receptor Type 3 [NCIt concept]
- C-X-C Chemokine Receptor Type 4 [NCIt concept]
- C-X-C Chemokine Receptor Type 5 [NCIt concept]
- C-X-C Motif Chemokine 10 [NCIt concept]
- C-X-C Motif Chemokine 11 [NCIt concept]
- C-X-C Motif Chemokine 13 [NCIt concept]
- C-X-C Motif Chemokine 16 [NCIt concept]
- C-X-C Motif Chemokine 2 [NCIt concept]
- C-X-C Motif Chemokine 3 [NCIt concept]
- C-X-C Motif Chemokine 5 [NCIt concept]
- C-X-C Motif Chemokine 6 [NCIt concept]
- C-X-C Motif Chemokine 9 [NCIt concept]
- C1GALT1 Gene [NCIt concept]
- C1GALT1 wt Allele [NCIt concept]
- C1GALT1-Specific Chaperone 1 [NCIt concept]
- C1GALT1C1 Gene [NCIt concept]
- C1GALT1C1 wt Allele [NCIt concept]
- C1QA Gene [NCIt concept]
- C1QA wt Allele [NCIt concept]
- C1S Gene [NCIt concept]
- C1S wt Allele [NCIt concept]
- C2 Gene [NCIt concept]
- C2 wt Allele [NCIt concept]
- C3 Gene [NCIt concept]
- C3 Gene Product [NCIt concept]
- C3 wt Allele [NCIt concept]
- C3D Format [NCIt concept]
- C3a Anaphylatoxin [NCIt concept]
- C3d Positive [NCIt concept]
- C4 Gene Product [NCIt concept]
- C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs [NCIt concept]
- C4A Gene [NCIt concept]
- C4A wt Allele [NCIt concept]
- C4B Gene [NCIt concept]
- C4B wt Allele [NCIt concept]
- C4B_2 Gene [NCIt concept]
- C4B_2 wt Allele [NCIt concept]
- C4d [NCIt concept]
- C5 Gene [NCIt concept]
- C5 Gene Mutation [NCIt concept]
- C5 Gene Product [NCIt concept]
- C5 wt Allele [NCIt concept]
- C5AR1 Gene [NCIt concept]
- C5AR1 wt Allele [NCIt concept]
- C5a Anaphylatoxin Chemotactic Receptor 1 [NCIt concept]
- C7R-expressing EBVSTs [NCIt concept]
- CA-125 Antigen [NCIt concept]
- CA1 Gene [NCIt concept]
- CA1 wt Allele [NCIt concept]
- CA125 50% Response [NCIt concept]
- CA125 II Assay [NCIt concept]
- CA125 to CEA Ratio Greater than or Equal to 25 [NCIt concept]
- CA19-9 Antigen [NCIt concept]
- CA19-9 Antigen Positive [NCIt concept]
- CA19-9 Greater than 500 U/mL [NCIt concept]
- CA19-9 Less than 500 U/mL [NCIt concept]
- CA19-9 Level Finding [NCIt concept]
- CA2 Gene [NCIt concept]
- CA2 wt Allele [NCIt concept]
- CA242 Antigen [NCIt concept]
- CA27-29 [NCIt concept]
- CA6 Antigen [NCIt concept]
- CA6 Gene [NCIt concept]
- CA6 wt Allele [NCIt concept]
- CA9 Gene [NCIt concept]
- CA9 wt Allele [NCIt concept]
- CA9-targeting Agent [NCIt concept]
- CABIN1 Gene [NCIt concept]
- CABIN1 wt Allele [NCIt concept]
- CACNA1D Gene [NCIt concept]
- CACNA1D wt Allele [NCIt concept]
- CACNA1G Gene [NCIt concept]
- CACNA1G wt Allele [NCIt concept]
- CADM1 Gene [NCIt concept]
- CADM1 wt Allele [NCIt concept]
- CALB2 Gene [NCIt concept]
- CALB2 wt Allele [NCIt concept]
- CALCA Gene [NCIt concept]
- CALCA wt Allele [NCIt concept]
- CALD1 Gene [NCIt concept]
- CALD1 wt Allele [NCIt concept]
- CALM1 Gene [NCIt concept]
- CALM1 wt Allele [NCIt concept]
- CALR Exon 9 Mutation [NCIt concept]
- CALR Gene [NCIt concept]
- CALR Gene Mutation [NCIt concept]
- CALR Variant Allele Frequency [NCIt concept]
- CALR wt Allele [NCIt concept]
- CAM Exercise Therapy [NCIt concept]
- CAMK1 Gene [NCIt concept]
- CAMK1 wt Allele [NCIt concept]
- CAMK2A Gene [NCIt concept]
- CAMK2A wt Allele [NCIt concept]
- CAMK2B Gene [NCIt concept]
- CAMK2B wt Allele [NCIt concept]
- CAMK2G Gene [NCIt concept]
- CAMK2G wt Allele [NCIt concept]
- CAMK2N1 Gene [NCIt concept]
- CAMK2N1 wt Allele [NCIt concept]
- CAMPATH-1 Antigen [NCIt concept]
- CAMTA1 Gene [NCIt concept]
- CAMTA1 wt Allele [NCIt concept]
- CANT1 Gene [NCIt concept]
- CANT1 wt Allele [NCIt concept]
- CANX Gene [NCIt concept]
- CANX wt Allele [NCIt concept]
- CAP-Gly Domain-Containing Linker Protein 1 [NCIt concept]
- CAPG Gene [NCIt concept]
- CAPG wt Allele [NCIt concept]
- CAPN1 Gene [NCIt concept]
- CAPN1 wt Allele [NCIt concept]
- CAPRIN1 Gene [NCIt concept]
- CAPRIN1 wt Allele [NCIt concept]
- CAR T-Cells AMG 119 [NCIt concept]
- CAR T-cell-Related Hemophagocytic Lymphohistiocytosis-like Syndrome [NCIt concept]
- CARD11-BCL10-MALT1 Complex Inhibitor XL114 [NCIt concept]
- CARD14 Gene [NCIt concept]
- CARD14 wt Allele [NCIt concept]
- CARD8 Gene [NCIt concept]
- CARD8 wt Allele [NCIt concept]
- CARS/ALK Fusion Gene [NCIt concept]
- CARS/ALK Fusion Protein [NCIt concept]
- CARS1 Gene [NCIt concept]
- CARS1 wt Allele [NCIt concept]
- CASP1 Gene [NCIt concept]
- CASP1 wt Allele [NCIt concept]
- CASP10 Gene [NCIt concept]
- CASP10 wt Allele [NCIt concept]
- CASP2 Gene [NCIt concept]
- CASP2 wt Allele [NCIt concept]
- CASP3 Gene [NCIt concept]
- CASP3 Gene Product [NCIt concept]
- CASP3 wt Allele [NCIt concept]
- CASP4 Gene [NCIt concept]
- CASP4 wt Allele [NCIt concept]
- CASP7 Gene [NCIt concept]
- CASP7 wt Allele [NCIt concept]
- CASP8 Gene [NCIt concept]
- CASP8 and FADD-Like Apoptosis Regulator [NCIt concept]
- CASP8 and FADD-Like Apoptosis Regulator Isoform 2 [NCIt concept]
- CASP8 wt Allele [NCIt concept]
- CASP8*1 Allele [NCIt concept]
- CASP9 Gene [NCIt concept]
- CASP9 Gene Product [NCIt concept]
- CASP9 wt Allele [NCIt concept]
- CATCH My Breath Vaping Prevention Program [NCIt concept]
- CAV2 Gene [NCIt concept]
- CAV2 wt Allele [NCIt concept]
- CB-17-08 [NCIt concept]
- CBFA2T2 Gene [NCIt concept]
- CBFA2T2 wt Allele [NCIt concept]
- CBFA2T3 Gene [NCIt concept]
- CBFA2T3 wt Allele [NCIt concept]
- CBFA2T3/GLIS2 Fusion Gene [NCIt concept]
- CBFA2T3/GLIS2 Fusion Protein [NCIt concept]
- CBFB Gene [NCIt concept]
- CBFB wt Allele [NCIt concept]
- CBFB/MYH11 Fusion Gene [NCIt concept]
- CBL Gene [NCIt concept]
- CBL Gene Mutation [NCIt concept]
- CBL wt Allele [NCIt concept]
- CBL-B Inhibitor HST-1011 [NCIt concept]
- CBL-B Inhibitor-treated Autologous Tumor-infiltrating Lymphocytes DeTIL-0255 [NCIt concept]
- CBLB Gene [NCIt concept]
- CBLB Gene Mutation [NCIt concept]
- CBLB wt Allele [NCIt concept]
- CBLC Gene [NCIt concept]
- CBLC wt Allele [NCIt concept]
- CBP/beta-catenin Modulator E7386 [NCIt concept]
- CBP/p300 Bromodomain Inhibitor OPN-6602 [NCIt concept]
- CBR1 Gene [NCIt concept]
- CBR1 wt Allele [NCIt concept]
- CBR3 Gene [NCIt concept]
- CBR3 wt Allele [NCIt concept]
- CBS Gene [NCIt concept]
- CBS wt Allele [NCIt concept]
- CCAAT Enhancer Binding Protein Gene Mutation [NCIt concept]
- CCAAT/Enhancer Binding Protein Alpha [NCIt concept]
- CCAAT/Enhancer Binding Protein Beta [NCIt concept]
- CCAAT/Enhancer Binding Protein Epsilon [NCIt concept]
- CCDC6 Gene [NCIt concept]
- CCDC6 wt Allele [NCIt concept]
- CCDC6/PDGFRB Fusion Gene [NCIt concept]
- CCDC6/PDGFRB Fusion Protein [NCIt concept]
- CCDC6/RET Fusion Gene [NCIt concept]
- CCDC6/RET Fusion Protein [NCIt concept]
- CCK Gene [NCIt concept]
- CCK wt Allele [NCIt concept]
- CCKAR Gene [NCIt concept]
- CCKAR wt Allele [NCIt concept]
- CCKBR Gene [NCIt concept]
- CCKBR wt Allele [NCIt concept]
- CCL1 Gene [NCIt concept]
- CCL1 wt Allele [NCIt concept]
- CCL13 Gene [NCIt concept]
- CCL13 wt Allele [NCIt concept]
- CCL15 Gene [NCIt concept]
- CCL15 wt Allele [NCIt concept]
- CCL17 Gene [NCIt concept]
- CCL17 wt Allele [NCIt concept]
- CCL18 Gene [NCIt concept]
- CCL18 wt Allele [NCIt concept]
- CCL19 Gene [NCIt concept]
- CCL19 wt Allele [NCIt concept]
- CCL2 Gene [NCIt concept]
- CCL2 wt Allele [NCIt concept]
- CCL20 Gene [NCIt concept]
- CCL20 wt Allele [NCIt concept]
- CCL21 Gene [NCIt concept]
- CCL21 wt Allele [NCIt concept]
- CCL21-expressing H1944 Cell Vaccine [NCIt concept]
- CCL22 Gene [NCIt concept]
- CCL22 wt Allele [NCIt concept]
- CCL24 Gene [NCIt concept]
- CCL24 wt Allele [NCIt concept]
- CCL26 Gene [NCIt concept]
- CCL26 wt Allele [NCIt concept]
- CCL27 Gene [NCIt concept]
- CCL27 wt Allele [NCIt concept]
- CCL3 Gene [NCIt concept]
- CCL3 wt Allele [NCIt concept]
- CCL4 Gene [NCIt concept]
- CCL4 wt Allele [NCIt concept]
- CCL7 Gene [NCIt concept]
- CCL7 wt Allele [NCIt concept]
- CCL8 Gene [NCIt concept]
- CCL8 wt Allele [NCIt concept]
- CCN Family Member 1 [NCIt concept]
- CCN Family Member 2 [NCIt concept]
- CCN Family Member 3 [NCIt concept]
- CCN1 Gene [NCIt concept]
- CCN1 wt Allele [NCIt concept]
- CCN2 Gene [NCIt concept]
- CCN2 wt Allele [NCIt concept]
- CCN3 Gene [NCIt concept]
- CCN3 wt Allele [NCIt concept]
- CCNA1 Gene [NCIt concept]
- CCNA1 wt Allele [NCIt concept]
- CCNB1 Gene [NCIt concept]
- CCNB1 wt Allele [NCIt concept]
- CCNB1IP1 Gene [NCIt concept]
- CCNB1IP1 wt Allele [NCIt concept]
- CCNB3 Gene [NCIt concept]
- CCNB3 wt Allele [NCIt concept]
- CCNC Gene [NCIt concept]
- CCNC wt Allele [NCIt concept]
- CCND1 3' Untranslated Region Deletion Mutation [NCIt concept]
- CCND1 Gene [NCIt concept]
- CCND1 Gene Amplification [NCIt concept]
- CCND1 Gene Mutation [NCIt concept]
- CCND1 Gene Mutation Negative [NCIt concept]
- CCND1 Gene Product [NCIt concept]
- CCND1 Gene Rearrangement [NCIt concept]
- CCND1 Gene Translocation [NCIt concept]
- CCND1 Negative [NCIt concept]
- CCND1 Positive [NCIt concept]
- CCND1 Protein Overexpression [NCIt concept]
- CCND1 Splice Variant Positive [NCIt concept]
- CCND1 mRNA Overexpression [NCIt concept]
- CCND1 wt Allele [NCIt concept]
- CCND1/FSTL3 Fusion Gene [NCIt concept]
- CCND1/IGH Fusion Negative [NCIt concept]
- CCND1/IGHG1 Fusion Gene [NCIt concept]
- CCND1/IGHG1 Fusion Negative [NCIt concept]
- CCND1/IGLC1 Fusion Gene [NCIt concept]
- CCND1/PTH Fusion Gene [NCIt concept]
- CCND2 3' Untranslated Region Deletion Mutation [NCIt concept]
- CCND2 Gene [NCIt concept]
- CCND2 Gene Amplification [NCIt concept]
- CCND2 Gene Mutation [NCIt concept]
- CCND2 Gene Translocation [NCIt concept]
- CCND2 Positive [NCIt concept]
- CCND2 Protein Overexpression [NCIt concept]
- CCND2 wt Allele [NCIt concept]
- CCND3 3' Untranslated Region Deletion Mutation [NCIt concept]
- CCND3 Gene [NCIt concept]
- CCND3 Gene Amplification [NCIt concept]
- CCND3 Gene Mutation [NCIt concept]
- CCND3 Gene Translocation [NCIt concept]
- CCND3 Positive [NCIt concept]
- CCND3 Protein Overexpression [NCIt concept]
- CCND3 wt Allele [NCIt concept]
- CCNE1 Gene [NCIt concept]
- CCNE1 Gene Amplification [NCIt concept]
- CCNE1 Gene Amplification Negative [NCIt concept]
- CCNE1 Gene Mutation [NCIt concept]
- CCNE1 wt Allele [NCIt concept]
- CCNE2 Gene [NCIt concept]
- CCNE2 wt Allele [NCIt concept]
- CCNH Gene [NCIt concept]
- CCNH wt Allele [NCIt concept]
- CCNK Gene [NCIt concept]
- CCNK Gene Deletion [NCIt concept]
- CCNK wt Allele [NCIt concept]
- CCR1 Gene [NCIt concept]
- CCR1 wt Allele [NCIt concept]
- CCR10 Gene [NCIt concept]
- CCR10 wt Allele [NCIt concept]
- CCR2 Antagonist CCX872-B [NCIt concept]
- CCR2 Antagonist PF-04136309 [NCIt concept]
- CCR2 Gene [NCIt concept]
- CCR2 wt Allele [NCIt concept]
- CCR2-targeting Chimera STX-0712 [NCIt concept]
- CCR2/CCR5 Antagonist BMS-813160 [NCIt concept]
- CCR3 Gene [NCIt concept]
- CCR3 wt Allele [NCIt concept]
- CCR4 Gene [NCIt concept]
- CCR4 wt Allele [NCIt concept]
- CCR4-NOT Transcription Complex Subunit 3 [NCIt concept]
- CCR5 Gene [NCIt concept]
- CCR5 Positive [NCIt concept]
- CCR5 wt Allele [NCIt concept]
- CCR6 Gene [NCIt concept]
- CCR6 wt Allele [NCIt concept]
- CCR7 Gene [NCIt concept]
- CCR7 wt Allele [NCIt concept]
- CCR8 Gene [NCIt concept]
- CCR8 Inhibitor [NCIt concept]
- CCR8 wt Allele [NCIt concept]
- CCR9 Gene [NCIt concept]
- CCR9 wt Allele [NCIt concept]
- CD-expressing Bifidobacterium APS001F [NCIt concept]
- CD103 Negative [NCIt concept]
- CD109 Antigen [NCIt concept]
- CD109 Gene [NCIt concept]
- CD109 wt Allele [NCIt concept]
- CD11b Agonist GB1275 [NCIt concept]
- CD11c Positive [NCIt concept]
- CD123-Specific Adapter SPRX002 [NCIt concept]
- CD123-targeting Agent [NCIt concept]
- CD137 Agonist [NCIt concept]
- CD137/Nectin-4 Bispecific-targeting Agent BT7480 [NCIt concept]
- CD137/PSMA/HSA Trispecific-targeting Agent CB 307 [NCIt concept]
- CD138CAR-CD137/TCRzeta-expressing T Lymphocytes [NCIt concept]
- CD14 Gene [NCIt concept]
- CD14 Gene Product [NCIt concept]
- CD14 Positive [NCIt concept]
- CD14 wt Allele [NCIt concept]
- CD15 Antigen [NCIt concept]
- CD159 Family [NCIt concept]
- CD16 Negative [NCIt concept]
- CD16+ CD56+ CD69+ Lymphocyte [NCIt concept]
- CD16-based ROR1-targeted NK Cell Engager PBA-0405 [NCIt concept]
- CD160 Antigen [NCIt concept]
- CD160 Gene [NCIt concept]
- CD160 wt Allele [NCIt concept]
- CD163 Gene [NCIt concept]
- CD163 wt Allele [NCIt concept]
- CD166 Antigen [NCIt concept]
- CD177 Antigen [NCIt concept]
- CD177 Gene [NCIt concept]
- CD177 wt Allele [NCIt concept]
- CD19 Gene [NCIt concept]
- CD19 Negative [NCIt concept]
- CD19 Positive [NCIt concept]
- CD19 wt Allele [NCIt concept]
- CD19-CD34tagged Metabolically Programmed CAR T-cells [NCIt concept]
- CD19-Positive Neoplastic Cells Present [NCIt concept]
- CD19-expressing Oncolytic Virus CF33 [NCIt concept]
- CD19-specific Adapter Molecule SWI019 [NCIt concept]
- CD19-targeting Agent [NCIt concept]
- CD198 Expression Measurement [NCIt concept]
- CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes [NCIt concept]
- CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes [NCIt concept]
- CD19CAR-CD28zeta-4-1BB-expressing Allogeneic T Lymphocytes [NCIt concept]
- CD19CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocyte Cells [NCIt concept]
- CD19R(EQ)-CD28-CD3zeta-EGFRt-expressing T-lymphocytes [NCIt concept]
- CD19x22 Bicistronic CAR T-cells [NCIt concept]
- CD1A Gene [NCIt concept]
- CD1A Positive [NCIt concept]
- CD1A wt Allele [NCIt concept]
- CD1C Gene [NCIt concept]
- CD1C Positive [NCIt concept]
- CD1C wt Allele [NCIt concept]
- CD1D Gene [NCIt concept]
- CD1D wt Allele [NCIt concept]
- CD1a-Positive Neoplastic Cells Present [NCIt concept]
- CD2 Antigen Cytoplasmic Tail-Binding Protein 2 [NCIt concept]
- CD2 Gene [NCIt concept]
- CD2 Negative [NCIt concept]
- CD2 Positive [NCIt concept]
- CD2 wt Allele [NCIt concept]
- CD20 Negative [NCIt concept]
- CD20 Positive [NCIt concept]
- CD20-Positive Neoplastic Cells Present [NCIt concept]
- CD20/CD47 Bispecific Fusion Protein CPO107 [NCIt concept]
- CD200 Activation Receptor Ligand hP1A8 [NCIt concept]
- CD200 Gene [NCIt concept]
- CD200 wt Allele [NCIt concept]
- CD209 Antigen [NCIt concept]
- CD209 Gene [NCIt concept]
- CD209 wt Allele [NCIt concept]
- CD22 Gene [NCIt concept]
- CD22 Positive [NCIt concept]
- CD22 wt Allele [NCIt concept]
- CD226 Antigen [NCIt concept]
- CD226 Gene [NCIt concept]
- CD226 wt Allele [NCIt concept]
- CD228-targeting Agent [NCIt concept]
- CD23-Positive Neoplastic Cells Present [NCIt concept]
- CD24 Gene [NCIt concept]
- CD24 wt Allele [NCIt concept]
- CD244 Gene [NCIt concept]
- CD244 wt Allele [NCIt concept]
- CD247 Gene [NCIt concept]
- CD247 Gene Product [NCIt concept]
- CD247 wt Allele [NCIt concept]
- CD248 Gene [NCIt concept]
- CD248 wt Allele [NCIt concept]
- CD25 Negative [NCIt concept]
- CD27 Antigen [NCIt concept]
- CD27 Gene [NCIt concept]
- CD27 Positive [NCIt concept]
- CD27 wt Allele [NCIt concept]
- CD27-targeting Agent [NCIt concept]
- CD274 Gene [NCIt concept]
- CD274 Gene Amplification [NCIt concept]
- CD274 Gene Mutation [NCIt concept]
- CD274 wt Allele [NCIt concept]
- CD276 Antigen [NCIt concept]
- CD276 Antigen Positive [NCIt concept]
- CD276 Gene [NCIt concept]
- CD276 wt Allele [NCIt concept]
- CD28 Gene [NCIt concept]
- CD28 Positive [NCIt concept]
- CD28 wt Allele [NCIt concept]
- CD2BP2 Gene [NCIt concept]
- CD2BP2 wt Allele [NCIt concept]
- CD3 Complex [NCIt concept]
- CD3 Negative [NCIt concept]
- CD3 Positive [NCIt concept]
- CD3 T-Cell Marker Measurement [NCIt concept]
- CD3+/CD19+ Cell-depleted Autologous Hematopoietic Stem Cells [NCIt concept]
- CD3+/CD19+ Cell-depleted Unrelated or Partially Matched Donor-derived Allogeneic Peripheral Blood Stem Cells [NCIt concept]
- CD3/CD28 Costimulated Autologous T-Cells [NCIt concept]
- CD30 CAR-expressing Autologous T Lymphocytes [NCIt concept]
- CD30-Positive Neoplastic Cells Present [NCIt concept]
- CD33 Expression 20 Percent or More of Neoplastic Cells [NCIt concept]
- CD33 Expression 50 Percent or More of Neoplastic Cells [NCIt concept]
- CD33 Gene [NCIt concept]
- CD33 Positive [NCIt concept]
- CD33 wt Allele [NCIt concept]
- CD33-Positive Neoplastic Cells Present [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Allogeneic T-lymphocytes [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- CD34 Gene [NCIt concept]
- CD34 Negative [NCIt concept]
- CD34 Positive [NCIt concept]
- CD34 wt Allele [NCIt concept]
- CD34/TK75 Retroviral Vector-Transduced Donor Lymphocytes [NCIt concept]
- CD36 Gene [NCIt concept]
- CD36 wt Allele [NCIt concept]
- CD366 Expression Measurement [NCIt concept]
- CD37 Gene [NCIt concept]
- CD37 Positive [NCIt concept]
- CD37 wt Allele [NCIt concept]
- CD37-targeting Agent [NCIt concept]
- CD371-specific/YSNVz/IL-18 CAR T Cells [NCIt concept]
- CD38 Expressing Cell Count [NCIt concept]
- CD38 Gene [NCIt concept]
- CD38 Positive [NCIt concept]
- CD38 wt Allele [NCIt concept]
- CD39-targeting Agent [NCIt concept]
- CD3D Gene [NCIt concept]
- CD3D wt Allele [NCIt concept]
- CD3E Gene [NCIt concept]
- CD3E wt Allele [NCIt concept]
- CD3G Gene [NCIt concept]
- CD3G wt Allele [NCIt concept]
- CD4 Expressing Cell Count [NCIt concept]
- CD4 Expressing T Cell Count [NCIt concept]
- CD4 Gene [NCIt concept]
- CD4 Negative [NCIt concept]
- CD4 Positive [NCIt concept]
- CD4 Positive Memory T-Lymphocyte [NCIt concept]
- CD4 and ICOS Expressing T-Lymphocyte Count [NCIt concept]
- CD4 wt Allele [NCIt concept]
- CD4+ CD25+ Regulatory T Cells [NCIt concept]
- CD4-Positive Neoplastic Cells Present [NCIt concept]
- CD4-Positive T-Lymphocyte [NCIt concept]
- CD40 Agonist [NCIt concept]
- CD40 Gene [NCIt concept]
- CD40 Ligand [NCIt concept]
- CD40 wt Allele [NCIt concept]
- CD40L-Fc Fusion Protein MEDI5083 [NCIt concept]
- CD40L-augmented Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- CD40LG Gene [NCIt concept]
- CD40LG Gene Mutation [NCIt concept]
- CD40LG wt Allele [NCIt concept]
- CD42 Complex [NCIt concept]
- CD43-Positive Neoplastic Cells Present [NCIt concept]
- CD44 Antigen [NCIt concept]
- CD44 Gene [NCIt concept]
- CD44 Positive [NCIt concept]
- CD44 Targeted Agent SPL-108 [NCIt concept]
- CD44 wt Allele [NCIt concept]
- CD45-Positive Neoplastic Cells Present [NCIt concept]
- CD45RA [NCIt concept]
- CD45RA-depleted Donor T-lymphocytes [NCIt concept]
- CD45RB [NCIt concept]
- CD45RC [NCIt concept]
- CD45RO [NCIt concept]
- CD45RO Antibody [NCIt concept]
- CD46 Gene [NCIt concept]
- CD46 wt Allele [NCIt concept]
- CD47 Gene [NCIt concept]
- CD47 wt Allele [NCIt concept]
- CD47-targeting Agent [NCIt concept]
- CD48 Antigen [NCIt concept]
- CD48 Gene [NCIt concept]
- CD48 wt Allele [NCIt concept]
- CD5 Gene [NCIt concept]
- CD5 Positive [NCIt concept]
- CD5 wt Allele [NCIt concept]
- CD5-Positive Blast Cells Greater than 50 Percent [NCIt concept]
- CD5-Positive Neoplastic Cells Present [NCIt concept]
- CD52 Gene [NCIt concept]
- CD52 Positive [NCIt concept]
- CD52 wt Allele [NCIt concept]
- CD52-Positive Neoplastic Cells Present [NCIt concept]
- CD55 Gene [NCIt concept]
- CD55 wt Allele [NCIt concept]
- CD57 Positive [NCIt concept]
- CD57-Positive Neoplastic Cells Present [NCIt concept]
- CD58 Gene [NCIt concept]
- CD58 wt Allele [NCIt concept]
- CD59 Gene [NCIt concept]
- CD59 Glycoprotein [NCIt concept]
- CD59 wt Allele [NCIt concept]
- CD6 Gene [NCIt concept]
- CD6 wt Allele [NCIt concept]
- CD63 Antigen [NCIt concept]
- CD63 Gene [NCIt concept]
- CD63 wt Allele [NCIt concept]
- CD68 Gene [NCIt concept]
- CD68 wt Allele [NCIt concept]
- CD69 Gene [NCIt concept]
- CD69 wt Allele [NCIt concept]
- CD7 Gene [NCIt concept]
- CD7 Positive [NCIt concept]
- CD7 wt Allele [NCIt concept]
- CD7-Positive Neoplastic Cells Present [NCIt concept]
- CD70 Antigen [NCIt concept]
- CD70 Gene [NCIt concept]
- CD70 Positive [NCIt concept]
- CD70 wt Allele [NCIt concept]
- CD70-targeting Agent [NCIt concept]
- CD73 Inhibitor LY3475070 [NCIt concept]
- CD73 Inhibitor ORIC-533 [NCIt concept]
- CD73-targeting Agent [NCIt concept]
- CD74 Gene [NCIt concept]
- CD74 wt Allele [NCIt concept]
- CD79A Gene [NCIt concept]
- CD79A Gene Mutation [NCIt concept]
- CD79A Positive [NCIt concept]
- CD79A wt Allele [NCIt concept]
- CD79B Gene [NCIt concept]
- CD79B Gene Mutation [NCIt concept]
- CD79B Positive [NCIt concept]
- CD79B wt Allele [NCIt concept]
- CD8 Enriched Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- CD8 Positive [NCIt concept]
- CD8 Positive Memory T-Lymphocyte [NCIt concept]
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR [NCIt concept]
- CD8-Positive Neoplastic Cells Present [NCIt concept]
- CD8-Positive T-Lymphocyte [NCIt concept]
- CD80 Gene [NCIt concept]
- CD80 wt Allele [NCIt concept]
- CD83 Antigen [NCIt concept]
- CD83 Gene [NCIt concept]
- CD83 wt Allele [NCIt concept]
- CD86 Gene [NCIt concept]
- CD86 Positive [NCIt concept]
- CD86 wt Allele [NCIt concept]
- CD8A Gene [NCIt concept]
- CD8A wt Allele [NCIt concept]
- CD8B Gene [NCIt concept]
- CD8B wt Allele [NCIt concept]
- CD9 Antigen [NCIt concept]
- CD9 Gene [NCIt concept]
- CD9 wt Allele [NCIt concept]
- CD93 Gene [NCIt concept]
- CD93 wt Allele [NCIt concept]
- CD96 Gene [NCIt concept]
- CD96 wt Allele [NCIt concept]
- CD99 Antigen [NCIt concept]
- CD99 Gene [NCIt concept]
- CD99 wt Allele [NCIt concept]
- CDA Gene [NCIt concept]
- CDA wt Allele [NCIt concept]
- CDAC Targeting EGFR Mutant BG-60366 [NCIt concept]
- CDC20 Gene [NCIt concept]
- CDC20 wt Allele [NCIt concept]
- CDC25A Gene [NCIt concept]
- CDC25A wt Allele [NCIt concept]
- CDC25B Gene [NCIt concept]
- CDC25B wt Allele [NCIt concept]
- CDC25C Gene [NCIt concept]
- CDC25C wt Allele [NCIt concept]
- CDC6 Gene [NCIt concept]
- CDC6 wt Allele [NCIt concept]
- CDC7 Gene [NCIt concept]
- CDC7 Inhibitor LBS-007 [NCIt concept]
- CDC7 Inhibitor SGR-2921 [NCIt concept]
- CDC7 Kinase Inhibitor BMS-863233 [NCIt concept]
- CDC7 Kinase Inhibitor NMS-1116354 [NCIt concept]
- CDC7 wt Allele [NCIt concept]
- CDCA8 Gene [NCIt concept]
- CDCA8 wt Allele [NCIt concept]
- CDH1 Gene [NCIt concept]
- CDH1 Gene Mutation [NCIt concept]
- CDH1 Pathogenic or Likely Pathogenic Gene Mutation [NCIt concept]
- CDH1 wt Allele [NCIt concept]
- CDH11 Gene [NCIt concept]
- CDH11 wt Allele [NCIt concept]
- CDH13 Gene [NCIt concept]
- CDH13 wt Allele [NCIt concept]
- CDH17 Gene [NCIt concept]
- CDH17 Positive [NCIt concept]
- CDH17 wt Allele [NCIt concept]
- CDH2 Gene [NCIt concept]
- CDH2 wt Allele [NCIt concept]
- CDH3 Gene [NCIt concept]
- CDH3 Positive [NCIt concept]
- CDH3 wt Allele [NCIt concept]
- CDH6 Gene [NCIt concept]
- CDH6 wt Allele [NCIt concept]
- CDK Gene Mutation [NCIt concept]
- CDK Inhibitor AT7519 [NCIt concept]
- CDK1 Gene [NCIt concept]
- CDK1 wt Allele [NCIt concept]
- CDK10 Gene [NCIt concept]
- CDK10 wt Allele [NCIt concept]
- CDK12 Gene [NCIt concept]
- CDK12 Gene Mutation [NCIt concept]
- CDK12 Loss of Function Mutation [NCIt concept]
- CDK12 wt Allele [NCIt concept]
- CDK19 Gene [NCIt concept]
- CDK19 wt Allele [NCIt concept]
- CDK2 Degrader NKT3964 [NCIt concept]
- CDK2 Gene [NCIt concept]
- CDK2 Gene Mutation [NCIt concept]
- CDK2 Inhibitor AVZO-021 [NCIt concept]
- CDK2 Inhibitor AZD8421 [NCIt concept]
- CDK2 Inhibitor BG-68501 [NCIt concept]
- CDK2 Inhibitor INCB123667 [NCIt concept]
- CDK2 Inhibitor INX-315 [NCIt concept]
- CDK2 Inhibitor NKT3447 [NCIt concept]
- CDK2 wt Allele [NCIt concept]
- CDK2/4/6 Inhibitor RGT-419B [NCIt concept]
- CDK2/4/6/FLT3 Inhibitor FN-1501 [NCIt concept]
- CDK4 Gene [NCIt concept]
- CDK4 Gene Amplification [NCIt concept]
- CDK4 Gene Mutation [NCIt concept]
- CDK4 Inhibitor BGB-43395 [NCIt concept]
- CDK4 Inhibitor P1446A-05 [NCIt concept]
- CDK4 Negative [NCIt concept]
- CDK4 wt Allele [NCIt concept]
- CDK4/6 Degrader BTX-9341 [NCIt concept]
- CDK4/6 Inhibitor GLR2007 [NCIt concept]
- CDK4/6 Inhibitor PRT3645 [NCIt concept]
- CDK4/6 Inhibitor UCT-03-008 [NCIt concept]
- CDK5 Gene [NCIt concept]
- CDK5 wt Allele [NCIt concept]
- CDK6 Gene [NCIt concept]
- CDK6 Gene Amplification [NCIt concept]
- CDK6 Gene Mutation [NCIt concept]
- CDK6 wt Allele [NCIt concept]
- CDK6/MLL Fusion Gene [NCIt concept]
- CDK6/MLL Fusion Protein [NCIt concept]
- CDK7 Gene [NCIt concept]
- CDK7 Inhibitor LY3405105 [NCIt concept]
- CDK7 Inhibitor LY3405105 Besylate [NCIt concept]
- CDK7 Inhibitor SY-5609 [NCIt concept]
- CDK7 wt Allele [NCIt concept]
- CDK8 Gene [NCIt concept]
- CDK8 wt Allele [NCIt concept]
- CDK8/19 Inhibitor RVU120 [NCIt concept]
- CDK9 Gene [NCIt concept]
- CDK9 wt Allele [NCIt concept]
- CDKN1A Gene [NCIt concept]
- CDKN1A Gene Mutation [NCIt concept]
- CDKN1A wt Allele [NCIt concept]
- CDKN1B Gene [NCIt concept]
- CDKN1B Gene Mutation [NCIt concept]
- CDKN1B wt Allele [NCIt concept]
- CDKN1C Gene [NCIt concept]
- CDKN1C wt Allele [NCIt concept]
- CDKN2A Gene [NCIt concept]
- CDKN2A Gene Amplification [NCIt concept]
- CDKN2A Gene Deletion [NCIt concept]
- CDKN2A Gene Inactivation [NCIt concept]
- CDKN2A Gene Mutation [NCIt concept]
- CDKN2A Gene Mutation Negative [NCIt concept]
- CDKN2A Negative [NCIt concept]
- CDKN2A Protein Variant [NCIt concept]
- CDKN2A wt Allele [NCIt concept]
- CDKN2A-p16 Negative [NCIt concept]
- CDKN2A-p16 Positive [NCIt concept]
- CDKN2B Gene [NCIt concept]
- CDKN2B Gene Deletion [NCIt concept]
- CDKN2B Gene Mutation [NCIt concept]
- CDKN2B Negative [NCIt concept]
- CDKN2B wt Allele [NCIt concept]
- CDKN2C Gene [NCIt concept]
- CDKN2C Gene Deletion [NCIt concept]
- CDKN2C Gene Mutation [NCIt concept]
- CDKN2C wt Allele [NCIt concept]
- CDKN2D Gene [NCIt concept]
- CDKN2D wt Allele [NCIt concept]
- CDKN3 Gene [NCIt concept]
- CDKN3 wt Allele [NCIt concept]
- CDX1 Gene [NCIt concept]
- CDX1 wt Allele [NCIt concept]
- CDX2 Gene [NCIt concept]
- CDX2 wt Allele [NCIt concept]
- CDX4 Gene [NCIt concept]
- CDX4 wt Allele [NCIt concept]
- CEA Family Gene [NCIt concept]
- CEA-MUC-1-TRICOM Vaccine CV301 [NCIt concept]
- CEA-targeting Agent [NCIt concept]
- CEA-targeting Agent RG6123 [NCIt concept]
- CEACAM1 Gene [NCIt concept]
- CEACAM1 wt Allele [NCIt concept]
- CEACAM5 Gene [NCIt concept]
- CEACAM5 Positive [NCIt concept]
- CEACAM5 wt Allele [NCIt concept]
- CEACAM6 Gene [NCIt concept]
- CEACAM6 Positive [NCIt concept]
- CEACAM6 wt Allele [NCIt concept]
- CEACAM8 Gene [NCIt concept]
- CEACAM8 wt Allele [NCIt concept]
- CEBPA Gene [NCIt concept]
- CEBPA Gene Mutation [NCIt concept]
- CEBPA wt Allele [NCIt concept]
- CEBPA-targeting saRNA MTL-CEBPA Liposome [NCIt concept]
- CEBPB Gene [NCIt concept]
- CEBPB wt Allele [NCIt concept]
- CEBPE Gene [NCIt concept]
- CEBPE wt Allele [NCIt concept]
- CELA1 Gene [NCIt concept]
- CELA1 wt Allele [NCIt concept]
- CELF2 Gene [NCIt concept]
- CELF2 wt Allele [NCIt concept]
- CENP-E Inhibitor GSK-923295A [NCIt concept]
- CENPF Gene [NCIt concept]
- CENPF wt Allele [NCIt concept]
- CENPS Gene [NCIt concept]
- CENPS wt Allele [NCIt concept]
- CENPX Gene [NCIt concept]
- CENPX wt Allele [NCIt concept]
- CEP 7 Probe [NCIt concept]
- CEP43 Gene [NCIt concept]
- CEP43 wt Allele [NCIt concept]
- CEP55 Gene [NCIt concept]
- CEP55 wt Allele [NCIt concept]
- CEP72 Gene [NCIt concept]
- CEP72 wt Allele [NCIt concept]
- CEP89 Gene [NCIt concept]
- CEP89 wt Allele [NCIt concept]
- CERK Gene [NCIt concept]
- CERK wt Allele [NCIt concept]
- CERKL Gene [NCIt concept]
- CERKL wt Allele [NCIt concept]
- CERS5 Gene [NCIt concept]
- CERS5 wt Allele [NCIt concept]
- CES1 Gene [NCIt concept]
- CES1 wt Allele [NCIt concept]
- CES2 Gene [NCIt concept]
- CES2 wt Allele [NCIt concept]
- CFD Gene [NCIt concept]
- CFD wt Allele [NCIt concept]
- CFH Gene [NCIt concept]
- CFH wt Allele [NCIt concept]
- CFLAR Gene [NCIt concept]
- CFLAR Gene Product [NCIt concept]
- CFLAR wt Allele [NCIt concept]
- CFP Gene [NCIt concept]
- CFP wt Allele [NCIt concept]
- CGA Gene [NCIt concept]
- CGA wt Allele [NCIt concept]
- CGAS Gene [NCIt concept]
- CGAS Positive [NCIt concept]
- CGAS wt Allele [NCIt concept]
- CGB3 Gene [NCIt concept]
- CGB3 wt Allele [NCIt concept]
- CGNL1 Gene [NCIt concept]
- CGNL1 wt Allele [NCIt concept]
- CGNL1/CYP19A1 Fusion Gene [NCIt concept]
- CH50 Measurement [NCIt concept]
- CHAF1A Gene [NCIt concept]
- CHAF1A wt Allele [NCIt concept]
- CHAT Gene [NCIt concept]
- CHAT wt Allele [NCIt concept]
- CHCHD7 Gene [NCIt concept]
- CHCHD7 wt Allele [NCIt concept]
- CHCHD7/PLAG1 Fusion Gene [NCIt concept]
- CHD1 Gene [NCIt concept]
- CHD1 Gene Deletion [NCIt concept]
- CHD1 wt Allele [NCIt concept]
- CHD1L Gene [NCIt concept]
- CHD1L wt Allele [NCIt concept]
- CHD4 Gene [NCIt concept]
- CHD4 Gene Mutation [NCIt concept]
- CHD4 wt Allele [NCIt concept]
- CHD5 Gene [NCIt concept]
- CHD5 wt Allele [NCIt concept]
- CHD7 Gene [NCIt concept]
- CHD7 wt Allele [NCIt concept]
- CHDH Gene [NCIt concept]
- CHDH wt Allele [NCIt concept]
- CHEK1 Gene [NCIt concept]
- CHEK1 Gene Mutation [NCIt concept]
- CHEK1 wt Allele [NCIt concept]
- CHEK2 Gene [NCIt concept]
- CHEK2 Gene Mutation [NCIt concept]
- CHEK2 NM_007194.4:c.1283C>T [NCIt concept]
- CHEK2 NM_007194.4:c.470T>C [NCIt concept]
- CHEK2 NP_009125.1:p.I157T [NCIt concept]
- CHEK2 NP_009125.1:p.S428F [NCIt concept]
- CHEK2 Protein Variant [NCIt concept]
- CHEK2 wt Allele [NCIt concept]
- CHFR Gene [NCIt concept]
- CHFR Promoter Methylation [NCIt concept]
- CHFR wt Allele [NCIt concept]
- CHGA Gene [NCIt concept]
- CHGA wt Allele [NCIt concept]
- CHIC2 Gene [NCIt concept]
- CHIC2 Gene Deletion [NCIt concept]
- CHIC2 wt Allele [NCIt concept]
- CHIC2/ETV6 Fusion Gene [NCIt concept]
- CHIC2/ETV6 Fusion Protein [NCIt concept]
- CHIT1 Gene [NCIt concept]
- CHIT1 wt Allele [NCIt concept]
- CHK1 Inhibitor MK-8776 [NCIt concept]
- CHK1 Inhibitor PF-477736 [NCIt concept]
- CHKA Gene [NCIt concept]
- CHKA wt Allele [NCIt concept]
- CHN1 Gene [NCIt concept]
- CHN1 wt Allele [NCIt concept]
- CHN2 Gene [NCIt concept]
- CHN2 wt Allele [NCIt concept]
- CHOP Regimen [NCIt concept]
- CHP-NY-ESO-1 Peptide Vaccine IMF-001 [NCIt concept]
- CHPT1 Gene [NCIt concept]
- CHPT1 wt Allele [NCIt concept]
- CHRNA3 Gene [NCIt concept]
- CHRNA3 wt Allele [NCIt concept]
- CHRNA5 Gene [NCIt concept]
- CHRNA5 wt Allele [NCIt concept]
- CHRNB4 Gene [NCIt concept]
- CHRNB4 wt Allele [NCIt concept]
- CHST15 Gene [NCIt concept]
- CHST15 wt Allele [NCIt concept]
- CHST3 Gene [NCIt concept]
- CHST3 wt Allele [NCIt concept]
- CHUK Gene [NCIt concept]
- CHUK wt Allele [NCIt concept]
- CIC Gene [NCIt concept]
- CIC Gene Mutation [NCIt concept]
- CIC Gene Rearrangement [NCIt concept]
- CIC wt Allele [NCIt concept]
- CIC/DUX4 Fusion Gene [NCIt concept]
- CIC/DUX4 Fusion Protein [NCIt concept]
- CIC/FOXO4 Fusion Gene [NCIt concept]
- CIC/LEUTX Fusion Gene [NCIt concept]
- CIC/MEGF8 Fusion Gene [NCIt concept]
- CIC/NUTM1 Fusion Gene [NCIt concept]
- CIITA Gene [NCIt concept]
- CIITA wt Allele [NCIt concept]
- CITED2 Gene [NCIt concept]
- CITED2 wt Allele [NCIt concept]
- CK1 Alpha Degrader CC-91633 [NCIt concept]
- CK1 Alpha Degrader GLB-001 [NCIt concept]
- CK1alpha/CDK7/CDK9 Inhibitor BTX-A51 [NCIt concept]
- CKB Gene [NCIt concept]
- CKB Positive [NCIt concept]
- CKB wt Allele [NCIt concept]
- CKS1B Gene [NCIt concept]
- CKS1B wt Allele [NCIt concept]
- CLCN6 Gene [NCIt concept]
- CLCN6 wt Allele [NCIt concept]
- CLCN7 Gene [NCIt concept]
- CLCN7 wt Allele [NCIt concept]
- CLDN1 Gene [NCIt concept]
- CLDN1 Positive [NCIt concept]
- CLDN1 wt Allele [NCIt concept]
- CLDN18 Gene [NCIt concept]
- CLDN18 wt Allele [NCIt concept]
- CLDN18.2 Positive [NCIt concept]
- CLDN18.2-targeting Agent [NCIt concept]
- CLDN4 Gene [NCIt concept]
- CLDN4 wt Allele [NCIt concept]
- CLDN6 Gene [NCIt concept]
- CLDN6 Positive [NCIt concept]
- CLDN6 RNA-LPX Vaccine [NCIt concept]
- CLDN6 wt Allele [NCIt concept]
- CLDN6-targeting Agent [NCIt concept]
- CLEC10A Gene [NCIt concept]
- CLEC10A wt Allele [NCIt concept]
- CLEC11A Gene [NCIt concept]
- CLEC11A Gene Product [NCIt concept]
- CLEC11A wt Allele [NCIt concept]
- CLEC12A Gene [NCIt concept]
- CLEC12A wt Allele [NCIt concept]
- CLEC12A-targeting CCR/Anti-ADGRE2 CAR T Cells ADCLEC.syn1 [NCIt concept]
- CLEC2A Gene [NCIt concept]
- CLEC2A wt Allele [NCIt concept]
- CLEC2D Gene [NCIt concept]
- CLEC2D wt Allele [NCIt concept]
- CLEC4C Gene [NCIt concept]
- CLEC4C wt Allele [NCIt concept]
- CLEC6A Gene [NCIt concept]
- CLEC6A wt Allele [NCIt concept]
- CLEC7A Gene [NCIt concept]
- CLEC7A wt Allele [NCIt concept]
- CLIP1 Gene [NCIt concept]
- CLIP1 wt Allele [NCIt concept]
- CLK Inhibitor BH-30236 [NCIt concept]
- CLK1 Gene [NCIt concept]
- CLK1 wt Allele [NCIt concept]
- CLK2 Gene [NCIt concept]
- CLK2 wt Allele [NCIt concept]
- CLK3 Gene [NCIt concept]
- CLK3 wt Allele [NCIt concept]
- CLK4 Gene [NCIt concept]
- CLK4 wt Allele [NCIt concept]
- CLL-1-targeting Agent [NCIt concept]
- CLLU1 Gene [NCIt concept]
- CLLU1 wt Allele [NCIt concept]
- CLP1 Gene [NCIt concept]
- CLP1 wt Allele [NCIt concept]
- CLPP Gene [NCIt concept]
- CLPP wt Allele [NCIt concept]
- CLSPN Gene [NCIt concept]
- CLSPN wt Allele [NCIt concept]
- CLTC Gene [NCIt concept]
- CLTC wt Allele [NCIt concept]
- CLTC/ALK Fusion Gene [NCIt concept]
- CLTC/ALK Fusion Protein [NCIt concept]
- CLTC/TFE3 Fusion Gene [NCIt concept]
- CLTC/TFE3 Fusion Protein [NCIt concept]
- CLTCL1 Gene [NCIt concept]
- CLTCL1 wt Allele [NCIt concept]
- CLU Gene [NCIt concept]
- CLU wt Allele [NCIt concept]
- CMA1 Gene [NCIt concept]
- CMA1 wt Allele [NCIt concept]
- CMTR2 Gene [NCIt concept]
- CMTR2 wt Allele [NCIt concept]
- CMV Pentamer Complex Proteins/gB-encoding mRNA Vaccine mRNA-1647 [NCIt concept]
- CMV UL38 Gene [NCIt concept]
- CMV pp65 Peptide-loaded Alpha-type-1 Polarized Dendritic Cell Vaccine [NCIt concept]
- CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- CMV pp65 mRNA Lipid Particle Vaccine [NCIt concept]
- CMVpp65/gB Plasmid Vaccine ASP0113 [NCIt concept]
- CNBP Gene [NCIt concept]
- CNBP wt Allele [NCIt concept]
- CNDO-109-activated Allogeneic Natural Killer Cells [NCIt concept]
- CNGRC Peptide-TNF Alpha Conjugate [NCIt concept]
- CNOT3 Gene [NCIt concept]
- CNOT3 wt Allele [NCIt concept]
- CNS 1 [NCIt concept]
- CNTN4 Gene [NCIt concept]
- CNTN4 wt Allele [NCIt concept]
- CNTRL Gene [NCIt concept]
- CNTRL wt Allele [NCIt concept]
- CNTRL/FGFR1 Fusion Gene [NCIt concept]
- CNTRL/FGFR1 Fusion Protein [NCIt concept]
- COL17A1 Gene [NCIt concept]
- COL17A1 wt Allele [NCIt concept]
- COL18A1 Gene [NCIt concept]
- COL18A1 wt Allele [NCIt concept]
- COL1A1 Gene [NCIt concept]
- COL1A1 wt Allele [NCIt concept]
- COL1A1/PDGFB Fusion Gene [NCIt concept]
- COL1A1/PDGFB Fusion Protein [NCIt concept]
- COL1A2 Gene [NCIt concept]
- COL1A2 wt Allele [NCIt concept]
- COL3A1 Gene [NCIt concept]
- COL3A1 wt Allele [NCIt concept]
- COL6A3 Gene [NCIt concept]
- COL6A3 Positive [NCIt concept]
- COL6A3 wt Allele [NCIt concept]
- COL7A1 Exon 73 Mutation [NCIt concept]
- COL7A1 Gene [NCIt concept]
- COL7A1 Gene Mutation [NCIt concept]
- COL7A1 wt Allele [NCIt concept]
- COMT Gene [NCIt concept]
- COMT wt Allele [NCIt concept]
- CONNECT Video Doctor [NCIt concept]
- COVID-19 Convalescent Plasma [NCIt concept]
- COVID-19 Infection [NCIt concept]
- COVID-19 Vaccine Ad26.COV2.S [NCIt concept]
- COX2 Positive [NCIt concept]
- COX6C Gene [NCIt concept]
- COX6C wt Allele [NCIt concept]
- CP Gene [NCIt concept]
- CP wt Allele [NCIt concept]
- CPA1 Gene [NCIt concept]
- CPA1 wt Allele [NCIt concept]
- CPB2 Gene [NCIt concept]
- CPB2 wt Allele [NCIt concept]
- CPT1A Gene [NCIt concept]
- CPT1A wt Allele [NCIt concept]
- CR2 Gene [NCIt concept]
- CR2 wt Allele [NCIt concept]
- CR2-fH Fusion Protein TT30 [NCIt concept]
- CRABP1 Gene [NCIt concept]
- CRABP1 wt Allele [NCIt concept]
- CRABP2 Gene [NCIt concept]
- CRABP2 wt Allele [NCIt concept]
- CRBN Gene [NCIt concept]
- CRBN wt Allele [NCIt concept]
- CREB-Binding Protein [NCIt concept]
- CREB-Regulated Transcription Coactivator 1 [NCIt concept]
- CREB-Regulated Transcription Coactivator 2 [NCIt concept]
- CREB1 Gene [NCIt concept]
- CREB1 wt Allele [NCIt concept]
- CREB3L2 Gene [NCIt concept]
- CREB3L2 wt Allele [NCIt concept]
- CREBBP Gene [NCIt concept]
- CREBBP Gene Mutation [NCIt concept]
- CREBBP wt Allele [NCIt concept]
- CRIP2 Gene [NCIt concept]
- CRIP2 wt Allele [NCIt concept]
- CRIPTO Gene [NCIt concept]
- CRIPTO wt Allele [NCIt concept]
- CRKL Gene [NCIt concept]
- CRKL wt Allele [NCIt concept]
- CRL4-CRBN Modulator KPG-818 [NCIt concept]
- CRLF1 Gene [NCIt concept]
- CRLF1 wt Allele [NCIt concept]
- CRLF2 Gene [NCIt concept]
- CRLF2 Gene Mutation [NCIt concept]
- CRLF2 Gene Rearrangement [NCIt concept]
- CRLF2 Positive [NCIt concept]
- CRLF2 wt Allele [NCIt concept]
- CRP Gene [NCIt concept]
- CRP Level Greater than or Equal to 3 mg/L [NCIt concept]
- CRP wt Allele [NCIt concept]
- CRTAM Gene [NCIt concept]
- CRTAM wt Allele [NCIt concept]
- CRTC1 Gene [NCIt concept]
- CRTC1 wt Allele [NCIt concept]
- CRTC1/MAML2 Fusion Gene [NCIt concept]
- CRTC1/MAML2 Fusion Protein [NCIt concept]
- CRTC2 Gene [NCIt concept]
- CRTC2 wt Allele [NCIt concept]
- CRY2 Gene [NCIt concept]
- CRY2 wt Allele [NCIt concept]
- CRYAB Gene [NCIt concept]
- CRYAB wt Allele [NCIt concept]
- CS1-CAR T Therapy [NCIt concept]
- CSF1 Gene [NCIt concept]
- CSF1 wt Allele [NCIt concept]
- CSF1-targeting Agent [NCIt concept]
- CSF1R Gene [NCIt concept]
- CSF1R Gene Amplification [NCIt concept]
- CSF1R Gene Mutation [NCIt concept]
- CSF1R Inhibitor PLX73086 [NCIt concept]
- CSF1R wt Allele [NCIt concept]
- CSF1R-targeting Agent [NCIt concept]
- CSF2 Antibody [NCIt concept]
- CSF2 Gene [NCIt concept]
- CSF2 wt Allele [NCIt concept]
- CSF2RA Gene [NCIt concept]
- CSF2RA wt Allele [NCIt concept]
- CSF3R Gene [NCIt concept]
- CSF3R Gene Mutation [NCIt concept]
- CSF3R wt Allele [NCIt concept]
- CSK Gene [NCIt concept]
- CSK wt Allele [NCIt concept]
- CSNK1A1 Gene [NCIt concept]
- CSNK1A1 wt Allele [NCIt concept]
- CSNK2A1 Gene [NCIt concept]
- CSNK2A1 wt Allele [NCIt concept]
- CSNK2B Gene [NCIt concept]
- CSNK2B wt Allele [NCIt concept]
- CSPG4 Gene [NCIt concept]
- CSPG4 wt Allele [NCIt concept]
- CST Complex Subunit CTC1 [NCIt concept]
- CST1 Gene [NCIt concept]
- CST1 wt Allele [NCIt concept]
- CST2 Gene [NCIt concept]
- CST2 wt Allele [NCIt concept]
- CST3 Gene [NCIt concept]
- CST3 wt Allele [NCIt concept]
- CST4 Gene [NCIt concept]
- CST4 wt Allele [NCIt concept]
- CST5 Gene [NCIt concept]
- CST5 wt Allele [NCIt concept]
- CSTA Gene [NCIt concept]
- CSTA wt Allele [NCIt concept]
- CSTB Gene [NCIt concept]
- CSTB wt Allele [NCIt concept]
- CT-RCC-1 Antigen [NCIt concept]
- CT-guided Stereotactic Body Radiation Therapy [NCIt concept]
- CT83 Gene [NCIt concept]
- CT83 Positive [NCIt concept]
- CT83 wt Allele [NCIt concept]
- CTAG1 Antibody [NCIt concept]
- CTAG1 Positive [NCIt concept]
- CTAG1 Positive Tumor Cells Present [NCIt concept]
- CTAG1A Gene [NCIt concept]
- CTAG1A wt Allele [NCIt concept]
- CTAG1B Gene [NCIt concept]
- CTAG1B Positive [NCIt concept]
- CTAG1B wt Allele [NCIt concept]
- CTAG2 Antibody [NCIt concept]
- CTAG2 Gene [NCIt concept]
- CTAG2 Positive [NCIt concept]
- CTAG2 wt Allele [NCIt concept]
- CTAGE5 Gene [NCIt concept]
- CTAGE5 wt Allele [NCIt concept]
- CTC1 Gene [NCIt concept]
- CTC1 Gene Mutation [NCIt concept]
- CTC1 wt Allele [NCIt concept]
- CTCF Gene [NCIt concept]
- CTCF wt Allele [NCIt concept]
- CTCFL Gene [NCIt concept]
- CTCFL wt Allele [NCIt concept]
- CTD Nuclear Envelope Phosphatase 1 [NCIt concept]
- CTDNEP1 Gene [NCIt concept]
- CTDNEP1 wt Allele [NCIt concept]
- CTHRC1 Gene [NCIt concept]
- CTHRC1 wt Allele [NCIt concept]
- CTLA-4 Ligand [NCIt concept]
- CTLA-4-targeting Agent [NCIt concept]
- CTLA4 Gene [NCIt concept]
- CTLA4 Positive [NCIt concept]
- CTLA4 Positive T-Lymphocytes [NCIt concept]
- CTLA4 wt Allele [NCIt concept]
- CTNNA1 Gene [NCIt concept]
- CTNNA1 Gene Mutation [NCIt concept]
- CTNNA1 wt Allele [NCIt concept]
- CTNNB1 Gene [NCIt concept]
- CTNNB1 Gene Mutation [NCIt concept]
- CTNNB1 NM_001098209.2:c.121A>G [NCIt concept]
- CTNNB1 NM_001904.4:c.110C>T [NCIt concept]
- CTNNB1 NM_001904.4:c.133T>C [NCIt concept]
- CTNNB1 NM_001904.4:c.134C>T [NCIt concept]
- CTNNB1 NP_001091679.1:p.T41A [NCIt concept]
- CTNNB1 NP_001895.1:p.S37F [NCIt concept]
- CTNNB1 NP_001895.1:p.S45F [NCIt concept]
- CTNNB1 NP_001895.1:p.S45P [NCIt concept]
- CTNNB1 Positive [NCIt concept]
- CTNNB1 wt Allele [NCIt concept]
- CTNNB1/PLAG1 Fusion Gene [NCIt concept]
- CTP Synthase 1 [NCIt concept]
- CTP Synthase 2 [NCIt concept]
- CTPS1 Gene [NCIt concept]
- CTPS1 wt Allele [NCIt concept]
- CTPS2 Gene [NCIt concept]
- CTPS2 Negative [NCIt concept]
- CTPS2 wt Allele [NCIt concept]
- CTRC Gene [NCIt concept]
- CTRC Gene Mutation [NCIt concept]
- CTRC wt Allele [NCIt concept]
- CTRP Clinical Finding [NCIt concept]
- CTSB Gene [NCIt concept]
- CTSB wt Allele [NCIt concept]
- CTSD Gene [NCIt concept]
- CTSD wt Allele [NCIt concept]
- CTSG Gene [NCIt concept]
- CTSG wt Allele [NCIt concept]
- CTSH Gene [NCIt concept]
- CTSH wt Allele [NCIt concept]
- CTSK Gene [NCIt concept]
- CTSK wt Allele [NCIt concept]
- CTSV Gene [NCIt concept]
- CTSV wt Allele [NCIt concept]
- CTTN Gene [NCIt concept]
- CTTN wt Allele [NCIt concept]
- CTX [NCIt concept]
- CUGBP Elav-Like Family Member 2 [NCIt concept]
- CUL3 Gene [NCIt concept]
- CUL3 wt Allele [NCIt concept]
- CUL4A Gene [NCIt concept]
- CUL4A wt Allele [NCIt concept]
- CUTA Gene [NCIt concept]
- CUTA wt Allele [NCIt concept]
- CX3C Chemokine Receptor 1 [NCIt concept]
- CX3CL1 Gene [NCIt concept]
- CX3CL1 wt Allele [NCIt concept]
- CX3CR1 Gene [NCIt concept]
- CX3CR1 wt Allele [NCIt concept]
- CXADR Gene [NCIt concept]
- CXADR wt Allele [NCIt concept]
- CXC Chemokine Receptor 2 Antagonist AZD5069 [NCIt concept]
- CXCL1 Gene [NCIt concept]
- CXCL1 wt Allele [NCIt concept]
- CXCL10 Gene [NCIt concept]
- CXCL10 wt Allele [NCIt concept]
- CXCL11 Gene [NCIt concept]
- CXCL11 wt Allele [NCIt concept]
- CXCL12 Gene [NCIt concept]
- CXCL12 wt Allele [NCIt concept]
- CXCL12-Abundant Reticular Cell [NCIt concept]
- CXCL13 Gene [NCIt concept]
- CXCL13 Positive [NCIt concept]
- CXCL13 wt Allele [NCIt concept]
- CXCL16 Gene [NCIt concept]
- CXCL16 wt Allele [NCIt concept]
- CXCL2 Gene [NCIt concept]
- CXCL2 wt Allele [NCIt concept]
- CXCL3 Gene [NCIt concept]
- CXCL3 wt Allele [NCIt concept]
- CXCL5 Gene [NCIt concept]
- CXCL5 wt Allele [NCIt concept]
- CXCL6 Gene [NCIt concept]
- CXCL6 wt Allele [NCIt concept]
- CXCL8 Gene [NCIt concept]
- CXCL8 Positive [NCIt concept]
- CXCL8 wt Allele [NCIt concept]
- CXCL9 Gene [NCIt concept]
- CXCL9 wt Allele [NCIt concept]
- CXCR1 Gene [NCIt concept]
- CXCR1 wt Allele [NCIt concept]
- CXCR2 Agonist MGTA-145 [NCIt concept]
- CXCR2 Antagonist QBM076 [NCIt concept]
- CXCR2 Gene [NCIt concept]
- CXCR2 wt Allele [NCIt concept]
- CXCR2-transduced Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- CXCR3 Gene [NCIt concept]
- CXCR3 wt Allele [NCIt concept]
- CXCR3/IL-12/TGFb1 Inhibitor Engineered Oncolytic Vaccinia Virus VET3-TGI [NCIt concept]
- CXCR4 Antagonist USL311 [NCIt concept]
- CXCR4 Gene [NCIt concept]
- CXCR4 Gene Mutation [NCIt concept]
- CXCR4 Inhibitor GPC-100 [NCIt concept]
- CXCR4 Inhibitor Q-122 [NCIt concept]
- CXCR4 Peptide Antagonist LY2510924 [NCIt concept]
- CXCR4 WHIM-Like Mutation [NCIt concept]
- CXCR4 wt Allele [NCIt concept]
- CXCR4-targeting Agent [NCIt concept]
- CXCR4/E-selectin Antagonist GMI-1359 [NCIt concept]
- CXCR5 Gene [NCIt concept]
- CXCR5 wt Allele [NCIt concept]
- CYBA Gene [NCIt concept]
- CYBA Gene Mutation [NCIt concept]
- CYBA wt Allele [NCIt concept]
- CYBB Gene [NCIt concept]
- CYBB Gene Mutation [NCIt concept]
- CYBB wt Allele [NCIt concept]
- CYCS Gene [NCIt concept]
- CYCS wt Allele [NCIt concept]
- CYFIP-Related Rac1 Interactor B [NCIt concept]
- CYFRA 21-1 [NCIt concept]
- CYLD Gene [NCIt concept]
- CYLD Gene Mutation [NCIt concept]
- CYLD wt Allele [NCIt concept]
- CYP11A1 Gene [NCIt concept]
- CYP11A1 Inhibitor ACE-232 [NCIt concept]
- CYP11A1 Inhibitor INV-9956 [NCIt concept]
- CYP11A1 wt Allele [NCIt concept]
- CYP11B1 Gene [NCIt concept]
- CYP11B1 wt Allele [NCIt concept]
- CYP11B2 Gene [NCIt concept]
- CYP11B2 wt Allele [NCIt concept]
- CYP17 Lyase Inhibitor ASN001 [NCIt concept]
- CYP17/CYP11B2 Inhibitor LAE001 [NCIt concept]
- CYP17A1 Gene [NCIt concept]
- CYP17A1 wt Allele [NCIt concept]
- CYP19A1 Gene [NCIt concept]
- CYP19A1 wt Allele [NCIt concept]
- CYP1A1 Gene [NCIt concept]
- CYP1A1 wt Allele [NCIt concept]
- CYP1A2 Gene [NCIt concept]
- CYP1A2 wt Allele [NCIt concept]
- CYP1A2*1 Allele [NCIt concept]
- CYP1A2*11 Allele [NCIt concept]
- CYP1A2*7 Allele [NCIt concept]
- CYP1B1 Gene [NCIt concept]
- CYP1B1 wt Allele [NCIt concept]
- CYP24A1 Gene [NCIt concept]
- CYP24A1 wt Allele [NCIt concept]
- CYP26A1 Gene [NCIt concept]
- CYP26A1 wt Allele [NCIt concept]
- CYP26B1 Gene [NCIt concept]
- CYP26B1 wt Allele [NCIt concept]
- CYP27A1 Gene [NCIt concept]
- CYP27A1 wt Allele [NCIt concept]
- CYP27B1 Gene [NCIt concept]
- CYP27B1 wt Allele [NCIt concept]
- CYP2A13 Gene [NCIt concept]
- CYP2A13 wt Allele [NCIt concept]
- CYP2A6 Gene [NCIt concept]
- CYP2A6 wt Allele [NCIt concept]
- CYP2A7 Gene [NCIt concept]
- CYP2A7 wt Allele [NCIt concept]
- CYP2B6 Gene [NCIt concept]
- CYP2B6 wt Allele [NCIt concept]
- CYP2C19 Gene [NCIt concept]
- CYP2C19 Inducer [NCIt concept]
- CYP2C19 Inhibitor [NCIt concept]
- CYP2C19 wt Allele [NCIt concept]
- CYP2C19*1 Allele [NCIt concept]
- CYP2C19*10 Allele [NCIt concept]
- CYP2C19*12 Allele [NCIt concept]
- CYP2C19*2 Allele [NCIt concept]
- CYP2C19*3 Allele [NCIt concept]
- CYP2C19*4 Allele [NCIt concept]
- CYP2C19*5 Allele [NCIt concept]
- CYP2C19*6 Allele [NCIt concept]
- CYP2C19*7 Allele [NCIt concept]
- CYP2C19*8 Allele [NCIt concept]
- CYP2C19*9 Allele [NCIt concept]
- CYP2C8 Gene [NCIt concept]
- CYP2C8 Inducer [NCIt concept]
- CYP2C8 wt Allele [NCIt concept]
- CYP2C8*2 Allele [NCIt concept]
- CYP2C8*3 Allele [NCIt concept]
- CYP2C8*4 Allele [NCIt concept]
- CYP2C8*5 Allele [NCIt concept]
- CYP2C8*6 Allele [NCIt concept]
- CYP2C8*7 Allele [NCIt concept]
- CYP2C8*8 Allele [NCIt concept]
- CYP2C9 Gene [NCIt concept]
- CYP2C9 Inhibitor [NCIt concept]
- CYP2C9 wt Allele [NCIt concept]
- CYP2C9*1 Allele [NCIt concept]
- CYP2C9*11 Allele [NCIt concept]
- CYP2C9*12 Allele [NCIt concept]
- CYP2C9*16 Allele [NCIt concept]
- CYP2C9*18 Allele [NCIt concept]
- CYP2C9*2 Allele [NCIt concept]
- CYP2C9*3 Allele [NCIt concept]
- CYP2C9*5 Allele [NCIt concept]
- CYP2C9*6 Allele [NCIt concept]
- CYP2C9*8 Allele [NCIt concept]
- CYP2D6 Gene [NCIt concept]
- CYP2D6 wt Allele [NCIt concept]
- CYP2D6*1 Allele [NCIt concept]
- CYP2D6*10 Allele [NCIt concept]
- CYP2D6*11 Allele [NCIt concept]
- CYP2D6*12 Allele [NCIt concept]
- CYP2D6*13 Allele [NCIt concept]
- CYP2D6*14 Allele [NCIt concept]
- CYP2D6*15 Allele [NCIt concept]
- CYP2D6*16 Allele [NCIt concept]
- CYP2D6*17 Allele [NCIt concept]
- CYP2D6*18 Allele [NCIt concept]
- CYP2D6*19 Allele [NCIt concept]
- CYP2D6*2 Allele [NCIt concept]
- CYP2D6*20 Allele [NCIt concept]
- CYP2D6*21 Allele [NCIt concept]
- CYP2D6*2N Allele [NCIt concept]
- CYP2D6*3 Allele [NCIt concept]
- CYP2D6*35X2 Allele [NCIt concept]
- CYP2D6*36 Allele [NCIt concept]
- CYP2D6*38 Allele [NCIt concept]
- CYP2D6*4 Allele [NCIt concept]
- CYP2D6*40 Allele [NCIt concept]
- CYP2D6*41 Allele [NCIt concept]
- CYP2D6*42 Allele [NCIt concept]
- CYP2D6*44 Allele [NCIt concept]
- CYP2D6*5 Allele [NCIt concept]
- CYP2D6*6 Allele [NCIt concept]
- CYP2D6*7 Allele [NCIt concept]
- CYP2D6*8 Allele [NCIt concept]
- CYP2D6*9 Allele [NCIt concept]
- CYP2E1 Gene [NCIt concept]
- CYP2E1 wt Allele [NCIt concept]
- CYP2E1*1 Allele [NCIt concept]
- CYP2E1*2 Allele [NCIt concept]
- CYP39A1 Gene [NCIt concept]
- CYP39A1 wt Allele [NCIt concept]
- CYP3A Gene Locus [NCIt concept]
- CYP3A4 Gene [NCIt concept]
- CYP3A4 Polymorphism Positive [NCIt concept]
- CYP3A4 Substrate [NCIt concept]
- CYP3A4 wt Allele [NCIt concept]
- CYP3A4*17 Allele [NCIt concept]
- CYP3A4*18 Allele [NCIt concept]
- CYP3A5 Gene [NCIt concept]
- CYP3A5 Polymorphism Positive [NCIt concept]
- CYP3A5 wt Allele [NCIt concept]
- CYP3A5*10 Allele [NCIt concept]
- CYP3A5*3 Allele [NCIt concept]
- CYP3A5*6 Allele [NCIt concept]
- CYP3A5*8 Allele [NCIt concept]
- CYP3A5*9 Allele [NCIt concept]
- CYP7A1 Gene [NCIt concept]
- CYP7A1 wt Allele [NCIt concept]
- CYRIB Gene [NCIt concept]
- CYRIB wt Allele [NCIt concept]
- CYSLTR2 Gene [NCIt concept]
- CYSLTR2 Gene Mutation [NCIt concept]
- CYSLTR2 wt Allele [NCIt concept]
- Cabazitaxel [NCIt concept]
- Cabergoline [NCIt concept]
- Cabiralizumab [NCIt concept]
- Cabotegravir [NCIt concept]
- Cabozantinib [NCIt concept]
- Cabozantinib S-malate [NCIt concept]
- Cachexia [NCIt concept]
- Cadazolid [NCIt concept]
- Cadherin-1 [NCIt concept]
- Cadherin-11 [NCIt concept]
- Cadherin-13 [NCIt concept]
- Cadherin-17 [NCIt concept]
- Cadherin-2 [NCIt concept]
- Cadherin-3 [NCIt concept]
- Cadherin-6 [NCIt concept]
- Cadmium [NCIt concept]
- Cafelkibart [NCIt concept]
- Caffeine [NCIt concept]
- Caffeine-based Cream [NCIt concept]
- Calaspargase Pegol [NCIt concept]
- Calcifediol Anhydrous [NCIt concept]
- Calcifying Epithelial Odontogenic Tumor [NCIt concept]
- Calcineurin [NCIt concept]
- Calcineurin Inhibitor [NCIt concept]
- Calcineurin-Binding Protein Cabin-1 [NCIt concept]
- Calcipotriene [NCIt concept]
- Calcitonin [NCIt concept]
- Calcitonin Precursor [NCIt concept]
- Calcitriol [NCIt concept]
- Calcitroic Acid [NCIt concept]
- Calcium [NCIt concept]
- Calcium Aluminosilicate Anti-Diarrheal [NCIt concept]
- Calcium Carbonate [NCIt concept]
- Calcium Citrate [NCIt concept]
- Calcium Gluconate [NCIt concept]
- Calcium Release-Activated Calcium Channel Protein 1 [NCIt concept]
- Calcium Release-activated Channels Inhibitor RP4010 [NCIt concept]
- Calcium Saccharate [NCIt concept]
- Calcium-Responsive Transactivator [NCIt concept]
- Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor 1 [NCIt concept]
- Calcium/Calmodulin-Dependent Protein Kinase Type 1 [NCIt concept]
- Calcium/Calmodulin-Dependent Protein Kinase Type II Subunit Alpha [NCIt concept]
- Calcium/Calmodulin-Dependent Protein Kinase Type II Subunit Beta [NCIt concept]
- Calcium/Calmodulin-Dependent Protein Kinase Type II Subunit Gamma [NCIt concept]
- Caldesmon [NCIt concept]
- Calendar [NCIt concept]
- Calendula Ointment [NCIt concept]
- Call [NCIt concept]
- Calmodulin [NCIt concept]
- Calmodulin-Binding Transcription Activator 1 [NCIt concept]
- Calnexin [NCIt concept]
- Calpain-1 Catalytic Subunit [NCIt concept]
- Calprotectin [NCIt concept]
- Calreticulin [NCIt concept]
- Calretinin [NCIt concept]
- Camibirstat [NCIt concept]
- Camidanlumab Tesirine [NCIt concept]
- Camizestrant [NCIt concept]
- Camonsertib [NCIt concept]
- Camoteskimab [NCIt concept]
- Camphor/Herbal Formulation-based Topical Plaster [NCIt concept]
- Camptothecin Analogue TLC388 [NCIt concept]
- Camptothecin-20(S)-O-Propionate Hydrate [NCIt concept]
- Camrelizumab [NCIt concept]
- Camsirubicin [NCIt concept]
- Canagliflozin [NCIt concept]
- Canakinumab [NCIt concept]
- Canalicular Multispecific Organic Anion Transporter 1 [NCIt concept]
- Canalicular Multispecific Organic Anion Transporter 2 [NCIt concept]
- Cancer Antigen 19-9 Measurement [NCIt concept]
- Cancer Antigen 72-4 Positive [NCIt concept]
- Cancer Genetics [NCIt concept]
- Cancer Other [NCIt concept]
- Cancer Pain Management [NCIt concept]
- Cancer Prevention [NCIt concept]
- Cancer Prevention Vaccination [NCIt concept]
- Cancer Risk [NCIt concept]
- Cancer Screening [NCIt concept]
- Cancer Stem Cell [NCIt concept]
- Cancer Surveillance Program [NCIt concept]
- Cancer Survivor [NCIt concept]
- Cancer Therapeutic Procedure [NCIt concept]
- Cancer Vision Goggles [NCIt concept]
- Cancer and Living Meaningfully Therapy [NCIt concept]
- Cancer-Associated Anorexia [NCIt concept]
- Cancer-Associated Fibroblast [NCIt concept]
- Cancer-Associated Pain [NCIt concept]
- Cancer-Predisposing Gene [NCIt concept]
- Cancer-Related Condition [NCIt concept]
- Cancer-Testis Antigen Family 45 Gene [NCIt concept]
- Cancer-related Cognitive Dysfunction [NCIt concept]
- Cancer/Testis Antigen [NCIt concept]
- Cancer/Testis Antigen 1 [NCIt concept]
- Cancer/Testis Antigen 2 [NCIt concept]
- Cancer/Testis Antigen 2 Isoform LAGE-1A [NCIt concept]
- Cancer/Testis Antigen Family 47 Gene [NCIt concept]
- Candida [NCIt concept]
- Candida albicans Antigen Injection [NCIt concept]
- Candidemia [NCIt concept]
- Canerpaturev [NCIt concept]
- Canertinib Dihydrochloride [NCIt concept]
- Canfosfamide Hydrochloride [NCIt concept]
- Cannabidiol [NCIt concept]
- Cannabis Use Disorder [NCIt concept]
- Cannabis sativa Extract [NCIt concept]
- Cantrixil [NCIt concept]
- Cantuzumab Ravtansine [NCIt concept]
- Cap-Specific mRNA (Nucleoside-2-O-)-Methyltransferase 2 [NCIt concept]
- Capecitabine [NCIt concept]
- Capillary Malformation-Arteriovenous Malformation Syndrome [NCIt concept]
- Capivasertib [NCIt concept]
- Caplacizumab [NCIt concept]
- Capmatinib [NCIt concept]
- Capmatinib Hydrochloride [NCIt concept]
- Caprin-1 [NCIt concept]
- Capsid Protein [NCIt concept]
- Carbohydrate Sulfotransferase 15 [NCIt concept]
- Carbohydrate Sulfotransferase 3 [NCIt concept]
- Carbohydrate Supplement Drink [NCIt concept]
- Carbomer/Polycarbophil-based Vaginal Gel [NCIt concept]
- Carbon C 11 AZ14193391 [NCIt concept]
- Carbon C 11 Alpha-methyltryptophan [NCIt concept]
- Carbon C 11 Choline [NCIt concept]
- Carbon C 11 Erlotinib Hydrochloride [NCIt concept]
- Carbon C 11 Glutamine [NCIt concept]
- Carbon C 11 Pittsburgh Compound B [NCIt concept]
- Carbon C 11 Sarcosine [NCIt concept]
- Carbon C 11 YJH08 [NCIt concept]
- Carbon C 13 Hyperpolarized Bicarbonate [NCIt concept]
- Carbon C 13 Lycopene [NCIt concept]
- Carbon C 13 Phytoene [NCIt concept]
- Carbon C 13 Phytofluene [NCIt concept]
- Carbon C 14 Gilteritinib [NCIt concept]
- Carbon C 14 Oxaliplatin [NCIt concept]
- Carbon C 14-labeled Ixazomib [NCIt concept]
- Carbon C11 Nicotine [NCIt concept]
- Carbon C11 Temozolomide [NCIt concept]
- Carbon C14 EGFR Inhibitor ASP8273 [NCIt concept]
- Carbon C14-labeled Carboplatin [NCIt concept]
- Carbon Dioxide Fractional Laser [NCIt concept]
- Carbon Ion Radiotherapy [NCIt concept]
- Carbon Monoxide [NCIt concept]
- Carbon-11 Acetate [NCIt concept]
- Carbonic Anhydrase 1 [NCIt concept]
- Carbonic Anhydrase 2 [NCIt concept]
- Carbonic Anhydrase 6 [NCIt concept]
- Carbonic Anhydrase 9 [NCIt concept]
- Carbonyl Compound [NCIt concept]
- Carbonyl Reductase [NADPH] 1 [NCIt concept]
- Carbonyl Reductase [NADPH] 3 [NCIt concept]
- Carboplatin [NCIt concept]
- Carboplatin/Paclitaxel Regimen [NCIt concept]
- Carboxyamidotriazole [NCIt concept]
- Carboxyamidotriazole Orotate [NCIt concept]
- Carboxyhemoglobin [NCIt concept]
- Carboxylesterase [NCIt concept]
- Carboxylesterase-expressing Allogeneic Neural Stem Cells [NCIt concept]
- Carboxypeptidase A1 [NCIt concept]
- Carboxypeptidase B2 [NCIt concept]
- Carcinoembryonic Antigen [NCIt concept]
- Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine [NCIt concept]
- Carcinoembryonic Antigen Positive [NCIt concept]
- Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine [NCIt concept]
- Carcinoembryonic Antigen-Expressing Measles Virus [NCIt concept]
- Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 [NCIt concept]
- Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 [NCIt concept]
- Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 [NCIt concept]
- Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 [NCIt concept]
- Carcinoid Syndrome [NCIt concept]
- Carcinoma [NCIt concept]
- Carcinoma of Unknown Primary [NCIt concept]
- Carcinoma of Unknown Primary with Gastrointestinal Profile [NCIt concept]
- Carcinosarcoma [NCIt concept]
- Cardiac Amyloidosis [NCIt concept]
- Cardiac Catheterization [NCIt concept]
- Cardiac Computerized Tomographic Angiography [NCIt concept]
- Cardiac Fibrosis [NCIt concept]
- Cardiac Monitoring [NCIt concept]
- Cardiac Rehabilitation [NCIt concept]
- Cardiac Resynchronization Therapy [NCIt concept]
- Cardiomyocyte-Specific Unmethylated CpG Pattern Positive [NCIt concept]
- Cardiopulmonary Assessment [NCIt concept]
- Cardiopulmonary Exercise Testing [NCIt concept]
- Cardiotoxicity [NCIt concept]
- Cardiovascular Complication [NCIt concept]
- Cardiovascular Complications Management [NCIt concept]
- Cardiovascular Neoplasm [NCIt concept]
- CarePrompter [NCIt concept]
- Caregiver [NCIt concept]
- Caregiver Oncology Needs Evaluation Tool [NCIt concept]
- Caregiver-Assisted Training [NCIt concept]
- Caregiver-Related Intervention or Procedure [NCIt concept]
- Carfilzomib [NCIt concept]
- CaringGuidance Program [NCIt concept]
- Caris Molecular Intelligence Tumor Profiling [NCIt concept]
- Carlumab [NCIt concept]
- Carmustine [NCIt concept]
- Carmustine Implant [NCIt concept]
- Carmustine with Propylene Glycol Formulation VI-0609 [NCIt concept]
- Carney Complex [NCIt concept]
- Carnitine O-Palmitoyltransferase 1, Liver Isoform [NCIt concept]
- Carnosine [NCIt concept]
- Carotenoid [NCIt concept]
- Carotid Body Paraganglioma [NCIt concept]
- Carotuximab [NCIt concept]
- Carrot Juice [NCIt concept]
- Carvedilol [NCIt concept]
- Carvedilol Phosphate [NCIt concept]
- Carvedilol Phosphate Extended-Release Capsule [NCIt concept]
- Cascade Testing [NCIt concept]
- Casdatifan [NCIt concept]
- Casdozokitug [NCIt concept]
- Case Management [NCIt concept]
- Casein Kinase 2 [NCIt concept]
- Casein Kinase I Isoform Alpha [NCIt concept]
- Casein Kinase II Subunit Alpha [NCIt concept]
- Casein Kinase II Subunit Beta [NCIt concept]
- Casirivimab [NCIt concept]
- Casirivimab/Imdevimab [NCIt concept]
- Caspase [NCIt concept]
- Caspase Recruitment Domain-Containing Protein 14 [NCIt concept]
- Caspase Recruitment Domain-Containing Protein 8 [NCIt concept]
- Caspase-1 [NCIt concept]
- Caspase-10 [NCIt concept]
- Caspase-2 [NCIt concept]
- Caspase-3 [NCIt concept]
- Caspase-4 [NCIt concept]
- Caspase-7 [NCIt concept]
- Caspase-8 [NCIt concept]
- Caspase-9 [NCIt concept]
- Caspofungin [NCIt concept]
- Caspofungin Acetate [NCIt concept]
- Castration Levels of Testosterone [NCIt concept]
- Castration-Resistant Prostate Carcinoma [NCIt concept]
- Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents [NCIt concept]
- Castration-Sensitive Prostate Carcinoma [NCIt concept]
- Catechol O-Methyltransferase [NCIt concept]
- Catecholamine Metabolite [NCIt concept]
- Catenin Alpha-1 [NCIt concept]
- Catenin Beta-1 [NCIt concept]
- Catenin Family Protein [NCIt concept]
- Catequentinib Hydrochloride [NCIt concept]
- Cathepsin [NCIt concept]
- Cathepsin B [NCIt concept]
- Cathepsin D [NCIt concept]
- Cathepsin G [NCIt concept]
- Cathepsin H [NCIt concept]
- Cathepsin K [NCIt concept]
- Cathepsin L2 [NCIt concept]
- Cathepsin-cleavable NIR Substrate Probe 6QC-ICG [NCIt concept]
- Cathepsin-cleavable NIR Substrate Probe 6QC-NIR [NCIt concept]
- Cathepsin-targeted Fluorescent Imaging Probe VGT-309 [NCIt concept]
- Catheter Device [NCIt concept]
- Catheter Management [NCIt concept]
- Catheterization [NCIt concept]
- Cation-Independent Mannose-6 Phosphate Receptor [NCIt concept]
- Cationic Peptide Cream Cypep-1 [NCIt concept]
- Catumaxomab [NCIt concept]
- Caveolin-2 [NCIt concept]
- Cavernous Nerve Electrical Stimulation [NCIt concept]
- Cavrotolimod [NCIt concept]
- Cbp/p300-Interacting Transactivator 2 [NCIt concept]
- Cecum Carcinoma [NCIt concept]
- Cecum Neuroendocrine Tumor G1 [NCIt concept]
- Cedazuridine [NCIt concept]
- Cedazuridine/Azacitidine Combination Agent ASTX030 [NCIt concept]
- Cediranib [NCIt concept]
- Cediranib Maleate [NCIt concept]
- Cefazolin [NCIt concept]
- Cefepime Hydrochloride [NCIt concept]
- Cefixime [NCIt concept]
- Cefoxitin Sodium [NCIt concept]
- Cefpodoxime Proxetil [NCIt concept]
- Ceftaroline Fosamil [NCIt concept]
- Ceftazidime/Avibactam Sodium [NCIt concept]
- Ceftolozane [NCIt concept]
- Celecoxib [NCIt concept]
- Celiac Plexus Neurolysis [NCIt concept]
- Celiac Plexus Radiosurgery [NCIt concept]
- Cell Adhesion Molecule 1 [NCIt concept]
- Cell Culture Procedure [NCIt concept]
- Cell Cycle Checkpoint Control Protein RAD9A [NCIt concept]
- Cell Cycle Checkpoint Control Protein RAD9B [NCIt concept]
- Cell Cycle Checkpoint Protein RAD17 [NCIt concept]
- Cell Cycle Checkpoint/DNA Repair Antagonist IC83 [NCIt concept]
- Cell Cycle Profile [NCIt concept]
- Cell Division Control Protein 6 Homolog [NCIt concept]
- Cell Division Cycle 7-Related Protein Kinase [NCIt concept]
- Cell Division Cycle Protein 20 Homolog [NCIt concept]
- Cell Membrane-anchored/CSV-targeted IL-12-expressing T-lymphocytes [NCIt concept]
- Cell Proliferation Assay [NCIt concept]
- Cell Response Index [NCIt concept]
- Cell Sorting [NCIt concept]
- Cell Surface A33 Antigen [NCIt concept]
- Cell Therapy Agent [NCIt concept]
- Cell-depleting Therapy [NCIt concept]
- Cell-free Circulating Tumor DNA Assay [NCIt concept]
- Cellectra 2000 Electroporation Device [NCIt concept]
- Cellular Differentiation [NCIt concept]
- Cellular Nucleic Acid-Binding Protein [NCIt concept]
- Cellular Physiologic Testing [NCIt concept]
- Cellular Retinoic Acid-Binding Protein 1 [NCIt concept]
- Cellular Retinoic Acid-Binding Protein 2 [NCIt concept]
- Cellular Therapy [NCIt concept]
- Cellular Tumor Antigen p53 [NCIt concept]
- Cellularity Measurement [NCIt concept]
- Cellulose, Microcrystalline [NCIt concept]
- Cemacabtagene Ansegedleucel [NCIt concept]
- Cemiplimab [NCIt concept]
- Cemsidomide [NCIt concept]
- Cenersen [NCIt concept]
- Cenisertib [NCIt concept]
- Central Line Management [NCIt concept]
- Central Lymph Node Dissection [NCIt concept]
- Central Memory Immune Cell [NCIt concept]
- Central Memory T-Lymphocyte [NCIt concept]
- Central Nervous System Carcinoma [NCIt concept]
- Central Nervous System Disorder [NCIt concept]
- Central Nervous System Germ Cell Tumor [NCIt concept]
- Central Nervous System Germinoma [NCIt concept]
- Central Nervous System Lesion [NCIt concept]
- Central Nervous System Leukemia [NCIt concept]
- Central Nervous System Medulloepithelioma [NCIt concept]
- Central Nervous System Neoplasm [NCIt concept]
- Central Nervous System Neuroblastoma, FOXR2-Activated [NCIt concept]
- Central Nervous System Prophylaxis [NCIt concept]
- Central Nervous System Radiation Therapy [NCIt concept]
- Central Nervous System Sarcoma [NCIt concept]
- Central Pancreatectomy [NCIt concept]
- Centriolin [NCIt concept]
- Centroblastic Lymphoma [NCIt concept]
- Centromere Protein F [NCIt concept]
- Centromere Protein S [NCIt concept]
- Centromere Protein X [NCIt concept]
- Centrosomal Protein 43 [NCIt concept]
- Centrosomal Protein of 55 kDa [NCIt concept]
- Centrosomal Protein of 72 kDa [NCIt concept]
- Centrosomal Protein of 89 kDa [NCIt concept]
- Cenvacibart [NCIt concept]
- Cephalexin [NCIt concept]
- Ceralasertib [NCIt concept]
- Ceramide [NCIt concept]
- Ceramide Glucosyltransferase [NCIt concept]
- Ceramide Kinase [NCIt concept]
- Ceramide Kinase-like Protein [NCIt concept]
- Ceramide Nanoliposome [NCIt concept]
- Ceramide Synthase 5 [NCIt concept]
- Ceramide/CLA/Cholesterol Controlled-release Skin Barrier Emulsion [NCIt concept]
- Cerdulatinib [NCIt concept]
- Cerebellar Peduncle Neoplasm [NCIt concept]
- Cereblon E3 Ubiquitin Ligase Modulating Drug BMS-986449 [NCIt concept]
- Cereblon Modulator BTX-1188 [NCIt concept]
- Cerebral Edema [NCIt concept]
- Cerebral Hemangioblastoma [NCIt concept]
- Cerebral Vein Thrombosis [NCIt concept]
- Cerenkov Luminescence Imaging [NCIt concept]
- Cergutuzumab Amunaleukin [NCIt concept]
- Ceritinib [NCIt concept]
- Certociclib [NCIt concept]
- Ceruloplasmin [NCIt concept]
- Cervical Adenocarcinoma [NCIt concept]
- Cervical Adenoid Basal Carcinoma [NCIt concept]
- Cervical Adenoid Cystic Carcinoma [NCIt concept]
- Cervical Adenosquamous Carcinoma [NCIt concept]
- Cervical Biopsy [NCIt concept]
- Cervical Cancer Screening [NCIt concept]
- Cervical Carcinoma [NCIt concept]
- Cervical Endometrioid Adenocarcinoma [NCIt concept]
- Cervical Intraepithelial Neoplasia [NCIt concept]
- Cervical Intraepithelial Neoplasia Grade 2/3 [NCIt concept]
- Cervical Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Cervical Neoplasm [NCIt concept]
- Cervical Neuroendocrine Carcinoma [NCIt concept]
- Cervical Non-Squamous Cell Carcinoma [NCIt concept]
- Cervical Papanicolaou Test [NCIt concept]
- Cervical Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Cervical Squamous Cell Carcinoma [NCIt concept]
- Cervical Squamous Cell Carcinoma In Situ [NCIt concept]
- Cervical Squamous Intraepithelial Neoplasia 2 [NCIt concept]
- Cervical Undifferentiated Carcinoma [NCIt concept]
- Cesium Cs-131 [NCIt concept]
- Cesium-131 Brachytherapy [NCIt concept]
- Cetrelimab [NCIt concept]
- Cetuximab [NCIt concept]
- Cetuximab Sarotalocan Sodium [NCIt concept]
- Cetuximab-IRDye 800CW [NCIt concept]
- Cevidoplenib Dimesylate [NCIt concept]
- Cevimeline Hydrochloride [NCIt concept]
- Cevostamab [NCIt concept]
- ChAdOx1-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine ChAdOx1-PCAQ [NCIt concept]
- Charcot-Marie-Tooth Disease Type 2A1 [NCIt concept]
- Charcot-Marie-Tooth Disease Type 2A2A [NCIt concept]
- Charcot-Marie-Tooth Disease Type 2A2B [NCIt concept]
- Checklist [NCIt concept]
- Checkpoint Blockade Immunotherapy [NCIt concept]
- Checkpoint Inhibitor Relapsed Tumor [NCIt concept]
- Checkpoint Kinase Inhibitor AZD7762 [NCIt concept]
- Checkpoint Kinase Inhibitor XL844 [NCIt concept]
- Chemical Exchange Saturation Transfer Magnetic Resonance Imaging [NCIt concept]
- Chemical Peel [NCIt concept]
- Chemically Induced Cardiotoxicity [NCIt concept]
- Chemically-Induced Menopause [NCIt concept]
- Chemokine [NCIt concept]
- Chemokine Expression Profile [NCIt concept]
- Chemokine Modulation Therapy [NCIt concept]
- Chemoprevention [NCIt concept]
- Chemoradiotherapy [NCIt concept]
- Chemosensitivity Assay [NCIt concept]
- Chemosensitization/Potentiation Therapy [NCIt concept]
- Chemotherapeutic Agent Toxicity [NCIt concept]
- Chemotherapeutic Perfusion [NCIt concept]
- Chemotherapeutic Underdose [NCIt concept]
- Chemotherapy [NCIt concept]
- Chemotherapy Recipient [NCIt concept]
- Chemotherapy-Induced Alopecia [NCIt concept]
- Chemotherapy-Induced Peripheral Neuropathy [NCIt concept]
- Chemotherapy-Induced Thrombocytopenia [NCIt concept]
- Chemotherapy-Related Nausea and/or Vomiting [NCIt concept]
- Chemotherapy-related Cognitive Impairment [NCIt concept]
- Cherry Juice [NCIt concept]
- Chest Computed Tomography [NCIt concept]
- Chest Radiation Therapy [NCIt concept]
- Chest Radiography [NCIt concept]
- Chest Wall Chondromesenchymal Hamartoma [NCIt concept]
- Chest Wall Radiation Therapy [NCIt concept]
- Chest Wall Sarcoma [NCIt concept]
- Child-Pugh Class A [NCIt concept]
- Child-Pugh Class B [NCIt concept]
- Childhood Acute Basophilic Leukemia [NCIt concept]
- Childhood Acute Eosinophilic Leukemia [NCIt concept]
- Childhood Acute Erythroid Leukemia [NCIt concept]
- Childhood Acute Leukemia in Remission [NCIt concept]
- Childhood Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Childhood Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood Acute Lymphoblastic Leukemia in Complete Remission [NCIt concept]
- Childhood Acute Lymphoblastic Leukemia in Partial Remission [NCIt concept]
- Childhood Acute Lymphoblastic Leukemia in Remission [NCIt concept]
- Childhood Acute Megakaryoblastic Leukemia [NCIt concept]
- Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A [NCIt concept]
- Childhood Acute Monoblastic Leukemia [NCIt concept]
- Childhood Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Childhood Acute Monocytic Leukemia [NCIt concept]
- Childhood Acute Myeloid Leukemia [NCIt concept]
- Childhood Acute Myeloid Leukemia in Remission [NCIt concept]
- Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q [NCIt concept]
- Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7 [NCIt concept]
- Childhood Acute Myeloid Leukemia with Maturation [NCIt concept]
- Childhood Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Childhood Acute Myeloid Leukemia without Maturation [NCIt concept]
- Childhood Acute Myelomonocytic Leukemia [NCIt concept]
- Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Childhood Alveolar Rhabdomyosarcoma [NCIt concept]
- Childhood Alveolar Soft Part Sarcoma [NCIt concept]
- Childhood Anaplastic Astrocytoma [NCIt concept]
- Childhood Anaplastic Astrocytoma, Not Otherwise Specified [NCIt concept]
- Childhood Anaplastic Ependymoma [NCIt concept]
- Childhood Anaplastic Large Cell Lymphoma [NCIt concept]
- Childhood Anaplastic Oligoastrocytoma [NCIt concept]
- Childhood Anaplastic Oligodendroglioma [NCIt concept]
- Childhood Angiosarcoma [NCIt concept]
- Childhood Astrocytic Tumor [NCIt concept]
- Childhood Astrocytoma [NCIt concept]
- Childhood Atypical Teratoid/Rhabdoid Tumor [NCIt concept]
- Childhood B Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Childhood B Lymphoblastic Lymphoma [NCIt concept]
- Childhood B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Childhood Benign Central Nervous System Neoplasm [NCIt concept]
- Childhood Bladder Carcinoma [NCIt concept]
- Childhood Botryoid-Type Embryonal Rhabdomyosarcoma [NCIt concept]
- Childhood Brain Germ Cell Tumor [NCIt concept]
- Childhood Brain Glioblastoma [NCIt concept]
- Childhood Brain Neoplasm [NCIt concept]
- Childhood Brain Oligodendroglioma [NCIt concept]
- Childhood Brain Stem Glioma [NCIt concept]
- Childhood Brain Stem Gliosarcoma [NCIt concept]
- Childhood Brain Stem Mixed Glioma [NCIt concept]
- Childhood Brain Stem Neoplasm [NCIt concept]
- Childhood Breast Carcinoma [NCIt concept]
- Childhood Burkitt Leukemia [NCIt concept]
- Childhood Burkitt Lymphoma [NCIt concept]
- Childhood Central Nervous System Choriocarcinoma [NCIt concept]
- Childhood Central Nervous System Embryonal Tumor [NCIt concept]
- Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified [NCIt concept]
- Childhood Central Nervous System Ganglioneuroblastoma [NCIt concept]
- Childhood Central Nervous System Germ Cell Tumor [NCIt concept]
- Childhood Central Nervous System Germinoma [NCIt concept]
- Childhood Central Nervous System Mixed Germ Cell Tumor [NCIt concept]
- Childhood Central Nervous System Neoplasm [NCIt concept]
- Childhood Central Nervous System Neuroblastoma, FOXR2-Activated [NCIt concept]
- Childhood Central Nervous System Teratoma [NCIt concept]
- Childhood Central Nervous System Yolk Sac Tumor [NCIt concept]
- Childhood Cerebellar Anaplastic Astrocytoma [NCIt concept]
- Childhood Cerebellar Astrocytoma [NCIt concept]
- Childhood Cerebral Anaplastic Astrocytoma [NCIt concept]
- Childhood Cerebral Astrocytoma [NCIt concept]
- Childhood Choroid Plexus Neoplasm [NCIt concept]
- Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Childhood Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Childhood Colorectal Carcinoma [NCIt concept]
- Childhood Craniopharyngioma [NCIt concept]
- Childhood Desmoplastic Small Round Cell Tumor [NCIt concept]
- Childhood Diffuse Astrocytoma [NCIt concept]
- Childhood Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Childhood Diffuse Large B-Cell Lymphoma [NCIt concept]
- Childhood Diffuse Large Cell Lymphoma [NCIt concept]
- Childhood Embryonal Rhabdomyosarcoma [NCIt concept]
- Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered [NCIt concept]
- Childhood Ependymal Tumor [NCIt concept]
- Childhood Ependymoma [NCIt concept]
- Childhood Epithelioid Hemangioendothelioma [NCIt concept]
- Childhood Epithelioid Sarcoma [NCIt concept]
- Childhood Esophageal Carcinoma [NCIt concept]
- Childhood Extracranial Germ Cell Tumor [NCIt concept]
- Childhood Favorable Prognosis Hodgkin Lymphoma [NCIt concept]
- Childhood Fibrillary Astrocytoma [NCIt concept]
- Childhood Fibrosarcoma [NCIt concept]
- Childhood Ganglioglioma [NCIt concept]
- Childhood Ganglioneuroblastoma [NCIt concept]
- Childhood Gastric Carcinoma [NCIt concept]
- Childhood Gastrointestinal Stromal Tumor [NCIt concept]
- Childhood Gemistocytic Astrocytoma [NCIt concept]
- Childhood Germ Cell Tumor [NCIt concept]
- Childhood Germinomatous Germ Cell Tumor [NCIt concept]
- Childhood Giant Cell Glioblastoma [NCIt concept]
- Childhood Glioblastoma [NCIt concept]
- Childhood Gliomatosis Cerebri [NCIt concept]
- Childhood Gliosarcoma [NCIt concept]
- Childhood Gonadal Germ Cell Tumor [NCIt concept]
- Childhood Grade 1 Meningioma [NCIt concept]
- Childhood Grade 2 Meningioma [NCIt concept]
- Childhood Grade 3 Meningioma [NCIt concept]
- Childhood Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Childhood Hematopoietic and Lymphatic System Neoplasm [NCIt concept]
- Childhood Hematopoietic and Lymphoid Cell Neoplasm [NCIt concept]
- Childhood Hepatoblastoma [NCIt concept]
- Childhood Hepatocellular Carcinoma [NCIt concept]
- Childhood Hodgkin Lymphoma [NCIt concept]
- Childhood Idiopathic Inflammatory Myopathy [NCIt concept]
- Childhood Immunoblastic Lymphoma [NCIt concept]
- Childhood Infratentorial Ependymoma [NCIt concept]
- Childhood Intracranial Meningioma [NCIt concept]
- Childhood Intraocular Retinoblastoma [NCIt concept]
- Childhood Iron-Deficiency Anemia [NCIt concept]
- Childhood Kidney Neoplasm [NCIt concept]
- Childhood Kidney Wilms Tumor [NCIt concept]
- Childhood L1 Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood L2 Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood Langerhans Cell Histiocytosis [NCIt concept]
- Childhood Large Cell Lymphoma [NCIt concept]
- Childhood Laryngeal Carcinoma [NCIt concept]
- Childhood Leiomyosarcoma [NCIt concept]
- Childhood Leukemia [NCIt concept]
- Childhood Liposarcoma [NCIt concept]
- Childhood Lymphoblastic Lymphoma [NCIt concept]
- Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma [NCIt concept]
- Childhood Lymphoma [NCIt concept]
- Childhood Malignant Central Nervous System Neoplasm [NCIt concept]
- Childhood Malignant Extragonadal Germ Cell Tumor [NCIt concept]
- Childhood Malignant Intestinal Neoplasm [NCIt concept]
- Childhood Malignant Liver Neoplasm [NCIt concept]
- Childhood Malignant Mesenchymoma [NCIt concept]
- Childhood Malignant Neoplasm [NCIt concept]
- Childhood Malignant Ovarian Germ Cell Tumor [NCIt concept]
- Childhood Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Childhood Malignant Pleural Neoplasm [NCIt concept]
- Childhood Malignant Solid Neoplasm [NCIt concept]
- Childhood Malignant Testicular Germ Cell Tumor [NCIt concept]
- Childhood Medulloblastoma [NCIt concept]
- Childhood Meningioma [NCIt concept]
- Childhood Mesenchymal Chondrosarcoma [NCIt concept]
- Childhood Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Childhood Mixed Glioma [NCIt concept]
- Childhood Myelodysplastic Syndrome [NCIt concept]
- Childhood Myeloid Leukemia in Remission [NCIt concept]
- Childhood Myeloid Sarcoma [NCIt concept]
- Childhood Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Childhood Neoplasm [NCIt concept]
- Childhood Neuroblastic Tumor [NCIt concept]
- Childhood Neuroblastoma [NCIt concept]
- Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Childhood Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Childhood Non-Hodgkin Lymphoma [NCIt concept]
- Childhood Non-T Non-B Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood Nongerminomatous Germ Cell Tumor [NCIt concept]
- Childhood Oligoastrocytoma [NCIt concept]
- Childhood Oligodendroglioma [NCIt concept]
- Childhood Osteosarcoma [NCIt concept]
- Childhood Ovarian Germ Cell Tumor [NCIt concept]
- Childhood Pilocytic Astrocytoma [NCIt concept]
- Childhood Pilomyxoid Astrocytoma [NCIt concept]
- Childhood Pineal Parenchymal Cell Neoplasm [NCIt concept]
- Childhood Pineoblastoma [NCIt concept]
- Childhood Pleomorphic Rhabdomyosarcoma [NCIt concept]
- Childhood Pleomorphic Xanthoastrocytoma [NCIt concept]
- Childhood Pre-B Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood Protoplasmic Astrocytoma [NCIt concept]
- Childhood Rectal Carcinoma [NCIt concept]
- Childhood Renal Cell Carcinoma [NCIt concept]
- Childhood Rhabdomyosarcoma [NCIt concept]
- Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features [NCIt concept]
- Childhood Severe Aplastic Anemia [NCIt concept]
- Childhood Small Intestinal Carcinoma [NCIt concept]
- Childhood Soft Tissue Sarcoma [NCIt concept]
- Childhood Solid Neoplasm [NCIt concept]
- Childhood Spinal Cord Neoplasm [NCIt concept]
- Childhood Subependymal Giant Cell Astrocytoma [NCIt concept]
- Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified [NCIt concept]
- Childhood Supratentorial Ependymoma, Not Otherwise Specified [NCIt concept]
- Childhood Synovial Sarcoma [NCIt concept]
- Childhood T Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood T Acute Lymphoblastic Leukemia in Remission [NCIt concept]
- Childhood T Lymphoblastic Lymphoma [NCIt concept]
- Childhood TdT Negative Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood TdT Positive Acute Lymphoblastic Leukemia [NCIt concept]
- Childhood Teratoma [NCIt concept]
- Childhood Testicular Germ Cell Tumor [NCIt concept]
- Childhood Thyroid Gland Carcinoma [NCIt concept]
- Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Childhood Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Childhood Unfavorable Prognosis Hodgkin Lymphoma [NCIt concept]
- Childhood Visual Pathway Glioma [NCIt concept]
- Childhood WHO Grade 3 Glioma [NCIt concept]
- Childhood WHO Grade 4 Glioma [NCIt concept]
- Chimeric Antigen Receptor T-Cell Therapy [NCIt concept]
- Chimeric Antigen Receptor T-cells [NCIt concept]
- Chimerism [NCIt concept]
- Chinese Herbal Formulation PHY906 [NCIt concept]
- Chitotriosidase-1 [NCIt concept]
- Chk1 Inhibitor [NCIt concept]
- Chk1 Inhibitor BBI-355 [NCIt concept]
- Chk1 Inhibitor GDC-0425 [NCIt concept]
- Chk1 Inhibitor GDC-0575 [NCIt concept]
- Chk1 Inhibitor LY2880070 [NCIt concept]
- Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Chlorambucil [NCIt concept]
- Chlorhexidine [NCIt concept]
- Chlorhexidine Gluconate [NCIt concept]
- Chlorhexidine Gluconate Skin Cleanser [NCIt concept]
- Chlorine Dioxide Sterilization [NCIt concept]
- Chloroquine [NCIt concept]
- Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes [NCIt concept]
- Cholangiocarcinoma [NCIt concept]
- Cholangitis [NCIt concept]
- Cholate [NCIt concept]
- Cholate Clearance Test [NCIt concept]
- Cholecalciferol [NCIt concept]
- Cholecystectomy [NCIt concept]
- Cholecystokinin [NCIt concept]
- Cholecystokinin Receptor Type A [NCIt concept]
- Cholesterol [NCIt concept]
- Cholesterol 7-Alpha-Monooxygenase [NCIt concept]
- Cholesterol Side-Chain Cleavage Enzyme, Mitochondrial [NCIt concept]
- Cholesterol Transporter ABCA5 [NCIt concept]
- Cholestyramine [NCIt concept]
- Cholic Acid-24-13C [NCIt concept]
- Cholic-2,2,4,4-D4 Acid [NCIt concept]
- Choline [NCIt concept]
- Choline Dehydrogenase, Mitochondrial [NCIt concept]
- Choline Kinase Alpha [NCIt concept]
- Choline Kinase Alpha Inhibitor TCD-717 [NCIt concept]
- Choline Magnesium Trisalicylate [NCIt concept]
- Choline Metabolite [NCIt concept]
- Choline O-Acetyltransferase [NCIt concept]
- Choline Transporter-Like Protein 1 [NCIt concept]
- Choline Transporter-Like Protein 4 [NCIt concept]
- Choline-Phosphate Cytidylyltransferase A [NCIt concept]
- Cholinephosphotransferase 1 [NCIt concept]
- Cholinesterase [NCIt concept]
- Chondroblastic Osteosarcoma [NCIt concept]
- Chondroitin Sulfate Proteoglycan 4 [NCIt concept]
- Chondrosarcoma [NCIt concept]
- Chordoma [NCIt concept]
- Choriocarcinoma [NCIt concept]
- Choriocarcinoma Combined with Other Germ Cell Elements [NCIt concept]
- Choriogonadotropin Subunit Beta 3 [NCIt concept]
- Choroid Disorder [NCIt concept]
- Choroid Plexus Carcinoma [NCIt concept]
- Chromaffin Granule Amine Transporter [NCIt concept]
- Chromatin [NCIt concept]
- Chromatin Assembly Factor 1 Subunit A [NCIt concept]
- Chromatin Modification-Related Protein MEAF6 [NCIt concept]
- Chromatography [NCIt concept]
- Chromodomain-Helicase-DNA-Binding Protein 1 [NCIt concept]
- Chromodomain-Helicase-DNA-Binding Protein 1-Like [NCIt concept]
- Chromodomain-Helicase-DNA-Binding Protein 4 [NCIt concept]
- Chromodomain-Helicase-DNA-Binding Protein 5 [NCIt concept]
- Chromodomain-Helicase-DNA-Binding Protein 7 [NCIt concept]
- Chromoendoscopy [NCIt concept]
- Chromogranin Gene [NCIt concept]
- Chromogranin Negative [NCIt concept]
- Chromogranin Positive [NCIt concept]
- Chromogranin-A [NCIt concept]
- Chromogranin-A Positive Neoplastic Cells Present [NCIt concept]
- Chromogranin-Positive Neoplastic Cells Present [NCIt concept]
- Chromophobe Renal Cell Carcinoma [NCIt concept]
- Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome [NCIt concept]
- Chromosomal Deletion [NCIt concept]
- Chromosomal Instability [NCIt concept]
- Chromosomal Inversion [NCIt concept]
- Chromosomal Rearrangement [NCIt concept]
- Chromosomal Translocation [NCIt concept]
- Chromosomal Translocation Analysis [NCIt concept]
- Chromosome 1 Satellite 2 [NCIt concept]
- Chromosome 12 Abnormality [NCIt concept]
- Chromosome 13 Abnormality [NCIt concept]
- Chromosome 13q Abnormality [NCIt concept]
- Chromosome 17 Centromere Probe [NCIt concept]
- Chromosome 17p Abnormality [NCIt concept]
- Chromosome 5 Rearrangement [NCIt concept]
- Chromosome 7 Abnormality [NCIt concept]
- Chromosome 7 Rearrangement [NCIt concept]
- Chromosome 9 Abnormality [NCIt concept]
- Chromosome Arm 16q Loss of Heterozygosity [NCIt concept]
- Chromosome Arm 1p Loss of Heterozygosity [NCIt concept]
- Chromosome Arm 3p Loss of Heterozygosity [NCIt concept]
- Chromosome Arm 9p Loss of Heterozygosity [NCIt concept]
- Chronic Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Chronic Cutaneous Graft Versus Host Disease [NCIt concept]
- Chronic Disease [NCIt concept]
- Chronic Eosinophilic Leukemia, Not Otherwise Specified [NCIt concept]
- Chronic Hemolysis [NCIt concept]
- Chronic Hepatitis B [NCIt concept]
- Chronic Idiopathic Neutropenia [NCIt concept]
- Chronic Inflammatory Demyelinating Polyneuropathy [NCIt concept]
- Chronic Leukemia [NCIt concept]
- Chronic Leukemia in Remission [NCIt concept]
- Chronic Lymphocytic Leukemia [NCIt concept]
- Chronic Lymphocytic Leukemia Up-Regulated Protein 1 [NCIt concept]
- Chronic Lymphocytic Leukemia in Remission [NCIt concept]
- Chronic Lymphoproliferative Disorder of NK-Cells [NCIt concept]
- Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission [NCIt concept]
- Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive [NCIt concept]
- Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive [NCIt concept]
- Chronic Myelomonocytic Leukemia [NCIt concept]
- Chronic Myelomonocytic Leukemia in Remission [NCIt concept]
- Chronic Neutrophilic Leukemia [NCIt concept]
- Chronic Obstructive Pulmonary Disease [NCIt concept]
- Chronic Ocular Graft Versus Host Disease [NCIt concept]
- Chronic Pancreatitis [NCIt concept]
- Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive [NCIt concept]
- Chronic Phase of Disease [NCIt concept]
- Chronic Pulmonary Aspergillosis [NCIt concept]
- Chylothorax [NCIt concept]
- Chymase [NCIt concept]
- Chymotrypsin-C [NCIt concept]
- Chymotrypsin-Like Elastase Family Member 1 [NCIt concept]
- Cibisatamab [NCIt concept]
- Cidofovir [NCIt concept]
- Ciforadenant [NCIt concept]
- Cifurtilimab [NCIt concept]
- Cigarette [NCIt concept]
- Cigarette Smoker [NCIt concept]
- Cigarette Smoking [NCIt concept]
- Cilengitide [NCIt concept]
- Cilgavimab/Tixagevimab [NCIt concept]
- Cilostazol [NCIt concept]
- Ciltacabtagene Autoleucel [NCIt concept]
- Cimdelirsen [NCIt concept]
- Cimetidine [NCIt concept]
- Cinacalcet Hydrochloride [NCIt concept]
- Cine Magnetic Resonance Imaging [NCIt concept]
- Cingulin-Like Protein 1 [NCIt concept]
- Cinobufagin [NCIt concept]
- Cinrebafusp Alfa [NCIt concept]
- Cintirorgon [NCIt concept]
- Cintredekin Besudotox [NCIt concept]
- Cipepofol [NCIt concept]
- Circadian Biometric Recorder [NCIt concept]
- Circadian Clock Protein PASD1 [NCIt concept]
- Circulating Adipose Stromal Cell [NCIt concept]
- Circulating Blasts 4-9 Percent [NCIt concept]
- Circulating Cancer-Associated Fibroblast [NCIt concept]
- Circulating Cell-Free DNA [NCIt concept]
- Circulating Cell-Free Human Papillomavirus DNA [NCIt concept]
- Circulating Cell-Free RNA [NCIt concept]
- Circulating Clonotypic B-Cell [NCIt concept]
- Circulating Deoxyribonucleotide [NCIt concept]
- Circulating EGF Measurement [NCIt concept]
- Circulating Endothelial Cell Count [NCIt concept]
- Circulating Epithelial Cell [NCIt concept]
- Circulating Human Papillomavirus DNA [NCIt concept]
- Circulating Melanoma Cell [NCIt concept]
- Circulating MicroRNA [NCIt concept]
- Circulating Myeloid Cell [NCIt concept]
- Circulating Neutrophil Extracellular Trap Measurement [NCIt concept]
- Circulating Plasma Cell [NCIt concept]
- Circulating Proteasome [NCIt concept]
- Circulating Stem Cell [NCIt concept]
- Circulating Tumor Cell [NCIt concept]
- Circulating Tumor Cell Analysis [NCIt concept]
- Circulating Tumor Cells Positive [NCIt concept]
- Circulating Tumor HPV DNA [NCIt concept]
- Circulating Tumor HPV-16 DNA [NCIt concept]
- Circulating Tumor HPV-18 DNA [NCIt concept]
- Circulating Tumor-Derived DNA [NCIt concept]
- Circulating Tumor-Derived DNA Mutation Positive [NCIt concept]
- Circulating Tumor-Derived DNA Negative [NCIt concept]
- Circulating Tumor-Derived DNA Positive [NCIt concept]
- Circulating Tumor-Derived RNA [NCIt concept]
- Circulating Tumor-Reactive T-Cell [NCIt concept]
- Cisplatin [NCIt concept]
- Cisplatin Nano-engineered Intraoperative System PRV211 [NCIt concept]
- Cisplatin Transmucosal Patch [NCIt concept]
- Cisplatin-Induced Tinnitus [NCIt concept]
- Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 [NCIt concept]
- Citalopram Hydrobromide [NCIt concept]
- Citarinostat [NCIt concept]
- Citrate [NCIt concept]
- Citric Acid Monohydrate [NCIt concept]
- Citrulline [NCIt concept]
- Citrullinemia Type I [NCIt concept]
- Citrullinemia Type II [NCIt concept]
- CivaSheet Directional Pd103 Brachytherapy Source [NCIt concept]
- Cixutumumab [NCIt concept]
- Cladribine [NCIt concept]
- ClariCore Optical Biopsy System [NCIt concept]
- Clarithromycin [NCIt concept]
- Claspin [NCIt concept]
- Classic Hodgkin Lymphoma [NCIt concept]
- Classic Kaposi Sarcoma [NCIt concept]
- Clathrin Heavy Chain 1 [NCIt concept]
- Clathrin Heavy Chain 2 [NCIt concept]
- Claturafenib [NCIt concept]
- Claudin-1 [NCIt concept]
- Claudin-18 [NCIt concept]
- Claudin-18 Isoform A2 [NCIt concept]
- Claudin-4 [NCIt concept]
- Claudin-6 [NCIt concept]
- Claudin-Low [NCIt concept]
- Clavulanic Acid [NCIt concept]
- Clazakizumab [NCIt concept]
- Clear Cell Renal Cell Carcinoma [NCIt concept]
- Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Clear Cell Sarcoma of the Kidney [NCIt concept]
- Clearing Agent [NCIt concept]
- Cleavage and Polyadenylation Specificity Factor Subunit 5 [NCIt concept]
- Cleveland Multiport Catheter [NCIt concept]
- CliniMACS CD34 Reagent System [NCIt concept]
- Clinical Breast Examination [NCIt concept]
- Clinical Encounter [NCIt concept]
- Clinical Evaluation [NCIt concept]
- Clinical Intervention or Procedure [NCIt concept]
- Clinical Observation [NCIt concept]
- Clinical Stage 0 Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage 0 Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage I Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage I Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage IB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage II Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage II Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IIA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage IIA Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage IIB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage IIB Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage IIC Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage III Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage III Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IV Cutaneous Melanoma AJCC v8 [NCIt concept]
- Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IV Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IVA Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Clinical Stage IVB Gastric Cancer AJCC v8 [NCIt concept]
- Clinical Trial [NCIt concept]
- Clinical or Research Activity [NCIt concept]
- Clinician [NCIt concept]
- Clitoral Carcinoma [NCIt concept]
- Clobetasol [NCIt concept]
- Clobetasol Propionate [NCIt concept]
- Clodronate Disodium [NCIt concept]
- Clofarabine [NCIt concept]
- Clofazimine [NCIt concept]
- Clofutriben [NCIt concept]
- Clonal CCND1 Gene Rearrangement [NCIt concept]
- Clonal Cytopenia of Undetermined Significance [NCIt concept]
- Clonal Gene Rearrangement [NCIt concept]
- Clonal Hematopoiesis [NCIt concept]
- Clonal Hematopoiesis of Indeterminate Potential [NCIt concept]
- Clonal Immunoglobulin Heavy Chain Gene Rearrangement [NCIt concept]
- Clonal Plasma Cells in Bone Marrow [NCIt concept]
- Clonal Subgroup [NCIt concept]
- Clonal T-Cell Receptor Gene Rearrangement [NCIt concept]
- Clonidine-containing Mucoadhesive Buccal Tablet [NCIt concept]
- Clopidogrel [NCIt concept]
- Clopidogrel Bisulfate [NCIt concept]
- Clostridia Strain Formulation VE303 [NCIt concept]
- Clostridioides difficile Toxin B-binding proteins/Endolysin Combination LMN-201 [NCIt concept]
- Clostridium Cluster [NCIt concept]
- Clostridium Cluster IV [NCIt concept]
- Clostridium Cluster XIV [NCIt concept]
- Clostridium Cluster XVI [NCIt concept]
- Clostridium Novyi-NT Spores [NCIt concept]
- Clostridium butyricum CBM 588 Probiotic Strain [NCIt concept]
- Clostridium butyricum-containing Probiotic [NCIt concept]
- Clostridium difficile [NCIt concept]
- Clostridium difficile Infection [NCIt concept]
- Clostridium difficile Positive [NCIt concept]
- Clostridium difficile Toxin A Positive [NCIt concept]
- Clostridium difficile Toxin B Positive [NCIt concept]
- Clostridium difficile Toxin Positive [NCIt concept]
- Clove Oil [NCIt concept]
- Cloxacillin [NCIt concept]
- Clusterin [NCIt concept]
- CoREST Inhibitor TNG260 [NCIt concept]
- Coach [NCIt concept]
- Coagulation Factor IX [NCIt concept]
- Coagulation Factor V [NCIt concept]
- Coagulation Factor VIII [NCIt concept]
- Coagulation Factor XII [NCIt concept]
- Cobalamin [NCIt concept]
- Cobblestone Area-Forming Cells [NCIt concept]
- Cobicistat [NCIt concept]
- Cobimetinib [NCIt concept]
- Cobiprostone [NCIt concept]
- Cobolimab [NCIt concept]
- Cobomarsen [NCIt concept]
- Cocaine Esterase [NCIt concept]
- Cockayne Syndrome [NCIt concept]
- Codrituzumab [NCIt concept]
- Coenzyme Q10 [NCIt concept]
- Cofetuzumab Pelidotin [NCIt concept]
- Cogmed Training Program [NCIt concept]
- Cognitive Assessment [NCIt concept]
- Cognitive Behavior Therapy [NCIt concept]
- Cognitive Behavior Therapy for Insomnia [NCIt concept]
- Cognitive Electrophysiology Assessment [NCIt concept]
- Cognitive Intervention [NCIt concept]
- Cognitive Medication Adherence Counseling [NCIt concept]
- Cognitive Side Effects of Cancer Therapy [NCIt concept]
- Cognitively-Based Compassion Training [NCIt concept]
- Cogstate Assessment Battery [NCIt concept]
- Coherent Anti-Stokes Raman Spectroscopy [NCIt concept]
- Cohesin Subunit SA-2 [NCIt concept]
- Coiled-Coil Domain-Containing Protein 6 [NCIt concept]
- Coiled-Coil-Helix-Coiled-Coil-Helix Domain-Containing Protein 7 [NCIt concept]
- Colchicine-Site Binding Agent ABT-751 [NCIt concept]
- Cold Agglutinin [NCIt concept]
- Cold Cap Therapy [NCIt concept]
- Cold Compress [NCIt concept]
- Cold Contaminant-free Iobenguane I-131 [NCIt concept]
- Cold Ischemia Procedure [NCIt concept]
- Colectomy [NCIt concept]
- Colesevelam Hydrochloride [NCIt concept]
- Colestipol [NCIt concept]
- Collagen [NCIt concept]
- Collagen Alpha-1(I) Chain [NCIt concept]
- Collagen Alpha-1(III) Chain [NCIt concept]
- Collagen Alpha-1(VII) Chain [NCIt concept]
- Collagen Alpha-1(XVII) Chain [NCIt concept]
- Collagen Alpha-1(XVIII) Chain [NCIt concept]
- Collagen Alpha-2(I) Chain [NCIt concept]
- Collagen Alpha-3(VI) Chain [NCIt concept]
- Collagen Tile Brachytherapy [NCIt concept]
- Collagen Triple Helix Repeat-Containing Protein 1 [NCIt concept]
- Collagenase [NCIt concept]
- Collection [NCIt concept]
- Colon Adenocarcinoma [NCIt concept]
- Colon Adenosquamous Carcinoma [NCIt concept]
- Colon Carcinoma [NCIt concept]
- Colon Imaging Study [NCIt concept]
- Colon Mucinous Adenocarcinoma [NCIt concept]
- Colon Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Colon Neuroendocrine Tumor G2 [NCIt concept]
- Colon Signet Ring Cell Adenocarcinoma [NCIt concept]
- Colon Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Colon Squamous Cell Carcinoma [NCIt concept]
- Colon Undifferentiated Carcinoma [NCIt concept]
- Colonoscopic Polypectomy [NCIt concept]
- Colonoscopy [NCIt concept]
- Colony Forming Unit-Endothelial Cells [NCIt concept]
- Colony Stimulating Factor [NCIt concept]
- Colony-Forming Unit-Fibroblasts [NCIt concept]
- Colorectal Adenocarcinoma [NCIt concept]
- Colorectal Adenocarcinoma Metastatic in the Liver [NCIt concept]
- Colorectal Adenoma with Severe Dysplasia [NCIt concept]
- Colorectal Adenosquamous Carcinoma [NCIt concept]
- Colorectal Carcinoma [NCIt concept]
- Colorectal Carcinoma Metastatic in the Liver [NCIt concept]
- Colorectal Carcinoma Metastatic in the Lung [NCIt concept]
- Colorectal Gastrointestinal Stromal Tumor [NCIt concept]
- Colorectal Goblet Cell Adenocarcinoma [NCIt concept]
- Colorectal Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Colorectal Neoplasm [NCIt concept]
- Colorectal Neuroendocrine Carcinoma [NCIt concept]
- Colorectal Sarcomatoid Carcinoma [NCIt concept]
- Colorectal Serrated Polyposis [NCIt concept]
- Colorectal Squamous Cell Carcinoma [NCIt concept]
- Colorectal Undifferentiated Carcinoma [NCIt concept]
- Colposcopic Biopsy [NCIt concept]
- Colposcopy [NCIt concept]
- Coltuximab Ravtansine [NCIt concept]
- Combined Gynecological Intracavitary and Interstitial Brachytherapy [NCIt concept]
- Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Combined Lung Carcinoma [NCIt concept]
- Combined Lung Small Cell Carcinoma [NCIt concept]
- Combined Thymus Epithelial Neoplasm [NCIt concept]
- Comedo [NCIt concept]
- Commensal Bacterial Strain Formulation VE800 [NCIt concept]
- Communication Analysis [NCIt concept]
- Communication Intervention [NCIt concept]
- Communication Skills Training [NCIt concept]
- Community Health Advisor [NCIt concept]
- Community Health Education [NCIt concept]
- Community Health Service [NCIt concept]
- Comparative Genomic Hybridization [NCIt concept]
- Comparison of Screening Methods [NCIt concept]
- Compassionate High-Alert Team Intervention [NCIt concept]
- Complement C1q Subcomponent Subunit A [NCIt concept]
- Complement C1s Subcomponent [NCIt concept]
- Complement C2 [NCIt concept]
- Complement C3 [NCIt concept]
- Complement C3 Beta Chain [NCIt concept]
- Complement C3d [NCIt concept]
- Complement C4-A [NCIt concept]
- Complement C4-B [NCIt concept]
- Complement C5 [NCIt concept]
- Complement Component C1q Receptor [NCIt concept]
- Complement Component-4 [NCIt concept]
- Complement Decay-Accelerating Factor [NCIt concept]
- Complement Factor D [NCIt concept]
- Complement Factor H [NCIt concept]
- Complement Hemolytic Activity Assay [NCIt concept]
- Complement Inhibitor [NCIt concept]
- Complement Receptor Type 2 [NCIt concept]
- Complement-Dependent Cytotoxicity [NCIt concept]
- Complementary or Alternative Medical Procedure [NCIt concept]
- Complete Estrogen Receptor Antagonist [NCIt concept]
- Complete Measurable Residual Disease Response [NCIt concept]
- Complete Remission in Leukemia with Incomplete Hematologic Recovery [NCIt concept]
- Complete Response of Multiple Myeloma or Plasma Cell Leukemia [NCIt concept]
- Complete Response without Minimal Residual Disease [NCIt concept]
- Complex Decongestive Therapy [NCIt concept]
- Compliance Cap [NCIt concept]
- Compliance Monitoring [NCIt concept]
- Complicated Parapneumonic Pleural Effusion [NCIt concept]
- Composite Lymphoma [NCIt concept]
- Comprehensive Geriatric Assessment [NCIt concept]
- Comprehensive Lifestyle Intervention Program [NCIt concept]
- Compression Garment [NCIt concept]
- Compression Therapy [NCIt concept]
- Compression Therapy for Neuropathy Prevention [NCIt concept]
- Computed Tomography [NCIt concept]
- Computed Tomography Assisted Biopsy [NCIt concept]
- Computed Tomography Colonography [NCIt concept]
- Computed Tomography Perfusion Imaging [NCIt concept]
- Computed Tomography of the Brain with Contrast [NCIt concept]
- Computed Tomography of the Chest, Abdomen and Pelvis without Contrast [NCIt concept]
- Computed Tomography-Guided Optical Sensor-Guided Percutaneous Needle Biopsy [NCIt concept]
- Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation [NCIt concept]
- Computer-Aided Diagnosis [NCIt concept]
- Computer-Assisted Cognitive Training [NCIt concept]
- Computer-Assisted Intervention [NCIt concept]
- Computer-Assisted Smoking Cessation Intervention [NCIt concept]
- Computer-Based Cognitive Stimulation Intervention [NCIt concept]
- Computerized Dynamic Posturography Assessment [NCIt concept]
- Computerized Neurocognitive Battery [NCIt concept]
- Conatumumab [NCIt concept]
- Concurrent Chemoradiation [NCIt concept]
- Conditionally Replicative Adenovirus 5/3-delta24 [NCIt concept]
- Conditionally-activated Anti-EpCAM Antibody-drug Conjugate CX-2051 [NCIt concept]
- Conditioning Chemotherapy [NCIt concept]
- Cone-Beam Computed Tomography [NCIt concept]
- Confirmatory Test [NCIt concept]
- Confocal Laser Endomicroscopy [NCIt concept]
- Confocal Laser Microlaryngoscopy [NCIt concept]
- Confocal Microscopy [NCIt concept]
- Congenital Amegakaryocytic Thrombocytopenia [NCIt concept]
- Congenital Central Hypoventilation [NCIt concept]
- Congenital Combined Immunodeficiency [NCIt concept]
- Congenital Malformation Syndrome [NCIt concept]
- Congenital Mesoblastic Nephroma [NCIt concept]
- Congenital Neutropenia [NCIt concept]
- Congenital Pseudarthrosis of Tibia [NCIt concept]
- Congenital Thrombotic Thrombocytopenic Purpura [NCIt concept]
- Congestive Hepatopathy [NCIt concept]
- Conization [NCIt concept]
- Conjugated Estrogens/Bazedoxifene [NCIt concept]
- Conjugated Linoleic Acid [NCIt concept]
- Conjunctival Diffuse Large B-Cell Lymphoma [NCIt concept]
- Conjunctival Kaposi Sarcoma [NCIt concept]
- Conjunctival Melanoma [NCIt concept]
- Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Conjunctival Squamous Cell Carcinoma [NCIt concept]
- Connective Tissue Disorder [NCIt concept]
- Connective Tissue-Activating Peptide III [NCIt concept]
- Connective and Soft Tissue Disorder [NCIt concept]
- Connective and Soft Tissue Neoplasm [NCIt concept]
- Constitutional Mismatch Repair Deficiency Syndrome [NCIt concept]
- Consultation [NCIt concept]
- Contactin-4 [NCIt concept]
- Contingency Management [NCIt concept]
- Continuous Glucose Monitoring System [NCIt concept]
- Continuous Positive Airway Pressure [NCIt concept]
- Continuous Temperature Monitoring Device [NCIt concept]
- Contrast Agent [NCIt concept]
- Contrast Enhanced Digital Mammography [NCIt concept]
- Contrast-Enhanced Harmonic Endoscopic Ultrasound [NCIt concept]
- Contrast-Enhanced Mammography [NCIt concept]
- Contrast-Enhanced Subharmonic Ultrasound Imaging [NCIt concept]
- Contrast-Enhanced Ultrasound [NCIt concept]
- Contrast-Enhanced Ultrasound-Guided Prostate Biopsy [NCIt concept]
- Contrast-enhanced Magnetic Resonance Imaging [NCIt concept]
- Contrast-enhanced Microholography [NCIt concept]
- Contusugene Ladenovec [NCIt concept]
- Convalescent Plasma [NCIt concept]
- Convection-Enhanced Delivery [NCIt concept]
- Conventional Dendritic Cell [NCIt concept]
- Conventional Magnetic Resonance Imaging [NCIt concept]
- Conventional Osteosarcoma [NCIt concept]
- Conventional Radiotherapy [NCIt concept]
- Conventional Surgery [NCIt concept]
- Coordination [NCIt concept]
- Copanlisib [NCIt concept]
- Copanlisib Hydrochloride [NCIt concept]
- Copper [NCIt concept]
- Copper 64 Cu-DOTA-daratumumab [NCIt concept]
- Copper 64 Cu-labeled Macrophage-targeted Nanoparticle [NCIt concept]
- Copper Cu 62 Ethylglyoxal Bis(thiosemicarbazone) [NCIt concept]
- Copper Cu 62-ATSM [NCIt concept]
- Copper Cu 62-PTSM [NCIt concept]
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Copper Cu 64 Dotatate [NCIt concept]
- Copper Cu 64 FAP-2286 [NCIt concept]
- Copper Cu 64 FBP8 [NCIt concept]
- Copper Cu 64 GRIP B [NCIt concept]
- Copper Cu 64 LNTH-1363S [NCIt concept]
- Copper Cu 64 NODAGA-TTX-MC138 [NCIt concept]
- Copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' Dots [NCIt concept]
- Copper Cu 64 SAR-Bombesin [NCIt concept]
- Copper Cu 64 TP3805 [NCIt concept]
- Copper Cu 64 Ucasareotide Dasaroxetan [NCIt concept]
- Copper Cu 64 Zadavotide Guraxetan [NCIt concept]
- Copper Cu 64-ATSM [NCIt concept]
- Copper Cu 64-CB-TE1A1P-PEG4-LLP2A [NCIt concept]
- Copper Cu 64-DOTA B-Fab [NCIt concept]
- Copper Cu 64-DOTA-Anti-HER3 Monoclonal Antibody U3-1287 [NCIt concept]
- Copper Cu 64-DOTA-ECL1i [NCIt concept]
- Copper Cu 64-DOTA-Rituximab [NCIt concept]
- Copper Cu 64-DOTA-Trastuzumab [NCIt concept]
- Copper Cu 64-DOTA-pembrolizumab [NCIt concept]
- Copper Cu 64-GRIP B [NCIt concept]
- Copper Cu 64-Tz-SarAr [NCIt concept]
- Copper Cu 67 Abefolastat Tesaroxetan [NCIt concept]
- Copper Cu 67 SAR-bombesin [NCIt concept]
- Copper Cu 67 Ucasareotide Dasaroxetan [NCIt concept]
- Copper Cu-64-DOTA-alendronate [NCIt concept]
- Copper Gluconate [NCIt concept]
- Copper-Transporting ATPase 1 [NCIt concept]
- Copy Number Polymorphism [NCIt concept]
- Cord Blood Transplant Recipient [NCIt concept]
- Cord Blood-derived CMV/AdV/EBV/BKV-specific Cytotoxic T-lymphocytes [NCIt concept]
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells [NCIt concept]
- Cordotomy [NCIt concept]
- Cordycepin [NCIt concept]
- Core Binding Factor Complex Mutation [NCIt concept]
- Core Biopsy [NCIt concept]
- Core Histone Macro-H2A [NCIt concept]
- Core Histone Macro-H2A.1 [NCIt concept]
- Core-Binding Factor [NCIt concept]
- Core-Binding Factor Subunit Beta [NCIt concept]
- Coriolus Versicolor Extract [NCIt concept]
- Cornea Donor [NCIt concept]
- Corneal Transplantation [NCIt concept]
- Coronary Angiography [NCIt concept]
- Coronavirus Infection [NCIt concept]
- Corpus Callosum Neoplasm [NCIt concept]
- Corticorelin Acetate [NCIt concept]
- Corticosteroid-Dependent Chronic Graft Versus Host Disease [NCIt concept]
- Corticosteroid-containing Eye Drop [NCIt concept]
- Corticosterone [NCIt concept]
- Corticotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Corticotropin [NCIt concept]
- Cortisol [NCIt concept]
- Cortisol Measurement [NCIt concept]
- Cortodoxone [NCIt concept]
- Corynebacterium aurimucosum [NCIt concept]
- Cosibelimab [NCIt concept]
- Cositecan [NCIt concept]
- Cost Effectiveness Analysis [NCIt concept]
- Cosyntropin [NCIt concept]
- Cotinine [NCIt concept]
- Cotinine Greater than or Equal to 30 ng/ml [NCIt concept]
- Cotinine Less than 10 ng/ml [NCIt concept]
- Cotinine Less than 30 ng/ml [NCIt concept]
- Cotinine Positive [NCIt concept]
- Cotsiranib [NCIt concept]
- Counseling [NCIt concept]
- Covalent BTK Inhibitor [NCIt concept]
- Cowden Syndrome [NCIt concept]
- Coxsackievirus and Adenovirus Receptor [NCIt concept]
- CpG Antibody [NCIt concept]
- CpG Island [NCIt concept]
- CpG Island Methylator Phenotype [NCIt concept]
- CpG Oligodeoxynucleotide GNKG168 [NCIt concept]
- CpG-28 Oligodeoxynucleotide [NCIt concept]
- CpG-STAT3 siRNA CAS3/SS3 [NCIt concept]
- Cranial Electrical Stimulation [NCIt concept]
- Cranial Nerve Neoplasm [NCIt concept]
- Craniospinal Irradiation [NCIt concept]
- Craniotomy [NCIt concept]
- Craniotomy Patient [NCIt concept]
- Creatine [NCIt concept]
- Creatine Kinase [NCIt concept]
- Creatine Kinase B-Type [NCIt concept]
- Creatine Kinase MB [NCIt concept]
- Creatine Monohydrate [NCIt concept]
- Creatine Supplementation [NCIt concept]
- Crelosidenib [NCIt concept]
- Crenigacestat [NCIt concept]
- Crenolanib Besylate [NCIt concept]
- Cribriform [NCIt concept]
- Crizanlizumab [NCIt concept]
- Crizotinib [NCIt concept]
- Crk-Like Protein [NCIt concept]
- Crofelemer [NCIt concept]
- Crohn Disease [NCIt concept]
- Crohn Disease-Associated Dysplasia of the Colorectum [NCIt concept]
- Crolibulin [NCIt concept]
- Crosslinked Multimeric Type III Procollagen Propeptide [NCIt concept]
- Crossover Junction Endonuclease MUS81 [NCIt concept]
- Crotonaldehyde [NCIt concept]
- Crovalimab [NCIt concept]
- Crown-Like Structure [NCIt concept]
- Crown-Like Structures of the Breast [NCIt concept]
- Cryoballoon Ablation Therapy [NCIt concept]
- Cryocompression Therapy [NCIt concept]
- Cryopreservation [NCIt concept]
- Cryopreserved Umbilical Cord Allograft [NCIt concept]
- Cryosurgery [NCIt concept]
- Cryotherapy [NCIt concept]
- Cryptochrome-2 [NCIt concept]
- Cudarolimab [NCIt concept]
- Cullin-3 [NCIt concept]
- Cullin-4A [NCIt concept]
- Cultured Lentinula edodes Mycelia Extract [NCIt concept]
- Curative Surgery [NCIt concept]
- Curcumin [NCIt concept]
- Curcumin-based Gel [NCIt concept]
- Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-containing Supplement [NCIt concept]
- Curcumin/Polyphenols-containing Botanical Agent APG-157 [NCIt concept]
- Current Daily Vaper [NCIt concept]
- Current Reformed Smoker Within 1 Year [NCIt concept]
- Current Smoker [NCIt concept]
- Current Vaper [NCIt concept]
- Cusatuzumab [NCIt concept]
- Cushing Disease [NCIt concept]
- Custirsen Sodium [NCIt concept]
- Cutaneous Acute Graft versus Host Disease [NCIt concept]
- Cutaneous Amelanotic Melanoma [NCIt concept]
- Cutaneous Dysplastic Nevus [NCIt concept]
- Cutaneous Mastocytosis [NCIt concept]
- Cutaneous Melanocytic Neoplasm [NCIt concept]
- Cutaneous Melanoma [NCIt concept]
- Cutaneous Melanoma of the Extremity [NCIt concept]
- Cutaneous Nodular Melanoma [NCIt concept]
- Cutaneous Oximetry [NCIt concept]
- Cxbladder [NCIt concept]
- Cyclic AMP [NCIt concept]
- Cyclic AMP-Dependent Transcription Factor ATF-1 [NCIt concept]
- Cyclic AMP-Dependent Transcription Factor ATF-3 [NCIt concept]
- Cyclic AMP-Dependent Transcription Factor ATF-4 [NCIt concept]
- Cyclic AMP-Dependent Transcription Factor ATF-5 [NCIt concept]
- Cyclic AMP-Dependent Transcription Factor ATF-6 Alpha [NCIt concept]
- Cyclic AMP-Responsive Element-Binding Protein 1 [NCIt concept]
- Cyclic AMP-Responsive Element-Binding Protein 3-Like Protein 2 [NCIt concept]
- Cyclic GMP [NCIt concept]
- Cyclic GMP-AMP Synthase [NCIt concept]
- Cyclical Hypofractionated Radiotherapy [NCIt concept]
- Cyclin [NCIt concept]
- Cyclin A/B RxL Inhibitor CID-078 [NCIt concept]
- Cyclin B [NCIt concept]
- Cyclin D [NCIt concept]
- Cyclin E [NCIt concept]
- Cyclin Gene [NCIt concept]
- Cyclin-A1 [NCIt concept]
- Cyclin-C [NCIt concept]
- Cyclin-Dependent Kinase [NCIt concept]
- Cyclin-Dependent Kinase 1 [NCIt concept]
- Cyclin-Dependent Kinase 10 [NCIt concept]
- Cyclin-Dependent Kinase 12 [NCIt concept]
- Cyclin-Dependent Kinase 19 [NCIt concept]
- Cyclin-Dependent Kinase 2 [NCIt concept]
- Cyclin-Dependent Kinase 2 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 4 [NCIt concept]
- Cyclin-Dependent Kinase 4 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 4 Inhibitor B [NCIt concept]
- Cyclin-Dependent Kinase 4 Inhibitor C [NCIt concept]
- Cyclin-Dependent Kinase 4 Inhibitor D [NCIt concept]
- Cyclin-Dependent Kinase 5 [NCIt concept]
- Cyclin-Dependent Kinase 6 [NCIt concept]
- Cyclin-Dependent Kinase 6 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 7 [NCIt concept]
- Cyclin-Dependent Kinase 7 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 8 [NCIt concept]
- Cyclin-Dependent Kinase 9 [NCIt concept]
- Cyclin-Dependent Kinase 9 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase Gene [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor 1 [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor 1B [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor 1C [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor 2A [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor 3 [NCIt concept]
- Cyclin-Dependent Kinases Regulatory Subunit 1 [NCIt concept]
- Cyclin-H [NCIt concept]
- Cyclin-K [NCIt concept]
- Cyclobenzaprine Hydrochloride [NCIt concept]
- Cyclobutane Pyrimidine Dimer [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Cyclosporine [NCIt concept]
- Cyclosporine Ophthalmic Emulsion [NCIt concept]
- Cyproheptadine Hydrochloride [NCIt concept]
- Cystathionine [NCIt concept]
- Cystathionine Beta-Synthase [NCIt concept]
- Cystatin-A [NCIt concept]
- Cystatin-B [NCIt concept]
- Cystatin-C [NCIt concept]
- Cystatin-D [NCIt concept]
- Cystatin-S [NCIt concept]
- Cystatin-SA [NCIt concept]
- Cystatin-SN [NCIt concept]
- Cystectomy [NCIt concept]
- Cysteine Protease ATG4C [NCIt concept]
- Cysteine-Rich Hydrophobic Domain-Containing Protein 2 [NCIt concept]
- Cysteine-Rich Protein 2 [NCIt concept]
- Cysteine-tRNA Ligase, Cytoplasmic [NCIt concept]
- Cysteinyl Leukotriene Receptor 2 [NCIt concept]
- Cystine [NCIt concept]
- Cystine/Glutamate Transporter Protein [NCIt concept]
- Cystoscopy [NCIt concept]
- Cytarabine [NCIt concept]
- Cytarabine Hydrochloride [NCIt concept]
- Cytidine Deaminase [NCIt concept]
- Cytidine Triphosphate [NCIt concept]
- Cytochrome B-245 Heavy Chain [NCIt concept]
- Cytochrome B-245 Light Chain [NCIt concept]
- Cytochrome C [NCIt concept]
- Cytochrome C Oxidase Subunit 1 [NCIt concept]
- Cytochrome C Oxidase Subunit 6C [NCIt concept]
- Cytochrome P450 [NCIt concept]
- Cytochrome P450 11B2, Mitochondrial [NCIt concept]
- Cytochrome P450 1A1 [NCIt concept]
- Cytochrome P450 1A2 [NCIt concept]
- Cytochrome P450 1B1 [NCIt concept]
- Cytochrome P450 26A1 [NCIt concept]
- Cytochrome P450 26B1 [NCIt concept]
- Cytochrome P450 2A13 [NCIt concept]
- Cytochrome P450 2A6 [NCIt concept]
- Cytochrome P450 2A7 [NCIt concept]
- Cytochrome P450 2B6 [NCIt concept]
- Cytochrome P450 2C19 [NCIt concept]
- Cytochrome P450 2C8 [NCIt concept]
- Cytochrome P450 2C9 [NCIt concept]
- Cytochrome P450 2D6 [NCIt concept]
- Cytochrome P450 2E1 [NCIt concept]
- Cytochrome P450 3A4 [NCIt concept]
- Cytochrome P450 3A5 [NCIt concept]
- Cytochrome P450 CYP11B1, Mitochondrial [NCIt concept]
- Cytochrome P450 Family 11 [NCIt concept]
- Cytochrome b-c1 Complex Subunit 6, Mitochondrial [NCIt concept]
- Cytogenetic Abnormality [NCIt concept]
- Cytogenetic Analysis [NCIt concept]
- Cytogenetic Complete Response [NCIt concept]
- Cytokine [NCIt concept]
- Cytokine Antibody [NCIt concept]
- Cytokine Expression Profile [NCIt concept]
- Cytokine Receptor Common Subunit Gamma [NCIt concept]
- Cytokine Receptor-Like Factor 1 [NCIt concept]
- Cytokine Receptor-Like Factor 2 [NCIt concept]
- Cytokine Therapy [NCIt concept]
- Cytokine and Angiogenic Factor Profile [NCIt concept]
- Cytokine-Induced Killer Cells [NCIt concept]
- Cytokine-treated Veto Cells [NCIt concept]
- Cytology Specimen Collection Procedure [NCIt concept]
- Cytomegaloviral Infection [NCIt concept]
- Cytomegalovirus [NCIt concept]
- Cytomegalovirus Antibody [NCIt concept]
- Cytomegalovirus DNA [NCIt concept]
- Cytomegalovirus MicroRNA [NCIt concept]
- Cytomegalovirus Negative [NCIt concept]
- Cytomegalovirus Positive [NCIt concept]
- Cytomegalovirus Reactivation Finding [NCIt concept]
- Cytomegalovirus mRNA [NCIt concept]
- Cytomegalovirus pp65-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Cytoplasmic Nucleophosmin Expression [NCIt concept]
- Cytoplasmic Tyrosine-Protein Kinase BMX [NCIt concept]
- Cytoreductive Surgery [NCIt concept]
- Cytosolic Purine 5'-Nucleotidase [NCIt concept]
- Cytospin-B [NCIt concept]
- Cytotoxic Agent-LAT1 Substrate QBS10072S [NCIt concept]
- Cytotoxic Chemotherapy [NCIt concept]
- Cytotoxic Granule Protein [NCIt concept]
- Cytotoxic Lymphoma [NCIt concept]
- Cytotoxic T-Lymphocyte [NCIt concept]
- Cytotoxic T-Lymphocyte Protein 4 [NCIt concept]
- Cytotoxic and Regulatory T-Cell Molecule [NCIt concept]
- D Vitamin [NCIt concept]
- D(2) Dopamine Receptor [NCIt concept]
- D(4) Dopamine Receptor [NCIt concept]
- D-Bifunctional Protein Deficiency [NCIt concept]
- D1/3-Mage-3-His Fusion Protein [NCIt concept]
- D17S250 [NCIt concept]
- D2S123 [NCIt concept]
- D3-Creatine Dilution [NCIt concept]
- D5S346 [NCIt concept]
- DAB2IP Gene [NCIt concept]
- DAB2IP wt Allele [NCIt concept]
- DACT2 Gene [NCIt concept]
- DACT2 wt Allele [NCIt concept]
- DAD1 Gene [NCIt concept]
- DAD1 wt Allele [NCIt concept]
- DAPI [NCIt concept]
- DAXX Gene [NCIt concept]
- DAXX Gene Mutation [NCIt concept]
- DAXX wt Allele [NCIt concept]
- DAZL Gene [NCIt concept]
- DAZL wt Allele [NCIt concept]
- DCAF1 Gene [NCIt concept]
- DCAF1 wt Allele [NCIt concept]
- DCAF7 Gene [NCIt concept]
- DCAF7 wt Allele [NCIt concept]
- DCC Gene [NCIt concept]
- DCC wt Allele [NCIt concept]
- DCEP Regimen [NCIt concept]
- DCK Gene [NCIt concept]
- DCK wt Allele [NCIt concept]
- DCLK1 Gene [NCIt concept]
- DCLK1 wt Allele [NCIt concept]
- DCLRE1A Gene [NCIt concept]
- DCLRE1A wt Allele [NCIt concept]
- DCLRE1C Gene [NCIt concept]
- DCLRE1C wt Allele [NCIt concept]
- DCN Gene [NCIt concept]
- DCN wt Allele [NCIt concept]
- DCT Gene [NCIt concept]
- DCT wt Allele [NCIt concept]
- DCTD Gene [NCIt concept]
- DCTD wt Allele [NCIt concept]
- DCTN1 Gene [NCIt concept]
- DCTN1 wt Allele [NCIt concept]
- DCX Gene [NCIt concept]
- DCX wt Allele [NCIt concept]
- DDB1- and CUL4-Associated Factor 1 [NCIt concept]
- DDB1- and CUL4-Associated Factor 7 [NCIt concept]
- DDB2 Gene [NCIt concept]
- DDB2 wt Allele [NCIt concept]
- DDC Gene [NCIt concept]
- DDC wt Allele [NCIt concept]
- DDIT3 Gene [NCIt concept]
- DDIT3 Gene Rearrangement [NCIt concept]
- DDIT3 wt Allele [NCIt concept]
- DDIT4 Gene [NCIt concept]
- DDIT4 wt Allele [NCIt concept]
- DDR1 Gene [NCIt concept]
- DDR1 wt Allele [NCIt concept]
- DDR1-2/VEGFR2-3/PDGFRalpha-beta Inhibitor ICP-033 [NCIt concept]
- DDR2 NM_001014796.3:c.1912A>T [NCIt concept]
- DDR2 NM_001014796.3:c.2304T>A [NCIt concept]
- DDR2 NM_001014796.3:c.716T>G [NCIt concept]
- DDR2 NP_001014796.1:p.I638F [NCIt concept]
- DDR2 NP_001014796.1:p.L239R [NCIt concept]
- DDR2 NP_001014796.1:p.S768R [NCIt concept]
- DDRD Signature [NCIt concept]
- DDX1 Gene [NCIt concept]
- DDX1 wt Allele [NCIt concept]
- DDX10 Gene [NCIt concept]
- DDX10 wt Allele [NCIt concept]
- DDX10/NUP98 Fusion Gene [NCIt concept]
- DDX31 Gene [NCIt concept]
- DDX31 wt Allele [NCIt concept]
- DDX39B Gene [NCIt concept]
- DDX39B wt Allele [NCIt concept]
- DDX3X Gene [NCIt concept]
- DDX3X wt Allele [NCIt concept]
- DDX41 Gene [NCIt concept]
- DDX41 Gene Mutation [NCIt concept]
- DDX41 wt Allele [NCIt concept]
- DDX5 Degrader FL118 [NCIt concept]
- DDX5 Gene [NCIt concept]
- DDX5 wt Allele [NCIt concept]
- DEGS1 Gene [NCIt concept]
- DEGS1 wt Allele [NCIt concept]
- DEGS2 Gene [NCIt concept]
- DEGS2 wt Allele [NCIt concept]
- DEK Gene [NCIt concept]
- DEK wt Allele [NCIt concept]
- DEK/NUP214 Fusion Gene [NCIt concept]
- DEK/NUP214 Fusion Protein [NCIt concept]
- DELEC1 Gene [NCIt concept]
- DELEC1 wt Allele [NCIt concept]
- DEP Domain-Containing Protein 1A [NCIt concept]
- DEPDC1 Gene [NCIt concept]
- DEPDC1 wt Allele [NCIt concept]
- DES Gene [NCIt concept]
- DES wt Allele [NCIt concept]
- DEXI Gene [NCIt concept]
- DEXI wt Allele [NCIt concept]
- DGCR8 Gene [NCIt concept]
- DGCR8 Gene Mutation [NCIt concept]
- DGCR8 wt Allele [NCIt concept]
- DGK Alpha/Zeta Inhibitor BMS-986408 [NCIt concept]
- DGK-alpha Inhibitor GS-9911 [NCIt concept]
- DGKA Gene [NCIt concept]
- DGKA wt Allele [NCIt concept]
- DGKZ Gene [NCIt concept]
- DGKZ wt Allele [NCIt concept]
- DGM7 Positive [NCIt concept]
- DHA-Paclitaxel [NCIt concept]
- DHFR Gene [NCIt concept]
- DHFR wt Allele [NCIt concept]
- DHH Gene [NCIt concept]
- DHH wt Allele [NCIt concept]
- DHODH Gene [NCIt concept]
- DHODH Inhibitor JBZ-001 [NCIt concept]
- DHODH wt Allele [NCIt concept]
- DHX9 Gene [NCIt concept]
- DHX9 Inhibitor ATX-559 [NCIt concept]
- DHX9 wt Allele [NCIt concept]
- DI-Leu16-IL2 Immunocytokine [NCIt concept]
- DIABLO Gene [NCIt concept]
- DIABLO wt Allele [NCIt concept]
- DICER1 Gene [NCIt concept]
- DICER1 Gene Mutation [NCIt concept]
- DICER1 wt Allele [NCIt concept]
- DIEP Flap [NCIt concept]
- DIRC3 Gene [NCIt concept]
- DIRC3 wt Allele [NCIt concept]
- DIRC3/HSPBAP1 Fusion Gene [NCIt concept]
- DKC1 Gene [NCIt concept]
- DKC1 Gene Mutation [NCIt concept]
- DKC1 wt Allele [NCIt concept]
- DKK1 Gene [NCIt concept]
- DKK1 wt Allele [NCIt concept]
- DKK2 Gene [NCIt concept]
- DKK2 wt Allele [NCIt concept]
- DKK3 Gene [NCIt concept]
- DKK3 wt Allele [NCIt concept]
- DKK4 Gene [NCIt concept]
- DKK4 wt Allele [NCIt concept]
- DL-Selenomethionine [NCIt concept]
- DLK1 Gene [NCIt concept]
- DLK1 wt Allele [NCIt concept]
- DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine [NCIt concept]
- DLL1 Gene [NCIt concept]
- DLL1 wt Allele [NCIt concept]
- DLL3 Gene [NCIt concept]
- DLL3 Gene Positive [NCIt concept]
- DLL3 Positive [NCIt concept]
- DLL3 wt Allele [NCIt concept]
- DLL3-targeting Agent [NCIt concept]
- DLL4 Gene [NCIt concept]
- DLL4 wt Allele [NCIt concept]
- DLX1 Gene [NCIt concept]
- DLX1 wt Allele [NCIt concept]
- DLX5 Gene [NCIt concept]
- DLX5 wt Allele [NCIt concept]
- DM1-containing Antibody-drug Conjugate [NCIt concept]
- DM4-containing Antibody-drug Conjugate [NCIt concept]
- DMD Gene [NCIt concept]
- DMD wt Allele [NCIt concept]
- DMP1 Gene [NCIt concept]
- DMP1 wt Allele [NCIt concept]
- DMRT1 Gene [NCIt concept]
- DMRT1 wt Allele [NCIt concept]
- DNA [NCIt concept]
- DNA (Cytosine-5)-Methyltransferase 1 [NCIt concept]
- DNA (Cytosine-5)-Methyltransferase 3-Like [NCIt concept]
- DNA (Cytosine-5)-Methyltransferase 3A [NCIt concept]
- DNA (Cytosine-5)-Methyltransferase 3B [NCIt concept]
- DNA Adduct [NCIt concept]
- DNA Adduction [NCIt concept]
- DNA Analysis [NCIt concept]
- DNA Cross-Link Repair 1A Protein [NCIt concept]
- DNA Damage [NCIt concept]
- DNA Damage Response Deficiency [NCIt concept]
- DNA Damage Response Deficiency Negative [NCIt concept]
- DNA Damage Response Gene Mutation [NCIt concept]
- DNA Damage-Binding Protein 2 [NCIt concept]
- DNA Damage-Inducible Transcript 3 Protein [NCIt concept]
- DNA Damage-Inducible Transcript 4 Protein [NCIt concept]
- DNA Demethylation Pathway mRNA Measurement [NCIt concept]
- DNA Double Strand Break [NCIt concept]
- DNA Excision Repair Protein ERCC-1 [NCIt concept]
- DNA Excision Repair Protein ERCC-6 [NCIt concept]
- DNA Fragmentation [NCIt concept]
- DNA Hydroxymethylation [NCIt concept]
- DNA Image Cytometry [NCIt concept]
- DNA Ligase [NCIt concept]
- DNA Ligase 1 [NCIt concept]
- DNA Ligase 3 [NCIt concept]
- DNA Ligase 4 [NCIt concept]
- DNA Methylation [NCIt concept]
- DNA Methylation Analysis [NCIt concept]
- DNA Methyltransferase [NCIt concept]
- DNA Minor Groove Binding Agent SG2000 [NCIt concept]
- DNA Mismatch Repair Protein Mlh1 [NCIt concept]
- DNA Mismatch Repair Protein Mlh3 [NCIt concept]
- DNA Mismatch Repair Protein Msh2 [NCIt concept]
- DNA Mismatch Repair Protein Msh3 [NCIt concept]
- DNA Mismatch Repair Protein Msh6 [NCIt concept]
- DNA Nucleotidylexotransferase [NCIt concept]
- DNA Plasmid Vaccine ITI-1001 [NCIt concept]
- DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151 [NCIt concept]
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457 [NCIt concept]
- DNA Ploidy Analysis [NCIt concept]
- DNA Polymerase [NCIt concept]
- DNA Polymerase Delta Catalytic Subunit [NCIt concept]
- DNA Polymerase Delta Subunit 3 [NCIt concept]
- DNA Polymerase Epsilon Catalytic Subunit A [NCIt concept]
- DNA Polymerase Eta [NCIt concept]
- DNA Polymerase Iota [NCIt concept]
- DNA Polymerase Kappa [NCIt concept]
- DNA Polymerase Processivity Factor [NCIt concept]
- DNA Polymerase Theta [NCIt concept]
- DNA Polymerase Theta Inhibitor [NCIt concept]
- DNA Polymerase Theta Inhibitor ART6043 [NCIt concept]
- DNA Polymerase Theta Inhibitor GSK4524101 [NCIt concept]
- DNA Polymerase Theta Inhibitor MOMA-313 [NCIt concept]
- DNA Polymerase Theta Inhibitor RP-3467 [NCIt concept]
- DNA Repair [NCIt concept]
- DNA Repair Capacity [NCIt concept]
- DNA Repair Endonuclease XPF [NCIt concept]
- DNA Repair Gene [NCIt concept]
- DNA Repair Gene Mutation [NCIt concept]
- DNA Repair Kinetics [NCIt concept]
- DNA Repair Protein [NCIt concept]
- DNA Repair Protein Complementing XP-A Cells [NCIt concept]
- DNA Repair Protein Complementing XP-C Cells [NCIt concept]
- DNA Repair Protein Complementing XP-G Cells [NCIt concept]
- DNA Repair Protein RAD50 [NCIt concept]
- DNA Repair Protein RAD51 Homolog 1 [NCIt concept]
- DNA Repair Protein RAD51 Homolog 2 [NCIt concept]
- DNA Repair Protein RAD51 Homolog 3 [NCIt concept]
- DNA Repair Protein RAD51 Homolog 4 [NCIt concept]
- DNA Repair Protein RAD52 Homolog [NCIt concept]
- DNA Repair Protein REV1 [NCIt concept]
- DNA Repair Protein XRCC1 [NCIt concept]
- DNA Repair Protein XRCC2 [NCIt concept]
- DNA Repair Protein XRCC3 [NCIt concept]
- DNA Repair Protein XRCC4 [NCIt concept]
- DNA Repair and Recombination Protein RAD54-Like [NCIt concept]
- DNA Repair and Recombination Protein RAD54B [NCIt concept]
- DNA Replication Licensing Factor MCM3 [NCIt concept]
- DNA Replication Licensing Factor MCM4 [NCIt concept]
- DNA Replication Licensing Factor MCM5 [NCIt concept]
- DNA Replication Licensing Factor MCM6 [NCIt concept]
- DNA Replication Licensing Factor MCM7 [NCIt concept]
- DNA Replication Timing [NCIt concept]
- DNA Sequencing [NCIt concept]
- DNA Topoisomerase 1 [NCIt concept]
- DNA Topoisomerase 1 Cleavable Complex [NCIt concept]
- DNA Topoisomerase 2-Alpha [NCIt concept]
- DNA Topoisomerase 2-Beta [NCIt concept]
- DNA Topoisomerase 2-Binding Protein 1 [NCIt concept]
- DNA Vector pPRA-PSM Vaccine [NCIt concept]
- DNA dC to dU-Editing Enzyme APOBEC-3G [NCIt concept]
- DNA-(Apurinic or Apyrimidinic Site) Lyase [NCIt concept]
- DNA-3-Methyladenine Glycosylase [NCIt concept]
- DNA-Binding Protein Ikaros [NCIt concept]
- DNA-Binding Protein Inhibitor ID-1 [NCIt concept]
- DNA-Binding Protein Inhibitor ID-2 [NCIt concept]
- DNA-Dependent Protein Kinase Catalytic Subunit [NCIt concept]
- DNA-Dependent Protein Kinase Complex [NCIt concept]
- DNA-Directed RNA Polymerases I, II, and III Subunit RPABC5 [NCIt concept]
- DNA-PK inhibitor AZD7648 [NCIt concept]
- DNA-PK/TOR Kinase Inhibitor CC-115 [NCIt concept]
- DNA-dependent Protein Kinase Inhibitor [NCIt concept]
- DNA-dependent Protein Kinase Inhibitor VX-984 [NCIt concept]
- DNA-directed RNA Polymerase [NCIt concept]
- DNAI7 Gene [NCIt concept]
- DNAI7 wt Allele [NCIt concept]
- DNAJ Protein [NCIt concept]
- DNAJA1 Gene [NCIt concept]
- DNAJA1 wt Allele [NCIt concept]
- DNAJB1 Gene [NCIt concept]
- DNAJB1 wt Allele [NCIt concept]
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine [NCIt concept]
- DNAJB1-PRKACA Fusion Protein Expression [NCIt concept]
- DNAJB1/PRKACA Fusion Gene [NCIt concept]
- DNAJB1/PRKACA Fusion Protein [NCIt concept]
- DND1 Gene [NCIt concept]
- DND1 wt Allele [NCIt concept]
- DNMT1 Gene [NCIt concept]
- DNMT1 Inhibitor NTX-301 [NCIt concept]
- DNMT1 wt Allele [NCIt concept]
- DNMT3 Family [NCIt concept]
- DNMT3A Gene [NCIt concept]
- DNMT3A Gene Mutation [NCIt concept]
- DNMT3A wt Allele [NCIt concept]
- DNMT3B Gene [NCIt concept]
- DNMT3B mRNA Measurement [NCIt concept]
- DNMT3B wt Allele [NCIt concept]
- DNMT3L Gene [NCIt concept]
- DNMT3L wt Allele [NCIt concept]
- DNR-expressing Nasopharyngeal Carcinoma-specific Cytotoxic T-Lymphocytes [NCIt concept]
- DNTT Gene [NCIt concept]
- DNTT Positive [NCIt concept]
- DNTT wt Allele [NCIt concept]
- DOCK8 Deficiency [NCIt concept]
- DOCK8 Gene [NCIt concept]
- DOCK8 Gene Mutation [NCIt concept]
- DOCK8 wt Allele [NCIt concept]
- DOT1L Gene [NCIt concept]
- DOT1L Gene Mutation [NCIt concept]
- DOT1L wt Allele [NCIt concept]
- DPACE Regimen [NCIt concept]
- DPEP3 Gene [NCIt concept]
- DPEP3 wt Allele [NCIt concept]
- DPP4 Gene [NCIt concept]
- DPP4 wt Allele [NCIt concept]
- DPX-E7 HPV Vaccine [NCIt concept]
- DPYD Exon 14 Skipping Mutation [NCIt concept]
- DPYD Gene [NCIt concept]
- DPYD Gene Mutation [NCIt concept]
- DPYD NM_000110.4:c.1236G>A [NCIt concept]
- DPYD NM_000110.4:c.1679T>G [NCIt concept]
- DPYD NM_000110.4:c.1905+1G>A [NCIt concept]
- DPYD NM_000110.4:c.2846A>T [NCIt concept]
- DPYD NM_000110.4:c.557A>G [NCIt concept]
- DPYD NP_000101.2:p.D949V [NCIt concept]
- DPYD NP_000101.2:p.I560S [NCIt concept]
- DPYD NP_000101.2:p.Y186C [NCIt concept]
- DPYD Negative [NCIt concept]
- DPYD Polymorphism Positive [NCIt concept]
- DPYD Protein Variant [NCIt concept]
- DPYD wt Allele [NCIt concept]
- DR1 Gene [NCIt concept]
- DR1 wt Allele [NCIt concept]
- DR5-targeting Agent [NCIt concept]
- DR5-targeting Tetrameric Nanobody Agonist TAS266 [NCIt concept]
- DRD2 1 Allele [NCIt concept]
- DRD2 2 Allele [NCIt concept]
- DRD2 Antagonist/ClpP Agonist ONC206 [NCIt concept]
- DRD2 Gene [NCIt concept]
- DRD2 Gene Mutation [NCIt concept]
- DRD2 NM_000795.3:c.-486_-485insC [NCIt concept]
- DRD2 NM_000795.3:c.957C>T [NCIt concept]
- DRD2 wt Allele [NCIt concept]
- DRD4 Gene [NCIt concept]
- DRD4 wt Allele [NCIt concept]
- DRG1 Gene [NCIt concept]
- DRG1 wt Allele [NCIt concept]
- DROSHA Gene [NCIt concept]
- DROSHA Gene Mutation [NCIt concept]
- DROSHA wt Allele [NCIt concept]
- DS Stage I Multiple Myeloma [NCIt concept]
- DS Stage II Multiple Myeloma [NCIt concept]
- DS Stage III Multiple Myeloma [NCIt concept]
- DSG3 Antibody Positive [NCIt concept]
- DSG3 Gene [NCIt concept]
- DSG3 wt Allele [NCIt concept]
- DSP Gene [NCIt concept]
- DSP wt Allele [NCIt concept]
- DST Gene [NCIt concept]
- DST wt Allele [NCIt concept]
- DT2219 Antibody [NCIt concept]
- DTA-H19 Plasmid [NCIt concept]
- DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 [NCIt concept]
- DTX2 Gene [NCIt concept]
- DTX2 wt Allele [NCIt concept]
- DU-PAN-2 [NCIt concept]
- DUSP10 Gene [NCIt concept]
- DUSP10 wt Allele [NCIt concept]
- DUSP4 Gene [NCIt concept]
- DUSP4 wt Allele [NCIt concept]
- DUSP5 Gene [NCIt concept]
- DUSP5 wt Allele [NCIt concept]
- DUSP6 Gene [NCIt concept]
- DUSP6 wt Allele [NCIt concept]
- DUT Gene [NCIt concept]
- DUT wt Allele [NCIt concept]
- DUX4 Gene [NCIt concept]
- DUX4 wt Allele [NCIt concept]
- DVL1 Gene [NCIt concept]
- DVL1 wt Allele [NCIt concept]
- Dabigatran [NCIt concept]
- Dabogratinib [NCIt concept]
- Dabrafenib [NCIt concept]
- Dabrafenib Mesylate [NCIt concept]
- Dacarbazine [NCIt concept]
- Dacetuzumab [NCIt concept]
- Daclizumab [NCIt concept]
- Dacomitinib [NCIt concept]
- Dactinomycin [NCIt concept]
- Dactolisib [NCIt concept]
- Dalantercept [NCIt concept]
- Dalbavancin [NCIt concept]
- Dalnicastobart [NCIt concept]
- Dalotuzumab [NCIt concept]
- Dalteparin [NCIt concept]
- Dalutrafusp Alfa [NCIt concept]
- Damage-Associated Molecular Pattern Molecule [NCIt concept]
- Danaparoid Sodium [NCIt concept]
- Danazol [NCIt concept]
- Danburstotug [NCIt concept]
- Danicopan [NCIt concept]
- Daniquidone [NCIt concept]
- Danusertib [NCIt concept]
- Danvatirsen [NCIt concept]
- Dapagliflozin [NCIt concept]
- Dapagliflozin Propanediol [NCIt concept]
- Dapansutrile [NCIt concept]
- Dapatifagene Navolactibac [NCIt concept]
- Dapolsertib [NCIt concept]
- Dapper Homolog 2 [NCIt concept]
- Dapsone Gel [NCIt concept]
- Daptomycin [NCIt concept]
- Daratumumab [NCIt concept]
- Daratumumab and Recombinant Human Hyaluronidase [NCIt concept]
- Daraxonrasib [NCIt concept]
- Darbepoetin Alfa [NCIt concept]
- Dargistotug [NCIt concept]
- Darinaparsin [NCIt concept]
- Darizmetinib [NCIt concept]
- Darleukin [NCIt concept]
- Darlifarnib [NCIt concept]
- Daromun [NCIt concept]
- Darovasertib [NCIt concept]
- Darunavir/Ritonavir [NCIt concept]
- Dasabuvir [NCIt concept]
- Dasatinib [NCIt concept]
- Dasatinib Anhydrous [NCIt concept]
- Dasminapant [NCIt concept]
- Data Capture [NCIt concept]
- Data Collection [NCIt concept]
- Data Collection Platform Smartphone Application [NCIt concept]
- Datopotamab Deruxtecan [NCIt concept]
- Daunorubicin [NCIt concept]
- Daunorubicin Hydrochloride [NCIt concept]
- Davamotecan Pegadexamer [NCIt concept]
- Davoceticept [NCIt concept]
- Davutamig [NCIt concept]
- Dazostinag Disodium [NCIt concept]
- De Novo Myelodysplastic Syndrome [NCIt concept]
- Dead End Protein Homolog 1 [NCIt concept]
- Death Domain-Associated Protein 6 [NCIt concept]
- Decipher Bladder Cancer Assay [NCIt concept]
- Decipher Genomic Score [NCIt concept]
- Decipher Prostate Cancer Test [NCIt concept]
- Decision Aid [NCIt concept]
- Decitabine [NCIt concept]
- Decitabine and Cedazuridine [NCIt concept]
- Decorin [NCIt concept]
- Decrease in Blasts [NCIt concept]
- Decreased CYBA Expression [NCIt concept]
- Decreased CYBB Expression [NCIt concept]
- Decreased Levels of HLA Class I Panel Reactive Antibody [NCIt concept]
- Decreased NCF1 Expression [NCIt concept]
- Decreased NCF2 Expression [NCIt concept]
- Decreased NCF4 Expression [NCIt concept]
- Decreased PARP Enzyme Activity [NCIt concept]
- Dedicator of Cytokinesis Protein 8 [NCIt concept]
- Dedifferentiated Liposarcoma [NCIt concept]
- Deep Ensemble for the Recognition of Malignancy Analysis [NCIt concept]
- Deep Inspiration Breath Hold [NCIt concept]
- Deep Vein Thrombosis [NCIt concept]
- Defactinib [NCIt concept]
- Defactinib Hydrochloride [NCIt concept]
- Deferasirox [NCIt concept]
- Deferoxamine [NCIt concept]
- Deferoxamine Mesylate [NCIt concept]
- Defibrotide Sodium [NCIt concept]
- Defosbarasertib [NCIt concept]
- Degarelix [NCIt concept]
- Degarelix Acetate [NCIt concept]
- Deglycosylated Ricin A Chain-Conjugated Anti-CD19/Anti-CD22 Immunotoxins [NCIt concept]
- Dehydroepiandrosterone 3-Glucuronide [NCIt concept]
- Dehydroepiandrosterone Measurement [NCIt concept]
- Dehydroepiandrosterone Sulfate Greater than 20 Micrograms/Deciliter [NCIt concept]
- Delamanid [NCIt concept]
- Delanzomib [NCIt concept]
- Deleted In Azoospermia-Like [NCIt concept]
- Deleted in Esophageal Cancer 1 [NCIt concept]
- Deleted in Esophageal Cancer 1 Long Non-Coding RNA [NCIt concept]
- Deleterious ABRAXAS1 Gene Mutation [NCIt concept]
- Deleterious ALK Gene Mutation [NCIt concept]
- Deleterious APC Gene Mutation [NCIt concept]
- Deleterious ARID1A Gene Mutation [NCIt concept]
- Deleterious ATM Gene Mutation [NCIt concept]
- Deleterious ATR Gene Mutation [NCIt concept]
- Deleterious ATRX Gene Mutation [NCIt concept]
- Deleterious BAP1 Gene Mutation [NCIt concept]
- Deleterious BARD1 Gene Mutation [NCIt concept]
- Deleterious BLM Gene Mutation [NCIt concept]
- Deleterious BMPR1A Gene Mutation [NCIt concept]
- Deleterious BRAF Gene Mutation [NCIt concept]
- Deleterious BRCA Gene Mutation [NCIt concept]
- Deleterious BRCA1 Gene Mutation [NCIt concept]
- Deleterious BRCA2 Gene Mutation [NCIt concept]
- Deleterious BRIP1 Gene Mutation [NCIt concept]
- Deleterious Biallelic MUTYH Gene Mutation [NCIt concept]
- Deleterious CDH1 Gene Mutation [NCIt concept]
- Deleterious CDK12 Gene Mutation [NCIt concept]
- Deleterious CDKN2A Gene Mutation [NCIt concept]
- Deleterious CHEK1 Gene Mutation [NCIt concept]
- Deleterious CHEK2 Gene Mutation [NCIt concept]
- Deleterious CYSLTR2 Gene Mutation [NCIt concept]
- Deleterious DICER1 Gene Mutation [NCIt concept]
- Deleterious DNA Damage Response Gene Mutation [NCIt concept]
- Deleterious EGFR Gene Mutation [NCIt concept]
- Deleterious EPCAM Gene Mutation [NCIt concept]
- Deleterious ERBB2 Gene Mutation [NCIt concept]
- Deleterious ERCC3 Gene Mutation [NCIt concept]
- Deleterious FANCA Gene Mutation [NCIt concept]
- Deleterious FANCC Gene Mutation [NCIt concept]
- Deleterious FANCD2 Gene Mutation [NCIt concept]
- Deleterious FANCE Gene Mutation [NCIt concept]
- Deleterious FANCF Gene Mutation [NCIt concept]
- Deleterious FANCL Gene Mutation [NCIt concept]
- Deleterious FANCM Gene Mutation [NCIt concept]
- Deleterious FBXW7 Gene Mutation [NCIt concept]
- Deleterious GATA2 Gene Mutation [NCIt concept]
- Deleterious GEN1 Gene Mutation [NCIt concept]
- Deleterious GNA11 Gene Mutation [NCIt concept]
- Deleterious GNAQ Gene Mutation [NCIt concept]
- Deleterious GREM1 Gene Mutation [NCIt concept]
- Deleterious Germline Mutation [NCIt concept]
- Deleterious HDAC2 Gene Mutation [NCIt concept]
- Deleterious Homologous Recombination Pathway Gene Mutation [NCIt concept]
- Deleterious IDH1 Gene Mutation [NCIt concept]
- Deleterious IDH2 Gene Mutation [NCIt concept]
- Deleterious IKZF1 Gene Mutation [NCIt concept]
- Deleterious Inactivating NF1 Gene Mutation [NCIt concept]
- Deleterious MET Gene Mutation [NCIt concept]
- Deleterious MLH1 Gene Mutation [NCIt concept]
- Deleterious MRE11 Gene Mutation [NCIt concept]
- Deleterious MSH2 Gene Mutation [NCIt concept]
- Deleterious MSH6 Gene Mutation [NCIt concept]
- Deleterious MUTYH Gene Mutation [NCIt concept]
- Deleterious Mutation [NCIt concept]
- Deleterious NBN Gene Mutation [NCIt concept]
- Deleterious NF1 Gene Mutation [NCIt concept]
- Deleterious NF2 Gene Mutation [NCIt concept]
- Deleterious NTRK Family Gene Mutation [NCIt concept]
- Deleterious PALB2 Gene Mutation [NCIt concept]
- Deleterious PIK3R1 Gene Mutation [NCIt concept]
- Deleterious PLCB4 Gene Mutation [NCIt concept]
- Deleterious PMS2 Gene Mutation [NCIt concept]
- Deleterious POLD1 Gene Mutation [NCIt concept]
- Deleterious POLE Gene Mutation [NCIt concept]
- Deleterious PPP2R2A Gene Mutation [NCIt concept]
- Deleterious PTEN Gene Mutation [NCIt concept]
- Deleterious RAD50 Gene Mutation [NCIt concept]
- Deleterious RAD51 Gene Mutation [NCIt concept]
- Deleterious RAD51B Gene Mutation [NCIt concept]
- Deleterious RAD51C Gene Mutation [NCIt concept]
- Deleterious RAD51D Gene Mutation [NCIt concept]
- Deleterious RAD54L Gene Mutation [NCIt concept]
- Deleterious RECQL Gene Mutation [NCIt concept]
- Deleterious RET Gene Mutation [NCIt concept]
- Deleterious ROS1 Gene Mutation [NCIt concept]
- Deleterious RPA1 Gene Mutation [NCIt concept]
- Deleterious SEM1 Gene Mutation [NCIt concept]
- Deleterious SMAD4 Gene Mutation [NCIt concept]
- Deleterious SMARCA4 Gene Mutation [NCIt concept]
- Deleterious SPOP Gene Mutation [NCIt concept]
- Deleterious STK11 Gene Mutation [NCIt concept]
- Deleterious TP53 Gene Mutation [NCIt concept]
- Deleterious TSC1 Gene Mutation [NCIt concept]
- Deleterious TSC2 Gene Mutation [NCIt concept]
- Deleterious WRN Gene Mutation [NCIt concept]
- Deleterious XRCC2 Gene Mutation [NCIt concept]
- Deletion Mutation [NCIt concept]
- Deletion of Chromosome 22 Associated Meningioma [NCIt concept]
- Deletion of Chromosome 3p Associated Meningioma [NCIt concept]
- Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma [NCIt concept]
- Delirium [NCIt concept]
- Delolimogene Mupadenorepvec [NCIt concept]
- Delphi Process [NCIt concept]
- Delta Catenin [NCIt concept]
- Delta-Like Protein 1 [NCIt concept]
- Delta-Like Protein 3 [NCIt concept]
- Delta-Like Protein 4 [NCIt concept]
- Delta-MRD400 [NCIt concept]
- Delta-Tocopherol [NCIt concept]
- Delta-Tocotrienol [NCIt concept]
- Delta13C [NCIt concept]
- Demcizumab [NCIt concept]
- Demeclocycline Hydrochloride [NCIt concept]
- Dencatistat [NCIt concept]
- Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466 [NCIt concept]
- Dendritic Cell [NCIt concept]
- Dendritic Cell Therapy [NCIt concept]
- Dendritic Cell Tumor Peptide Vaccine [NCIt concept]
- Dendritic Cell-MART-1 Peptide Vaccine [NCIt concept]
- Denenicokin [NCIt concept]
- Denfivontinib Hydrochloride [NCIt concept]
- Denibulin Hydrochloride [NCIt concept]
- Denifanstat [NCIt concept]
- Denileukin Diftitox [NCIt concept]
- Denintuzumab Mafodotin [NCIt concept]
- Denosumab [NCIt concept]
- Dental Agenesis [NCIt concept]
- Dental Procedure [NCIt concept]
- Dentin Matrix Acidic Phosphoprotein 1 [NCIt concept]
- Dentinogenic Ghost Cell Tumor [NCIt concept]
- Deoxyaminopteroic Acid [NCIt concept]
- Deoxycholic Acid [NCIt concept]
- Deoxycytidine Kinase [NCIt concept]
- Deoxycytidine Kinase Inhibitor TRE-515 [NCIt concept]
- Deoxycytidylate Deaminase [NCIt concept]
- Deoxygenated Hemoglobin [NCIt concept]
- Deoxypyridinoline [NCIt concept]
- Deoxyribonucleotide Triphosphate [NCIt concept]
- Deoxysphingolipid [NCIt concept]
- Deoxyuridine [NCIt concept]
- Deoxyuridine 5'-Triphosphate Nucleotidohydrolase, Mitochondrial [NCIt concept]
- Deoxyuridine Triphosphate [NCIt concept]
- Depatuxizumab [NCIt concept]
- Depatuxizumab Mafodotin [NCIt concept]
- Depression [NCIt concept]
- Derazantinib [NCIt concept]
- Dermatitis [NCIt concept]
- Dermatofibrosarcoma Protuberans [NCIt concept]
- Dermatologic Complication [NCIt concept]
- Dermatologic Complications Management [NCIt concept]
- Dermatoscope [NCIt concept]
- Dermatosis [NCIt concept]
- Dermoid Cyst [NCIt concept]
- Dermoscopy [NCIt concept]
- Dersimelagon [NCIt concept]
- Des-Gamma Carboxyprothrombin [NCIt concept]
- Desert Hedgehog Protein [NCIt concept]
- Desipramine Hydrochloride [NCIt concept]
- Deslorelin [NCIt concept]
- Desmin [NCIt concept]
- Desmoglein-3 [NCIt concept]
- Desmoid Fibromatosis [NCIt concept]
- Desmoplakin [NCIt concept]
- Desmoplastic [NCIt concept]
- Desmoplastic Melanoma [NCIt concept]
- Desmoplastic Mesothelioma [NCIt concept]
- Desmoplastic Small Round Cell Tumor [NCIt concept]
- Desmosine [NCIt concept]
- Desoxycorticosterone [NCIt concept]
- Desulfovibrio [NCIt concept]
- Deupirfenidone [NCIt concept]
- Deutenzalutamide [NCIt concept]
- Deuterated Glucose [NCIt concept]
- Deuterated Phenanthrene [NCIt concept]
- Deuterium Oxide [NCIt concept]
- Developmental Neuropsychological Assessment [NCIt concept]
- Developmentally-Regulated GTP-Binding Protein 1 [NCIt concept]
- Device [NCIt concept]
- Device Feasibility Study [NCIt concept]
- Device Microscopic Inspection Evaluation Method [NCIt concept]
- Devimistat [NCIt concept]
- Dexamethasone [NCIt concept]
- Dexamethasone Acetate, Unspecified [NCIt concept]
- Dexamethasone Sodium Phosphate [NCIt concept]
- Dexamethasone-Induced Protein [NCIt concept]
- Dexanabinol [NCIt concept]
- Dexmedetomidine Hydrochloride [NCIt concept]
- Dexrazoxane [NCIt concept]
- Dexrazoxane Hydrochloride [NCIt concept]
- Dextran 1 Subfraction-based Cryoprotective Agent [NCIt concept]
- Dextromethorphan Hydrobromide [NCIt concept]
- Dextromethorphan/Bupropion Tablet AXS-05 [NCIt concept]
- Dezamizumab [NCIt concept]
- Dezapelisib [NCIt concept]
- Diabetes Mellitus [NCIt concept]
- Diablo IAP-Binding Mitochondrial Protein [NCIt concept]
- Diacylglycerol Kinase Alpha [NCIt concept]
- Diacylglycerol Kinase Zeta [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor ASP1570 [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor BGB-30813 [NCIt concept]
- Diagnostic Bronchoscopy [NCIt concept]
- Diagnostic Colonoscopy [NCIt concept]
- Diagnostic Cystoscopy [NCIt concept]
- Diagnostic DNA Methylation Signature [NCIt concept]
- Diagnostic Endoscopic Procedure [NCIt concept]
- Diagnostic Imaging Testing [NCIt concept]
- Diagnostic Laboratory Biomarker Analysis [NCIt concept]
- Diagnostic Laparoscopic Surgery [NCIt concept]
- Diagnostic Laparoscopy [NCIt concept]
- Diagnostic Lymphadenectomy [NCIt concept]
- Diagnostic Mammography [NCIt concept]
- Diagnostic Microscopy [NCIt concept]
- Diagnostic Procedure [NCIt concept]
- Diagnostic Surgical Procedure [NCIt concept]
- Diameter [NCIt concept]
- Diamine Acetyltransferase 1 [NCIt concept]
- Diamond-Blackfan Anemia [NCIt concept]
- Dianhydrogalactitol [NCIt concept]
- Dianicline [NCIt concept]
- Diaphragm Fluoroscopy [NCIt concept]
- Diarrhea [NCIt concept]
- Diary [NCIt concept]
- Diazepam [NCIt concept]
- Diazepinomicin [NCIt concept]
- Dibotatug [NCIt concept]
- Dicarboxylic Acid [NCIt concept]
- Dickkopf-Related Protein 1 [NCIt concept]
- Dickkopf-Related Protein 2 [NCIt concept]
- Dickkopf-Related Protein 3 [NCIt concept]
- Dickkopf-Related Protein 4 [NCIt concept]
- Diclofenac Epolamine [NCIt concept]
- Diclofenac Sodium Gel [NCIt concept]
- Dietary Fiber [NCIt concept]
- Dietary Intervention [NCIt concept]
- Dietary Supplement [NCIt concept]
- Diethyl Phthalate [NCIt concept]
- Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Differentiating Neuroblastoma [NCIt concept]
- Diffuse [NCIt concept]
- Diffuse Hyperplastic Perilobar Nephroblastomatosis [NCIt concept]
- Diffuse Large B-Cell Lymphoma [NCIt concept]
- Diffuse Large B-Cell Lymphoma Activated B-Cell Type [NCIt concept]
- Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease [NCIt concept]
- Diffuse Large B-Cell Lymphoma Unclassifiable [NCIt concept]
- Diffuse Large B-Cell Lymphoma in Complete Remission [NCIt concept]
- Diffuse Large B-Cell Lymphoma in Partial Remission [NCIt concept]
- Diffuse Large B-Cell Lymphoma with Associated Monoclonal Small B-Cell Population in Bone Marrow [NCIt concept]
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Diffuse Optical Imaging [NCIt concept]
- Diffuse Optical Tomography [NCIt concept]
- Diffusing Alpha-emitter Radiation Therapy [NCIt concept]
- Diffusion Anisotropy [NCIt concept]
- Diffusion Basis Spectrum Imaging [NCIt concept]
- Diffusion Kurtosis Imaging [NCIt concept]
- Diffusion MRI [NCIt concept]
- Diffusion Spectrum Imaging [NCIt concept]
- Diffusion Tensor Imaging [NCIt concept]
- Diffusion Weighted Imaging [NCIt concept]
- Diflunisal [NCIt concept]
- Digestible Starch [NCIt concept]
- Digestive System Adenocarcinoma [NCIt concept]
- Digestive System Carcinoma [NCIt concept]
- Digestive System Carcinoma In Situ [NCIt concept]
- Digestive System Complication [NCIt concept]
- Digestive System Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Digestive System Neoplasm [NCIt concept]
- Digestive System Neuroendocrine Tumor [NCIt concept]
- Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Digital Cognitive Behavioral Stress Management [NCIt concept]
- Digital Health Education and Wellness Intervention [NCIt concept]
- Digital Image Analysis [NCIt concept]
- Digital Mammography [NCIt concept]
- Digital Papillary Adenocarcinoma [NCIt concept]
- Digital Photography [NCIt concept]
- Digital Rectal Examination [NCIt concept]
- Digital Scale [NCIt concept]
- Digital Tomosynthesis Mammography [NCIt concept]
- Digoxin [NCIt concept]
- Dihydro-5-Azacytidine [NCIt concept]
- Dihydrofolate Reductase [NCIt concept]
- Dihydromethysticin [NCIt concept]
- Dihydroorotate Dehydrogenase (Quinone), Mitochondrial [NCIt concept]
- Dihydroorotate Dehydrogenase Inhibitor AG-636 [NCIt concept]
- Dihydropyrimidine Dehydrogenase Deficiency [NCIt concept]
- Dihydropyrimidine Dehydrogenase [NADP(+)] [NCIt concept]
- Dihydrotestosterone [NCIt concept]
- Diindolylmethane [NCIt concept]
- Dilanubicel [NCIt concept]
- Dilpacimab [NCIt concept]
- Dimerizing Agent Regulated Immunoreceptor Complex-expressing CD33-specific Autologous CAR T Cells SC-DARIC33 [NCIt concept]
- Dimesna [NCIt concept]
- Dimethicone/Polymer Barrier Cream [NCIt concept]
- Dimethyl Ellagic Acid [NCIt concept]
- Dimethyl Ellagic Acid Glucuronide [NCIt concept]
- Dimethyl Fumarate [NCIt concept]
- Dimethyl Sulfoxide [NCIt concept]
- Dinaciclib [NCIt concept]
- Dinitrophenyl [NCIt concept]
- Dinutuximab [NCIt concept]
- Diode Laser Fiber Type Selective Stimulator [NCIt concept]
- Dipeptidase 3 [NCIt concept]
- Dipeptidyl Peptidase 4 [NCIt concept]
- Diphenhydramine [NCIt concept]
- Diphenhydramine Hydrochloride [NCIt concept]
- Diphenhydramine/Lidocaine/Antacid Mouthwash [NCIt concept]
- Diphenoxylate Hydrochloride/Atropine Sulfate [NCIt concept]
- Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed [NCIt concept]
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed [NCIt concept]
- Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine [NCIt concept]
- Direct Electrocortical Stimulation [NCIt concept]
- Direct Oral Anticoagulant [NCIt concept]
- Disabled Homolog 2-Interacting Protein [NCIt concept]
- Disaccharide Tripeptide Glycerol Dipalmitoyl [NCIt concept]
- Discrete Choice Study [NCIt concept]
- Discussion [NCIt concept]
- Disease Grade Qualifier [NCIt concept]
- Disease Morphology Qualifier [NCIt concept]
- Disease Screening [NCIt concept]
- Disease Stage Qualifier [NCIt concept]
- Disease or Disorder [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 10 [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 11 [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 12 [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 17 [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 19 [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 8 [NCIt concept]
- Disintegrin and Metalloproteinase Domain-Containing Protein 9 [NCIt concept]
- Disitamab Vedotin [NCIt concept]
- Disrupted In Renal Carcinoma 3 [NCIt concept]
- Disseminated Peritoneal Leiomyomatosis [NCIt concept]
- Disseminated Tumor Cell [NCIt concept]
- Disseminated Tumor Cells Positive [NCIt concept]
- Distal Bile Duct Carcinoma [NCIt concept]
- Distal Cholangiocarcinoma [NCIt concept]
- Distal Esophagus Adenocarcinoma [NCIt concept]
- Distal Esophagus Squamous Cell Carcinoma [NCIt concept]
- Distal Urethral Carcinoma [NCIt concept]
- Distress over Spiritual or Religious Concerns Question [NCIt concept]
- Disufenton Sodium [NCIt concept]
- Disulfiram [NCIt concept]
- Divarasib [NCIt concept]
- Diverticulitis [NCIt concept]
- Dixon MRI [NCIt concept]
- DnaJ Homolog Subfamily A Member 1 [NCIt concept]
- DnaJ Homolog Subfamily B Member 1 [NCIt concept]
- Docetaxel [NCIt concept]
- Docetaxel Emulsion ANX-514 [NCIt concept]
- Docetaxel-loaded Nanopharmaceutical CRLX301 [NCIt concept]
- Docetaxel/Ritonavir [NCIt concept]
- Dociparstat sodium [NCIt concept]
- Docosahexaenoic Acid [NCIt concept]
- Dodecyl Maltoside [NCIt concept]
- Dolasetron Mesylate [NCIt concept]
- Dolastatin 10 [NCIt concept]
- Dolcanatide [NCIt concept]
- Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1 [NCIt concept]
- Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit DAD1 [NCIt concept]
- Dolutegravir [NCIt concept]
- Domatinostat [NCIt concept]
- Domperidone [NCIt concept]
- Domvanalimab [NCIt concept]
- Donepezil [NCIt concept]
- Donepezil Hydrochloride [NCIt concept]
- Donepezil Hydrochloride/Memantine Hydrochloride Extended Release [NCIt concept]
- Donor Derived HIV-Specific T-cells with Non-escaped Epitope Targets [NCIt concept]
- Donor Lymphocyte Infusion [NCIt concept]
- Donor Lymphocytes [NCIt concept]
- Donor Regulatory T-lymphocytes [NCIt concept]
- Donor-derived Cytokine-induced Memory-like Natural Killer Cells [NCIt concept]
- Donor-derived Haploidentical IL-21-Expanded Natural Killer Cells [NCIt concept]
- Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes [NCIt concept]
- Donor-specific Antibody [NCIt concept]
- Dopamine Receptor [NCIt concept]
- Doppler Ultrasound [NCIt concept]
- Doravirine [NCIt concept]
- Dornase Alfa Inhalation Solution [NCIt concept]
- Dorsal Root Ganglion Stimulation [NCIt concept]
- Dose-escalated Radiation Therapy [NCIt concept]
- Dostarlimab [NCIt concept]
- Double Homeobox Protein 4 [NCIt concept]
- Double-Negative Prostate Carcinoma [NCIt concept]
- Double-Strand Break Repair Protein MRE11 [NCIt concept]
- Double-Strand-Break Repair Protein Rad21 Homolog [NCIt concept]
- Double-Unit Umbilical Cord Blood Transplantation [NCIt concept]
- Double-Walled Airbag Breast Immobilization Device [NCIt concept]
- Doublesex- and Mab-3-Related Transcription Factor 1 [NCIt concept]
- Douglas Bag Method [NCIt concept]
- Dovitinib [NCIt concept]
- Dovitinib Lactate [NCIt concept]
- Doxepin Hydrochloride [NCIt concept]
- Doxercalciferol [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370 [NCIt concept]
- Doxorubicin-Eluting Beads [NCIt concept]
- Doxorubicin-loaded EGFR-targeting Nanocells [NCIt concept]
- Doxycycline [NCIt concept]
- Doxycycline Hyclate [NCIt concept]
- Doxycycline Hyclate Matrix Formulation [NCIt concept]
- Dresden Prostate Carcinoma Protein 2 [NCIt concept]
- Dronabinol [NCIt concept]
- Dronedarone Hydrochloride [NCIt concept]
- Droplet-BC Test [NCIt concept]
- Drozitumab [NCIt concept]
- Drug Delivery Microdevice [NCIt concept]
- Drug Interrupted [NCIt concept]
- Drug Modulation Therapy [NCIt concept]
- Drug Skin Rash [NCIt concept]
- Drug Toxicity [NCIt concept]
- Drug Withdrawn [NCIt concept]
- Drug- and Toxin-Induced Pulmonary Arterial Hypertension [NCIt concept]
- Drug-drug Conjugate NUV-1511 [NCIt concept]
- Dual IGF-1R/InsR Inhibitor BMS-754807 [NCIt concept]
- Dual IRAK1/4 Inhibitor R906289 Monosodium [NCIt concept]
- Dual Specificity Mitogen-Activated Protein Kinase Kinase 1 [NCIt concept]
- Dual Specificity Mitogen-Activated Protein Kinase Kinase 2 [NCIt concept]
- Dual Specificity Mitogen-Activated Protein Kinase Kinase 4 [NCIt concept]
- Dual Specificity Protein Kinase CLK1 [NCIt concept]
- Dual Specificity Protein Kinase CLK2 [NCIt concept]
- Dual Specificity Protein Kinase CLK3 [NCIt concept]
- Dual Specificity Protein Kinase CLK4 [NCIt concept]
- Dual Specificity Protein Phosphatase 10 [NCIt concept]
- Dual Specificity Protein Phosphatase 4 [NCIt concept]
- Dual Specificity Protein Phosphatase 5 [NCIt concept]
- Dual Specificity Protein Phosphatase 6 [NCIt concept]
- Dual X-ray Absorptiometry [NCIt concept]
- Dual-Energy Computed Tomography [NCIt concept]
- Dual-Energy Contrast-Enhanced Digital Spectral Mammography [NCIt concept]
- Dual-activating Polyvalent STING Agonist ONM-501 [NCIt concept]
- Dubermatinib [NCIt concept]
- Ductal Epithelial Cell [NCIt concept]
- Duffy Null Polymorphism [NCIt concept]
- Dulanermin [NCIt concept]
- Dulbecco's Phosphate-Buffered Saline [NCIt concept]
- Duligotuzumab [NCIt concept]
- Duloxetine Hydrochloride [NCIt concept]
- Duodenal Carcinoma [NCIt concept]
- Duodenal Neuroendocrine Tumor G2 [NCIt concept]
- Duodenal-Type Follicular Lymphoma [NCIt concept]
- Duodenectomy [NCIt concept]
- Dupilumab [NCIt concept]
- Duplex Ultrasound [NCIt concept]
- Dural Polyethylene Glycol-based Surgical Sealant [NCIt concept]
- Durvalumab [NCIt concept]
- Dusigitumab [NCIt concept]
- Dusquetide [NCIt concept]
- Dutasteride [NCIt concept]
- Duvelisib [NCIt concept]
- Duvortuxizumab [NCIt concept]
- Dye [NCIt concept]
- Dynactin Subunit 1 [NCIt concept]
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging [NCIt concept]
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography [NCIt concept]
- Dynamic Contrast-Enhanced Ultrasound Imaging [NCIt concept]
- Dynamic Contrast-enhanced MR Perfusion [NCIt concept]
- Dynamic Enhanced CT [NCIt concept]
- Dynamic Scan [NCIt concept]
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging [NCIt concept]
- Dynamic Susceptibility Contrast-Perfusion-Weighted Imaging [NCIt concept]
- Dynamometry [NCIt concept]
- Dynein Axonemal Intermediate Chain 7 [NCIt concept]
- Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum [NCIt concept]
- Dysgeusia [NCIt concept]
- Dyskeratosis Congenita [NCIt concept]
- Dysphagia [NCIt concept]
- Dyspnea [NCIt concept]
- Dyspnea Management [NCIt concept]
- Dystonin [NCIt concept]
- Dystrophin [NCIt concept]
- E-101 Solution [NCIt concept]
- E-Selectin [NCIt concept]
- E. coli CD-expressing Genetically Modified Neural Stem Cells [NCIt concept]
- E. coli-targeting Genetically Modified Bacteriophage SNIPR001 [NCIt concept]
- E1 Ubiquitin-Activating Enzyme [NCIt concept]
- E1A Lipid Complex [NCIt concept]
- E1A-Binding Protein P400 [NCIt concept]
- E1M(184V) Peptide Vaccine [NCIt concept]
- E2F Transcription Factor Family [NCIt concept]
- E2F1 Gene [NCIt concept]
- E2F1 wt Allele [NCIt concept]
- E2F3 Gene [NCIt concept]
- E2F3 wt Allele [NCIt concept]
- E2F6 Gene [NCIt concept]
- E2F6 wt Allele [NCIt concept]
- E3 SUMO-Protein Ligase PIAS1 [NCIt concept]
- E3 SUMO-Protein Ligase RanBP2 [NCIt concept]
- E3 Ubiquitin-Protein Ligase AMFR [NCIt concept]
- E3 Ubiquitin-Protein Ligase CBL [NCIt concept]
- E3 Ubiquitin-Protein Ligase CBL-B [NCIt concept]
- E3 Ubiquitin-Protein Ligase CBL-C [NCIt concept]
- E3 Ubiquitin-Protein Ligase CCNB1IP1 [NCIt concept]
- E3 Ubiquitin-Protein Ligase CHFR [NCIt concept]
- E3 Ubiquitin-Protein Ligase FANCL [NCIt concept]
- E3 Ubiquitin-Protein Ligase MARCH9 [NCIt concept]
- E3 Ubiquitin-Protein Ligase MDM2 [NCIt concept]
- E3 Ubiquitin-Protein Ligase MIB1 [NCIt concept]
- E3 Ubiquitin-Protein Ligase Makorin-1 [NCIt concept]
- E3 Ubiquitin-Protein Ligase RAD18 [NCIt concept]
- E3 Ubiquitin-Protein Ligase RNF130 [NCIt concept]
- E3 Ubiquitin-Protein Ligase RNF213 [NCIt concept]
- E3 Ubiquitin-Protein Ligase RNF216 [NCIt concept]
- E3 Ubiquitin-Protein Ligase RNF43 [NCIt concept]
- E3 Ubiquitin-Protein Ligase TRAF7 [NCIt concept]
- E3 Ubiquitin-Protein Ligase TRIM21 [NCIt concept]
- E3 Ubiquitin-Protein Ligase TRIM33 [NCIt concept]
- E3 Ubiquitin-Protein Ligase TRIM63 [NCIt concept]
- E3 Ubiquitin-Protein Ligase UBR5 [NCIt concept]
- E3 Ubiquitin-Protein Ligase XIAP [NCIt concept]
- E3 Ubiquitin-Protein Ligase ZNRF3 [NCIt concept]
- EBF1 Gene [NCIt concept]
- EBF1 wt Allele [NCIt concept]
- EBF1/PDGFRB Fusion Gene [NCIt concept]
- EBF1/PDGFRB Fusion Protein [NCIt concept]
- EBI3 Gene [NCIt concept]
- EBI3 wt Allele [NCIt concept]
- EBNA-1 inhibitor VK-2019 [NCIt concept]
- EBP Gene [NCIt concept]
- EBP Inhibitor DSP-0390 [NCIt concept]
- EBP wt Allele [NCIt concept]
- EBV BARF1 Gene [NCIt concept]
- EBV Infection [NCIt concept]
- EBV Secreted Protein BARF1 [NCIt concept]
- EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- EBV-Positive Mucocutaneous Ulcer [NCIt concept]
- EBV-Positive Neoplastic Cells Present [NCIt concept]
- EBV-Related Gastric Carcinoma [NCIt concept]
- EBV-Related Leiomyosarcoma [NCIt concept]
- EBV-Related Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- EBV-Related T/NK-Cell Lymphoproliferative Disorder [NCIt concept]
- ECOG Performance Status 0 [NCIt concept]
- ECOG Performance Status 1 [NCIt concept]
- ECOG Performance Status 2 [NCIt concept]
- ECT-001 Expanded Cord Blood [NCIt concept]
- ECT2 Gene [NCIt concept]
- ECT2 wt Allele [NCIt concept]
- ECT2L Gene [NCIt concept]
- ECT2L wt Allele [NCIt concept]
- EDB-FN-targeting Gadolinium-based Contrast Agent MT218 [NCIt concept]
- EDN1 Gene [NCIt concept]
- EDN1 wt Allele [NCIt concept]
- EDNRA Gene [NCIt concept]
- EDNRA wt Allele [NCIt concept]
- EDNRB Gene [NCIt concept]
- EDNRB Positive [NCIt concept]
- EDNRB wt Allele [NCIt concept]
- EED Gene [NCIt concept]
- EED Inhibitor MAK683 [NCIt concept]
- EED wt Allele [NCIt concept]
- EEF2 Gene [NCIt concept]
- EEF2 wt Allele [NCIt concept]
- EEG Monitoring via Cap [NCIt concept]
- EF5 [NCIt concept]
- EFEMP1 Gene [NCIt concept]
- EFEMP1 wt Allele [NCIt concept]
- EFNB2 Gene [NCIt concept]
- EFNB2 wt Allele [NCIt concept]
- EGF Antibody [NCIt concept]
- EGF Gene [NCIt concept]
- EGF wt Allele [NCIt concept]
- EGF-Containing Fibulin-Like Extracellular Matrix Protein 1 [NCIt concept]
- EGFL7 Gene [NCIt concept]
- EGFL7 wt Allele [NCIt concept]
- EGFR Antibody [NCIt concept]
- EGFR Antisense DNA [NCIt concept]
- EGFR Driver Mutation Negative [NCIt concept]
- EGFR Exon 18 Mutation [NCIt concept]
- EGFR Exon 19 Deletion Mutation [NCIt concept]
- EGFR Exon 19 Deletion Mutation Negative [NCIt concept]
- EGFR Exon 19 Insertion Mutation [NCIt concept]
- EGFR Exon 19 Mutation [NCIt concept]
- EGFR Exon 20 Deletion Mutation [NCIt concept]
- EGFR Exon 20 Inhibitor [NCIt concept]
- EGFR Exon 20 Insertion Mutation [NCIt concept]
- EGFR Exon 20 Mutation [NCIt concept]
- EGFR Exon 20 Tyrosine Kinase Inhibitor Resistant Mutation [NCIt concept]
- EGFR Exon 21 Mutation [NCIt concept]
- EGFR Gene [NCIt concept]
- EGFR Gene Alteration Negative [NCIt concept]
- EGFR Gene Alteration Positive [NCIt concept]
- EGFR Gene Amplification [NCIt concept]
- EGFR Gene Amplification Negative [NCIt concept]
- EGFR Gene Mutation [NCIt concept]
- EGFR Gene Mutation Negative [NCIt concept]
- EGFR Gene Rearrangement [NCIt concept]
- EGFR Inhibitor ERAS-801 [NCIt concept]
- EGFR Inhibitor NRC-2694 Hydrochloride [NCIt concept]
- EGFR L858R Negative [NCIt concept]
- EGFR Mutant-selective Inhibitor BBT-207 [NCIt concept]
- EGFR Mutant-selective Inhibitor BLU-701 [NCIt concept]
- EGFR Mutant-selective Inhibitor FWD1509 MsOH [NCIt concept]
- EGFR Mutant-selective Inhibitor WZ4002 [NCIt concept]
- EGFR Mutant-specific Inhibitor CK-101 [NCIt concept]
- EGFR Mutant-specific Inhibitor DZD6008 [NCIt concept]
- EGFR Mutant-specific Inhibitor ZN-e4 [NCIt concept]
- EGFR NM_005228.2:c.2499G>T [NCIt concept]
- EGFR NM_005228.3:c.1474A>C [NCIt concept]
- EGFR NM_005228.3:c.1476C>A [NCIt concept]
- EGFR NM_005228.3:c.1793G>T [NCIt concept]
- EGFR NM_005228.3:c.2125_2129delGAAAC [NCIt concept]
- EGFR NM_005228.3:c.2154_2155delinsTT [NCIt concept]
- EGFR NM_005228.3:c.2155G>A [NCIt concept]
- EGFR NM_005228.3:c.2155G>T [NCIt concept]
- EGFR NM_005228.3:c.2156G>A [NCIt concept]
- EGFR NM_005228.3:c.2156G>C [NCIt concept]
- EGFR NM_005228.3:c.2156delG [NCIt concept]
- EGFR NM_005228.3:c.2219_2220ins18 [NCIt concept]
- EGFR NM_005228.3:c.2231_2232ins18 [NCIt concept]
- EGFR NM_005228.3:c.2232_2233ins18 [NCIt concept]
- EGFR NM_005228.3:c.2233_2247del15 [NCIt concept]
- EGFR NM_005228.3:c.2234_2236delAGG [NCIt concept]
- EGFR NM_005228.3:c.2235_2246del12 [NCIt concept]
- EGFR NM_005228.3:c.2235_2249del15 [NCIt concept]
- EGFR NM_005228.3:c.2235_2252del18 [NCIt concept]
- EGFR NM_005228.3:c.2236_2237ins18 [NCIt concept]
- EGFR NM_005228.3:c.2236_2250del15 [NCIt concept]
- EGFR NM_005228.3:c.2236_2253del18 [NCIt concept]
- EGFR NM_005228.3:c.2238_2252del15 [NCIt concept]
- EGFR NM_005228.3:c.2239_2247del9 [NCIt concept]
- EGFR NM_005228.3:c.2239_2253del15 [NCIt concept]
- EGFR NM_005228.3:c.2239_2256del18 [NCIt concept]
- EGFR NM_005228.3:c.2239_2262del24 [NCIt concept]
- EGFR NM_005228.3:c.2240_2254del15 [NCIt concept]
- EGFR NM_005228.3:c.2246_2260del15 [NCIt concept]
- EGFR NM_005228.3:c.2247_2273del27 [NCIt concept]
- EGFR NM_005228.3:c.2250_2273del24 [NCIt concept]
- EGFR NM_005228.3:c.2253_2276del24 [NCIt concept]
- EGFR NM_005228.3:c.2254_2277del24 [NCIt concept]
- EGFR NM_005228.3:c.2257_2277del21 [NCIt concept]
- EGFR NM_005228.3:c.2283_2284ins12 [NCIt concept]
- EGFR NM_005228.3:c.2290_2291ins12 [NCIt concept]
- EGFR NM_005228.3:c.2298_2299insGCCATA [NCIt concept]
- EGFR NM_005228.3:c.2302_2303ins9 [NCIt concept]
- EGFR NM_005228.3:c.2303G>T [NCIt concept]
- EGFR NM_005228.3:c.2303_2304ins9 [NCIt concept]
- EGFR NM_005228.3:c.2307_2308ins15 [NCIt concept]
- EGFR NM_005228.3:c.2307_2308ins9 [NCIt concept]
- EGFR NM_005228.3:c.2307_2308insGACAACGTG [NCIt concept]
- EGFR NM_005228.3:c.2307_2308insTGCGTG [NCIt concept]
- EGFR NM_005228.3:c.2308_2309ins9 [NCIt concept]
- EGFR NM_005228.3:c.2308_2309insACGGCG [NCIt concept]
- EGFR NM_005228.3:c.2308_2309insGCAGCGTGG [NCIt concept]
- EGFR NM_005228.3:c.2308_2309insGGGTCGTGG [NCIt concept]
- EGFR NM_005228.3:c.2309_2310delinsCCAGCGTGGAT [NCIt concept]
- EGFR NM_005228.3:c.2309_2310ins14 [NCIt concept]
- EGFR NM_005228.3:c.2310_2311ins9 [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insAAC [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insAACCCCCAC [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insAGCGTGGAC [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insGGC [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insGGGGAC [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insGGGTTA [NCIt concept]
- EGFR NM_005228.3:c.2310_2311insGGT [NCIt concept]
- EGFR NM_005228.3:c.2311_2312ins12 [NCIt concept]
- EGFR NM_005228.3:c.2311_2312ins9 [NCIt concept]
- EGFR NM_005228.3:c.2313_2314insAAC [NCIt concept]
- EGFR NM_005228.3:c.2315_2316insGACACACCC [NCIt concept]
- EGFR NM_005228.3:c.2316_2321dup [NCIt concept]
- EGFR NM_005228.3:c.2318_2319insCCCCCA [NCIt concept]
- EGFR NM_005228.3:c.2319_2320ins9 [NCIt concept]
- EGFR NM_005228.3:c.2319_2320insCAC [NCIt concept]
- EGFR NM_005228.3:c.2319_2320insCCCCAC [NCIt concept]
- EGFR NM_005228.3:c.2320_2321ins12 [NCIt concept]
- EGFR NM_005228.3:c.2321_2322insCCACGT [NCIt concept]
- EGFR NM_005228.3:c.2322_2323insCACGTG [NCIt concept]
- EGFR NM_005228.3:c.2369C>T [NCIt concept]
- EGFR NM_005228.3:c.2389T>A [NCIt concept]
- EGFR NM_005228.3:c.2390G>C [NCIt concept]
- EGFR NM_005228.3:c.2572C>A [NCIt concept]
- EGFR NM_005228.3:c.2572C>T [NCIt concept]
- EGFR NM_005228.3:c.2572_2573delinsAA [NCIt concept]
- EGFR NM_005228.3:c.2572_2573delinsAG [NCIt concept]
- EGFR NM_005228.3:c.2573T>A [NCIt concept]
- EGFR NM_005228.3:c.2573T>G [NCIt concept]
- EGFR NM_005228.3:c.2573_2574delinsGT [NCIt concept]
- EGFR NM_005228.3:c.2581C>G [NCIt concept]
- EGFR NM_005228.3:c.2582T>A [NCIt concept]
- EGFR NM_005228.3:c.2582T>G [NCIt concept]
- EGFR NM_005228.3:c.323G>A [NCIt concept]
- EGFR NM_005228.3:c.334_1137del804 [NCIt concept]
- EGFR NM_005228.3:c.787A>C [NCIt concept]
- EGFR NM_005228.3:c.865G>A [NCIt concept]
- EGFR NM_005228.3:c.866C>A [NCIt concept]
- EGFR NM_005228.3:c.866C>T [NCIt concept]
- EGFR NM_005228.5:c.1787C>T [NCIt concept]
- EGFR NM_005228.5:c.2125G>A [NCIt concept]
- EGFR NM_005228.5:c.2224G>A [NCIt concept]
- EGFR NM_005228.5:c.2232_2249delinsAAA [NCIt concept]
- EGFR NM_005228.5:c.2237_2254del [NCIt concept]
- EGFR NM_005228.5:c.2303_2304delinsTT [NCIt concept]
- EGFR NM_005228.5:c.2305G>A [NCIt concept]
- EGFR NM_005228.5:c.2305G>C [NCIt concept]
- EGFR NM_005228.5:c.2305G>T [NCIt concept]
- EGFR NM_005228.5:c.2320G>A [NCIt concept]
- EGFR NM_005228.5:c.2491C>T [NCIt concept]
- EGFR NM_005228.5:c.2492G>A [NCIt concept]
- EGFR NM_005228.5:c.2497T>G [NCIt concept]
- EGFR NM_005228.5:c.2500G>C [NCIt concept]
- EGFR NM_005228.5:c.2500G>T [NCIt concept]
- EGFR NM_005228.5:c.2504A>T [NCIt concept]
- EGFR NM_005228.5:c.2527G>A [NCIt concept]
- EGFR NM_005228.5:c.2582T>C [NCIt concept]
- EGFR NM_005228.5:c.2591C>T [NCIt concept]
- EGFR NM_005228.5:c.2609A>G [NCIt concept]
- EGFR NM_005228.5:c.664C>T [NCIt concept]
- EGFR NP_005219.2:p.A289D [NCIt concept]
- EGFR NP_005219.2:p.A289T [NCIt concept]
- EGFR NP_005219.2:p.A289V [NCIt concept]
- EGFR NP_005219.2:p.A750_E758del [NCIt concept]
- EGFR NP_005219.2:p.A750_K754del [NCIt concept]
- EGFR NP_005219.2:p.A750_K757del [NCIt concept]
- EGFR NP_005219.2:p.A763_Y764insFQEA [NCIt concept]
- EGFR NP_005219.2:p.A767_S768insTLA [NCIt concept]
- EGFR NP_005219.2:p.A859S [NCIt concept]
- EGFR NP_005219.2:p.A864V [NCIt concept]
- EGFR NP_005219.2:p.A871E [NCIt concept]
- EGFR NP_005219.2:p.C797S [NCIt concept]
- EGFR NP_005219.2:p.C797X [NCIt concept]
- EGFR NP_005219.2:p.C797X TKI Resistant Mutation [NCIt concept]
- EGFR NP_005219.2:p.D761_E762insEAFQ [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insAPW [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insD [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insDG [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insG [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insGD [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insGL [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insMATP [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insN [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insNPH [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insSVD [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insSVP [NCIt concept]
- EGFR NP_005219.2:p.D770_N771insSVQ [NCIt concept]
- EGFR NP_005219.2:p.D770fs*61 [NCIt concept]
- EGFR NP_005219.2:p.E709* [NCIt concept]
- EGFR NP_005219.2:p.E709K [NCIt concept]
- EGFR NP_005219.2:p.E746_A750del [NCIt concept]
- EGFR NP_005219.2:p.E746_E749del [NCIt concept]
- EGFR NP_005219.2:p.E746_P753del [NCIt concept]
- EGFR NP_005219.2:p.E746_R748del [NCIt concept]
- EGFR NP_005219.2:p.E746_S752del [NCIt concept]
- EGFR NP_005219.2:p.E746_S752delinsA [NCIt concept]
- EGFR NP_005219.2:p.E746_T751del [NCIt concept]
- EGFR NP_005219.2:p.E746del [NCIt concept]
- EGFR NP_005219.2:p.G598V [NCIt concept]
- EGFR NP_005219.2:p.G719A [NCIt concept]
- EGFR NP_005219.2:p.G719C [NCIt concept]
- EGFR NP_005219.2:p.G719D [NCIt concept]
- EGFR NP_005219.2:p.G719S [NCIt concept]
- EGFR NP_005219.2:p.G719V [NCIt concept]
- EGFR NP_005219.2:p.G719X [NCIt concept]
- EGFR NP_005219.2:p.G719fs*29 [NCIt concept]
- EGFR NP_005219.2:p.H773_V774insG [NCIt concept]
- EGFR NP_005219.2:p.H773_V774insGH [NCIt concept]
- EGFR NP_005219.2:p.H773_V774insGNPH [NCIt concept]
- EGFR NP_005219.2:p.H773_V774insH [NCIt concept]
- EGFR NP_005219.2:p.H773_V774insNPH [NCIt concept]
- EGFR NP_005219.2:p.H773_V774insPH [NCIt concept]
- EGFR NP_005219.2:p.H835L [NCIt concept]
- EGFR NP_005219.2:p.H870R [NCIt concept]
- EGFR NP_005219.2:p.I740_P741insPVAIKI [NCIt concept]
- EGFR NP_005219.2:p.I744_K745insKIPVAI [NCIt concept]
- EGFR NP_005219.2:p.I789_L792del [NCIt concept]
- EGFR NP_005219.2:p.K29_N298insG [NCIt concept]
- EGFR NP_005219.2:p.K745_A750del [NCIt concept]
- EGFR NP_005219.2:p.K745_E746insVPVAIK [NCIt concept]
- EGFR NP_005219.2:p.K745_E749del [NCIt concept]
- EGFR NP_005219.2:p.K745_L747del [NCIt concept]
- EGFR NP_005219.2:p.K860I [NCIt concept]
- EGFR NP_005219.2:p.L747_A750del [NCIt concept]
- EGFR NP_005219.2:p.L747_A755del [NCIt concept]
- EGFR NP_005219.2:p.L747_E749del [NCIt concept]
- EGFR NP_005219.2:p.L747_K754del [NCIt concept]
- EGFR NP_005219.2:p.L747_P753del [NCIt concept]
- EGFR NP_005219.2:p.L747_S752del [NCIt concept]
- EGFR NP_005219.2:p.L747_T751del [NCIt concept]
- EGFR NP_005219.2:p.L747del [NCIt concept]
- EGFR NP_005219.2:p.L833F [NCIt concept]
- EGFR NP_005219.2:p.L833V [NCIt concept]
- EGFR NP_005219.2:p.L858A [NCIt concept]
- EGFR NP_005219.2:p.L858G [NCIt concept]
- EGFR NP_005219.2:p.L858K [NCIt concept]
- EGFR NP_005219.2:p.L858M [NCIt concept]
- EGFR NP_005219.2:p.L858P [NCIt concept]
- EGFR NP_005219.2:p.L858Q [NCIt concept]
- EGFR NP_005219.2:p.L858R [NCIt concept]
- EGFR NP_005219.2:p.L858W [NCIt concept]
- EGFR NP_005219.2:p.L861F [NCIt concept]
- EGFR NP_005219.2:p.L861P [NCIt concept]
- EGFR NP_005219.2:p.L861Q [NCIt concept]
- EGFR NP_005219.2:p.L861R [NCIt concept]
- EGFR NP_005219.2:p.L861V [NCIt concept]
- EGFR NP_005219.2:p.L861X [NCIt concept]
- EGFR NP_005219.2:p.M766_A767insAI [NCIt concept]
- EGFR NP_005219.2:p.N756_L760del [NCIt concept]
- EGFR NP_005219.2:p.N771_P772insH [NCIt concept]
- EGFR NP_005219.2:p.N771_P772insN [NCIt concept]
- EGFR NP_005219.2:p.P596L [NCIt concept]
- EGFR NP_005219.2:p.P753_I759del [NCIt concept]
- EGFR NP_005219.2:p.P772_H773insDHP [NCIt concept]
- EGFR NP_005219.2:p.P772_H773insDNP [NCIt concept]
- EGFR NP_005219.2:p.P772_H773insPR [NCIt concept]
- EGFR NP_005219.2:p.P772_H773insQV [NCIt concept]
- EGFR NP_005219.2:p.P772_H773insTHP [NCIt concept]
- EGFR NP_005219.2:p.P772_H773insYNP [NCIt concept]
- EGFR NP_005219.2:p.R108K [NCIt concept]
- EGFR NP_005219.2:p.R222C [NCIt concept]
- EGFR NP_005219.2:p.R748_P753del [NCIt concept]
- EGFR NP_005219.2:p.R748_S752del [NCIt concept]
- EGFR NP_005219.2:p.R831C [NCIt concept]
- EGFR NP_005219.2:p.R831H [NCIt concept]
- EGFR NP_005219.2:p.S492R [NCIt concept]
- EGFR NP_005219.2:p.S752_I759del [NCIt concept]
- EGFR NP_005219.2:p.S752_V769del [NCIt concept]
- EGFR NP_005219.2:p.S768I [NCIt concept]
- EGFR NP_005219.2:p.S768X [NCIt concept]
- EGFR NP_005219.2:p.S768_V769insAWT [NCIt concept]
- EGFR NP_005219.2:p.S768_V769insVAS [NCIt concept]
- EGFR NP_005219.2:p.T263P [NCIt concept]
- EGFR NP_005219.2:p.T751_E758del [NCIt concept]
- EGFR NP_005219.2:p.T790M [NCIt concept]
- EGFR NP_005219.2:p.V742I [NCIt concept]
- EGFR NP_005219.2:p.V765_M766insMAS [NCIt concept]
- EGFR NP_005219.2:p.V769L [NCIt concept]
- EGFR NP_005219.2:p.V769M [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insASV [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insCV [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insDNV [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insGSV [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insGV [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insGVV [NCIt concept]
- EGFR NP_005219.2:p.V769_D770insMASVD [NCIt concept]
- EGFR NP_005219.2:p.V774M [NCIt concept]
- EGFR NP_005219.2:p.V774_C775insHV [NCIt concept]
- EGFR NP_005219.2:p.V774del [NCIt concept]
- EGFR NP_005219.2:p.V834L [NCIt concept]
- EGFR NP_005219.2:p.V834del [NCIt concept]
- EGFR NP_005219.2:p.V843I [NCIt concept]
- EGFR NP_005219.2:p.Y764_V765insHH [NCIt concept]
- EGFR Negative [NCIt concept]
- EGFR Positive [NCIt concept]
- EGFR Protein Overexpression [NCIt concept]
- EGFR Protein Translocation [NCIt concept]
- EGFR Protein Variant [NCIt concept]
- EGFR Signaling Pathway Alteration Positive [NCIt concept]
- EGFR T790M Mutation Negative [NCIt concept]
- EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma [NCIt concept]
- EGFR Tyrosine Kinase Inhibitor Therapy [NCIt concept]
- EGFR wt Allele [NCIt concept]
- EGFR-GRB2 Complex [NCIt concept]
- EGFR-TKI Resistant Mutation [NCIt concept]
- EGFR-TKI Sensitizing Mutation [NCIt concept]
- EGFR-targeted IL-2/IL-10 Dual Cytokine Fusion Protein DK210 (EGFR) [NCIt concept]
- EGFR-targeting Agent [NCIt concept]
- EGFR/CD3-targeting T-cell Engaging Molecule TAK-186 [NCIt concept]
- EGFR/EGFRvIII Inhibitor WSD0922-FU [NCIt concept]
- EGFR/HER2 Inhibitor AV-412 [NCIt concept]
- EGFR/HER2 Inhibitor TAS2940 [NCIt concept]
- EGFR/HER2 Kinase Inhibitor TAK-285 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor BH-30643 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor STX-721 [NCIt concept]
- EGFRBi-Armed Autologous T Cells [NCIt concept]
- EGFRt/19-28z/IL-12 CAR T-lymphocytes [NCIt concept]
- EGFRvIII Antibody [NCIt concept]
- EGFRvIII Negative [NCIt concept]
- EGFRvIII Positive [NCIt concept]
- EGFRvIII-specific CAR-transduced Autologous T Lymphocytes [NCIt concept]
- EGR1 Gene [NCIt concept]
- EGR1 wt Allele [NCIt concept]
- EGR3 Gene [NCIt concept]
- EGR3 wt Allele [NCIt concept]
- EGb761 [NCIt concept]
- EH Domain-Containing Protein 1 [NCIt concept]
- EHD1 Gene [NCIt concept]
- EHD1 wt Allele [NCIt concept]
- EIF2AK2 Gene [NCIt concept]
- EIF2AK2 wt Allele [NCIt concept]
- EIF2AK3 Gene [NCIt concept]
- EIF2AK3 wt Allele [NCIt concept]
- EIF2AK4 Gene [NCIt concept]
- EIF2AK4 wt Allele [NCIt concept]
- EIF2S1 Gene [NCIt concept]
- EIF2S1 wt Allele [NCIt concept]
- EIF3B Gene [NCIt concept]
- EIF3B wt Allele [NCIt concept]
- EIF3K Gene [NCIt concept]
- EIF3K wt Allele [NCIt concept]
- EIF4A1 Gene [NCIt concept]
- EIF4A1 wt Allele [NCIt concept]
- EIF4A2 Gene [NCIt concept]
- EIF4A2 wt Allele [NCIt concept]
- EIF4B Gene [NCIt concept]
- EIF4B wt Allele [NCIt concept]
- EIF4E Gene [NCIt concept]
- EIF4E wt Allele [NCIt concept]
- EIF4EBP1 Gene [NCIt concept]
- EIF4EBP1 wt Allele [NCIt concept]
- EIF5 Gene [NCIt concept]
- EIF5 wt Allele [NCIt concept]
- EIF5A Gene [NCIt concept]
- EIF5A wt Allele [NCIt concept]
- ELAC2 Gene [NCIt concept]
- ELAC2 wt Allele [NCIt concept]
- ELANE Gene [NCIt concept]
- ELANE wt Allele [NCIt concept]
- ELAPOR1 Gene [NCIt concept]
- ELAPOR1 wt Allele [NCIt concept]
- ELAV-Like Protein 1 [NCIt concept]
- ELAVL1 Gene [NCIt concept]
- ELAVL1 wt Allele [NCIt concept]
- ELF4 Gene [NCIt concept]
- ELF4 wt Allele [NCIt concept]
- ELISA [NCIt concept]
- ELK1 Gene [NCIt concept]
- ELK1 wt Allele [NCIt concept]
- ELK4 Gene [NCIt concept]
- ELK4 wt Allele [NCIt concept]
- ELKS/Rab6-Interacting/CAST Family Member 1 [NCIt concept]
- ELL Gene [NCIt concept]
- ELL wt Allele [NCIt concept]
- ELN Allele with Mm Haplotype for INT20/INT23 [NCIt concept]
- ELN Gene [NCIt concept]
- ELN wt Allele [NCIt concept]
- ELOC Gene [NCIt concept]
- ELOC Gene Mutation [NCIt concept]
- ELOC wt Allele [NCIt concept]
- EMC-92-Gene Signature [NCIt concept]
- EML4 Gene [NCIt concept]
- EML4 wt Allele [NCIt concept]
- EML4/ALK Fusion Gene [NCIt concept]
- EML4/ALK Fusion Gene Variant 1 [NCIt concept]
- EML4/ALK Fusion Gene Variant 2 [NCIt concept]
- EML4/ALK Fusion Gene Variant 3a [NCIt concept]
- EML4/ALK Fusion Gene Variant 3b [NCIt concept]
- EML4/ALK Fusion Gene Variant 4 [NCIt concept]
- EML4/ALK Fusion Gene Variant 5a [NCIt concept]
- EML4/ALK Fusion Gene Variant 5b [NCIt concept]
- EML4/ALK Fusion Negative [NCIt concept]
- EML4/ALK Fusion Protein [NCIt concept]
- EML4/ALK Fusion Protein Variant 1 [NCIt concept]
- EML4/ALK Fusion Protein Variant 2 [NCIt concept]
- EML4/ALK Fusion Protein Variant 3a [NCIt concept]
- EML4/ALK Fusion Protein Variant 3b [NCIt concept]
- EML4/ALK Fusion Protein Variant 4 [NCIt concept]
- EML4/ALK Fusion Protein Variant 5a [NCIt concept]
- EML4/ALK Fusion Protein Variant 5b [NCIt concept]
- EMP1 Gene [NCIt concept]
- EMP1 wt Allele [NCIt concept]
- EMSY Gene [NCIt concept]
- EMSY Gene Amplification [NCIt concept]
- EMSY Gene Mutation [NCIt concept]
- EMSY wt Allele [NCIt concept]
- ENAH Gene [NCIt concept]
- ENAH Protein Isoform Expression Assay [NCIt concept]
- ENAH wt Allele [NCIt concept]
- ENO1 Gene [NCIt concept]
- ENO1 wt Allele [NCIt concept]
- ENO2 Gene [NCIt concept]
- ENO2 wt Allele [NCIt concept]
- ENPP1 Gene [NCIt concept]
- ENPP1 wt Allele [NCIt concept]
- ENPP2 Gene [NCIt concept]
- ENPP2 wt Allele [NCIt concept]
- ENPP3 Gene [NCIt concept]
- ENPP3 Positive [NCIt concept]
- ENPP3 wt Allele [NCIt concept]
- ENPP3-targeting Agent [NCIt concept]
- ENSAT Stage I Adrenal Cortical Carcinoma [NCIt concept]
- ENSAT Stage II Adrenal Cortical Carcinoma [NCIt concept]
- ENSAT Stage III Adrenal Cortical Carcinoma [NCIt concept]
- ENSAT Stage IV Adrenal Cortical Carcinoma [NCIt concept]
- ENTPD1 Gene [NCIt concept]
- ENTPD1 wt Allele [NCIt concept]
- ENTPD2 Gene [NCIt concept]
- ENTPD2 wt Allele [NCIt concept]
- EOMES Gene [NCIt concept]
- EOMES wt Allele [NCIt concept]
- EP2/EP4 Antagonist TPST-1495 [NCIt concept]
- EP300 Gene [NCIt concept]
- EP300 Gene Mutation [NCIt concept]
- EP300 wt Allele [NCIt concept]
- EP4 Antagonist INV-1120 [NCIt concept]
- EP4 Antagonist ONO-4578 [NCIt concept]
- EP400 Gene [NCIt concept]
- EP400 wt Allele [NCIt concept]
- EPAS1 Gene [NCIt concept]
- EPAS1 Gene Mutation [NCIt concept]
- EPAS1 wt Allele [NCIt concept]
- EPC1 Gene [NCIt concept]
- EPC1 wt Allele [NCIt concept]
- EPCAM Gene [NCIt concept]
- EPCAM Gene Mutation [NCIt concept]
- EPCAM Loss of Nuclear Expression [NCIt concept]
- EPCAM Protein Variant [NCIt concept]
- EPCAM wt Allele [NCIt concept]
- EPGN Gene [NCIt concept]
- EPGN wt Allele [NCIt concept]
- EPHA1 Gene [NCIt concept]
- EPHA1 wt Allele [NCIt concept]
- EPHA2 Gene [NCIt concept]
- EPHA2 Gene Mutation [NCIt concept]
- EPHA2 Protein Overexpression [NCIt concept]
- EPHA2 wt Allele [NCIt concept]
- EPHA3 Gene [NCIt concept]
- EPHA3 wt Allele [NCIt concept]
- EPHA5 Gene [NCIt concept]
- EPHA5 Negative [NCIt concept]
- EPHA5 Positive [NCIt concept]
- EPHA5 wt Allele [NCIt concept]
- EPHA7 Gene [NCIt concept]
- EPHA7 wt Allele [NCIt concept]
- EPHB1 Gene [NCIt concept]
- EPHB1 wt Allele [NCIt concept]
- EPHB2 Gene [NCIt concept]
- EPHB2 wt Allele [NCIt concept]
- EPHB4 Gene [NCIt concept]
- EPHB4 wt Allele [NCIt concept]
- EPO Gene [NCIt concept]
- EPO wt Allele [NCIt concept]
- EPOCH Regimen [NCIt concept]
- EPOR Fusion Positive [NCIt concept]
- EPOR Gene [NCIt concept]
- EPOR wt Allele [NCIt concept]
- ER Alpha-targeting Chimeric Protein Degrader AC682 [NCIt concept]
- ER-targeting Agent [NCIt concept]
- ERBB Family Gene Fusion Positive [NCIt concept]
- ERBB Receptor Feedback Inhibitor 1 [NCIt concept]
- ERBB2 Antibody [NCIt concept]
- ERBB2 Exon 18 Mutation [NCIt concept]
- ERBB2 Exon 19 Mutation [NCIt concept]
- ERBB2 Exon 20 Insertion Mutation [NCIt concept]
- ERBB2 Exon 20 Mutation [NCIt concept]
- ERBB2 Exon 21 Mutation [NCIt concept]
- ERBB2 Fusion Positive [NCIt concept]
- ERBB2 Gene [NCIt concept]
- ERBB2 Gene Alteration Positive [NCIt concept]
- ERBB2 Gene Amplification [NCIt concept]
- ERBB2 Gene Amplification Negative [NCIt concept]
- ERBB2 Gene Fusion Positive [NCIt concept]
- ERBB2 Gene Mutation [NCIt concept]
- ERBB2 Gene Mutation Negative [NCIt concept]
- ERBB2 Gene Rearrangement [NCIt concept]
- ERBB2 NM_004448.1:c.2413T>A [NCIt concept]
- ERBB2 NM_004448.2:c.2324_2325ins12 [NCIt concept]
- ERBB2 NM_004448.2:c.2325_2326ins12 [NCIt concept]
- ERBB2 NM_004448.3:c.1963A>G [NCIt concept]
- ERBB2 NM_004448.3:c.1976_1977delinsAG [NCIt concept]
- ERBB2 NM_004448.3:c.2033G>A [NCIt concept]
- ERBB2 NM_004448.3:c.2089G>C [NCIt concept]
- ERBB2 NM_004448.3:c.2089G>T [NCIt concept]
- ERBB2 NM_004448.3:c.2198C>T [NCIt concept]
- ERBB2 NM_004448.3:c.2301C>G [NCIt concept]
- ERBB2 NM_004448.3:c.2305G>A [NCIt concept]
- ERBB2 NM_004448.3:c.2305G>C [NCIt concept]
- ERBB2 NM_004448.3:c.2305G>T [NCIt concept]
- ERBB2 NM_004448.3:c.2317G>A [NCIt concept]
- ERBB2 NM_004448.3:c.2329G>A [NCIt concept]
- ERBB2 NM_004448.3:c.2329G>C [NCIt concept]
- ERBB2 NM_004448.3:c.2329G>T [NCIt concept]
- ERBB2 NM_004448.3:c.2356C>G [NCIt concept]
- ERBB2 NM_004448.3:c.2524G>A [NCIt concept]
- ERBB2 NM_004448.3:c.2606T>G [NCIt concept]
- ERBB2 NM_004448.3:c.929C>A [NCIt concept]
- ERBB2 NM_004448.3:c.929C>T [NCIt concept]
- ERBB2 NM_004448.4:c.1958C>G [NCIt concept]
- ERBB2 NM_004448.4:c.1979G>A [NCIt concept]
- ERBB2 NM_004448.4:c.2077G>A [NCIt concept]
- ERBB2 NM_004448.4:c.2126A>T [NCIt concept]
- ERBB2 NM_004448.4:c.2263_2264delinsCC [NCIt concept]
- ERBB2 NM_004448.4:c.2264T>C [NCIt concept]
- ERBB2 NM_004448.4:c.2264_2278del [NCIt concept]
- ERBB2 NM_004448.4:c.2326G>T [NCIt concept]
- ERBB2 NM_004448.4:c.2327G>T [NCIt concept]
- ERBB2 NM_004448.4:c.2331_2339dup [NCIt concept]
- ERBB2 NM_004448.4:c.2332_2340dup [NCIt concept]
- ERBB2 NM_004448.4:c.2521C>G [NCIt concept]
- ERBB2 NM_004448.4:c.2584A>G [NCIt concept]
- ERBB2 NM_004448.4:c.2596C>A [NCIt concept]
- ERBB2 NM_004448.4:c.2632C>T [NCIt concept]
- ERBB2 NM_004448.4:c.2686C>T [NCIt concept]
- ERBB2 NM_004448.4:c.926G>A [NCIt concept]
- ERBB2 NM_004448.4:c.926G>C [NCIt concept]
- ERBB2 NP_004439.2:p.C805S [NCIt concept]
- ERBB2 NP_004439.2:p.D769H [NCIt concept]
- ERBB2 NP_004439.2:p.D769N [NCIt concept]
- ERBB2 NP_004439.2:p.D769Y [NCIt concept]
- ERBB2 NP_004439.2:p.E693K [NCIt concept]
- ERBB2 NP_004439.2:p.G309A [NCIt concept]
- ERBB2 NP_004439.2:p.G309E [NCIt concept]
- ERBB2 NP_004439.2:p.G660D [NCIt concept]
- ERBB2 NP_004439.2:p.G776C [NCIt concept]
- ERBB2 NP_004439.2:p.G776V [NCIt concept]
- ERBB2 NP_004439.2:p.G778_P780dup [NCIt concept]
- ERBB2 NP_004439.2:p.H878Y [NCIt concept]
- ERBB2 NP_004439.2:p.I655V [NCIt concept]
- ERBB2 NP_004439.2:p.I767M [NCIt concept]
- ERBB2 NP_004439.2:p.L755P [NCIt concept]
- ERBB2 NP_004439.2:p.L755S [NCIt concept]
- ERBB2 NP_004439.2:p.L755X [NCIt concept]
- ERBB2 NP_004439.2:p.L755_T759del [NCIt concept]
- ERBB2 NP_004439.2:p.L786V [NCIt concept]
- ERBB2 NP_004439.2:p.L841V [NCIt concept]
- ERBB2 NP_004439.2:p.L866M [NCIt concept]
- ERBB2 NP_004439.2:p.L869R [NCIt concept]
- ERBB2 NP_004439.2:p.Q709L [NCIt concept]
- ERBB2 NP_004439.2:p.R678Q [NCIt concept]
- ERBB2 NP_004439.2:p.R896C [NCIt concept]
- ERBB2 NP_004439.2:p.S310F [NCIt concept]
- ERBB2 NP_004439.2:p.S310Y [NCIt concept]
- ERBB2 NP_004439.2:p.S653C [NCIt concept]
- ERBB2 NP_004439.2:p.T733I [NCIt concept]
- ERBB2 NP_004439.2:p.T862A [NCIt concept]
- ERBB2 NP_004439.2:p.T862I [NCIt concept]
- ERBB2 NP_004439.2:p.V659E [NCIt concept]
- ERBB2 NP_004439.2:p.V697L [NCIt concept]
- ERBB2 NP_004439.2:p.V773M [NCIt concept]
- ERBB2 NP_004439.2:p.V777L [NCIt concept]
- ERBB2 NP_004439.2:p.V777M [NCIt concept]
- ERBB2 NP_004439.2:p.V842I [NCIt concept]
- ERBB2 NP_004439.2:p.Y772_A775dup [NCIt concept]
- ERBB2 Overexpression [NCIt concept]
- ERBB2 Protein Overexpression [NCIt concept]
- ERBB2 Protein Variant [NCIt concept]
- ERBB2 wt Allele [NCIt concept]
- ERBB3 Fusion Positive [NCIt concept]
- ERBB3 Gene [NCIt concept]
- ERBB3 Gene Amplification [NCIt concept]
- ERBB3 Gene Fusion Positive [NCIt concept]
- ERBB3 Gene Mutation [NCIt concept]
- ERBB3 Gene Overexpression Positive [NCIt concept]
- ERBB3 Overexpression Positive [NCIt concept]
- ERBB3 Positive [NCIt concept]
- ERBB3 wt Allele [NCIt concept]
- ERBB4 Gene [NCIt concept]
- ERBB4 Gene Mutation [NCIt concept]
- ERBB4 wt Allele [NCIt concept]
- ERC1 Gene [NCIt concept]
- ERC1 wt Allele [NCIt concept]
- ERC1/RET Fusion Gene [NCIt concept]
- ERC1/RET Fusion Protein [NCIt concept]
- ERCC Family Gene [NCIt concept]
- ERCC Family Gene Mutation [NCIt concept]
- ERCC1 Gene [NCIt concept]
- ERCC1 Gene Mutation [NCIt concept]
- ERCC1 wt Allele [NCIt concept]
- ERCC2 Gene [NCIt concept]
- ERCC2 Gene Mutation [NCIt concept]
- ERCC2 wt Allele [NCIt concept]
- ERCC3 Gene [NCIt concept]
- ERCC3 Gene Mutation [NCIt concept]
- ERCC3 wt Allele [NCIt concept]
- ERCC4 Gene [NCIt concept]
- ERCC4 Gene Mutation [NCIt concept]
- ERCC4 wt Allele [NCIt concept]
- ERCC5 Gene [NCIt concept]
- ERCC5 Gene Mutation [NCIt concept]
- ERCC5 wt Allele [NCIt concept]
- ERCC6 Gene [NCIt concept]
- ERCC6 wt Allele [NCIt concept]
- ERG Gene [NCIt concept]
- ERG wt Allele [NCIt concept]
- ERK Family Gene Mutation [NCIt concept]
- ERK Inhibitor [NCIt concept]
- ERK Inhibitor CC-90003 [NCIt concept]
- ERK Inhibitor MK-8353 [NCIt concept]
- ERK1/2 Inhibitor D3S-002 [NCIt concept]
- ERK1/2 Inhibitor ERAS-007 [NCIt concept]
- ERK1/2 Inhibitor HH2710 [NCIt concept]
- ERK1/2 Inhibitor IPN01194 [NCIt concept]
- ERK1/2 Inhibitor JSI-1187 [NCIt concept]
- ERK1/2 Inhibitor KO-947 [NCIt concept]
- ERK1/2 Inhibitor UCT-01-097 [NCIt concept]
- ERN1 Gene [NCIt concept]
- ERN1 wt Allele [NCIt concept]
- ERO1-Like Protein Alpha [NCIt concept]
- ERO1A Gene [NCIt concept]
- ERO1A wt Allele [NCIt concept]
- ERRFI1 Gene [NCIt concept]
- ERRFI1 wt Allele [NCIt concept]
- ESM1 Gene [NCIt concept]
- ESM1 wt Allele [NCIt concept]
- ESR1 Gene [NCIt concept]
- ESR1 Gene Mutation [NCIt concept]
- ESR1 Gene Mutation Negative [NCIt concept]
- ESR1 Peptides/GM-CSF/Montanide ISA Vaccine [NCIt concept]
- ESR1 wt Allele [NCIt concept]
- ESR2 Gene [NCIt concept]
- ESR2 Negative [NCIt concept]
- ESR2 Positive [NCIt concept]
- ESR2 wt Allele [NCIt concept]
- ESRP1 Gene [NCIt concept]
- ESRP1 wt Allele [NCIt concept]
- ETNK1 Gene [NCIt concept]
- ETNK1 wt Allele [NCIt concept]
- ETS Domain-Containing Protein Elk-1 [NCIt concept]
- ETS Domain-Containing Protein Elk-4 [NCIt concept]
- ETS Family Fusion Gene [NCIt concept]
- ETS Family Gene [NCIt concept]
- ETS Family Gene Fusion Positive [NCIt concept]
- ETS Family Protein [NCIt concept]
- ETS Translocation Variant 1 [NCIt concept]
- ETS Translocation Variant 4 [NCIt concept]
- ETS Translocation Variant 5 [NCIt concept]
- ETS-Related Transcription Factor Elf-4 [NCIt concept]
- ETS1 Gene [NCIt concept]
- ETS1 wt Allele [NCIt concept]
- ETS2 Gene [NCIt concept]
- ETS2 wt Allele [NCIt concept]
- ETV1 Gene [NCIt concept]
- ETV1 wt Allele [NCIt concept]
- ETV4 Gene [NCIt concept]
- ETV4 wt Allele [NCIt concept]
- ETV5 Gene [NCIt concept]
- ETV5 wt Allele [NCIt concept]
- ETV6 Gene [NCIt concept]
- ETV6 Gene Mutation [NCIt concept]
- ETV6 Gene Rearrangement [NCIt concept]
- ETV6 wt Allele [NCIt concept]
- ETV6-JAK2 Fusion Protein Expression [NCIt concept]
- ETV6/ABL2 Fusion Gene [NCIt concept]
- ETV6/ABL2 Fusion Protein [NCIt concept]
- ETV6/ACSL6 Fusion Gene [NCIt concept]
- ETV6/ARNT Fusion Gene [NCIt concept]
- ETV6/ARNT Fusion Protein [NCIt concept]
- ETV6/JAK2 Fusion Gene [NCIt concept]
- ETV6/JAK2 Fusion Protein [NCIt concept]
- ETV6/MDS2 Fusion Gene [NCIt concept]
- ETV6/MN1 Fusion Gene [NCIt concept]
- ETV6/NTRK3 Fusion Gene [NCIt concept]
- ETV6/NTRK3 Fusion Protein [NCIt concept]
- ETV6/PDGFRB Fusion Gene [NCIt concept]
- ETV6/PDGFRB Fusion Protein [NCIt concept]
- ETV6/PER1 Fusion Gene [NCIt concept]
- ETV6/RUNX1 Fusion Gene [NCIt concept]
- ETV6/RUNX1 Fusion Protein [NCIt concept]
- EVL Gene [NCIt concept]
- EVL wt Allele [NCIt concept]
- EWSR1 Fusion Positive [NCIt concept]
- EWSR1 Gene [NCIt concept]
- EWSR1 Gene Translocation [NCIt concept]
- EWSR1 wt Allele [NCIt concept]
- EWSR1/ATF1 Fusion Gene [NCIt concept]
- EWSR1/ATF1 Fusion Gene Type 1 [NCIt concept]
- EWSR1/ATF1 Fusion Gene Type 2 [NCIt concept]
- EWSR1/ATF1 Fusion Protein [NCIt concept]
- EWSR1/ATF1 Fusion Protein Type 1 [NCIt concept]
- EWSR1/ATF1 Fusion Protein Type 2 [NCIt concept]
- EWSR1/CREB1 Fusion Gene [NCIt concept]
- EWSR1/CREB1 Fusion Protein [NCIt concept]
- EWSR1/DDIT3 Fusion Gene [NCIt concept]
- EWSR1/DDIT3 Fusion Protein [NCIt concept]
- EWSR1/ERG Fusion Gene [NCIt concept]
- EWSR1/ERG Fusion Protein [NCIt concept]
- EWSR1/ETV1 Fusion Gene [NCIt concept]
- EWSR1/ETV1 Fusion Protein [NCIt concept]
- EWSR1/ETV4 Fusion Gene [NCIt concept]
- EWSR1/ETV4 Fusion Protein [NCIt concept]
- EWSR1/FEV Fusion Gene [NCIt concept]
- EWSR1/FEV Fusion Protein [NCIt concept]
- EWSR1/FLI1 Fusion Gene [NCIt concept]
- EWSR1/FLI1 Fusion Gene Type 1 [NCIt concept]
- EWSR1/FLI1 Fusion Gene Type 2 [NCIt concept]
- EWSR1/FLI1 Fusion Protein [NCIt concept]
- EWSR1/FLI1 Fusion Protein Type 1 [NCIt concept]
- EWSR1/FLI1 Fusion Protein Type 2 [NCIt concept]
- EWSR1/NFATC2 Fusion Gene [NCIt concept]
- EWSR1/NFATC2 Fusion Protein [NCIt concept]
- EWSR1/NR4A3 Fusion Gene [NCIt concept]
- EWSR1/NR4A3 Fusion Protein [NCIt concept]
- EWSR1/PATZ1 Fusion Gene [NCIt concept]
- EWSR1/PATZ1 Fusion Gene Long A Isoform [NCIt concept]
- EWSR1/PATZ1 Fusion Gene Long B Isoform [NCIt concept]
- EWSR1/PATZ1 Fusion Gene Short Isoform [NCIt concept]
- EWSR1/PATZ1 Fusion Protein [NCIt concept]
- EWSR1/PATZ1 Fusion Protein Long A Isoform [NCIt concept]
- EWSR1/PATZ1 Fusion Protein Long B Isoform [NCIt concept]
- EWSR1/PATZ1 Fusion Protein Short Isoform [NCIt concept]
- EWSR1/POU5F1 Fusion Gene [NCIt concept]
- EWSR1/POU5F1 Fusion Protein [NCIt concept]
- EWSR1/SMARCA5 Fusion Gene [NCIt concept]
- EWSR1/SMARCA5 Fusion Protein [NCIt concept]
- EWSR1/SP3 Fusion Gene [NCIt concept]
- EWSR1/SP3 Fusion Protein [NCIt concept]
- EWSR1/WT1 Fusion Gene [NCIt concept]
- EWSR1/WT1 Fusion Positive [NCIt concept]
- EWSR1/WT1 Fusion Protein [NCIt concept]
- EXO1 Gene [NCIt concept]
- EXO1 Gene Mutation [NCIt concept]
- EXO1 wt Allele [NCIt concept]
- EXOSC5 Gene [NCIt concept]
- EXOSC5 wt Allele [NCIt concept]
- EYA1 Gene [NCIt concept]
- EYA1 wt Allele [NCIt concept]
- EZH Inhibitory Protein [NCIt concept]
- EZH1/2 Inhibitor HH2853 [NCIt concept]
- EZH2 Gene [NCIt concept]
- EZH2 Gene Copy Number Alteration Positive [NCIt concept]
- EZH2 Gene Mutation [NCIt concept]
- EZH2 Gene Mutation Negative [NCIt concept]
- EZH2 Inhibitor [NCIt concept]
- EZH2 wt Allele [NCIt concept]
- EZHIP Gene [NCIt concept]
- EZHIP wt Allele [NCIt concept]
- Early Activation Antigen CD69 [NCIt concept]
- Early E1A Protein [NCIt concept]
- Early Growth Response Protein 1 [NCIt concept]
- Early Growth Response Protein 3 [NCIt concept]
- Early Hepatocellular Carcinoma [NCIt concept]
- Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Early Stage Bladder Urothelial Carcinoma [NCIt concept]
- Early Stage Breast Carcinoma [NCIt concept]
- Early Stage Cervical Carcinoma [NCIt concept]
- Early Stage Clear Cell Renal Cell Carcinoma [NCIt concept]
- Early Stage Colon Carcinoma [NCIt concept]
- Early Stage Colorectal Carcinoma [NCIt concept]
- Early Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck [NCIt concept]
- Early Stage Endometrial Carcinoma [NCIt concept]
- Early Stage Esophageal Carcinoma [NCIt concept]
- Early Stage HER2-Negative Breast Carcinoma [NCIt concept]
- Early Stage HER2-Positive Breast Carcinoma [NCIt concept]
- Early Stage Hepatocellular Carcinoma [NCIt concept]
- Early Stage Lung Non-Small Cell Carcinoma [NCIt concept]
- Early Stage Malignant Skin Neoplasm [NCIt concept]
- Early Stage Malignant Solid Neoplasm [NCIt concept]
- Early Stage Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Early Stage Skin Squamous Cell Carcinoma [NCIt concept]
- Early Stage Triple-Negative Breast Carcinoma [NCIt concept]
- East Indian Sandalwood Oil Mouth Rinse [NCIt concept]
- Ebvaciclib [NCIt concept]
- Eccrine Carcinoma [NCIt concept]
- Echinoderm Microtubule-Associated Protein-Like 4 [NCIt concept]
- Echo-Planar Imaging [NCIt concept]
- EchoMark [NCIt concept]
- EchoSure [NCIt concept]
- Echocardiography Test [NCIt concept]
- Eclutatug [NCIt concept]
- Ecological Momentary Assessment [NCIt concept]
- Ecromeximab [NCIt concept]
- Ectonucleoside Triphosphate Diphosphohydrolase 1 [NCIt concept]
- Ectonucleoside Triphosphate Diphosphohydrolase 2 [NCIt concept]
- Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 [NCIt concept]
- Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 [NCIt concept]
- Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 [NCIt concept]
- Ectopic ACTH Secretion Syndrome [NCIt concept]
- Ecubectedin [NCIt concept]
- Edetate Calcium Disodium [NCIt concept]
- Edicotinib [NCIt concept]
- Edodekin alfa [NCIt concept]
- Edoxaban [NCIt concept]
- Edrecolomab [NCIt concept]
- Education of Caregivers [NCIt concept]
- Educational Intervention [NCIt concept]
- Efanesoctocog Alfa [NCIt concept]
- Efaprinermin Alfa [NCIt concept]
- Efatutazone Dihydrochloride [NCIt concept]
- Efavirenz [NCIt concept]
- Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate [NCIt concept]
- Efbemalenograstim alfa [NCIt concept]
- Efdelikofusp Alfa [NCIt concept]
- Effector Immune Cell [NCIt concept]
- Effector Memory Immune Cell [NCIt concept]
- Effector Memory T-Lymphocyte [NCIt concept]
- Effector T-Lymphocyte [NCIt concept]
- Efgitasialase Alfa [NCIt concept]
- Efgivanermin Alfa [NCIt concept]
- Efineptakin alfa [NCIt concept]
- Eflapegrastim [NCIt concept]
- Eflepedocokin Alfa [NCIt concept]
- Eflornithine [NCIt concept]
- Eflornithine Hydrochloride [NCIt concept]
- Eflornithine Hydrochloride Ointment [NCIt concept]
- Efmarodocokin Alfa [NCIt concept]
- Efocipegtrutide [NCIt concept]
- Efprezimod Alfa [NCIt concept]
- Eftilagimod Alpha [NCIt concept]
- Eftozanermin Alfa [NCIt concept]
- Eganelisib [NCIt concept]
- Egaptivon Pegol [NCIt concept]
- Egg Preservation [NCIt concept]
- Eggerthella [NCIt concept]
- Eicosanoid [NCIt concept]
- Eicosapentaenoic Acid [NCIt concept]
- Eight [NCIt concept]
- Eighteen [NCIt concept]
- Eiletoclax [NCIt concept]
- Elacestrant [NCIt concept]
- Elacytarabine [NCIt concept]
- Elafin [NCIt concept]
- Elapegademase [NCIt concept]
- Elasomeran [NCIt concept]
- Elastin [NCIt concept]
- Elastography [NCIt concept]
- Elbasvir/Grazoprevir [NCIt concept]
- Elective Plasma-based CancerSEEK Testing [NCIt concept]
- Electric Field Therapy [NCIt concept]
- Electrical Stimulation Pain Therapy [NCIt concept]
- Electroacupuncture Therapy [NCIt concept]
- Electrocardiogram [NCIt concept]
- Electrocardiography [NCIt concept]
- Electrocauterization [NCIt concept]
- Electrocorticography [NCIt concept]
- Electrodessication and Curettage [NCIt concept]
- Electroencephalography [NCIt concept]
- Electromagnetic Navigation Bronchoscopy [NCIt concept]
- Electromagnetic Tracking Device Procedure [NCIt concept]
- Electromyography [NCIt concept]
- Electron Beam Therapy [NCIt concept]
- Electron Microscopy [NCIt concept]
- Electronic Cigarette [NCIt concept]
- Electronic Form [NCIt concept]
- Electronic Health Record Review [NCIt concept]
- Electronic Nicotine Delivery Device [NCIt concept]
- Electronic Nicotine Delivery System User [NCIt concept]
- Electronic Patient Visit Assessment [NCIt concept]
- Electronic Patient-reported Outcome System [NCIt concept]
- Electronic Portal Imaging [NCIt concept]
- Electronic Tracking Database [NCIt concept]
- Electronically Activated Recording [NCIt concept]
- Electroporation [NCIt concept]
- Electroporation-Mediated Plasmid DNA Vaccine Therapy [NCIt concept]
- Elesclomol [NCIt concept]
- Elesclomol Sodium [NCIt concept]
- Elevated AFP-L3 [NCIt concept]
- Elevated ALCAM [NCIt concept]
- Elevated Alpha-Fetoprotein [NCIt concept]
- Elevated Alpha-Hydroxyglutarate [NCIt concept]
- Elevated CA-125 [NCIt concept]
- Elevated CA15-3 [NCIt concept]
- Elevated CA19-9 [NCIt concept]
- Elevated CA27-29 [NCIt concept]
- Elevated CCR8 Expression [NCIt concept]
- Elevated CEA [NCIt concept]
- Elevated Catecholamine Metabolites [NCIt concept]
- Elevated Choriogonadotropin Subunit Beta [NCIt concept]
- Elevated DKK1 [NCIt concept]
- Elevated EBV DNA [NCIt concept]
- Elevated HMGA2 [NCIt concept]
- Elevated Human Chorionic Gonadotropin [NCIt concept]
- Elevated LDH [NCIt concept]
- Elevated LIF [NCIt concept]
- Elevated MET Protein Expression [NCIt concept]
- Elevated MHC Class II [NCIt concept]
- Elevated SLC34A2 Positive [NCIt concept]
- Elevated Serum CA 27-29 Tumor Antigen Levels [NCIt concept]
- Elevated Serum CA-125 Tumor Antigen [NCIt concept]
- Elevated Type I Collagen Cross-Linked N-Telopeptide [NCIt concept]
- Elevated WT1 [NCIt concept]
- Elgemtumab [NCIt concept]
- Elimusertib [NCIt concept]
- Elironrasib [NCIt concept]
- Elisidepsin [NCIt concept]
- Ellagitannin [NCIt concept]
- Elongation Factor 1 [NCIt concept]
- Elongation Factor 2 [NCIt concept]
- Elongin-C [NCIt concept]
- Elotuzumab [NCIt concept]
- Elraglusib [NCIt concept]
- Elranatamab [NCIt concept]
- Elritercept [NCIt concept]
- Eltanexor [NCIt concept]
- Eltivutabart [NCIt concept]
- Eltrapuldencel-T [NCIt concept]
- Eltrombopag [NCIt concept]
- Eltrombopag Olamine [NCIt concept]
- Eluvixtamab [NCIt concept]
- Elzovantinib [NCIt concept]
- Emactuzumab [NCIt concept]
- Emapalumab [NCIt concept]
- Emavusertib [NCIt concept]
- Embolization Therapy [NCIt concept]
- Embolization Therapy Patient [NCIt concept]
- Embryonal Carcinoma [NCIt concept]
- Emepepimut-S [NCIt concept]
- Emerfetamab [NCIt concept]
- Emibetuzumab [NCIt concept]
- Emicizumab [NCIt concept]
- Emiltatug Ledadotin [NCIt concept]
- Emirodatamab [NCIt concept]
- Emotion Identification and Verbalization [NCIt concept]
- Empagliflozin [NCIt concept]
- Emtricitabine [NCIt concept]
- Emunkitug [NCIt concept]
- Emvododstat [NCIt concept]
- Emzadirib [NCIt concept]
- EnVisio Navigation System [NCIt concept]
- Ena/VASP-Like Protein [NCIt concept]
- Enadenotucirev [NCIt concept]
- Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A [NCIt concept]
- Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641 [NCIt concept]
- Enalapril Maleate [NCIt concept]
- Enapotamab Vedotin [NCIt concept]
- Enasidenib [NCIt concept]
- Enasidenib Mesylate [NCIt concept]
- Enavatuzumab [NCIt concept]
- Enbezotinib [NCIt concept]
- Encapsulated Rapamycin [NCIt concept]
- Encelimab [NCIt concept]
- Encequidar [NCIt concept]
- Encorafenib [NCIt concept]
- Encounter for Screening Mammogram for Malignancy [NCIt concept]
- End-of-Life Treatment Management [NCIt concept]
- EndoRotor [NCIt concept]
- Endobronchial Cryotherapy [NCIt concept]
- Endobronchial Obstruction [NCIt concept]
- Endobronchial Ultrasound Bronchoscopy [NCIt concept]
- Endobronchial Ultrasound-Guided Miniforceps Biopsy [NCIt concept]
- Endocannabinoid [NCIt concept]
- Endocervical Adenocarcinoma, Usual-Type [NCIt concept]
- Endocervical Biopsy [NCIt concept]
- Endocrine Neoplasm [NCIt concept]
- Endocrine Therapy-Induced Alopecia [NCIt concept]
- Endocrinologist [NCIt concept]
- Endoesophageal Brachytherapy [NCIt concept]
- Endogenous Cushing Syndrome [NCIt concept]
- Endoluminal Bypass Sheath Placement [NCIt concept]
- Endolymphatic Sac Tumor [NCIt concept]
- Endometrial Adenocarcinoma [NCIt concept]
- Endometrial Adenosquamous Carcinoma [NCIt concept]
- Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia [NCIt concept]
- Endometrial Carcinoma [NCIt concept]
- Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Secretory Variant [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation [NCIt concept]
- Endometrial High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Endometrial Hyperplasia [NCIt concept]
- Endometrial Hyperplasia without Atypia [NCIt concept]
- Endometrial Serous Adenocarcinoma [NCIt concept]
- Endometrial Squamous Cell Carcinoma [NCIt concept]
- Endometrioid Adenocarcinoma [NCIt concept]
- Endometrioid Stromal Sarcoma [NCIt concept]
- Endometriosis [NCIt concept]
- Endonuclease 8-Like 1 [NCIt concept]
- Endonuclease 8-Like 3 [NCIt concept]
- Endonuclease III-Like Protein 1 [NCIt concept]
- Endophilin-A2 [NCIt concept]
- Endoplasmic Reticulum Export Factor CTAGE5 [NCIt concept]
- Endorectal Coil [NCIt concept]
- Endoribonuclease Dicer [NCIt concept]
- Endoscope Distal Attachment Cap [NCIt concept]
- Endoscopic Biopsy [NCIt concept]
- Endoscopic Procedure [NCIt concept]
- Endoscopic Retrograde Cholangiopancreatography [NCIt concept]
- Endoscopic Submucosal Dissection [NCIt concept]
- Endoscopic Surgery [NCIt concept]
- Endoscopic Ultrasound [NCIt concept]
- Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis [NCIt concept]
- Endoscopic Ultrasound-Guided Fine-Needle Aspiration [NCIt concept]
- Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas [NCIt concept]
- Endoscopic Ultrasound-Guided Gastroenterostomy [NCIt concept]
- Endoscopic Ultrasound-Guided Radiofrequency Ablation [NCIt concept]
- Endosialin [NCIt concept]
- Endosome/Lysosome-Associated Apoptosis and Autophagy Regulator 1 [NCIt concept]
- Endostatin [NCIt concept]
- Endothelial Cell-Derived Microparticle [NCIt concept]
- Endothelial Cell-Specific Molecule 1 [NCIt concept]
- Endothelial PAS Domain-Containing Protein 1 [NCIt concept]
- Endothelial Protein C Receptor [NCIt concept]
- Endothelial Transcription Factor GATA-2 [NCIt concept]
- Endothelin Receptor Type B [NCIt concept]
- Endothelin-1 [NCIt concept]
- Endothelin-1 Receptor [NCIt concept]
- Endotoxin [NCIt concept]
- Endoxifen Hydrochloride [NCIt concept]
- Energy Expenditure [NCIt concept]
- Engineered Cytokine ORB-021 [NCIt concept]
- Engineered Human Umbilical Vein Endothelial Cells AB-205 [NCIt concept]
- Engineered IL-12 Prodrug WTX-330 [NCIt concept]
- Engineered IL-2 Prodrug WTX-124 [NCIt concept]
- Engineered Interferon ORB-011 [NCIt concept]
- Engineered Mobilized Peripheral Blood-derived Donor Graft OGFT-001 [NCIt concept]
- Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 [NCIt concept]
- Engineered Red Blood Cells Expressing 4-1BBL/IL-12 RTX-224 [NCIt concept]
- Engineered Red Blood Cells Expressing HPV16 E7/4-1BBL/IL-12 RTX-321 [NCIt concept]
- Engineered Toxin Body Targeting CD38 MT-0169 [NCIt concept]
- Engineered Toxin Body Targeting CTLA-4 MT-8421 [NCIt concept]
- Engineered Toxin Body Targeting HER2 MT-5111 [NCIt concept]
- Engineered Toxin Body Targeting PD-L1 MT-6402 [NCIt concept]
- Enhanced Academic Detailing [NCIt concept]
- Enhancer [NCIt concept]
- Enhancer of Polycomb Homolog 1 [NCIt concept]
- Eniluracil [NCIt concept]
- Enitociclib [NCIt concept]
- Enoblituzumab [NCIt concept]
- Enobosarm [NCIt concept]
- Enoticumab [NCIt concept]
- Enoxaparin [NCIt concept]
- Enozertinib [NCIt concept]
- Enristomig [NCIt concept]
- Ensartinib Hydrochloride [NCIt concept]
- Ensituximab [NCIt concept]
- Ensomafusp Alfa [NCIt concept]
- Enteral Tube Feeding [NCIt concept]
- Enteric-Coated Zoledronic Acid Tablet MER-101 [NCIt concept]
- Enterobacter [NCIt concept]
- Enterococcus gallinarum Strain MRx0518 [NCIt concept]
- Enteropathic Arthritis [NCIt concept]
- Enteropathic Spondylitis [NCIt concept]
- Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Entinostat [NCIt concept]
- Entolimod [NCIt concept]
- Entospletinib [NCIt concept]
- Enucleation [NCIt concept]
- Envafolimab [NCIt concept]
- Environmental Carcinogenesis [NCIt concept]
- Environmental Tobacco Smoke [NCIt concept]
- Enzalutamide [NCIt concept]
- Enzastaurin [NCIt concept]
- Enzastaurin Hydrochloride [NCIt concept]
- Enzomenib [NCIt concept]
- Enzyme Activation Therapy [NCIt concept]
- Enzyme Inhibitor Protein [NCIt concept]
- Enzyme Inhibitor Therapy [NCIt concept]
- Enzyme Kinetics [NCIt concept]
- Enzyme-inducing Antiepileptic Drug [NCIt concept]
- Eomesodermin Homolog [NCIt concept]
- Eosinophil [NCIt concept]
- Eosinophilia Greater than 1500 cells per Microliter [NCIt concept]
- Epacadostat [NCIt concept]
- Epacmarstobart [NCIt concept]
- Epcoritamab [NCIt concept]
- EphA Receptor Family [NCIt concept]
- EphA2-targeting DOPC-encapsulated siRNA [NCIt concept]
- Ephrin Receptor [NCIt concept]
- Ephrin Type-A Receptor 1 [NCIt concept]
- Ephrin Type-A Receptor 2 [NCIt concept]
- Ephrin Type-A Receptor 3 [NCIt concept]
- Ephrin Type-A Receptor 5 [NCIt concept]
- Ephrin Type-A Receptor 7 [NCIt concept]
- Ephrin Type-B Receptor 1 [NCIt concept]
- Ephrin Type-B Receptor 2 [NCIt concept]
- Ephrin Type-B Receptor 4 [NCIt concept]
- Ephrin-A [NCIt concept]
- Ephrin-B2 [NCIt concept]
- Epicatechin-3-Gallate [NCIt concept]
- Epidemiology Research [NCIt concept]
- Epidermal Growth Factor [NCIt concept]
- Epidermal Growth Factor Receptor [NCIt concept]
- Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Lesion [NCIt concept]
- Epidermal Growth Factor-Like Protein 7 [NCIt concept]
- Epidermolysis Bullosa [NCIt concept]
- Epididymal Papillary Cystadenoma [NCIt concept]
- Epidural Block [NCIt concept]
- Epigallocatechin [NCIt concept]
- Epigen [NCIt concept]
- Epigenetic Process [NCIt concept]
- Epigenetic Profile [NCIt concept]
- Epiglottic Carcinoma [NCIt concept]
- Epinephrine [NCIt concept]
- Epiretinal Membrane [NCIt concept]
- Epirubicin [NCIt concept]
- Epirubicin Hydrochloride [NCIt concept]
- Epithelial Cell Adhesion Molecule [NCIt concept]
- Epithelial Cell-Transforming Sequence 2 Oncogene-Like [NCIt concept]
- Epithelial Discoidin Domain-Containing Receptor 1 [NCIt concept]
- Epithelial Membrane Protein 1 [NCIt concept]
- Epithelial Predominant Kidney Wilms Tumor [NCIt concept]
- Epithelial Splicing Regulatory Protein 1 [NCIt concept]
- Epithelial-to-Mesenchymal Transition [NCIt concept]
- Epithelioid Leiomyosarcoma [NCIt concept]
- Epithelioid Mesothelioma [NCIt concept]
- Epithelioid Sarcoma [NCIt concept]
- Epithelioid Trophoblastic Tumor [NCIt concept]
- Eplontersen [NCIt concept]
- Epoetin Alfa [NCIt concept]
- Epoprostenol [NCIt concept]
- Epoxyeicosatrienoic Acid [NCIt concept]
- Epratuzumab [NCIt concept]
- Epratuzumab-cys-tesirine [NCIt concept]
- Eprodisate Disodium [NCIt concept]
- Epstein Barr Nuclear Antigen Antibody [NCIt concept]
- Epstein-Barr Nuclear Antigen 1 [NCIt concept]
- Epstein-Barr Nuclear Antigen 2 [NCIt concept]
- Epstein-Barr Virus [NCIt concept]
- Epstein-Barr Virus Antibody [NCIt concept]
- Epstein-Barr Virus Antibody Positive [NCIt concept]
- Epstein-Barr Virus Capsid Antigen Antibody [NCIt concept]
- Epstein-Barr Virus DNA [NCIt concept]
- Epstein-Barr Virus DNA Positive [NCIt concept]
- Epstein-Barr Virus Early RNA [NCIt concept]
- Epstein-Barr Virus Early RNA Positive [NCIt concept]
- Epstein-Barr Virus Negative [NCIt concept]
- Epstein-Barr Virus Positive [NCIt concept]
- Epstein-Barr Virus Reactivation [NCIt concept]
- Equecabtagene Autoleucel [NCIt concept]
- Equilibrative Nucleoside Transporter 1 [NCIt concept]
- Equilibrative Nucleoside Transporter 2 [NCIt concept]
- Equilibrative Nucleoside Transporter 4 [NCIt concept]
- Equine Thymocyte Immune Globulin [NCIt concept]
- Eragidomide [NCIt concept]
- Eramkafusp Alfa [NCIt concept]
- Erastin Analogue PRLX 93936 [NCIt concept]
- ErbB Family Pathway Deregulation [NCIt concept]
- ErbB Receptor Family Protein [NCIt concept]
- Erdafitinib [NCIt concept]
- Erectile Dysfunction [NCIt concept]
- Erenumab [NCIt concept]
- Ergocalciferol [NCIt concept]
- Eribulin Mesylate [NCIt concept]
- Eritoran [NCIt concept]
- Erlotinib [NCIt concept]
- Erlotinib Hydrochloride [NCIt concept]
- Ertumaxomab [NCIt concept]
- Eryaspase [NCIt concept]
- Erythema Measurement [NCIt concept]
- Erythematosquamous Dermatosis [NCIt concept]
- Erythrocyte [NCIt concept]
- Erythrocyte Sedimentation Rate Measurement [NCIt concept]
- Erythroid Burst Forming Unit [NCIt concept]
- Erythroid Colony Forming Unit [NCIt concept]
- Erythroid Stem Cell [NCIt concept]
- Erythroid Transcription Factor [NCIt concept]
- Erythropoietin [NCIt concept]
- Erythropoietin Receptor [NCIt concept]
- Erzotabart [NCIt concept]
- Escherichia coli [NCIt concept]
- Escitalopram [NCIt concept]
- Escitalopram Oxalate [NCIt concept]
- Esomeprazole Magnesium [NCIt concept]
- Esophageal Adenocarcinoma [NCIt concept]
- Esophageal Adenoid Cystic Carcinoma [NCIt concept]
- Esophageal Adenosquamous Carcinoma [NCIt concept]
- Esophageal Anastomotic Stricture [NCIt concept]
- Esophageal Balloon Biopsy [NCIt concept]
- Esophageal Basaloid Squamous Cell Carcinoma [NCIt concept]
- Esophageal Biopsy [NCIt concept]
- Esophageal Carcinoma [NCIt concept]
- Esophageal Dilation [NCIt concept]
- Esophageal Disorder [NCIt concept]
- Esophageal Gastrointestinal Stromal Tumor [NCIt concept]
- Esophageal Intramucosal Adenocarcinoma [NCIt concept]
- Esophageal Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Esophageal Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Esophageal Moderately Differentiated Squamous Cell Carcinoma [NCIt concept]
- Esophageal Mucoepidermoid Carcinoma [NCIt concept]
- Esophageal Neoplasm [NCIt concept]
- Esophageal Neuroendocrine Carcinoma [NCIt concept]
- Esophageal Poorly Differentiated Squamous Cell Carcinoma [NCIt concept]
- Esophageal Spindle Cell Carcinoma [NCIt concept]
- Esophageal Squamous Cell Carcinoma [NCIt concept]
- Esophageal Undifferentiated Carcinoma [NCIt concept]
- Esophageal Verrucous Carcinoma [NCIt concept]
- Esophageal Well Differentiated Squamous Cell Carcinoma [NCIt concept]
- Esophagectomy [NCIt concept]
- Esophagogastroduodenoscopy [NCIt concept]
- Esophagogastroduodenoscopy Patient [NCIt concept]
- Essential Thrombocythemia [NCIt concept]
- Essential Thrombocythemia with CALR Mutation [NCIt concept]
- Essential Thrombocythemia with Recurrent Thrombosis [NCIt concept]
- Esterase [NCIt concept]
- Estimated Glomerular Filtration Rate [NCIt concept]
- Estradiol [NCIt concept]
- Estradiol 17-Beta-Dehydrogenase 1 [NCIt concept]
- Estradiol Greater than 10 pg/mL [NCIt concept]
- Estradiol Vaginal Ring [NCIt concept]
- Estramustine Phosphate Sodium [NCIt concept]
- Estriol [NCIt concept]
- Estrogen [NCIt concept]
- Estrogen Receptor [NCIt concept]
- Estrogen Receptor Agonist GTx-758 [NCIt concept]
- Estrogen Receptor Beta [NCIt concept]
- Estrogen Receptor Family [NCIt concept]
- Estrogen Receptor Negative [NCIt concept]
- Estrogen Receptor Positive [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry 1-10 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry 1-9 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Greater than or Equal to 1 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Greater than or Equal to 10 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Less than 1 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Less than 10 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Less than 20 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Less than or Equal to 10 Percent [NCIt concept]
- Estrogen Receptor Positive by Immunohistochemistry Less than or Equal to 9 Percent [NCIt concept]
- Estrogen Receptor Status [NCIt concept]
- Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Estrogen Sulfotransferase [NCIt concept]
- Estrone [NCIt concept]
- Estrone Conjugate [NCIt concept]
- Estrone Sulfate [NCIt concept]
- Esuberaprost Sodium [NCIt concept]
- Etakafusp Alfa [NCIt concept]
- Etanercept [NCIt concept]
- Etanidazole [NCIt concept]
- Etaracizumab [NCIt concept]
- Etavopivat [NCIt concept]
- Etentamig [NCIt concept]
- Etevritamab [NCIt concept]
- Ethanol-containing Nasal Solution [NCIt concept]
- Ethanolamine Kinase 1 [NCIt concept]
- Ethinyl Estradiol [NCIt concept]
- Ethinyl Estradiol/Levonorgestrel [NCIt concept]
- Ethinyl Estradiol/Norethindrone [NCIt concept]
- Ethiodized Oil [NCIt concept]
- Ethylbenzene [NCIt concept]
- Ethylene Oxide [NCIt concept]
- Etigilimab [NCIt concept]
- Etirinotecan Pegol [NCIt concept]
- Etodolac [NCIt concept]
- Etoposide [NCIt concept]
- Etoposide Phosphate [NCIt concept]
- Etrumadenant [NCIt concept]
- Ets-family Transcription Factor Inhibitor TK216 [NCIt concept]
- Eubacterium [NCIt concept]
- Eucerin [NCIt concept]
- Eukaryotic Initiation Factor 4A-I [NCIt concept]
- Eukaryotic Initiation Factor 4A-II [NCIt concept]
- Eukaryotic Peptide Chain Release Factor GTP-Binding Subunit ERF3A [NCIt concept]
- Eukaryotic Translation Initiation Factor 2 Subunit 1 [NCIt concept]
- Eukaryotic Translation Initiation Factor 2-Alpha Kinase 3 [NCIt concept]
- Eukaryotic Translation Initiation Factor 2-Alpha Kinase 4 [NCIt concept]
- Eukaryotic Translation Initiation Factor 3 Subunit B [NCIt concept]
- Eukaryotic Translation Initiation Factor 3 Subunit K [NCIt concept]
- Eukaryotic Translation Initiation Factor 4 Gamma Family [NCIt concept]
- Eukaryotic Translation Initiation Factor 4A Family [NCIt concept]
- Eukaryotic Translation Initiation Factor 4B [NCIt concept]
- Eukaryotic Translation Initiation Factor 4E [NCIt concept]
- Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 [NCIt concept]
- Eukaryotic Translation Initiation Factor 4F [NCIt concept]
- Eukaryotic Translation Initiation Factor 5 [NCIt concept]
- Eukaryotic Translation Initiation Factor 5A-1 [NCIt concept]
- Eutectic Mixture of Local Anesthetics [NCIt concept]
- Evaluation [NCIt concept]
- Evaluation of Cancer Risk Factors [NCIt concept]
- Everolimus [NCIt concept]
- Everolimus/Exemestane Regimen [NCIt concept]
- Evexomostat [NCIt concept]
- Evofosfamide [NCIt concept]
- Evorpacept [NCIt concept]
- Ewing Sarcoma [NCIt concept]
- Ewing Sarcoma of Bone [NCIt concept]
- Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion [NCIt concept]
- Ex Vivo-Expanded HER2-Specific T Cells [NCIt concept]
- Ex Vivo-expanded Autologous T Cells IMA101 [NCIt concept]
- Ex-Vivo Umbilical Cord Blood Expansion [NCIt concept]
- Ex-vivo T-Cell and B-Cell Depletion [NCIt concept]
- ExAblate 4000 Type 2.0 [NCIt concept]
- Exagamglogene Autotemcel [NCIt concept]
- Examination Under Anesthesia [NCIt concept]
- Exatecan Derivative-containing Antibody-drug Conjugate [NCIt concept]
- Excision [NCIt concept]
- Excision Repair Cross-Complementing Family [NCIt concept]
- Executive Function Disorder [NCIt concept]
- Exemestane [NCIt concept]
- Exercise [NCIt concept]
- Exercise Counseling [NCIt concept]
- Exercise Intervention [NCIt concept]
- Exercise Log [NCIt concept]
- Exhaled Carbon Monoxide Concentration Finding [NCIt concept]
- Exhaled Carbon Monoxide Concentration Greater than 8 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Greater than or Equal to 10 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Greater than or Equal to 6 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Greater than or Equal to 7 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Greater than or Equal to 8 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than 10 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than 5 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than 6 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than 7 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than 8 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than or Equal to 4 ppm [NCIt concept]
- Exhaled Carbon Monoxide Concentration Less than or Equal to 5 ppm [NCIt concept]
- Exhausted T-Cell [NCIt concept]
- Exicorilant [NCIt concept]
- Exisulind [NCIt concept]
- Exlinkibart [NCIt concept]
- ExoDx Prostate Intelliscore [NCIt concept]
- Exocervical Carcinoma [NCIt concept]
- Exon [NCIt concept]
- Exonuclease 1 [NCIt concept]
- Exosome [NCIt concept]
- Exosome Complex Component RRP46 [NCIt concept]
- Expanded Cord Blood Stem Cells Mixed with Engineered Human Endothelial Cells AB-110 [NCIt concept]
- Experimental Tobacco Marketplace [NCIt concept]
- Expiratory Muscle Strength Training [NCIt concept]
- Explantation [NCIt concept]
- Exploratory Laparotomy [NCIt concept]
- Exportin-1 [NCIt concept]
- Extended Release Bupivacaine Hydrochloride Resorbable Matrix Formulation [NCIt concept]
- Extended Release Flucytosine [NCIt concept]
- Extended Release Metformin Hydrochloride [NCIt concept]
- Extended-release Galantamine Hydrobromide [NCIt concept]
- Extended-release Microsphere Capsule-based Oxycodone [NCIt concept]
- Extension for Community Healthcare Outcomes [NCIt concept]
- Extensive Stage Lung Small Cell Carcinoma [NCIt concept]
- External Beam Radiation Therapy [NCIt concept]
- External Ear Basal Cell Carcinoma [NCIt concept]
- External Examination [NCIt concept]
- External Qigong Therapy [NCIt concept]
- Extra Domain B Fibronectin [NCIt concept]
- Extra-Adrenal Paraganglioma [NCIt concept]
- Extracavitary Primary Effusion Lymphoma [NCIt concept]
- Extracellular Sulfatase Sulf-2 [NCIt concept]
- Extracellular Superoxide Dismutase [Cu-Zn] [NCIt concept]
- Extracorporeal Photopheresis [NCIt concept]
- Extracranial Solid Neoplasm [NCIt concept]
- Extracutaneous Mastocytoma [NCIt concept]
- Extragonadal Germ Cell Tumor [NCIt concept]
- Extragonadal Seminoma [NCIt concept]
- Extrahepatic Bile Duct Adenocarcinoma [NCIt concept]
- Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Extramedullary Disease in Multiple Myeloma Involving the Uterine Corpus [NCIt concept]
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System [NCIt concept]
- Extranodal Non-Hodgkin Lymphoma [NCIt concept]
- Extraocular Retinoblastoma [NCIt concept]
- Extraosseous Plasmacytoma [NCIt concept]
- Extrapleural Pneumonectomy [NCIt concept]
- Extrapulmonary Neuroendocrine Carcinoma [NCIt concept]
- Extrapulmonary Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Extraskeletal Ewing Sarcoma [NCIt concept]
- Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Extremely Dense Breast [NCIt concept]
- Eye Enucleation [NCIt concept]
- Eye Examination [NCIt concept]
- Eye Fundus Photography [NCIt concept]
- Eye Movement Measurement [NCIt concept]
- Eye Tracking [NCIt concept]
- Eye Tracking via Glasses [NCIt concept]
- Ezabenlimab [NCIt concept]
- Ezatiostat Hydrochloride [NCIt concept]
- Ezetimibe [NCIt concept]
- Ezetimibe/Simvastatin [NCIt concept]
- Ezobresib [NCIt concept]
- Ezurpimtrostat [NCIt concept]
- F-18 16 Alpha-Fluoroestradiol [NCIt concept]
- F-18 Fluciclovine Positron Emission Tomography and Computed Tomography [NCIt concept]
- F-18 Sodium Fluoride Positron Emission Tomography [NCIt concept]
- F-BAR and Double SH3 Domains Protein 1 [NCIt concept]
- F-Box Only Protein 11 [NCIt concept]
- F-Box Only Protein 3 [NCIt concept]
- F-Box Only Protein 31 [NCIt concept]
- F-Box Only Protein 32 [NCIt concept]
- F-Box Only Protein 38 [NCIt concept]
- F-Box Only Protein 5 [NCIt concept]
- F-Box-Like/WD Repeat-Containing Protein TBL1X [NCIt concept]
- F-Box-Like/WD Repeat-Containing Protein TBL1Y [NCIt concept]
- F-Box/LRR-Repeat Protein 18 [NCIt concept]
- F-Box/WD Repeat-Containing Protein 7 [NCIt concept]
- F-actin [NCIt concept]
- F1.2 [NCIt concept]
- F11R Gene [NCIt concept]
- F11R wt Allele [NCIt concept]
- F12 Gene [NCIt concept]
- F12 wt Allele [NCIt concept]
- F2 Gene [NCIt concept]
- F2 Gene Mutation [NCIt concept]
- F2 Gene Product [NCIt concept]
- F2 Isoprostane Measurement [NCIt concept]
- F2 NM_000506.4:c.*97G>A [NCIt concept]
- F2 wt Allele [NCIt concept]
- F2R Gene [NCIt concept]
- F2R wt Allele [NCIt concept]
- F3 Gene [NCIt concept]
- F3 Positive [NCIt concept]
- F3 wt Allele [NCIt concept]
- F4-Isoprostane [NCIt concept]
- F5 Gene [NCIt concept]
- F5 Gene Mutation [NCIt concept]
- F5 NM_000130.4:c.1601G>A [NCIt concept]
- F5 NP_000121.2:p.R534Q [NCIt concept]
- F5 Protein Variant [NCIt concept]
- F5 wt Allele [NCIt concept]
- F8 Gene [NCIt concept]
- F8 wt Allele [NCIt concept]
- F9 Gene [NCIt concept]
- F9 wt Allele [NCIt concept]
- FA Complementation Group Gene [NCIt concept]
- FAAP20 Gene [NCIt concept]
- FAAP20 Gene Mutation [NCIt concept]
- FAAP20 wt Allele [NCIt concept]
- FAAP24 Gene [NCIt concept]
- FAAP24 wt Allele [NCIt concept]
- FABP1 Gene [NCIt concept]
- FABP1 wt Allele [NCIt concept]
- FABP2 Gene [NCIt concept]
- FABP4 Gene [NCIt concept]
- FABP4 wt Allele [NCIt concept]
- FABP6 Gene [NCIt concept]
- FABP6 wt Allele [NCIt concept]
- FACT Complex [NCIt concept]
- FACT Complex Subunit SPT16 [NCIt concept]
- FACT Complex Subunit SSRP1 [NCIt concept]
- FACT Complex-targeting Curaxin CBL0137 [NCIt concept]
- FACT-H&N Questionnaire [NCIt concept]
- FACT-MM Questionnaire [NCIt concept]
- FADD Gene [NCIt concept]
- FADD wt Allele [NCIt concept]
- FAK Inhibitor [NCIt concept]
- FAK Inhibitor VS-4718 [NCIt concept]
- FAM3C Gene [NCIt concept]
- FAM3C wt Allele [NCIt concept]
- FAN1 Gene [NCIt concept]
- FAN1 Gene Mutation [NCIt concept]
- FAN1 wt Allele [NCIt concept]
- FANCA Biallelic Inactivation [NCIt concept]
- FANCA Gene [NCIt concept]
- FANCA Gene Amplification [NCIt concept]
- FANCA Gene Mutation [NCIt concept]
- FANCA wt Allele [NCIt concept]
- FANCB Gene [NCIt concept]
- FANCB Gene Mutation [NCIt concept]
- FANCB wt Allele [NCIt concept]
- FANCC Gene [NCIt concept]
- FANCC Gene Amplification [NCIt concept]
- FANCC Gene Mutation [NCIt concept]
- FANCC wt Allele [NCIt concept]
- FANCD2 Gene [NCIt concept]
- FANCD2 Gene Amplification [NCIt concept]
- FANCD2 Gene Mutation [NCIt concept]
- FANCD2 wt Allele [NCIt concept]
- FANCE Gene [NCIt concept]
- FANCE Gene Amplification [NCIt concept]
- FANCE Gene Mutation [NCIt concept]
- FANCE wt Allele [NCIt concept]
- FANCF Gene [NCIt concept]
- FANCF Gene Mutation [NCIt concept]
- FANCF wt Allele [NCIt concept]
- FANCG Gene [NCIt concept]
- FANCG Gene Mutation [NCIt concept]
- FANCG wt Allele [NCIt concept]
- FANCI Gene [NCIt concept]
- FANCI Gene Mutation [NCIt concept]
- FANCI wt Allele [NCIt concept]
- FANCL Gene [NCIt concept]
- FANCL Gene Mutation [NCIt concept]
- FANCL Gene Mutation Negative [NCIt concept]
- FANCL wt Allele [NCIt concept]
- FANCM Gene [NCIt concept]
- FANCM Gene Mutation [NCIt concept]
- FANCM wt Allele [NCIt concept]
- FAP Gene [NCIt concept]
- FAP Positive [NCIt concept]
- FAP wt Allele [NCIt concept]
- FAP/4-1BB-targeting Fusion Protein RO7122290 [NCIt concept]
- FAS Gene [NCIt concept]
- FAS wt Allele [NCIt concept]
- FAS-Associated Death Domain Protein [NCIt concept]
- FASLG Gene [NCIt concept]
- FASLG wt Allele [NCIt concept]
- FASN Gene [NCIt concept]
- FASN wt Allele [NCIt concept]
- FAT1 Gene [NCIt concept]
- FAT1 Gene Mutation [NCIt concept]
- FAT1 wt Allele [NCIt concept]
- FAT4 Gene [NCIt concept]
- FAT4 wt Allele [NCIt concept]
- FBN2 Gene [NCIt concept]
- FBN2 wt Allele [NCIt concept]
- FBXL18 Gene [NCIt concept]
- FBXL18 wt Allele [NCIt concept]
- FBXO11 Gene [NCIt concept]
- FBXO11 wt Allele [NCIt concept]
- FBXO3 Gene [NCIt concept]
- FBXO3 Gene Deletion [NCIt concept]
- FBXO3 wt Allele [NCIt concept]
- FBXO31 Gene [NCIt concept]
- FBXO31 Gene Deletion [NCIt concept]
- FBXO31 wt Allele [NCIt concept]
- FBXO32 Gene [NCIt concept]
- FBXO32 wt Allele [NCIt concept]
- FBXO38 Gene [NCIt concept]
- FBXO38 wt Allele [NCIt concept]
- FBXO5 Gene [NCIt concept]
- FBXO5 wt Allele [NCIt concept]
- FBXW7 Gene [NCIt concept]
- FBXW7 Gene Mutation [NCIt concept]
- FBXW7 Gene Mutation Negative [NCIt concept]
- FBXW7 wt Allele [NCIt concept]
- FCER2 Gene [NCIt concept]
- FCER2 Negative [NCIt concept]
- FCER2 Positive [NCIt concept]
- FCER2 wt Allele [NCIt concept]
- FCGR1A Gene [NCIt concept]
- FCGR1A wt Allele [NCIt concept]
- FCGR2A Gene [NCIt concept]
- FCGR2A wt Allele [NCIt concept]
- FCGR2B Gene [NCIt concept]
- FCGR2B wt Allele [NCIt concept]
- FCGR2C Gene [NCIt concept]
- FCGR2C wt Allele [NCIt concept]
- FCGR3A Gene [NCIt concept]
- FCGR3A wt Allele [NCIt concept]
- FCGR3B Gene [NCIt concept]
- FCGR3B wt Allele [NCIt concept]
- FCHSD1 Gene [NCIt concept]
- FCHSD1 wt Allele [NCIt concept]
- FCN2 Gene [NCIt concept]
- FCN2 wt Allele [NCIt concept]
- FCRL1 Gene [NCIt concept]
- FCRL1 wt Allele [NCIt concept]
- FCRL2 Gene [NCIt concept]
- FCRL2 wt Allele [NCIt concept]
- FCRL4 Gene [NCIt concept]
- FCRL4 wt Allele [NCIt concept]
- FCRL5 Gene [NCIt concept]
- FCRL5 wt Allele [NCIt concept]
- FDG-Positron Emission Tomography [NCIt concept]
- FDG-Positron Emission Tomography/Computed Tomography of the Whole Body [NCIt concept]
- FDPS Gene [NCIt concept]
- FDPS wt Allele [NCIt concept]
- FEN1 Gene [NCIt concept]
- FEN1 Gene Mutation [NCIt concept]
- FEN1 wt Allele [NCIt concept]
- FERMT2 Gene [NCIt concept]
- FERMT2 wt Allele [NCIt concept]
- FET Family Fusion Gene [NCIt concept]
- FET Family Gene [NCIt concept]
- FET Family Gene Translocation [NCIt concept]
- FET/ETS Family Fusion Gene [NCIt concept]
- FEV Gene [NCIt concept]
- FEV wt Allele [NCIt concept]
- FFAR4 Gene [NCIt concept]
- FFAR4 wt Allele [NCIt concept]
- FGD4 Gene [NCIt concept]
- FGD4 wt Allele [NCIt concept]
- FGD5 Gene [NCIt concept]
- FGD5 wt Allele [NCIt concept]
- FGF Family Alteration Positive [NCIt concept]
- FGF Receptor Antagonist HGS1036 [NCIt concept]
- FGF1 Gene [NCIt concept]
- FGF1 Gene Amplification [NCIt concept]
- FGF1 Gene Fusion Positive [NCIt concept]
- FGF1 Gene Mutation [NCIt concept]
- FGF1 wt Allele [NCIt concept]
- FGF10 Gene [NCIt concept]
- FGF10 wt Allele [NCIt concept]
- FGF13 Gene [NCIt concept]
- FGF13 wt Allele [NCIt concept]
- FGF19 Gene [NCIt concept]
- FGF19 Gene Amplification [NCIt concept]
- FGF19 Positive [NCIt concept]
- FGF19 wt Allele [NCIt concept]
- FGF2 Gene [NCIt concept]
- FGF2 wt Allele [NCIt concept]
- FGF21 Gene [NCIt concept]
- FGF21 wt Allele [NCIt concept]
- FGF22 Gene [NCIt concept]
- FGF22 wt Allele [NCIt concept]
- FGF23 Gene [NCIt concept]
- FGF23 Overexpression Positive [NCIt concept]
- FGF23 wt Allele [NCIt concept]
- FGF3 Gene [NCIt concept]
- FGF3 Gene Amplification [NCIt concept]
- FGF3 Gene Fusion Positive [NCIt concept]
- FGF3 Gene Mutation [NCIt concept]
- FGF3 wt Allele [NCIt concept]
- FGF4 Gene [NCIt concept]
- FGF4 Gene Amplification [NCIt concept]
- FGF4 wt Allele [NCIt concept]
- FGF5 Gene [NCIt concept]
- FGF5 wt Allele [NCIt concept]
- FGF7 Gene [NCIt concept]
- FGF7 wt Allele [NCIt concept]
- FGF8 Gene [NCIt concept]
- FGF8 wt Allele [NCIt concept]
- FGF9 Gene [NCIt concept]
- FGF9 Gene Amplification [NCIt concept]
- FGF9 wt Allele [NCIt concept]
- FGFR Family Alteration Negative [NCIt concept]
- FGFR Family Alteration Positive [NCIt concept]
- FGFR Gene Amplification [NCIt concept]
- FGFR Gene Fusion Positive [NCIt concept]
- FGFR Gene Mutation [NCIt concept]
- FGFR Gene Rearrangement [NCIt concept]
- FGFR Gene Translocation [NCIt concept]
- FGFR Inhibitor ASP5878 [NCIt concept]
- FGFR Kinase Domain Tandem Duplication [NCIt concept]
- FGFR-targeting Agent [NCIt concept]
- FGFR/TACC Family Fusion Gene [NCIt concept]
- FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999 [NCIt concept]
- FGFR1 Gene [NCIt concept]
- FGFR1 Gene Alteration Positive [NCIt concept]
- FGFR1 Gene Amplification [NCIt concept]
- FGFR1 Gene Fusion Positive [NCIt concept]
- FGFR1 Gene Mutation [NCIt concept]
- FGFR1 Gene Rearrangement [NCIt concept]
- FGFR1 Gene Translocation [NCIt concept]
- FGFR1 Oncogene Partner 2 [NCIt concept]
- FGFR1 Overexpression Positive [NCIt concept]
- FGFR1 Positive [NCIt concept]
- FGFR1 wt Allele [NCIt concept]
- FGFR1/2/3 Inhibitor TYRA-200 [NCIt concept]
- FGFR1/FGFR1OP Fusion Gene [NCIt concept]
- FGFR1/TACC1 Fusion Gene [NCIt concept]
- FGFR1/TACC1 Fusion Protein [NCIt concept]
- FGFR1/ZMYM2 Fusion Gene [NCIt concept]
- FGFR1OP/FGFR1 Fusion Gene [NCIt concept]
- FGFR1OP/FGFR1 Fusion Protein [NCIt concept]
- FGFR1OP2 Gene [NCIt concept]
- FGFR1OP2 wt Allele [NCIt concept]
- FGFR1OP2/FGFR1 Fusion Gene [NCIt concept]
- FGFR1OP2/FGFR1 Fusion Protein [NCIt concept]
- FGFR2 Fusion Positive [NCIt concept]
- FGFR2 Gene [NCIt concept]
- FGFR2 Gene Alteration Positive [NCIt concept]
- FGFR2 Gene Amplification [NCIt concept]
- FGFR2 Gene Fusion Positive [NCIt concept]
- FGFR2 Gene Mutation [NCIt concept]
- FGFR2 Gene Product [NCIt concept]
- FGFR2 Gene Rearrangement [NCIt concept]
- FGFR2 Gene Translocation [NCIt concept]
- FGFR2 Inhibitor 3HP-2827 [NCIt concept]
- FGFR2 NM_000141.4:c.1115C>G [NCIt concept]
- FGFR2 NM_000141.4:c.1124A>G [NCIt concept]
- FGFR2 NM_000141.4:c.1144T>C [NCIt concept]
- FGFR2 NM_000141.4:c.1645A>C [NCIt concept]
- FGFR2 NM_000141.4:c.1647T>A [NCIt concept]
- FGFR2 NM_000141.4:c.1647T>G [NCIt concept]
- FGFR2 NM_000141.4:c.1975A>G [NCIt concept]
- FGFR2 NM_000141.4:c.755C>G [NCIt concept]
- FGFR2 NM_000141.4:c.758C>G [NCIt concept]
- FGFR2 NP_000132.3:p.C382R [NCIt concept]
- FGFR2 NP_000132.3:p.K659E [NCIt concept]
- FGFR2 NP_000132.3:p.N549H [NCIt concept]
- FGFR2 NP_000132.3:p.N549K [NCIt concept]
- FGFR2 NP_000132.3:p.P253R [NCIt concept]
- FGFR2 NP_000132.3:p.S252W [NCIt concept]
- FGFR2 NP_000132.3:p.S372C [NCIt concept]
- FGFR2 NP_000132.3:p.Y375C [NCIt concept]
- FGFR2 Overexpression Positive [NCIt concept]
- FGFR2 Positive [NCIt concept]
- FGFR2 Protein Variant [NCIt concept]
- FGFR2 wt Allele [NCIt concept]
- FGFR2/3 Inhibitor CGT4859 [NCIt concept]
- FGFR2/BICC1 Fusion Gene [NCIt concept]
- FGFR2/BICC1 Fusion Protein [NCIt concept]
- FGFR2/CASP7 Fusion Gene [NCIt concept]
- FGFR2/CASP7 Fusion Protein [NCIt concept]
- FGFR2/INA Fusion Gene [NCIt concept]
- FGFR2B Overexpression [NCIt concept]
- FGFR2IIIb Positive [NCIt concept]
- FGFR3 Gene [NCIt concept]
- FGFR3 Gene Alteration Positive [NCIt concept]
- FGFR3 Gene Amplification [NCIt concept]
- FGFR3 Gene Fusion Positive [NCIt concept]
- FGFR3 Gene Mutation [NCIt concept]
- FGFR3 Gene Rearrangement [NCIt concept]
- FGFR3 Gene Translocation [NCIt concept]
- FGFR3 Inhibitor LOXO-435 [NCIt concept]
- FGFR3 NM_000142.4:c.1108G>T [NCIt concept]
- FGFR3 NM_000142.4:c.1111A>T [NCIt concept]
- FGFR3 NM_000142.4:c.1118A>G [NCIt concept]
- FGFR3 NM_000142.4:c.1138G>A [NCIt concept]
- FGFR3 NM_000142.4:c.1138G>C [NCIt concept]
- FGFR3 NM_000142.4:c.1948A>G [NCIt concept]
- FGFR3 NM_000142.4:c.742C>T [NCIt concept]
- FGFR3 NM_000142.4:c.746C>G [NCIt concept]
- FGFR3 NP_000133.1:p.G370C [NCIt concept]
- FGFR3 NP_000133.1:p.G380R [NCIt concept]
- FGFR3 NP_000133.1:p.K650E [NCIt concept]
- FGFR3 NP_000133.1:p.R248C [NCIt concept]
- FGFR3 NP_000133.1:p.S249C [NCIt concept]
- FGFR3 NP_000133.1:p.S371C [NCIt concept]
- FGFR3 NP_000133.1:p.Y373C [NCIt concept]
- FGFR3 Overexpression Positive [NCIt concept]
- FGFR3 Protein Variant [NCIt concept]
- FGFR3 wt Allele [NCIt concept]
- FGFR3/4 Inhibitor TYRA-430 [NCIt concept]
- FGFR3/BAIAP2L1 Fusion Gene [NCIt concept]
- FGFR3/BAIAP2L1 Fusion Protein [NCIt concept]
- FGFR3/TACC3 Fusion Gene [NCIt concept]
- FGFR3/TACC3 Fusion Protein [NCIt concept]
- FGFR4 Alteration Positive [NCIt concept]
- FGFR4 Antagonist INCB062079 [NCIt concept]
- FGFR4 Gene [NCIt concept]
- FGFR4 Gene Amplification [NCIt concept]
- FGFR4 Gene Fusion Positive [NCIt concept]
- FGFR4 Gene Mutation [NCIt concept]
- FGFR4 Gene Rearrangement [NCIt concept]
- FGFR4 Gene Translocation [NCIt concept]
- FGFR4 Inhibitor H3B-6527 [NCIt concept]
- FGFR4 Positive [NCIt concept]
- FGFR4 wt Allele [NCIt concept]
- FGR Gene [NCIt concept]
- FGR wt Allele [NCIt concept]
- FH Alteration Positive [NCIt concept]
- FH Gene [NCIt concept]
- FH Gene Mutation [NCIt concept]
- FH wt Allele [NCIt concept]
- FH2 Domain-Containing Protein 1 [NCIt concept]
- FHDC1 Gene [NCIt concept]
- FHDC1 wt Allele [NCIt concept]
- FIGO Stage IC1 Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IC2 Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IC3 Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage II Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage III Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IIIA Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IIIA1 Ovarian Cancer [NCIt concept]
- FIGO Stage IIIA1(i) Ovarian Cancer [NCIt concept]
- FIGO Stage IIIA1(ii) Ovarian Cancer [NCIt concept]
- FIGO Stage IIIA2 Ovarian Cancer [NCIt concept]
- FIGO Stage IIIB Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IIIC Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IV Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IVA Ovarian Cancer 2014 [NCIt concept]
- FIGO Stage IVB Ovarian Cancer 2014 [NCIt concept]
- FIP1L1 Gene [NCIt concept]
- FIP1L1 wt Allele [NCIt concept]
- FIP1L1-PDGFRalpha Fusion Protein Expression [NCIt concept]
- FIP1L1/PDGFRA Fusion Gene [NCIt concept]
- FIP1L1/PDGFRA Fusion Protein [NCIt concept]
- FKBP1A Gene [NCIt concept]
- FKBP1A wt Allele [NCIt concept]
- FKBP5 Gene [NCIt concept]
- FKBP5 wt Allele [NCIt concept]
- FKBP8 Gene [NCIt concept]
- FKBP8 wt Allele [NCIt concept]
- FLCN Gene [NCIt concept]
- FLCN Gene Mutation [NCIt concept]
- FLCN wt Allele [NCIt concept]
- FLG Gene [NCIt concept]
- FLG wt Allele [NCIt concept]
- FLI1 Gene [NCIt concept]
- FLI1 wt Allele [NCIt concept]
- FLICE Inhibitory Protein [NCIt concept]
- FLNA Gene [NCIt concept]
- FLNA wt Allele [NCIt concept]
- FLOT1 Gene [NCIt concept]
- FLOT1 wt Allele [NCIt concept]
- FLT-Positron Emission Tomography [NCIt concept]
- FLT1 Gene [NCIt concept]
- FLT1 Gene Amplification [NCIt concept]
- FLT1 Gene Mutation [NCIt concept]
- FLT1 Overexpression Positive [NCIt concept]
- FLT1 wt Allele [NCIt concept]
- FLT3 Activation Loop Mutation [NCIt concept]
- FLT3 Agonist-Fc Fusion Protein GS-3583 [NCIt concept]
- FLT3 Gene [NCIt concept]
- FLT3 Gene Amplification [NCIt concept]
- FLT3 Gene Mutation [NCIt concept]
- FLT3 Gene Mutation Negative [NCIt concept]
- FLT3 Inhibitor BMF-500 [NCIt concept]
- FLT3 Inhibitor FF-10101 Succinate [NCIt concept]
- FLT3 Internal Tandem Duplication [NCIt concept]
- FLT3 Internal Tandem Duplication Negative [NCIt concept]
- FLT3 Internal Tandem Duplication Positive [NCIt concept]
- FLT3 Juxtamembrane Domain Point Mutation [NCIt concept]
- FLT3 NM_004119.2:c.2525A>G [NCIt concept]
- FLT3 NP_004110.2:p.D835X [NCIt concept]
- FLT3 NP_004110.2:p.F691L [NCIt concept]
- FLT3 NP_004110.2:p.I836X [NCIt concept]
- FLT3 NP_004110.2:p.Y842C [NCIt concept]
- FLT3 Non-Internal Tandem Duplication Activating Mutation Positive [NCIt concept]
- FLT3 Overexpression Positive [NCIt concept]
- FLT3 Positive [NCIt concept]
- FLT3 Protein Variant [NCIt concept]
- FLT3 Tyrosine Kinase Domain Mutation Negative [NCIt concept]
- FLT3 Tyrosine Kinase Domain Point Mutation [NCIt concept]
- FLT3 Tyrosine Kinase Inhibitor TTT-3002 [NCIt concept]
- FLT3 wt Allele [NCIt concept]
- FLT3-Internal Tandem Duplication High Allelic Ratio [NCIt concept]
- FLT3/ABL/Aurora Kinase Inhibitor KW-2449 [NCIt concept]
- FLT3/CDK4/6 Inhibitor FLX925 [NCIt concept]
- FLT3/KIT/CSF1R Inhibitor NMS-03592088 [NCIt concept]
- FLT3LG Gene [NCIt concept]
- FLT3LG wt Allele [NCIt concept]
- FLT4 Gene [NCIt concept]
- FLT4 Gene Amplification [NCIt concept]
- FLT4 Gene Mutation [NCIt concept]
- FLT4 Overexpression Positive [NCIt concept]
- FLT4 wt Allele [NCIt concept]
- FMC7 Positive [NCIt concept]
- FMO1 Gene [NCIt concept]
- FMO1 wt Allele [NCIt concept]
- FMO3 Gene [NCIt concept]
- FMO3 wt Allele [NCIt concept]
- FMOD Gene [NCIt concept]
- FMOD wt Allele [NCIt concept]
- FN1 Gene [NCIt concept]
- FN1 wt Allele [NCIt concept]
- FNBP1 Gene [NCIt concept]
- FNBP1 wt Allele [NCIt concept]
- FNDC5 Gene [NCIt concept]
- FNDC5 Gene Product [NCIt concept]
- FNDC5 wt Allele [NCIt concept]
- FOLFIRI Regimen [NCIt concept]
- FOLFIRI-Bevacizumab Regimen [NCIt concept]
- FOLFOX Regimen [NCIt concept]
- FOLFOX-6 Regimen [NCIt concept]
- FOLH1 Antibody [NCIt concept]
- FOLH1 Gene [NCIt concept]
- FOLH1 Positive [NCIt concept]
- FOLH1 wt Allele [NCIt concept]
- FOLR1 Gene [NCIt concept]
- FOLR1 wt Allele [NCIt concept]
- FOLR1-targeting Agent [NCIt concept]
- FOLR2 Gene [NCIt concept]
- FOLR2 Positive [NCIt concept]
- FOLR2 wt Allele [NCIt concept]
- FOS Gene [NCIt concept]
- FOS wt Allele [NCIt concept]
- FOSL1 Gene [NCIt concept]
- FOSL1 wt Allele [NCIt concept]
- FOXL2 Gene [NCIt concept]
- FOXL2 wt Allele [NCIt concept]
- FOXM1 Gene [NCIt concept]
- FOXM1 wt Allele [NCIt concept]
- FOXO Family [NCIt concept]
- FOXO1 Fusion Negative [NCIt concept]
- FOXO1 Fusion Positive [NCIt concept]
- FOXO1 Gene [NCIt concept]
- FOXO1 wt Allele [NCIt concept]
- FOXO1/PAX3 Fusion Gene [NCIt concept]
- FOXO1/PAX7 Fusion Gene [NCIt concept]
- FOXO3 Gene [NCIt concept]
- FOXO3 wt Allele [NCIt concept]
- FOXO4 Gene [NCIt concept]
- FOXO4 wt Allele [NCIt concept]
- FOXP1 Gene [NCIt concept]
- FOXP1 wt Allele [NCIt concept]
- FOXP3 Gene [NCIt concept]
- FOXP3 Treg-Specific Demethylated Region [NCIt concept]
- FOXP3 wt Allele [NCIt concept]
- FOXP3-Expressing Regulatory T-Lymphocyte Count Percent Change From Baseline [NCIt concept]
- FOXR2 Gene [NCIt concept]
- FOXR2 Gene Mutation [NCIt concept]
- FOXR2 wt Allele [NCIt concept]
- FPGS Gene [NCIt concept]
- FPGS wt Allele [NCIt concept]
- FPV Vaccine CV301 [NCIt concept]
- FPV-Brachyury-TRICOM Vaccine [NCIt concept]
- FRAT1 Gene [NCIt concept]
- FRAT1 wt Allele [NCIt concept]
- FRK Positive [NCIt concept]
- FRS2 Gene [NCIt concept]
- FRS2 wt Allele [NCIt concept]
- FRS3 Gene [NCIt concept]
- FRS3 wt Allele [NCIt concept]
- FSCN1 Gene [NCIt concept]
- FSCN1 wt Allele [NCIt concept]
- FSHB Gene [NCIt concept]
- FSHB wt Allele [NCIt concept]
- FSHR Gene [NCIt concept]
- FSHR Positive [NCIt concept]
- FSHR wt Allele [NCIt concept]
- FST Gene [NCIt concept]
- FST wt Allele [NCIt concept]
- FSTL3 Gene [NCIt concept]
- FTO Gene [NCIt concept]
- FTO wt Allele [NCIt concept]
- FUBP1 Gene [NCIt concept]
- FUBP1 wt Allele [NCIt concept]
- FUS Gene [NCIt concept]
- FUS Gene Translocation [NCIt concept]
- FUS wt Allele [NCIt concept]
- FUS/ATF1 Fusion Gene [NCIt concept]
- FUS/ATF1 Fusion Protein [NCIt concept]
- FUS/CREB3L2 Fusion Gene [NCIt concept]
- FUS/CREB3L2 Fusion Protein [NCIt concept]
- FUS/DDIT3 Fusion Gene [NCIt concept]
- FUS/DDIT3 Fusion Protein [NCIt concept]
- FUS/ERG Fusion Gene [NCIt concept]
- FUS/ERG Fusion Protein [NCIt concept]
- FUS/NFATC2 Fusion Gene [NCIt concept]
- FUS/NFATC2 Fusion Protein [NCIt concept]
- FUT4 Gene [NCIt concept]
- FUT4 wt Allele [NCIt concept]
- FYN Gene [NCIt concept]
- FYN Gene Mutation [NCIt concept]
- FYN wt Allele [NCIt concept]
- FYVE, RhoGEF and PH Domain-Containing Protein 4 [NCIt concept]
- FYVE, RhoGEF and PH Domain-Containing Protein 5 [NCIt concept]
- FZD1 Gene [NCIt concept]
- FZD1 wt Allele [NCIt concept]
- FZD2 Gene [NCIt concept]
- FZD2 wt Allele [NCIt concept]
- FZD3 Gene [NCIt concept]
- FZD3 wt Allele [NCIt concept]
- FZD7 Gene [NCIt concept]
- FZD7 wt Allele [NCIt concept]
- FZD8 Gene [NCIt concept]
- FZD8 wt Allele [NCIt concept]
- Factor VII-targeting Immunoconjugate Protein ICON-1 [NCIt concept]
- Fadraciclib [NCIt concept]
- Falbikitug [NCIt concept]
- Falimarev [NCIt concept]
- Fall Risk Assessment [NCIt concept]
- Fallopian Tube Adenocarcinoma [NCIt concept]
- Fallopian Tube Adenosarcoma [NCIt concept]
- Fallopian Tube Carcinoma [NCIt concept]
- Fallopian Tube Carcinosarcoma [NCIt concept]
- Fallopian Tube Clear Cell Adenocarcinoma [NCIt concept]
- Fallopian Tube Gestational Choriocarcinoma [NCIt concept]
- Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Fallopian Tube Leiomyosarcoma [NCIt concept]
- Fallopian Tube Mucinous Adenocarcinoma [NCIt concept]
- Fallopian Tube Papillary Adenocarcinoma [NCIt concept]
- Fallopian Tube Serous Adenocarcinoma [NCIt concept]
- Fallopian Tube Squamous Cell Carcinoma [NCIt concept]
- Fallopian Tube Transitional Cell Carcinoma [NCIt concept]
- Fallopian Tube Undifferentiated Carcinoma [NCIt concept]
- Familial Adenomatous Polyposis [NCIt concept]
- Familial Amyloid Neuropathy [NCIt concept]
- Familial Hemophagocytic Lymphohistiocytosis [NCIt concept]
- Familial Polycythemia [NCIt concept]
- Familial Testicular Germ Cell Tumor [NCIt concept]
- Familial Waldenstrom Macroglobulinemia [NCIt concept]
- Family Therapy [NCIt concept]
- Famotidine [NCIt concept]
- Fanconi Anemia [NCIt concept]
- Fanconi Anemia Complementation Group Gene Mutation [NCIt concept]
- Fanconi Anemia Complementation Group Gene Mutation Negative [NCIt concept]
- Fanconi Anemia Core Complex-Associated Protein 20 [NCIt concept]
- Fanconi Anemia Core Complex-Associated Protein 24 [NCIt concept]
- Fanconi Anemia Group A Protein [NCIt concept]
- Fanconi Anemia Group B Protein [NCIt concept]
- Fanconi Anemia Group C Protein [NCIt concept]
- Fanconi Anemia Group D2 Protein [NCIt concept]
- Fanconi Anemia Group E Protein [NCIt concept]
- Fanconi Anemia Group F Protein [NCIt concept]
- Fanconi Anemia Group G Protein [NCIt concept]
- Fanconi Anemia Group I Protein [NCIt concept]
- Fanconi Anemia Group J Protein [NCIt concept]
- Fanconi Anemia Group M Protein [NCIt concept]
- Fanconi-Associated Nuclease 1 [NCIt concept]
- Far Upstream Element-Binding Protein 1 [NCIt concept]
- Faricimab [NCIt concept]
- Farletuzumab [NCIt concept]
- Farletuzumab Ecteribulin [NCIt concept]
- Farnesyl Protein Transferase [NCIt concept]
- Farnesyl Pyrophosphate Synthetase [NCIt concept]
- Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells [NCIt concept]
- Fascin [NCIt concept]
- Fascin Inhibitor NP-G2-044 [NCIt concept]
- Fatigue [NCIt concept]
- Fatigue Assessment and Management [NCIt concept]
- Fatty Acid [NCIt concept]
- Fatty Acid Binding Protein 1 Measurement [NCIt concept]
- Fatty Acid Synthase [NCIt concept]
- Fatty Acid-Binding Protein, Adipocyte [NCIt concept]
- Fatty Acid-Binding Protein, Liver [NCIt concept]
- Favezelimab [NCIt concept]
- Favezelimab/Pembrolizumab Formulation [NCIt concept]
- Favorable Intermediate Risk Prostate Carcinoma [NCIt concept]
- Fc Fusion IL-7 Mimetic MDK-703 [NCIt concept]
- Fc Receptor [NCIt concept]
- Fc Receptor-Like Protein 1 [NCIt concept]
- Fc Receptor-Like Protein 2 [NCIt concept]
- Fc Receptor-Like Protein 4 [NCIt concept]
- Fc Receptor-Like Protein 5 [NCIt concept]
- Fc-Gamma Receptor [NCIt concept]
- Fc-Gamma Receptor II [NCIt concept]
- Fc-Gamma Receptor III [NCIt concept]
- Fecal DNA Test [NCIt concept]
- Fecal Immunochemical Test [NCIt concept]
- Fecal Incontinence [NCIt concept]
- Fecal Microbiota Preparation MTP-101P [NCIt concept]
- Fecal Microbiota Transplantation [NCIt concept]
- Fecal Microbiota Transplantation Capsule [NCIt concept]
- Fecal Occult Blood Test [NCIt concept]
- Fedratinib [NCIt concept]
- Fedratinib Hydrochloride [NCIt concept]
- Feedback [NCIt concept]
- Feeding Method [NCIt concept]
- Feeding Tube Dependency [NCIt concept]
- Feladilimab [NCIt concept]
- Felcisetrag [NCIt concept]
- Felezonexor [NCIt concept]
- Felmetatug Vedotin [NCIt concept]
- Female Breast Carcinoma [NCIt concept]
- Female Reproductive System Adnexal Neoplasm [NCIt concept]
- Female Reproductive System Neoplasm [NCIt concept]
- Fencabtagene Autoleucel [NCIt concept]
- Fenebrutinib [NCIt concept]
- Fenofibrate [NCIt concept]
- Fenofibric Acid [NCIt concept]
- Fenretinide [NCIt concept]
- Fenretinide Lipid Matrix [NCIt concept]
- Fentanyl [NCIt concept]
- Fentanyl Citrate [NCIt concept]
- Fentanyl Citrate Buccal Tablet [NCIt concept]
- Fentanyl Citrate Pectin-Based Nasal Spray [NCIt concept]
- Fentanyl Citrate-containing Nasal Spray [NCIt concept]
- Fermented Soybean Extract [NCIt concept]
- Fermented Soybean Protein Beverage [NCIt concept]
- Fermitin Family Homolog 2 [NCIt concept]
- Ferric Carboxymaltose [NCIt concept]
- Ferric Derisomaltose [NCIt concept]
- Ferritin [NCIt concept]
- Ferrous Sulfate [NCIt concept]
- Fertility Assessment and Management [NCIt concept]
- Ferumoxides Non-Stoichiometric Magnetite [NCIt concept]
- Ferumoxtran-10 [NCIt concept]
- Ferumoxytol [NCIt concept]
- Fever, Sweat, and Hot Flashes [NCIt concept]
- Fexagratinib [NCIt concept]
- Fezolinetant [NCIt concept]
- Fianlimab [NCIt concept]
- Fiber-Optic Spectroscopy [NCIt concept]
- Fibrillin-2 [NCIt concept]
- Fibrin Monomer [NCIt concept]
- Fibrin Sealant [NCIt concept]
- Fibrin-Associated Diffuse Large B-Cell Lymphoma [NCIt concept]
- Fibrinogen [NCIt concept]
- Fibroblast Activation Protein Alpha-activated Doxorubicin Prodrug AVA6000 [NCIt concept]
- Fibroblast Growth Factor 1 [NCIt concept]
- Fibroblast Growth Factor 10 [NCIt concept]
- Fibroblast Growth Factor 13 [NCIt concept]
- Fibroblast Growth Factor 19 [NCIt concept]
- Fibroblast Growth Factor 2 [NCIt concept]
- Fibroblast Growth Factor 21 [NCIt concept]
- Fibroblast Growth Factor 22 [NCIt concept]
- Fibroblast Growth Factor 23 [NCIt concept]
- Fibroblast Growth Factor 3 [NCIt concept]
- Fibroblast Growth Factor 4 [NCIt concept]
- Fibroblast Growth Factor 5 [NCIt concept]
- Fibroblast Growth Factor 7 [NCIt concept]
- Fibroblast Growth Factor 8 [NCIt concept]
- Fibroblast Growth Factor 9 [NCIt concept]
- Fibroblast Growth Factor Gene Family [NCIt concept]
- Fibroblast Growth Factor Receptor 1 [NCIt concept]
- Fibroblast Growth Factor Receptor 2 [NCIt concept]
- Fibroblast Growth Factor Receptor 2 Isoform IIIb [NCIt concept]
- Fibroblast Growth Factor Receptor 3 [NCIt concept]
- Fibroblast Growth Factor Receptor 4 [NCIt concept]
- Fibroblast Growth Factor Receptor Family [NCIt concept]
- Fibroblast Growth Factor Receptor Family Gene [NCIt concept]
- Fibroblast Growth Factor Receptor Family Isoform IIIb [NCIt concept]
- Fibroblast Growth Factor Receptor Family Isoform IIIc [NCIt concept]
- Fibroblast Growth Factor Receptor Substrate 2 [NCIt concept]
- Fibroblast Growth Factor Receptor Substrate 3 [NCIt concept]
- Fibroblast-activation Protein Inhibitor [NCIt concept]
- Fibroblastic Osteosarcoma [NCIt concept]
- Fibroblastic Reticular Cell Sarcoma [NCIt concept]
- Fibrocyte [NCIt concept]
- Fibrolamellar Carcinoma [NCIt concept]
- Fibromodulin [NCIt concept]
- Fibronectin [NCIt concept]
- Fibronectin Type III Domain-Containing Protein 5 [NCIt concept]
- Ficerafusp Alfa [NCIt concept]
- Ficlatuzumab [NCIt concept]
- Ficolin-2 [NCIt concept]
- Fidaxomicin [NCIt concept]
- Fiducial Marker [NCIt concept]
- Figitumumab [NCIt concept]
- Filaggrin [NCIt concept]
- Filamin-A [NCIt concept]
- Filanesib [NCIt concept]
- Filgrastim [NCIt concept]
- Filgrastim-primed Peripheral Blood Progenitor Cells [NCIt concept]
- Fimaporfin [NCIt concept]
- Fimepinostat [NCIt concept]
- Financial Navigation [NCIt concept]
- Finasteride [NCIt concept]
- Finding [NCIt concept]
- Fine-Needle Aspiration [NCIt concept]
- Fingolimod [NCIt concept]
- Fingolimod Hydrochloride [NCIt concept]
- Firastotug [NCIt concept]
- Fire Fighting and Prevention Workers [NCIt concept]
- Firicabtagene Autoleucel [NCIt concept]
- First Degree Family History of Esophageal or Gastric Esophageal Cancer [NCIt concept]
- Firtecan Pegol [NCIt concept]
- Fish Oil [NCIt concept]
- Fisogatinib [NCIt concept]
- Fistula [NCIt concept]
- FitBit [NCIt concept]
- Flanvotumab [NCIt concept]
- Flap Endonuclease 1 [NCIt concept]
- Flap Endonuclease GEN Homolog 1 [NCIt concept]
- Flap Surgical Reconstruction [NCIt concept]
- Flavin-Containing Monooxygenase 1 [NCIt concept]
- Flavin-Containing Monooxygenase 3 [NCIt concept]
- Flaxseed [NCIt concept]
- Flaxseed Lignan [NCIt concept]
- Flexible Heteroarotinoid Sulfur Heteroarotinoid A2 [NCIt concept]
- Flibanserin [NCIt concept]
- Flizasertib [NCIt concept]
- FloTrac System [NCIt concept]
- Florbenguane F18 [NCIt concept]
- Florbetaben (18F) [NCIt concept]
- Flortaucipir F-18 [NCIt concept]
- Flotetuzumab [NCIt concept]
- Flotillin-1 [NCIt concept]
- Flotufolastat F-18 Gallium [NCIt concept]
- Flow Cytometry [NCIt concept]
- Flow-Mediated Vasodilation [NCIt concept]
- Floxuridine [NCIt concept]
- Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01 [NCIt concept]
- Flt3/MerTK Inhibitor MRX-2843 [NCIt concept]
- Fluciclatide F 18 [NCIt concept]
- Fluciclovine F18 [NCIt concept]
- Fluconazole [NCIt concept]
- Flucytosine [NCIt concept]
- Fludarabine Phosphate [NCIt concept]
- Fludeoxyglucose F-18 [NCIt concept]
- Fludrocortisone [NCIt concept]
- Fluid Therapy [NCIt concept]
- Fluocinolone Acetonide [NCIt concept]
- Fluocinonide Cream [NCIt concept]
- Fluorescein Sodium Injection [NCIt concept]
- Fluorescence Activated Cell Sorting [NCIt concept]
- Fluorescence Angiography [NCIt concept]
- Fluorescence Bronchoscopy [NCIt concept]
- Fluorescence Imaging [NCIt concept]
- Fluorescence In Situ Hybridization [NCIt concept]
- Fluorescence Spectroscopy [NCIt concept]
- Fluorescent Antibody Procedure [NCIt concept]
- Fluorescent Dye LS301 [NCIt concept]
- Fluorescent cRGDY PEG-Cy5.5 C Dots [NCIt concept]
- Fluorine F 18 3F-PHPG [NCIt concept]
- Fluorine F 18 4-Fluoro-1-naphthol [NCIt concept]
- Fluorine F 18 4-L-fluoroglutamine (2S,4R) [NCIt concept]
- Fluorine F 18 5-Fluoro-2-deoxycytidine [NCIt concept]
- Fluorine F 18 Ara-G [NCIt concept]
- Fluorine F 18 C-SNAT4 [NCIt concept]
- Fluorine F 18 CP18 Peptide [NCIt concept]
- Fluorine F 18 Clofarabine [NCIt concept]
- Fluorine F 18 DASA-23 [NCIt concept]
- Fluorine F 18 DCFBC [NCIt concept]
- Fluorine F 18 DPA-714 [NCIt concept]
- Fluorine F 18 Dasatinib [NCIt concept]
- Fluorine F 18 EF5 [NCIt concept]
- Fluorine F 18 FAPI-74 [NCIt concept]
- Fluorine F 18 FP-R01-MG-F2 [NCIt concept]
- Fluorine F 18 FTC-146 [NCIt concept]
- Fluorine F 18 Florbetapir [NCIt concept]
- Fluorine F 18 Florilglutamic Acid [NCIt concept]
- Fluorine F 18 Fluoro Furanyl Norprogesterone Positron Emission Tomography and Computed Tomography [NCIt concept]
- Fluorine F 18 Fluorobenzyl Triphenyl Phosphonium [NCIt concept]
- Fluorine F 18 Fluorocholine [NCIt concept]
- Fluorine F 18 Fluoroethylcholine [NCIt concept]
- Fluorine F 18 Fluoropivalate [NCIt concept]
- Fluorine F 18 Fluorthanatrace [NCIt concept]
- Fluorine F 18 GEH121224 [NCIt concept]
- Fluorine F 18 NOS [NCIt concept]
- Fluorine F 18 PARP Inhibitor [NCIt concept]
- Fluorine F 18 PSMA-1007 [NCIt concept]
- Fluorine F 18 RGD-K5 [NCIt concept]
- Fluorine F 18 Tetrafluoroborate [NCIt concept]
- Fluorine F 18 Trioxolane [NCIt concept]
- Fluorine F 18 W372 [NCIt concept]
- Fluorine F 18 WC-4-116 [NCIt concept]
- Fluorine F 18 alphaVbeta6-Binding Peptide [NCIt concept]
- Fluorine F 18 d-FMAU [NCIt concept]
- Fluorine F 18-AlF-cys-variant 3 pH Low Insertion Peptides [NCIt concept]
- Fluorine F 18-BMS-986229 [NCIt concept]
- Fluorine F 18-FETrp [NCIt concept]
- Fluorine F 18-VM4-037 [NCIt concept]
- Fluorine F 18-labeled 2-FACPC [NCIt concept]
- Fluorine F 18-labeled MeFAMP [NCIt concept]
- Fluorine F-18 6-Fluorodopamine [NCIt concept]
- Fluorine F-18 Fluoropaclitaxel [NCIt concept]
- Fluorine F-18 HX4 [NCIt concept]
- Fluorine F-18 ML-10 [NCIt concept]
- Fluorine F18 BMS-986192 [NCIt concept]
- Fluorodeoxygalactose F-18 [NCIt concept]
- Fluorodopa F 18 [NCIt concept]
- Fluorometholone Acetate Ophthalmic Suspension [NCIt concept]
- Fluoropyrimidine [NCIt concept]
- Fluoroquinolone Antibiotic [NCIt concept]
- Fluoroscopy [NCIt concept]
- Fluorothymidine F-18 [NCIt concept]
- Fluorouracil [NCIt concept]
- Fluoxetine [NCIt concept]
- Fluphenazine Hydrochloride [NCIt concept]
- Flutamide [NCIt concept]
- Flutemetamol F 18 [NCIt concept]
- Fluticasone Propionate [NCIt concept]
- Fluvastatin Sodium [NCIt concept]
- Fluvoxamine Maleate [NCIt concept]
- Fms-Related Tyrosine Kinase 3 Ligand [NCIt concept]
- Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate [NCIt concept]
- Focal Adhesion Kinase 1 [NCIt concept]
- Focus Group [NCIt concept]
- Focused Ultrasound Mesencephalotomy [NCIt concept]
- Folate Binding Protein E39 Peptide Vaccine [NCIt concept]
- Folate Binding Protein J65 Peptide Vaccine [NCIt concept]
- Folate Receptor Alpha [NCIt concept]
- Folate Receptor Alpha Negative [NCIt concept]
- Folate Receptor Alpha Positive [NCIt concept]
- Folate Receptor Beta [NCIt concept]
- Folate Receptor Family Negative [NCIt concept]
- Folate Receptor Family Positive [NCIt concept]
- Folate Receptor Targeted Epothilone BMS753493 [NCIt concept]
- Folate Receptor-Targeted Technetium Tc-99m EC20 [NCIt concept]
- Folate Receptor-Targeted Tubulysin Conjugate EC1456 [NCIt concept]
- Folate Receptor-Targeted Vinca Alkaloid EC0489 [NCIt concept]
- Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225 [NCIt concept]
- Folate Transporter 1 [NCIt concept]
- Folate-FITC [NCIt concept]
- Folfirinox Regimen [NCIt concept]
- Folic Acid [NCIt concept]
- Follicle-Stimulating Hormone [NCIt concept]
- Follicle-Stimulating Hormone Receptor [NCIt concept]
- Follicular Dendritic Cell Sarcoma [NCIt concept]
- Follicular Helper T Cell [NCIt concept]
- Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Follicular Lymphoma [NCIt concept]
- Folliculin [NCIt concept]
- Follistatin [NCIt concept]
- Follistatin-Related Protein 3 [NCIt concept]
- Follitropin Subunit Beta [NCIt concept]
- Follow-Up [NCIt concept]
- Follow-Up Care [NCIt concept]
- Folylpolyglutamate Synthase, Mitochondrial [NCIt concept]
- Fondaparinux Sodium [NCIt concept]
- Food [NCIt concept]
- Food Assistance Programs [NCIt concept]
- Food Diary [NCIt concept]
- Foregut Neuroendocrine Tumor [NCIt concept]
- Foretinib [NCIt concept]
- Foritinib Succinate [NCIt concept]
- Forkhead Box Protein L2 [NCIt concept]
- Forkhead Box Protein M1 [NCIt concept]
- Forkhead Box Protein O1 [NCIt concept]
- Forkhead Box Protein O3 [NCIt concept]
- Forkhead Box Protein O4 [NCIt concept]
- Forkhead Box Protein P1 [NCIt concept]
- Forkhead Box Protein P3 [NCIt concept]
- Forkhead Box Protein R2 [NCIt concept]
- Formaldehyde [NCIt concept]
- Former Smoker [NCIt concept]
- Formin-Binding Protein 1 [NCIt concept]
- Forodesine Hydrochloride [NCIt concept]
- Fos-Related Antigen 1 [NCIt concept]
- Fosaprepitant [NCIt concept]
- Fosaprepitant Dimeglumine [NCIt concept]
- Fosbretabulin Disodium [NCIt concept]
- Fosbretabulin Tromethamine [NCIt concept]
- Foscarnet [NCIt concept]
- Foscarnet Sodium [NCIt concept]
- Foscenvivint [NCIt concept]
- Fosciclopirox [NCIt concept]
- Fosgemcitabine Palabenamide [NCIt concept]
- Fosifloxuridine Nafalbenamide [NCIt concept]
- Fosmanogepix [NCIt concept]
- Fosnetupitant/Palonosetron Hydrochloride [NCIt concept]
- Fostamatinib [NCIt concept]
- Fostamatinib Disodium [NCIt concept]
- Four Quadrants Transverse Abdominis Plane Block [NCIt concept]
- Fourier Transform Ion Cyclotron Resonance Mass Spectrometry [NCIt concept]
- Fourth-generation EGFR Inhibitor [NCIt concept]
- Fovinaciclib [NCIt concept]
- Fowlpox Virus Antibody [NCIt concept]
- Fractalkine [NCIt concept]
- Fractional Excretion of Sodium [NCIt concept]
- Fractional Laser Treatment [NCIt concept]
- Fractionated Stereotactic Radiation Therapy [NCIt concept]
- Frameless Fractionated Stereotactic Radiation Therapy [NCIt concept]
- Free Fatty Acid Receptor 4 [NCIt concept]
- Free Hemoglobin Measurement [NCIt concept]
- Free Immunoglobulin Light Chain [NCIt concept]
- Free Testosterone Less than 70 pg/mL [NCIt concept]
- Free Testosterone Measurement [NCIt concept]
- Free Thyroxine Measurement [NCIt concept]
- Freenome Test [NCIt concept]
- Freeze-dried Black Raspberry Bioadhesive Gel [NCIt concept]
- Frenlosirsen [NCIt concept]
- Frequency-Domain Photon Migration [NCIt concept]
- Fresh Frozen Plasma Transfusion [NCIt concept]
- Freshstart [NCIt concept]
- Fresolimumab [NCIt concept]
- Freund's Adjuvant [NCIt concept]
- Friend Leukemia Integration 1 Transcription Factor [NCIt concept]
- Frizzled-1 [NCIt concept]
- Frizzled-2 [NCIt concept]
- Frizzled-3 [NCIt concept]
- Frizzled-7 [NCIt concept]
- Frizzled-8 [NCIt concept]
- Frozen Section Excision [NCIt concept]
- Fructooligosaccharide [NCIt concept]
- Fructooligosaccharide Supplement [NCIt concept]
- Fructosamine Measurement [NCIt concept]
- Fructose [NCIt concept]
- Fructose-Bisphosphate Aldolase [NCIt concept]
- Fruit and Vegetable Extract [NCIt concept]
- Fruquintinib [NCIt concept]
- Fucosidosis [NCIt concept]
- Fucosyl GM1 Antibody [NCIt concept]
- Fucosyl Monosialotetrahexosylganglioside [NCIt concept]
- Fucosylated Umbilical Cord Blood Regulatory T Cells [NCIt concept]
- Fulranumab [NCIt concept]
- Fulvestrant [NCIt concept]
- Fumagillin-Derived Polymer Conjugate XMT-1107 [NCIt concept]
- Fumarate Hydratase, Mitochondrial [NCIt concept]
- Fumarate Hydratase-Deficient Renal Cell Carcinoma [NCIt concept]
- Fumonisin B1 [NCIt concept]
- Functional Assessment [NCIt concept]
- Functional Connectivity Magnetic Resonance Imaging [NCIt concept]
- Functional Imaging [NCIt concept]
- Functional Magnetic Resonance Imaging [NCIt concept]
- Functional Near-Infrared Spectroscopy [NCIt concept]
- Functional Photoacoustic Microscopy [NCIt concept]
- Functioning Pituitary Neuroendocrine Tumor [NCIt concept]
- Fungal Infection [NCIt concept]
- Furanocoumarin [NCIt concept]
- Fusobacterium [NCIt concept]
- Futermestotug [NCIt concept]
- Futuximab [NCIt concept]
- G Antigen 1 [NCIt concept]
- G Antigen 2A [NCIt concept]
- G Antigen 2D [NCIt concept]
- G Antigen 4 [NCIt concept]
- G Antigen 5 [NCIt concept]
- G Antigen 6 [NCIt concept]
- G Antigen 7 [NCIt concept]
- G Protein-Coupled Receptor Kinase 4 [NCIt concept]
- G Protein-coupled Estrogen Receptor Agonist LNS8801 [NCIt concept]
- G-Protein Coupled Estrogen Receptor 1 [NCIt concept]
- G-Protein Coupled Receptor 20 [NCIt concept]
- G-Protein Coupled Receptor Family C Group 5 Member D [NCIt concept]
- G-Quadruplex-selective Transcription Inhibitor QN-302 [NCIt concept]
- G/T Mismatch-Specific Thymine DNA Glycosylase [NCIt concept]
- G1/S-Specific Cyclin-D1 [NCIt concept]
- G1/S-Specific Cyclin-D1b [NCIt concept]
- G1/S-Specific Cyclin-D2 [NCIt concept]
- G1/S-Specific Cyclin-D3 [NCIt concept]
- G1/S-Specific Cyclin-E1 [NCIt concept]
- G1/S-Specific Cyclin-E2 [NCIt concept]
- G2 Arrest Time [NCIt concept]
- G2/Mitotic-Specific Cyclin-B1 [NCIt concept]
- G2/Mitotic-Specific Cyclin-B3 [NCIt concept]
- G6PC3 Gene [NCIt concept]
- G6PC3 Gene Mutation [NCIt concept]
- G6PC3 Loss of Function Gene Mutation [NCIt concept]
- G6PC3 wt Allele [NCIt concept]
- G6PD Gene [NCIt concept]
- G6PD wt Allele [NCIt concept]
- GAB1 Gene [NCIt concept]
- GAB1 wt Allele [NCIt concept]
- GAB2 Gene [NCIt concept]
- GAB2 wt Allele [NCIt concept]
- GABARAPL2 Gene [NCIt concept]
- GABARAPL2 wt Allele [NCIt concept]
- GABBR2 Gene [NCIt concept]
- GABBR2 wt Allele [NCIt concept]
- GABRG1 Gene [NCIt concept]
- GABRG1 wt Allele [NCIt concept]
- GADD45A Gene [NCIt concept]
- GADD45A wt Allele [NCIt concept]
- GADD45B Gene [NCIt concept]
- GADD45B wt Allele [NCIt concept]
- GAGE [NCIt concept]
- GAGE1 Gene [NCIt concept]
- GAGE1 wt Allele [NCIt concept]
- GAGE2A Gene [NCIt concept]
- GAGE2A wt Allele [NCIt concept]
- GAGE4 Gene [NCIt concept]
- GAGE4 wt Allele [NCIt concept]
- GAGE5 Gene [NCIt concept]
- GAGE5 wt Allele [NCIt concept]
- GAGE6 Gene [NCIt concept]
- GAGE6 wt Allele [NCIt concept]
- GAGE7 Gene [NCIt concept]
- GAGE7 wt Allele [NCIt concept]
- GAGE8 Gene [NCIt concept]
- GAGE8 wt Allele [NCIt concept]
- GAITRite Mat [NCIt concept]
- GAPDH Gene [NCIt concept]
- GAPDH wt Allele [NCIt concept]
- GART Gene [NCIt concept]
- GART wt Allele [NCIt concept]
- GAS1 Gene [NCIt concept]
- GAS1 wt Allele [NCIt concept]
- GAS2 Gene [NCIt concept]
- GAS2 wt Allele [NCIt concept]
- GAS6 Gene [NCIt concept]
- GAS6 wt Allele [NCIt concept]
- GAS7 Gene [NCIt concept]
- GAS7 wt Allele [NCIt concept]
- GAST Gene [NCIt concept]
- GAST wt Allele [NCIt concept]
- GATA-Type Zinc Finger Protein 1 [NCIt concept]
- GATA1 Exon 2 Mutation [NCIt concept]
- GATA1 Exon 3 Mutation [NCIt concept]
- GATA1 Gene [NCIt concept]
- GATA1 Gene Mutation [NCIt concept]
- GATA1 wt Allele [NCIt concept]
- GATA2 Deficiency [NCIt concept]
- GATA2 Gene [NCIt concept]
- GATA2 Gene Mutation [NCIt concept]
- GATA2 wt Allele [NCIt concept]
- GATA2/MECOM Fusion Gene [NCIt concept]
- GATA3 Gene [NCIt concept]
- GATA3 Gene Mutation [NCIt concept]
- GATA3 wt Allele [NCIt concept]
- GATA4 Gene [NCIt concept]
- GATA4 wt Allele [NCIt concept]
- GATA5 Gene [NCIt concept]
- GATA5 wt Allele [NCIt concept]
- GATA6 Gene [NCIt concept]
- GATA6 wt Allele [NCIt concept]
- GATM Gene [NCIt concept]
- GATM wt Allele [NCIt concept]
- GATOR Complex Protein NPRL3 [NCIt concept]
- GBA1 Gene [NCIt concept]
- GBA1 wt Allele [NCIt concept]
- GBA2 Gene [NCIt concept]
- GBA2 wt Allele [NCIt concept]
- GCG Gene [NCIt concept]
- GCG wt Allele [NCIt concept]
- GCKR Gene [NCIt concept]
- GCKR wt Allele [NCIt concept]
- GCLM Gene [NCIt concept]
- GCLM wt Allele [NCIt concept]
- GCN2 Modulator HC-7366-K [NCIt concept]
- GCSAM Gene [NCIt concept]
- GCSAM wt Allele [NCIt concept]
- GD2 Antibody [NCIt concept]
- GD2 Lactone/GD3 Lactone-KLH Conjugate Bivalent Vaccine [NCIt concept]
- GD2-CAR-expressing Autologous T-lymphocytes [NCIt concept]
- GD2L Antibody [NCIt concept]
- GD3L Antibody [NCIt concept]
- GDF11 Gene [NCIt concept]
- GDF11 wt Allele [NCIt concept]
- GDF15 Gene [NCIt concept]
- GDF15 wt Allele [NCIt concept]
- GDF2 Gene [NCIt concept]
- GDF2 wt Allele [NCIt concept]
- GDNF Family Receptor Alpha-4 [NCIt concept]
- GDNF Family Receptor Alpha-Like [NCIt concept]
- GDP-Mannose 4,6 Dehydratase [NCIt concept]
- GEMIN2 Gene [NCIt concept]
- GEMIN2 wt Allele [NCIt concept]
- GEN1 Gene [NCIt concept]
- GEN1 Gene Mutation [NCIt concept]
- GEN1 wt Allele [NCIt concept]
- GFAP Gene [NCIt concept]
- GFAP wt Allele [NCIt concept]
- GFI1B Gene [NCIt concept]
- GFI1B wt Allele [NCIt concept]
- GFRA4 Gene [NCIt concept]
- GFRA4 wt Allele [NCIt concept]
- GFRAL Gene [NCIt concept]
- GFRAL wt Allele [NCIt concept]
- GGAA Microsatellite Repeat [NCIt concept]
- GGH Gene [NCIt concept]
- GGH wt Allele [NCIt concept]
- GH1 Gene [NCIt concept]
- GH1 wt Allele [NCIt concept]
- GHR Gene [NCIt concept]
- GHR wt Allele [NCIt concept]
- GHRL Gene [NCIt concept]
- GHRL wt Allele [NCIt concept]
- GI-4000 Vaccine [NCIt concept]
- GIP Gene [NCIt concept]
- GIP wt Allele [NCIt concept]
- GIT1 Gene [NCIt concept]
- GIT1 wt Allele [NCIt concept]
- GITR-targeting Agent [NCIt concept]
- GITRL RNA-transfected Autologous Dendritic Cell Vaccine [NCIt concept]
- GJA1 Gene [NCIt concept]
- GJA1 wt Allele [NCIt concept]
- GJB2 Gene [NCIt concept]
- GJB2 wt Allele [NCIt concept]
- GLB1 Gene [NCIt concept]
- GLB1 wt Allele [NCIt concept]
- GLI1 Gene [NCIt concept]
- GLI1 Gene Product [NCIt concept]
- GLI1 Positive [NCIt concept]
- GLI1 wt Allele [NCIt concept]
- GLI3 Gene [NCIt concept]
- GLI3 wt Allele [NCIt concept]
- GLIS2 Gene [NCIt concept]
- GLIS2 wt Allele [NCIt concept]
- GLP1R Gene [NCIt concept]
- GLP1R wt Allele [NCIt concept]
- GLRX Gene [NCIt concept]
- GLRX wt Allele [NCIt concept]
- GM-CSF Receptor [NCIt concept]
- GM-CSF-encoding Oncolytic Adenovirus CGTG-102 [NCIt concept]
- GM-CSF-secreting Lethally Irradiated Tumor Cell Vaccine [NCIt concept]
- GM-K562 Cell Vaccine [NCIt concept]
- GM.CD40L Cell Vaccine [NCIt concept]
- GM1 Gangliosidosis [NCIt concept]
- GM2-KLH Vaccine [NCIt concept]
- GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine [NCIt concept]
- GMDS Gene [NCIt concept]
- GMDS wt Allele [NCIt concept]
- GMNN Gene [NCIt concept]
- GMNN wt Allele [NCIt concept]
- GMP Synthase [Glutamine-Hydrolyzing] [NCIt concept]
- GMPS Gene [NCIt concept]
- GMPS wt Allele [NCIt concept]
- GNA11 Gene [NCIt concept]
- GNA11 Gene Mutation [NCIt concept]
- GNA11 wt Allele [NCIt concept]
- GNAI2 Gene [NCIt concept]
- GNAI2 wt Allele [NCIt concept]
- GNAO1 Gene [NCIt concept]
- GNAO1 wt Allele [NCIt concept]
- GNAQ Gene [NCIt concept]
- GNAQ Gene Mutation [NCIt concept]
- GNAQ wt Allele [NCIt concept]
- GNAQ/GNA11 Antagonist DYP688 [NCIt concept]
- GNAS Gene [NCIt concept]
- GNAS Gene Mutation [NCIt concept]
- GNAS wt Allele [NCIt concept]
- GNB3 Gene [NCIt concept]
- GNB3 wt Allele [NCIt concept]
- GNG11 Gene [NCIt concept]
- GNG11 wt Allele [NCIt concept]
- GNG12 Gene [NCIt concept]
- GNG12 wt Allele [NCIt concept]
- GNG2 Gene [NCIt concept]
- GNG2 wt Allele [NCIt concept]
- GNLY Gene [NCIt concept]
- GNLY wt Allele [NCIt concept]
- GNP Regimen [NCIt concept]
- GNRHR Gene [NCIt concept]
- GNRHR Positive [NCIt concept]
- GNRHR wt Allele [NCIt concept]
- GOLGA5 Gene [NCIt concept]
- GOLGA5 wt Allele [NCIt concept]
- GOLGA5/RET Fusion Gene [NCIt concept]
- GOLGA5/RET Fusion Protein [NCIt concept]
- GOLM1 Gene [NCIt concept]
- GOLM1 wt Allele [NCIt concept]
- GOLPH3 Gene [NCIt concept]
- GOLPH3 wt Allele [NCIt concept]
- GOPC Gene [NCIt concept]
- GOPC wt Allele [NCIt concept]
- GOPC/ROS1 Fusion Gene [NCIt concept]
- GOPC/ROS1 Fusion Protein [NCIt concept]
- GP1BA Gene [NCIt concept]
- GP1BA wt Allele [NCIt concept]
- GP2 Peptide/GM-CSF Vaccine [NCIt concept]
- GPA33 Gene [NCIt concept]
- GPA33 wt Allele [NCIt concept]
- GPAT3 Gene [NCIt concept]
- GPAT3 wt Allele [NCIt concept]
- GPBP1L1 Gene [NCIt concept]
- GPBP1L1 wt Allele [NCIt concept]
- GPC2 Gene [NCIt concept]
- GPC2 wt Allele [NCIt concept]
- GPC3 Gene [NCIt concept]
- GPC3 Positive [NCIt concept]
- GPC3 wt Allele [NCIt concept]
- GPC3-targeting Agent [NCIt concept]
- GPER1 Gene [NCIt concept]
- GPER1 wt Allele [NCIt concept]
- GPHN Gene [NCIt concept]
- GPHN wt Allele [NCIt concept]
- GPNMB Gene [NCIt concept]
- GPNMB Positive [NCIt concept]
- GPNMB wt Allele [NCIt concept]
- GPR101 Gene [NCIt concept]
- GPR101 wt Allele [NCIt concept]
- GPR20 Gene [NCIt concept]
- GPR20 wt Allele [NCIt concept]
- GPR31 Gene [NCIt concept]
- GPR31 wt Allele [NCIt concept]
- GPR35 Inhibitor CT3001 [NCIt concept]
- GPRC5D Gene [NCIt concept]
- GPRC5D wt Allele [NCIt concept]
- GPRC5D-targeting Agent [NCIt concept]
- GPX2 Gene [NCIt concept]
- GPX2 wt Allele [NCIt concept]
- GPX3 Gene [NCIt concept]
- GPX3 wt Allele [NCIt concept]
- GRB2 Gene [NCIt concept]
- GRB2 wt Allele [NCIt concept]
- GRB2-Associated-Binding Protein 1 [NCIt concept]
- GRB2-Associated-Binding Protein 2 [NCIt concept]
- GRB7 Gene [NCIt concept]
- GRB7 wt Allele [NCIt concept]
- GREB1 Gene [NCIt concept]
- GREB1 wt Allele [NCIt concept]
- GREM1 Gene [NCIt concept]
- GREM1 Gene Mutation [NCIt concept]
- GREM1 wt Allele [NCIt concept]
- GRIA2 Gene [NCIt concept]
- GRIA2 wt Allele [NCIt concept]
- GRIN2A Gene [NCIt concept]
- GRIN2A wt Allele [NCIt concept]
- GRIN2B Gene [NCIt concept]
- GRIN2B wt Allele [NCIt concept]
- GRK4 Gene [NCIt concept]
- GRK4 wt Allele [NCIt concept]
- GRM1 Gene [NCIt concept]
- GRM1 wt Allele [NCIt concept]
- GRM2 Gene [NCIt concept]
- GRM2 wt Allele [NCIt concept]
- GRM3 Gene [NCIt concept]
- GRM3 wt Allele [NCIt concept]
- GRM4 Gene [NCIt concept]
- GRM4 wt Allele [NCIt concept]
- GRM5 Gene [NCIt concept]
- GRM5 wt Allele [NCIt concept]
- GRM6 Gene [NCIt concept]
- GRM6 wt Allele [NCIt concept]
- GRM7 Gene [NCIt concept]
- GRM7 wt Allele [NCIt concept]
- GRM8 Gene [NCIt concept]
- GRM8 wt Allele [NCIt concept]
- GRN Gene [NCIt concept]
- GRN wt Allele [NCIt concept]
- GRP Gene [NCIt concept]
- GRP Gene Product [NCIt concept]
- GRP wt Allele [NCIt concept]
- GRPR Gene [NCIt concept]
- GRPR Overexpression Positive [NCIt concept]
- GRPR Positive [NCIt concept]
- GRPR wt Allele [NCIt concept]
- GRPR-targeted Radioligand Therapy [NCIt concept]
- GRPR-targeting Radioconjugate [NCIt concept]
- GSK-3 Inhibitor LY2090314 [NCIt concept]
- GSK3A Gene [NCIt concept]
- GSK3A wt Allele [NCIt concept]
- GSK3B Gene [NCIt concept]
- GSK3B Gene Mutation [NCIt concept]
- GSK3B wt Allele [NCIt concept]
- GSPT1 Gene [NCIt concept]
- GSPT1 MGD MRT-2359 [NCIt concept]
- GSPT1 wt Allele [NCIt concept]
- GSR Gene [NCIt concept]
- GSR wt Allele [NCIt concept]
- GSTA1 Gene [NCIt concept]
- GSTA1 wt Allele [NCIt concept]
- GSTA4 Gene [NCIt concept]
- GSTA4 wt Allele [NCIt concept]
- GSTM1 Gene [NCIt concept]
- GSTM1 Gene Mutation [NCIt concept]
- GSTM1 wt Allele [NCIt concept]
- GSTM3 Gene [NCIt concept]
- GSTM3 wt Allele [NCIt concept]
- GSTM4 Gene [NCIt concept]
- GSTM4 wt Allele [NCIt concept]
- GSTP1 Gene [NCIt concept]
- GSTP1 Gene Mutation [NCIt concept]
- GSTP1 wt Allele [NCIt concept]
- GSTT1 Gene [NCIt concept]
- GSTT1 wt Allele [NCIt concept]
- GSTZ1 Gene [NCIt concept]
- GSTZ1 wt Allele [NCIt concept]
- GTF2H1 Gene [NCIt concept]
- GTF2H1 wt Allele [NCIt concept]
- GTF2H2 Gene [NCIt concept]
- GTF2H2 wt Allele [NCIt concept]
- GTF2H3 Gene [NCIt concept]
- GTF2H3 wt Allele [NCIt concept]
- GTF2H4 Gene [NCIt concept]
- GTF2H4 wt Allele [NCIt concept]
- GTF2H5 Gene [NCIt concept]
- GTF2H5 wt Allele [NCIt concept]
- GTP-Binding Protein RAD [NCIt concept]
- GTP-Binding Protein Rheb [NCIt concept]
- GTP-Binding Protein Rit1 [NCIt concept]
- GTP-Binding Protein SAR1b [NCIt concept]
- GTPase HRas [NCIt concept]
- GTPase KRas [NCIt concept]
- GTPase Nras [NCIt concept]
- GUCA2A Gene [NCIt concept]
- GUCA2A wt Allele [NCIt concept]
- GUCY2C Antibody [NCIt concept]
- GUCY2C Gene [NCIt concept]
- GUCY2C Positive [NCIt concept]
- GUCY2C wt Allele [NCIt concept]
- GUSB Gene [NCIt concept]
- GUSB wt Allele [NCIt concept]
- GZMA Gene [NCIt concept]
- GZMA wt Allele [NCIt concept]
- GZMB Gene [NCIt concept]
- GZMB wt Allele [NCIt concept]
- Ga-68 NeoBOMB1 PET/MRI Positron Emission Tomography and Magnetic Resonance Imaging [NCIt concept]
- Ga-68 PET/CT Scan [NCIt concept]
- Ga-68 PSMA-R2 Positron Emission Tomography and Magnetic Resonance Imaging [NCIt concept]
- Gabapentin [NCIt concept]
- Gadobutrol [NCIt concept]
- Gadodiamide [NCIt concept]
- Gadofosveset Trisodium [NCIt concept]
- Gadolinium [NCIt concept]
- Gadolinium Contrast-enhanced Abbreviated MRI [NCIt concept]
- Gadolinium-Chelate [NCIt concept]
- Gadopentetate Dimeglumine [NCIt concept]
- Gadopiclenol [NCIt concept]
- Gadoquatrane [NCIt concept]
- Gadoterate Meglumine [NCIt concept]
- Gadoxetate Disodium [NCIt concept]
- Gag:267-274 Peptide Vaccine [NCIt concept]
- Gain of Chromosome 12q [NCIt concept]
- Gain of Chromosome 17q [NCIt concept]
- Gain of Chromosome 1q [NCIt concept]
- Gain of Chromosome 1q21 [NCIt concept]
- Gain of Chromosome 2p [NCIt concept]
- Gain of Chromosome 5p [NCIt concept]
- Gain of Chromosome 7 [NCIt concept]
- Gait Assessment Test [NCIt concept]
- Galacto-oligosaccharide Prebiotic Supplement [NCIt concept]
- Galactomannan Derivative [NCIt concept]
- Galactosylgalactosylxylosylprotein 3-Beta-Glucuronosyltransferase 1 [NCIt concept]
- Galactosylgalactosylxylosylprotein 3-Beta-Glucuronosyltransferase 2 [NCIt concept]
- Galantamine Hydrobromide [NCIt concept]
- Galectin-1 [NCIt concept]
- Galectin-3 [NCIt concept]
- Galectin-9 [NCIt concept]
- Galeterone [NCIt concept]
- Galinpepimut-S [NCIt concept]
- Galiximab [NCIt concept]
- Gallbladder Adenocarcinoma [NCIt concept]
- Gallbladder Adenocarcinoma with Squamous Metaplasia [NCIt concept]
- Gallbladder Adenosquamous Carcinoma [NCIt concept]
- Gallbladder Carcinoma [NCIt concept]
- Gallbladder Carcinosarcoma [NCIt concept]
- Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma [NCIt concept]
- Gallbladder Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Gallbladder Neuroendocrine Carcinoma [NCIt concept]
- Gallbladder Squamous Cell Carcinoma [NCIt concept]
- Gallbladder Undifferentiated Carcinoma [NCIt concept]
- Gallium Ga 68 Boclatixafortide [NCIt concept]
- Gallium Ga 68 Citrate [NCIt concept]
- Gallium Ga 68 FAP-2286 [NCIt concept]
- Gallium Ga 68 FAPi-46 [NCIt concept]
- Gallium Ga 68 GPC3-targeted Peptide RYZ811 [NCIt concept]
- Gallium Ga 68 Gozetotide [NCIt concept]
- Gallium Ga 68 NNS309 [NCIt concept]
- Gallium Ga 68 NODAGA-CBP8 [NCIt concept]
- Gallium Ga 68 P15-041 [NCIt concept]
- Gallium Ga 68 PSMA-R2 [NCIt concept]
- Gallium Ga 68 R8760 [NCIt concept]
- Gallium Ga 68 Satoreotide Tetraxetan [NCIt concept]
- Gallium Ga 68 Satoreotide Trizoxetan [NCIt concept]
- Gallium Ga 68 Trivehexin [NCIt concept]
- Gallium Ga 68-DOTA-5G [NCIt concept]
- Gallium Ga 68-DOTATATE [NCIt concept]
- Gallium Ga 68-EVS459 [NCIt concept]
- Gallium Ga 68-Edotreotide [NCIt concept]
- Gallium Ga 68-HA-DOTA-TATE [NCIt concept]
- Gallium Ga 68-NeoB [NCIt concept]
- Gallium Ga 68-P16-093 [NCIt concept]
- Gallium Ga 68-PNT6555 [NCIt concept]
- Gallium Ga 68-R10602 [NCIt concept]
- Gallium Ga 68-VMT02 [NCIt concept]
- Gallium Ga 68-labeled MLN6907 [NCIt concept]
- Gallium Ga 68-labeled RM2 [NCIt concept]
- Gallium Ga-labeled PSMA-11-Gadoxetate [NCIt concept]
- Gallium-68 DOTATATE Positron Emission Tomography [NCIt concept]
- Gallium-based Bone Resorption Inhibitor AP-002 [NCIt concept]
- Galunisertib [NCIt concept]
- Gamitrinib [NCIt concept]
- Gamma Secretase [NCIt concept]
- Gamma-Adducin [NCIt concept]
- Gamma-Aminobutyric Acid Receptor Subunit Gamma-1 [NCIt concept]
- Gamma-Aminobutyric Acid Receptor-Associated Protein-Like 2 [NCIt concept]
- Gamma-Aminobutyric Acid Type B Receptor Subunit 2 [NCIt concept]
- Gamma-Enolase [NCIt concept]
- Gamma-Glutamyl Hydrolase [NCIt concept]
- Gamma-Glutamyl Transpeptidase [NCIt concept]
- Gamma-Secretase Inhibitor [NCIt concept]
- Gamma-Secretase Inhibitor RO4929097 [NCIt concept]
- Gamma-Secretase Subunit PEN-2 [NCIt concept]
- Gamma-Synuclein [NCIt concept]
- Gamma-Tocopherol [NCIt concept]
- Gamma-Tubulin [NCIt concept]
- Gamma-hydroxy-1,N(2)-propanodeoxyguanosine [NCIt concept]
- Gamma/Delta T-Lymphocyte [NCIt concept]
- Ganciclovir [NCIt concept]
- Gandotinib [NCIt concept]
- Ganetespib [NCIt concept]
- Ganglion Impar Neurolysis [NCIt concept]
- Ganglioneuroblastoma [NCIt concept]
- Ganglioneuroma [NCIt concept]
- Ganglioneuroma Component Present [NCIt concept]
- Ganglioside GD2 [NCIt concept]
- Ganglioside GD2 Negative [NCIt concept]
- Ganglioside GD2 Positive [NCIt concept]
- Ganglioside GD3 [NCIt concept]
- Ganglioside GM2 [NCIt concept]
- Ganglioside GM2 Antibody [NCIt concept]
- Ganglioside GQ [NCIt concept]
- Ganitumab [NCIt concept]
- Gap Junction Alpha-1 Protein [NCIt concept]
- Gap Junction Beta-2 Protein [NCIt concept]
- Gardasil Immunogenicity with Needle-Free Injection [NCIt concept]
- Garetatug Rezetecan [NCIt concept]
- Garsorasib [NCIt concept]
- Gartisertib [NCIt concept]
- Gas Chromatography [NCIt concept]
- Gastrectomy [NCIt concept]
- Gastrectomy Patient [NCIt concept]
- Gastric Adenocarcinoma [NCIt concept]
- Gastric Adenosquamous Carcinoma [NCIt concept]
- Gastric Body Carcinoma [NCIt concept]
- Gastric Carcinoma [NCIt concept]
- Gastric Cardia Carcinoma [NCIt concept]
- Gastric Diffuse Adenocarcinoma [NCIt concept]
- Gastric Disorder [NCIt concept]
- Gastric Fundus Carcinoma [NCIt concept]
- Gastric Gastrointestinal Stromal Tumor [NCIt concept]
- Gastric Inhibitory Polypeptide [NCIt concept]
- Gastric Intestinal-Type Adenocarcinoma [NCIt concept]
- Gastric Mixed Adenocarcinoma [NCIt concept]
- Gastric Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Gastric Mucinous Adenocarcinoma [NCIt concept]
- Gastric Neoplasm [NCIt concept]
- Gastric Neuroendocrine Carcinoma [NCIt concept]
- Gastric Neuroendocrine Tumor G1 [NCIt concept]
- Gastric Neuroendocrine Tumor G2 [NCIt concept]
- Gastric Pylorus Carcinoma [NCIt concept]
- Gastric Squamous Cell Carcinoma [NCIt concept]
- Gastric Undifferentiated Carcinoma [NCIt concept]
- Gastrin [NCIt concept]
- Gastrin-Producing Neuroendocrine Tumor [NCIt concept]
- Gastrin-Releasing Peptide [NCIt concept]
- Gastrin-Releasing Peptide Receptor [NCIt concept]
- Gastrin/Cholecystokinin Type B Receptor [NCIt concept]
- Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Gastroesophageal Reflux Disease [NCIt concept]
- Gastrointestinal Carcinomatosis [NCIt concept]
- Gastrointestinal Complications Management [NCIt concept]
- Gastrointestinal Dysfunction [NCIt concept]
- Gastrointestinal Endoscopy [NCIt concept]
- Gastrointestinal Mucositis [NCIt concept]
- Gastrointestinal Stenting [NCIt concept]
- Gastrointestinal Stromal Tumor [NCIt concept]
- Gastrointestinal Stromal Tumor of the Gastrointestinal Tract [NCIt concept]
- Gastrointestinal Thrombotic Microangiopathy [NCIt concept]
- Gastrointestinal Tract [NCIt concept]
- Gastrointestinal Tract Acute Graft Versus Host Disease [NCIt concept]
- Gastroscopy [NCIt concept]
- Gastrotropin [NCIt concept]
- Gataparsen Sodium [NCIt concept]
- Gavocabtagene Autoleucel [NCIt concept]
- Gebasaxturev [NCIt concept]
- Gedatolisib [NCIt concept]
- Gefitinib [NCIt concept]
- Gem-Associated Protein 2 [NCIt concept]
- Gemcitabine Elaidate [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
- Gemcitabine Prodrug LY2334737 [NCIt concept]
- Gemcitabine-Releasing Intravesical System [NCIt concept]
- Gemfibrozil [NCIt concept]
- Geminin [NCIt concept]
- Gemogenovatucel-T [NCIt concept]
- Gemtuzumab Ozogamicin [NCIt concept]
- Gene Amplification Abnormality [NCIt concept]
- Gene Expression [NCIt concept]
- Gene Expression Analysis [NCIt concept]
- Gene Mapping [NCIt concept]
- Gene Rearrangement Analysis [NCIt concept]
- Gene Signature [NCIt concept]
- Gene Signature Assessment [NCIt concept]
- Gene Therapy [NCIt concept]
- Gene Therapy Agent [NCIt concept]
- Gene-Modified Tumor Cell Vaccine Therapy [NCIt concept]
- Gene-edited Autologous Neoantigen-targeted NeoTCR-P1 T-cells [NCIt concept]
- General Anesthesia Procedure [NCIt concept]
- General Transcription Factor IIH Subunit 1 [NCIt concept]
- General Transcription Factor IIH Subunit 2 [NCIt concept]
- General Transcription Factor IIH Subunit 3 [NCIt concept]
- General Transcription Factor IIH Subunit 4 [NCIt concept]
- General Transcription Factor IIH Subunit 5 [NCIt concept]
- General Transcription and DNA Repair Factor IIH Helicase Subunit XPD [NCIt concept]
- Generalized Eruptive Histiocytosis [NCIt concept]
- Genetic Counseling [NCIt concept]
- Genetic Counseling Student [NCIt concept]
- Genetic Counselor [NCIt concept]
- Genetic Disorder [NCIt concept]
- Genetic Linkage Analysis [NCIt concept]
- Genetic Polymorphism [NCIt concept]
- Genetic Predisposition to Disease [NCIt concept]
- Genetic Predisposition to Malignant Ovarian Neoplasm [NCIt concept]
- Genetic Susceptibility [NCIt concept]
- Genetic Testing [NCIt concept]
- Genetic Variation [NCIt concept]
- Genetic Variation Analysis [NCIt concept]
- Genetically Engineered Hematopoietic Stem Progenitor Cells [NCIt concept]
- Genetically Engineered Lymphocyte Therapy [NCIt concept]
- Genetically Engineered NY-ESO-1-specific T Lymphocytes [NCIt concept]
- Genetically-engineered Cell [NCIt concept]
- Genetically-engineered T-cells [NCIt concept]
- Geneticist [NCIt concept]
- Genistein [NCIt concept]
- Genitourinary Syndrome of Menopause [NCIt concept]
- Genitourinary System Neoplasm [NCIt concept]
- Genodermatosis [NCIt concept]
- Genome-Wide 5-Hydroxymethylcytosine Profile [NCIt concept]
- Genome-Wide Allelic Status [NCIt concept]
- Genome-Wide DNA Copy Number [NCIt concept]
- Genomic Prescribing System [NCIt concept]
- Genomic Profile [NCIt concept]
- Genomically-Directed Monotherapy [NCIt concept]
- Genotyping [NCIt concept]
- Gentamicin [NCIt concept]
- Gentamicin Sulfate [NCIt concept]
- Gephyrin [NCIt concept]
- Geranylgeranyl Transferase [NCIt concept]
- Geranylgeranyltransferase I Inhibitor [NCIt concept]
- Germ Cell Tumor [NCIt concept]
- Germinal Center B-Cell Gene Expression Signature [NCIt concept]
- Germinal Center B-Lymphocyte [NCIt concept]
- Germinal Center B-Lymphocyte Count [NCIt concept]
- Germinal Center-Associated Signaling and Motility Protein [NCIt concept]
- Germline APC Gene Mutation [NCIt concept]
- Germline APC Promoter 1B Variant [NCIt concept]
- Germline ATM Gene Mutation [NCIt concept]
- Germline BRCA1 Gene Mutation [NCIt concept]
- Germline BRCA2 Gene Mutation [NCIt concept]
- Germline CHEK2 Gene Mutation [NCIt concept]
- Germline Genotype Testing [NCIt concept]
- Germline HOXB13 Gene Mutation [NCIt concept]
- Germline PALB2 Gene Mutation [NCIt concept]
- Germline RUNX1 Gene Mutation [NCIt concept]
- Germline Variation [NCIt concept]
- Gestational Trophoblastic Tumor [NCIt concept]
- Gevokizumab [NCIt concept]
- Giloralimab [NCIt concept]
- Gilteritinib [NCIt concept]
- Gilteritinib Fumarate [NCIt concept]
- Gimatecan [NCIt concept]
- Gimistotug [NCIt concept]
- Ginger Extract [NCIt concept]
- Ginisortamab [NCIt concept]
- Gintemetostat [NCIt concept]
- Giredestrant [NCIt concept]
- Girentuximab [NCIt concept]
- Givastomig [NCIt concept]
- Givosiran [NCIt concept]
- Glasdegib [NCIt concept]
- Glasdegib Maleate [NCIt concept]
- Gleason Grade Group 4 [NCIt concept]
- Glecaprevir/Pibrentasvir [NCIt concept]
- Glecirasib [NCIt concept]
- Glembatumumab Vedotin [NCIt concept]
- Glesatinib [NCIt concept]
- Glial Fibrillary Acidic Protein [NCIt concept]
- Glioblastoma Cancer Vaccine ERC1671 [NCIt concept]
- Glioblastoma Multiforme Multipeptide Vaccine IMA950 [NCIt concept]
- Glioma [NCIt concept]
- Glioma Lysate Vaccine GBM6-AD [NCIt concept]
- Glioma-Associated Antigen [NCIt concept]
- Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Global DNA Methylation Profile [NCIt concept]
- Globo H Antibody [NCIt concept]
- Globo H Positive [NCIt concept]
- Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine [NCIt concept]
- Globohexaosylceramide [NCIt concept]
- Glofitamab [NCIt concept]
- Glomerular Filtration Rate [NCIt concept]
- Glottis Carcinoma [NCIt concept]
- Glucagon [NCIt concept]
- Glucagon-Like Peptide 1 Receptor [NCIt concept]
- Glucarpidase [NCIt concept]
- Glucocorticoid [NCIt concept]
- Glucocorticoid Receptor [NCIt concept]
- Glucocorticoid Receptor Antagonist ORIC-101 [NCIt concept]
- Glucokinase Regulatory Protein [NCIt concept]
- Glucosamine Sulfate/Chondroitin Sulfate Tablet [NCIt concept]
- Glucose Measurement [NCIt concept]
- Glucose-6-Phosphatase 3 [NCIt concept]
- Glucose-6-Phosphatase 3 Deficiency [NCIt concept]
- Glucose-6-Phosphate 1-Dehydrogenase [NCIt concept]
- Glucose-6-Phosphate Dehydrogenase Deficiency [NCIt concept]
- Glucose-6-Phosphate Exchanger SLC37A4 [NCIt concept]
- Glucosinolate [NCIt concept]
- Glufosfamide [NCIt concept]
- Glutamate Carboxypeptidase 2 [NCIt concept]
- Glutamate Decarboxylase Autoantibody [NCIt concept]
- Glutamate Receptor 2 [NCIt concept]
- Glutamate Receptor Ionotropic, NMDA 2A [NCIt concept]
- Glutamate Receptor Ionotropic, NMDA 2B [NCIt concept]
- Glutamate and Glutamine Measurement [NCIt concept]
- Glutamate-Cysteine Ligase Regulatory Subunit [NCIt concept]
- Glutamic Acid [NCIt concept]
- Glutaminase Family [NCIt concept]
- Glutaminase-1 Inhibitor IACS-6274 [NCIt concept]
- Glutamine [NCIt concept]
- Glutaredoxin-1 [NCIt concept]
- Glutathione [NCIt concept]
- Glutathione Disulfide NOV-002 [NCIt concept]
- Glutathione Peroxidase 2 [NCIt concept]
- Glutathione Peroxidase 3 [NCIt concept]
- Glutathione Reductase, Mitochondrial [NCIt concept]
- Glutathione S-Transferase [NCIt concept]
- Glutathione S-Transferase A1 [NCIt concept]
- Glutathione S-Transferase A4 [NCIt concept]
- Glutathione S-Transferase Alpha [NCIt concept]
- Glutathione S-Transferase Mu [NCIt concept]
- Glutathione S-Transferase Mu 1 [NCIt concept]
- Glutathione S-Transferase Mu 3 [NCIt concept]
- Glutathione S-Transferase Mu 4 [NCIt concept]
- Glutathione S-Transferase P [NCIt concept]
- Glutathione S-Transferase Theta-1 [NCIt concept]
- Glyburide [NCIt concept]
- Glycan Antibody [NCIt concept]
- Glycan Profile [NCIt concept]
- Glycated Hemoglobin Measurement [NCIt concept]
- Glycemic Measurement Finding [NCIt concept]
- Glyceraldehyde-3-Phosphate Dehydrogenase [NCIt concept]
- Glycerin [NCIt concept]
- Glycerol-3-Phosphate Acyltransferase 3 [NCIt concept]
- Glycine Amidinotransferase, Mitochondrial [NCIt concept]
- Glycocyamine [NCIt concept]
- Glycogen Synthase Kinase 3 [NCIt concept]
- Glycogen Synthase Kinase-3 Alpha [NCIt concept]
- Glycogen Synthase Kinase-3 Beta [NCIt concept]
- Glycome [NCIt concept]
- Glycoprotein Hormones Alpha Chain Protein [NCIt concept]
- Glycoprotein K8.1 Antibody [NCIt concept]
- Glycoprotein-N-Acetylgalactosamine 3-Beta-Galactosyltransferase 1 [NCIt concept]
- Glycosaminoglycan [NCIt concept]
- Glycosylated Recombinant Human Interleukin-7 [NCIt concept]
- Glypican-2 [NCIt concept]
- Glypican-3 [NCIt concept]
- Goal Setting [NCIt concept]
- Goat Milk [NCIt concept]
- Gocatamig [NCIt concept]
- Golcadomide [NCIt concept]
- Gold Sodium Thiomalate [NCIt concept]
- Golgi Membrane Protein 1 [NCIt concept]
- Golgi Phosphoprotein 3 [NCIt concept]
- Golgi-Associated PDZ and Coiled-Coil Motif-Containing Protein [NCIt concept]
- Golgin Subfamily A Member 5 [NCIt concept]
- Golidocitinib [NCIt concept]
- Golimumab [NCIt concept]
- Golnerminogene Pradenovec [NCIt concept]
- Golotimod [NCIt concept]
- Golvatinib [NCIt concept]
- Gomiliximab [NCIt concept]
- Gonadal Polyembryoma [NCIt concept]
- Gonadal Thrombosis [NCIt concept]
- Gonadotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Gonadotrophin Releasing Hormone [NCIt concept]
- Gonadotropin [NCIt concept]
- Gonadotropin Releasing Hormone Antagonist [NCIt concept]
- Gonadotropin-Releasing Hormone Receptor [NCIt concept]
- Gonadotropin-releasing Hormone Analog [NCIt concept]
- Gontivimab [NCIt concept]
- Good Prognosis Metastatic Gestational Trophoblastic Tumor [NCIt concept]
- Gorilla-derived Adenovirus-expressing HPV-16/18 E6/E7 Vaccine [NCIt concept]
- Gorilla-derived Adenovirus-expressing HPV-6/11 Vaccine PRGN-2012 [NCIt concept]
- Goserelin [NCIt concept]
- Goserelin Acetate [NCIt concept]
- Gotistobart [NCIt concept]
- Gozetotide [NCIt concept]
- Grade 1 Follicular Lymphoma [NCIt concept]
- Grade 1 Meningioma [NCIt concept]
- Grade 2 Cutaneous Follicular Lymphoma [NCIt concept]
- Grade 2 Follicular Lymphoma [NCIt concept]
- Grade 2 Meningioma [NCIt concept]
- Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Grade 3 Follicular Lymphoma [NCIt concept]
- Grade 3 Meningioma [NCIt concept]
- Grade 3b Follicular Lymphoma [NCIt concept]
- Grade I Lymphomatoid Granulomatosis [NCIt concept]
- Grade II Lymphomatoid Granulomatosis [NCIt concept]
- Gradient Echo MRI [NCIt concept]
- Graft [NCIt concept]
- Graft Versus Host Disease [NCIt concept]
- Graft Versus Host Disease Prophylaxis/Therapy [NCIt concept]
- Graft-Versus-Tumor Induction [NCIt concept]
- Gram Negative Bacteria [NCIt concept]
- Gram Positive Bacteria [NCIt concept]
- Granisetron Hydrochloride [NCIt concept]
- Granisetron Transdermal Patch [NCIt concept]
- Granulocyte [NCIt concept]
- Granulocyte Colony-Stimulating Factor Receptor [NCIt concept]
- Granulocyte-Macrophage Colony Forming Unit [NCIt concept]
- Granulocyte-Macrophage Colony-Stimulating Factor [NCIt concept]
- Granulocyte-Macrophage Colony-Stimulating Factor Receptor Subunit Alpha [NCIt concept]
- Granulocyte-Monocyte Progenitor Cell [NCIt concept]
- Granulomatous [NCIt concept]
- Granulysin [NCIt concept]
- Granzyme [NCIt concept]
- Granzyme A [NCIt concept]
- Granzyme B [NCIt concept]
- Grape Seed Extract Supplement [NCIt concept]
- Grapiprant [NCIt concept]
- Gray-Zone Lymphoma [NCIt concept]
- Green Tea [NCIt concept]
- Green Tea Extract [NCIt concept]
- Green Tea Lozenge [NCIt concept]
- Gremlin-1 [NCIt concept]
- Gresonitamab [NCIt concept]
- Gridegalutamide [NCIt concept]
- Grief Counseling [NCIt concept]
- Grief Therapy [NCIt concept]
- Grip Strength [NCIt concept]
- Group D Retinoblastoma [NCIt concept]
- Growth Arrest and DNA Damage-Inducible Protein GADD45 Alpha [NCIt concept]
- Growth Arrest and DNA Damage-Inducible Protein GADD45 Beta [NCIt concept]
- Growth Arrest-Specific Protein 1 [NCIt concept]
- Growth Arrest-Specific Protein 2 [NCIt concept]
- Growth Arrest-Specific Protein 6 [NCIt concept]
- Growth Arrest-Specific Protein 7 [NCIt concept]
- Growth Factor [NCIt concept]
- Growth Factor Receptor-Bound Protein 2 [NCIt concept]
- Growth Factor Receptor-Bound Protein 7 [NCIt concept]
- Growth Hormone Receptor [NCIt concept]
- Growth-Regulated Alpha Protein [NCIt concept]
- Growth/Differentiation Factor 11 [NCIt concept]
- Growth/Differentiation Factor 15 [NCIt concept]
- Growth/Differentiation Factor 2 [NCIt concept]
- Growth/Differentiation Factor 8 [NCIt concept]
- Gruticibart [NCIt concept]
- Guadecitabine [NCIt concept]
- Guadecitabine Sodium [NCIt concept]
- Guanabenz Acetate [NCIt concept]
- Guanine Nucleotide Exchange Factor VAV2 [NCIt concept]
- Guanine Nucleotide-Binding Protein G(I)/G(S)/G(O) Subunit Gamma-11 [NCIt concept]
- Guanine Nucleotide-Binding Protein G(I)/G(S)/G(O) Subunit Gamma-12 [NCIt concept]
- Guanine Nucleotide-Binding Protein G(I)/G(S)/G(O) Subunit Gamma-2 [NCIt concept]
- Guanine Nucleotide-Binding Protein G(I)/G(S)/G(T) Subunit Beta-3 [NCIt concept]
- Guanine Nucleotide-Binding Protein G(i) Subunit Alpha-2 [NCIt concept]
- Guanine Nucleotide-Binding Protein G(o) Subunit Alpha [NCIt concept]
- Guanine Nucleotide-Binding Protein G(q) Subunit Alpha [NCIt concept]
- Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms Short [NCIt concept]
- Guanine Nucleotide-Binding Protein G(s) Subunit Alpha Isoforms XLas [NCIt concept]
- Guanine Nucleotide-Binding Protein Subunit Alpha-11 [NCIt concept]
- Guanylin [NCIt concept]
- Guardant360 Profiling System [NCIt concept]
- Guardian [NCIt concept]
- Guideline Concordant Care [NCIt concept]
- Gunagratinib [NCIt concept]
- Guretolimod [NCIt concept]
- Guselkumab [NCIt concept]
- Gym Membership [NCIt concept]
- Gynecologic Surgery Patient [NCIt concept]
- Gynecological Surgical Procedure [NCIt concept]
- H(+)/Cl(-) Exchange Transporter 6 [NCIt concept]
- H(+)/Cl(-) Exchange Transporter 7 [NCIt concept]
- H-Y Antibody [NCIt concept]
- H/ACA Ribonucleoprotein Complex Subunit 2 [NCIt concept]
- H/ACA Ribonucleoprotein Complex Subunit 3 [NCIt concept]
- H/ACA Ribonucleoprotein Complex Subunit 4 [NCIt concept]
- H1-1 Gene [NCIt concept]
- H1-1 wt Allele [NCIt concept]
- H19 Gene [NCIt concept]
- H19 Imprinted Maternal Untranslated mRNA [NCIt concept]
- H19 Opposite Tumor Suppressor [NCIt concept]
- H19 wt Allele [NCIt concept]
- H2 Receptor Antagonist Therapy [NCIt concept]
- H2AX Gene [NCIt concept]
- H2AX wt Allele [NCIt concept]
- H2AZ1 Gene [NCIt concept]
- H2AZ1 wt Allele [NCIt concept]
- H2BC5 Gene [NCIt concept]
- H2BC5 wt Allele [NCIt concept]
- H2C4 NM_003530.4:c.83A>T [NCIt concept]
- H3 G35R Variant [NCIt concept]
- H3 G35V Variant [NCIt concept]
- H3 G35X Variant [NCIt concept]
- H3 K27M Negative [NCIt concept]
- H3 K27M Variant [NCIt concept]
- H3 K28X Variant [NCIt concept]
- H3 Protein Variant [NCIt concept]
- H3-3A Gene [NCIt concept]
- H3-3A Gene Mutation [NCIt concept]
- H3-3A NM_002107.4:c.83A>T [NCIt concept]
- H3-3A wt Allele [NCIt concept]
- H3-3B Gene [NCIt concept]
- H3-3B Gene Mutation [NCIt concept]
- H3-3B wt Allele [NCIt concept]
- H3.1 K27M Variant [NCIt concept]
- H3.3 G35X Variant [NCIt concept]
- H3.3 K27M Variant [NCIt concept]
- H3.3K27M-specific Peptide Vaccine [NCIt concept]
- H3C1 Gene [NCIt concept]
- H3C1 wt Allele [NCIt concept]
- H3C10 Gene [NCIt concept]
- H3C10 wt Allele [NCIt concept]
- H3C11 Gene [NCIt concept]
- H3C11 wt Allele [NCIt concept]
- H3C12 Gene [NCIt concept]
- H3C12 wt Allele [NCIt concept]
- H3C2 Gene [NCIt concept]
- H3C2 Gene Mutation [NCIt concept]
- H3C2 NM_003537.3:c.83A>T [NCIt concept]
- H3C2 wt Allele [NCIt concept]
- H3C3 Gene [NCIt concept]
- H3C3 Gene Mutation [NCIt concept]
- H3C3 NM_003531.2:c.83A>T [NCIt concept]
- H3C3 wt Allele [NCIt concept]
- H3C4 Gene [NCIt concept]
- H3C4 Gene Mutation [NCIt concept]
- H3C4 wt Allele [NCIt concept]
- H3C6 Gene [NCIt concept]
- H3C6 wt Allele [NCIt concept]
- H3C7 Gene [NCIt concept]
- H3C7 wt Allele [NCIt concept]
- H3C8 Gene [NCIt concept]
- H3C8 wt Allele [NCIt concept]
- H4C9 Gene [NCIt concept]
- H4C9 wt Allele [NCIt concept]
- HA-1(H) Genotype Positive [NCIt concept]
- HA-2 Genotype Positive [NCIt concept]
- HAAH Lambda phage Vaccine SNS-301 [NCIt concept]
- HACL1 Gene [NCIt concept]
- HACL1 wt Allele [NCIt concept]
- HAMP Gene [NCIt concept]
- HAMP Gene Product [NCIt concept]
- HAMP wt Allele [NCIt concept]
- HAS2 Gene [NCIt concept]
- HAS2 wt Allele [NCIt concept]
- HAVCR1 Gene [NCIt concept]
- HAVCR1 wt Allele [NCIt concept]
- HAVCR2 Gene [NCIt concept]
- HAVCR2 wt Allele [NCIt concept]
- HBA1 Gene [NCIt concept]
- HBA1 wt Allele [NCIt concept]
- HBA2 Gene [NCIt concept]
- HBA2 Gene Mutation [NCIt concept]
- HBA2 wt Allele [NCIt concept]
- HBB Gene [NCIt concept]
- HBB Gene Mutation [NCIt concept]
- HBB NM_000518.4:c.20A>T [NCIt concept]
- HBB NM_000518.4:c.364G>A [NCIt concept]
- HBB NM_000518.4:c.364G>C [NCIt concept]
- HBB NM_000518.5:c.19G>A [NCIt concept]
- HBB NM_000518.5:c.79G>A [NCIt concept]
- HBB NP_000509.1:p.E122K [NCIt concept]
- HBB NP_000509.1:p.E122Q [NCIt concept]
- HBB NP_000509.1:p.E27K [NCIt concept]
- HBB NP_000509.1:p.E7K [NCIt concept]
- HBB NP_000509.1:p.E7V [NCIt concept]
- HBB Protein Variant [NCIt concept]
- HBB wt Allele [NCIt concept]
- HBEGF Gene [NCIt concept]
- HBEGF wt Allele [NCIt concept]
- HBG1 Gene [NCIt concept]
- HBG1 wt Allele [NCIt concept]
- HBG2 Gene [NCIt concept]
- HBG2 wt Allele [NCIt concept]
- HCK Gene [NCIt concept]
- HCK wt Allele [NCIt concept]
- HCV DNA Vaccine INO-8000 [NCIt concept]
- HD Chest [NCIt concept]
- HDAC Inhibitor OBP-801 [NCIt concept]
- HDAC Inhibitor REC-2282 [NCIt concept]
- HDAC/EGFR/HER2 Inhibitor CUDC-101 [NCIt concept]
- HDAC1 Gene [NCIt concept]
- HDAC1 wt Allele [NCIt concept]
- HDAC10 Gene [NCIt concept]
- HDAC10 wt Allele [NCIt concept]
- HDAC11 Gene [NCIt concept]
- HDAC11 wt Allele [NCIt concept]
- HDAC2 Gene [NCIt concept]
- HDAC2 Gene Mutation [NCIt concept]
- HDAC2 mRNA Measurement [NCIt concept]
- HDAC2 wt Allele [NCIt concept]
- HDAC3 Gene [NCIt concept]
- HDAC3 wt Allele [NCIt concept]
- HDAC6 Gene [NCIt concept]
- HDAC6 Inhibitor KA2507 [NCIt concept]
- HDAC6 wt Allele [NCIt concept]
- HDAC7 Gene [NCIt concept]
- HDAC7 wt Allele [NCIt concept]
- HDAC8 Gene [NCIt concept]
- HDAC8 wt Allele [NCIt concept]
- HDAC9 Gene [NCIt concept]
- HDAC9 wt Allele [NCIt concept]
- HDM2 Inhibitor MK-8242 [NCIt concept]
- HEMGN Gene [NCIt concept]
- HEMGN wt Allele [NCIt concept]
- HER-2/PD-L1-targeting CAR-T Cells [NCIt concept]
- HER-2/neu Intracellular Domain Protein [NCIt concept]
- HER-2/neu Peptide Vaccine [NCIt concept]
- HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901 [NCIt concept]
- HER2 Inhibitor [NCIt concept]
- HER2 Inhibitor DZD1516 [NCIt concept]
- HER2 Inhibitor ELVN-002 [NCIt concept]
- HER2 Inhibitor IAM1363 [NCIt concept]
- HER2 Inhibitor TAS0728 [NCIt concept]
- HER2 Inhibitor ZN-A-1041 [NCIt concept]
- HER2 Mutant-selective Inhibitor NVL-330 [NCIt concept]
- HER2-Negative Breast Carcinoma [NCIt concept]
- HER2-Positive Lung Non-Small Cell Carcinoma [NCIt concept]
- HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 [NCIt concept]
- HER2-targeted Therapy [NCIt concept]
- HER2-targeting Agent [NCIt concept]
- HER2-targeting Antibody Fc Fragment FS102 [NCIt concept]
- HER2/Neu Copy Number Ratio Less than 2 by FISH [NCIt concept]
- HER2/Neu Expression by Immunohistochemistry 0 [NCIt concept]
- HER2/Neu Expression by Immunohistochemistry 1+ [NCIt concept]
- HER2/Neu Expression by Immunohistochemistry 2+ [NCIt concept]
- HER2/Neu Expression by Immunohistochemistry 3+ [NCIt concept]
- HER2/Neu Gene Copy Number Less than 6 [NCIt concept]
- HER2/Neu Low Expression [NCIt concept]
- HER2/Neu Negative [NCIt concept]
- HER2/Neu Negative by FISH [NCIt concept]
- HER2/Neu Positive [NCIt concept]
- HER2/Neu Status [NCIt concept]
- HER2/neu Peptide Vaccine GLSI-100 [NCIt concept]
- HER2Bi-Armed Activated T Cells [NCIt concept]
- HER3-targeting Agent [NCIt concept]
- HERPUD1 Gene [NCIt concept]
- HERPUD1 wt Allele [NCIt concept]
- HERV-H LTR-Associating Protein 2 [NCIt concept]
- HERV-K [NCIt concept]
- HES1 Gene [NCIt concept]
- HES1 wt Allele [NCIt concept]
- HES2 Gene [NCIt concept]
- HES2 wt Allele [NCIt concept]
- HES3 Gene [NCIt concept]
- HES3 wt Allele [NCIt concept]
- HES4 Gene [NCIt concept]
- HES4 wt Allele [NCIt concept]
- HES5 Gene [NCIt concept]
- HES5 wt Allele [NCIt concept]
- HES6 Gene [NCIt concept]
- HES6 wt Allele [NCIt concept]
- HEY1 Gene [NCIt concept]
- HEY1 wt Allele [NCIt concept]
- HEY2 Gene [NCIt concept]
- HEY2 wt Allele [NCIt concept]
- HEYL Gene [NCIt concept]
- HEYL wt Allele [NCIt concept]
- HGF Gene [NCIt concept]
- HGF Gene Amplification [NCIt concept]
- HGF Gene Mutation [NCIt concept]
- HGF wt Allele [NCIt concept]
- HGF-targeting Agent [NCIt concept]
- HGFAC Gene [NCIt concept]
- HGFAC wt Allele [NCIt concept]
- HHIP Gene [NCIt concept]
- HHIP wt Allele [NCIt concept]
- HHLA2 Gene [NCIt concept]
- HHLA2 wt Allele [NCIt concept]
- HHV6 Infection [NCIt concept]
- HHV8 K2 Gene [NCIt concept]
- HHV8 ORF50 Gene [NCIt concept]
- HHV8 ORF59 Gene [NCIt concept]
- HHV8 ORF71 Gene [NCIt concept]
- HHV8 ORF73 Gene [NCIt concept]
- HHV8 ORF74 Gene [NCIt concept]
- HHV8-Positive Germinotropic Lymphoproliferative Disorder [NCIt concept]
- HHV8-Positive Multicentric Castleman Disease [NCIt concept]
- HHV8-Related Lymphoproliferative Disorder [NCIt concept]
- HIF-1alpha Inhibitor PX-478 [NCIt concept]
- HIF-2alpha Inhibitor [NCIt concept]
- HIF-2alpha Inhibitor PT2385 [NCIt concept]
- HIF1A Gene [NCIt concept]
- HIF1A wt Allele [NCIt concept]
- HIF2alpha Inhibitor DFF332 [NCIt concept]
- HIP1 Gene [NCIt concept]
- HIP1 wt Allele [NCIt concept]
- HIP1/PDGFRB Fusion Gene [NCIt concept]
- HIP1/PDGFRB Fusion Protein [NCIt concept]
- HIRA Gene [NCIt concept]
- HIRA wt Allele [NCIt concept]
- HIST1H4I/BCL6 Fusion Gene [NCIt concept]
- HIV Infection [NCIt concept]
- HIV Screening [NCIt concept]
- HIV Viral Load Measurement [NCIt concept]
- HIV-1 RNA Measurement [NCIt concept]
- HJV Gene [NCIt concept]
- HJV wt Allele [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-0201 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-0201 Alpha Chain Positive [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-0205 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-0206 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-0301 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-1 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-11 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-2 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-24 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, A-2402 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, Alpha Chain G [NCIt concept]
- HLA Class I Histocompatibility Antigen, B-3508 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, B-44 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, B-5501 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, B-7 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, C Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, C-0102 Alpha Chain [NCIt concept]
- HLA Class I Histocompatibility Antigen, C-0401 Alpha Chain [NCIt concept]
- HLA Class I Panel Reactive Antibody [NCIt concept]
- HLA Class II Histocompatibility Antigen DRB [NCIt concept]
- HLA Class II Histocompatibility Antigen Gamma Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DQ Alpha 1 Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DQ Alpha 2 Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DQ Beta 1 Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DQ Beta 2 Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DR Alpha Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DR Beta 3-0101 Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DR Beta 3-0202 Chain [NCIt concept]
- HLA Class II Histocompatibility Antigen, DRB1-4 Beta Chain Protein [NCIt concept]
- HLA Complex [NCIt concept]
- HLA Phenotype Positive [NCIt concept]
- HLA-A Gene [NCIt concept]
- HLA-A Gene Product [NCIt concept]
- HLA-A wt Allele [NCIt concept]
- HLA-A*01:01 Exon 3/4 Splicing Mutation [NCIt concept]
- HLA-A*01:01 Negative [NCIt concept]
- HLA-A*01:01 Positive Cells Present [NCIt concept]
- HLA-A*0201 HA-1 Positive Cells Present [NCIt concept]
- HLA-A*0201 Negative [NCIt concept]
- HLA-A*0201 Positive Cells Present [NCIt concept]
- HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 Multipeptide Vaccine [NCIt concept]
- HLA-A*0202 Positive Cells Present [NCIt concept]
- HLA-A*0203 Positive Cells Present [NCIt concept]
- HLA-A*0204 Positive Cells Present [NCIt concept]
- HLA-A*0205 Positive Cells Present [NCIt concept]
- HLA-A*0206 Positive Cells Present [NCIt concept]
- HLA-A*0207 Positive Cells Present [NCIt concept]
- HLA-A*0209 Positive Cells Present [NCIt concept]
- HLA-A*0210 Positive Cells Present [NCIt concept]
- HLA-A*0211 Positive Cells Present [NCIt concept]
- HLA-A*02:01/TP53aa264-272 Complex [NCIt concept]
- HLA-A*02:642 Positive Cells Present [NCIt concept]
- HLA-A*03:01 Positive Cells Present [NCIt concept]
- HLA-A*24:02 Positive Cells Present [NCIt concept]
- HLA-A*26 Positive Cells Present [NCIt concept]
- HLA-A*68:01 Positive Cells Present [NCIt concept]
- HLA-A1 Positive Cells Present [NCIt concept]
- HLA-A11 Positive Cells Present [NCIt concept]
- HLA-A1101 Positive Cells Present [NCIt concept]
- HLA-A2 Positive Cells Present [NCIt concept]
- HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine [NCIt concept]
- HLA-A2-restricted IL-13Ra2/EphA2/Survivin/Tetanus Toxoid T-helper Epitopes-Montanide 51 Vaccine [NCIt concept]
- HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201 [NCIt concept]
- HLA-A24 Positive Cells Present [NCIt concept]
- HLA-A3 Positive Cells Present [NCIt concept]
- HLA-B Gene [NCIt concept]
- HLA-B Gene Product [NCIt concept]
- HLA-B wt Allele [NCIt concept]
- HLA-B*07 Positive Cells Present [NCIt concept]
- HLA-B*08:01 Positive Cells Present [NCIt concept]
- HLA-B*13:02 Positive Cells Present [NCIt concept]
- HLA-B*1501 Positive Cells Present [NCIt concept]
- HLA-B*35:01 Negative [NCIt concept]
- HLA-B*35:08 Positive Cells Present [NCIt concept]
- HLA-B*44:02 Positive Cells Present [NCIt concept]
- HLA-B*44:03 Positive Cells Present [NCIt concept]
- HLA-B*4601 Positive Cells Present [NCIt concept]
- HLA-B*5103 Positive Cells Present [NCIt concept]
- HLA-B*55:01 Positive Cells Present [NCIt concept]
- HLA-B*57:01 Positive Cells Present [NCIt concept]
- HLA-Bw4 Antigen [NCIt concept]
- HLA-Bw6 Antigen [NCIt concept]
- HLA-C Gene [NCIt concept]
- HLA-C Gene Product [NCIt concept]
- HLA-C wt Allele [NCIt concept]
- HLA-C*01:02 Positive Cells Present [NCIt concept]
- HLA-C*0404 Positive Cells Present [NCIt concept]
- HLA-C*04:01 Positive Cells Present [NCIt concept]
- HLA-C*07:02 Positive Cells Present [NCIt concept]
- HLA-C*08 Positive Cells Present [NCIt concept]
- HLA-C*0802 Positive Cells Present [NCIt concept]
- HLA-Cw Serotype [NCIt concept]
- HLA-DP4 Antigen [NCIt concept]
- HLA-DP4 Positive Cells Present [NCIt concept]
- HLA-DPA1 Gene [NCIt concept]
- HLA-DPA1 wt Allele [NCIt concept]
- HLA-DPB1 Gene [NCIt concept]
- HLA-DPB1 wt Allele [NCIt concept]
- HLA-DPB1*0401 Positive Cells Present [NCIt concept]
- HLA-DQA1 Gene [NCIt concept]
- HLA-DQA1 wt Allele [NCIt concept]
- HLA-DQA2 Gene [NCIt concept]
- HLA-DQA2 wt Allele [NCIt concept]
- HLA-DQB1 Gene [NCIt concept]
- HLA-DQB1 wt Allele [NCIt concept]
- HLA-DQB2 Gene [NCIt concept]
- HLA-DQB2 wt Allele [NCIt concept]
- HLA-DR Antigen [NCIt concept]
- HLA-DR Antigen 1D10 [NCIt concept]
- HLA-DR13 Antigen [NCIt concept]
- HLA-DR15 Antigen [NCIt concept]
- HLA-DR53 Antigen [NCIt concept]
- HLA-DRB1 Gene [NCIt concept]
- HLA-DRB1 wt Allele [NCIt concept]
- HLA-DRB1*03:01 Positive Cells Present [NCIt concept]
- HLA-DRB1*04:01 Positive Cells Present [NCIt concept]
- HLA-DRB1*04:04 Positive Cells Present [NCIt concept]
- HLA-DRB1*11:04 Positive Cells Present [NCIt concept]
- HLA-DRB1*13:03 Positive Cells Present [NCIt concept]
- HLA-DRB1*15:01 Positive Cells Present [NCIt concept]
- HLA-DRB1*15:01/HLA-DQA1*01:02/HLA-DQB1*06:02 Positive [NCIt concept]
- HLA-DRB3 Gene [NCIt concept]
- HLA-DRB3 Gene Product [NCIt concept]
- HLA-DRB3 wt Allele [NCIt concept]
- HLA-G Gene [NCIt concept]
- HLA-G Positive Cells Present [NCIt concept]
- HLA-G wt Allele [NCIt concept]
- HLA-KIR Compound Genotype [NCIt concept]
- HLF Gene [NCIt concept]
- HLF wt Allele [NCIt concept]
- HMB-45 [NCIt concept]
- HMB-45-Positive Neoplastic Cells Present [NCIt concept]
- HMB45-Positive Cells Present [NCIt concept]
- HMGA2 Gene [NCIt concept]
- HMGA2 wt Allele [NCIt concept]
- HMGA2/ALDH2 Fusion Gene [NCIt concept]
- HMGA2/ALDH2 Fusion Protein [NCIt concept]
- HMGA2/CCNB1IP1 Fusion Gene [NCIt concept]
- HMGA2/CCNB1IP1 Fusion Protein [NCIt concept]
- HMGA2/COX6C Fusion Gene [NCIt concept]
- HMGA2/COX6C Fusion Protein [NCIt concept]
- HMGA2/LHFP Fusion Gene [NCIt concept]
- HMGA2/LPP Long Fusion Gene [NCIt concept]
- HMGA2/LPP Long Fusion Protein [NCIt concept]
- HMGA2/LPP Short Fusion Gene [NCIt concept]
- HMGA2/LPP Short Fusion Protein [NCIt concept]
- HMGA2/RAD51B Fusion Gene [NCIt concept]
- HMGA2/RAD51B Fusion Protein [NCIt concept]
- HMGB1 Gene [NCIt concept]
- HMGB1 wt Allele [NCIt concept]
- HMGCR Gene [NCIt concept]
- HMGCR wt Allele [NCIt concept]
- HMGCS1 Gene [NCIt concept]
- HMGCS1 wt Allele [NCIt concept]
- HMGN2P46 Gene [NCIt concept]
- HMGN2P46 wt Allele [NCIt concept]
- HMOX1 Gene [NCIt concept]
- HMOX1 wt Allele [NCIt concept]
- HNF1A Gene [NCIt concept]
- HNF1A wt Allele [NCIt concept]
- HNF4A Gene [NCIt concept]
- HNF4A wt Allele [NCIt concept]
- HNRNPA2B1 Gene [NCIt concept]
- HNRNPA2B1 wt Allele [NCIt concept]
- HOMER3 Gene [NCIt concept]
- HOMER3 wt Allele [NCIt concept]
- HOOK3 Gene [NCIt concept]
- HOOK3 wt Allele [NCIt concept]
- HOTS Gene [NCIt concept]
- HOTS wt Allele [NCIt concept]
- HOX Pathway Mutation [NCIt concept]
- HOXA Gene Family [NCIt concept]
- HOXA1 Gene [NCIt concept]
- HOXA1 wt Allele [NCIt concept]
- HOXA10 Gene [NCIt concept]
- HOXA10 Positive [NCIt concept]
- HOXA10 wt Allele [NCIt concept]
- HOXA11 Gene [NCIt concept]
- HOXA11 wt Allele [NCIt concept]
- HOXA13 Gene [NCIt concept]
- HOXA13 wt Allele [NCIt concept]
- HOXA3 Gene [NCIt concept]
- HOXA3 wt Allele [NCIt concept]
- HOXA7 Gene [NCIt concept]
- HOXA7 wt Allele [NCIt concept]
- HOXA9 Gene [NCIt concept]
- HOXA9 Positive [NCIt concept]
- HOXA9 wt Allele [NCIt concept]
- HOXB Gene Family [NCIt concept]
- HOXB13 Gene [NCIt concept]
- HOXB13 Gene Mutation [NCIt concept]
- HOXB13 wt Allele [NCIt concept]
- HOXB4 Gene [NCIt concept]
- HOXB4 wt Allele [NCIt concept]
- HOXB6 Gene [NCIt concept]
- HOXB6 wt Allele [NCIt concept]
- HOXC11 Gene [NCIt concept]
- HOXC11 wt Allele [NCIt concept]
- HOXC13 Gene [NCIt concept]
- HOXC13 wt Allele [NCIt concept]
- HOXC5 Gene [NCIt concept]
- HOXC5 wt Allele [NCIt concept]
- HOXC6 Gene [NCIt concept]
- HOXC9 Gene [NCIt concept]
- HOXC9 wt Allele [NCIt concept]
- HOXD11 Gene [NCIt concept]
- HOXD11 wt Allele [NCIt concept]
- HOXD13 Gene [NCIt concept]
- HOXD13 wt Allele [NCIt concept]
- HPP1 Gene [NCIt concept]
- HPPH [NCIt concept]
- HPRT1 Gene [NCIt concept]
- HPRT1 wt Allele [NCIt concept]
- HPSE Gene [NCIt concept]
- HPSE wt Allele [NCIt concept]
- HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 [NCIt concept]
- HPV 16 E7:12-20 Peptide Vaccine [NCIt concept]
- HPV 16 E7:86-93 Peptide Vaccine [NCIt concept]
- HPV 16/18 E6/E7 DNA Vaccine pBI-11 [NCIt concept]
- HPV 16/18 E6/E7-encoding Lentiviral Vector-based Vaccine Lenti-HPV-07 [NCIt concept]
- HPV E6/E7-encoding Arenavirus Vaccine HB-201 [NCIt concept]
- HPV Major Capsid Protein L1 [NCIt concept]
- HPV Regulatory Protein E2 Antibody [NCIt concept]
- HPV Replication Protein E1 Antibody [NCIt concept]
- HPV Self-Collection [NCIt concept]
- HPV Transforming Protein E6 Antibody [NCIt concept]
- HPV Transforming Protein E7 Antibody [NCIt concept]
- HPV-11 Protein E6 [NCIt concept]
- HPV-11 Protein E7 [NCIt concept]
- HPV-16 E6 Peptides Vaccine/Candida albicans Extract [NCIt concept]
- HPV-16 E7 TCR Expressing T-cells [NCIt concept]
- HPV-16 Major Capsid Protein L1 [NCIt concept]
- HPV-16 Minor Capsid Protein L2 [NCIt concept]
- HPV-6 Protein E6 [NCIt concept]
- HPV-6-targeting Immunotherapeutic Vaccine INO-3106 [NCIt concept]
- HPV-High Risk [NCIt concept]
- HPV-Reactive T-Cell Finding [NCIt concept]
- HPV16 E6/7 mRNA Vaccine BNT113 [NCIt concept]
- HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101 [NCIt concept]
- HPV16 Infection [NCIt concept]
- HPV16 RG1 VLP Vaccine [NCIt concept]
- HPV16 Transforming Protein E6 Antibody [NCIt concept]
- HPV16 Vaccine [NCIt concept]
- HPV6/11-targeted DNA Plasmid Vaccine INO-3107 [NCIt concept]
- HPX Gene [NCIt concept]
- HPX wt Allele [NCIt concept]
- HRAS Gene [NCIt concept]
- HRAS Gene Amplification [NCIt concept]
- HRAS Gene Mutation [NCIt concept]
- HRAS NM_005343.3:c.35G>A [NCIt concept]
- HRAS NM_005343.3:c.35G>T [NCIt concept]
- HRAS NM_005343.3:c.35_36delinsAT [NCIt concept]
- HRAS NM_005343.3:c.35_36delinsTA [NCIt concept]
- HRAS NP_005334.1:p.G12D [NCIt concept]
- HRAS NP_005334.1:p.G12V [NCIt concept]
- HRAS NP_005334.1:p.G12X [NCIt concept]
- HRAS NP_005334.1:p.G13X [NCIt concept]
- HRAS NP_005334.1:p.Q61X [NCIt concept]
- HRAS Overexpression Positive [NCIt concept]
- HRAS Positive [NCIt concept]
- HRAS Protein Variant [NCIt concept]
- HRAS wt Allele [NCIt concept]
- HRH2 Gene [NCIt concept]
- HRH2 wt Allele [NCIt concept]
- HRK Gene [NCIt concept]
- HRK wt Allele [NCIt concept]
- HS3ST1 Gene [NCIt concept]
- HS3ST1 wt Allele [NCIt concept]
- HSATII DNA [NCIt concept]
- HSATII RNA [NCIt concept]
- HSD11B1 Gene [NCIt concept]
- HSD11B1 wt Allele [NCIt concept]
- HSD17B1 Gene [NCIt concept]
- HSD17B1 wt Allele [NCIt concept]
- HSD17B3 Gene [NCIt concept]
- HSD17B3 wt Allele [NCIt concept]
- HSD17B4 Gene [NCIt concept]
- HSD17B4 wt Allele [NCIt concept]
- HSD17B6 Gene [NCIt concept]
- HSD17B6 wt Allele [NCIt concept]
- HSD3B1 Gene [NCIt concept]
- HSD3B1 Gene Mutation [NCIt concept]
- HSD3B1 NM_000862.2:c.1100= [NCIt concept]
- HSD3B1 NM_000862.2:c.1100C>A [NCIt concept]
- HSD3B1 NP_000853.1:p.T367= [NCIt concept]
- HSD3B1 NP_000853.1:p.T367N [NCIt concept]
- HSD3B1 Protein Variant [NCIt concept]
- HSD3B1 wt Allele [NCIt concept]
- HSD3B2 Gene [NCIt concept]
- HSD3B2 wt Allele [NCIt concept]
- HSF1 Gene [NCIt concept]
- HSF1 wt Allele [NCIt concept]
- HSP90 Inhibitor [NCIt concept]
- HSP90AA1 Gene [NCIt concept]
- HSP90AA1 wt Allele [NCIt concept]
- HSP90AB1 Gene [NCIt concept]
- HSP90AB1 wt Allele [NCIt concept]
- HSP90B2P Gene [NCIt concept]
- HSP90B2P wt Allele [NCIt concept]
- HSPA1A Gene [NCIt concept]
- HSPA1A wt Allele [NCIt concept]
- HSPA1B Gene [NCIt concept]
- HSPA1B wt Allele [NCIt concept]
- HSPA4L Gene [NCIt concept]
- HSPA4L wt Allele [NCIt concept]
- HSPA5 Gene [NCIt concept]
- HSPA5 wt Allele [NCIt concept]
- HSPB1 Gene [NCIt concept]
- HSPB1 wt Allele [NCIt concept]
- HSPB1-Associated Protein 1 [NCIt concept]
- HSPBAP1 Gene [NCIt concept]
- HSPBAP1 wt Allele [NCIt concept]
- HSPD1 Gene [NCIt concept]
- HSPD1 wt Allele [NCIt concept]
- HSPH1 Gene [NCIt concept]
- HSPH1 T17 Repeat [NCIt concept]
- HSPH1 wt Allele [NCIt concept]
- HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2 [NCIt concept]
- HSV-TK-Transduced Donor Lymphocytes [NCIt concept]
- HTC2 Gene [NCIt concept]
- HTLV Positive [NCIt concept]
- HTLV-1 [NCIt concept]
- HTLV-1 Antibody [NCIt concept]
- HTLV-1 Antibody Positive [NCIt concept]
- HTLV-1 Infection [NCIt concept]
- HTLV-1 Positive [NCIt concept]
- HTLV-2 Positive [NCIt concept]
- HTR1A Gene [NCIt concept]
- HTR1A wt Allele [NCIt concept]
- HTR1B Gene [NCIt concept]
- HTR1B wt Allele [NCIt concept]
- HTR2A 1 Allele [NCIt concept]
- HTR2A 2 Allele [NCIt concept]
- HTR2A Gene [NCIt concept]
- HTR2A wt Allele [NCIt concept]
- HTR3A Gene [NCIt concept]
- HTR3A wt Allele [NCIt concept]
- HULLK Gene [NCIt concept]
- HULLK wt Allele [NCIt concept]
- Hafnium Oxide-containing Nanoparticles NBTXR3 [NCIt concept]
- Hairy Cell [NCIt concept]
- Hairy Cell Leukemia [NCIt concept]
- Hairy/Enhancer-of-Split Related With YRPW Motif Protein 2 [NCIt concept]
- Hairy/Enhancer-of-Split Related With YRPW Motif-Like Protein [NCIt concept]
- Hairy/Enhancer-of-Split Related with YRPW Motif Protein 1 [NCIt concept]
- Halofuginone Hydrobromide [NCIt concept]
- Haloperidol [NCIt concept]
- Hamartin [NCIt concept]
- Hand Function Test [NCIt concept]
- Hand-held Dynamometry [NCIt concept]
- Handout [NCIt concept]
- Haploidentical Hematopoietic Cell Transplantation [NCIt concept]
- Haploidentical Natural Killer Cells K-NK002 [NCIt concept]
- Haptoglobin [NCIt concept]
- Harmonic Ace+7 [NCIt concept]
- Harmonic Motion Image-guided Focused Ultrasound Surgery [NCIt concept]
- Harmonic Motion Imaging [NCIt concept]
- Harvest Procedure [NCIt concept]
- Head and Neck Carcinoma [NCIt concept]
- Head and Neck Carcinoma of Unknown Primary [NCIt concept]
- Head and Neck Lymph Node [NCIt concept]
- Head and Neck Lymphedema [NCIt concept]
- Head and Neck Merkel Cell Carcinoma [NCIt concept]
- Head and Neck Mucosal Melanoma [NCIt concept]
- Head and Neck Neoplasm [NCIt concept]
- Head and Neck Radiation Therapy [NCIt concept]
- Head and Neck Surgery [NCIt concept]
- Head and Neck Survivorship Tool: Assessment and Recommendations [NCIt concept]
- Health Assessment Questionnaire [NCIt concept]
- Health Behavior [NCIt concept]
- Health Care Professional [NCIt concept]
- Health Care Provider [NCIt concept]
- Health Education [NCIt concept]
- Health Information Exchange [NCIt concept]
- Health Insurance Navigation Program [NCIt concept]
- Health Promotion [NCIt concept]
- Health Promotion and Care [NCIt concept]
- Health Promotion and Education [NCIt concept]
- Health Risk Assessment [NCIt concept]
- Health Status Unknown [NCIt concept]
- Health Telemonitoring [NCIt concept]
- Health and Wellness Coach [NCIt concept]
- Healthcare Activity [NCIt concept]
- Healthy Control [NCIt concept]
- Healthy Stem Cell Donor [NCIt concept]
- Healthy Subject [NCIt concept]
- Heart Disorder [NCIt concept]
- Heat Shock 70 kDa Protein 1A/1B [NCIt concept]
- Heat Shock 70 kDa Protein 4L [NCIt concept]
- Heat Shock Factor 1 Pathway Inhibitor NXP800 [NCIt concept]
- Heat Shock Factor Protein 1 [NCIt concept]
- Heat Shock Protein 105 kDa [NCIt concept]
- Heat Shock Protein 70 [NCIt concept]
- Heat Shock Protein 75 kDa, Mitochondrial [NCIt concept]
- Heat Shock Protein 90 [NCIt concept]
- Heat Shock Protein Beta-1 [NCIt concept]
- Heat Shock Protein HSP 90-Alpha [NCIt concept]
- Heat Shock Protein HSP 90-Beta [NCIt concept]
- Heat Shock Protein Inhibitor [NCIt concept]
- Heat-Stable Enterotoxin Receptor [NCIt concept]
- Heat-Treated Varicella-Zoster Virus Vaccine V212 [NCIt concept]
- Heated Tobacco Product [NCIt concept]
- Hedgehog Family [NCIt concept]
- Hedgehog Family-Mediated Signaling Pathway [NCIt concept]
- Hedgehog Signaling Pathway [NCIt concept]
- Hedgehog-Interacting Protein [NCIt concept]
- Helicobacter pylori [NCIt concept]
- Helicobacter pylori Negative [NCIt concept]
- Helicobacter pylori Positive [NCIt concept]
- Helper T-Lymphocytes to Cytotoxic T-Lymphocytes Ratio Measurement [NCIt concept]
- Helper-Inducer T-Lymphocyte [NCIt concept]
- Hemangioma [NCIt concept]
- Hematocrit Less than 45 Percent [NCIt concept]
- Hematogenous CSF Blasts [NCIt concept]
- Hematologic Improvement-Erythroid Response [NCIt concept]
- Hematologic Improvement-Neutrophil Response [NCIt concept]
- Hematologic Improvement-Platelet Response [NCIt concept]
- Hematologic Malignancy-Associated Skin Squamous Cell Carcinoma [NCIt concept]
- Hematologic Neoplasm Associated with Down Syndrome [NCIt concept]
- Hematologic Toxicity Attenuation [NCIt concept]
- Hematology Test [NCIt concept]
- Hematopoietic Blast Cell [NCIt concept]
- Hematopoietic Cell Transplant Recipient [NCIt concept]
- Hematopoietic Cell Transplantation [NCIt concept]
- Hematopoietic Immune Cell [NCIt concept]
- Hematopoietic Progenitor Cell Antigen CD34 [NCIt concept]
- Hematopoietic Stem Cell [NCIt concept]
- Hematopoietic and Lymphatic System Neoplasm [NCIt concept]
- Hematopoietic and Lymphoid Cell Neoplasm [NCIt concept]
- Hematuria [NCIt concept]
- Heme Oxygenase 1 [NCIt concept]
- Hemi-body Radiotherapy [NCIt concept]
- Hemipelvectomy [NCIt concept]
- Hemoblast Bellows [NCIt concept]
- Hemogen [NCIt concept]
- Hemoglobin [NCIt concept]
- Hemoglobin A1C Measurement [NCIt concept]
- Hemoglobin Beta Heterozygous Hemoglobin E Plus Null Genotype [NCIt concept]
- Hemoglobin Beta Heterozygous Insufficiency Plus Null Genotype [NCIt concept]
- Hemoglobin D Disease [NCIt concept]
- Hemoglobin F [NCIt concept]
- Hemoglobin F Measurement [NCIt concept]
- Hemoglobin Greater than 11 g/dL [NCIt concept]
- Hemoglobin Increase Greater than or Equal to 1.0 g/dL [NCIt concept]
- Hemoglobin Increase Greater than or Equal to 1.5 g/dL [NCIt concept]
- Hemoglobin Less than 11 g/dL [NCIt concept]
- Hemoglobin S/O-Arab Heterozygote [NCIt concept]
- Hemoglobin Subunit Alpha [NCIt concept]
- Hemoglobin Subunit Beta [NCIt concept]
- Hemoglobin Subunit Gamma-1 [NCIt concept]
- Hemoglobin Subunit Gamma-2 [NCIt concept]
- Hemoglobin Tetramer Measurement [NCIt concept]
- Hemojuvelin [NCIt concept]
- Hemolytic Uremic Syndrome [NCIt concept]
- Hemopexin [NCIt concept]
- Hemophagocytic Lymphohistiocytosis [NCIt concept]
- Hemophilia A [NCIt concept]
- Hemoptysis [NCIt concept]
- Hemopurification [NCIt concept]
- Hemopurifier [NCIt concept]
- Hemostatic Agent [NCIt concept]
- Heparan Sulfate [NCIt concept]
- Heparan Sulfate Glucosamine 3-O-Sulfotransferase 1 [NCIt concept]
- Heparanase [NCIt concept]
- Heparin [NCIt concept]
- Heparin Binding Growth Factor [NCIt concept]
- Heparin Cofactor 2 [NCIt concept]
- Heparin-Binding EGF-Like Growth Factor [NCIt concept]
- Hepatectomy [NCIt concept]
- Hepatic Artery Embolization [NCIt concept]
- Hepatic Complication [NCIt concept]
- Hepatic Leukemia Factor [NCIt concept]
- Hepatic Steatosis [NCIt concept]
- Hepatic Thrombosis [NCIt concept]
- Hepatic Triacylglycerol Lipase [NCIt concept]
- Hepatitis A Vaccine [NCIt concept]
- Hepatitis A Virus Cellular Receptor 1 [NCIt concept]
- Hepatitis A Virus Cellular Receptor 2 [NCIt concept]
- Hepatitis B Antigen Positive [NCIt concept]
- Hepatitis B Antigen Vaccine [NCIt concept]
- Hepatitis B Infection [NCIt concept]
- Hepatitis B Screening [NCIt concept]
- Hepatitis B Surface Antibody Negative [NCIt concept]
- Hepatitis B Surface Antibody Positive [NCIt concept]
- Hepatitis B Vaccine [NCIt concept]
- Hepatitis B Virus [NCIt concept]
- Hepatitis B Virus Antisense Oligonucleotide AHB-137 [NCIt concept]
- Hepatitis B Virus Core Antibody Negative [NCIt concept]
- Hepatitis B Virus Core Antibody Positive [NCIt concept]
- Hepatitis B Virus HBsAg Surface Protein Antigen [NCIt concept]
- Hepatitis B Virus Negative [NCIt concept]
- Hepatitis B Virus Positive [NCIt concept]
- Hepatitis B Virus Surface Antigen Negative [NCIt concept]
- Hepatitis C Antibody [NCIt concept]
- Hepatitis C Infection [NCIt concept]
- Hepatitis C Virus [NCIt concept]
- Hepatitis C Virus Antibody Positive [NCIt concept]
- Hepatitis C Virus Genotype 4 Positive [NCIt concept]
- Hepatitis C Virus Positive [NCIt concept]
- Hepatitis C Virus RNA Positive [NCIt concept]
- Hepatitis Virus-Related Hepatocellular Carcinoma [NCIt concept]
- Hepatobiliary Iminodiacetic Acid Scan [NCIt concept]
- Hepatobiliary Neoplasm [NCIt concept]
- Hepatoblastoma [NCIt concept]
- Hepatocellular Carcinoma [NCIt concept]
- Hepatocellular Clear Cell Carcinoma [NCIt concept]
- Hepatocellular Lymphocyte-Rich Carcinoma [NCIt concept]
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified [NCIt concept]
- Hepatocellular Moderately Differentiated Carcinoma [NCIt concept]
- Hepatocellular Pleomorphic Carcinoma [NCIt concept]
- Hepatocellular Poorly Differentiated Carcinoma [NCIt concept]
- Hepatocellular Sarcomatoid Carcinoma [NCIt concept]
- Hepatocellular Scirrhous Carcinoma [NCIt concept]
- Hepatocellular Well Differentiated Carcinoma [NCIt concept]
- Hepatocyte Growth Factor [NCIt concept]
- Hepatocyte Growth Factor Activator [NCIt concept]
- Hepatocyte Growth Factor Receptor [NCIt concept]
- Hepatocyte Nuclear Factor 1-Alpha [NCIt concept]
- Hepatocyte Nuclear Factor 4-Alpha [NCIt concept]
- Hepatosplenic T-Cell Lymphoma [NCIt concept]
- Hepcidin [NCIt concept]
- Hepcidin-25 [NCIt concept]
- Herb [NCIt concept]
- Hereditary Breast Carcinoma [NCIt concept]
- Hereditary Cardiac ATTR Amyloidosis [NCIt concept]
- Hereditary Clear Cell Renal Cell Carcinoma [NCIt concept]
- Hereditary Colon Carcinoma [NCIt concept]
- Hereditary Colorectal Cancer Syndrome [NCIt concept]
- Hereditary Fallopian Tube Carcinoma [NCIt concept]
- Hereditary Hemochromatosis [NCIt concept]
- Hereditary Kidney Oncocytoma [NCIt concept]
- Hereditary Kidney Wilms Tumor [NCIt concept]
- Hereditary Leiomyomatosis and Renal Cell Carcinoma [NCIt concept]
- Hereditary Malignant Urinary System Neoplasm [NCIt concept]
- Hereditary Melanoma [NCIt concept]
- Hereditary Meningioma [NCIt concept]
- Hereditary Neoplastic Syndrome [NCIt concept]
- Hereditary Neuroblastoma [NCIt concept]
- Hereditary Nonmedullary Thyroid Gland Carcinoma [NCIt concept]
- Hereditary Nonpolyposis Colorectal Cancer Syndrome [NCIt concept]
- Hereditary Ovarian Carcinoma [NCIt concept]
- Hereditary Pancreatic Carcinoma [NCIt concept]
- Hereditary Pancreatitis [NCIt concept]
- Hereditary Papillary Renal Cell Carcinoma [NCIt concept]
- Hereditary Paraganglioma [NCIt concept]
- Hereditary Prostate Carcinoma [NCIt concept]
- Hereditary Renal Cell Carcinoma [NCIt concept]
- Hereditary Thyroid Gland Medullary Carcinoma [NCIt concept]
- Hereditary Transthyretin Amyloidosis with Polyneuropathy [NCIt concept]
- Heregulin Positive [NCIt concept]
- Heritable Pulmonary Arterial Hypertension [NCIt concept]
- Hermansky-Pudlak Syndrome 1 [NCIt concept]
- Hermansky-Pudlak Syndrome 2 [NCIt concept]
- Hermansky-Pudlak Syndrome 6 [NCIt concept]
- Hernia [NCIt concept]
- Herpes Simplex Virus Infection [NCIt concept]
- Herpesvirus [NCIt concept]
- Herpesvirus Infection [NCIt concept]
- Heterochromatin Protein 1 [NCIt concept]
- Heterocyclic Amines [NCIt concept]
- Heterogeneity Diffusion Imaging [NCIt concept]
- Heterogeneous Nuclear Ribonucleoprotein A2/B1 [NCIt concept]
- Heterogeneously Dense Breast [NCIt concept]
- Hexabrominated Diphenyl Ether 153 [NCIt concept]
- Hexaminolevulinate [NCIt concept]
- Hexaminolevulinate Hydrochloride [NCIt concept]
- Hexokinase [NCIt concept]
- High Affinity Copper Uptake Protein 1 [NCIt concept]
- High Affinity Immunoglobulin Gamma Fc Receptor I [NCIt concept]
- High Affinity Nerve Growth Factor Receptor [NCIt concept]
- High Affinity Nerve Growth Factor Receptor Isoform TrkA-III [NCIt concept]
- High Affinity cAMP-Specific and IBMX-Insensitive 3',5'-Cyclic Phosphodiesterase 8B [NCIt concept]
- High CpG Island Methylator Phenotype [NCIt concept]
- High Density Lipoprotein [NCIt concept]
- High Dose Chemotherapy [NCIt concept]
- High Field Strength Magnetic Resonance Imaging [NCIt concept]
- High Frequency Ultrasound Imaging [NCIt concept]
- High Grade Anal Intraepithelial Neoplasia [NCIt concept]
- High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements [NCIt concept]
- High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements [NCIt concept]
- High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements [NCIt concept]
- High Grade B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- High Grade Dysplasia in Barrett Esophagus [NCIt concept]
- High Grade Endometrial Carcinoma [NCIt concept]
- High Grade Myeloid Neoplasm [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia [NCIt concept]
- High Grade Squamous Intraepithelial Neoplasia [NCIt concept]
- High Level of Hyaluronic Acid [NCIt concept]
- High Mobility Group Protein B1 [NCIt concept]
- High Neoplasm Polygenic Risk Score [NCIt concept]
- High Performance Liquid Chromatography [NCIt concept]
- High Resolution Anoscopy [NCIt concept]
- High Resolution Anoscopy with Biopsy [NCIt concept]
- High Resolution Computed Tomography [NCIt concept]
- High Resolution Peripheral Quantitative Computed Tomography [NCIt concept]
- High Risk Acute Lymphoblastic Leukemia [NCIt concept]
- High Risk Acute Myeloid Leukemia [NCIt concept]
- High Risk Barrett Esophagus [NCIt concept]
- High Risk Breast Carcinoma [NCIt concept]
- High Risk Chronic Myelogenous Leukemia, BCR-ABL1 Positive [NCIt concept]
- High Risk Chronic Myelomonocytic Leukemia [NCIt concept]
- High Risk Meningioma [NCIt concept]
- High Risk Multiple Myeloma [NCIt concept]
- High Risk Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- High Risk Myelodysplastic Syndrome [NCIt concept]
- High Risk Neuroblastoma [NCIt concept]
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- High Risk Prostate Carcinoma [NCIt concept]
- High Risk Study Participant [NCIt concept]
- High Sensitivity C-Reactive Protein Measurement [NCIt concept]
- High Sensitivity Troponin T Assay [NCIt concept]
- High Tumor Mutation Burden [NCIt concept]
- High-Dose Chemotherapy with Stem Cell Support [NCIt concept]
- High-Dose Cytarabine Regimen [NCIt concept]
- High-Dose Methotrexate Regimen [NCIt concept]
- High-Dose Rate Brachytherapy [NCIt concept]
- High-Dose-Rate Vaginal Brachytherapy [NCIt concept]
- High-Dose-Rate Vaginal Cuff Brachytherapy [NCIt concept]
- High-Flow Nasal Cannula Oxygen Therapy [NCIt concept]
- High-Frequency Microsatellite Instability [NCIt concept]
- High-Intensity Focused Ultrasound Ablation [NCIt concept]
- High-Intensity Focused Ultrasound Ablation of the Prostate [NCIt concept]
- High-Intensity Interval Training [NCIt concept]
- High-LET Neutron Therapy [NCIt concept]
- High-Mobility Group Protein HMGI-C [NCIt concept]
- High-Protein Nutritional Supplement [NCIt concept]
- High-Resolution Microendoscopy [NCIt concept]
- High-Selenium Brassica juncea [NCIt concept]
- High-amylose Resistant Starch [NCIt concept]
- High-energy Photon Therapy [NCIt concept]
- High-titer RSV Immune Globulin RI-001 [NCIt concept]
- Higher Risk Myelodysplastic Syndrome [NCIt concept]
- Hilar Cholangiocarcinoma [NCIt concept]
- Hippocampal-Avoidance Craniospinal Irradiation [NCIt concept]
- Hippocampal-Avoidance Whole-Brain Radiotherapy [NCIt concept]
- Histamine [NCIt concept]
- Histamine H2 Receptor [NCIt concept]
- Histidine [NCIt concept]
- Histiocytic Sarcoma [NCIt concept]
- Histiocytic and Dendritic Cell Neoplasm [NCIt concept]
- Histiocytosis [NCIt concept]
- Histological Procedure [NCIt concept]
- Histone [NCIt concept]
- Histone Acetylase [NCIt concept]
- Histone Acetylation [NCIt concept]
- Histone Acetyltransferase KAT2A [NCIt concept]
- Histone Acetyltransferase KAT2B [NCIt concept]
- Histone Acetyltransferase KAT5 [NCIt concept]
- Histone Acetyltransferase KAT6A [NCIt concept]
- Histone Acetyltransferase KAT6B [NCIt concept]
- Histone Acetyltransferase p300 [NCIt concept]
- Histone Deacetylase [NCIt concept]
- Histone Deacetylase 1 [NCIt concept]
- Histone Deacetylase 10 [NCIt concept]
- Histone Deacetylase 11 [NCIt concept]
- Histone Deacetylase 2 [NCIt concept]
- Histone Deacetylase 3 [NCIt concept]
- Histone Deacetylase 6 [NCIt concept]
- Histone Deacetylase 7 [NCIt concept]
- Histone Deacetylase 8 [NCIt concept]
- Histone Deacetylase 9 [NCIt concept]
- Histone Gene Mutation [NCIt concept]
- Histone H1 [NCIt concept]
- Histone H1.1 [NCIt concept]
- Histone H2 [NCIt concept]
- Histone H2A [NCIt concept]
- Histone H2A.Z [NCIt concept]
- Histone H2AX [NCIt concept]
- Histone H2B [NCIt concept]
- Histone H2B Type 1-D [NCIt concept]
- Histone H3 [NCIt concept]
- Histone H3 Acetyl Lys28 [NCIt concept]
- Histone H3 Dimethyl Lys28 [NCIt concept]
- Histone H3 Dimethyl Lys4 [NCIt concept]
- Histone H3 Gene [NCIt concept]
- Histone H3 Gene Mutation [NCIt concept]
- Histone H3 Gene Mutation Negative [NCIt concept]
- Histone H3 Lysine 28 [NCIt concept]
- Histone H3 Lysine 4 [NCIt concept]
- Histone H3 Lysine 79 [NCIt concept]
- Histone H3 Lysine 9 [NCIt concept]
- Histone H3 Methyl Lys4 [NCIt concept]
- Histone H3 Trimethyl Lys36 [NCIt concept]
- Histone H3 Trimethyl Lys4 [NCIt concept]
- Histone H3 Trimethyl Lysine 28 Negative [NCIt concept]
- Histone H3.1 [NCIt concept]
- Histone H3.3 [NCIt concept]
- Histone H4 [NCIt concept]
- Histone Modification [NCIt concept]
- Histone-Binding Protein RBBP4 [NCIt concept]
- Histone-Lysine N-Methyltransferase 2A [NCIt concept]
- Histone-Lysine N-Methyltransferase 2B [NCIt concept]
- Histone-Lysine N-Methyltransferase 2C [NCIt concept]
- Histone-Lysine N-Methyltransferase 2D [NCIt concept]
- Histone-Lysine N-Methyltransferase EZH2 [NCIt concept]
- Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126 [NCIt concept]
- Histone-Lysine N-Methyltransferase H3 Lysine-79 Specific [NCIt concept]
- Histone-Lysine N-Methyltransferase MECOM [NCIt concept]
- Histone-Lysine N-Methyltransferase NSD2 [NCIt concept]
- Histone-Lysine N-Methyltransferase NSD3 [NCIt concept]
- Histone-Lysine N-Methyltransferase PRDM16 [NCIt concept]
- Histone-Lysine N-Methyltransferase SETD2 [NCIt concept]
- Histone-Lysine N-Methyltransferase SETMAR [NCIt concept]
- Histone-Lysine N-Methyltransferase, H3 Lysine-36 and H4 Lysine-20 Specific [NCIt concept]
- Histopathologic Examination [NCIt concept]
- History and Physical Exam [NCIt concept]
- Histotripsy [NCIt concept]
- Histrelin [NCIt concept]
- Hodgkin Lymphoma [NCIt concept]
- Hodgkin Lymphoma During Pregnancy [NCIt concept]
- Hodgkin Lymphoma in Remission [NCIt concept]
- Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine [NCIt concept]
- Holmium Laser Enucleation of the Prostate [NCIt concept]
- Holter Monitoring [NCIt concept]
- Home Care [NCIt concept]
- Home Health Encounter [NCIt concept]
- Homeless [NCIt concept]
- Homeobox Prospero-Like Protein PROX1 [NCIt concept]
- Homeobox Protein CDX-1 [NCIt concept]
- Homeobox Protein CDX-2 [NCIt concept]
- Homeobox Protein CDX-4 [NCIt concept]
- Homeobox Protein DLX-1 [NCIt concept]
- Homeobox Protein DLX-5 [NCIt concept]
- Homeobox Protein Hox-A1 [NCIt concept]
- Homeobox Protein Hox-A10 [NCIt concept]
- Homeobox Protein Hox-A11 [NCIt concept]
- Homeobox Protein Hox-A13 [NCIt concept]
- Homeobox Protein Hox-A3 [NCIt concept]
- Homeobox Protein Hox-A7 [NCIt concept]
- Homeobox Protein Hox-A9 [NCIt concept]
- Homeobox Protein Hox-B13 [NCIt concept]
- Homeobox Protein Hox-B4 [NCIt concept]
- Homeobox Protein Hox-B6 [NCIt concept]
- Homeobox Protein Hox-C11 [NCIt concept]
- Homeobox Protein Hox-C13 [NCIt concept]
- Homeobox Protein Hox-C5 [NCIt concept]
- Homeobox Protein Hox-C9 [NCIt concept]
- Homeobox Protein Hox-D11 [NCIt concept]
- Homeobox Protein Hox-D13 [NCIt concept]
- Homeobox Protein Meis1 [NCIt concept]
- Homeobox Protein Meis2 [NCIt concept]
- Homeobox Protein NANOG [NCIt concept]
- Homeobox Protein Nkx-3.1 [NCIt concept]
- Homeobox Protein OTX2 [NCIt concept]
- Homeobox Protein SIX1 [NCIt concept]
- Homeobox Protein SIX2 [NCIt concept]
- Homeobox Protein SIX4 [NCIt concept]
- Homeobox Protein SIX5 [NCIt concept]
- Homeopathy Therapy [NCIt concept]
- Homeostatic Model Assessment of Insulin Resistance [NCIt concept]
- Homer Protein Homolog 3 [NCIt concept]
- Homocysteine [NCIt concept]
- Homocysteine-Responsive Endoplasmic Reticulum-Resident Ubiquitin-Like Domain Member 1 Protein [NCIt concept]
- Homologous Recombination Deficiency [NCIt concept]
- Homologous Recombination Repair Biallelic Inactivation [NCIt concept]
- Homologous Recombination Repair Gene [NCIt concept]
- Homologous Recombination Repair Gene Alteration Positive [NCIt concept]
- Homologous Recombination Repair Gene Mutation [NCIt concept]
- Homologous Recombination Repair Proficient [NCIt concept]
- Homovanillic Acid [NCIt concept]
- Homozygosity [NCIt concept]
- Homozygous ATM Gene Mutation [NCIt concept]
- Homozygous CDKN2A Gene Deletion [NCIt concept]
- Homozygous CDKN2B Gene Deletion [NCIt concept]
- Homozygous MTAP Gene Deletion [NCIt concept]
- Homozygous UGT1A1*28 Positive [NCIt concept]
- Homozygous UGT1A1*36 Positive [NCIt concept]
- Homozygous UGT1A1*37 Positive [NCIt concept]
- Homozygous UGT1A1*6 Positive [NCIt concept]
- Hormone Antagonist [NCIt concept]
- Hormone Receptor Negative [NCIt concept]
- Hormone Receptor Positive [NCIt concept]
- Hormone Receptor-Negative Breast Carcinoma [NCIt concept]
- Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Hormone Therapy [NCIt concept]
- Hormone Therapy Agent [NCIt concept]
- Hormone-Resistant Breast Carcinoma [NCIt concept]
- Hormone-Resistant Prostate Carcinoma [NCIt concept]
- Hormone-Upregulated Long Non-Coding RNA within LCK [NCIt concept]
- Hospice Care [NCIt concept]
- Hospital Anxiety and Depression Scale Questionnaire [NCIt concept]
- Hot Flashes [NCIt concept]
- Hpk1 Inhibitor BGB-15025 [NCIt concept]
- Hpk1 Inhibitor BGB-26808 [NCIt concept]
- Hpk1 Inhibitor CFI-402411 [NCIt concept]
- Hpk1 Inhibitor FB849 [NCIt concept]
- Hpk1 Inhibitor GRC 54276 [NCIt concept]
- Hpk1 Inhibitor NDI-101150 [NCIt concept]
- Hpk1 Inhibitor PF-07265028 [NCIt concept]
- Hsp90 Antagonist KW-2478 [NCIt concept]
- Hsp90 Inhibitor BIIB021 [NCIt concept]
- Hsp90 Inhibitor BIIB028 [NCIt concept]
- Hsp90 Inhibitor DS-2248 [NCIt concept]
- Hsp90 Inhibitor LAM-003 [NCIt concept]
- Hsp90 Inhibitor SNX-5422 Mesylate [NCIt concept]
- Hsp90 Inhibitor XL888 [NCIt concept]
- Hsp90-targeted Photosensitizer HS-201 [NCIt concept]
- HuaChanSu [NCIt concept]
- Human Acellular Dermal Matrix [NCIt concept]
- Human Adenovirus Type 5 Early Region 1 [NCIt concept]
- Human Adenovirus Type 5 Encoding HPV-16 E6/E7 Vaccine IBRX-042 [NCIt concept]
- Human Anti-Anti-Idiotype Antibody [NCIt concept]
- Human Anti-CD30 CAR-expressing Autologous T-lymphocytes [NCIt concept]
- Human Anti-Chimeric Antibody [NCIt concept]
- Human Anti-Chimeric Antibody Positive [NCIt concept]
- Human Anti-Fusion Protein Antibody [NCIt concept]
- Human Anti-Human Antibody [NCIt concept]
- Human Anti-Human Minibody Antibody [NCIt concept]
- Human Anti-Idiotype Antibody [NCIt concept]
- Human Anti-Mouse Antibodies Negative [NCIt concept]
- Human Anti-Mouse Antibodies Positive [NCIt concept]
- Human Anti-Ricin Antibody [NCIt concept]
- Human Chorionic Gonadotropin [NCIt concept]
- Human Chromosome 1 [NCIt concept]
- Human Chromosome 10 [NCIt concept]
- Human Chromosome 11 [NCIt concept]
- Human Chromosome 12 [NCIt concept]
- Human Chromosome 13 [NCIt concept]
- Human Chromosome 14 [NCIt concept]
- Human Chromosome 15 [NCIt concept]
- Human Chromosome 16 [NCIt concept]
- Human Chromosome 17 [NCIt concept]
- Human Chromosome 19 [NCIt concept]
- Human Chromosome 2 [NCIt concept]
- Human Chromosome 20 [NCIt concept]
- Human Chromosome 21 [NCIt concept]
- Human Chromosome 22 [NCIt concept]
- Human Chromosome 3 [NCIt concept]
- Human Chromosome 4 [NCIt concept]
- Human Chromosome 5 [NCIt concept]
- Human Chromosome 6 [NCIt concept]
- Human Chromosome 7 [NCIt concept]
- Human Chromosome 8 [NCIt concept]
- Human Chromosome 9 [NCIt concept]
- Human Chromosome X [NCIt concept]
- Human Chromosome Y [NCIt concept]
- Human Cytomegalovirus Envelope Glycoprotein B [NCIt concept]
- Human Cytomegalovirus Envelope Glycoprotein B Immunoglobulin G [NCIt concept]
- Human Cytomegalovirus Envelope Pentamer Complex [NCIt concept]
- Human Cytomegalovirus Envelope Pentamer Immunoglobulin G [NCIt concept]
- Human Herpesvirus 1 [NCIt concept]
- Human Herpesvirus 1 Antibody [NCIt concept]
- Human Herpesvirus 1 DNA Positive [NCIt concept]
- Human Herpesvirus 1 Positive [NCIt concept]
- Human Herpesvirus 2 [NCIt concept]
- Human Herpesvirus 2 DNA Positive [NCIt concept]
- Human Herpesvirus 2 Positive [NCIt concept]
- Human Herpesvirus 6 [NCIt concept]
- Human Herpesvirus 6 Positive [NCIt concept]
- Human Herpesvirus 8 [NCIt concept]
- Human Herpesvirus 8 Positive [NCIt concept]
- Human Herpesvirus 8-Positive Neoplastic Cells Present [NCIt concept]
- Human Herpesvirus-8 Immediate-Early Region-4 Gene Locus [NCIt concept]
- Human Immunodeficiency Virus [NCIt concept]
- Human Immunodeficiency Virus 1 [NCIt concept]
- Human Immunodeficiency Virus 1 Positive [NCIt concept]
- Human Immunodeficiency Virus Antibody Negative [NCIt concept]
- Human Immunodeficiency Virus DNA [NCIt concept]
- Human Immunodeficiency Virus Negative [NCIt concept]
- Human Immunodeficiency Virus Positive [NCIt concept]
- Human Immunodeficiency Virus RNA [NCIt concept]
- Human Immunoglobulin G [NCIt concept]
- Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104 [NCIt concept]
- Human Metapneumovirus [NCIt concept]
- Human Metapneumovirus Infection [NCIt concept]
- Human Metapneumovirus Virus Positive [NCIt concept]
- Human Milk Oligosaccharides-based Formulation PBCLN-010 [NCIt concept]
- Human Monkeypox Virus Measurement Finding [NCIt concept]
- Human Monoclonal Antibody 216 [NCIt concept]
- Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 [NCIt concept]
- Human Papilloma Virus Vaccine [NCIt concept]
- Human Papillomavirus [NCIt concept]
- Human Papillomavirus 16 Transforming Protein E6 Seropositive [NCIt concept]
- Human Papillomavirus Antibody [NCIt concept]
- Human Papillomavirus DNA [NCIt concept]
- Human Papillomavirus DNA Test [NCIt concept]
- Human Papillomavirus Infection [NCIt concept]
- Human Papillomavirus Negative [NCIt concept]
- Human Papillomavirus Positive [NCIt concept]
- Human Papillomavirus Screening [NCIt concept]
- Human Papillomavirus Tumor Antigen Vaccine [NCIt concept]
- Human Papillomavirus Vaccine V503 [NCIt concept]
- Human Papillomavirus mRNA [NCIt concept]
- Human Papillomavirus-11 [NCIt concept]
- Human Papillomavirus-11 Positive [NCIt concept]
- Human Papillomavirus-16 [NCIt concept]
- Human Papillomavirus-16 Negative [NCIt concept]
- Human Papillomavirus-16 Positive [NCIt concept]
- Human Papillomavirus-18 [NCIt concept]
- Human Papillomavirus-18 Negative [NCIt concept]
- Human Papillomavirus-18 Positive [NCIt concept]
- Human Papillomavirus-31 [NCIt concept]
- Human Papillomavirus-31 Positive [NCIt concept]
- Human Papillomavirus-33 [NCIt concept]
- Human Papillomavirus-33 Positive [NCIt concept]
- Human Papillomavirus-33/58 Positive [NCIt concept]
- Human Papillomavirus-35 [NCIt concept]
- Human Papillomavirus-35 Positive [NCIt concept]
- Human Papillomavirus-35/39/68 Positive [NCIt concept]
- Human Papillomavirus-39 Positive [NCIt concept]
- Human Papillomavirus-45 [NCIt concept]
- Human Papillomavirus-45 Positive [NCIt concept]
- Human Papillomavirus-51 Positive [NCIt concept]
- Human Papillomavirus-52 [NCIt concept]
- Human Papillomavirus-52 Positive [NCIt concept]
- Human Papillomavirus-56 Positive [NCIt concept]
- Human Papillomavirus-56/59/66 Positive [NCIt concept]
- Human Papillomavirus-58 [NCIt concept]
- Human Papillomavirus-58 Positive [NCIt concept]
- Human Papillomavirus-59 Positive [NCIt concept]
- Human Papillomavirus-6 [NCIt concept]
- Human Papillomavirus-6 Positive [NCIt concept]
- Human Papillomavirus-66 Positive [NCIt concept]
- Human Papillomavirus-68 Positive [NCIt concept]
- Human Papillomavirus-Negative Neck Squamous Cell Carcinoma of Unknown Primary [NCIt concept]
- Human Papillomavirus-Related Cervical Carcinoma [NCIt concept]
- Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma [NCIt concept]
- Human Papillomavirus-Related Head and Neck Mucosal Squamous Cell Carcinoma [NCIt concept]
- Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary [NCIt concept]
- Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Human Papillomavirus-Related Sinonasal Multiphenotypic Carcinoma [NCIt concept]
- Human Papillomavirus-Related Squamous Cell Carcinoma [NCIt concept]
- Human Placenta-derived Stem Cell Transplantation [NCIt concept]
- Human Prescription Drug Distribution [NCIt concept]
- Human Respiratory Syncytial Virus [NCIt concept]
- Human Study Subject [NCIt concept]
- Hunter Syndrome [NCIt concept]
- Huntingtin-Interacting Protein 1 [NCIt concept]
- Hurler Syndrome [NCIt concept]
- Hyaluronan Synthase 2 [NCIt concept]
- Hyaluronic Acid [NCIt concept]
- Hyaluronic Acid-based Gel [NCIt concept]
- Hyaluronidase-zzxf/Pertuzumab/Trastuzumab [NCIt concept]
- Hybrid Argon Plasma Coagulation [NCIt concept]
- Hybrid Imaging [NCIt concept]
- Hybrid Salivary Gland Tumor [NCIt concept]
- Hydatidiform Mole [NCIt concept]
- Hydralazine Hydrochloride [NCIt concept]
- Hydrated Sodium Calcium Aluminosilicate [NCIt concept]
- Hydration Therapy [NCIt concept]
- Hydrocodone [NCIt concept]
- Hydrocortisone Sodium Succinate [NCIt concept]
- Hydrocortisone/Placebo [NCIt concept]
- Hydrogel-based Resiquimod STM-416 [NCIt concept]
- Hydrogel-encapsulated Breast Biopsy Clip Localization [NCIt concept]
- Hydrogen Peroxide [NCIt concept]
- Hydromorphone [NCIt concept]
- Hydroxocobalamin [NCIt concept]
- Hydroxychloroquine [NCIt concept]
- Hydroxychloroquine Sulfate [NCIt concept]
- Hydroxylated Polybrominated Diphenyl Ether [NCIt concept]
- Hydroxymethylglutaryl-CoA Synthase, Cytoplasmic [NCIt concept]
- Hydroxyprogesterone [NCIt concept]
- Hydroxytyrosol [NCIt concept]
- Hydroxyurea [NCIt concept]
- Hyper-Sialylated IgG M254 [NCIt concept]
- Hyperbaric Oxygen Therapy [NCIt concept]
- Hypercalcemia [NCIt concept]
- Hypercalcemia of Malignancy [NCIt concept]
- Hyperdiploidy [NCIt concept]
- Hyperfractionated Accelerated Radiation Delivered with Integrated Neck Surgery [NCIt concept]
- Hyperfractioned Radiation Therapy [NCIt concept]
- Hyperglycemia [NCIt concept]
- Hypericin Sodium [NCIt concept]
- Hyperimmunoglobulin M Syndrome [NCIt concept]
- Hyperkalemia [NCIt concept]
- Hypermethylation Profile [NCIt concept]
- Hypermutated Colorectal Carcinoma [NCIt concept]
- Hypermutation Phenotype [NCIt concept]
- Hyperparathyroidism [NCIt concept]
- Hyperploidy [NCIt concept]
- Hyperpolarized Carbon 13 Alpha-ketoglutarate [NCIt concept]
- Hyperpolarized Carbon C 13 Pyruvate [NCIt concept]
- Hyperpolarized Carbon C 13/Nitrogen N 15-labeled Urea [NCIt concept]
- Hyperspectral Camera System [NCIt concept]
- Hyperspectral Endoscopy [NCIt concept]
- Hypertension [NCIt concept]
- Hyperthermia Treatment [NCIt concept]
- Hyperthermic Intraperitoneal Chemotherapy [NCIt concept]
- Hypertonic Saline [NCIt concept]
- Hyperuricemia [NCIt concept]
- Hypnosedation [NCIt concept]
- Hypnotherapy [NCIt concept]
- Hypocalcemia [NCIt concept]
- Hypodontia [NCIt concept]
- Hypofractionated External Beam Radiation Therapy [NCIt concept]
- Hypofractionated Image-Guided Radiation Therapy [NCIt concept]
- Hypofractionated Radiation Therapy [NCIt concept]
- Hypoglycemia [NCIt concept]
- Hypomethylation [NCIt concept]
- Hypomethylation Profile [NCIt concept]
- Hypomethylation Therapy [NCIt concept]
- Hyponatremia [NCIt concept]
- Hypopharyngeal Carcinoma [NCIt concept]
- Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Hypoplasia [NCIt concept]
- Hypoploidy [NCIt concept]
- Hypothalamic Obesity [NCIt concept]
- Hypothyroidism [NCIt concept]
- Hypoxanthine-Guanine Phosphoribosyltransferase [NCIt concept]
- Hypoxia Inducible Factor Family [NCIt concept]
- Hypoxia-Inducible Factor 1-Alpha [NCIt concept]
- Hysterectomy [NCIt concept]
- Hysterectomy Patient [NCIt concept]
- Hysterosonography [NCIt concept]
- I Kappa B [NCIt concept]
- I-131 Uptake Test [NCIt concept]
- I-Cell Disease [NCIt concept]
- I-Kappa-B Kinase [NCIt concept]
- IAP Family Protein [NCIt concept]
- IAP Inhibitor HGS1029 [NCIt concept]
- ICAM1 Gene [NCIt concept]
- ICAM1 wt Allele [NCIt concept]
- ICAM2 Gene [NCIt concept]
- ICAM2 wt Allele [NCIt concept]
- ICOS Gene [NCIt concept]
- ICOS Ligand [NCIt concept]
- ICOS Positive [NCIt concept]
- ICOS wt Allele [NCIt concept]
- ICOSLG Gene [NCIt concept]
- ICOSLG wt Allele [NCIt concept]
- ICT-121 Dendritic Cell Vaccine [NCIt concept]
- ID1 Gene [NCIt concept]
- ID1 wt Allele [NCIt concept]
- ID2 Gene [NCIt concept]
- ID2 wt Allele [NCIt concept]
- IDH Family Wildtype [NCIt concept]
- IDH Gene Family [NCIt concept]
- IDH Gene Family Mutation [NCIt concept]
- IDH1 Gene [NCIt concept]
- IDH1 Gene Mutation [NCIt concept]
- IDH1 Gene Mutation Negative [NCIt concept]
- IDH1 NM_005896.3:c.394_395delinsGT [NCIt concept]
- IDH1 NM_005896.3:c.395G>A [NCIt concept]
- IDH1 NM_005896.3:c.395_396inv [NCIt concept]
- IDH1 NP_005887.2:p.R132C [NCIt concept]
- IDH1 NP_005887.2:p.R132G [NCIt concept]
- IDH1 NP_005887.2:p.R132H [NCIt concept]
- IDH1 NP_005887.2:p.R132L [NCIt concept]
- IDH1 NP_005887.2:p.R132S [NCIt concept]
- IDH1 NP_005887.2:p.R132V [NCIt concept]
- IDH1 NP_005887.2:p.R132X [NCIt concept]
- IDH1 Protein Variant [NCIt concept]
- IDH1 R132H Negative [NCIt concept]
- IDH1 wt Allele [NCIt concept]
- IDH1(R132) Inhibitor IDH305 [NCIt concept]
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M [NCIt concept]
- IDH2 Gene [NCIt concept]
- IDH2 Gene Mutation [NCIt concept]
- IDH2 Gene Mutation Negative [NCIt concept]
- IDH2 NM_002168.3:c.418C>T [NCIt concept]
- IDH2 NM_002168.3:c.419G>A [NCIt concept]
- IDH2 NM_002168.3:c.419G>T [NCIt concept]
- IDH2 NM_002168.3:c.516G>C [NCIt concept]
- IDH2 NM_002168.3:c.516G>T [NCIt concept]
- IDH2 NP_002159.2:p.R140L [NCIt concept]
- IDH2 NP_002159.2:p.R140Q [NCIt concept]
- IDH2 NP_002159.2:p.R140W [NCIt concept]
- IDH2 NP_002159.2:p.R140X [NCIt concept]
- IDH2 NP_002159.2:p.R172G [NCIt concept]
- IDH2 NP_002159.2:p.R172K [NCIt concept]
- IDH2 NP_002159.2:p.R172M [NCIt concept]
- IDH2 NP_002159.2:p.R172S [NCIt concept]
- IDH2 NP_002159.2:p.R172W [NCIt concept]
- IDH2 NP_002159.2:p.R172X [NCIt concept]
- IDH2 Protein Variant [NCIt concept]
- IDH2 wt Allele [NCIt concept]
- IDO-1 Inhibitor LY3381916 [NCIt concept]
- IDO1 Gene [NCIt concept]
- IDO1 Inhibitor [NCIt concept]
- IDO1 Inhibitor KHK2455 [NCIt concept]
- IDO1 Inhibitor MK-7162 [NCIt concept]
- IDO1 Inhibitor PF-06840003 [NCIt concept]
- IDO1 wt Allele [NCIt concept]
- IDO1/TDO2 Inhibitor M4112 [NCIt concept]
- IDUA Gene [NCIt concept]
- IDUA Gene Mutation [NCIt concept]
- IDUA wt Allele [NCIt concept]
- IFI44 Gene [NCIt concept]
- IFI44 wt Allele [NCIt concept]
- IFIT1 Gene [NCIt concept]
- IFIT1 wt Allele [NCIt concept]
- IFITM1 Gene [NCIt concept]
- IFITM1 wt Allele [NCIt concept]
- IFITM3 Gene [NCIt concept]
- IFITM3 wt Allele [NCIt concept]
- IFNA2 Gene [NCIt concept]
- IFNA2 wt Allele [NCIt concept]
- IFNAR1 Gene [NCIt concept]
- IFNAR1 wt Allele [NCIt concept]
- IFNAR2 Gene [NCIt concept]
- IFNAR2 wt Allele [NCIt concept]
- IFNB1 Gene [NCIt concept]
- IFNB1 wt Allele [NCIt concept]
- IFNG Gene [NCIt concept]
- IFNG wt Allele [NCIt concept]
- IFNGR1 Gene [NCIt concept]
- IFNGR1 wt Allele [NCIt concept]
- IFNL1 Gene [NCIt concept]
- IFNL1 wt Allele [NCIt concept]
- IFNL2 Gene [NCIt concept]
- IFNL2 wt Allele [NCIt concept]
- IFNL4 Gene [NCIt concept]
- IFNL4 wt Allele [NCIt concept]
- IFT88 Gene [NCIt concept]
- IFT88 wt Allele [NCIt concept]
- IGF-1R Antisense Oligodeoxynucleotide-treated Autologous Glioma Cells IGV-001 [NCIt concept]
- IGF-1R Inhibitor PL225B [NCIt concept]
- IGF-1R/IR Inhibitor KW-2450 [NCIt concept]
- IGF-methotrexate Conjugate [NCIt concept]
- IGF1 Gene [NCIt concept]
- IGF1 Positive [NCIt concept]
- IGF1 wt Allele [NCIt concept]
- IGF1R Gene [NCIt concept]
- IGF1R Gene Product [NCIt concept]
- IGF1R Negative [NCIt concept]
- IGF1R Positive [NCIt concept]
- IGF1R wt Allele [NCIt concept]
- IGF2 Antisense RNA [NCIt concept]
- IGF2 Gene [NCIt concept]
- IGF2 wt Allele [NCIt concept]
- IGF2-AS Gene [NCIt concept]
- IGF2-AS wt Allele [NCIt concept]
- IGF2BP3 Autoantibody [NCIt concept]
- IGF2BP3 Gene [NCIt concept]
- IGF2BP3 wt Allele [NCIt concept]
- IGF2R Gene [NCIt concept]
- IGF2R wt Allele [NCIt concept]
- IGFBP1 Gene [NCIt concept]
- IGFBP1 wt Allele [NCIt concept]
- IGFBP2 Gene [NCIt concept]
- IGFBP2 wt Allele [NCIt concept]
- IGFBP3 Gene [NCIt concept]
- IGFBP3 wt Allele [NCIt concept]
- IGFBP4 Gene [NCIt concept]
- IGFBP4 wt Allele [NCIt concept]
- IGFBP5 Gene [NCIt concept]
- IGFBP5 wt Allele [NCIt concept]
- IGFBP6 Gene [NCIt concept]
- IGFBP6 wt Allele [NCIt concept]
- IGFBP7 Gene [NCIt concept]
- IGFBP7 wt Allele [NCIt concept]
- IGH/CRLF2 Fusion Gene [NCIt concept]
- IGHG1 Gene [NCIt concept]
- IGHG1 wt Allele [NCIt concept]
- IGHV3-21 Gene [NCIt concept]
- IGHV3-21 wt Allele [NCIt concept]
- IGHV4-34 Gene [NCIt concept]
- IGHV4-34 Positive [NCIt concept]
- IGHV4-34 wt Allele [NCIt concept]
- IGK Positive [NCIt concept]
- IGKV1D-13 Gene [NCIt concept]
- IGKV1D-13 wt Allele [NCIt concept]
- IGKV4-1 Gene [NCIt concept]
- IGKV4-1 wt Allele [NCIt concept]
- IGLC1 Gene [NCIt concept]
- IGLC1 wt Allele [NCIt concept]
- IGLL1 Gene [NCIt concept]
- IGLL1 wt Allele [NCIt concept]
- IH636 Grape Seed Proanthocyanidin Extract [NCIt concept]
- IHH Gene [NCIt concept]
- IHH wt Allele [NCIt concept]
- IKBKB Gene [NCIt concept]
- IKBKB wt Allele [NCIt concept]
- IKBKE Gene [NCIt concept]
- IKBKE Gene Mutation [NCIt concept]
- IKBKE wt Allele [NCIt concept]
- IKZF1 Gene [NCIt concept]
- IKZF1 Gene Mutation [NCIt concept]
- IKZF1 wt Allele [NCIt concept]
- IKZF1/BCL6 Fusion Gene [NCIt concept]
- IKZF2 Gene [NCIt concept]
- IKZF2 Protein Degrader DKY709 [NCIt concept]
- IKZF2 wt Allele [NCIt concept]
- IKZF3 Gene [NCIt concept]
- IKZF3 wt Allele [NCIt concept]
- IKZF4 Gene [NCIt concept]
- IKZF4 wt Allele [NCIt concept]
- IL-10 Immunomodulator MK-1966 [NCIt concept]
- IL-12-Fc Fusion Protein XmAb662 [NCIt concept]
- IL-12-expressing HSV-1 NSC 733972 [NCIt concept]
- IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000 [NCIt concept]
- IL-15 Superagonist SOT201 [NCIt concept]
- IL-15(N72D)/IL-15Ralpha-sFc Fusion Protein Complex FL115 [NCIt concept]
- IL-15/IL-15 Receptor alpha Heterodimer NIZ985 [NCIt concept]
- IL-2 Fusion Protein PTX-912 [NCIt concept]
- IL-2 Mutein/Fc Fusion Protein HM16390 [NCIt concept]
- IL-2 Recombinant Fusion Protein ALT-801 [NCIt concept]
- IL-2 Superkine-Recombinant Human Albumin Fusion Protein MDNA11 [NCIt concept]
- IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1 [NCIt concept]
- IL-2/Anti-IL-2 Antibody Conjugate SLC-3010 [NCIt concept]
- IL-2/IL-12-based Fusion Protein CLN-617 [NCIt concept]
- IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine [NCIt concept]
- IL-34 Inhibitor [NCIt concept]
- IL10 Gene [NCIt concept]
- IL10 wt Allele [NCIt concept]
- IL10RA Gene [NCIt concept]
- IL10RA wt Allele [NCIt concept]
- IL11 Gene [NCIt concept]
- IL11 wt Allele [NCIt concept]
- IL11RA Gene [NCIt concept]
- IL11RA wt Allele [NCIt concept]
- IL12A Gene [NCIt concept]
- IL12A wt Allele [NCIt concept]
- IL12B Gene [NCIt concept]
- IL12B wt Allele [NCIt concept]
- IL12RB1 Gene [NCIt concept]
- IL12RB1 wt Allele [NCIt concept]
- IL12RB2 Gene [NCIt concept]
- IL12RB2 wt Allele [NCIt concept]
- IL13 Gene [NCIt concept]
- IL13 wt Allele [NCIt concept]
- IL13RA1 Gene [NCIt concept]
- IL13RA1 wt Allele [NCIt concept]
- IL13RA2 Gene [NCIt concept]
- IL13RA2 Positive [NCIt concept]
- IL13RA2 wt Allele [NCIt concept]
- IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells [NCIt concept]
- IL15 Antibody [NCIt concept]
- IL15 Gene [NCIt concept]
- IL15 wt Allele [NCIt concept]
- IL15RA Gene [NCIt concept]
- IL15RA wt Allele [NCIt concept]
- IL16 Gene [NCIt concept]
- IL16 wt Allele [NCIt concept]
- IL17A Gene [NCIt concept]
- IL17A wt Allele [NCIt concept]
- IL17F Gene [NCIt concept]
- IL17F wt Allele [NCIt concept]
- IL18 Gene [NCIt concept]
- IL18 wt Allele [NCIt concept]
- IL18BP Gene [NCIt concept]
- IL18BP wt Allele [NCIt concept]
- IL18R1 Gene [NCIt concept]
- IL18R1 wt Allele [NCIt concept]
- IL19 Gene [NCIt concept]
- IL19 wt Allele [NCIt concept]
- IL1A Gene [NCIt concept]
- IL1A wt Allele [NCIt concept]
- IL1B Gene [NCIt concept]
- IL1B wt Allele [NCIt concept]
- IL1R1 Gene [NCIt concept]
- IL1R1 wt Allele [NCIt concept]
- IL1R2 Gene [NCIt concept]
- IL1R2 wt Allele [NCIt concept]
- IL1RAP Gene [NCIt concept]
- IL1RAP wt Allele [NCIt concept]
- IL1RAPL1 Gene [NCIt concept]
- IL1RAPL1 wt Allele [NCIt concept]
- IL1RAPL1/DMD Fusion Gene [NCIt concept]
- IL1RL1 Gene [NCIt concept]
- IL1RL1 Positive [NCIt concept]
- IL1RL1 wt Allele [NCIt concept]
- IL1RL2 Gene [NCIt concept]
- IL1RL2 wt Allele [NCIt concept]
- IL1RN Gene [NCIt concept]
- IL1RN wt Allele [NCIt concept]
- IL2 Receptor Antibody [NCIt concept]
- IL20 Gene [NCIt concept]
- IL20 wt Allele [NCIt concept]
- IL21 Gene [NCIt concept]
- IL21 wt Allele [NCIt concept]
- IL21R Gene [NCIt concept]
- IL21R wt Allele [NCIt concept]
- IL21R/BCL6 Fusion Gene [NCIt concept]
- IL22 Gene [NCIt concept]
- IL22 wt Allele [NCIt concept]
- IL23A Gene [NCIt concept]
- IL23A wt Allele [NCIt concept]
- IL25 Gene [NCIt concept]
- IL25 wt Allele [NCIt concept]
- IL27 Gene [NCIt concept]
- IL27 wt Allele [NCIt concept]
- IL2RA Gene [NCIt concept]
- IL2RA Positive [NCIt concept]
- IL2RA wt Allele [NCIt concept]
- IL2RB Gene [NCIt concept]
- IL2RB Positive [NCIt concept]
- IL2RB wt Allele [NCIt concept]
- IL2RG Gene [NCIt concept]
- IL2RG Gene Mutation [NCIt concept]
- IL2RG wt Allele [NCIt concept]
- IL3 Gene [NCIt concept]
- IL3 wt Allele [NCIt concept]
- IL31 Gene [NCIt concept]
- IL31 wt Allele [NCIt concept]
- IL32 Gene [NCIt concept]
- IL32 wt Allele [NCIt concept]
- IL33 Gene [NCIt concept]
- IL33 wt Allele [NCIt concept]
- IL34 Gene [NCIt concept]
- IL34 wt Allele [NCIt concept]
- IL3RA Gene [NCIt concept]
- IL3RA wt Allele [NCIt concept]
- IL4 Gene [NCIt concept]
- IL4 wt Allele [NCIt concept]
- IL4R Gene [NCIt concept]
- IL4R wt Allele [NCIt concept]
- IL5RA Gene [NCIt concept]
- IL5RA wt Allele [NCIt concept]
- IL6 Gene [NCIt concept]
- IL6 wt Allele [NCIt concept]
- IL6R Gene [NCIt concept]
- IL6R wt Allele [NCIt concept]
- IL7 Antibody [NCIt concept]
- IL7 Gene [NCIt concept]
- IL7 wt Allele [NCIt concept]
- IL7R Gene [NCIt concept]
- IL7R Gene Mutation [NCIt concept]
- IL7R wt Allele [NCIt concept]
- IL9 Gene [NCIt concept]
- IL9 wt Allele [NCIt concept]
- ILDR2 Gene [NCIt concept]
- ILDR2 wt Allele [NCIt concept]
- ILK Gene [NCIt concept]
- ILK wt Allele [NCIt concept]
- IMADetect [NCIt concept]
- IMAGE-HN [NCIt concept]
- IMP3 Gene [NCIt concept]
- IMP3 wt Allele [NCIt concept]
- IMT-1012 Immunotherapeutic Vaccine [NCIt concept]
- INA Gene [NCIt concept]
- INA wt Allele [NCIt concept]
- INHA Gene [NCIt concept]
- INHA wt Allele [NCIt concept]
- INHBA Gene [NCIt concept]
- INHBA wt Allele [NCIt concept]
- INHBB Gene [NCIt concept]
- INHBB wt Allele [NCIt concept]
- INHBE Gene [NCIt concept]
- INHBE wt Allele [NCIt concept]
- INPP4A Gene [NCIt concept]
- INPP4A Gene Mutation [NCIt concept]
- INPP4A wt Allele [NCIt concept]
- INPP4B Gene [NCIt concept]
- INPP4B Gene Mutation [NCIt concept]
- INPP4B wt Allele [NCIt concept]
- INPP5D Gene [NCIt concept]
- INPP5D Gene Mutation [NCIt concept]
- INPP5D Gene Product [NCIt concept]
- INPP5D wt Allele [NCIt concept]
- INPPL1 Gene [NCIt concept]
- INPPL1 Gene Mutation [NCIt concept]
- INPPL1 wt Allele [NCIt concept]
- INRG Stage L1 [NCIt concept]
- INRG Stage L2 [NCIt concept]
- INRG Stage M [NCIt concept]
- INRG Stage MS [NCIt concept]
- INS Gene [NCIt concept]
- INS Gene Product [NCIt concept]
- INS wt Allele [NCIt concept]
- INSR Gene [NCIt concept]
- INSR wt Allele [NCIt concept]
- INTS4 Gene [NCIt concept]
- INTS4 wt Allele [NCIt concept]
- IPSS Risk Category Intermediate-1 [NCIt concept]
- IPSS Risk Category Intermediate-2 [NCIt concept]
- IPSS Risk Category Low [NCIt concept]
- IQ Domain-Containing Protein J [NCIt concept]
- IQCJ Gene [NCIt concept]
- IQCJ wt Allele [NCIt concept]
- IQCJ/SCHIP1 Fusion Gene [NCIt concept]
- IQCJ/SCHIP1 Fusion Protein [NCIt concept]
- IRAK1 Fusion Positive [NCIt concept]
- IRAK1 Gene [NCIt concept]
- IRAK1 Gene Mutation [NCIt concept]
- IRAK1 wt Allele [NCIt concept]
- IRAK3 Gene [NCIt concept]
- IRAK3 wt Allele [NCIt concept]
- IRE1 RNase Inhibitor ORIN1001 [NCIt concept]
- IRF1 Gene [NCIt concept]
- IRF1 wt Allele [NCIt concept]
- IRF2BP2 Gene [NCIt concept]
- IRF2BP2 wt Allele [NCIt concept]
- IRF3 Gene [NCIt concept]
- IRF3 wt Allele [NCIt concept]
- IRF4 Gene [NCIt concept]
- IRF4 Gene Rearrangement [NCIt concept]
- IRF4 Positive [NCIt concept]
- IRF4 wt Allele [NCIt concept]
- IRF7 Gene [NCIt concept]
- IRF7 wt Allele [NCIt concept]
- IRF8 Gene [NCIt concept]
- IRF8 wt Allele [NCIt concept]
- IRF9 Gene [NCIt concept]
- IRF9 wt Allele [NCIt concept]
- IRS1 Gene [NCIt concept]
- IRS1 wt Allele [NCIt concept]
- IRS1/IRS2/STAT3 Inhibitor NT219 [NCIt concept]
- IRS2 Gene [NCIt concept]
- IRS2 wt Allele [NCIt concept]
- ISG15 Gene [NCIt concept]
- ISG15 Positive [NCIt concept]
- ISG15 wt Allele [NCIt concept]
- ISS Stage I Multiple Myeloma [NCIt concept]
- ISS Stage II Multiple Myeloma [NCIt concept]
- ISS Stage III Multiple Myeloma [NCIt concept]
- ISX Gene [NCIt concept]
- ISX wt Allele [NCIt concept]
- ITAM [NCIt concept]
- ITGA2 Gene [NCIt concept]
- ITGA2 wt Allele [NCIt concept]
- ITGA2B Gene [NCIt concept]
- ITGA2B wt Allele [NCIt concept]
- ITGA4 Gene [NCIt concept]
- ITGA4 wt Allele [NCIt concept]
- ITGA5 Gene [NCIt concept]
- ITGA5 wt Allele [NCIt concept]
- ITGA6 Gene [NCIt concept]
- ITGA6 wt Allele [NCIt concept]
- ITGAE Gene [NCIt concept]
- ITGAE wt Allele [NCIt concept]
- ITGAL Gene [NCIt concept]
- ITGAL wt Allele [NCIt concept]
- ITGAM Gene [NCIt concept]
- ITGAM wt Allele [NCIt concept]
- ITGAV Gene [NCIt concept]
- ITGAV wt Allele [NCIt concept]
- ITGAX Gene [NCIt concept]
- ITGAX wt Allele [NCIt concept]
- ITGB1 Gene [NCIt concept]
- ITGB1 wt Allele [NCIt concept]
- ITGB2 Gene [NCIt concept]
- ITGB2 Gene Mutation [NCIt concept]
- ITGB2 wt Allele [NCIt concept]
- ITGB3 Gene [NCIt concept]
- ITGB3 wt Allele [NCIt concept]
- ITGB5 Gene [NCIt concept]
- ITGB5 wt Allele [NCIt concept]
- ITGB6 Gene [NCIt concept]
- ITGB6 wt Allele [NCIt concept]
- ITGB7 Gene [NCIt concept]
- ITGB7 wt Allele [NCIt concept]
- ITGB8 Gene [NCIt concept]
- ITGB8 wt Allele [NCIt concept]
- ITK Gene [NCIt concept]
- ITK Inhibitor [NCIt concept]
- ITK wt Allele [NCIt concept]
- ITLN1 Gene [NCIt concept]
- ITLN1 wt Allele [NCIt concept]
- ITPKC Gene [NCIt concept]
- ITPKC wt Allele [NCIt concept]
- ITPR2 Gene [NCIt concept]
- ITPR2 wt Allele [NCIt concept]
- ITSN1 Gene [NCIt concept]
- ITSN1 wt Allele [NCIt concept]
- IVL Gene [NCIt concept]
- IVL wt Allele [NCIt concept]
- Iadademstat [NCIt concept]
- Ibandronate Sodium [NCIt concept]
- Ibcasertib [NCIt concept]
- Ibentatug [NCIt concept]
- Iberdomide Hydrochloride [NCIt concept]
- Iboctadekin [NCIt concept]
- Ibrexafungerp [NCIt concept]
- Ibritumomab Tiuxetan [NCIt concept]
- Ibrutinib [NCIt concept]
- Ibrutinib Resistance [NCIt concept]
- Ibudilast [NCIt concept]
- Ibuprofen [NCIt concept]
- Icatibant [NCIt concept]
- Icosapent Ethyl [NCIt concept]
- Icotinib Hydrochloride [NCIt concept]
- Icovamenib [NCIt concept]
- Icrucumab [NCIt concept]
- Idarubicin [NCIt concept]
- Idarubicin Hydrochloride [NCIt concept]
- Idasanutlin [NCIt concept]
- Idecabtagene Vicleucel [NCIt concept]
- Idelalisib [NCIt concept]
- Idiopathic Cytopenia of Undetermined Significance [NCIt concept]
- Idiopathic Dysplasia of Uncertain Significance [NCIt concept]
- Idiopathic Hypereosinophilic Syndrome [NCIt concept]
- Idiopathic Inflammatory Myopathy [NCIt concept]
- Idoxuridine [NCIt concept]
- Idronoxil [NCIt concept]
- Idronoxil Suppository NOX66 [NCIt concept]
- Idroxioleic Acid [NCIt concept]
- Iduronicrin Genleukocel-T [NCIt concept]
- Ieramilimab [NCIt concept]
- Ifabotuzumab [NCIt concept]
- Ifebemtinib [NCIt concept]
- Ifetroban [NCIt concept]
- Ifinatamab Deruxtecan [NCIt concept]
- Ifosfamide [NCIt concept]
- IgA [NCIt concept]
- IgA Monoclonal Gammopathy [NCIt concept]
- IgE [NCIt concept]
- IgG [NCIt concept]
- IgG Monoclonal Gammopathy [NCIt concept]
- IgM [NCIt concept]
- IgM Monoclonal Gammopathy [NCIt concept]
- IgM Monoclonal Gammopathy of Undetermined Significance [NCIt concept]
- Ilantimod [NCIt concept]
- Ileal Neuroendocrine Tumor G2 [NCIt concept]
- Ileostomy [NCIt concept]
- Ilginatinib [NCIt concept]
- Ilixadencel [NCIt concept]
- Ilorasertib [NCIt concept]
- Image Acquired [NCIt concept]
- Image Guided Biopsy [NCIt concept]
- Image Guided Radiation Therapy [NCIt concept]
- Image-Guided Adaptive Radiation Therapy [NCIt concept]
- Image-Guided Needle Confocal Laser Endomicroscopy [NCIt concept]
- Image-Guided Surgery [NCIt concept]
- Image-Guided Therapy [NCIt concept]
- Image-guided Thermal Ablation [NCIt concept]
- Imagery Therapy [NCIt concept]
- Imaging Agent [NCIt concept]
- Imaging Biomarker Analysis [NCIt concept]
- Imaging Phantom [NCIt concept]
- Imaging Procedure [NCIt concept]
- Imalumab [NCIt concept]
- Imaradenant [NCIt concept]
- Imatinib [NCIt concept]
- Imatinib Mesylate [NCIt concept]
- Imdatifan [NCIt concept]
- Imdevimab [NCIt concept]
- Imetelstat [NCIt concept]
- Imetelstat Sodium [NCIt concept]
- Imexon [NCIt concept]
- Imgatuzumab [NCIt concept]
- Imifoplatin [NCIt concept]
- Imipenem-Cilastatin-Relebactam [NCIt concept]
- Imipramine Blue [NCIt concept]
- Imipramine Hydrochloride [NCIt concept]
- Imiquimod [NCIt concept]
- Imisopasem Manganese [NCIt concept]
- Imlunestrant [NCIt concept]
- Immature Myeloid Cell [NCIt concept]
- Immature Ovarian Teratoma [NCIt concept]
- Immediate-release Bupropion [NCIt concept]
- Immediate-release Oxymorphone Hydrochloride Liquid Formulation [NCIt concept]
- Immune Cell [NCIt concept]
- Immune Checkpoint Inhibitor [NCIt concept]
- Immune Checkpoint Inhibitor-Induced Dermatitis [NCIt concept]
- Immune Checkpoint Inhibitor-related Myocarditis [NCIt concept]
- Immune Checkpoint Modulator [NCIt concept]
- Immune Function Testing [NCIt concept]
- Immune Reconstitution Inflammatory Syndrome Associated with Kaposi Sarcoma [NCIt concept]
- Immune System Disorder [NCIt concept]
- Immune-Mediated Colitis [NCIt concept]
- Immune-Mediated Diarrhea [NCIt concept]
- Immunizing Neoantigen Peptide Antibody [NCIt concept]
- Immuno-oncology Therapy [NCIt concept]
- Immunoblastic Lymphoma [NCIt concept]
- Immunocytokine NHS-IL2-LT [NCIt concept]
- Immunocytokine PDS01ADC [NCIt concept]
- Immunodeficiency [NCIt concept]
- Immunoenzyme Procedure [NCIt concept]
- Immunoglobulin [NCIt concept]
- Immunoglobulin Heavy Chain [NCIt concept]
- Immunoglobulin Heavy Chain Complementarity Determining Region 3 [NCIt concept]
- Immunoglobulin Heavy Chain Diversity Region [NCIt concept]
- Immunoglobulin Heavy Chain Diversity and Joining Region Gene Rearrangement [NCIt concept]
- Immunoglobulin Heavy Chain Joining Region [NCIt concept]
- Immunoglobulin Heavy Chain Locus Variable Region Mutation [NCIt concept]
- Immunoglobulin Heavy Chain Variable Domain [NCIt concept]
- Immunoglobulin Heavy Chain Variable, Diversity, and Joining Region Gene Rearrangement [NCIt concept]
- Immunoglobulin Heavy Constant Gamma 1 [NCIt concept]
- Immunoglobulin Heavy Locus [NCIt concept]
- Immunoglobulin Heavy Variable 3-21 [NCIt concept]
- Immunoglobulin Heavy Variable 4-34 [NCIt concept]
- Immunoglobulin J Chain [NCIt concept]
- Immunoglobulin Kappa Locus [NCIt concept]
- Immunoglobulin Kappa Variable 1D-13 [NCIt concept]
- Immunoglobulin Kappa Variable 4-1 [NCIt concept]
- Immunoglobulin Lambda Constant 1 [NCIt concept]
- Immunoglobulin Lambda-Like Polypeptide 1 [NCIt concept]
- Immunoglobulin Light Chain [NCIt concept]
- Immunoglobulin Light Chain, Kappa [NCIt concept]
- Immunoglobulin Light Chain, Lambda [NCIt concept]
- Immunoglobulin Variable Region [NCIt concept]
- Immunoglobulin-Like Domain-Containing Receptor 2 [NCIt concept]
- Immunohistochemical Status of PD-L1 [NCIt concept]
- Immunohistochemistry Staining Method [NCIt concept]
- Immunologic Technique [NCIt concept]
- Immunomodulation Therapy [NCIt concept]
- Immunomodulatory Agent CC-11006 [NCIt concept]
- Immunomodulatory Drug-Associated Osteonecrosis [NCIt concept]
- Immunomodulatory Imide Drug [NCIt concept]
- Immunophenotypic Finding [NCIt concept]
- Immunoscintigraphy [NCIt concept]
- Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoietic Cell Transplantation [NCIt concept]
- Immunosuppressive Therapy [NCIt concept]
- Immunotherapeutic Agent [NCIt concept]
- Immunotherapeutic Combination Product CMB305 [NCIt concept]
- Immunotherapy [NCIt concept]
- Immunotherapy Regimen MKC-1106-MT [NCIt concept]
- Immunotherapy-Related Enterocolitis [NCIt concept]
- Immunotoxin D2C7-(scdsFv)-PE38KDEL [NCIt concept]
- Immunotoxin Therapy [NCIt concept]
- Imneskibart [NCIt concept]
- Implantable Cardioverter-Defibrillator [NCIt concept]
- Implantable Pump [NCIt concept]
- Implantable Tibial Nerve Stimulation [NCIt concept]
- Implanted Fiducial-Based Imaging System [NCIt concept]
- Implanted Medical Device [NCIt concept]
- Implementation Research [NCIt concept]
- Imsidolimab [NCIt concept]
- Imvotamab [NCIt concept]
- Imzokitug [NCIt concept]
- In Situ [NCIt concept]
- In Vitro Kinase Inhibitor Assay [NCIt concept]
- In Vitro Sensitivity-Directed Chemotherapy [NCIt concept]
- In Vitro Treated Peripheral Blood Lymphocyte Therapy [NCIt concept]
- In Vitro-Treated Bone Marrow Transplantation [NCIt concept]
- In Vitro-Treated Peripheral Blood Stem Cell Transplantation [NCIt concept]
- In Vivo Imaging [NCIt concept]
- In-home Sleep Monitoring [NCIt concept]
- Inactivated Poliovirus Vaccine [NCIt concept]
- Inactivating APC Gene Mutation [NCIt concept]
- Inactivating ARID1A Gene Mutation [NCIt concept]
- Inactivating ATM Gene Mutation [NCIt concept]
- Inactivating ATRX Gene Mutation [NCIt concept]
- Inactivating AXIN2 Gene Mutation [NCIt concept]
- Inactivating BARD1 Gene Mutation [NCIt concept]
- Inactivating BLM Gene Mutation [NCIt concept]
- Inactivating BRAF Gene Mutation [NCIt concept]
- Inactivating BRCA Gene Mutation [NCIt concept]
- Inactivating BRCA1 Gene Mutation [NCIt concept]
- Inactivating BRCA2 Gene Mutation [NCIt concept]
- Inactivating BRIP1 Gene Mutation [NCIt concept]
- Inactivating CDKN2B Gene Mutation [NCIt concept]
- Inactivating CDKN2C Gene Mutation [NCIt concept]
- Inactivating CHEK1 Gene Mutation [NCIt concept]
- Inactivating CHEK2 Gene Mutation [NCIt concept]
- Inactivating DAXX Gene Mutation [NCIt concept]
- Inactivating EPCAM Gene Mutation [NCIt concept]
- Inactivating ERCC1 Gene Mutation [NCIt concept]
- Inactivating ERCC2 Gene Mutation [NCIt concept]
- Inactivating ERCC3 Gene Mutation [NCIt concept]
- Inactivating ERCC4 Gene Mutation [NCIt concept]
- Inactivating ERCC5 Gene Mutation [NCIt concept]
- Inactivating FANCA Gene Mutation [NCIt concept]
- Inactivating FANCB Gene Mutation [NCIt concept]
- Inactivating FANCC Gene Mutation [NCIt concept]
- Inactivating FANCD2 Gene Mutation [NCIt concept]
- Inactivating FANCE Gene Mutation [NCIt concept]
- Inactivating FANCF Gene Mutation [NCIt concept]
- Inactivating FANCG Gene Mutation [NCIt concept]
- Inactivating FANCI Gene Mutation [NCIt concept]
- Inactivating FANCL Gene Mutation [NCIt concept]
- Inactivating FANCM Gene Mutation [NCIt concept]
- Inactivating FBXW7 Gene Mutation [NCIt concept]
- Inactivating KDM6A Gene Mutation [NCIt concept]
- Inactivating KMT2C Gene Mutation [NCIt concept]
- Inactivating KMT2D Gene Mutation [NCIt concept]
- Inactivating MLH1 Gene Mutation [NCIt concept]
- Inactivating MPO Gene Mutation [NCIt concept]
- Inactivating MRE11 Gene Mutation [NCIt concept]
- Inactivating MSH2 Gene Mutation [NCIt concept]
- Inactivating MSH3 Gene Mutation [NCIt concept]
- Inactivating MSH6 Gene Mutation [NCIt concept]
- Inactivating MTAP Gene Mutation [NCIt concept]
- Inactivating NBN Gene Mutation [NCIt concept]
- Inactivating PALB2 Gene Mutation [NCIt concept]
- Inactivating PARP1 Gene Mutation [NCIt concept]
- Inactivating PIK3R1 Gene Mutation [NCIt concept]
- Inactivating PMS2 Gene Mutation [NCIt concept]
- Inactivating POLD1 Gene Mutation [NCIt concept]
- Inactivating PRKDC Gene Mutation [NCIt concept]
- Inactivating RAC2 Gene Mutation [NCIt concept]
- Inactivating RAD50 Gene Mutation [NCIt concept]
- Inactivating RAD51 Gene Mutation [NCIt concept]
- Inactivating RAD51B Gene Mutation [NCIt concept]
- Inactivating RAD51C Gene Mutation [NCIt concept]
- Inactivating RAD51D Gene Mutation [NCIt concept]
- Inactivating RNF43 Gene Mutation [NCIt concept]
- Inactivating SETD2 Gene Mutation [NCIt concept]
- Inactivating SSBP1 Gene Mutation [NCIt concept]
- Inactivating STAG2 Gene Mutation [NCIt concept]
- Inactivating TCF7L2 Gene Mutation [NCIt concept]
- Inactivating WRN Gene Mutation [NCIt concept]
- Inactivating WT1 Gene Mutation [NCIt concept]
- Inactivating XRCC2 Gene Mutation [NCIt concept]
- Inactivating XRCC3 Gene Mutation [NCIt concept]
- Inactive Tyrosine-Protein Kinase 7 [NCIt concept]
- Inactive Tyrosine-Protein Kinase Transmembrane Receptor ROR1 [NCIt concept]
- Inactivity [NCIt concept]
- Inalimarev [NCIt concept]
- Inavolisib [NCIt concept]
- Inborn Error of Immunity [NCIt concept]
- Incisional Biopsy [NCIt concept]
- Incisional Vacuum-Assisted Closure Therapy [NCIt concept]
- Incomplete Freund's Adjuvant [NCIt concept]
- Incomplete, Incorrect or Alternative Diagnosis Code Assigned [NCIt concept]
- Increasing Levels of Measurable Residual Disease [NCIt concept]
- Incyclinide [NCIt concept]
- Indatuximab Ravtansine [NCIt concept]
- India Ink [NCIt concept]
- Indian Hedgehog Protein [NCIt concept]
- Indican [NCIt concept]
- Indinavir Sulfate [NCIt concept]
- Indisulam [NCIt concept]
- Indium In 111 Anti-CD45 Monoclonal Antibody BC8 [NCIt concept]
- Indium In 111 Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Indium In 111 CHX-A DTPA Trastuzumab [NCIt concept]
- Indium In 111 Capromab Pendetide [NCIt concept]
- Indium In 111 Daclizumab [NCIt concept]
- Indium In 111 FPI-2058 [NCIt concept]
- Indium In 111 FPI-2071 [NCIt concept]
- Indium In 111 Panitumumab [NCIt concept]
- Indium In 111 Rosopatamab Tetraxetan [NCIt concept]
- Indium In 111 Vofatamab [NCIt concept]
- Indium In 111-ABD147 [NCIt concept]
- Indium In 111-Autologous CMV-pp65-LAMP mRNA Loaded Dendritic Cells [NCIt concept]
- Indium In 111-DOTA-Basiliximab [NCIt concept]
- Indium In 111-DOTA-Daratumumab [NCIt concept]
- Indium In 111-DOTA-h11B6 [NCIt concept]
- Indium In 111-FL-020 [NCIt concept]
- Indium In 111-FPI-1547 [NCIt concept]
- Indium In 111-XYIMSR-01 [NCIt concept]
- Indium In 111-labeled Macroaggregated Albumin [NCIt concept]
- Indium In-111 Ibritumomab Tiuxetan [NCIt concept]
- Indium In-111 Pentetreotide [NCIt concept]
- Individualized MVA-based Vaccine TG4050 [NCIt concept]
- Indocyanine Green [NCIt concept]
- Indocyanine Green Solution [NCIt concept]
- Indole-3-Carbinol [NCIt concept]
- Indoleamine 2,3-Dioxygenase 1 [NCIt concept]
- Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Indolent B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Indolent Systemic Mastocytosis [NCIt concept]
- Indomethacin [NCIt concept]
- Indoximod [NCIt concept]
- Indoximod Prodrug NLG802 [NCIt concept]
- Induced Anti-Tumor Antigen-specific Antibody [NCIt concept]
- Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 [NCIt concept]
- Inducible CD4+CD25+ Regulatory T Cells [NCIt concept]
- Inducible T-Cell Costimulator [NCIt concept]
- Indusatumab Vedotin [NCIt concept]
- Indwelling Catheter [NCIt concept]
- Inebilizumab [NCIt concept]
- Inecalcitol [NCIt concept]
- Inezetamab [NCIt concept]
- Infant Acute Biphenotypic Leukemia [NCIt concept]
- Infant Acute Undifferentiated Leukemia [NCIt concept]
- Infant T Acute Lymphoblastic Leukemia [NCIt concept]
- Infantile Refsum Disease [NCIt concept]
- Infection Prophylaxis and Management [NCIt concept]
- Infectious Disorder [NCIt concept]
- Infertility [NCIt concept]
- Infertility Related to Medical Condition [NCIt concept]
- Infertility Related to Treatment [NCIt concept]
- Infigratinib [NCIt concept]
- Infigratinib Phosphate [NCIt concept]
- Infliximab [NCIt concept]
- Influenza A Virus [NCIt concept]
- Influenza A Virus Positive [NCIt concept]
- Influenza B Virus [NCIt concept]
- Influenza B Virus Positive [NCIt concept]
- Influenza Virus Antibody [NCIt concept]
- Informational Intervention [NCIt concept]
- Informed Consent [NCIt concept]
- Infrared Laser Therapy [NCIt concept]
- Infrared Photocoagulation Therapy [NCIt concept]
- Infrared Thermography [NCIt concept]
- Infusion Procedure [NCIt concept]
- Ingitamig [NCIt concept]
- Inhibin Alpha Chain [NCIt concept]
- Inhibin Beta A Chain [NCIt concept]
- Inhibin Beta B Chain [NCIt concept]
- Inhibin Beta E Chain [NCIt concept]
- Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Alpha [NCIt concept]
- Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta [NCIt concept]
- Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Epsilon [NCIt concept]
- Iniparib [NCIt concept]
- Inixaciclib [NCIt concept]
- Inlexisertib [NCIt concept]
- Innate Immunostimulator rBBX-01 [NCIt concept]
- Innate Lymphoid Cell [NCIt concept]
- Innate Lymphoid Cell Count [NCIt concept]
- Inodiftagene Vixteplasmid [NCIt concept]
- Inoperable Disease [NCIt concept]
- Inosine Monophosphate Dehydrogenase [NCIt concept]
- Inosinic Acid [NCIt concept]
- Inositol [NCIt concept]
- Inositol 1,4,5-Trisphosphate [NCIt concept]
- Inositol 1,4,5-Trisphosphate Receptor Type 2 [NCIt concept]
- Inositol Polyphosphate 4-Phosphatase Type II [NCIt concept]
- Inositol Polyphosphate-4-Phosphatase Type I A [NCIt concept]
- Inositol-Trisphosphate 3-Kinase C [NCIt concept]
- Inotersen [NCIt concept]
- Inotuzumab Ozogamicin [NCIt concept]
- Inreach [NCIt concept]
- Insertion Mutation [NCIt concept]
- Insulin [NCIt concept]
- Insulin Aspart [NCIt concept]
- Insulin Autoantibody [NCIt concept]
- Insulin Autoantibody Measurement [NCIt concept]
- Insulin Glargine [NCIt concept]
- Insulin Measurement [NCIt concept]
- Insulin Receptor [NCIt concept]
- Insulin Receptor Substrate 1 [NCIt concept]
- Insulin Receptor Substrate 2 [NCIt concept]
- Insulin, NPH [NCIt concept]
- Insulin-Like Growth Factor [NCIt concept]
- Insulin-Like Growth Factor 1 Receptor [NCIt concept]
- Insulin-Like Growth Factor 1 Receptor Beta Chain [NCIt concept]
- Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 [NCIt concept]
- Insulin-Like Growth Factor I [NCIt concept]
- Insulin-Like Growth Factor II [NCIt concept]
- Insulin-Like Growth Factor Receptor [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 1 [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 2 [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 3 [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 4 [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 5 [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 6 [NCIt concept]
- Insulin-Like Growth Factor-Binding Protein 7 [NCIt concept]
- Integra Dermal Regeneration Template [NCIt concept]
- Integrated Fitness Assessment [NCIt concept]
- Integrative Medicine at Home Program [NCIt concept]
- Integrator Complex Subunit 4 [NCIt concept]
- Integrin [NCIt concept]
- Integrin Alpha V Beta 3-targeting Protein ACT50 [NCIt concept]
- Integrin Alpha-2 [NCIt concept]
- Integrin Alpha-4 [NCIt concept]
- Integrin Alpha-5 [NCIt concept]
- Integrin Alpha-6 [NCIt concept]
- Integrin Alpha-E [NCIt concept]
- Integrin Alpha-IIb [NCIt concept]
- Integrin Alpha-IIb/Beta-3 [NCIt concept]
- Integrin Alpha-L [NCIt concept]
- Integrin Alpha-M [NCIt concept]
- Integrin Alpha-V [NCIt concept]
- Integrin Alpha-X [NCIt concept]
- Integrin Alpha4/Beta1 [NCIt concept]
- Integrin Alpha4/Beta7 [NCIt concept]
- Integrin AlphaL/Beta2 [NCIt concept]
- Integrin AlphaM/Beta2 [NCIt concept]
- Integrin AlphaV/Beta3 [NCIt concept]
- Integrin AlphaV/Beta5 [NCIt concept]
- Integrin AlphaV/Beta6 [NCIt concept]
- Integrin AlphaV/Beta8 [NCIt concept]
- Integrin Beta-1 [NCIt concept]
- Integrin Beta-2 [NCIt concept]
- Integrin Beta-3 [NCIt concept]
- Integrin Beta-5 [NCIt concept]
- Integrin Beta-6 [NCIt concept]
- Integrin Beta-7 [NCIt concept]
- Integrin Beta-8 [NCIt concept]
- Integrin alpha-2 Inhibitor E7820 [NCIt concept]
- Integrin-Linked Protein Kinase [NCIt concept]
- Intelectin-1 [NCIt concept]
- Intensity-Modulated Proton Therapy [NCIt concept]
- Intensity-Modulated Radiation Therapy [NCIt concept]
- Intensity-Modulated Spot-Scanning Proton Therapy [NCIt concept]
- Intercellular Adhesion Molecule 1 [NCIt concept]
- Intercellular Adhesion Molecule 2 [NCIt concept]
- Interdigitating Dendritic Cell Sarcoma [NCIt concept]
- Interferon [NCIt concept]
- Interferon Alpha [NCIt concept]
- Interferon Alpha Receptor Complex [NCIt concept]
- Interferon Alpha-2 [NCIt concept]
- Interferon Alpha/Beta Receptor 1 [NCIt concept]
- Interferon Alpha/Beta Receptor 2 [NCIt concept]
- Interferon Beta [NCIt concept]
- Interferon Beta-1A [NCIt concept]
- Interferon Beta-secreting Mesenchymal Stem Cells [NCIt concept]
- Interferon Gamma [NCIt concept]
- Interferon Gamma Receptor 1 [NCIt concept]
- Interferon Gamma-1b [NCIt concept]
- Interferon Lambda-1 [NCIt concept]
- Interferon Lambda-2 [NCIt concept]
- Interferon Lambda-4 [NCIt concept]
- Interferon Regulatory Factor 1 [NCIt concept]
- Interferon Regulatory Factor 2-Binding Protein 2 [NCIt concept]
- Interferon Regulatory Factor 3 [NCIt concept]
- Interferon Regulatory Factor 4 [NCIt concept]
- Interferon Regulatory Factor 7 [NCIt concept]
- Interferon Regulatory Factor 8 [NCIt concept]
- Interferon Regulatory Factor 9 [NCIt concept]
- Interferon Therapy [NCIt concept]
- Interferon Type I [NCIt concept]
- Interferon-Induced GTP-Binding Protein Mx1 [NCIt concept]
- Interferon-Induced Protein 44 [NCIt concept]
- Interferon-Induced Protein with Tetratricopeptide Repeats 1 [NCIt concept]
- Interferon-Induced Protein with Tetratricopeptide Repeats Family [NCIt concept]
- Interferon-Induced Transmembrane Protein 1 [NCIt concept]
- Interferon-Induced Transmembrane Protein 3 [NCIt concept]
- Interferon-Induced, Double-Stranded RNA-Activated Protein Kinase [NCIt concept]
- Interferon-Inducible Protein AIM2 [NCIt concept]
- Interferon-Related DNA Damage Resistance Gene Signature [NCIt concept]
- Intergroup Rhabdomyosarcoma Group III [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIIa [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIIb [NCIt concept]
- Interleukin [NCIt concept]
- Interleukin 12 Receptor [NCIt concept]
- Interleukin 3 Receptor [NCIt concept]
- Interleukin Gene [NCIt concept]
- Interleukin-1 [NCIt concept]
- Interleukin-1 Alpha [NCIt concept]
- Interleukin-1 Beta [NCIt concept]
- Interleukin-1 Receptor Accessory Protein [NCIt concept]
- Interleukin-1 Receptor Accessory Protein-Like 1 [NCIt concept]
- Interleukin-1 Receptor Antagonist Protein [NCIt concept]
- Interleukin-1 Receptor Type 1 [NCIt concept]
- Interleukin-1 Receptor Type 2 [NCIt concept]
- Interleukin-1 Receptor-Associated Kinase 1 [NCIt concept]
- Interleukin-1 Receptor-Associated Kinase 3 [NCIt concept]
- Interleukin-1 Receptor-Like 1 [NCIt concept]
- Interleukin-1 Receptor-Like 2 [NCIt concept]
- Interleukin-10 [NCIt concept]
- Interleukin-10 Receptor Subunit Alpha [NCIt concept]
- Interleukin-11 [NCIt concept]
- Interleukin-11 Receptor Subunit Alpha [NCIt concept]
- Interleukin-12 [NCIt concept]
- Interleukin-12 Gene [NCIt concept]
- Interleukin-12 Receptor Subunit Beta-1 [NCIt concept]
- Interleukin-12 Receptor Subunit Beta-2 [NCIt concept]
- Interleukin-12 Subunit Alpha [NCIt concept]
- Interleukin-12 Subunit Beta [NCIt concept]
- Interleukin-12-Fc Fusion Protein DF6002 [NCIt concept]
- Interleukin-13 [NCIt concept]
- Interleukin-13 Receptor Subunit Alpha-1 [NCIt concept]
- Interleukin-13 Receptor Subunit Alpha-2 [NCIt concept]
- Interleukin-15 [NCIt concept]
- Interleukin-15 Fusion Protein BJ-001 [NCIt concept]
- Interleukin-15 Receptor [NCIt concept]
- Interleukin-15 Receptor Subunit Alpha [NCIt concept]
- Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306 [NCIt concept]
- Interleukin-16 [NCIt concept]
- Interleukin-17A [NCIt concept]
- Interleukin-17F [NCIt concept]
- Interleukin-18 [NCIt concept]
- Interleukin-18 Receptor 1 [NCIt concept]
- Interleukin-18-Binding Protein [NCIt concept]
- Interleukin-19 [NCIt concept]
- Interleukin-2 [NCIt concept]
- Interleukin-2 Gene [NCIt concept]
- Interleukin-2 Receptor [NCIt concept]
- Interleukin-2 Receptor Subunit Alpha [NCIt concept]
- Interleukin-2 Receptor Subunit Beta [NCIt concept]
- Interleukin-2/Interleukin-15 Receptor Agonist NL-201 [NCIt concept]
- Interleukin-20 [NCIt concept]
- Interleukin-21 [NCIt concept]
- Interleukin-21 Receptor [NCIt concept]
- Interleukin-22 [NCIt concept]
- Interleukin-23 [NCIt concept]
- Interleukin-23 Subunit Alpha [NCIt concept]
- Interleukin-25 [NCIt concept]
- Interleukin-27 [NCIt concept]
- Interleukin-27 Subunit Alpha [NCIt concept]
- Interleukin-27 Subunit Beta [NCIt concept]
- Interleukin-3 [NCIt concept]
- Interleukin-3 Receptor Subunit Alpha [NCIt concept]
- Interleukin-3 Receptor Subunit Alpha Positive [NCIt concept]
- Interleukin-31 [NCIt concept]
- Interleukin-32 [NCIt concept]
- Interleukin-33 [NCIt concept]
- Interleukin-34 [NCIt concept]
- Interleukin-4 [NCIt concept]
- Interleukin-4 Receptor Subunit Alpha [NCIt concept]
- Interleukin-5 [NCIt concept]
- Interleukin-5 Receptor Subunit Alpha [NCIt concept]
- Interleukin-6 [NCIt concept]
- Interleukin-6 Greater than or Equal to 80 pg/ml [NCIt concept]
- Interleukin-6 Receptor Subunit Alpha [NCIt concept]
- Interleukin-7 [NCIt concept]
- Interleukin-7 Receptor Subunit Alpha [NCIt concept]
- Interleukin-8 [NCIt concept]
- Interleukin-8 Receptor [NCIt concept]
- Interleukin-9 [NCIt concept]
- Intermediate Risk Myelodysplastic Syndrome [NCIt concept]
- Intermediate Risk Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Internalized-arginylglycylaspartic Acid Cyclic Peptide [NCIt concept]
- Internet Mobile Technology [NCIt concept]
- Internet Service Provider [NCIt concept]
- Internet-Based Intervention [NCIt concept]
- Interpretation [NCIt concept]
- Intersectin-1 [NCIt concept]
- Interstitial Collagenase [NCIt concept]
- Interstitial Photodynamic Therapy [NCIt concept]
- Interstitial Radiation Therapy [NCIt concept]
- Interval Debulking Surgery [NCIt concept]
- Intervention by Caregiver [NCIt concept]
- Interventional Radiology Procedure [NCIt concept]
- Interview [NCIt concept]
- Intestinal Flora [NCIt concept]
- Intestinal Polyposis Syndrome [NCIt concept]
- Intestinal T-Cell Lymphoma [NCIt concept]
- Intestinal T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Intestine-Specific Homeobox [NCIt concept]
- Intetumumab [NCIt concept]
- Intimacy Enhancement Intervention [NCIt concept]
- Intismeran Autogene [NCIt concept]
- Intra-oral Reflectance Confocal Microscopy [NCIt concept]
- Intracavity Hydrogel Packing [NCIt concept]
- Intrachromosomal Amplification of Chromosome 21 [NCIt concept]
- Intracranial Catheter Placement [NCIt concept]
- Intracranial Extension [NCIt concept]
- Intracranial Hemangioma [NCIt concept]
- Intraflagellar Transport Protein 88 Homolog [NCIt concept]
- Intrafraction Motion Monitoring [NCIt concept]
- Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma [NCIt concept]
- Intrahepatic Cholangiocarcinoma [NCIt concept]
- Intrahepatic Infusion Procedure [NCIt concept]
- Intraocular Retinoblastoma [NCIt concept]
- Intraoperative Complication Management and Prevention [NCIt concept]
- Intraoperative Imaging [NCIt concept]
- Intraoperative Radiation Therapy [NCIt concept]
- Intraoperative Ultrasound [NCIt concept]
- Intraperitoneal Chemotherapy [NCIt concept]
- Intraperitoneal Port Placement [NCIt concept]
- Intraperitoneal Route of Administration [NCIt concept]
- Intraspinal Neuroblastoma [NCIt concept]
- Intrathecal Chemotherapy [NCIt concept]
- Intrathecal Deferoxamine [NCIt concept]
- Intratubular Embryonal Carcinoma [NCIt concept]
- Intratubular Seminoma [NCIt concept]
- Intratumoral Genetic Heterogeneity [NCIt concept]
- Intravascular Large B-Cell Lymphoma [NCIt concept]
- Intravascular Optical Coherence Tomography [NCIt concept]
- Intravenous Immunoglobulin Therapy [NCIt concept]
- Intravenous Infusion [NCIt concept]
- Intravenous Patient-Controlled Analgesia [NCIt concept]
- Intubation Procedure [NCIt concept]
- Inupadenant [NCIt concept]
- Invasive [NCIt concept]
- Invasive Bladder Carcinoma [NCIt concept]
- Invasive Bladder Micropapillary Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Mixed Carcinoma [NCIt concept]
- Invasive Bladder Plasmacytoid Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Poorly Differentiated Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Sarcomatoid Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma [NCIt concept]
- Invasive Bladder Urothelial Carcinoma with Glandular Differentiation [NCIt concept]
- Invasive Bladder Urothelial Carcinoma with Squamous Differentiation [NCIt concept]
- Invasive Breast Carcinoma [NCIt concept]
- Invasive Breast Carcinoma of No Special Type [NCIt concept]
- Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component [NCIt concept]
- Invasive Breast Ductal Carcinoma and Lobular Carcinoma [NCIt concept]
- Invasive Breast Lobular Carcinoma [NCIt concept]
- Invasive Breast Lobular Carcinoma with Predominant In Situ Component [NCIt concept]
- Invasive Cervical Carcinoma [NCIt concept]
- Invasive Cutaneous Melanoma [NCIt concept]
- Invasive Hydatidiform Mole [NCIt concept]
- Invasive Lung Mucinous Adenocarcinoma [NCIt concept]
- Invasive Prostate Carcinoma [NCIt concept]
- Invasive Pulmonary Aspergillosis [NCIt concept]
- Investigative Subject [NCIt concept]
- Involucrin [NCIt concept]
- Involved Node Radiation Therapy [NCIt concept]
- Involved-Field Radiation Therapy [NCIt concept]
- Involved-site Radiation Therapy [NCIt concept]
- Iobenguane [NCIt concept]
- Iobenguane I-123 [NCIt concept]
- Iobenguane I-124 [NCIt concept]
- Iobenguane I-131 [NCIt concept]
- Iodinated Contrast Agent [NCIt concept]
- Iodinated Polyethylene Glycol-based Hydrogel Tissue Marker [NCIt concept]
- Iodine I 123 Anti-CEA Recombinant Diabody T84.66 [NCIt concept]
- Iodine I 123 RISAD-P [NCIt concept]
- Iodine I 124 [NCIt concept]
- Iodine I 124 Icapamespib [NCIt concept]
- Iodine I 124 Iopofosine [NCIt concept]
- Iodine I 124 Monoclonal Antibody 3F8 [NCIt concept]
- Iodine I 124 Monoclonal Antibody M5A [NCIt concept]
- Iodine I 124 Omburtamab [NCIt concept]
- Iodine I 124 hJAA-F11 [NCIt concept]
- Iodine I 124-cRGDY-PEG-C Dots [NCIt concept]
- Iodine I 124-labeled Albumin [NCIt concept]
- Iodine I 124-labeled Anti-PSCA A11 Minibody [NCIt concept]
- Iodine I 124-labeled Hsp90 Inhibitor PUH71 [NCIt concept]
- Iodine I 125 RISAD-P [NCIt concept]
- Iodine I 131 Apamistamab [NCIt concept]
- Iodine I 131 Derlotuximab Biotin [NCIt concept]
- Iodine I 131 Iopofosine [NCIt concept]
- Iodine I 131 MIP-1095 [NCIt concept]
- Iodine I 131 Monoclonal Antibody 81C6 [NCIt concept]
- Iodine I 131 Monoclonal Antibody CC49-deltaCH2 [NCIt concept]
- Iodine I 131 Omburtamab [NCIt concept]
- Iodine I 131 Radiation Therapy [NCIt concept]
- Iodine I 131 SGMIB-Anti-HER2 CAM-H2 [NCIt concept]
- Iodine I 131 TM-601 [NCIt concept]
- Iodine I 131 Tositumomab [NCIt concept]
- Iodine I-123 [NCIt concept]
- Iodine I-123 ADAM [NCIt concept]
- Iodine I-123 MIP-1095 [NCIt concept]
- Iodine I-124 FIAU [NCIt concept]
- Iodine I-124 Girentuximab [NCIt concept]
- Iodine I-125 [NCIt concept]
- Iodine I-131 [NCIt concept]
- Iodixanol [NCIt concept]
- Iodoacetamide [NCIt concept]
- Iofolastat I123 [NCIt concept]
- Iopamidol [NCIt concept]
- Ioversol [NCIt concept]
- Ipafricept [NCIt concept]
- Ipamorelin [NCIt concept]
- Iparomlimab/Tuvonralimab [NCIt concept]
- Ipatasertib [NCIt concept]
- Ipilimumab [NCIt concept]
- Ipsilateral Breast Radiation Therapy [NCIt concept]
- Ipsilateral Peripheral Intravenous Catheter Insertion [NCIt concept]
- Iratumumab [NCIt concept]
- Irinotecan [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Irinotecan Sucrosofate [NCIt concept]
- Irinotecan-Eluting Beads [NCIt concept]
- Iris Melanoma [NCIt concept]
- Irisin [NCIt concept]
- Irofulven [NCIt concept]
- Iron [NCIt concept]
- Iron Conjugated Polymers in Saline Suspension [NCIt concept]
- Iron Deficiency without Anemia [NCIt concept]
- Iron Dextran [NCIt concept]
- Iron Measurement [NCIt concept]
- Iron Overload [NCIt concept]
- Iron Sucrose [NCIt concept]
- Iron-56 Ion Irradiation [NCIt concept]
- Irosustat [NCIt concept]
- Isatuximab [NCIt concept]
- Isavuconazole [NCIt concept]
- Isavuconazonium Sulfate [NCIt concept]
- Iso-fludelone [NCIt concept]
- Isocitrate Dehydrogenase [NADP] Cytoplasmic [NCIt concept]
- Isocitrate Dehydrogenase [NADP], Mitochondrial [NCIt concept]
- Isoflavone [NCIt concept]
- Isofuran [NCIt concept]
- Isohemagglutinin [NCIt concept]
- Isolated Chemotherapeutic Limb Perfusion [NCIt concept]
- Isolated Chemotherapeutic Lung Perfusion [NCIt concept]
- Isoleucine [NCIt concept]
- Isoproterenol [NCIt concept]
- Isosulfan Blue [NCIt concept]
- Isothiocyanate [NCIt concept]
- Isotretinoin [NCIt concept]
- Ispectamab Debotansine [NCIt concept]
- Ispinesib [NCIt concept]
- Istiratumab [NCIt concept]
- Istisociclib [NCIt concept]
- Isunakinra [NCIt concept]
- Isuventatug [NCIt concept]
- Itacitinib [NCIt concept]
- Itacitinib Adipate [NCIt concept]
- Itacnosertib [NCIt concept]
- Itanistomig [NCIt concept]
- Itraconazole [NCIt concept]
- Itraconazole Dispersion In Polymer Matrix [NCIt concept]
- Ivabradine [NCIt concept]
- Ivabradine Hydrochloride [NCIt concept]
- Ivicentamab [NCIt concept]
- Ivosidenib [NCIt concept]
- Ivospemin Hydrochloride [NCIt concept]
- Ivuxolimab [NCIt concept]
- Ixabepilone [NCIt concept]
- Ixazomib Citrate [NCIt concept]
- Ixotatug Vedotin [NCIt concept]
- Izalontamab Brengitecan [NCIt concept]
- Izastobart [NCIt concept]
- Izeltabart Tapatansine [NCIt concept]
- Izorlisib [NCIt concept]
- Izuralimab [NCIt concept]
- JAG1 Gene [NCIt concept]
- JAG1 wt Allele [NCIt concept]
- JAG2 Gene [NCIt concept]
- JAG2 wt Allele [NCIt concept]
- JAK Family Gene Mutation [NCIt concept]
- JAK Inhibitor [NCIt concept]
- JAK1 Gene [NCIt concept]
- JAK1 Gene Mutation [NCIt concept]
- JAK1 Inhibitor INCB052793 [NCIt concept]
- JAK1 wt Allele [NCIt concept]
- JAK2 Exon 12 Mutation [NCIt concept]
- JAK2 Exon 14 Mutation [NCIt concept]
- JAK2 Exon 16 Mutation [NCIt concept]
- JAK2 Fusion Positive [NCIt concept]
- JAK2 Gene [NCIt concept]
- JAK2 Gene Mutation [NCIt concept]
- JAK2 Gene Mutation Negative [NCIt concept]
- JAK2 Gene Rearrangement [NCIt concept]
- JAK2 Inhibitor AZD1480 [NCIt concept]
- JAK2 Inhibitor BMS-911543 [NCIt concept]
- JAK2 Inhibitor XL019 [NCIt concept]
- JAK2 NM_004972.3:c.1848_1849delinsCT [NCIt concept]
- JAK2 NM_004972.3:c.1849G>T [NCIt concept]
- JAK2 NM_004972.3:c.2624C>A [NCIt concept]
- JAK2 NM_004972.3:c.2792A>G [NCIt concept]
- JAK2 NP_004963.1:p.E985K [NCIt concept]
- JAK2 NP_004963.1:p.G935R [NCIt concept]
- JAK2 NP_004963.1:p.I960V [NCIt concept]
- JAK2 NP_004963.1:p.M929I [NCIt concept]
- JAK2 NP_004963.1:p.R938L [NCIt concept]
- JAK2 NP_004963.1:p.T875N [NCIt concept]
- JAK2 NP_004963.1:p.V617F [NCIt concept]
- JAK2 NP_004963.1:p.V617X [NCIt concept]
- JAK2 NP_004963.1:p.Y931C [NCIt concept]
- JAK2 Protein Variant [NCIt concept]
- JAK2 wt Allele [NCIt concept]
- JAK2V617F Inhibitor INCB160058 [NCIt concept]
- JAK3 Fusion Positive [NCIt concept]
- JAK3 Gene [NCIt concept]
- JAK3 Gene Mutation [NCIt concept]
- JAK3 wt Allele [NCIt concept]
- JAZF1 Gene [NCIt concept]
- JAZF1 wt Allele [NCIt concept]
- JAZF1/SUZ12 Fusion Gene [NCIt concept]
- JAZF1/SUZ12 Fusion Protein [NCIt concept]
- JC Virus [NCIt concept]
- JC Virus Infection [NCIt concept]
- JC Virus Positive [NCIt concept]
- JCHAIN Gene [NCIt concept]
- JCHAIN wt Allele [NCIt concept]
- JNK1 Inhibitor BMS-986360 [NCIt concept]
- JPT1 Gene [NCIt concept]
- JPT1 wt Allele [NCIt concept]
- JUN Gene [NCIt concept]
- JUN wt Allele [NCIt concept]
- JUNB Gene [NCIt concept]
- JUNB wt Allele [NCIt concept]
- JUND Gene [NCIt concept]
- JUND wt Allele [NCIt concept]
- Janus Kinase Family [NCIt concept]
- Jejunal Melanoma [NCIt concept]
- Jejunal Neuroendocrine Tumor G2 [NCIt concept]
- Jejunectomy [NCIt concept]
- Joint Contracture [NCIt concept]
- Jojoba Oil [NCIt concept]
- Junctate [NCIt concept]
- Junctin-1 [NCIt concept]
- Junctin-2 [NCIt concept]
- Junctional Adhesion Molecule A [NCIt concept]
- Jupiter Microtubule Associated Homolog 1 [NCIt concept]
- Juven [NCIt concept]
- Juvenile Myelomonocytic Leukemia [NCIt concept]
- Juvenile Xanthogranuloma [NCIt concept]
- Juxtaposed With Another Zinc Finger Protein 1 [NCIt concept]
- KAAG1 Gene [NCIt concept]
- KAAG1 wt Allele [NCIt concept]
- KAT2A Gene [NCIt concept]
- KAT2A wt Allele [NCIt concept]
- KAT2A/KAT2B Degrader AUTX-703 [NCIt concept]
- KAT2B Gene [NCIt concept]
- KAT2B wt Allele [NCIt concept]
- KAT6 Inhibitor MEN2312 [NCIt concept]
- KAT6A Gene [NCIt concept]
- KAT6A wt Allele [NCIt concept]
- KAT6A/CREBBP Fusion Gene [NCIt concept]
- KAT6A/CREBBP Fusion Protein [NCIt concept]
- KAT6A/NCOA2 Fusion Gene [NCIt concept]
- KAT6A/NCOA2 Fusion Protein [NCIt concept]
- KAT6B Gene [NCIt concept]
- KAT6B wt Allele [NCIt concept]
- KCNQ1 Gene [NCIt concept]
- KCNQ1 Opposite Strand/Antisense Transcript 1 [NCIt concept]
- KCNQ1 wt Allele [NCIt concept]
- KCNQ1OT1 Gene [NCIt concept]
- KCNQ1OT1 wt Allele [NCIt concept]
- KDM1A Gene [NCIt concept]
- KDM1A wt Allele [NCIt concept]
- KDM2B Gene [NCIt concept]
- KDM2B Gene Mutation [NCIt concept]
- KDM2B wt Allele [NCIt concept]
- KDM3A Gene [NCIt concept]
- KDM5A Gene [NCIt concept]
- KDM5A wt Allele [NCIt concept]
- KDM5C Gene [NCIt concept]
- KDM5C wt Allele [NCIt concept]
- KDM6A Gene [NCIt concept]
- KDM6A Gene Mutation [NCIt concept]
- KDM6A wt Allele [NCIt concept]
- KDR Gene [NCIt concept]
- KDR Gene Amplification [NCIt concept]
- KDR Gene Mutation [NCIt concept]
- KDR Gene Product [NCIt concept]
- KDR Intron 2 VNTR [NCIt concept]
- KDR Overexpression Positive [NCIt concept]
- KDR Positive [NCIt concept]
- KDR wt Allele [NCIt concept]
- KDSR Gene [NCIt concept]
- KDSR wt Allele [NCIt concept]
- KEAP1 Alteration Positive [NCIt concept]
- KEAP1 Gene [NCIt concept]
- KEAP1 Gene Alteration Positive [NCIt concept]
- KEAP1 Gene Mutation [NCIt concept]
- KEAP1 Gene Mutation Negative [NCIt concept]
- KEAP1 wt Allele [NCIt concept]
- KH Domain-Containing, RNA-Binding, Signal Transduction-Associated Protein 1 [NCIt concept]
- KHDRBS1 Gene [NCIt concept]
- KHDRBS1 wt Allele [NCIt concept]
- KIAA1549 Gene [NCIt concept]
- KIAA1549 wt Allele [NCIt concept]
- KIAA1549-BRAF Fusion Protein Expression [NCIt concept]
- KIAA1549/BRAF Fusion Gene [NCIt concept]
- KIAA1549/BRAF Fusion Protein [NCIt concept]
- KIF11 Gene [NCIt concept]
- KIF11 wt Allele [NCIt concept]
- KIF18A Gene [NCIt concept]
- KIF18A Inhibitor [NCIt concept]
- KIF18A Inhibitor ATX-295 [NCIt concept]
- KIF18A Inhibitor VLS-1488 [NCIt concept]
- KIF18A wt Allele [NCIt concept]
- KIF20B Gene [NCIt concept]
- KIF20B wt Allele [NCIt concept]
- KIF23 Gene [NCIt concept]
- KIF23 wt Allele [NCIt concept]
- KIF2C Gene [NCIt concept]
- KIF2C wt Allele [NCIt concept]
- KIF5B Gene [NCIt concept]
- KIF5B wt Allele [NCIt concept]
- KIF5B/RET Fusion Gene [NCIt concept]
- KIF5B/RET Fusion Protein [NCIt concept]
- KIR Ligand [NCIt concept]
- KIR Ligand Negative [NCIt concept]
- KIR2DL1 Gene [NCIt concept]
- KIR2DL1 Polymorphism Positive [NCIt concept]
- KIR2DL1 wt Allele [NCIt concept]
- KIR2DL2 Gene [NCIt concept]
- KIR2DL2 wt Allele [NCIt concept]
- KIR2DL3 Gene [NCIt concept]
- KIR2DL3 wt Allele [NCIt concept]
- KIR2DS4 Gene [NCIt concept]
- KIR2DS4 wt Allele [NCIt concept]
- KIR3DL1 Gene [NCIt concept]
- KIR3DL1 wt Allele [NCIt concept]
- KIR3DL2 Gene [NCIt concept]
- KIR3DL2 Positive [NCIt concept]
- KIR3DL2 wt Allele [NCIt concept]
- KIR3DL3 Gene [NCIt concept]
- KIR3DL3 wt Allele [NCIt concept]
- KIT Exon 11 Mutation [NCIt concept]
- KIT Exon 13 Mutation [NCIt concept]
- KIT Exon 14 Mutation [NCIt concept]
- KIT Exon 17 Mutation [NCIt concept]
- KIT Exon 18 Mutation [NCIt concept]
- KIT Exon 8 Mutation [NCIt concept]
- KIT Exon 9 Mutation [NCIt concept]
- KIT Gene [NCIt concept]
- KIT Gene Amplification [NCIt concept]
- KIT Gene Mutation [NCIt concept]
- KIT Gene Mutation Negative [NCIt concept]
- KIT K642E Negative [NCIt concept]
- KIT L576P Negative [NCIt concept]
- KIT NM_000222.2:c.1669T>A [NCIt concept]
- KIT NM_000222.2:c.1669T>C [NCIt concept]
- KIT NM_000222.2:c.1676T>C [NCIt concept]
- KIT NM_000222.2:c.1727T>C [NCIt concept]
- KIT NM_000222.2:c.1924A>G [NCIt concept]
- KIT NM_000222.2:c.1961T>C [NCIt concept]
- KIT NM_000222.2:c.2447A>T [NCIt concept]
- KIT NM_000222.3:c.1676T>A [NCIt concept]
- KIT NP_000213.1:p.D816V [NCIt concept]
- KIT NP_000213.1:p.K642E [NCIt concept]
- KIT NP_000213.1:p.L576P [NCIt concept]
- KIT NP_000213.1:p.T670X [NCIt concept]
- KIT NP_000213.1:p.V559A [NCIt concept]
- KIT NP_000213.1:p.V559D [NCIt concept]
- KIT NP_000213.1:p.V654A [NCIt concept]
- KIT NP_000213.1:p.W557R [NCIt concept]
- KIT Non-Exon 9 Mutation [NCIt concept]
- KIT Overexpression Positive [NCIt concept]
- KIT Positive [NCIt concept]
- KIT Protein Variant [NCIt concept]
- KIT V559A Negative [NCIt concept]
- KIT V559D Negative [NCIt concept]
- KIT W557R Negative [NCIt concept]
- KIT wt Allele [NCIt concept]
- KIT-mutant Inhibitor DCC-3009 [NCIt concept]
- KIT-mutant Inhibitor IDRX-42 [NCIt concept]
- KITLG Gene [NCIt concept]
- KITLG wt Allele [NCIt concept]
- KL Gene [NCIt concept]
- KL wt Allele [NCIt concept]
- KLB Gene [NCIt concept]
- KLB Positive [NCIt concept]
- KLB wt Allele [NCIt concept]
- KLF1 Gene [NCIt concept]
- KLF1 wt Allele [NCIt concept]
- KLF4 Gene [NCIt concept]
- KLF4 wt Allele [NCIt concept]
- KLF6 Gene [NCIt concept]
- KLF6 wt Allele [NCIt concept]
- KLH/NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine [NCIt concept]
- KLHL6 Gene [NCIt concept]
- KLHL6 wt Allele [NCIt concept]
- KLK11 Gene [NCIt concept]
- KLK11 wt Allele [NCIt concept]
- KLK2 Gene [NCIt concept]
- KLK2 wt Allele [NCIt concept]
- KLK3 Gene [NCIt concept]
- KLK3 wt Allele [NCIt concept]
- KLKB1 Gene [NCIt concept]
- KLKB1 wt Allele [NCIt concept]
- KLRB1 Gene [NCIt concept]
- KLRB1 wt Allele [NCIt concept]
- KLRC1 Gene [NCIt concept]
- KLRC1 wt Allele [NCIt concept]
- KLRC2 Gene [NCIt concept]
- KLRC2 wt Allele [NCIt concept]
- KLRG1 Gene [NCIt concept]
- KLRG1 Positive Lymphocyte [NCIt concept]
- KLRG1 wt Allele [NCIt concept]
- KLRK1 Gene [NCIt concept]
- KLRK1 wt Allele [NCIt concept]
- KMT2A Fusion Positive [NCIt concept]
- KMT2A Gene [NCIt concept]
- KMT2A Gene Alteration Positive [NCIt concept]
- KMT2A Gene Amplification [NCIt concept]
- KMT2A Gene Rearrangement [NCIt concept]
- KMT2A Gene Rearrangement Negative [NCIt concept]
- KMT2A Gene Translocation [NCIt concept]
- KMT2A Partial Tandem Duplication [NCIt concept]
- KMT2A wt Allele [NCIt concept]
- KMT2A/MLLT3 Fusion Gene [NCIt concept]
- KMT2C Gene [NCIt concept]
- KMT2C Gene Mutation [NCIt concept]
- KMT2C wt Allele [NCIt concept]
- KMT2D Gene [NCIt concept]
- KMT2D Gene Mutation [NCIt concept]
- KMT2D wt Allele [NCIt concept]
- KNG1 Gene [NCIt concept]
- KNG1 wt Allele [NCIt concept]
- KNL1 Gene [NCIt concept]
- KNL1 wt Allele [NCIt concept]
- KRAS Activating Mutation [NCIt concept]
- KRAS Exon 2 Mutation [NCIt concept]
- KRAS Exon 2 Mutation Negative [NCIt concept]
- KRAS Exon 3 Mutation [NCIt concept]
- KRAS Exon 3 Mutation Negative [NCIt concept]
- KRAS Exon 4 Mutation [NCIt concept]
- KRAS Exon 4 Mutation Negative [NCIt concept]
- KRAS G12C Inhibitor [NCIt concept]
- KRAS G12C Inhibitor BBO-8520 [NCIt concept]
- KRAS G12C Inhibitor BI 1823911 [NCIt concept]
- KRAS G12C Inhibitor FMC-376 [NCIt concept]
- KRAS G12C Inhibitor JNJ-74699157 [NCIt concept]
- KRAS G12C Inhibitor LY3499446 [NCIt concept]
- KRAS G12C Inhibitor MK-1084 [NCIt concept]
- KRAS G12D Degrader ASP3082 [NCIt concept]
- KRAS G12D Degrader ASP4396 [NCIt concept]
- KRAS G12D Degrader PT0253 [NCIt concept]
- KRAS G12D Inhibitor [NCIt concept]
- KRAS G12D Inhibitor AZD0022 [NCIt concept]
- KRAS G12D Inhibitor INCB161734 [NCIt concept]
- KRAS G12D Inhibitor LY3962673 [NCIt concept]
- KRAS G12D Inhibitor QTX3046 [NCIt concept]
- KRAS G12D Inhibitor RG6620 [NCIt concept]
- KRAS G12D Inhibitor TSN1611 [NCIt concept]
- KRAS Gene [NCIt concept]
- KRAS Gene Alteration Positive [NCIt concept]
- KRAS Gene Amplification [NCIt concept]
- KRAS Gene Mutation [NCIt concept]
- KRAS Gene Mutation Negative [NCIt concept]
- KRAS Gene Rearrangement [NCIt concept]
- KRAS Inhibitor [NCIt concept]
- KRAS Inhibitor BI 3706674 [NCIt concept]
- KRAS Mutant Inhibitor ALTA3263 [NCIt concept]
- KRAS Mutant Inhibitor BBO-11818 [NCIt concept]
- KRAS Mutant Inhibitor KQB365 [NCIt concept]
- KRAS Mutant Inhibitor QTX3034 [NCIt concept]
- KRAS Mutant Inhibitor QTX3544 [NCIt concept]
- KRAS NM_004985.3:c.180_181delinsAA [NCIt concept]
- KRAS NM_004985.3:c.180_181delinsCA [NCIt concept]
- KRAS NM_004985.3:c.181C>A [NCIt concept]
- KRAS NM_004985.3:c.181C>G [NCIt concept]
- KRAS NM_004985.3:c.182A>C [NCIt concept]
- KRAS NM_004985.3:c.182A>G [NCIt concept]
- KRAS NM_004985.3:c.182A>T [NCIt concept]
- KRAS NM_004985.3:c.183A>C [NCIt concept]
- KRAS NM_004985.3:c.183A>T [NCIt concept]
- KRAS NM_004985.3:c.34G>A [NCIt concept]
- KRAS NM_004985.3:c.34G>C [NCIt concept]
- KRAS NM_004985.3:c.34G>T [NCIt concept]
- KRAS NM_004985.3:c.34_35delinsAA [NCIt concept]
- KRAS NM_004985.3:c.34_35delinsAT [NCIt concept]
- KRAS NM_004985.3:c.34_35delinsCT [NCIt concept]
- KRAS NM_004985.3:c.34_35delinsTA [NCIt concept]
- KRAS NM_004985.3:c.34_35delinsTT [NCIt concept]
- KRAS NM_004985.3:c.34_36delinsTGC [NCIt concept]
- KRAS NM_004985.3:c.34_36delinsTGG [NCIt concept]
- KRAS NM_004985.3:c.35G>A [NCIt concept]
- KRAS NM_004985.3:c.35G>C [NCIt concept]
- KRAS NM_004985.3:c.35G>T [NCIt concept]
- KRAS NM_004985.3:c.35_36delinsAA [NCIt concept]
- KRAS NM_004985.3:c.35_36delinsAG [NCIt concept]
- KRAS NM_004985.3:c.35_36delinsTC [NCIt concept]
- KRAS NM_004985.3:c.35_36inv [NCIt concept]
- KRAS NM_004985.3:c.36T>C [NCIt concept]
- KRAS NM_004985.3:c.37G>A [NCIt concept]
- KRAS NM_004985.3:c.37G>C [NCIt concept]
- KRAS NM_004985.3:c.37G>T [NCIt concept]
- KRAS NM_004985.3:c.37_38delinsAA [NCIt concept]
- KRAS NM_004985.3:c.37_39delinsCGT [NCIt concept]
- KRAS NM_004985.3:c.38G>A [NCIt concept]
- KRAS NM_004985.3:c.38G>C [NCIt concept]
- KRAS NM_004985.3:c.38G>T [NCIt concept]
- KRAS NM_004985.3:c.38_39delinsAA [NCIt concept]
- KRAS NM_004985.3:c.38_39delinsAG [NCIt concept]
- KRAS NM_004985.3:c.38_39delinsAT [NCIt concept]
- KRAS NM_004985.3:c.38_39delinsTG [NCIt concept]
- KRAS NM_004985.3:c.38_39delinsTT [NCIt concept]
- KRAS NM_004985.3:c.39C>A [NCIt concept]
- KRAS NM_004985.3:c.39C>G [NCIt concept]
- KRAS NM_004985.3:c.39C>T [NCIt concept]
- KRAS NP_004976.2:p.A146X [NCIt concept]
- KRAS NP_004976.2:p.A59X [NCIt concept]
- KRAS NP_004976.2:p.G12A [NCIt concept]
- KRAS NP_004976.2:p.G12C [NCIt concept]
- KRAS NP_004976.2:p.G12D [NCIt concept]
- KRAS NP_004976.2:p.G12E [NCIt concept]
- KRAS NP_004976.2:p.G12F [NCIt concept]
- KRAS NP_004976.2:p.G12I [NCIt concept]
- KRAS NP_004976.2:p.G12L [NCIt concept]
- KRAS NP_004976.2:p.G12N [NCIt concept]
- KRAS NP_004976.2:p.G12R [NCIt concept]
- KRAS NP_004976.2:p.G12S [NCIt concept]
- KRAS NP_004976.2:p.G12V [NCIt concept]
- KRAS NP_004976.2:p.G12W [NCIt concept]
- KRAS NP_004976.2:p.G12X [NCIt concept]
- KRAS NP_004976.2:p.G12Y [NCIt concept]
- KRAS NP_004976.2:p.G13A [NCIt concept]
- KRAS NP_004976.2:p.G13C [NCIt concept]
- KRAS NP_004976.2:p.G13D [NCIt concept]
- KRAS NP_004976.2:p.G13E [NCIt concept]
- KRAS NP_004976.2:p.G13N [NCIt concept]
- KRAS NP_004976.2:p.G13R [NCIt concept]
- KRAS NP_004976.2:p.G13S [NCIt concept]
- KRAS NP_004976.2:p.G13V [NCIt concept]
- KRAS NP_004976.2:p.G13X [NCIt concept]
- KRAS NP_004976.2:p.K117X [NCIt concept]
- KRAS NP_004976.2:p.Q61D [NCIt concept]
- KRAS NP_004976.2:p.Q61E [NCIt concept]
- KRAS NP_004976.2:p.Q61H [NCIt concept]
- KRAS NP_004976.2:p.Q61K [NCIt concept]
- KRAS NP_004976.2:p.Q61L [NCIt concept]
- KRAS NP_004976.2:p.Q61P [NCIt concept]
- KRAS NP_004976.2:p.Q61R [NCIt concept]
- KRAS NP_004976.2:p.Q61X [NCIt concept]
- KRAS Positive [NCIt concept]
- KRAS Protein Variant [NCIt concept]
- KRAS wt Allele [NCIt concept]
- KRN5500 [NCIt concept]
- KRT1 Gene [NCIt concept]
- KRT1 wt Allele [NCIt concept]
- KRT10 Gene [NCIt concept]
- KRT10 wt Allele [NCIt concept]
- KRT13 Gene [NCIt concept]
- KRT13 wt Allele [NCIt concept]
- KRT14 Gene [NCIt concept]
- KRT14 wt Allele [NCIt concept]
- KRT16 Gene [NCIt concept]
- KRT16 wt Allele [NCIt concept]
- KRT17 Gene [NCIt concept]
- KRT17 wt Allele [NCIt concept]
- KRT18 Gene [NCIt concept]
- KRT18 wt Allele [NCIt concept]
- KRT19 Gene [NCIt concept]
- KRT19 wt Allele [NCIt concept]
- KRT20 Gene [NCIt concept]
- KRT20 wt Allele [NCIt concept]
- KRT5 Gene [NCIt concept]
- KRT5 Gene Mutation [NCIt concept]
- KRT5 wt Allele [NCIt concept]
- KRT7 Gene [NCIt concept]
- KRT7 wt Allele [NCIt concept]
- KRT72 Gene [NCIt concept]
- KRT72 Gene Mutation [NCIt concept]
- KRT72 wt Allele [NCIt concept]
- KRT8 Gene [NCIt concept]
- KRT8 wt Allele [NCIt concept]
- KSHV Inflammatory Cytokine Syndrome [NCIt concept]
- KSP Inhibitor AZD4877 [NCIt concept]
- KSP Inhibitor SB-743921 [NCIt concept]
- KSR1 Gene [NCIt concept]
- KSR1 wt Allele [NCIt concept]
- KSR2 Gene [NCIt concept]
- KSR2 wt Allele [NCIt concept]
- KTN1 Gene [NCIt concept]
- KTN1 wt Allele [NCIt concept]
- Kallikrein Inhibitor MDPK67b [NCIt concept]
- Kallikrein-11 [NCIt concept]
- Kallikrein-2 [NCIt concept]
- Kanglaite [NCIt concept]
- Kaposi Sarcoma [NCIt concept]
- Kaposi Sarcoma Related to Immunosuppressive Treatment [NCIt concept]
- Kappa Light Chain-Restriction [NCIt concept]
- Karyotype [NCIt concept]
- Kava-based Supplement [NCIt concept]
- Kefir [NCIt concept]
- Kegel Exercise [NCIt concept]
- Kegel Nation App [NCIt concept]
- Kelch-Like ECH-Associated Protein 1 [NCIt concept]
- Kelch-Like Protein 6 [NCIt concept]
- Keratin, Type I Cytoskeletal 10 [NCIt concept]
- Keratin, Type I Cytoskeletal 13 [NCIt concept]
- Keratin, Type I Cytoskeletal 14 [NCIt concept]
- Keratin, Type I Cytoskeletal 16 [NCIt concept]
- Keratin, Type I Cytoskeletal 17 [NCIt concept]
- Keratin, Type I Cytoskeletal 18 [NCIt concept]
- Keratin, Type I Cytoskeletal 19 [NCIt concept]
- Keratin, Type I Cytoskeletal 20 [NCIt concept]
- Keratin, Type II Cytoskeletal 1 [NCIt concept]
- Keratin, Type II Cytoskeletal 5 [NCIt concept]
- Keratin, Type II Cytoskeletal 7 [NCIt concept]
- Keratin, Type II Cytoskeletal 72 [NCIt concept]
- Keratin, Type II Cytoskeletal 8 [NCIt concept]
- Keratinocyte Growth Factor Therapy [NCIt concept]
- Keratography [NCIt concept]
- Ketamine [NCIt concept]
- Ketamine Hydrochloride [NCIt concept]
- Ketamine/Amitriptyline NP-H Cream [NCIt concept]
- Ketoconazole [NCIt concept]
- Ketogenic Diet [NCIt concept]
- Ketone [NCIt concept]
- Ketoprofen [NCIt concept]
- Ketorolac [NCIt concept]
- Ketorolac Tromethamine [NCIt concept]
- Keyhole Limpet Hemocyanin [NCIt concept]
- Keyhole Limpet Hemocyanin Antibody [NCIt concept]
- Ki-67 Positive Cells 1-10 Percent [NCIt concept]
- Ki-67 Positive Cells 15 Percent or Less [NCIt concept]
- Ki-67 Positive Cells 20 Percent or Less [NCIt concept]
- Ki-67 Positive Cells 3-55 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than 10 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than 20 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than 50 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 10 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 15 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 20 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 3 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 30 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 5 Percent [NCIt concept]
- Ki-67 Positive Cells Greater than or Equal to 50 Percent [NCIt concept]
- Ki-67 Positive Cells Less than 10 Percent [NCIt concept]
- Ki-67 Positive Cells Less than or Equal to 1 Percent [NCIt concept]
- Ki-67 Positive Cells Less than or Equal to 10 Percent [NCIt concept]
- Ki-67 Positive Cells Less than or Equal to 30 Percent [NCIt concept]
- Ki-67 Positive Cells Less than or Equal to 50 Percent [NCIt concept]
- Ki-67 Positive Cells Less than or Equal to 55 Percent [NCIt concept]
- Ki67 Cell Surface Expression Measurement [NCIt concept]
- Ki67 Measurement [NCIt concept]
- Kidney Biopsy [NCIt concept]
- Kidney Burkitt Lymphoma [NCIt concept]
- Kidney Carcinoma [NCIt concept]
- Kidney Diffuse Large B-Cell Lymphoma [NCIt concept]
- Kidney Injury Molecule-1 Measurement [NCIt concept]
- Kidney Neoplasm [NCIt concept]
- Kidney Radiation Therapy [NCIt concept]
- Kidney Transplant Recipient [NCIt concept]
- Kidney Transplantation [NCIt concept]
- Kidney-Associated Antigen 1 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 2DL1 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 2DL2 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 2DL3 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 2DS4 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 3DL1 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 3DL2 [NCIt concept]
- Killer Cell Immunoglobulin-Like Receptor 3DL3 [NCIt concept]
- Killer Cell Lectin-Like Receptor Subfamily B Member 1 [NCIt concept]
- Killer Cell Lectin-Like Receptor Subfamily G Member 1 [NCIt concept]
- Killer-Cell Immunoglobulin-Like Receptor [NCIt concept]
- Kinase Inhibitor Sensitivity [NCIt concept]
- Kinase Suppressor of Ras 1 [NCIt concept]
- Kinase Suppressor of Ras 2 [NCIt concept]
- Kinect-Enhanced Training for The-Optimal-Lymph-Flow [NCIt concept]
- Kinectin [NCIt concept]
- Kinesin-1 Heavy Chain [NCIt concept]
- Kinesin-Like Protein KIF11 [NCIt concept]
- Kinesin-Like Protein KIF18A [NCIt concept]
- Kinesin-Like Protein KIF20B [NCIt concept]
- Kinesin-Like Protein KIF23 [NCIt concept]
- Kinesin-Like Protein KIF2C [NCIt concept]
- Kinetochore Protein NDC80 Homolog [NCIt concept]
- Kinetochore Protein Nuf2 [NCIt concept]
- Kinetochore Scaffold 1 [NCIt concept]
- Kininogen-1 [NCIt concept]
- Kinome [NCIt concept]
- Kinome Response Profile [NCIt concept]
- Kit Ligand [NCIt concept]
- Kita-Kyushu Lung Cancer Antigen 1 [NCIt concept]
- Klotho [NCIt concept]
- Krabbe Disease [NCIt concept]
- Krueppel-Like Factor 4 [NCIt concept]
- Krueppel-Like Factor 6 [NCIt concept]
- Kunitz-Type Protease Inhibitor 1 [NCIt concept]
- Kv/Mv Imaging [NCIt concept]
- Kynurenine [NCIt concept]
- Kyphoplasty [NCIt concept]
- L Antigen Family Member 3 [NCIt concept]
- L-4-chlorokynurenine [NCIt concept]
- L-Arginine/Korean Ginseng/Ginkgo biloba/Damiana-Based Supplement [NCIt concept]
- L-Dopachrome Tautomerase [NCIt concept]
- L-Epicatechin [NCIt concept]
- L-Lactate Dehydrogenase A Chain [NCIt concept]
- L-Lysine [NCIt concept]
- L-Selectin [NCIt concept]
- L-Selenomethionine [NCIt concept]
- L-Type Amino Acid Transporter [NCIt concept]
- L-Tyrosine [NCIt concept]
- L-lysine/L-arginine-containing Amino Acid [NCIt concept]
- L-methylfolate [NCIt concept]
- L1CAM Gene [NCIt concept]
- L1CAM wt Allele [NCIt concept]
- L2 Acute Lymphoblastic Leukemia [NCIt concept]
- LAG-3-targeting Agent [NCIt concept]
- LAG3 Gene [NCIt concept]
- LAG3 Positive [NCIt concept]
- LAG3 wt Allele [NCIt concept]
- LAGE-1A Positive [NCIt concept]
- LAGE3 Gene [NCIt concept]
- LAGE3 wt Allele [NCIt concept]
- LAIR-2 Fusion Protein NC410 [NCIt concept]
- LAIR1 Gene [NCIt concept]
- LAIR1 wt Allele [NCIt concept]
- LALBA Gene [NCIt concept]
- LALBA wt Allele [NCIt concept]
- LAMP1 Gene [NCIt concept]
- LAMP1 wt Allele [NCIt concept]
- LAMP2 Gene [NCIt concept]
- LAMP2 wt Allele [NCIt concept]
- LAMP3 Gene [NCIt concept]
- LAMP3 wt Allele [NCIt concept]
- LAMTOR5 Gene [NCIt concept]
- LAMTOR5 wt Allele [NCIt concept]
- LAPTM4B Gene [NCIt concept]
- LAPTM4B wt Allele [NCIt concept]
- LASP1 Gene [NCIt concept]
- LASP1 wt Allele [NCIt concept]
- LASP1/MLL Fusion Gene [NCIt concept]
- LASP1/MLL Fusion Protein [NCIt concept]
- LATS1 Gene [NCIt concept]
- LATS1 Gene Mutation [NCIt concept]
- LATS1 wt Allele [NCIt concept]
- LATS2 Gene [NCIt concept]
- LATS2 Gene Mutation [NCIt concept]
- LATS2 wt Allele [NCIt concept]
- LBP Gene [NCIt concept]
- LBP wt Allele [NCIt concept]
- LCK Gene [NCIt concept]
- LCK Gene Mutation [NCIt concept]
- LCK wt Allele [NCIt concept]
- LCN2 Gene [NCIt concept]
- LCN2 wt Allele [NCIt concept]
- LCP1 Antibody [NCIt concept]
- LCP1 Gene [NCIt concept]
- LCP1 wt Allele [NCIt concept]
- LCP1/BCL6 Fusion Gene [NCIt concept]
- LDB2 Gene [NCIt concept]
- LDB2 wt Allele [NCIt concept]
- LDHA Gene [NCIt concept]
- LDHA wt Allele [NCIt concept]
- LDL-C Oxidation [NCIt concept]
- LDLR Chaperone MESD [NCIt concept]
- LDLR Gene [NCIt concept]
- LDLR wt Allele [NCIt concept]
- LED Therapy [NCIt concept]
- LEF1 Gene [NCIt concept]
- LEF1 wt Allele [NCIt concept]
- LEP Gene [NCIt concept]
- LEP wt Allele [NCIt concept]
- LEPR Gene [NCIt concept]
- LEPR wt Allele [NCIt concept]
- LEUTX Gene [NCIt concept]
- LEUTX wt Allele [NCIt concept]
- LGALS1 Gene [NCIt concept]
- LGALS1 wt Allele [NCIt concept]
- LGALS3 Antibody [NCIt concept]
- LGALS3 Gene [NCIt concept]
- LGALS3 wt Allele [NCIt concept]
- LGALS9 Gene [NCIt concept]
- LGALS9 wt Allele [NCIt concept]
- LGR5 Gene [NCIt concept]
- LGR5 Gene Mutation [NCIt concept]
- LGR5 wt Allele [NCIt concept]
- LGR6 Gene [NCIt concept]
- LGR6 wt Allele [NCIt concept]
- LHB Gene [NCIt concept]
- LHB wt Allele [NCIt concept]
- LHFPL Tetraspan Subfamily Member 6 Protein [NCIt concept]
- LHFPL6 Gene [NCIt concept]
- LHFPL6 wt Allele [NCIt concept]
- LHX3 Gene [NCIt concept]
- LHX3 wt Allele [NCIt concept]
- LHX4 Gene [NCIt concept]
- LHX4 wt Allele [NCIt concept]
- LHX4/IGHG1 Fusion Gene [NCIt concept]
- LIF Gene [NCIt concept]
- LIF wt Allele [NCIt concept]
- LIG1 Gene [NCIt concept]
- LIG1 wt Allele [NCIt concept]
- LIG3 Gene [NCIt concept]
- LIG3 Gene Mutation [NCIt concept]
- LIG3 wt Allele [NCIt concept]
- LIG4 Gene [NCIt concept]
- LIG4 Gene Mutation [NCIt concept]
- LIG4 wt Allele [NCIt concept]
- LILRB1 Gene [NCIt concept]
- LILRB1 wt Allele [NCIt concept]
- LILRB2 Gene [NCIt concept]
- LILRB2 wt Allele [NCIt concept]
- LILRB4 Gene [NCIt concept]
- LILRB4 wt Allele [NCIt concept]
- LILRB4-targeting Agent [NCIt concept]
- LIM Domain-Binding Protein 2 [NCIt concept]
- LIM Domain-Containing Protein Ajuba [NCIt concept]
- LIM and SH3 Domain Protein 1 [NCIt concept]
- LIM/Homeobox Protein LHX3 [NCIt concept]
- LIM/Homeobox Protein Lhx4 [NCIt concept]
- LIPC Gene [NCIt concept]
- LIPC wt Allele [NCIt concept]
- LMB-2 Immunotoxin [NCIt concept]
- LMNA Gene [NCIt concept]
- LMNA wt Allele [NCIt concept]
- LMO1 Gene [NCIt concept]
- LMO1 wt Allele [NCIt concept]
- LMO2 Gene [NCIt concept]
- LMO2 wt Allele [NCIt concept]
- LMP1/BARF1/EBNA1-specific Cytotoxic T-lymphocytes [NCIt concept]
- LMP7 Inhibitor M3258 [NCIt concept]
- LORETA Neurofeedback Training [NCIt concept]
- LORICRIN Gene [NCIt concept]
- LORICRIN wt Allele [NCIt concept]
- LOX Gene [NCIt concept]
- LOX wt Allele [NCIt concept]
- LOXL2 Gene [NCIt concept]
- LOXL2 wt Allele [NCIt concept]
- LPAR3 Gene [NCIt concept]
- LPAR3 wt Allele [NCIt concept]
- LPL Gene [NCIt concept]
- LPL wt Allele [NCIt concept]
- LPP Gene [NCIt concept]
- LPP wt Allele [NCIt concept]
- LPP/MLL Fusion Gene [NCIt concept]
- LPP/MLL Fusion Protein [NCIt concept]
- LRIG3 Gene [NCIt concept]
- LRIG3 wt Allele [NCIt concept]
- LRP1 Gene [NCIt concept]
- LRP1 wt Allele [NCIt concept]
- LRP1B Gene [NCIt concept]
- LRP1B wt Allele [NCIt concept]
- LRP2 Gene [NCIt concept]
- LRP2 wt Allele [NCIt concept]
- LRP4 Autoantibody [NCIt concept]
- LRP5 Antagonist BI 905681 [NCIt concept]
- LRP5 Gene [NCIt concept]
- LRP5 wt Allele [NCIt concept]
- LRP6 Gene [NCIt concept]
- LRP6 Gene Mutation [NCIt concept]
- LRP6 wt Allele [NCIt concept]
- LRRC15 Gene [NCIt concept]
- LRRC15 wt Allele [NCIt concept]
- LRRC19 Gene [NCIt concept]
- LRRC19 wt Allele [NCIt concept]
- LRRC32 Gene [NCIt concept]
- LRRC32 wt Allele [NCIt concept]
- LSD1 Inhibitor GSK2879552 [NCIt concept]
- LSM14A Gene [NCIt concept]
- LSM14A wt Allele [NCIt concept]
- LTA4H Gene [NCIt concept]
- LTA4H wt Allele [NCIt concept]
- LTB Gene [NCIt concept]
- LTB wt Allele [NCIt concept]
- LTBR Gene [NCIt concept]
- LTBR wt Allele [NCIt concept]
- LTF Gene [NCIt concept]
- LTF wt Allele [NCIt concept]
- LTK Gene [NCIt concept]
- LTK wt Allele [NCIt concept]
- LUM Gene [NCIt concept]
- LUM Imaging Device [NCIt concept]
- LUM Imaging System [NCIt concept]
- LUM wt Allele [NCIt concept]
- LY6E Gene [NCIt concept]
- LY6E wt Allele [NCIt concept]
- LY6K Gene [NCIt concept]
- LY6K wt Allele [NCIt concept]
- LY75 Gene [NCIt concept]
- LY75 Positive [NCIt concept]
- LY75 wt Allele [NCIt concept]
- LYL1 Gene [NCIt concept]
- LYL1 wt Allele [NCIt concept]
- LYN Gene [NCIt concept]
- LYN Gene Mutation [NCIt concept]
- LYN wt Allele [NCIt concept]
- LYPD3 Gene [NCIt concept]
- LYPD3 Positive [NCIt concept]
- LYPD3 wt Allele [NCIt concept]
- LYPLA1 Gene [NCIt concept]
- LYPLA1 wt Allele [NCIt concept]
- LYST Gene [NCIt concept]
- LYST Gene Mutation [NCIt concept]
- LYST wt Allele [NCIt concept]
- LYVE1 Gene [NCIt concept]
- LYVE1 wt Allele [NCIt concept]
- LZTR1 Gene [NCIt concept]
- LZTR1 Gene Mutation [NCIt concept]
- LZTR1 wt Allele [NCIt concept]
- LZTS1 Gene [NCIt concept]
- LZTS1 wt Allele [NCIt concept]
- Labetuzumab Govitecan [NCIt concept]
- Labia Majora Carcinoma [NCIt concept]
- Labia Minora Carcinoma [NCIt concept]
- Laboratory Biomarker Analysis [NCIt concept]
- Laboratory Procedure [NCIt concept]
- Laboratory Test Result [NCIt concept]
- Laboratory-Confirmed Human Monkeypox Infection [NCIt concept]
- Labyrinthin Peptide Vaccine LabVax 3(22)-23 [NCIt concept]
- Lack of Expression of PD-L1 [NCIt concept]
- Lacnotuzumab [NCIt concept]
- Lacosamide [NCIt concept]
- Lactadherin [NCIt concept]
- Lactate Dehydrogenase [NCIt concept]
- Lactate Dehydrogenase Isoenzyme 5 [NCIt concept]
- Lactobacillus [NCIt concept]
- Lactobacillus brevis CD2 Lozenge [NCIt concept]
- Lactobacillus plantarum 299v/Lactobacillus acidophilus/Bifidobacterium lactis Probiotic Supplement [NCIt concept]
- Lactobacillus plantarum strain 299 [NCIt concept]
- Lactobacillus plantarum strain 299v [NCIt concept]
- Lactobacillus rhamnosus GG [NCIt concept]
- Lactotransferrin [NCIt concept]
- Lactotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Lacutamab [NCIt concept]
- Ladiratuzumab Vedotin [NCIt concept]
- Lambert Eaton Myasthenic Syndrome [NCIt concept]
- Lamin B [NCIt concept]
- Lamin-A/C [NCIt concept]
- Lamina-Associated Polypeptide 2, Isoform Alpha [NCIt concept]
- Lamina-Associated Polypeptide 2, Isoforms Beta/Gamma [NCIt concept]
- Laminin [NCIt concept]
- Lamivudine [NCIt concept]
- Landogrozumab [NCIt concept]
- Lanerkitug [NCIt concept]
- Langerhans Cell [NCIt concept]
- Langerhans Cell Histiocytosis [NCIt concept]
- Lanreotide Acetate [NCIt concept]
- Lanreotide Long-Acting Aqueous Gel [NCIt concept]
- Laparoscopic Prostatectomy [NCIt concept]
- Laparoscopic Radical Prostatectomy [NCIt concept]
- Laparoscopic Surgery [NCIt concept]
- Laparoscopy [NCIt concept]
- Laparotomy [NCIt concept]
- Lapatinib Ditosylate [NCIt concept]
- Lapatinib/Letrozole Regimen [NCIt concept]
- Lapine T-Lymphocyte Immune Globulin [NCIt concept]
- Laprituximab Emtansine [NCIt concept]
- Lapuleucel-T [NCIt concept]
- Large B-Cell Lymphoma with 11q Aberration [NCIt concept]
- Large B-Cell Lymphoma with IRF4 Rearrangement [NCIt concept]
- Large Granular Lymphocyte [NCIt concept]
- Large Neutral Amino Acids Transporter Small Subunit 1 [NCIt concept]
- Large Neutral Amino Acids Transporter Small Subunit 2 [NCIt concept]
- Large Neutral Amino Acids Transporter Small Subunit 3 [NCIt concept]
- Large Neutral Amino Acids Transporter Small Subunit 4 [NCIt concept]
- Large-Scale State Transition [NCIt concept]
- Laromustine [NCIt concept]
- Laronidase [NCIt concept]
- Larotaxel [NCIt concept]
- Larotrectinib Sulfate [NCIt concept]
- Lartesertib [NCIt concept]
- Laryngeal Adenoid Cystic Carcinoma [NCIt concept]
- Laryngeal Adenosquamous Carcinoma [NCIt concept]
- Laryngeal Carcinoma [NCIt concept]
- Laryngeal Mask Airway [NCIt concept]
- Laryngeal Mucoepidermoid Carcinoma [NCIt concept]
- Laryngeal Papillomatosis [NCIt concept]
- Laryngeal Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Laryngeal Undifferentiated Carcinoma [NCIt concept]
- Laryngeal Verrucous Carcinoma [NCIt concept]
- Laryngopharyngectomy [NCIt concept]
- Laser Ablation [NCIt concept]
- Laser Doppler Imaging [NCIt concept]
- Laser Interstitial Thermal Therapy [NCIt concept]
- Laser Scanning Cytometry [NCIt concept]
- Laser Speckle Imaging [NCIt concept]
- Laser Surgery [NCIt concept]
- Laser Therapy [NCIt concept]
- Lasofoxifene [NCIt concept]
- Latent Membrane Protein 1 [NCIt concept]
- Latent Membrane Protein 1 Positive [NCIt concept]
- Latent Membrane Protein 2 [NCIt concept]
- Latent Nuclear Antigen [NCIt concept]
- Latent Nuclear Antigen Antibody [NCIt concept]
- Latent Nuclear Antigen Antibody Positive [NCIt concept]
- Lateral Flow Assay [NCIt concept]
- Latikafusp [NCIt concept]
- Lattice Stereotactic Body Radiation Therapy [NCIt concept]
- Lavage [NCIt concept]
- Lavender Oil [NCIt concept]
- Lawsonia inermis-based Supplement [NCIt concept]
- Laxative [NCIt concept]
- Lazertinib [NCIt concept]
- Lead Metal [NCIt concept]
- Lead Pb 203 VMT-a-NET [NCIt concept]
- Lead Pb 203-VMT01 [NCIt concept]
- Lead Pb 212 DOTAMTATE [NCIt concept]
- Lead Pb 212 TCMC-trastuzumab [NCIt concept]
- Lead Pb 212 VMT-a-NET [NCIt concept]
- Lead Pb 212-DOTAM-GRPR1 [NCIt concept]
- Lead Pb 212-VMT01 [NCIt concept]
- Lead Pb-207 [NCIt concept]
- Leaky Severe Combined Immunodeficiency [NCIt concept]
- Lebrikizumab [NCIt concept]
- Ledipasvir [NCIt concept]
- Lefitolimod [NCIt concept]
- Leflunomide [NCIt concept]
- Left Colectomy [NCIt concept]
- Left Ventricular Electromechanical Mapping [NCIt concept]
- Left-Sided Breast Carcinoma [NCIt concept]
- Leiomyoma [NCIt concept]
- Leiomyosarcoma [NCIt concept]
- Lemzoparlimab [NCIt concept]
- Lenalidomide [NCIt concept]
- Lenalidomide Analog KPG-121 [NCIt concept]
- Lenti-D/ABCD1-transduced Autologous Hematopoietic Stem Cells [NCIt concept]
- Lentigo Maligna Melanoma [NCIt concept]
- Lentiviral Vector Recipient [NCIt concept]
- Lentivirus Vector CCR5 shRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor Cells [NCIt concept]
- Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Progenitor Cells [NCIt concept]
- Lenumlostat [NCIt concept]
- Lenvatinib [NCIt concept]
- Lenvatinib Mesylate [NCIt concept]
- Lenzilumab [NCIt concept]
- Leptin [NCIt concept]
- Leptin Measurement [NCIt concept]
- Leptin Receptor [NCIt concept]
- Lerapolturev [NCIt concept]
- Leriglitazone [NCIt concept]
- Lerociclib [NCIt concept]
- Leronlimab [NCIt concept]
- Lestaurtinib [NCIt concept]
- Letaplimab [NCIt concept]
- Letetresgene Autoleucel [NCIt concept]
- Letolizumab [NCIt concept]
- Letrozole [NCIt concept]
- Letrozole/Palbociclib Regimen [NCIt concept]
- Letterer-Siwe Disease [NCIt concept]
- Leu-Enkephalin [NCIt concept]
- Leucine [NCIt concept]
- Leucine Zipper Putative Tumor Suppressor 1 [NCIt concept]
- Leucine-Rich Repeat Protein SHOC-2 [NCIt concept]
- Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 5 [NCIt concept]
- Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 6 [NCIt concept]
- Leucine-Rich Repeat-Containing Protein 15 [NCIt concept]
- Leucine-Rich Repeat-Containing Protein 19 [NCIt concept]
- Leucine-Rich Repeat-Containing Protein 32 [NCIt concept]
- Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 3 [NCIt concept]
- Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein Family [NCIt concept]
- Leucine-Zipper-Like Transcriptional Regulator 1 [NCIt concept]
- Leucovorin [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Leukapheresis [NCIt concept]
- Leukemia [NCIt concept]
- Leukemia Finding [NCIt concept]
- Leukemia Inhibitory Factor [NCIt concept]
- Leukemia in Remission [NCIt concept]
- Leukemic Blast Count [NCIt concept]
- Leukemic Hematopoietic Stem Cell [NCIt concept]
- Leukemic Infiltration of Brain [NCIt concept]
- Leukocyte [NCIt concept]
- Leukocyte Adhesion Deficiency Type 1 [NCIt concept]
- Leukocyte Antigen CD37 [NCIt concept]
- Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1 [NCIt concept]
- Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2 [NCIt concept]
- Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 4 [NCIt concept]
- Leukocyte Surface Antigen CD47 [NCIt concept]
- Leukocyte Therapy [NCIt concept]
- Leukocyte Tyrosine Kinase Receptor [NCIt concept]
- Leukocyte-Associated Immunoglobulin-Like Receptor 1 [NCIt concept]
- Leukosialin [NCIt concept]
- Leukotriene [NCIt concept]
- Leukotriene A-4 Hydrolase [NCIt concept]
- Leukotriene B4 [NCIt concept]
- Leukotriene D4 [NCIt concept]
- Leukotriene E4 [NCIt concept]
- Leukotriene Receptor Family [NCIt concept]
- Leuprolide [NCIt concept]
- Leuprolide Acetate [NCIt concept]
- Leuprolide Acetate for Injectable Suspension TOL2506 [NCIt concept]
- Levamisole Hydrochloride [NCIt concept]
- Levocarnitine [NCIt concept]
- Levocetirizine Dihydrochloride [NCIt concept]
- Levofloxacin [NCIt concept]
- Levoketoconazole [NCIt concept]
- Levoleucovorin [NCIt concept]
- Levonorgestrel [NCIt concept]
- Levonorgestrel-Releasing Intrauterine System [NCIt concept]
- Levorphanol [NCIt concept]
- Levothyroxine [NCIt concept]
- Levothyroxine Sodium [NCIt concept]
- Lewis Y Antigen [NCIt concept]
- Leydig Cell Tumor [NCIt concept]
- Li-Fraumeni Syndrome [NCIt concept]
- Lidocaine [NCIt concept]
- Lidocaine Hydrochloride [NCIt concept]
- Lidocaine Patch [NCIt concept]
- Lidocaine Topical [NCIt concept]
- Lidofenin [NCIt concept]
- Lifastuzumab Vedotin [NCIt concept]
- Life Review Therapy [NCIt concept]
- Lifestyle Counseling [NCIt concept]
- Lifestyle Therapy [NCIt concept]
- Lifileucel [NCIt concept]
- Lifirafenib [NCIt concept]
- Ligand Directed Degrader BMS-986460 [NCIt concept]
- Light Chain Cast Nephropathy [NCIt concept]
- Light Chain Deposition Disease [NCIt concept]
- Light Dosimetry [NCIt concept]
- Light-Scattering Spectroscopy [NCIt concept]
- Light-Stimulated Thermal Imaging [NCIt concept]
- Lignan [NCIt concept]
- Lilotomab [NCIt concept]
- Limantrafin [NCIt concept]
- Limb Cryocompression [NCIt concept]
- Limited Stage Lung Small Cell Carcinoma [NCIt concept]
- Limited Walking Ability [NCIt concept]
- Limits of Stability Test [NCIt concept]
- Limonene, (+)- [NCIt concept]
- Linaclotide [NCIt concept]
- Linaclotide Acetate [NCIt concept]
- Linavonkibart [NCIt concept]
- LincRNA [NCIt concept]
- Linear Array HPV Genotyping Test [NCIt concept]
- Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy [NCIt concept]
- Linezolid [NCIt concept]
- Linifanib [NCIt concept]
- Linoleic Acid [NCIt concept]
- Linoleyl Carbonate-Paclitaxel [NCIt concept]
- Linperlisib [NCIt concept]
- Linrodostat [NCIt concept]
- Linsitinib [NCIt concept]
- Lintuzumab [NCIt concept]
- Linvoseltamab [NCIt concept]
- Liothyronine Sodium [NCIt concept]
- Lip Basal Cell Carcinoma [NCIt concept]
- Lip Carcinoma [NCIt concept]
- Lip and Oral Cavity Carcinoma [NCIt concept]
- Lip and Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Lipegfilgrastim [NCIt concept]
- Lipemic [NCIt concept]
- Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1 [NCIt concept]
- Lipid Hydroperoxide [NCIt concept]
- Lipid Measurement [NCIt concept]
- Lipid Metabolism Disorder [NCIt concept]
- Lipid Nanoparticle Encapsulated MYC-targeting mRNA-based Agent OTX-2002 [NCIt concept]
- Lipid Nanoparticle Encapsulated OX40L mRNA-2416 [NCIt concept]
- Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 JCXH-211 [NCIt concept]
- Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 STX-001 [NCIt concept]
- Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191 [NCIt concept]
- Lipid Nanoparticle Encapsulating Beta-catenin siRNA ALN-BCAT [NCIt concept]
- Lipid Nanoparticle Encapsulating hAQP1 Circular RNA RXRG001 [NCIt concept]
- Lipid Nanoparticle Encapsulating mRNA Encoding Cas9 Protein and TTR-targeting Single Guide RNA NTLA-2001 [NCIt concept]
- Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752 [NCIt concept]
- Lipid Peroxidation [NCIt concept]
- Lipid R1 MRI [NCIt concept]
- Lipocalin Family Protein [NCIt concept]
- Lipoma-Preferred Partner [NCIt concept]
- Lipopolysaccharide [NCIt concept]
- Lipopolysaccharide-Binding Protein [NCIt concept]
- Lipoprotein Lipase [NCIt concept]
- Liposarcoma [NCIt concept]
- Liposomal Alpha Galactosylceramide [NCIt concept]
- Liposomal Amphotericin B [NCIt concept]
- Liposomal Bupivacaine [NCIt concept]
- Liposomal CMTR2 Inhibitor AT-1965 [NCIt concept]
- Liposomal Chk1 Inhibitor SMP-3124 SMP-3124LP [NCIt concept]
- Liposomal Curcumin [NCIt concept]
- Liposomal Cytarabine [NCIt concept]
- Liposomal Daunorubicin Citrate [NCIt concept]
- Liposomal Docetaxel [NCIt concept]
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 [NCIt concept]
- Liposomal MnSOD Plasmid [NCIt concept]
- Liposomal Topotecan FF-10850 [NCIt concept]
- Liposomal Vinorelbine Tartrate [NCIt concept]
- Liposomal iNKT Agonist PORT-2 [NCIt concept]
- Liposomal-based Cream Base [NCIt concept]
- Liposome-Encapsulated Doxorubicin Citrate [NCIt concept]
- Liposome-encapsulated Daunorubicin-Cytarabine [NCIt concept]
- Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94 [NCIt concept]
- Liposome-encapsulated miR-34 Mimic MRX34 [NCIt concept]
- Lipoteichoic Acid [NCIt concept]
- Lipoxin A4 [NCIt concept]
- Liprin-Beta-1 [NCIt concept]
- Liquid Chromatography [NCIt concept]
- Liquid Embolization [NCIt concept]
- Lirafugratinib [NCIt concept]
- Liraglutide [NCIt concept]
- Lirametostat [NCIt concept]
- Lirilumab [NCIt concept]
- Lisaftoclax [NCIt concept]
- Lisavanbulin [NCIt concept]
- Lisch Nodule [NCIt concept]
- Lisdexamfetamine Dimesylate [NCIt concept]
- Lisinopril [NCIt concept]
- Lisocabtagene Maraleucel [NCIt concept]
- Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142 [NCIt concept]
- Listeria monocytogenes-LLO-Prostate Cancer Neoantigens Vaccine ADXS-504 [NCIt concept]
- Lithium Carbonate [NCIt concept]
- Lithotripsy [NCIt concept]
- Litronesib [NCIt concept]
- Live Freeze-Dried Lactic Acid Bacteria Probiotic [NCIt concept]
- Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207 [NCIt concept]
- Liver Adenosquamous Carcinoma [NCIt concept]
- Liver Biopsy [NCIt concept]
- Liver Carboxylesterase 1 [NCIt concept]
- Liver Carcinoma [NCIt concept]
- Liver Carcinosarcoma [NCIt concept]
- Liver Embryonal Sarcoma [NCIt concept]
- Liver Fibrosis [NCIt concept]
- Liver Lesion [NCIt concept]
- Liver Neoplasm [NCIt concept]
- Liver Neuroendocrine Carcinoma [NCIt concept]
- Liver Radiation Therapy [NCIt concept]
- Liver Surgery Patient [NCIt concept]
- Liver Transplantation [NCIt concept]
- Liver Ultrasonographic Elastography [NCIt concept]
- Liver Undifferentiated Carcinoma [NCIt concept]
- Liver X Receptor-Like Family [NCIt concept]
- Liver and Intrahepatic Bile Duct Disorder [NCIt concept]
- Liver-directed Therapy [NCIt concept]
- Living Healthy Together [NCIt concept]
- Livmoniplimab [NCIt concept]
- Lm-tLLO-neoantigens Vaccine ADXS-NEO [NCIt concept]
- LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine OST31-164 [NCIt concept]
- Lobectomy [NCIt concept]
- Lobectomy Patient [NCIt concept]
- Local Consolidation Therapy [NCIt concept]
- Local Skin Heating [NCIt concept]
- Local Therapy [NCIt concept]
- Localization [NCIt concept]
- Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Localized Anal Carcinoma [NCIt concept]
- Localized Anal Margin Carcinoma [NCIt concept]
- Localized Anaplastic Large Cell Lymphoma [NCIt concept]
- Localized Bladder Carcinoma [NCIt concept]
- Localized Breast Carcinoma [NCIt concept]
- Localized Childhood Soft Tissue Sarcoma [NCIt concept]
- Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Localized Colorectal Carcinoma [NCIt concept]
- Localized Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Localized Esophageal Carcinoma [NCIt concept]
- Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Localized Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Localized Gallbladder Carcinoma [NCIt concept]
- Localized Gastric Adenocarcinoma [NCIt concept]
- Localized Head and Neck Carcinoma [NCIt concept]
- Localized High Grade Osteosarcoma of the Extremity [NCIt concept]
- Localized Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Localized Kidney Carcinoma [NCIt concept]
- Localized Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Localized Lip and Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Localized Lung Carcinoma [NCIt concept]
- Localized Malignant Digestive System Neoplasm [NCIt concept]
- Localized Malignant Female Reproductive System Neoplasm [NCIt concept]
- Localized Malignant Head and Neck Neoplasm [NCIt concept]
- Localized Malignant Kidney Neoplasm [NCIt concept]
- Localized Malignant Mesothelioma [NCIt concept]
- Localized Malignant Pancreatic Neoplasm [NCIt concept]
- Localized Malignant Solid Neoplasm [NCIt concept]
- Localized Malignant Supratentorial Neoplasm [NCIt concept]
- Localized Malignant Thoracic Neoplasm [NCIt concept]
- Localized Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Localized Myxofibrosarcoma [NCIt concept]
- Localized Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Localized Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Localized Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Localized Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Localized Osteosarcoma [NCIt concept]
- Localized Pancreatic Adenocarcinoma [NCIt concept]
- Localized Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Localized Parathyroid Gland Carcinoma [NCIt concept]
- Localized Prostate Adenocarcinoma [NCIt concept]
- Localized Prostate Carcinoma [NCIt concept]
- Localized Rectal Adenocarcinoma [NCIt concept]
- Localized Renal Cell Carcinoma [NCIt concept]
- Localized Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Localized Resectable Adult Liver Carcinoma [NCIt concept]
- Localized Resectable Neuroblastoma [NCIt concept]
- Localized Scleroderma [NCIt concept]
- Localized Skin Angiosarcoma [NCIt concept]
- Localized Soft Tissue Sarcoma [NCIt concept]
- Localized Triple-Negative Breast Carcinoma [NCIt concept]
- Localized Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Localized Unresectable Adult Hepatocellular Carcinoma [NCIt concept]
- Localized Unresectable Adult Liver Carcinoma [NCIt concept]
- Localized Unresectable Neuroblastoma [NCIt concept]
- Localized Uveal Melanoma [NCIt concept]
- Localized Vibration Therapy [NCIt concept]
- Locally Advanced Adenoid Cystic Carcinoma [NCIt concept]
- Locally Advanced Adrenal Cortical Carcinoma [NCIt concept]
- Locally Advanced Adrenal Gland Pheochromocytoma [NCIt concept]
- Locally Advanced Alveolar Soft Part Sarcoma [NCIt concept]
- Locally Advanced Ampulla of Vater Carcinoma [NCIt concept]
- Locally Advanced Anal Carcinoma [NCIt concept]
- Locally Advanced Angiosarcoma [NCIt concept]
- Locally Advanced Appendix Adenocarcinoma [NCIt concept]
- Locally Advanced Basal Cell Carcinoma [NCIt concept]
- Locally Advanced Bile Duct Carcinoma [NCIt concept]
- Locally Advanced Biliary Tract Carcinoma [NCIt concept]
- Locally Advanced Bladder Adenocarcinoma [NCIt concept]
- Locally Advanced Bladder Carcinoma [NCIt concept]
- Locally Advanced Bladder Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Bladder Urothelial Carcinoma [NCIt concept]
- Locally Advanced Bone Sarcoma [NCIt concept]
- Locally Advanced Breast Adenocarcinoma [NCIt concept]
- Locally Advanced Breast Carcinoma [NCIt concept]
- Locally Advanced Castration-Resistant Prostate Carcinoma [NCIt concept]
- Locally Advanced Cervical Adenosquamous Carcinoma [NCIt concept]
- Locally Advanced Cervical Carcinoma [NCIt concept]
- Locally Advanced Cervical Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Cholangiocarcinoma [NCIt concept]
- Locally Advanced Chondrosarcoma [NCIt concept]
- Locally Advanced Chordoma [NCIt concept]
- Locally Advanced Chromophobe Renal Cell Carcinoma [NCIt concept]
- Locally Advanced Clear Cell Renal Cell Carcinoma [NCIt concept]
- Locally Advanced Colon Adenocarcinoma [NCIt concept]
- Locally Advanced Colon Carcinoma [NCIt concept]
- Locally Advanced Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Locally Advanced Cutaneous Melanoma [NCIt concept]
- Locally Advanced Dedifferentiated Liposarcoma [NCIt concept]
- Locally Advanced Desmoplastic Small Round Cell Tumor [NCIt concept]
- Locally Advanced Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Locally Advanced Digestive System Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Locally Advanced Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Locally Advanced Digestive System Neuroendocrine Tumor G2 [NCIt concept]
- Locally Advanced Digestive System Neuroendocrine Tumor G3 [NCIt concept]
- Locally Advanced Distal Bile Duct Carcinoma [NCIt concept]
- Locally Advanced Distal Cholangiocarcinoma [NCIt concept]
- Locally Advanced Distal Esophagus Adenocarcinoma [NCIt concept]
- Locally Advanced Endometrial Carcinoma [NCIt concept]
- Locally Advanced Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Locally Advanced Epithelioid Hemangioendothelioma [NCIt concept]
- Locally Advanced Epithelioid Sarcoma [NCIt concept]
- Locally Advanced Esophageal Adenocarcinoma [NCIt concept]
- Locally Advanced Esophageal Carcinoma [NCIt concept]
- Locally Advanced Esophageal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Ewing Sarcoma [NCIt concept]
- Locally Advanced Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Locally Advanced Extrahepatic Cholangiocarcinoma [NCIt concept]
- Locally Advanced Extraskeletal Myxoid Chondrosarcoma [NCIt concept]
- Locally Advanced Fallopian Tube Carcinoma [NCIt concept]
- Locally Advanced Gallbladder Carcinoma [NCIt concept]
- Locally Advanced Gastric Adenocarcinoma [NCIt concept]
- Locally Advanced Gastric Carcinoma [NCIt concept]
- Locally Advanced Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Locally Advanced Gastroesophageal Junction Carcinoma [NCIt concept]
- Locally Advanced Gastrointestinal Stromal Tumor [NCIt concept]
- Locally Advanced Glioblastoma [NCIt concept]
- Locally Advanced Glioma [NCIt concept]
- Locally Advanced HER2-Low Breast Carcinoma [NCIt concept]
- Locally Advanced HER2-Negative Breast Carcinoma [NCIt concept]
- Locally Advanced HER2-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Hepatocellular Carcinoma [NCIt concept]
- Locally Advanced Hepatopancreatobiliary Carcinoma [NCIt concept]
- Locally Advanced High Grade Sarcoma [NCIt concept]
- Locally Advanced Hindgut Neuroendocrine Tumor [NCIt concept]
- Locally Advanced Hypopharyngeal Carcinoma [NCIt concept]
- Locally Advanced Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Intrahepatic Cholangiocarcinoma [NCIt concept]
- Locally Advanced Kidney Medullary Carcinoma [NCIt concept]
- Locally Advanced Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Laryngeal Carcinoma [NCIt concept]
- Locally Advanced Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Leiomyosarcoma [NCIt concept]
- Locally Advanced Lip and Oral Cavity Carcinoma [NCIt concept]
- Locally Advanced Liposarcoma [NCIt concept]
- Locally Advanced Liver Carcinoma [NCIt concept]
- Locally Advanced Lung Adenocarcinoma [NCIt concept]
- Locally Advanced Lung Adenosquamous Carcinoma [NCIt concept]
- Locally Advanced Lung Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Lung Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Lung Neuroendocrine Neoplasm [NCIt concept]
- Locally Advanced Lung Non-Small Cell Carcinoma [NCIt concept]
- Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Locally Advanced Lung Small Cell Carcinoma [NCIt concept]
- Locally Advanced Lung Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Lymphoma [NCIt concept]
- Locally Advanced Malignant Digestive System Neoplasm [NCIt concept]
- Locally Advanced Malignant Female Reproductive System Neoplasm [NCIt concept]
- Locally Advanced Malignant Glomus Tumor [NCIt concept]
- Locally Advanced Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Locally Advanced Malignant Solid Neoplasm [NCIt concept]
- Locally Advanced Melanoma [NCIt concept]
- Locally Advanced Merkel Cell Carcinoma [NCIt concept]
- Locally Advanced Microsatellite Stable Colon Carcinoma [NCIt concept]
- Locally Advanced Microsatellite Stable Colorectal Carcinoma [NCIt concept]
- Locally Advanced Midgut Neuroendocrine Tumor [NCIt concept]
- Locally Advanced Mucosal Melanoma [NCIt concept]
- Locally Advanced Myxofibrosarcoma [NCIt concept]
- Locally Advanced Myxoid Liposarcoma [NCIt concept]
- Locally Advanced Nasal Cavity Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Non-Muscle Invasive Bladder Carcinoma [NCIt concept]
- Locally Advanced Ocular Melanoma [NCIt concept]
- Locally Advanced Olfactory Neuroblastoma [NCIt concept]
- Locally Advanced Oral Cavity Carcinoma [NCIt concept]
- Locally Advanced Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Orbital Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Oropharyngeal Carcinoma [NCIt concept]
- Locally Advanced Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Oropharyngeal Undifferentiated Carcinoma [NCIt concept]
- Locally Advanced Osteosarcoma [NCIt concept]
- Locally Advanced Ovarian Carcinoma [NCIt concept]
- Locally Advanced Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Locally Advanced Ovarian Serous Adenocarcinoma [NCIt concept]
- Locally Advanced Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Locally Advanced Pancreatic Adenocarcinoma [NCIt concept]
- Locally Advanced Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Locally Advanced Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Pancreatic Neuroendocrine Tumor [NCIt concept]
- Locally Advanced Pancreatic Neuroendocrine Tumor G3 [NCIt concept]
- Locally Advanced Pancreatobiliary Carcinoma [NCIt concept]
- Locally Advanced Papillary Renal Cell Carcinoma [NCIt concept]
- Locally Advanced Paraganglioma [NCIt concept]
- Locally Advanced Paranasal Sinus Carcinoma [NCIt concept]
- Locally Advanced Paranasal Sinus Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Parathyroid Gland Carcinoma [NCIt concept]
- Locally Advanced Penile Carcinoma [NCIt concept]
- Locally Advanced Penile Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Periorbital Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Pharyngeal Carcinoma [NCIt concept]
- Locally Advanced Pituitary Neuroendocrine Tumor [NCIt concept]
- Locally Advanced Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Locally Advanced Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Locally Advanced Pleomorphic Liposarcoma [NCIt concept]
- Locally Advanced Pleural Malignant Mesothelioma [NCIt concept]
- Locally Advanced Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Locally Advanced Primary Malignant Brain Neoplasm [NCIt concept]
- Locally Advanced Primary Malignant Central Nervous System Neoplasm [NCIt concept]
- Locally Advanced Primary Peritoneal Carcinoma [NCIt concept]
- Locally Advanced Progesterone Receptor-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Prostate Carcinoma [NCIt concept]
- Locally Advanced Prostate Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Rectal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Renal Cell Carcinoma [NCIt concept]
- Locally Advanced Renal Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Locally Advanced Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Locally Advanced Rhabdomyosarcoma [NCIt concept]
- Locally Advanced Round Cell Liposarcoma [NCIt concept]
- Locally Advanced Salivary Gland Carcinoma [NCIt concept]
- Locally Advanced Sarcomatoid Renal Cell Carcinoma [NCIt concept]
- Locally Advanced Sinonasal Carcinoma [NCIt concept]
- Locally Advanced Sinonasal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Small Intestinal Adenocarcinoma [NCIt concept]
- Locally Advanced Small Intestinal Carcinoma [NCIt concept]
- Locally Advanced Soft Tissue Sarcoma [NCIt concept]
- Locally Advanced Soft Tissue Sarcoma, Excluding Liposarcoma [NCIt concept]
- Locally Advanced Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Squamous Cell Carcinoma of Unknown Primary [NCIt concept]
- Locally Advanced Synovial Sarcoma [NCIt concept]
- Locally Advanced Thymus Carcinoma [NCIt concept]
- Locally Advanced Thyroid Gland Anaplastic Carcinoma [NCIt concept]
- Locally Advanced Thyroid Gland Carcinoma [NCIt concept]
- Locally Advanced Thyroid Gland Follicular Carcinoma [NCIt concept]
- Locally Advanced Thyroid Gland Medullary Carcinoma [NCIt concept]
- Locally Advanced Thyroid Gland Oncocytic Carcinoma [NCIt concept]
- Locally Advanced Thyroid Gland Papillary Carcinoma [NCIt concept]
- Locally Advanced Transitional Cell Carcinoma [NCIt concept]
- Locally Advanced Triple-Negative Breast Carcinoma [NCIt concept]
- Locally Advanced Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Locally Advanced Unresectable Acral Melanoma [NCIt concept]
- Locally Advanced Unresectable Angiosarcoma [NCIt concept]
- Locally Advanced Unresectable Basal Cell Carcinoma [NCIt concept]
- Locally Advanced Unresectable Bone Sarcoma [NCIt concept]
- Locally Advanced Unresectable Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Breast Ductal Carcinoma [NCIt concept]
- Locally Advanced Unresectable Breast Lobular Carcinoma [NCIt concept]
- Locally Advanced Unresectable Cholangiocarcinoma [NCIt concept]
- Locally Advanced Unresectable Clear Cell Renal Cell Carcinoma [NCIt concept]
- Locally Advanced Unresectable Colon Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Colorectal Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Colorectal Carcinoma [NCIt concept]
- Locally Advanced Unresectable Conjunctival Melanoma [NCIt concept]
- Locally Advanced Unresectable Cutaneous Melanoma [NCIt concept]
- Locally Advanced Unresectable Digestive System Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Locally Advanced Unresectable Endometrial Carcinoma [NCIt concept]
- Locally Advanced Unresectable Esophageal Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma [NCIt concept]
- Locally Advanced Unresectable Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Fallopian Tube Carcinoma [NCIt concept]
- Locally Advanced Unresectable Gallbladder Carcinoma [NCIt concept]
- Locally Advanced Unresectable Gastric Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable HER2-Negative BRCA-Associated Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable HER2-Negative Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable HER2-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Hepatocellular Carcinoma [NCIt concept]
- Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Lung Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Lung Non-Small Cell Carcinoma [NCIt concept]
- Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Locally Advanced Unresectable Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Locally Advanced Unresectable Malignant PEComa [NCIt concept]
- Locally Advanced Unresectable Malignant Solid Neoplasm [NCIt concept]
- Locally Advanced Unresectable Mucosal Melanoma [NCIt concept]
- Locally Advanced Unresectable Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Pancreatic Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Primary Central Chondrosarcoma [NCIt concept]
- Locally Advanced Unresectable Primary Peritoneal Carcinoma [NCIt concept]
- Locally Advanced Unresectable Rectal Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Soft Tissue Sarcoma [NCIt concept]
- Locally Advanced Unresectable Triple-Negative Breast Carcinoma [NCIt concept]
- Locally Advanced Unresectable Urothelial Carcinoma [NCIt concept]
- Locally Advanced Unresectable Uveal Melanoma [NCIt concept]
- Locally Advanced Ureter Urothelial Carcinoma [NCIt concept]
- Locally Advanced Urethral Carcinoma [NCIt concept]
- Locally Advanced Urethral Urothelial Carcinoma [NCIt concept]
- Locally Advanced Urothelial Carcinoma [NCIt concept]
- Locally Advanced Uterine Corpus Leiomyosarcoma [NCIt concept]
- Locally Advanced Uveal Melanoma [NCIt concept]
- Locally Advanced Vaginal Carcinoma [NCIt concept]
- Locally Advanced Vulvar Carcinoma [NCIt concept]
- Locally Invasive Desmoid-Type Fibromatosis [NCIt concept]
- Locally Recurrent Anal Canal Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Biliary Tract Carcinoma [NCIt concept]
- Locally Recurrent Breast Carcinoma [NCIt concept]
- Locally Recurrent Cervical Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Chordoma [NCIt concept]
- Locally Recurrent Clear Cell Renal Cell Carcinoma [NCIt concept]
- Locally Recurrent Colorectal Carcinoma [NCIt concept]
- Locally Recurrent Endometrial Carcinoma [NCIt concept]
- Locally Recurrent Esophageal Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Fallopian Tube Carcinoma [NCIt concept]
- Locally Recurrent Gastric Carcinoma [NCIt concept]
- Locally Recurrent Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Lung Non-Small Cell Carcinoma [NCIt concept]
- Locally Recurrent Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Locally Recurrent Malignant Solid Neoplasm [NCIt concept]
- Locally Recurrent Merkel Cell Carcinoma [NCIt concept]
- Locally Recurrent Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Ovarian Carcinoma [NCIt concept]
- Locally Recurrent Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Locally Recurrent Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Locally Recurrent Primary Peritoneal Carcinoma [NCIt concept]
- Locally Recurrent Prostate Carcinoma [NCIt concept]
- Locally Recurrent Rectal Carcinoma [NCIt concept]
- Locally Recurrent Retroperitoneal Sarcoma [NCIt concept]
- Locally Recurrent Skin Squamous Cell Carcinoma [NCIt concept]
- Locally Recurrent Triple-Negative Breast Carcinoma [NCIt concept]
- Locally Recurrent Unresectable Breast Carcinoma [NCIt concept]
- Locally Recurrent Urothelial Carcinoma [NCIt concept]
- Locally Recurrent Uterine Corpus Leiomyosarcoma [NCIt concept]
- Locnartecan [NCIt concept]
- Locus [NCIt concept]
- Lodapolimab [NCIt concept]
- Lomonitinib [NCIt concept]
- Lomustine [NCIt concept]
- Lonafarnib [NCIt concept]
- Loncastuximab Tesirine [NCIt concept]
- Long Course Chemoradiotherapy [NCIt concept]
- Long Ensemble Angular-Coherence Doppler Ultrasound [NCIt concept]
- Long Interspersed Element [NCIt concept]
- Long Interspersed Nucleotide Element-1 [NCIt concept]
- Long Peptide Vaccine 7 [NCIt concept]
- Long-Chain-Fatty-Acid-CoA Ligase 3 [NCIt concept]
- Long-Chain-Fatty-Acid-CoA Ligase 6 [NCIt concept]
- Long-Term Effects Secondary to Cancer Therapy [NCIt concept]
- Long-Term Effects Secondary to Cancer Therapy in Adults [NCIt concept]
- Long-Term Effects Secondary to Cancer Therapy in Children [NCIt concept]
- Long-Term Screening [NCIt concept]
- Long-acting Nicotine Replacement Therapy [NCIt concept]
- Long-acting Recombinant Erwinia asparaginase JZP-341 [NCIt concept]
- Long-acting Release Pasireotide [NCIt concept]
- Long-term Follow-up [NCIt concept]
- Loop Electrosurgical Excision [NCIt concept]
- Loperamide [NCIt concept]
- Lopinavir [NCIt concept]
- Lopinavir/Ritonavir [NCIt concept]
- Lorazepam [NCIt concept]
- Loricrin [NCIt concept]
- Lorigerlimab [NCIt concept]
- Lorlatinib [NCIt concept]
- Lorpucitinib [NCIt concept]
- Lorukafusp alfa [NCIt concept]
- Lorvotuzumab Mertansine [NCIt concept]
- Losartan [NCIt concept]
- Losartan Potassium [NCIt concept]
- Losatuxizumab Vedotin [NCIt concept]
- Loss of BRG1 Protein Expression [NCIt concept]
- Loss of Chromosome 11 [NCIt concept]
- Loss of Chromosome 11q [NCIt concept]
- Loss of Chromosome 12p [NCIt concept]
- Loss of Chromosome 13q [NCIt concept]
- Loss of Chromosome 14q [NCIt concept]
- Loss of Chromosome 17 [NCIt concept]
- Loss of Chromosome 17p [NCIt concept]
- Loss of Chromosome 1p [NCIt concept]
- Loss of Chromosome 3 [NCIt concept]
- Loss of Chromosome 3p [NCIt concept]
- Loss of Chromosome 3q [NCIt concept]
- Loss of Chromosome 4p [NCIt concept]
- Loss of Chromosome 5 [NCIt concept]
- Loss of Chromosome 5q [NCIt concept]
- Loss of Chromosome 6 [NCIt concept]
- Loss of Chromosome 6q [NCIt concept]
- Loss of Chromosome 7 [NCIt concept]
- Loss of Chromosome 7q [NCIt concept]
- Loss of Chromosome 9q [NCIt concept]
- Loss of EPCAM Expression [NCIt concept]
- Loss of FH Expression [NCIt concept]
- Loss of Heterozygosity [NCIt concept]
- Loss of Heterozygosity Analysis [NCIt concept]
- Loss of INI 1 Protein Expression [NCIt concept]
- Loss of MLH1 Expression [NCIt concept]
- Loss of MSH2 Expression [NCIt concept]
- Loss of MSH3 Expression [NCIt concept]
- Loss of MSH6 Expression [NCIt concept]
- Loss of Merlin Expression [NCIt concept]
- Loss of PMS2 Expression [NCIt concept]
- Loss of SDH Expression [NCIt concept]
- Loss of Serine-Protein Kinase ATM Expression [NCIt concept]
- Loss, Grief, and Bereavement [NCIt concept]
- Lottery [NCIt concept]
- Lovastatin [NCIt concept]
- Lovotibeglogene Autotemcel [NCIt concept]
- Low ADAMTS13 Activity [NCIt concept]
- Low Affinity Immunoglobulin Epsilon Fc Receptor [NCIt concept]
- Low Affinity Immunoglobulin Gamma Fc Region Receptor II-A [NCIt concept]
- Low Affinity Immunoglobulin Gamma Fc Region Receptor II-B [NCIt concept]
- Low Affinity Immunoglobulin Gamma Fc Region Receptor II-C [NCIt concept]
- Low Affinity Immunoglobulin Gamma Fc Region Receptor III-A [NCIt concept]
- Low Affinity Immunoglobulin Gamma Fc Region Receptor III-B [NCIt concept]
- Low Anterior Resection [NCIt concept]
- Low Anterior Resection Syndrome [NCIt concept]
- Low Carbohydrate High Fat Diet [NCIt concept]
- Low Density Array Gene Signature [NCIt concept]
- Low Density Lipoprotein [NCIt concept]
- Low Density Lipoprotein Cholesterol Measurement [NCIt concept]
- Low Dose Computed Tomography of the Chest [NCIt concept]
- Low Field Strength Magnetic Resonance Imaging [NCIt concept]
- Low Glutathione Level [NCIt concept]
- Low Grade Cervical Squamous Intraepithelial Neoplasia [NCIt concept]
- Low Grade Dysplasia in Barrett Esophagus [NCIt concept]
- Low Grade Dysplasia in Ulcerative Colitis [NCIt concept]
- Low Grade Glioma [NCIt concept]
- Low Grade Squamous Intraepithelial Neoplasia [NCIt concept]
- Low Intensity Vibration Therapy [NCIt concept]
- Low Molecular Weight Cyclin E [NCIt concept]
- Low Molecular Weight Heparin [NCIt concept]
- Low Neoplasm Polygenic Risk Score [NCIt concept]
- Low Nicotine Content Cigarette [NCIt concept]
- Low Risk Myelodysplastic Syndrome [NCIt concept]
- Low-CSD Melanoma, Superficial Spreading Melanoma Subtype [NCIt concept]
- Low-Density Lipoprotein Receptor [NCIt concept]
- Low-Density Lipoprotein Receptor-Related Protein 1B [NCIt concept]
- Low-Density Lipoprotein Receptor-Related Protein 2 [NCIt concept]
- Low-Density Lipoprotein Receptor-Related Protein 5 [NCIt concept]
- Low-Density Lipoprotein Receptor-Related Protein 6 [NCIt concept]
- Low-Dose Aspirin [NCIt concept]
- Low-Dose-Rate Vaginal Cuff Brachytherapy [NCIt concept]
- Low-Frequency Microsatellite Instability [NCIt concept]
- Low-LET Cobalt-60 Gamma Ray Therapy [NCIt concept]
- Low-LET Electron Therapy [NCIt concept]
- Low-LET Photon Therapy [NCIt concept]
- Low-dose Cytarabine Regimen [NCIt concept]
- Lower Alveolar Ridge Squamous Cell Carcinoma [NCIt concept]
- Lubricant [NCIt concept]
- Lucanthone [NCIt concept]
- Lucatumumab [NCIt concept]
- Lucicebtide [NCIt concept]
- Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8 [NCIt concept]
- Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8 [NCIt concept]
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 [NCIt concept]
- Lugol's Solution [NCIt concept]
- Lumbar Spinal Stenosis [NCIt concept]
- Lumbar Spine Neoplasm [NCIt concept]
- Lumican [NCIt concept]
- Luminal A Breast Carcinoma [NCIt concept]
- Luminal Androgen Receptor Breast Carcinoma [NCIt concept]
- Luminal Androgen Receptor Finding [NCIt concept]
- Luminespib [NCIt concept]
- Lumpectomy [NCIt concept]
- Lumpectomy Patient [NCIt concept]
- Lunbotinib [NCIt concept]
- Lung Adenocarcinoma [NCIt concept]
- Lung Adenocarcinoma In Situ [NCIt concept]
- Lung Adenoid Cystic Carcinoma [NCIt concept]
- Lung Adenosquamous Carcinoma [NCIt concept]
- Lung Anaplastic Large Cell Lymphoma [NCIt concept]
- Lung Basaloid Squamous Cell Carcinoma [NCIt concept]
- Lung Carcinoma [NCIt concept]
- Lung Cyst [NCIt concept]
- Lung Disorder [NCIt concept]
- Lung Epithelial-Myoepithelial Carcinoma [NCIt concept]
- Lung Hilum Carcinoma [NCIt concept]
- Lung Injury [NCIt concept]
- Lung Large Cell Carcinoma [NCIt concept]
- Lung Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Lung Lesion [NCIt concept]
- Lung Mucoepidermoid Carcinoma [NCIt concept]
- Lung Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Lung Neoplasm [NCIt concept]
- Lung Neuroendocrine Tumor [NCIt concept]
- Lung Non-Small Cell Carcinoma [NCIt concept]
- Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Lung Osteosarcoma [NCIt concept]
- Lung Papillary Adenocarcinoma [NCIt concept]
- Lung Radiation Therapy [NCIt concept]
- Lung Rhabdomyosarcoma [NCIt concept]
- Lung Sarcoma [NCIt concept]
- Lung Secretory Carcinoma [NCIt concept]
- Lung Small Cell Carcinoma [NCIt concept]
- Lung Spindle Cell Carcinoma [NCIt concept]
- Lung Squamous Cell Carcinoma [NCIt concept]
- Lung Squamous Cell Carcinoma In Situ [NCIt concept]
- Lunresertib [NCIt concept]
- Lurbinectedin [NCIt concept]
- Luspatercept [NCIt concept]
- Lutadenovec Autogene [NCIt concept]
- Lutein [NCIt concept]
- Luteinizing Hormone [NCIt concept]
- Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1 [NCIt concept]
- Lutetium Lu 177 DOTA-N3-CTT1403 [NCIt concept]
- Lutetium Lu 177 DOTA-Tetulomab [NCIt concept]
- Lutetium Lu 177 Dotatate [NCIt concept]
- Lutetium Lu 177 FF58 [NCIt concept]
- Lutetium Lu 177 Ludotadipep [NCIt concept]
- Lutetium Lu 177 NNS309 [NCIt concept]
- Lutetium Lu 177 Rosopatamab Tetraxetan [NCIt concept]
- Lutetium Lu 177 Satoreotide Tetraxetan [NCIt concept]
- Lutetium Lu 177 Vipivotide Tetraxetan [NCIt concept]
- Lutetium Lu 177 Zadavotide Guraxetan [NCIt concept]
- Lutetium Lu 177 Zalsenertant Tetraxetan [NCIt concept]
- Lutetium Lu 177-DOTA [NCIt concept]
- Lutetium Lu 177-DOTA-ABM-5G [NCIt concept]
- Lutetium Lu 177-DOTA-EB-TATE [NCIt concept]
- Lutetium Lu 177-DTPA-omburtamab [NCIt concept]
- Lutetium Lu 177-EVS459 [NCIt concept]
- Lutetium Lu 177-Edotreotide [NCIt concept]
- Lutetium Lu 177-FAP-2286 [NCIt concept]
- Lutetium Lu 177-NeoB [NCIt concept]
- Lutetium Lu 177-PNT6555 [NCIt concept]
- Lutetium Lu-177 PSMA-R2 [NCIt concept]
- Lutetium-177-labeled PSMA-targeting Ligand [NCIt concept]
- Lutropin Subunit Beta [NCIt concept]
- Luveltamab Tazevibulin [NCIt concept]
- Luvixasertib [NCIt concept]
- Luxdegalutamide [NCIt concept]
- Luxeptinib [NCIt concept]
- Ly6/PLAUR Domain-Containing Protein 3 [NCIt concept]
- Lycopene [NCIt concept]
- Lymph Node Assessment [NCIt concept]
- Lymph Node Biopsy [NCIt concept]
- Lymph Node Disorder [NCIt concept]
- Lymph Node Gene Expression Signature [NCIt concept]
- Lymph Node Mapping [NCIt concept]
- Lymphadenectomy [NCIt concept]
- Lymphangiography [NCIt concept]
- Lymphangioleiomyomatosis [NCIt concept]
- Lymphangioma [NCIt concept]
- Lymphangioma Circumscriptum [NCIt concept]
- Lymphatic Reconstruction [NCIt concept]
- Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 [NCIt concept]
- Lymphedema [NCIt concept]
- Lymphedema Management [NCIt concept]
- Lymphoblast [NCIt concept]
- Lymphoblastic Lymphoma [NCIt concept]
- Lymphoblasts 1 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts 20 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Lymphoblasts 5 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts 5 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Lymphoblasts 5-25 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts Less than 5 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts More Than 50 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts More than 10 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoblasts More than 10 Percent of Peripheral Blood White Cells [NCIt concept]
- Lymphoblasts with Surface Immunoglobulin Present [NCIt concept]
- Lymphocele [NCIt concept]
- Lymphocyte [NCIt concept]
- Lymphocyte Activation Gene 3 Protein [NCIt concept]
- Lymphocyte Antigen 6E [NCIt concept]
- Lymphocyte Antigen 6K [NCIt concept]
- Lymphocyte Antigen 75 [NCIt concept]
- Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Lymphocyte-Rich Classic Hodgkin Lymphoma [NCIt concept]
- Lymphoid Enhancer-Binding Factor 1 [NCIt concept]
- Lymphoid Leukemia [NCIt concept]
- Lymphoid Leukemia in Remission [NCIt concept]
- Lymphoid Progenitor Cell [NCIt concept]
- Lymphokine-Activated Killer T-Cell-Originated Protein Kinase [NCIt concept]
- Lymphoma [NCIt concept]
- Lymphoma Cells More than 25 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Lymphoma TAA-specific Cytotoxic T Lymphocytes [NCIt concept]
- Lymphoma in Remission [NCIt concept]
- Lymphomatous Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Lymphomatous Involvement of Non-Cutaneous Extranodal Site [NCIt concept]
- Lymphopenia [NCIt concept]
- Lymphoplasmacytic Infiltrate [NCIt concept]
- Lymphoplasmacytic Lymphoma [NCIt concept]
- Lymphoproliferative Disorder [NCIt concept]
- Lymphoscintigraphy [NCIt concept]
- Lymphotactin [NCIt concept]
- Lymphotoxin-Alpha [NCIt concept]
- Lymphotoxin-Beta [NCIt concept]
- Lymphovenous Bypass [NCIt concept]
- Lynch Syndrome [NCIt concept]
- Lyophilized Black Raspberry Lozenge [NCIt concept]
- Lyophilized Inactivated Group A Streptococcus TARA-002 [NCIt concept]
- Lys-63-Specific Deubiquitinase BRCC36 [NCIt concept]
- Lysine [NCIt concept]
- Lysine-Specific Demethylase 2B [NCIt concept]
- Lysine-Specific Demethylase 5A [NCIt concept]
- Lysine-Specific Demethylase 5C [NCIt concept]
- Lysine-Specific Demethylase 6A [NCIt concept]
- Lysine-Specific Histone Demethylase 1A [NCIt concept]
- Lysine-specific Demethylase 1 Inhibitor INCB059872 [NCIt concept]
- Lyso-Thermosensitive Liposome Doxorubicin [NCIt concept]
- Lysophosphatidic Acid Receptor 3 [NCIt concept]
- Lysophospholipid Acyltransferase 2 [NCIt concept]
- Lysosomal Acid Glucosylceramidase [NCIt concept]
- Lysosomal Storage Disease [NCIt concept]
- Lysosomal-Associated Transmembrane Protein 4B [NCIt concept]
- Lysosomal-Trafficking Regulator [NCIt concept]
- Lysosome-Associated Membrane Glycoprotein 1 [NCIt concept]
- Lysosome-Associated Membrane Glycoprotein 2 [NCIt concept]
- Lysosome-Associated Membrane Glycoprotein 3 [NCIt concept]
- Lysyl Oxidase Homolog 2 [NCIt concept]
- M Protein [NCIt concept]
- M-Phase Inducer Phosphatase 1 [NCIt concept]
- M-Phase Inducer Phosphatase 2 [NCIt concept]
- M-Phase Inducer Phosphatase 3 [NCIt concept]
- M1 Macrophage [NCIt concept]
- M1 Macrophage to M2 Macrophage Ratio Measurement [NCIt concept]
- M2 Macrophage [NCIt concept]
- M65-Antigen [NCIt concept]
- MACC1 Gene [NCIt concept]
- MACC1 wt Allele [NCIt concept]
- MACROH2A1 Gene [NCIt concept]
- MACROH2A1 wt Allele [NCIt concept]
- MAD2L1 Gene [NCIt concept]
- MAD2L1 wt Allele [NCIt concept]
- MAD2L2 Gene [NCIt concept]
- MAD2L2 wt Allele [NCIt concept]
- MADCAM1 Gene [NCIt concept]
- MADCAM1 wt Allele [NCIt concept]
- MAF Gene [NCIt concept]
- MAF wt Allele [NCIt concept]
- MAFA Gene [NCIt concept]
- MAFA wt Allele [NCIt concept]
- MAFB Gene [NCIt concept]
- MAFB wt Allele [NCIt concept]
- MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells [NCIt concept]
- MAGE-A3 Peptide Vaccine [NCIt concept]
- MAGE-A3 Reactive T Cell Receptor-transduced Autologous T Cells [NCIt concept]
- MAGE-A3-specific Immunotherapeutic GSK 2132231A [NCIt concept]
- MAGE-A3/12-specific TCR Gene-transduced Autologous PBLs [NCIt concept]
- MAGE-A4-specific T-cell Engager CDR404 [NCIt concept]
- MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 [NCIt concept]
- MAGEA1 Antibody [NCIt concept]
- MAGEA1 Gene [NCIt concept]
- MAGEA1 Positive [NCIt concept]
- MAGEA1 wt Allele [NCIt concept]
- MAGEA10 Gene [NCIt concept]
- MAGEA10 Positive [NCIt concept]
- MAGEA10 wt Allele [NCIt concept]
- MAGEA11 Gene [NCIt concept]
- MAGEA11 wt Allele [NCIt concept]
- MAGEA12 Gene [NCIt concept]
- MAGEA12 Positive [NCIt concept]
- MAGEA12 wt Allele [NCIt concept]
- MAGEA2 Gene [NCIt concept]
- MAGEA2 wt Allele [NCIt concept]
- MAGEA3 Antibody [NCIt concept]
- MAGEA3 Gene [NCIt concept]
- MAGEA3 Positive [NCIt concept]
- MAGEA3 wt Allele [NCIt concept]
- MAGEA4 Gene [NCIt concept]
- MAGEA4 Positive [NCIt concept]
- MAGEA4 wt Allele [NCIt concept]
- MAGEA6 Gene [NCIt concept]
- MAGEA6 Positive [NCIt concept]
- MAGEA6 wt Allele [NCIt concept]
- MAGEB18 Gene [NCIt concept]
- MAGEB18 wt Allele [NCIt concept]
- MAGEB2 Gene [NCIt concept]
- MAGEB2 wt Allele [NCIt concept]
- MAGEC1 Gene [NCIt concept]
- MAGEC1 Positive [NCIt concept]
- MAGEC1 wt Allele [NCIt concept]
- MAGEC2 Gene [NCIt concept]
- MAGEC2 wt Allele [NCIt concept]
- MAGI2 Gene [NCIt concept]
- MAGI2 Gene Mutation [NCIt concept]
- MAGI2 wt Allele [NCIt concept]
- MAGT1 Gene [NCIt concept]
- MAGT1 Gene Mutation [NCIt concept]
- MAGT1 wt Allele [NCIt concept]
- MALAT1 Gene [NCIt concept]
- MALAT1 wt Allele [NCIt concept]
- MALAT1/TFEB Fusion Gene [NCIt concept]
- MALT1 Gene [NCIt concept]
- MALT1 Inhibitor [NCIt concept]
- MALT1 Inhibitor ABBV-525 [NCIt concept]
- MALT1 Inhibitor MPT-0118 [NCIt concept]
- MALT1 wt Allele [NCIt concept]
- MAML1 Gene [NCIt concept]
- MAML1 wt Allele [NCIt concept]
- MAML2 Gene [NCIt concept]
- MAML2 wt Allele [NCIt concept]
- MAML3 Gene [NCIt concept]
- MAML3 wt Allele [NCIt concept]
- MAOA Gene [NCIt concept]
- MAOA wt Allele [NCIt concept]
- MAP Kinase Gene [NCIt concept]
- MAP Kinase-Activated Protein Kinase 2 [NCIt concept]
- MAP Kinase-Interacting Serine/Threonine-Protein Kinase 1 [NCIt concept]
- MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 [NCIt concept]
- MAP/Microtubule Affinity-Regulating Kinase 3 [NCIt concept]
- MAP/Microtubule Affinity-Regulating Kinase 4 [NCIt concept]
- MAP1LC3A Gene [NCIt concept]
- MAP1LC3A wt Allele [NCIt concept]
- MAP1LC3B Gene [NCIt concept]
- MAP1LC3B wt Allele [NCIt concept]
- MAP1LC3C Gene [NCIt concept]
- MAP1LC3C wt Allele [NCIt concept]
- MAP2 Gene [NCIt concept]
- MAP2 wt Allele [NCIt concept]
- MAP2K1 Fusion Positive [NCIt concept]
- MAP2K1 Gene [NCIt concept]
- MAP2K1 Gene Amplification [NCIt concept]
- MAP2K1 Gene Mutation [NCIt concept]
- MAP2K1 Gene Mutation Negative [NCIt concept]
- MAP2K1 Gene Rearrangement [NCIt concept]
- MAP2K1 wt Allele [NCIt concept]
- MAP2K2 Fusion Positive [NCIt concept]
- MAP2K2 Gene [NCIt concept]
- MAP2K2 Gene Amplification [NCIt concept]
- MAP2K2 Gene Mutation [NCIt concept]
- MAP2K2 Gene Rearrangement [NCIt concept]
- MAP2K2 wt Allele [NCIt concept]
- MAP2K4 Gene [NCIt concept]
- MAP2K4 wt Allele [NCIt concept]
- MAP3K1 Gene [NCIt concept]
- MAP3K1 Gene Mutation [NCIt concept]
- MAP3K1 wt Allele [NCIt concept]
- MAP3K14 Gene [NCIt concept]
- MAP3K14 wt Allele [NCIt concept]
- MAP3K5 Gene [NCIt concept]
- MAP3K5 wt Allele [NCIt concept]
- MAP3K8 Gene [NCIt concept]
- MAP3K8 Gene Mutation [NCIt concept]
- MAP3K8 wt Allele [NCIt concept]
- MAP4 Gene [NCIt concept]
- MAP4 wt Allele [NCIt concept]
- MAPK Gene Alteration Positive [NCIt concept]
- MAPK Pathway Activating Gene Alteration Positive [NCIt concept]
- MAPK Pathway Alteration Positive [NCIt concept]
- MAPK/MAK/MRK Overlapping Kinase [NCIt concept]
- MAPK1 Fusion Positive [NCIt concept]
- MAPK1 Gene [NCIt concept]
- MAPK1 Gene Mutation [NCIt concept]
- MAPK1 wt Allele [NCIt concept]
- MAPK11 Gene [NCIt concept]
- MAPK11 wt Allele [NCIt concept]
- MAPK14 Gene [NCIt concept]
- MAPK14 wt Allele [NCIt concept]
- MAPK3 Fusion Positive [NCIt concept]
- MAPK3 Gene [NCIt concept]
- MAPK3 Gene Mutation [NCIt concept]
- MAPK3 wt Allele [NCIt concept]
- MAPKAP1 Gene [NCIt concept]
- MAPKAP1 wt Allele [NCIt concept]
- MAPKAPK2 Gene [NCIt concept]
- MAPKAPK2 wt Allele [NCIt concept]
- MARCHF9 Gene [NCIt concept]
- MARCHF9 wt Allele [NCIt concept]
- MARCKS Gene [NCIt concept]
- MARCKS wt Allele [NCIt concept]
- MARK2 Gene [NCIt concept]
- MARK2 wt Allele [NCIt concept]
- MARK3 Gene [NCIt concept]
- MARK3 wt Allele [NCIt concept]
- MARK4 Gene [NCIt concept]
- MARK4 wt Allele [NCIt concept]
- MART-1 Antigen [NCIt concept]
- MART-1 Reactive CD8+ T-lymphocytes [NCIt concept]
- MART-1:26-35(27L) Peptide Vaccine [NCIt concept]
- MART-1:27-35 Peptide Vaccine [NCIt concept]
- MART1 Antibody [NCIt concept]
- MASP2 Gene [NCIt concept]
- MASP2 wt Allele [NCIt concept]
- MAST1 Gene [NCIt concept]
- MAST1 wt Allele [NCIt concept]
- MAST2 Gene [NCIt concept]
- MAST2 wt Allele [NCIt concept]
- MAT2A Gene [NCIt concept]
- MAT2A Inhibitor [NCIt concept]
- MAT2A Inhibitor AG-270 [NCIt concept]
- MAT2A Inhibitor IDE397 [NCIt concept]
- MAT2A wt Allele [NCIt concept]
- MAX Gene [NCIt concept]
- MAX Gene Mutation [NCIt concept]
- MAX wt Allele [NCIt concept]
- MBD2 Gene [NCIt concept]
- MBD2 mRNA Measurement [NCIt concept]
- MBD2 wt Allele [NCIt concept]
- MBD4 Gene [NCIt concept]
- MBD4 Gene Mutation [NCIt concept]
- MBD4 wt Allele [NCIt concept]
- MBL2 Gene [NCIt concept]
- MBL2 wt Allele [NCIt concept]
- MBOAT2 Gene [NCIt concept]
- MBOAT2 wt Allele [NCIt concept]
- MBP Gene [NCIt concept]
- MBP wt Allele [NCIt concept]
- MBT Domain-Containing Protein 1 [NCIt concept]
- MBTD1 Gene [NCIt concept]
- MBTD1 wt Allele [NCIt concept]
- MC1R Gene [NCIt concept]
- MC1R wt Allele [NCIt concept]
- MC5-A Scrambler Therapy [NCIt concept]
- MCL-1 Inhibitor ABBV-467 [NCIt concept]
- MCL1 Gene [NCIt concept]
- MCL1 Inhibitor GS-9716 [NCIt concept]
- MCL1 wt Allele [NCIt concept]
- MCM10 Gene [NCIt concept]
- MCM10 wt Allele [NCIt concept]
- MCM3 Gene [NCIt concept]
- MCM3 wt Allele [NCIt concept]
- MCM4 Gene [NCIt concept]
- MCM4 wt Allele [NCIt concept]
- MCM5 Gene [NCIt concept]
- MCM5 wt Allele [NCIt concept]
- MCM6 Gene [NCIt concept]
- MCM6 wt Allele [NCIt concept]
- MCM7 Gene [NCIt concept]
- MCM7 wt Allele [NCIt concept]
- MCPH1 Gene [NCIt concept]
- MCPH1 wt Allele [NCIt concept]
- MCPyV Negative [NCIt concept]
- MCPyV Positive [NCIt concept]
- MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells [NCIt concept]
- MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000 [NCIt concept]
- MDC1 Gene [NCIt concept]
- MDC1 Gene Mutation [NCIt concept]
- MDC1 wt Allele [NCIt concept]
- MDK Gene [NCIt concept]
- MDK wt Allele [NCIt concept]
- MDM2 Antagonist ASTX295 [NCIt concept]
- MDM2 Antagonist RO5045337 [NCIt concept]
- MDM2 Degrader KT-253 [NCIt concept]
- MDM2 Gene [NCIt concept]
- MDM2 Gene Amplification [NCIt concept]
- MDM2 Gene Amplification Negative [NCIt concept]
- MDM2 Inhibitor [NCIt concept]
- MDM2 Inhibitor SA53-OS [NCIt concept]
- MDM2 Positive [NCIt concept]
- MDM2 wt Allele [NCIt concept]
- MDM4 Gene [NCIt concept]
- MDM4 Gene Amplification [NCIt concept]
- MDM4 wt Allele [NCIt concept]
- MDS Neoantigen-specific Autologous T-lymphocytes [NCIt concept]
- MDS2 Gene [NCIt concept]
- MDS2 wt Allele [NCIt concept]
- ME1 Gene [NCIt concept]
- ME1 wt Allele [NCIt concept]
- MEAF6 Gene [NCIt concept]
- MEAF6 wt Allele [NCIt concept]
- MECOM Gene [NCIt concept]
- MECOM Gene Product [NCIt concept]
- MECOM Positive [NCIt concept]
- MECOM Protein Isoform Evi-1a [NCIt concept]
- MECOM Protein Isoform MDS1 [NCIt concept]
- MECOM Protein Isoform Mds1/Evi1 [NCIt concept]
- MECOM wt Allele [NCIt concept]
- MECOM-RUNX1 Fusion Protein Expression [NCIt concept]
- MED12 Gene [NCIt concept]
- MED12 Gene Mutation [NCIt concept]
- MED12 wt Allele [NCIt concept]
- MEF2C Gene [NCIt concept]
- MEF2C wt Allele [NCIt concept]
- MEGF8 Gene [NCIt concept]
- MEGF8 wt Allele [NCIt concept]
- MEIS1 Gene [NCIt concept]
- MEIS1 wt Allele [NCIt concept]
- MEIS2 Gene [NCIt concept]
- MEIS2 wt Allele [NCIt concept]
- MEK 1/2 Inhibitor AS703988/MSC2015103B [NCIt concept]
- MEK Family Gene Mutation [NCIt concept]
- MEK Inhibitor AZD8330 [NCIt concept]
- MEK Inhibitor GDC-0623 [NCIt concept]
- MEK Inhibitor IMM-1-104 [NCIt concept]
- MEK Inhibitor IMM-6-415 [NCIt concept]
- MEK Inhibitor REC-4881 [NCIt concept]
- MEK-1/MEKK-1 Inhibitor E6201 [NCIt concept]
- MEK/RAF Molecular Glue IK-595 [NCIt concept]
- MEK/RAF Molecular Glue SPYK04 [NCIt concept]
- MEK1/2 Inhibitor ABM-168 [NCIt concept]
- MELITAC 12.1 Peptide Vaccine [NCIt concept]
- MELK Inhibitor OTS167 [NCIt concept]
- MELTF Gene [NCIt concept]
- MELTF wt Allele [NCIt concept]
- MEN1 Gene [NCIt concept]
- MEN1 Gene Mutation [NCIt concept]
- MEN1 wt Allele [NCIt concept]
- MERTK Gene [NCIt concept]
- MERTK wt Allele [NCIt concept]
- MESD Gene [NCIt concept]
- MESD wt Allele [NCIt concept]
- MESDC2/SENP1 Fusion Gene [NCIt concept]
- MESDC2/SENP1 Fusion Protein [NCIt concept]
- MET Exon 14 Mutation [NCIt concept]
- MET Exon 14 Skipping Mutation [NCIt concept]
- MET Exon 14 Skipping Mutation Negative [NCIt concept]
- MET Gene [NCIt concept]
- MET Gene Alteration Negative [NCIt concept]
- MET Gene Alteration Positive [NCIt concept]
- MET Gene Amplification Negative [NCIt concept]
- MET Gene Deletion [NCIt concept]
- MET Gene Fusion Negative [NCIt concept]
- MET Gene Fusion Positive [NCIt concept]
- MET Gene Mutation [NCIt concept]
- MET Gene Mutation Negative [NCIt concept]
- MET NP_000236.2:p.D1228X [NCIt concept]
- MET NP_000236.2:p.Y1003X [NCIt concept]
- MET NP_000236.2:p.Y1230X [NCIt concept]
- MET Overexpression Positive [NCIt concept]
- MET Positive [NCIt concept]
- MET Protein Variant [NCIt concept]
- MET Tyrosine Kinase Inhibitor EMD 1204831 [NCIt concept]
- MET Tyrosine Kinase Inhibitor PF-04217903 [NCIt concept]
- MET Tyrosine Kinase Inhibitor SAR125844 [NCIt concept]
- MET wt Allele [NCIt concept]
- MET/CEP7 Ratio Greater than or Equal to 4 [NCIt concept]
- METAP2 Gene [NCIt concept]
- METAP2 wt Allele [NCIt concept]
- METTL-3 Inhibitor STC-15 [NCIt concept]
- MFGE8 Gene [NCIt concept]
- MFGE8 wt Allele [NCIt concept]
- MG7 Antigen [NCIt concept]
- MGMT Gene [NCIt concept]
- MGMT Gene Promoter Hypermethylation [NCIt concept]
- MGMT Gene Promoter Methylation [NCIt concept]
- MGMT wt Allele [NCIt concept]
- MGMT-Methylated Glioblastoma [NCIt concept]
- MGST2 Gene [NCIt concept]
- MGST2 wt Allele [NCIt concept]
- MHC Class I Polypeptide-Related Sequence A [NCIt concept]
- MHC Class I Polypeptide-Related Sequence B [NCIt concept]
- MHC Class I Protein [NCIt concept]
- MHC Class II Gene [NCIt concept]
- MHC Class II Gene Expression Signature [NCIt concept]
- MHC Class II Protein [NCIt concept]
- MHC Class II Transactivator [NCIt concept]
- MHCII Immune Activation Score [NCIt concept]
- MIA Gene [NCIt concept]
- MIA wt Allele [NCIt concept]
- MIA2 Gene [NCIt concept]
- MIA2 wt Allele [NCIt concept]
- MIB1 Gene [NCIt concept]
- MIB1 wt Allele [NCIt concept]
- MICA Gene [NCIt concept]
- MICA wt Allele [NCIt concept]
- MICB Gene [NCIt concept]
- MICB wt Allele [NCIt concept]
- MIF Gene [NCIt concept]
- MIF wt Allele [NCIt concept]
- MINT31 [NCIt concept]
- MIR10B Gene [NCIt concept]
- MIR10B Pre-miRNA [NCIt concept]
- MIR10B wt Allele [NCIt concept]
- MIR124-2 Gene [NCIt concept]
- MIR124-2 Pre-miRNA [NCIt concept]
- MIR124-2 wt Allele [NCIt concept]
- MIR1246 Gene [NCIt concept]
- MIR1246 Pre-miRNA [NCIt concept]
- MIR1246 wt Allele [NCIt concept]
- MIR1290 Gene [NCIt concept]
- MIR1290 Pre-miRNA [NCIt concept]
- MIR1290 wt Allele [NCIt concept]
- MIR144 Gene [NCIt concept]
- MIR144 Pre-miRNA [NCIt concept]
- MIR144 wt Allele [NCIt concept]
- MIR145 Gene [NCIt concept]
- MIR145 Pre-miRNA [NCIt concept]
- MIR145 wt Allele [NCIt concept]
- MIR150 Gene [NCIt concept]
- MIR150 Pre-miRNA [NCIt concept]
- MIR150 wt Allele [NCIt concept]
- MIR155 Gene [NCIt concept]
- MIR155 Pre-miRNA [NCIt concept]
- MIR155 wt Allele [NCIt concept]
- MIR17 Gene [NCIt concept]
- MIR17 Pre-miRNA [NCIt concept]
- MIR17 wt Allele [NCIt concept]
- MIR182 Gene [NCIt concept]
- MIR182 Pre-miRNA [NCIt concept]
- MIR182 wt Allele [NCIt concept]
- MIR191 Gene [NCIt concept]
- MIR191 Pre-miRNA [NCIt concept]
- MIR191 wt Allele [NCIt concept]
- MIR193A Gene [NCIt concept]
- MIR193A Pre-miRNA [NCIt concept]
- MIR193A wt Allele [NCIt concept]
- MIR200C Gene [NCIt concept]
- MIR200C Pre-miRNA [NCIt concept]
- MIR200C wt Allele [NCIt concept]
- MIR203A Gene [NCIt concept]
- MIR203A Pre-miRNA [NCIt concept]
- MIR203A wt Allele [NCIt concept]
- MIR206 Gene [NCIt concept]
- MIR206 Pre-miRNA [NCIt concept]
- MIR206 wt Allele [NCIt concept]
- MIR210 Gene [NCIt concept]
- MIR210 Pre-miRNA [NCIt concept]
- MIR210 wt Allele [NCIt concept]
- MIR214 Gene [NCIt concept]
- MIR214 Pre-miRNA [NCIt concept]
- MIR214 wt Allele [NCIt concept]
- MIR221 Gene [NCIt concept]
- MIR221 Pre-miRNA [NCIt concept]
- MIR221 wt Allele [NCIt concept]
- MIR223 Gene [NCIt concept]
- MIR223 Pre-miRNA [NCIt concept]
- MIR223 wt Allele [NCIt concept]
- MIR34A Gene [NCIt concept]
- MIR34A pre-miRNA [NCIt concept]
- MIR34A wt Allele [NCIt concept]
- MIR373 Gene [NCIt concept]
- MIR373 Pre-miRNA [NCIt concept]
- MIR373 wt Allele [NCIt concept]
- MIR382 Gene [NCIt concept]
- MIR382 Pre-miRNA [NCIt concept]
- MIR382 wt Allele [NCIt concept]
- MIR518E Gene [NCIt concept]
- MIR518E Pre-miRNA [NCIt concept]
- MIR518E wt Allele [NCIt concept]
- MIR551A Gene [NCIt concept]
- MIR551A Pre-miRNA [NCIt concept]
- MIR551A wt Allele [NCIt concept]
- MIR574 Gene [NCIt concept]
- MIR574 Pre-miRNA [NCIt concept]
- MIR574 wt Allele [NCIt concept]
- MITF Gene [NCIt concept]
- MITF Gene Mutation [NCIt concept]
- MITF Positive [NCIt concept]
- MITF wt Allele [NCIt concept]
- MKC-1 [NCIt concept]
- MKI67 Gene [NCIt concept]
- MKI67 Positive [NCIt concept]
- MKI67 wt Allele [NCIt concept]
- MKL1/RBM15 Fusion Gene [NCIt concept]
- MKNK1 Gene [NCIt concept]
- MKNK1 Inhibitor BAY 1143269 [NCIt concept]
- MKNK1 wt Allele [NCIt concept]
- MKNK2 Gene [NCIt concept]
- MKNK2 wt Allele [NCIt concept]
- MKRN1 Gene [NCIt concept]
- MKRN1 wt Allele [NCIt concept]
- MLANA Gene [NCIt concept]
- MLANA Positive [NCIt concept]
- MLANA wt Allele [NCIt concept]
- MLF1 Gene [NCIt concept]
- MLF1 wt Allele [NCIt concept]
- MLH1 Gene [NCIt concept]
- MLH1 Gene Mutation [NCIt concept]
- MLH1 Loss of Nuclear Expression [NCIt concept]
- MLH1 Negative [NCIt concept]
- MLH1 Nuclear Expression Intact [NCIt concept]
- MLH1 Protein Variant [NCIt concept]
- MLH1 wt Allele [NCIt concept]
- MLH3 Gene [NCIt concept]
- MLH3 Gene Mutation [NCIt concept]
- MLH3 wt Allele [NCIt concept]
- MLKL Gene [NCIt concept]
- MLKL wt Allele [NCIt concept]
- MLL Gene Mutation [NCIt concept]
- MLL Positive [NCIt concept]
- MLL/ABI1 Fusion Gene [NCIt concept]
- MLL/ABI1 Fusion Protein [NCIt concept]
- MLL/AFF1 Fusion Gene [NCIt concept]
- MLL/AFF1 Fusion Protein [NCIt concept]
- MLL/AFF3 Fusion Gene [NCIt concept]
- MLL/AFF3 Fusion Protein [NCIt concept]
- MLL/ARHGAP26 Fusion Gene [NCIt concept]
- MLL/ARHGAP26 Fusion Protein [NCIt concept]
- MLL/ARHGEF12 Fusion Gene [NCIt concept]
- MLL/ARHGEF12 Fusion Protein [NCIt concept]
- MLL/CASC5 Fusion Gene [NCIt concept]
- MLL/CASC5 Fusion Protein [NCIt concept]
- MLL/CBL Fusion Gene [NCIt concept]
- MLL/CBL Fusion Protein [NCIt concept]
- MLL/ELL Fusion Gene [NCIt concept]
- MLL/FNBP1 Fusion Gene [NCIt concept]
- MLL/FNBP1 Fusion Protein [NCIt concept]
- MLL/GMPS Fusion Gene [NCIt concept]
- MLL/GMPS Fusion Protein [NCIt concept]
- MLL/GPHN Fusion Gene [NCIt concept]
- MLL/GPHN Fusion Protein [NCIt concept]
- MLL/LASP1 Fusion Gene [NCIt concept]
- MLL/LASP1 Fusion Protein [NCIt concept]
- MLL/LPP Fusion Gene [NCIt concept]
- MLL/LPP Fusion Protein [NCIt concept]
- MLL/MAML2 Fusion Gene [NCIt concept]
- MLL/MAML2 Fusion Protein [NCIt concept]
- MLL/MLLT1 Fusion Gene [NCIt concept]
- MLL/MLLT1 Fusion Protein [NCIt concept]
- MLL/MLLT10 Fusion Gene [NCIt concept]
- MLL/MLLT10 Fusion Protein [NCIt concept]
- MLL/MLLT11 Fusion Gene [NCIt concept]
- MLL/MLLT11 Fusion Protein [NCIt concept]
- MLL/MLLT3 Fusion Protein [NCIt concept]
- MLL/MLLT4 Fusion Gene [NCIt concept]
- MLL/MLLT4 Fusion Protein [NCIt concept]
- MLL/SARNP Fusion Gene [NCIt concept]
- MLL/SARNP Fusion Protein [NCIt concept]
- MLL/SEPT5 Fusion Gene [NCIt concept]
- MLL/SEPT5 Fusion Protein [NCIt concept]
- MLL/SEPT6 Fusion Gene [NCIt concept]
- MLL/SEPT6 Fusion Protein [NCIt concept]
- MLL/SH3GL1 Fusion Gene [NCIt concept]
- MLL/SH3GL1 Fusion Protein [NCIt concept]
- MLLT1 Gene [NCIt concept]
- MLLT1 Gene Mutation [NCIt concept]
- MLLT1 wt Allele [NCIt concept]
- MLLT10 Gene [NCIt concept]
- MLLT10 wt Allele [NCIt concept]
- MLLT10/CLP1 Fusion Gene [NCIt concept]
- MLLT10/PICALM Fusion Gene [NCIt concept]
- MLLT10/PICALM Fusion Protein [NCIt concept]
- MLLT11 Gene [NCIt concept]
- MLLT11 wt Allele [NCIt concept]
- MLLT3 Gene [NCIt concept]
- MLLT3 wt Allele [NCIt concept]
- MME Gene [NCIt concept]
- MME Negative [NCIt concept]
- MME Positive [NCIt concept]
- MME wt Allele [NCIt concept]
- MMP1 Gene [NCIt concept]
- MMP1 wt Allele [NCIt concept]
- MMP10 Gene [NCIt concept]
- MMP10 wt Allele [NCIt concept]
- MMP14 Gene [NCIt concept]
- MMP14 wt Allele [NCIt concept]
- MMP16 Gene [NCIt concept]
- MMP16 wt Allele [NCIt concept]
- MMP2 Gene [NCIt concept]
- MMP2 wt Allele [NCIt concept]
- MMP3 Gene [NCIt concept]
- MMP3 wt Allele [NCIt concept]
- MMP7 Gene [NCIt concept]
- MMP7 wt Allele [NCIt concept]
- MMP8 Gene [NCIt concept]
- MMP8 wt Allele [NCIt concept]
- MMP9 Gene [NCIt concept]
- MMP9 wt Allele [NCIt concept]
- MMRN1 Gene [NCIt concept]
- MMRN1 wt Allele [NCIt concept]
- MN1 Gene [NCIt concept]
- MN1 Gene Mutation [NCIt concept]
- MN1 wt Allele [NCIt concept]
- MN1/ETV6 Fusion Gene [NCIt concept]
- MN1/ETV6 Fusion Protein [NCIt concept]
- MNX1 Gene [NCIt concept]
- MNX1 wt Allele [NCIt concept]
- MNX1/ETV6 Fusion Gene [NCIt concept]
- MNX1/ETV6 Fusion Protein [NCIt concept]
- MOF Compound RiMO-301 [NCIt concept]
- MOK Gene [NCIt concept]
- MOK wt Allele [NCIt concept]
- MOv19 CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocytes [NCIt concept]
- MPG Gene [NCIt concept]
- MPG wt Allele [NCIt concept]
- MPL Gene [NCIt concept]
- MPL Gene Mutation [NCIt concept]
- MPL NM_005373.2:c.1543_1544delinsAA [NCIt concept]
- MPL NM_005373.2:c.1543_1545delinsAAA [NCIt concept]
- MPL NM_005373.2:c.1544G>T [NCIt concept]
- MPL NP_005364.1:p.W515K [NCIt concept]
- MPL NP_005364.1:p.W515L [NCIt concept]
- MPL Protein Variant [NCIt concept]
- MPL wt Allele [NCIt concept]
- MPO Gene [NCIt concept]
- MPO Gene Mutation [NCIt concept]
- MPO Positive [NCIt concept]
- MPO wt Allele [NCIt concept]
- MPS1 Inhibitor [NCIt concept]
- MPS1 Kinase Inhibitor NMS-01940153E [NCIt concept]
- MR Fingerprinting [NCIt concept]
- MR Sialography [NCIt concept]
- MR-Compatible Sectioning and Localization Device [NCIt concept]
- MR1 Gene [NCIt concept]
- MR1 wt Allele [NCIt concept]
- MRAS Gene [NCIt concept]
- MRAS Gene Mutation [NCIt concept]
- MRAS wt Allele [NCIt concept]
- MRC1 Gene [NCIt concept]
- MRC1 wt Allele [NCIt concept]
- MRC2 Gene [NCIt concept]
- MRC2 wt Allele [NCIt concept]
- MRE11 Gene [NCIt concept]
- MRE11 Gene Mutation [NCIt concept]
- MRE11 wt Allele [NCIt concept]
- MRI Patient [NCIt concept]
- MRI Ultrasound Fusion Guided Biopsy [NCIt concept]
- MRI-Based Angiogram [NCIt concept]
- MRI-Guided Focused Ultrasound Ablation [NCIt concept]
- MRI-Guided Transurethral Ultrasound Ablation [NCIt concept]
- MRI-guided Stereotactic Biopsy [NCIt concept]
- MRI-guided Stereotactic Body Radiation Therapy [NCIt concept]
- MRTFA Gene [NCIt concept]
- MRTFA wt Allele [NCIt concept]
- MS4A1 Gene [NCIt concept]
- MS4A1 wt Allele [NCIt concept]
- MSCV-MGMT(P140K) Vaccine [NCIt concept]
- MSH2 Gene [NCIt concept]
- MSH2 Gene Mutation [NCIt concept]
- MSH2 Loss of Nuclear Expression [NCIt concept]
- MSH2 NM_000251.2:c.1906G>C [NCIt concept]
- MSH2 NP_000242.1:p.A636P [NCIt concept]
- MSH2 Negative [NCIt concept]
- MSH2 Nuclear Expression Intact [NCIt concept]
- MSH2 Protein Variant [NCIt concept]
- MSH2 wt Allele [NCIt concept]
- MSH3 Gene [NCIt concept]
- MSH3 Gene Mutation [NCIt concept]
- MSH3 Loss of Nuclear Expression [NCIt concept]
- MSH3 wt Allele [NCIt concept]
- MSH6 Gene [NCIt concept]
- MSH6 Gene Mutation [NCIt concept]
- MSH6 Loss of Nuclear Expression [NCIt concept]
- MSH6 Negative [NCIt concept]
- MSH6 Nuclear Expression Intact [NCIt concept]
- MSH6 Protein Variant [NCIt concept]
- MSH6 wt Allele [NCIt concept]
- MSI-H Negative [NCIt concept]
- MSI2 Gene [NCIt concept]
- MSI2 wt Allele [NCIt concept]
- MSI2/HOXA9 Fusion Gene [NCIt concept]
- MSI2/HOXA9 Fusion Protein [NCIt concept]
- MSLN Antibody [NCIt concept]
- MSLN Gene [NCIt concept]
- MSLN Gene Product [NCIt concept]
- MSLN wt Allele [NCIt concept]
- MSLN-targeting Agent [NCIt concept]
- MSLNL Gene [NCIt concept]
- MSLNL wt Allele [NCIt concept]
- MSMB Gene [NCIt concept]
- MSMB wt Allele [NCIt concept]
- MSN Gene [NCIt concept]
- MSN wt Allele [NCIt concept]
- MSR1 Gene [NCIt concept]
- MSR1 wt Allele [NCIt concept]
- MST1L Gene [NCIt concept]
- MST1L wt Allele [NCIt concept]
- MST1R Gene [NCIt concept]
- MST1R wt Allele [NCIt concept]
- MSTN Gene [NCIt concept]
- MSTN wt Allele [NCIt concept]
- MT-CO1 Gene [NCIt concept]
- MT-CO1 wt Allele [NCIt concept]
- MT-RNR1 Gene [NCIt concept]
- MT-RNR1 wt Allele [NCIt concept]
- MT1G Gene [NCIt concept]
- MT1G wt Allele [NCIt concept]
- MTA1 Gene [NCIt concept]
- MTA1 wt Allele [NCIt concept]
- MTAP Gene [NCIt concept]
- MTAP Gene Deletion [NCIt concept]
- MTAP Gene Mutation [NCIt concept]
- MTAP Negative [NCIt concept]
- MTAP wt Allele [NCIt concept]
- MTF-1 Inhibitor APTO-253 HCl [NCIt concept]
- MTHFD1 Gene [NCIt concept]
- MTHFD1 wt Allele [NCIt concept]
- MTHFD2 Gene [NCIt concept]
- MTHFD2 wt Allele [NCIt concept]
- MTHFR Gene [NCIt concept]
- MTHFR Gene Mutation [NCIt concept]
- MTHFR wt Allele [NCIt concept]
- MTOR Gene [NCIt concept]
- MTOR Gene Mutation [NCIt concept]
- MTOR Gene Rearrangement [NCIt concept]
- MTOR wt Allele [NCIt concept]
- MTR Gene [NCIt concept]
- MTR wt Allele [NCIt concept]
- MTRR Gene [NCIt concept]
- MTRR wt Allele [NCIt concept]
- MTTP Gene [NCIt concept]
- MTTP wt Allele [NCIt concept]
- MUC-1 Antigen [NCIt concept]
- MUC-1 Peptide Vaccine [NCIt concept]
- MUC-1-targeting Agent [NCIt concept]
- MUC1 Antibody [NCIt concept]
- MUC1 Gene [NCIt concept]
- MUC1 Peptide-Poly-ICLC Vaccine [NCIt concept]
- MUC1 Positive [NCIt concept]
- MUC1 with Truncated O-Glycans-Positive Neoplastic Cells Present [NCIt concept]
- MUC1 wt Allele [NCIt concept]
- MUC1*-Positive Cells Present [NCIt concept]
- MUC1-targeted Peptide GO-203-2C [NCIt concept]
- MUC16 Ectodomain Antigen Positive [NCIt concept]
- MUC16 Gene [NCIt concept]
- MUC16 Positive [NCIt concept]
- MUC16 wt Allele [NCIt concept]
- MUC17 Gene [NCIt concept]
- MUC17 Positive [NCIt concept]
- MUC17 wt Allele [NCIt concept]
- MUC2 Gene [NCIt concept]
- MUC2 wt Allele [NCIt concept]
- MUC20 Gene [NCIt concept]
- MUC20 wt Allele [NCIt concept]
- MUC4 Gene [NCIt concept]
- MUC4 wt Allele [NCIt concept]
- MUC5AC Gene [NCIt concept]
- MUC5AC Positive [NCIt concept]
- MUC5AC wt Allele [NCIt concept]
- MUCL1 Gene [NCIt concept]
- MUCL1 wt Allele [NCIt concept]
- MUS81 Gene [NCIt concept]
- MUS81 wt Allele [NCIt concept]
- MUSK Autoantibody [NCIt concept]
- MUTYH Gene [NCIt concept]
- MUTYH Gene Mutation [NCIt concept]
- MUTYH wt Allele [NCIt concept]
- MUTYH-Associated Polyposis [NCIt concept]
- MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP [NCIt concept]
- MVA-BN-Brachyury-TRICOM Vaccine [NCIt concept]
- MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ [NCIt concept]
- MVP Gene [NCIt concept]
- MVP wt Allele [NCIt concept]
- MX1 Gene [NCIt concept]
- MX1 wt Allele [NCIt concept]
- MYB Gene [NCIt concept]
- MYB Gene Fusion Positive [NCIt concept]
- MYB Gene Rearrangement [NCIt concept]
- MYB wt Allele [NCIt concept]
- MYB/NFIB Fusion Gene [NCIt concept]
- MYB/NFIB Fusion Protein [NCIt concept]
- MYBL1 Gene [NCIt concept]
- MYBL1 Gene Fusion Positive [NCIt concept]
- MYBL1 Gene Rearrangement [NCIt concept]
- MYBL1 wt Allele [NCIt concept]
- MYBL2 Gene [NCIt concept]
- MYBL2 wt Allele [NCIt concept]
- MYC Box-Dependent-Interacting Protein 1 [NCIt concept]
- MYC Family Gene [NCIt concept]
- MYC Family Protein [NCIt concept]
- MYC Gene [NCIt concept]
- MYC Gene Amplification [NCIt concept]
- MYC Gene Amplification Negative [NCIt concept]
- MYC Gene Mutation [NCIt concept]
- MYC Gene Rearrangement [NCIt concept]
- MYC Gene Rearrangement and BCL2 Gene Rearrangement Positive [NCIt concept]
- MYC Gene Rearrangement and BCL6 Gene Rearrangement Positive [NCIt concept]
- MYC Gene Rearrangement, BCL2 Gene Rearrangement, and BCL6 Gene Rearrangement Positive [NCIt concept]
- MYC Negative [NCIt concept]
- MYC Positive [NCIt concept]
- MYC Protein Overexpression [NCIt concept]
- MYC wt Allele [NCIt concept]
- MYC-targeting siRNA DCR-MYC [NCIt concept]
- MYCL Gene [NCIt concept]
- MYCL Gene Amplification [NCIt concept]
- MYCL Messenger RNA Expression Measurement [NCIt concept]
- MYCL wt Allele [NCIt concept]
- MYCN Gene [NCIt concept]
- MYCN Gene Amplification [NCIt concept]
- MYCN Gene Translocation [NCIt concept]
- MYCN Messenger RNA Expression Measurement [NCIt concept]
- MYCN Negative [NCIt concept]
- MYCN Positive [NCIt concept]
- MYCN wt Allele [NCIt concept]
- MYD88 Fusion Positive [NCIt concept]
- MYD88 Gene [NCIt concept]
- MYD88 Gene Mutation [NCIt concept]
- MYD88 Gene Mutation Negative [NCIt concept]
- MYD88 NM_002468.4:c.794T>C [NCIt concept]
- MYD88 NP_002459.2:p.L265P [NCIt concept]
- MYD88 Protein Variant [NCIt concept]
- MYD88 wt Allele [NCIt concept]
- MYH1 Gene [NCIt concept]
- MYH1 wt Allele [NCIt concept]
- MYH11 Gene [NCIt concept]
- MYH11 wt Allele [NCIt concept]
- MYH2 Gene [NCIt concept]
- MYH2 wt Allele [NCIt concept]
- MYH9 Gene [NCIt concept]
- MYH9 wt Allele [NCIt concept]
- MYO18A Gene [NCIt concept]
- MYO18A wt Allele [NCIt concept]
- MYO18A/PDGFRB Fusion Gene [NCIt concept]
- MYO18A/PDGFRB Fusion Protein [NCIt concept]
- MYO1G Gene [NCIt concept]
- MYO1G Gene Mutation [NCIt concept]
- MYO1G NM_033054.3:c.145G>A [NCIt concept]
- MYO1G NP_149043.2:p.V49M [NCIt concept]
- MYO1G Protein Variant [NCIt concept]
- MYO1G wt Allele [NCIt concept]
- MYO5A Gene [NCIt concept]
- MYO5A wt Allele [NCIt concept]
- MYOD1 Gene [NCIt concept]
- MYOD1 Gene Mutation [NCIt concept]
- MYOD1 Gene Mutation Negative [NCIt concept]
- MYOD1 NM_002478.5:c.365T>G [NCIt concept]
- MYOD1 NP_002469.2:p.L122R [NCIt concept]
- MYOD1 wt Allele [NCIt concept]
- Maackia amurensis Seed Lectin [NCIt concept]
- Macimorelin [NCIt concept]
- Macitentan [NCIt concept]
- Macrocycle-bridged STING Agonist E7766 [NCIt concept]
- Macrophage [NCIt concept]
- Macrophage Activation Syndrome [NCIt concept]
- Macrophage Colony-Stimulating Factor 1 [NCIt concept]
- Macrophage Colony-Stimulating Factor 1 Receptor [NCIt concept]
- Macrophage Inflammatory Protein [NCIt concept]
- Macrophage Mannose Receptor 1 [NCIt concept]
- Macrophage Migration Inhibitory Factor [NCIt concept]
- Macrophage Scavenger Receptor Types I and II [NCIt concept]
- Macrophage-Capping Protein [NCIt concept]
- Macrophage-Stimulating Protein Receptor [NCIt concept]
- Macrosialin [NCIt concept]
- Macrovessel Density [NCIt concept]
- Macy Catheter [NCIt concept]
- Magic Mouthwash [NCIt concept]
- Magnesium Chloride-based Lotion [NCIt concept]
- Magnesium Glycinate [NCIt concept]
- Magnesium Measurement [NCIt concept]
- Magnesium Oxide [NCIt concept]
- Magnesium Sulfate [NCIt concept]
- Magnesium Transporter Protein 1 [NCIt concept]
- Magnesium-based Bone Void Filler [NCIt concept]
- Magnetic Affinity Cell Sorting [NCIt concept]
- Magnetic Resonance Angiography [NCIt concept]
- Magnetic Resonance Cholangiopancreatography [NCIt concept]
- Magnetic Resonance Elastography [NCIt concept]
- Magnetic Resonance Imaging [NCIt concept]
- Magnetic Resonance Imaging of the Abdomen with and without Contrast [NCIt concept]
- Magnetic Resonance Imaging of the Abdomen without Contrast [NCIt concept]
- Magnetic Resonance Imaging of the Brain with and without Contrast [NCIt concept]
- Magnetic Resonance Imaging of the Breast without Contrast [NCIt concept]
- Magnetic Resonance Imaging of the Heart [NCIt concept]
- Magnetic Resonance Imaging of the Pelvis without Contrast [NCIt concept]
- Magnetic Resonance Neurography [NCIt concept]
- Magnetic Resonance Spectroscopic Imaging [NCIt concept]
- Magnetic Resonance Thermal Imaging [NCIt concept]
- Magnetic Resonance Whole Body Diffusion-Weighted Imaging [NCIt concept]
- Magnetic Resonance-Guided Radiotherapy [NCIt concept]
- Magnetic Seed Localization [NCIt concept]
- Magnetization Transfer Magnetic Resonance Imaging [NCIt concept]
- Magnetoencephalography [NCIt concept]
- Maintenance Therapy [NCIt concept]
- Maitake Mushroom Extract [NCIt concept]
- Major Histocompatibility Complex Class I-Related Gene Protein [NCIt concept]
- Major Pathologic Response [NCIt concept]
- Major Salivary Gland Adenocarcinoma [NCIt concept]
- Major Salivary Gland Adenoid Cystic Carcinoma [NCIt concept]
- Major Salivary Gland Carcinoma [NCIt concept]
- Major Salivary Gland Carcinoma ex Pleomorphic Adenoma [NCIt concept]
- Major Salivary Gland Mucoepidermoid Carcinoma [NCIt concept]
- Major Vault Protein [NCIt concept]
- Malate Dehydrogenase [NCIt concept]
- Male Breast Carcinoma [NCIt concept]
- Male Reproductive System Neoplasm [NCIt concept]
- Maleylacetoacetate Isomerase [NCIt concept]
- Malglycemia [NCIt concept]
- Malignancy in Giant Cell Tumor of Bone [NCIt concept]
- Malignant [NCIt concept]
- Malignant Adrenal Gland Neoplasm [NCIt concept]
- Malignant Adult Hemangiopericytoma [NCIt concept]
- Malignant Anal Neoplasm [NCIt concept]
- Malignant Biliary Obstruction [NCIt concept]
- Malignant Bladder Neoplasm [NCIt concept]
- Malignant Bone Neoplasm [NCIt concept]
- Malignant Brain Glioma [NCIt concept]
- Malignant Brain Neoplasm [NCIt concept]
- Malignant Breast Neoplasm [NCIt concept]
- Malignant Bronchial Neoplasm [NCIt concept]
- Malignant Cardiovascular Neoplasm [NCIt concept]
- Malignant Cecum Neoplasm [NCIt concept]
- Malignant Central Nervous System Neoplasm [NCIt concept]
- Malignant Cerebral Neoplasm [NCIt concept]
- Malignant Cervical Neoplasm [NCIt concept]
- Malignant Childhood Hemangiopericytoma [NCIt concept]
- Malignant Ciliary Body Medulloepithelioma [NCIt concept]
- Malignant Ciliary Body Neoplasm [NCIt concept]
- Malignant Conjunctival Neoplasm [NCIt concept]
- Malignant Digestive System Neoplasm [NCIt concept]
- Malignant Endocervical Neoplasm [NCIt concept]
- Malignant Endocrine Neoplasm [NCIt concept]
- Malignant Extragonadal Germ Cell Tumor [NCIt concept]
- Malignant Extragonadal Nongerminomatous Germ Cell Tumor [NCIt concept]
- Malignant Eye Neoplasm [NCIt concept]
- Malignant Eyelid Neoplasm [NCIt concept]
- Malignant Female Reproductive System Neoplasm [NCIt concept]
- Malignant Gallbladder Neoplasm [NCIt concept]
- Malignant Gastric Gastrointestinal Stromal Tumor [NCIt concept]
- Malignant Gastric Neoplasm [NCIt concept]
- Malignant Gastrinoma [NCIt concept]
- Malignant Gastrointestinal Stromal Tumor [NCIt concept]
- Malignant Genitourinary System Neoplasm [NCIt concept]
- Malignant Gingival Neoplasm [NCIt concept]
- Malignant Glioma [NCIt concept]
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Malignant Head and Neck Mucosal Neoplasm [NCIt concept]
- Malignant Head and Neck Neoplasm [NCIt concept]
- Malignant Hepatobiliary Neoplasm [NCIt concept]
- Malignant Hypopharyngeal Neoplasm [NCIt concept]
- Malignant Hypothalamic Neoplasm [NCIt concept]
- Malignant Kidney Neoplasm [NCIt concept]
- Malignant Lacrimal Drainage System Neoplasm [NCIt concept]
- Malignant Lesion [NCIt concept]
- Malignant Lip Neoplasm [NCIt concept]
- Malignant Lung Neoplasm [NCIt concept]
- Malignant Male Reproductive System Neoplasm [NCIt concept]
- Malignant Mediastinal Neoplasm [NCIt concept]
- Malignant Meningeal Neoplasm [NCIt concept]
- Malignant Mesothelioma [NCIt concept]
- Malignant Mixed Tumor of the Salivary Gland [NCIt concept]
- Malignant Muscle Neoplasm [NCIt concept]
- Malignant Musculoskeletal Neoplasm [NCIt concept]
- Malignant Nasopharyngeal Neoplasm [NCIt concept]
- Malignant Neoplasm [NCIt concept]
- Malignant Neoplasm of Unknown Primary [NCIt concept]
- Malignant Neoplasm of the Abdominal Esophagus [NCIt concept]
- Malignant Nipple Neoplasm [NCIt concept]
- Malignant Non-Hodgkin's Lymphoma, Small Cleaved Cell [NCIt concept]
- Malignant Odontogenic Neoplasm [NCIt concept]
- Malignant Oral Cavity Neoplasm [NCIt concept]
- Malignant Ovarian Brenner Tumor [NCIt concept]
- Malignant Ovarian Epithelial Tumor [NCIt concept]
- Malignant Ovarian Neoplasm [NCIt concept]
- Malignant Palate Neoplasm [NCIt concept]
- Malignant Pancreatic Gastrinoma [NCIt concept]
- Malignant Pancreatic Glucagonoma [NCIt concept]
- Malignant Pancreatic Insulinoma [NCIt concept]
- Malignant Pancreatic Neoplasm [NCIt concept]
- Malignant Pancreatic Somatostatinoma [NCIt concept]
- Malignant Parapharyngeal Neoplasm [NCIt concept]
- Malignant Parotid Gland Neoplasm [NCIt concept]
- Malignant Pelvic Neoplasm [NCIt concept]
- Malignant Pericardial Effusion [NCIt concept]
- Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Malignant Peripheral Nervous System Neoplasm [NCIt concept]
- Malignant Peritoneal Effusion [NCIt concept]
- Malignant Pharyngeal Neoplasm [NCIt concept]
- Malignant Pleural Effusion [NCIt concept]
- Malignant Pleural Neoplasm [NCIt concept]
- Malignant Posterior Tongue Neoplasm [NCIt concept]
- Malignant Prostate Neoplasm [NCIt concept]
- Malignant Pylorus Neoplasm [NCIt concept]
- Malignant Rectal Neoplasm [NCIt concept]
- Malignant Rectosigmoid Neoplasm [NCIt concept]
- Malignant Renal Pelvis Neoplasm [NCIt concept]
- Malignant Respiratory System Neoplasm [NCIt concept]
- Malignant Retinal Neoplasm [NCIt concept]
- Malignant Retroperitoneal Germ Cell Tumor [NCIt concept]
- Malignant Retropharyngeal Neoplasm [NCIt concept]
- Malignant Salivary Gland Neoplasm [NCIt concept]
- Malignant Skin Neoplasm [NCIt concept]
- Malignant Small Intestinal Neoplasm [NCIt concept]
- Malignant Solid Neoplasm [NCIt concept]
- Malignant Somatostatinoma [NCIt concept]
- Malignant Spermatic Cord Neoplasm [NCIt concept]
- Malignant Sphenoid Sinus Neoplasm [NCIt concept]
- Malignant Supratentorial Neoplasm [NCIt concept]
- Malignant Testicular Germ Cell Tumor [NCIt concept]
- Malignant Testicular Neoplasm [NCIt concept]
- Malignant Testicular Non-Seminomatous Germ Cell Tumor [NCIt concept]
- Malignant Thoracic Neoplasm [NCIt concept]
- Malignant Thymoma [NCIt concept]
- Malignant Tongue Neoplasm [NCIt concept]
- Malignant Type A Thymoma [NCIt concept]
- Malignant Type AB Thymoma [NCIt concept]
- Malignant Type B1 Thymoma [NCIt concept]
- Malignant Type B2 Thymoma [NCIt concept]
- Malignant Ureter Neoplasm [NCIt concept]
- Malignant Urinary System Neoplasm [NCIt concept]
- Malignant Uterine Corpus Neoplasm [NCIt concept]
- Malignant Uterine Neoplasm [NCIt concept]
- Malnutrition [NCIt concept]
- Malondialdehyde [NCIt concept]
- Malondialdehyde-Lysine [NCIt concept]
- Malposition of Uterus [NCIt concept]
- Mammaglobin-A [NCIt concept]
- Mammaglobin-A DNA Vaccine [NCIt concept]
- Mammographically Dense Breast [NCIt concept]
- Mammography [NCIt concept]
- Mammoplasty [NCIt concept]
- Mammoplasty Patient [NCIt concept]
- Management of Therapy Complications [NCIt concept]
- Manganese [NCIt concept]
- Manganese/L-alanine/Vitamin D3-containing Contrast Agent Formulation [NCIt concept]
- Mannan-Binding Lectin Serine Protease 2 [NCIt concept]
- Mannitol [NCIt concept]
- Mannose-Binding Lectin [NCIt concept]
- Mannose-Binding Protein C [NCIt concept]
- Mannosidosis [NCIt concept]
- Manometry [NCIt concept]
- Mantle Cell Lymphoma [NCIt concept]
- Mantle Field Radiation Therapy [NCIt concept]
- Manual Therapy [NCIt concept]
- Manufactured Autologous Anti-BCMA CAR-T Cells [NCIt concept]
- Manuka Honey [NCIt concept]
- Manuka Honey Breast Pads [NCIt concept]
- Mapatumumab [NCIt concept]
- Maplirpacept [NCIt concept]
- Maraba Oncolytic Virus Expressing Mutant HPV E6/E7 [NCIt concept]
- Maraviroc [NCIt concept]
- Maresin 1 [NCIt concept]
- Margetuximab [NCIt concept]
- Marginal Zone Lymphoma [NCIt concept]
- Maribavir [NCIt concept]
- Marizomib [NCIt concept]
- Marlotamig [NCIt concept]
- Maroteaux-Lamy Syndrome [NCIt concept]
- Masaoka-Koga Stage I [NCIt concept]
- Masaoka-Koga Stage II [NCIt concept]
- Masaoka-Koga Stage III [NCIt concept]
- Masaoka-Koga Stage IV [NCIt concept]
- Masaoka-Koga Stage IVa [NCIt concept]
- Masaoka-Koga Stage IVb [NCIt concept]
- Masitinib Mesylate [NCIt concept]
- Masofaniten [NCIt concept]
- Masoprocol [NCIt concept]
- Mass Spectrometry [NCIt concept]
- Mass Spectrometry-based Cancer Detection via Hand-held Extraction Device [NCIt concept]
- Massage Therapy [NCIt concept]
- Mast Cell [NCIt concept]
- Mast Cell Leukemia [NCIt concept]
- Mast Cell Sarcoma [NCIt concept]
- Mast/Stem Cell Growth Factor Receptor Kit [NCIt concept]
- Mastectomy [NCIt concept]
- Mastectomy Patient [NCIt concept]
- Mastermind-Like Protein 1 [NCIt concept]
- Mastermind-Like Protein 2 [NCIt concept]
- Mastermind-Like Protein 3 [NCIt concept]
- Mastitis [NCIt concept]
- Mastocytosis [NCIt concept]
- Matched Unrelated Donor Hematopoietic Cell Transplantation [NCIt concept]
- Matrilysin [NCIt concept]
- Matrix Metalloproteinase [NCIt concept]
- Matrix Metalloproteinase-14 [NCIt concept]
- Matrix Metalloproteinase-16 [NCIt concept]
- Matrix Metalloproteinase-9 [NCIt concept]
- Matrix-Assisted Laser Desorption Ionization Mass Spectrometry [NCIt concept]
- Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [NCIt concept]
- Mature B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Mature Ovarian Teratoma [NCIt concept]
- Mature T-Cell and NK-Cell Neoplasm [NCIt concept]
- Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Mavelertinib [NCIt concept]
- Maveropepimut-S [NCIt concept]
- Mavorixafor [NCIt concept]
- Mavrostobart [NCIt concept]
- Maximal Inspiratory Pressure [NCIt concept]
- Mcl-1 Inhibitor MIK665 [NCIt concept]
- Measles Virus Antibody [NCIt concept]
- Measles Virus N mRNA [NCIt concept]
- Measles Virus Nucleoprotein [NCIt concept]
- Measles morbillivirus [NCIt concept]
- Measurable Residual Disease [NCIt concept]
- Measurable Residual Disease 0.01 Percent or Greater [NCIt concept]
- Measurable Residual Disease 0.1 Percent or Greater [NCIt concept]
- Measurable Residual Disease Less than 0.01 Percent [NCIt concept]
- Measurable Residual Disease Less than 0.1 Percent [NCIt concept]
- Measurable Residual Disease Less than 0.2 Percent [NCIt concept]
- Measurable Residual Disease Less than 1 Percent [NCIt concept]
- Measurable Residual Disease Negativity [NCIt concept]
- Measurable Residual Disease Persistence [NCIt concept]
- Measurable Residual Disease Relapse [NCIt concept]
- Measurable Residual Disease Response [NCIt concept]
- Mebendazole [NCIt concept]
- Mechlorethamine Hydrochloride [NCIt concept]
- Meclizine [NCIt concept]
- Meclofenamate Sodium [NCIt concept]
- Media Campaign [NCIt concept]
- Media Intervention [NCIt concept]
- Mediastinal Disorder [NCIt concept]
- Mediastinal Lymph Node Dissection [NCIt concept]
- Mediastinal Lymphoma [NCIt concept]
- Mediastinal Radiation Therapy [NCIt concept]
- Mediastinoscopy [NCIt concept]
- Mediator of DNA Damage Checkpoint Protein 1 [NCIt concept]
- Mediator of RNA Polymerase II Transcription Subunit 12 [NCIt concept]
- Medical Assistant [NCIt concept]
- Medical Chart Review [NCIt concept]
- Medical Device [NCIt concept]
- Medical Evaluation of Speech, Language, and Hearing Problems [NCIt concept]
- Medical Examination Assessment [NCIt concept]
- Medical Oncologist [NCIt concept]
- Medication Administration [NCIt concept]
- Meditation Therapy [NCIt concept]
- Meditation-Based Stress Reduction Program [NCIt concept]
- Medium- to Long-Chain Acylcarnitine Ratio Measurement [NCIt concept]
- Medium/Large Size Posterior Uveal Melanoma [NCIt concept]
- Medroxyprogesterone [NCIt concept]
- Medroxyprogesterone Acetate [NCIt concept]
- Medullary Hemangioblastoma [NCIt concept]
- Medulloblastoma, Not Otherwise Specified [NCIt concept]
- Medulloblastoma, SHH-2 [NCIt concept]
- Medulloblastoma, SHH-3 [NCIt concept]
- Medulloblastoma, SHH-4 [NCIt concept]
- Mefloquine [NCIt concept]
- Megakaryocyte [NCIt concept]
- Megakaryocyte Colony Forming Unit [NCIt concept]
- Megakaryocyte-Potentiating Factor [NCIt concept]
- Megavoltage Cone Beam Computed Tomography [NCIt concept]
- Megavoltage Topographic Imaging [NCIt concept]
- Megestrol [NCIt concept]
- Megestrol Acetate [NCIt concept]
- Meiotic Recombination Gene Mutation [NCIt concept]
- Melanocortin-4 Receptor Agonist LB54640 [NCIt concept]
- Melanocyte Protein PMEL [NCIt concept]
- Melanocyte-Stimulating Hormone Receptor [NCIt concept]
- Melanocytic Neoplasm [NCIt concept]
- Melanoma [NCIt concept]
- Melanoma Advanced Imaging Dermatoscope [NCIt concept]
- Melanoma Antigen Preferentially Expressed in Tumors [NCIt concept]
- Melanoma Antigen Recognized by T-Cells 1 [NCIt concept]
- Melanoma Arising in Blue Nevus [NCIt concept]
- Melanoma Arising in Congenital Melanocytic Nevus [NCIt concept]
- Melanoma Helper Peptide Vaccine [NCIt concept]
- Melanoma Inhibitory Activity Protein 2 [NCIt concept]
- Melanoma in Junctional Nevus [NCIt concept]
- Melanoma in Precancerous Melanosis [NCIt concept]
- Melanoma of Unknown Primary [NCIt concept]
- Melanoma-Associated Antigen 1 [NCIt concept]
- Melanoma-Associated Antigen 10 [NCIt concept]
- Melanoma-Associated Antigen 11 [NCIt concept]
- Melanoma-Associated Antigen 12 [NCIt concept]
- Melanoma-Associated Antigen 2 [NCIt concept]
- Melanoma-Associated Antigen 3 [NCIt concept]
- Melanoma-Associated Antigen 4 [NCIt concept]
- Melanoma-Associated Antigen 6 [NCIt concept]
- Melanoma-Associated Antigen B18 [NCIt concept]
- Melanoma-Associated Antigen B2 [NCIt concept]
- Melanoma-Associated Antigen C1 [NCIt concept]
- Melanoma-Associated Antigen C2 [NCIt concept]
- Melanoma-Associated Antigen Family [NCIt concept]
- Melanoma-Associated Antigen Family A [NCIt concept]
- Melanoma-Derived Growth Regulatory Protein [NCIt concept]
- Melanotransferrin [NCIt concept]
- Melanotropin Alpha [NCIt concept]
- Melatonin [NCIt concept]
- Melia azadirachta Flower Extract [NCIt concept]
- Meloxicam [NCIt concept]
- Melphalan [NCIt concept]
- Melphalan Flufenamide [NCIt concept]
- Melphalan Hydrochloride [NCIt concept]
- Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex [NCIt concept]
- Memantine [NCIt concept]
- Memantine Hydrochloride [NCIt concept]
- Membrane Cofactor Protein [NCIt concept]
- Membrane Transport Protein XK [NCIt concept]
- Membrane-Associated Guanylate Kinase, WW and PDZ Domain-Containing Protein 2 [NCIt concept]
- Membrane-Associated Progesterone Receptor Component 1 [NCIt concept]
- Membrane-Associated Transporter Protein [NCIt concept]
- Membrane-Associated Tyrosine- and Threonine-Specific Cdc2-Inhibitory Kinase [NCIt concept]
- Membrane-bound IL-15-expressing Tumor-infiltrating Lymphocytes OBX-115 [NCIt concept]
- Membrane-bound Interleukin-21-Expanded Haploidentical Natural Killer Cells [NCIt concept]
- Memory B-Lymphocyte [NCIt concept]
- Memory Intervention [NCIt concept]
- Memory T-Lymphocyte [NCIt concept]
- Men who have Sex with Men [NCIt concept]
- Menadione Topical Lotion [NCIt concept]
- Menin [NCIt concept]
- Meningeal [NCIt concept]
- Meningeal Leukemia [NCIt concept]
- Meningeal Lymphoma [NCIt concept]
- Meningeal Neoplasm [NCIt concept]
- Meningioma [NCIt concept]
- Menopausal Symptom [NCIt concept]
- Mepolizumab [NCIt concept]
- Mercaptopurine [NCIt concept]
- Mercury [NCIt concept]
- Merestinib [NCIt concept]
- Merkel Cell Carcinoma [NCIt concept]
- Merkel Cell Polyomavirus [NCIt concept]
- Merkel Cell Polyomavirus T Antigen Positive [NCIt concept]
- Merlin [NCIt concept]
- Mesalamine [NCIt concept]
- Mesenchymal Stem Cell [NCIt concept]
- Mesenchymal Stem Cell Transplantation [NCIt concept]
- Mesenchymal Stromal Cell [NCIt concept]
- Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA [NCIt concept]
- Mesenteric Gastrointestinal Stromal Tumor [NCIt concept]
- Mesenteric Thrombosis [NCIt concept]
- Mesmulogene Ancovacivec [NCIt concept]
- Mesna [NCIt concept]
- Mesothelial Neoplasm [NCIt concept]
- Mesothelin [NCIt concept]
- Mesothelin Positive [NCIt concept]
- Mesothelin-Like Protein [NCIt concept]
- Mesothelin-specific Chimeric Antigen Receptor-engineered Peripheral Blood Lymphocytes [NCIt concept]
- Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536 [NCIt concept]
- Messenger RNA [NCIt concept]
- Met-Enkephalin [NCIt concept]
- Metabolic Abnormality Assessment [NCIt concept]
- Metabolic Dysfunction-Associated Steatotic Liver Disease [NCIt concept]
- Metabolic Syndrome [NCIt concept]
- Metabolite [NCIt concept]
- Metabolomics [NCIt concept]
- Metabotropic Glutamate Receptor 1 [NCIt concept]
- Metabotropic Glutamate Receptor 2 [NCIt concept]
- Metabotropic Glutamate Receptor 3 [NCIt concept]
- Metabotropic Glutamate Receptor 4 [NCIt concept]
- Metabotropic Glutamate Receptor 5 [NCIt concept]
- Metabotropic Glutamate Receptor 6 [NCIt concept]
- Metabotropic Glutamate Receptor 7 [NCIt concept]
- Metabotropic Glutamate Receptor 8 [NCIt concept]
- Metachromatic Leukodystrophy [NCIt concept]
- Metalloproteinase Inhibitor 1 [NCIt concept]
- Metalloproteinase Inhibitor 3 [NCIt concept]
- Metalloproteinase Inhibitor 4 [NCIt concept]
- Metalloreductase STEAP1 [NCIt concept]
- Metalloreductase STEAP2 [NCIt concept]
- Metallothionein-1G [NCIt concept]
- Metanephrine [NCIt concept]
- Metaplastic [NCIt concept]
- Metarrestin [NCIt concept]
- Metastasectomy [NCIt concept]
- Metastasis-Associated Lung Adenocarcinoma Transcript 1 [NCIt concept]
- Metastasis-Associated Protein MTA1 [NCIt concept]
- Metastasis-Associated in Colon Cancer Protein 1 [NCIt concept]
- Metastatic Acral Lentiginous Melanoma [NCIt concept]
- Metastatic Acral Melanoma [NCIt concept]
- Metastatic Adenocarcinoma [NCIt concept]
- Metastatic Adenoid Cystic Carcinoma [NCIt concept]
- Metastatic Adnexal Carcinoma [NCIt concept]
- Metastatic Adrenal Gland Pheochromocytoma [NCIt concept]
- Metastatic Ampulla of Vater Carcinoma [NCIt concept]
- Metastatic Anal Canal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Anal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Androgen Receptor-Positive Breast Carcinoma [NCIt concept]
- Metastatic Appendix Mucinous Adenocarcinoma [NCIt concept]
- Metastatic BRCA Hereditary Breast Carcinoma [NCIt concept]
- Metastatic Basal Cell Carcinoma [NCIt concept]
- Metastatic Bladder Adenocarcinoma [NCIt concept]
- Metastatic Bladder Carcinoma [NCIt concept]
- Metastatic Bladder Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Bladder Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Bladder Squamous Cell Carcinoma [NCIt concept]
- Metastatic Bladder Urothelial Carcinoma [NCIt concept]
- Metastatic Bone Sarcoma [NCIt concept]
- Metastatic Breast Adenocarcinoma [NCIt concept]
- Metastatic Breast Carcinoma in the Bone [NCIt concept]
- Metastatic Breast Carcinoma in the Brain [NCIt concept]
- Metastatic Breast Carcinoma in the Central Nervous System [NCIt concept]
- Metastatic Breast Carcinoma in the Liver [NCIt concept]
- Metastatic Breast Carcinoma in the Lung [NCIt concept]
- Metastatic Breast Carcinoma in the Lymph Nodes [NCIt concept]
- Metastatic Breast Carcinoma in the Skin [NCIt concept]
- Metastatic Breast Carcinoma in the Spine [NCIt concept]
- Metastatic Breast Inflammatory Carcinoma [NCIt concept]
- Metastatic Breast Lobular Carcinoma [NCIt concept]
- Metastatic CIC-Rearranged Sarcoma [NCIt concept]
- Metastatic Carcinoma [NCIt concept]
- Metastatic Carcinoma in the Lung [NCIt concept]
- Metastatic Carcinoma in the Pancreas [NCIt concept]
- Metastatic Carcinoma in the Rectum [NCIt concept]
- Metastatic Cardiac Paraganglioma [NCIt concept]
- Metastatic Castration-Resistant Prostate Carcinoma [NCIt concept]
- Metastatic Castration-Sensitive Prostate Carcinoma [NCIt concept]
- Metastatic Cervical Adenocarcinoma [NCIt concept]
- Metastatic Cervical Adenosquamous Carcinoma [NCIt concept]
- Metastatic Cervical Non-Squamous Cell Carcinoma [NCIt concept]
- Metastatic Cervical Squamous Cell Carcinoma [NCIt concept]
- Metastatic Childhood Colorectal Carcinoma [NCIt concept]
- Metastatic Childhood Lung Carcinoma [NCIt concept]
- Metastatic Childhood Malignant Solid Neoplasm [NCIt concept]
- Metastatic Childhood Soft Tissue Sarcoma [NCIt concept]
- Metastatic Cholangiocarcinoma [NCIt concept]
- Metastatic Chordoma [NCIt concept]
- Metastatic Choroid Melanoma [NCIt concept]
- Metastatic Chromophobe Renal Cell Carcinoma [NCIt concept]
- Metastatic Clear Cell (Glycogen-Rich) Urothelial Carcinoma [NCIt concept]
- Metastatic Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Metastatic Colon Adenocarcinoma [NCIt concept]
- Metastatic Colon Carcinoma [NCIt concept]
- Metastatic Colorectal Adenocarcinoma [NCIt concept]
- Metastatic Colorectal Carcinoma [NCIt concept]
- Metastatic Colorectal Mucinous Adenocarcinoma [NCIt concept]
- Metastatic Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Metastatic Conjunctival Melanoma [NCIt concept]
- Metastatic Dedifferentiated Liposarcoma [NCIt concept]
- Metastatic Desmoplastic Small Round Cell Tumor [NCIt concept]
- Metastatic Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Metastatic Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Metastatic Digestive System Carcinoma [NCIt concept]
- Metastatic Digestive System Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Metastatic Digestive System Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Metastatic Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Metastatic Digestive System Neuroendocrine Tumor G2 [NCIt concept]
- Metastatic Distal Cholangiocarcinoma [NCIt concept]
- Metastatic Distal Esophagus Adenocarcinoma [NCIt concept]
- Metastatic Embryonal Rhabdomyosarcoma [NCIt concept]
- Metastatic Embryonal Tumor with Multilayered Rosettes [NCIt concept]
- Metastatic Endocrine Carcinoma [NCIt concept]
- Metastatic Endometrial Adenosquamous Carcinoma [NCIt concept]
- Metastatic Endometrial Carcinoma [NCIt concept]
- Metastatic Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Metastatic Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Metastatic Ependymoma [NCIt concept]
- Metastatic Epithelioid Hemangioendothelioma [NCIt concept]
- Metastatic Esophageal Carcinoma [NCIt concept]
- Metastatic Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Metastatic Exocrine Pancreas Carcinoma [NCIt concept]
- Metastatic Extracranial Malignant Solid Neoplasm [NCIt concept]
- Metastatic Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Metastatic Extrahepatic Cholangiocarcinoma [NCIt concept]
- Metastatic Extramammary Paget Disease [NCIt concept]
- Metastatic Extrapulmonary Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Extrapulmonary Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Fallopian Tube Carcinoma [NCIt concept]
- Metastatic Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Fibrolamellar Carcinoma [NCIt concept]
- Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinoma [NCIt concept]
- Metastatic Gallbladder Carcinoma [NCIt concept]
- Metastatic Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Metastatic Gastroesophageal Junction Carcinoma [NCIt concept]
- Metastatic Gastrointestinal Stromal Tumor [NCIt concept]
- Metastatic Genitourinary System Carcinoma [NCIt concept]
- Metastatic Giant Cell Urothelial Carcinoma [NCIt concept]
- Metastatic Glioblastoma [NCIt concept]
- Metastatic Glioma [NCIt concept]
- Metastatic HER2-Negative BRCA-Associated Breast Carcinoma [NCIt concept]
- Metastatic Head and Neck Carcinoma [NCIt concept]
- Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Metastatic Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Metastatic Hepatoblastoma [NCIt concept]
- Metastatic Hepatopancreatobiliary Carcinoma [NCIt concept]
- Metastatic High Grade Sarcoma [NCIt concept]
- Metastatic Hilar Cholangiocarcinoma [NCIt concept]
- Metastatic Hindgut Neuroendocrine Tumor [NCIt concept]
- Metastatic Hormone Receptor-Negative Breast Carcinoma [NCIt concept]
- Metastatic Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Metastatic Human Papillomavirus-Related Malignant Neoplasm [NCIt concept]
- Metastatic Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Intracranial Malignant Neoplasm [NCIt concept]
- Metastatic Intrahepatic Cholangiocarcinoma [NCIt concept]
- Metastatic Kidney Carcinoma [NCIt concept]
- Metastatic Kidney Medullary Carcinoma [NCIt concept]
- Metastatic Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Lesion [NCIt concept]
- Metastatic Lipid-Rich Urothelial Carcinoma [NCIt concept]
- Metastatic Low Grade Astrocytoma [NCIt concept]
- Metastatic Low Grade Glioma [NCIt concept]
- Metastatic Lung Adenocarcinoma [NCIt concept]
- Metastatic Lung Adenosquamous Carcinoma [NCIt concept]
- Metastatic Lung Carcinoma in the Central Nervous System [NCIt concept]
- Metastatic Lung Large Cell Carcinoma [NCIt concept]
- Metastatic Lung Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Lung Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Lung Neuroendocrine Neoplasm [NCIt concept]
- Metastatic Lung Neuroendocrine Tumor [NCIt concept]
- Metastatic Lung Non-Small Cell Carcinoma [NCIt concept]
- Metastatic Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Metastatic Lung Small Cell Carcinoma [NCIt concept]
- Metastatic Malignant Abdominal Neoplasm [NCIt concept]
- Metastatic Malignant Colorectal Neoplasm [NCIt concept]
- Metastatic Malignant Digestive System Neoplasm [NCIt concept]
- Metastatic Malignant Extragonadal Germ Cell Tumor [NCIt concept]
- Metastatic Malignant Female Reproductive System Neoplasm [NCIt concept]
- Metastatic Malignant Genitourinary System Neoplasm [NCIt concept]
- Metastatic Malignant Germ Cell Tumor [NCIt concept]
- Metastatic Malignant Glomus Tumor [NCIt concept]
- Metastatic Malignant Hepatobiliary Neoplasm [NCIt concept]
- Metastatic Malignant Mesothelioma [NCIt concept]
- Metastatic Malignant Neoplasm [NCIt concept]
- Metastatic Malignant Neoplasm in the Bone [NCIt concept]
- Metastatic Malignant Neoplasm in the Brain [NCIt concept]
- Metastatic Malignant Neoplasm in the Central Nervous System [NCIt concept]
- Metastatic Malignant Neoplasm in the Colon [NCIt concept]
- Metastatic Malignant Neoplasm in the Leptomeninges [NCIt concept]
- Metastatic Malignant Neoplasm in the Liver [NCIt concept]
- Metastatic Malignant Neoplasm in the Lung [NCIt concept]
- Metastatic Malignant Neoplasm in the Lymph Nodes [NCIt concept]
- Metastatic Malignant Neoplasm in the Peritoneum [NCIt concept]
- Metastatic Malignant Neoplasm in the Retroperitoneum [NCIt concept]
- Metastatic Malignant Neoplasm in the Skin [NCIt concept]
- Metastatic Malignant Neoplasm in the Soft Tissue [NCIt concept]
- Metastatic Malignant Neoplasm in the Spinal Cord [NCIt concept]
- Metastatic Malignant Neoplasm in the Spine [NCIt concept]
- Metastatic Malignant Neoplasm in the Supraclavicular Lymph Nodes [NCIt concept]
- Metastatic Malignant Neoplasm in the Thoracic Cavity [NCIt concept]
- Metastatic Malignant Neoplasm in the Upper Abdominal Lymph Nodes [NCIt concept]
- Metastatic Malignant Neoplasm in the Viscera [NCIt concept]
- Metastatic Malignant Nongerminomatous Germ Cell Tumor [NCIt concept]
- Metastatic Malignant PEComa [NCIt concept]
- Metastatic Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Metastatic Malignant Skin Neoplasm [NCIt concept]
- Metastatic Malignant Soft Tissue Neoplasm [NCIt concept]
- Metastatic Malignant Solid Neoplasm [NCIt concept]
- Metastatic Malignant Testicular Germ Cell Tumor [NCIt concept]
- Metastatic Malignant Uterine Corpus Neoplasm [NCIt concept]
- Metastatic Medulloblastoma [NCIt concept]
- Metastatic Melanoma [NCIt concept]
- Metastatic Melanoma in the Brain [NCIt concept]
- Metastatic Melanoma in the Central Nervous System [NCIt concept]
- Metastatic Merkel Cell Carcinoma [NCIt concept]
- Metastatic Mesonephric Adenocarcinoma [NCIt concept]
- Metastatic Micropapillary Urothelial Carcinoma [NCIt concept]
- Metastatic Microsatellite Stable Colon Carcinoma [NCIt concept]
- Metastatic Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Metastatic Microsatellite Stable Ovarian Carcinoma [NCIt concept]
- Metastatic Midgut Neuroendocrine Tumor [NCIt concept]
- Metastatic Midgut Neuroendocrine Tumor G1 [NCIt concept]
- Metastatic Midgut Neuroendocrine Tumor G2 [NCIt concept]
- Metastatic Mismatch Repair Proficient Colorectal Carcinoma [NCIt concept]
- Metastatic Mixed Neuroendocrine Non-Neuroendocrine Neoplasm [NCIt concept]
- Metastatic Mucosal Melanoma [NCIt concept]
- Metastatic Myxofibrosarcoma [NCIt concept]
- Metastatic Myxoid Liposarcoma [NCIt concept]
- Metastatic NUT Carcinoma [NCIt concept]
- Metastatic Nasal Cavity Squamous Cell Carcinoma [NCIt concept]
- Metastatic Nasopharyngeal Carcinoma [NCIt concept]
- Metastatic Nasopharyngeal Non-Keratinizing Carcinoma [NCIt concept]
- Metastatic Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Nested Urothelial Carcinoma [NCIt concept]
- Metastatic Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Neuroendocrine Neoplasm [NCIt concept]
- Metastatic Non-Functioning Neuroendocrine Tumor [NCIt concept]
- Metastatic Non-Muscle Invasive Bladder Carcinoma [NCIt concept]
- Metastatic Non-Small Cell Carcinoma [NCIt concept]
- Metastatic Non-Sun Exposed Skin Melanoma [NCIt concept]
- Metastatic Ocular Melanoma [NCIt concept]
- Metastatic Olfactory Neuroblastoma [NCIt concept]
- Metastatic Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Metastatic Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Osteosarcoma [NCIt concept]
- Metastatic Ovarian Carcinoma [NCIt concept]
- Metastatic Ovarian High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Metastatic Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Serous Adenocarcinoma [NCIt concept]
- Metastatic Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Metastatic Ovarian Undifferentiated Carcinoma [NCIt concept]
- Metastatic Pancreatic Acinar Cell Carcinoma [NCIt concept]
- Metastatic Pancreatic Adenocarcinoma [NCIt concept]
- Metastatic Pancreatic Adenosquamous Carcinoma [NCIt concept]
- Metastatic Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Metastatic Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Pancreatic Neuroendocrine Neoplasm [NCIt concept]
- Metastatic Pancreatic Neuroendocrine Tumor [NCIt concept]
- Metastatic Pancreatic Squamous Cell Carcinoma [NCIt concept]
- Metastatic Pancreatobiliary Carcinoma [NCIt concept]
- Metastatic Paraganglioma [NCIt concept]
- Metastatic Paranasal Sinus Squamous Cell Carcinoma [NCIt concept]
- Metastatic Parathyroid Gland Carcinoma [NCIt concept]
- Metastatic Penile Squamous Cell Carcinoma [NCIt concept]
- Metastatic Peritoneal Malignant Mesothelioma [NCIt concept]
- Metastatic Pharyngeal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Plasmacytoid Urothelial Carcinoma [NCIt concept]
- Metastatic Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Metastatic Platinum-Resistant Fallopian Tube Carcinoma [NCIt concept]
- Metastatic Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Metastatic Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Platinum-Resistant Primary Peritoneal Carcinoma [NCIt concept]
- Metastatic Pleomorphic Liposarcoma [NCIt concept]
- Metastatic Pleural Malignant Mesothelioma [NCIt concept]
- Metastatic Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Metastatic Primary Central Chondrosarcoma [NCIt concept]
- Metastatic Primary Malignant Brain Neoplasm [NCIt concept]
- Metastatic Primary Malignant Central Nervous System Neoplasm [NCIt concept]
- Metastatic Primary Peritoneal Carcinoma [NCIt concept]
- Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Metastatic Primary Peritoneal Serous Adenocarcinoma [NCIt concept]
- Metastatic Progesterone Receptor-Positive Breast Carcinoma [NCIt concept]
- Metastatic Prostate Adenocarcinoma [NCIt concept]
- Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Metastatic Prostate Carcinoma [NCIt concept]
- Metastatic Prostate Carcinoma in the Lymph Nodes [NCIt concept]
- Metastatic Prostate Carcinoma in the Soft Tissue [NCIt concept]
- Metastatic Prostate Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Proximal Gastric Adenocarcinoma [NCIt concept]
- Metastatic Rectal Adenocarcinoma [NCIt concept]
- Metastatic Rectal Squamous Cell Carcinoma [NCIt concept]
- Metastatic Renal Cell Carcinoma [NCIt concept]
- Metastatic Renal Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Metastatic Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Metastatic Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Metastatic Resectable Colorectal Adenocarcinoma [NCIt concept]
- Metastatic Rhabdoid Tumor [NCIt concept]
- Metastatic Rhabdomyosarcoma [NCIt concept]
- Metastatic Round Cell Liposarcoma [NCIt concept]
- Metastatic Round Cell Sarcoma with EWSR1-non-ETS Fusion [NCIt concept]
- Metastatic Salivary Duct Carcinoma [NCIt concept]
- Metastatic Salivary Gland Adenocarcinoma, Not Otherwise Specified [NCIt concept]
- Metastatic Salivary Gland Carcinoma [NCIt concept]
- Metastatic Salivary Gland Secretory Carcinoma [NCIt concept]
- Metastatic Salivary Gland Squamous Cell Carcinoma [NCIt concept]
- Metastatic Sarcoma with BCOR Genetic Alterations [NCIt concept]
- Metastatic Sarcomatoid Renal Cell Carcinoma [NCIt concept]
- Metastatic Sarcomatoid Urothelial Carcinoma [NCIt concept]
- Metastatic Sebaceous Carcinoma [NCIt concept]
- Metastatic Sinonasal Carcinoma [NCIt concept]
- Metastatic Skin Angiosarcoma [NCIt concept]
- Metastatic Skin Sarcoma [NCIt concept]
- Metastatic Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Small Cell Sarcoma [NCIt concept]
- Metastatic Small Intestinal Carcinoma [NCIt concept]
- Metastatic Soft Tissue Leiomyosarcoma [NCIt concept]
- Metastatic Soft Tissue Sarcoma [NCIt concept]
- Metastatic Soft Tissue Sarcoma, Excluding Liposarcoma [NCIt concept]
- Metastatic Squamous Cell Carcinoma in the Breast [NCIt concept]
- Metastatic Squamous Cell Carcinoma in the Cervical Lymph Nodes [NCIt concept]
- Metastatic Squamous Cell Carcinoma in the Skin [NCIt concept]
- Metastatic Succinate Dehydrogenase-Deficient Renal Cell Carcinoma [NCIt concept]
- Metastatic Thymus Carcinoma [NCIt concept]
- Metastatic Thymus Neuroendocrine Neoplasm [NCIt concept]
- Metastatic Thyroid Gland Anaplastic Carcinoma [NCIt concept]
- Metastatic Thyroid Gland Carcinoma [NCIt concept]
- Metastatic Thyroid Gland Medullary Carcinoma [NCIt concept]
- Metastatic Thyroid Gland Oncocytic Carcinoma [NCIt concept]
- Metastatic Tonsillar Squamous Cell Carcinoma [NCIt concept]
- Metastatic Transitional Cell Carcinoma [NCIt concept]
- Metastatic Triple-Negative Breast Carcinoma [NCIt concept]
- Metastatic Triple-Negative Breast Inflammatory Carcinoma [NCIt concept]
- Metastatic Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Metastatic Undifferentiated Round Cell Sarcoma [NCIt concept]
- Metastatic Undifferentiated Sarcoma, Not Otherwise Specified [NCIt concept]
- Metastatic Unresectable Colorectal Carcinoma [NCIt concept]
- Metastatic Unresectable Gastric Adenocarcinoma [NCIt concept]
- Metastatic Unresectable Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Unresectable Sarcoma [NCIt concept]
- Metastatic Urachal Urothelial Carcinoma [NCIt concept]
- Metastatic Ureter Urothelial Carcinoma [NCIt concept]
- Metastatic Urethral Urothelial Carcinoma [NCIt concept]
- Metastatic Urothelial Carcinoma [NCIt concept]
- Metastatic Uterine Corpus Carcinosarcoma [NCIt concept]
- Metastatic Uterine Corpus Leiomyosarcoma [NCIt concept]
- Metastatic Uterine Corpus Sarcoma [NCIt concept]
- Metastatic Uveal Melanoma [NCIt concept]
- Metastatic Vaginal Carcinoma [NCIt concept]
- Metastatic Vulvar Carcinoma [NCIt concept]
- Metastatic Vulvar Squamous Cell Carcinoma [NCIt concept]
- Metformin [NCIt concept]
- Metformin Hydrochloride [NCIt concept]
- Metformin Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet [NCIt concept]
- Methadone [NCIt concept]
- Methadone Hydrochloride [NCIt concept]
- Methemoglobin [NCIt concept]
- Methemoglobin Reductase Deficiency [NCIt concept]
- Methicillin-Resistant Staphylococcus aureus Infection [NCIt concept]
- Methicillin-Sensitive Staphylococcus aureus Infection [NCIt concept]
- Methimazole [NCIt concept]
- Methionine [NCIt concept]
- Methionine Aminopeptidase 2 [NCIt concept]
- Methionine Aminopeptidase 2 Inhibitor M8891 [NCIt concept]
- Methionine C 11 [NCIt concept]
- Methionine Synthase [NCIt concept]
- Methionine Synthase Reductase [NCIt concept]
- Methionine-Restricted Diet [NCIt concept]
- Methotrexate [NCIt concept]
- Methotrexate Sodium [NCIt concept]
- Methoxsalen [NCIt concept]
- Methoxyamine [NCIt concept]
- Methoxyamine Hydrochloride [NCIt concept]
- Methyl Bacteriopurpurinimide [NCIt concept]
- Methyl-5-Aminolevulinate Hydrochloride Cream [NCIt concept]
- Methyl-CpG-Binding Domain Protein 2 [NCIt concept]
- Methyl-CpG-Binding Domain Protein 4 [NCIt concept]
- Methylated Circulating Tumor-Derived DNA [NCIt concept]
- Methylated-DNA-Protein-Cysteine Methyltransferase [NCIt concept]
- Methylcytosine Dioxygenase TET1 [NCIt concept]
- Methylcytosine Dioxygenase TET2 [NCIt concept]
- Methylene Blue [NCIt concept]
- Methylene Blue Oral Rinse [NCIt concept]
- Methylenetetrahydrofolate Reductase [NCIt concept]
- Methylnaltrexone [NCIt concept]
- Methylphenidate [NCIt concept]
- Methylphenidate Hydrochloride [NCIt concept]
- Methylprednisolone [NCIt concept]
- Methylprednisolone Sodium Succinate [NCIt concept]
- Methylselenocysteine [NCIt concept]
- Metoclopramide [NCIt concept]
- Metoprolol [NCIt concept]
- Metoprolol Succinate [NCIt concept]
- Metoprolol Tartrate [NCIt concept]
- Mevociclib [NCIt concept]
- Mexiletine [NCIt concept]
- Mexiletine Hydrochloride [NCIt concept]
- Mezagitamab [NCIt concept]
- Mezigdomide [NCIt concept]
- Mibefradil Dihydrochloride [NCIt concept]
- Micafungin [NCIt concept]
- Micafungin Sodium [NCIt concept]
- Micellar Nanoparticle-encapsulated Epirubicin [NCIt concept]
- Michelia alba Leaf Oil [NCIt concept]
- Micro Needle Array-Doxorubicin [NCIt concept]
- Micro-ultrasound Imaging [NCIt concept]
- MicroRNA 10b-5p [NCIt concept]
- MicroRNA 124 [NCIt concept]
- MicroRNA 1246 [NCIt concept]
- MicroRNA 126-3p [NCIt concept]
- MicroRNA 1290 [NCIt concept]
- MicroRNA 181 [NCIt concept]
- MicroRNA 181b [NCIt concept]
- MicroRNA 19B [NCIt concept]
- MicroRNA 205-5p [NCIt concept]
- MicroRNA 29b [NCIt concept]
- MicroRNA 335-5p [NCIt concept]
- MicroRNA 574-3p [NCIt concept]
- MicroRNA 9 [NCIt concept]
- MicroRNA Expression Profile [NCIt concept]
- MicroRNA-10b Antagomir-Iron Oxide/Dextran-based Nanoparticle TTX-MC138 [NCIt concept]
- Microarray Analysis [NCIt concept]
- Microbial DNA [NCIt concept]
- Microbiome [NCIt concept]
- Microbiome GEN-001 [NCIt concept]
- Microbiome SER-155 [NCIt concept]
- Microbiome SER-401 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2040 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2401 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2463 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO4010 [NCIt concept]
- Microbiota-based Formulation RBX7455 [NCIt concept]
- Microcephalin [NCIt concept]
- Microdialysis [NCIt concept]
- Microglia [NCIt concept]
- Microgranular Acute Promyelocytic Leukemia [NCIt concept]
- Microinvasive [NCIt concept]
- Microinvasive Anal Carcinoma [NCIt concept]
- Microinvasive Breast Carcinoma [NCIt concept]
- Microneedle Drug Delivery System [NCIt concept]
- Micronucleus [NCIt concept]
- Microorganism [NCIt concept]
- Microparticle [NCIt concept]
- Microparticle MDP/Bacterial DNA-containing MIS416 [NCIt concept]
- Microphthalmia-Associated Transcription Factor [NCIt concept]
- Microprocessor Complex Subunit DGCR8 [NCIt concept]
- Microsatellite Instability [NCIt concept]
- Microsatellite Instability Analysis [NCIt concept]
- Microsatellite Mutator Phenotype [NCIt concept]
- Microsatellite Stable [NCIt concept]
- Microsatellite Stable Colon Carcinoma [NCIt concept]
- Microsatellite Stable Ovarian Carcinoma [NCIt concept]
- Microsatellite Stable Rectal Carcinoma [NCIt concept]
- Microscopy [NCIt concept]
- Microscopy with Ultraviolet Surface Excitation [NCIt concept]
- Microsomal Glutathione S-Transferase 2 [NCIt concept]
- Microsomal Prostaglandin E Synthase Family [NCIt concept]
- Microsomal Triglyceride Transfer Protein Large Subunit [NCIt concept]
- Microsphere-Mediated Lymphocele Prevention [NCIt concept]
- Microtransplantation [NCIt concept]
- Microtubule-Associated Protein 2 [NCIt concept]
- Microtubule-Associated Protein 4 [NCIt concept]
- Microtubule-Associated Proteins 1A/1B Light Chain 3 [NCIt concept]
- Microtubule-Associated Proteins 1A/1B Light Chain 3-I [NCIt concept]
- Microtubule-Associated Proteins 1A/1B Light Chain 3-II [NCIt concept]
- Microtubule-Associated Proteins 1A/1B Light Chain 3A [NCIt concept]
- Microtubule-Associated Proteins 1A/1B Light Chain 3B [NCIt concept]
- Microtubule-Associated Proteins 1A/1B Light Chain 3C [NCIt concept]
- Microtubule-Associated Serine/Threonine-Protein Kinase 1 [NCIt concept]
- Microtubule-Associated Serine/Threonine-Protein Kinase 2 [NCIt concept]
- Microvascular Density [NCIt concept]
- Microwave Ablation [NCIt concept]
- Micvotabart Pelidotin [NCIt concept]
- Midazolam [NCIt concept]
- Midazolam Hydrochloride [NCIt concept]
- Middle Ear Embryonal Rhabdomyosarcoma [NCIt concept]
- Midgut Neuroendocrine Tumor [NCIt concept]
- Midgut Neuroendocrine Tumor G1 [NCIt concept]
- Midgut Neuroendocrine Tumor G2 [NCIt concept]
- Midkine [NCIt concept]
- Midostaurin [NCIt concept]
- Mifamurtide [NCIt concept]
- Mifepristone [NCIt concept]
- Migoprotafib [NCIt concept]
- Milademetan Tosylate [NCIt concept]
- Milatuzumab [NCIt concept]
- Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110 [NCIt concept]
- Mild Soap Skin Cleanser [NCIt concept]
- Millimeter-Wave Holographic Imaging [NCIt concept]
- Mind Body Program for Fear of Recurrence [NCIt concept]
- Mind-Body Intervention Procedure [NCIt concept]
- Mind/body Exercise [NCIt concept]
- Mindfulness Relaxation [NCIt concept]
- Mindset Intervention [NCIt concept]
- Minibeam Radiation Therapy [NCIt concept]
- Minibody [NCIt concept]
- Minicore Myopathy with External Ophthalmoplegia [NCIt concept]
- Minimal Deviation Melanoma [NCIt concept]
- Minimal Disseminated Disease [NCIt concept]
- Minimally Invasive Distal Pancreatectomy [NCIt concept]
- Minimally Invasive Lung Adenocarcinoma [NCIt concept]
- Minimally Invasive Lung Non-Mucinous Adenocarcinoma [NCIt concept]
- Minimally Invasive Proximal Gastrectomy [NCIt concept]
- Minimally Invasive Surgery [NCIt concept]
- Mino-Lok Therapy [NCIt concept]
- Minocycline Hydrochloride [NCIt concept]
- Minocycline-EDTA [NCIt concept]
- Minor Histocompatibility Antigen HA-1 [NCIt concept]
- Minor Salivary Gland Carcinoma [NCIt concept]
- Mipasetamab Uzoptirine [NCIt concept]
- Mipicoledine [NCIt concept]
- Mipletamig [NCIt concept]
- Mipsagargin [NCIt concept]
- Miptenalimab [NCIt concept]
- Mirdametinib [NCIt concept]
- Miridesap [NCIt concept]
- Mirivadelgat [NCIt concept]
- Mirtazapine [NCIt concept]
- Mirvetuximab Soravtansine [NCIt concept]
- Mirzotamab Clezutoclax [NCIt concept]
- Misetionamide [NCIt concept]
- Mismatch Repair [NCIt concept]
- Mismatch Repair Deficiency [NCIt concept]
- Mismatch Repair Endonuclease PMS2 [NCIt concept]
- Mismatch Repair Gene Mutation [NCIt concept]
- Mismatch Repair Gene Promoter Methylation [NCIt concept]
- Mismatch Repair Proficient [NCIt concept]
- Mismatch Repair Protein [NCIt concept]
- Mismatch Repair Protein Deficiency [NCIt concept]
- Mismatch Repair Protein Proficient [NCIt concept]
- Mitapivat [NCIt concept]
- Mitazalimab [NCIt concept]
- Mitochondria-targeted Antioxidant MIT-001 [NCIt concept]
- Mitochondrial DNA [NCIt concept]
- Mitochondrial Import Receptor Subunit TOM20 Homolog [NCIt concept]
- Mitochondrial Neurogastrointestinal Encephalopathy [NCIt concept]
- Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101 [NCIt concept]
- Mitochondrial-Derived Peptide MOTS-c [NCIt concept]
- Mitogen-Activated Protein Kinase [NCIt concept]
- Mitogen-Activated Protein Kinase 1 [NCIt concept]
- Mitogen-Activated Protein Kinase 11 [NCIt concept]
- Mitogen-Activated Protein Kinase 14 [NCIt concept]
- Mitogen-Activated Protein Kinase 3 [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase Inhibitor [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase Kinase 1 [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase Kinase 14 [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase Kinase 5 [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase Kinase 8 [NCIt concept]
- Mitomycin [NCIt concept]
- Mitosis-Karyorrhexis Index [NCIt concept]
- Mitotane [NCIt concept]
- Mitotic Catastrophe [NCIt concept]
- Mitotic Checkpoint Serine/Threonine-Protein Kinase BUB1 [NCIt concept]
- Mitotic Checkpoint Serine/Threonine-Protein Kinase BUB1 Beta [NCIt concept]
- Mitotic Spindle Assembly Checkpoint Protein MAD2A [NCIt concept]
- Mitotic Spindle Assembly Checkpoint Protein MAD2B [NCIt concept]
- Mitoxantrone [NCIt concept]
- Mitoxantrone Hydrochloride [NCIt concept]
- Mivavotinib [NCIt concept]
- Mivebresib [NCIt concept]
- Mixed (Normal and Tumor) [NCIt concept]
- Mixed Cell Type Kidney Wilms Tumor [NCIt concept]
- Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Mixed Germ Cell Tumor [NCIt concept]
- Mixed Glioma [NCIt concept]
- Mixed Lineage Kinase Domain-Like Protein [NCIt concept]
- Mixed Osteosarcoma [NCIt concept]
- Mixed Phenotype Acute Leukemia [NCIt concept]
- Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/Myeloid [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/T [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/T/Myeloid [NCIt concept]
- Mixed Phenotype Acute Leukemia, Rare Types [NCIt concept]
- Mixed Phenotype Acute Leukemia, T/Myeloid [NCIt concept]
- MnSOD Mimetic BMX-001 [NCIt concept]
- Mobocertinib [NCIt concept]
- Mobocertinib Succinate [NCIt concept]
- Mocaciclib [NCIt concept]
- Mocetinostat [NCIt concept]
- Modafinil [NCIt concept]
- Modakafusp Alfa [NCIt concept]
- Modified Aldesleukin/Palivizumab Fusion Protein IOV-3001 [NCIt concept]
- Modified Barium Swallow [NCIt concept]
- Modified FOLFOX6 Regimen [NCIt concept]
- Modified Hematologic Improvement-Erythroid Response [NCIt concept]
- Modified Interleukin-2 DF6215 [NCIt concept]
- Modified Radical Mastectomy [NCIt concept]
- Modified Radical Neck Dissection [NCIt concept]
- Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine [NCIt concept]
- Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208 [NCIt concept]
- Modified Vaccinia Virus Ankara Antibody [NCIt concept]
- Modified Vaccinia Virus Ankara Expressing Flt3L/OX40L MQ710 [NCIt concept]
- Modified Vaccinia Virus Ankara Vaccine Expressing p53 [NCIt concept]
- Modified-release Calcifediol Capsule [NCIt concept]
- Modotuximab [NCIt concept]
- Moesin [NCIt concept]
- Mogamulizumab [NCIt concept]
- Mohs Surgery [NCIt concept]
- Mold [NCIt concept]
- Mold Device [NCIt concept]
- Molecular Fingerprint of Tumor [NCIt concept]
- Molecular Genetic Technique [NCIt concept]
- Molecular Major Response [NCIt concept]
- Molecular Nanotechnology [NCIt concept]
- Molecular Pathologist [NCIt concept]
- Molecular Profiling [NCIt concept]
- Molecular Response [NCIt concept]
- Molecular Risk Assessment [NCIt concept]
- Molecular Signature [NCIt concept]
- Molibresib [NCIt concept]
- Molibresib Besylate [NCIt concept]
- Molluscum Contagiosum [NCIt concept]
- Momelotinib [NCIt concept]
- Mometasone Furoate [NCIt concept]
- Monitoring [NCIt concept]
- Monitoring Device [NCIt concept]
- Monkeypox [NCIt concept]
- Monoacylglycerol Lipase ABHD12 [NCIt concept]
- Monoallelic BARD1 Gene Inactivation [NCIt concept]
- Monoallelic BRCA1 Gene Inactivation [NCIt concept]
- Monoallelic BRCA2 Gene Inactivation [NCIt concept]
- Monoallelic BRIP1 Gene Inactivation [NCIt concept]
- Monoallelic MUTYH Gene Mutation [NCIt concept]
- Monoallelic PALB2 Gene Inactivation [NCIt concept]
- Monoallelic RAD51 Gene Inactivation [NCIt concept]
- Monoallelic RAD51B Gene Inactivation [NCIt concept]
- Monoallelic RAD51C Gene Inactivation [NCIt concept]
- Monoallelic RAD51D Gene Inactivation [NCIt concept]
- Monoallelic RB1 Gene Mutation [NCIt concept]
- Monocarboxylate Transporter 1 [NCIt concept]
- Monocarboxylate Transporter 4 [NCIt concept]
- Monocarboxylate Transporter 5 [NCIt concept]
- Monoclonal Antibody [NCIt concept]
- Monoclonal Antibody 3F8 [NCIt concept]
- Monoclonal Antibody AbGn-7 [NCIt concept]
- Monoclonal Antibody CAM 5.2 [NCIt concept]
- Monoclonal Antibody CEP-37250/KHK2804 [NCIt concept]
- Monoclonal Antibody M30 [NCIt concept]
- Monoclonal Antibody Mik-Beta-1 [NCIt concept]
- Monoclonal Antibody Therapy [NCIt concept]
- Monoclonal B-Cell Lymphocytosis [NCIt concept]
- Monoclonal Band [NCIt concept]
- Monoclonal Gammopathy [NCIt concept]
- Monoclonal Gammopathy of Undetermined Significance [NCIt concept]
- Monoclonal Immunoglobulin Deposition Disease [NCIt concept]
- Monoclonal Mast Cell Activation Syndrome [NCIt concept]
- Monoclonal Microbial EDP1503 [NCIt concept]
- Monocyte [NCIt concept]
- Monocyte Differentiation Antigen CD14 [NCIt concept]
- Monocyte-Derived Microparticle [NCIt concept]
- Monocytic Myeloid-Derived Suppressor Cell [NCIt concept]
- Monoethanolamine [NCIt concept]
- Monohydroxybutylmercapturic Acid [NCIt concept]
- Monomethyl Auristatin E-containing Antibody-drug Conjugate [NCIt concept]
- Monosialotetrahexosylganglioside [NCIt concept]
- Monosodium Glutamate [NCIt concept]
- Monosomy 17 [NCIt concept]
- Monosomy 3 [NCIt concept]
- Monosomy 5 [NCIt concept]
- Monosomy 6 [NCIt concept]
- Monosomy 7 [NCIt concept]
- Montanide ISA 51 VG [NCIt concept]
- Montanide ISA 720 [NCIt concept]
- Montanide ISA-51 VG/KLH/NY-ESO-1/MART-1 Peptide Vaccine [NCIt concept]
- Montanide ISA-51/Survivin Peptide Vaccine [NCIt concept]
- Montelukast [NCIt concept]
- Montelukast Sodium [NCIt concept]
- Morisky Medication Adherence Scale [NCIt concept]
- Morphine [NCIt concept]
- Morphine Sulfate [NCIt concept]
- Morphine Sulfate Sustained-Release Tablet [NCIt concept]
- Mosunetuzumab [NCIt concept]
- Motacabtagene Lurevgedleucel [NCIt concept]
- Motesanib Diphosphate [NCIt concept]
- Motexafin Gadolinium [NCIt concept]
- Motexafin Lutetium [NCIt concept]
- Mothers Against Decapentaplegic Homolog 1 [NCIt concept]
- Mothers Against Decapentaplegic Homolog 2 [NCIt concept]
- Mothers Against Decapentaplegic Homolog 3 [NCIt concept]
- Mothers Against Decapentaplegic Homolog 4 [NCIt concept]
- Mothers Against Decapentaplegic Homolog 5 [NCIt concept]
- Motivational Interviewing [NCIt concept]
- Motixafortide [NCIt concept]
- Motolimod [NCIt concept]
- Motor Control Test [NCIt concept]
- Motor Function Assessment [NCIt concept]
- Motor Neuron and Pancreas Homeobox Protein 1 [NCIt concept]
- Motor Skills Assessment [NCIt concept]
- Mount Sinai Acute Graft Versus Host Disease International Consortium Grade II [NCIt concept]
- Mount Sinai Acute Graft Versus Host Disease International Consortium Grade III [NCIt concept]
- Mount Sinai Acute Graft Versus Host Disease International Consortium Grade IV [NCIt concept]
- Mouse Renal Adenocarcinoma Cell-Encapsulated Agarose-Agarose Macrobeads [NCIt concept]
- Moxetumomab Pasudotox [NCIt concept]
- Moxifloxacin [NCIt concept]
- Moxifloxacin Hydrochloride [NCIt concept]
- Mozafancogene Autotemcel [NCIt concept]
- Mozistobart Zoratolimod [NCIt concept]
- Mps1 Inhibitor BAY 1217389 [NCIt concept]
- Mu-Type Opioid Receptor [NCIt concept]
- Mucin-1 [NCIt concept]
- Mucin-16 [NCIt concept]
- Mucin-16-targeting Agent [NCIt concept]
- Mucin-17 [NCIt concept]
- Mucin-2 [NCIt concept]
- Mucin-20 [NCIt concept]
- Mucin-4 [NCIt concept]
- Mucin-5AC [NCIt concept]
- Mucin-Like Protein 1 [NCIt concept]
- Mucinous [NCIt concept]
- Mucoadhesive Oral Wound Rinse [NCIt concept]
- Mucoadhesive Paclitaxel Formulation [NCIt concept]
- Mucoadhesive Polymer Hydrogel Vehicle [NCIt concept]
- Mucoepidermoid Carcinoma [NCIt concept]
- Mucolipidosis [NCIt concept]
- Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 [NCIt concept]
- Mucosal Addressin Cell Adhesion Molecule 1 [NCIt concept]
- Mucosal Lavage [NCIt concept]
- Mucosal Lesion [NCIt concept]
- Mucosal Melanoma [NCIt concept]
- Mucosal-Dominant Pemphigus Vulgaris [NCIt concept]
- Muellerian-Inhibiting Factor [NCIt concept]
- Mulnitorsen [NCIt concept]
- Multi-Drug Resistant Organism [NCIt concept]
- Multi-Energy Computed Tomography [NCIt concept]
- Multi-antigen-directed Autologous T-cells NEXI-002 [NCIt concept]
- Multi-detector Computed Tomography [NCIt concept]
- Multi-detector Computed Tomography Angiography [NCIt concept]
- Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 [NCIt concept]
- Multi-epitope Folate Receptor Alpha Peptide Vaccine [NCIt concept]
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine H2NVAC [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine TPIV100 [NCIt concept]
- Multi-epitope Melanoma Peptide Vaccine [NCIt concept]
- Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107 [NCIt concept]
- Multi-kinase Inhibitor LNK01002 [NCIt concept]
- Multi-modal Acceptance and Commitment Therapy [NCIt concept]
- Multi-neo-epitope Vaccine OSE 2101 [NCIt concept]
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine [NCIt concept]
- Multicentric Breast Carcinoma [NCIt concept]
- Multicentric Castleman Disease [NCIt concept]
- Multicentric Reticulohistiocytosis [NCIt concept]
- Multidrug Resistance Protein 1 [NCIt concept]
- Multidrug Resistance-Associated Protein 1 [NCIt concept]
- Multidrug Resistance-Associated Protein 4 [NCIt concept]
- Multidrug Resistance-Associated Protein 5 [NCIt concept]
- Multidrug Resistance-Associated Protein 6 [NCIt concept]
- Multidrug and Toxin Extrusion Protein 1 [NCIt concept]
- Multidrug and Toxin Extrusion Protein 2 [NCIt concept]
- Multifocal Breast Carcinoma [NCIt concept]
- Multikinase Inhibitor AT9283 [NCIt concept]
- Multikinase Inhibitor SAR103168 [NCIt concept]
- Multilocular Cystic Renal Neoplasm of Low Malignant Potential [NCIt concept]
- Multimerin-1 [NCIt concept]
- Multimodal Education [NCIt concept]
- Multimodal Ultrasound Tomography [NCIt concept]
- Multinodular and Vacuolated Neuronal Tumor [NCIt concept]
- Multiparametric Magnetic Resonance Imaging [NCIt concept]
- Multipeptide Vaccine S-588210 [NCIt concept]
- Multiphoton Microscopy [NCIt concept]
- Multiple Acyl-CoA Dehydrogenase Deficiency [NCIt concept]
- Multiple Endocrine Neoplasia [NCIt concept]
- Multiple Endocrine Neoplasia Type 1 [NCIt concept]
- Multiple Endocrine Neoplasia Type 2A [NCIt concept]
- Multiple Epidermal Growth Factor-Like Domains Protein 8 [NCIt concept]
- Multiple Myeloma [NCIt concept]
- Multiple Sclerosis [NCIt concept]
- Multiplexed Low Coherence Interferometry [NCIt concept]
- Multipotent Bone Marrow Stem Cell [NCIt concept]
- Multispectral Imaging [NCIt concept]
- Multispectral Optoacoustic Tomography [NCIt concept]
- Multitargeted Tyrosine Kinase Inhibitor [NCIt concept]
- Multivitamin [NCIt concept]
- Mupadolimab [NCIt concept]
- Muparfostat [NCIt concept]
- Murizatoclax [NCIt concept]
- Muromonab-CD3 [NCIt concept]
- Muscadine Grape Extract [NCIt concept]
- Muscadine Grape Skin Extract [NCIt concept]
- Muscle Invasive Bladder Carcinoma [NCIt concept]
- Muscle Invasive Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Muscle Invasive Ureter Urothelial Carcinoma [NCIt concept]
- Muscle Invasive Urethral Urothelial Carcinoma [NCIt concept]
- Musculoskeletal Complication [NCIt concept]
- Musculoskeletal Complications Management [NCIt concept]
- Musculoskeletal Examination [NCIt concept]
- Musculoskeletal Neoplasm [NCIt concept]
- Music Therapy [NCIt concept]
- Mutant p53 Activator COTI-2 [NCIt concept]
- Mutant-selective PI3K-alpha H1047R Inhibitor LOXO-783 [NCIt concept]
- Mutant-selective PI3K-alpha H1047R Inhibitor OKI-219 [NCIt concept]
- Mutant-selective PI3K-alpha H1047X Inhibitor SNV4818 [NCIt concept]
- Mutation Abnormality [NCIt concept]
- Mutation Carrier Screening [NCIt concept]
- Mutation-Negative Lynch Syndrome [NCIt concept]
- Muzastotug [NCIt concept]
- MyPatientPal [NCIt concept]
- Myasthenia Gravis Foundation of America Class IIA [NCIt concept]
- Myasthenia Gravis Foundation of America Class IIB [NCIt concept]
- Myasthenia Gravis Foundation of America Class IIIA [NCIt concept]
- Myasthenia Gravis Foundation of America Class IIIB [NCIt concept]
- Myasthenia Gravis Foundation of America Class IVA [NCIt concept]
- Myasthenia Gravis Foundation of America Class IVB [NCIt concept]
- Myb-Related Protein A [NCIt concept]
- Myb-Related Protein B [NCIt concept]
- Myc Proto-Oncogene Protein [NCIt concept]
- Mycobacterial Cell Wall-DNA Complex [NCIt concept]
- Mycobacterium tuberculosis [NCIt concept]
- Mycobiome [NCIt concept]
- Mycophenolate Mofetil [NCIt concept]
- Mycophenolic Acid [NCIt concept]
- Mycosis Fungoides [NCIt concept]
- Mycosis Fungoides and Sezary Syndrome [NCIt concept]
- Mycotoxin [NCIt concept]
- Myelin Basic Protein [NCIt concept]
- Myelin-binding Imaging Agent [NCIt concept]
- Myeloblastin [NCIt concept]
- Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts 10 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts 20 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Myeloblasts 5 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts 5 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts 5-19 Percent of Peripheral Blood White Cells [NCIt concept]
- Myeloblasts 5-30 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts More than 5 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts Present [NCIt concept]
- Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts Under 10 Percent of Peripheral Blood White Cells [NCIt concept]
- Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts Under 20 Percent of Peripheral Blood White Cells [NCIt concept]
- Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Myeloblasts Under 5 Percent of Peripheral Blood White Cells [NCIt concept]
- Myelodysplastic Syndrome [NCIt concept]
- Myelodysplastic Syndrome 2 Translocation-Associated Protein [NCIt concept]
- Myelodysplastic Syndrome Clone [NCIt concept]
- Myelodysplastic Syndrome with Excess Blasts [NCIt concept]
- Myelodysplastic Syndrome with Ring Sideroblasts [NCIt concept]
- Myelodysplastic Syndrome with del(5q) [NCIt concept]
- Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia [NCIt concept]
- Myelodysplastic/Myeloproliferative Neoplasm [NCIt concept]
- Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Myelogram [NCIt concept]
- Myeloid Cell [NCIt concept]
- Myeloid Cell Leukemia 1 Inhibitor PRT1419 [NCIt concept]
- Myeloid Cell Surface Antigen CD33 [NCIt concept]
- Myeloid Differentiation Primary Response Protein Myd88 [NCIt concept]
- Myeloid Leukemia [NCIt concept]
- Myeloid Leukemia Factor 1 [NCIt concept]
- Myeloid Leukemia in Remission [NCIt concept]
- Myeloid Neoplasm [NCIt concept]
- Myeloid Sarcoma [NCIt concept]
- Myeloid Sarcoma in Remission [NCIt concept]
- Myeloid-Derived Suppressor Cell [NCIt concept]
- Myeloid-Derived Suppressor Cell Count [NCIt concept]
- Myeloid/Lymphoid Neoplasms with JAK2 Rearrangement [NCIt concept]
- Myeloperoxidase [NCIt concept]
- Myeloperoxidase-DNA Complex [NCIt concept]
- Myeloproliferative Neoplasm [NCIt concept]
- Myeloproliferative Neoplasm with CALR Mutation [NCIt concept]
- Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Myoblast Determination Protein 1 [NCIt concept]
- Myocardin-Related Transcription Factor A [NCIt concept]
- Myocyte-Specific Enhancer Factor 2C [NCIt concept]
- Myofibroma [NCIt concept]
- Myokine [NCIt concept]
- Myomegalin [NCIt concept]
- Myopenia [NCIt concept]
- Myosin-1 [NCIt concept]
- Myosin-11 [NCIt concept]
- Myosin-2 [NCIt concept]
- Myosin-9 [NCIt concept]
- Myrciaria dubia Prebiotic Supplement [NCIt concept]
- Myristoylated Alanine-Rich C-Kinase Substrate [NCIt concept]
- Myxofibrosarcoma [NCIt concept]
- Myxoid Glioneuronal Tumor [NCIt concept]
- N(6)-(1-Carboxyethyl)Lysine [NCIt concept]
- N(6)-Carboxymethyllysine [NCIt concept]
- N(6)-Hydroxymethyl-2'-Deoxyadenosine [NCIt concept]
- N-Acetyl-S-(2-Hydroxyethyl)Cysteine [NCIt concept]
- N-Acetylaspartate [NCIt concept]
- N-Acetylcysteine Amide [NCIt concept]
- N-Acetylserotonin [NCIt concept]
- N-Chimaerin [NCIt concept]
- N-Glycosylase/DNA Lyase [NCIt concept]
- N-Myc Proto-Oncogene Protein [NCIt concept]
- N-Propionylated Polysialic Acid Antibody [NCIt concept]
- N-Telopeptide [NCIt concept]
- N-Terminal Fragment Brain Natriuretic Protein [NCIt concept]
- N-dihydrogalactochitosan [NCIt concept]
- N-oleyl-phosphatidylethanolamine/Epigallocatechin Gallate Supplement [NCIt concept]
- NA17.A2 Peptide Vaccine [NCIt concept]
- NAB2 Gene [NCIt concept]
- NAB2 wt Allele [NCIt concept]
- NAB2/STAT6 Fusion Gene [NCIt concept]
- NAB2/STAT6 Fusion Protein [NCIt concept]
- NACA Gene [NCIt concept]
- NACA wt Allele [NCIt concept]
- NACC2 Gene [NCIt concept]
- NACC2 wt Allele [NCIt concept]
- NACHT, LRR and PYD Domains-Containing Protein 1 [NCIt concept]
- NACHT, LRR and PYD Domains-Containing Protein 3 [NCIt concept]
- NACHT, LRR and PYD Domains-Containing Protein 4 [NCIt concept]
- NAD(P)H Dehydrogenase [Quinone] 1 [NCIt concept]
- NAD-Dependent Deacetylase Sirtuin-2 [NCIt concept]
- NAD-Dependent Protein Deacetylase Sirtuin-1 [NCIt concept]
- NADH Dehydrogenase (Ubiquinone) [NCIt concept]
- NADP-Dependent Malic Enzyme [NCIt concept]
- NADPH Oxidase 1 [NCIt concept]
- NADPH Oxidase 4 [NCIt concept]
- NAE1 Gene [NCIt concept]
- NAE1 wt Allele [NCIt concept]
- NAMPT Gene [NCIt concept]
- NAMPT Inhibitor OT-82 [NCIt concept]
- NAMPT wt Allele [NCIt concept]
- NANOG Gene [NCIt concept]
- NANOG wt Allele [NCIt concept]
- NANOS3 Gene [NCIt concept]
- NANOS3 wt Allele [NCIt concept]
- NAPA Gene [NCIt concept]
- NAPA wt Allele [NCIt concept]
- NAT1 Gene [NCIt concept]
- NAT1 wt Allele [NCIt concept]
- NAT2 Gene [NCIt concept]
- NAT2 wt Allele [NCIt concept]
- NAT2*14 Allele [NCIt concept]
- NAT2*5 Allele [NCIt concept]
- NAT2*6 Allele [NCIt concept]
- NAT2*7 Allele [NCIt concept]
- NBAS Gene [NCIt concept]
- NBAS wt Allele [NCIt concept]
- NBN Gene [NCIt concept]
- NBN Gene Mutation [NCIt concept]
- NBN wt Allele [NCIt concept]
- NCAM1 Gene [NCIt concept]
- NCAM1 Negative [NCIt concept]
- NCAM1 Positive [NCIt concept]
- NCAM1 wt Allele [NCIt concept]
- NCF1 Gene [NCIt concept]
- NCF1 Gene Mutation [NCIt concept]
- NCF1 wt Allele [NCIt concept]
- NCF2 Gene [NCIt concept]
- NCF2 Gene Mutation [NCIt concept]
- NCF2 wt Allele [NCIt concept]
- NCF4 Gene [NCIt concept]
- NCF4 Gene Mutation [NCIt concept]
- NCF4 wt Allele [NCIt concept]
- NCK-Interacting Protein with SH3 Domain [NCIt concept]
- NCKIPSD Gene [NCIt concept]
- NCKIPSD wt Allele [NCIt concept]
- NCL Gene [NCIt concept]
- NCL wt Allele [NCIt concept]
- NCOA1 Gene [NCIt concept]
- NCOA1 wt Allele [NCIt concept]
- NCOA2 Gene [NCIt concept]
- NCOA2 wt Allele [NCIt concept]
- NCOA3 Gene [NCIt concept]
- NCOA3 wt Allele [NCIt concept]
- NCOA4 Gene [NCIt concept]
- NCOA4 wt Allele [NCIt concept]
- NCOA4/RET Fusion Gene [NCIt concept]
- NCOA4/RET Fusion Protein [NCIt concept]
- NCOR1 Gene [NCIt concept]
- NCOR1 wt Allele [NCIt concept]
- NCR1 Gene [NCIt concept]
- NCR1 wt Allele [NCIt concept]
- NCR2 Gene [NCIt concept]
- NCR2 wt Allele [NCIt concept]
- NCR3 Gene [NCIt concept]
- NCR3 wt Allele [NCIt concept]
- NCR3LG1 Gene [NCIt concept]
- NCR3LG1 wt Allele [NCIt concept]
- NDC80 Gene [NCIt concept]
- NDC80 wt Allele [NCIt concept]
- NDN Gene [NCIt concept]
- NDN wt Allele [NCIt concept]
- NDRG1 Gene [NCIt concept]
- NDRG1 wt Allele [NCIt concept]
- NDRG2 Gene [NCIt concept]
- NDRG2 wt Allele [NCIt concept]
- NDRG4 Gene [NCIt concept]
- NDRG4 wt Allele [NCIt concept]
- NECTIN1 Gene [NCIt concept]
- NECTIN1 wt Allele [NCIt concept]
- NECTIN2 Gene [NCIt concept]
- NECTIN2 Positive [NCIt concept]
- NECTIN2 wt Allele [NCIt concept]
- NECTIN4 Expression by Immunohistochemistry 2+ [NCIt concept]
- NECTIN4 Expression by Immunohistochemistry 3+ [NCIt concept]
- NECTIN4 Gene [NCIt concept]
- NECTIN4 Gene Amplification [NCIt concept]
- NECTIN4 Overexpression Positive [NCIt concept]
- NECTIN4 Positive [NCIt concept]
- NECTIN4 Status by Immunohistochemistry [NCIt concept]
- NECTIN4 wt Allele [NCIt concept]
- NEDD4-Like E3 Ubiquitin-Protein Ligase WWP1 [NCIt concept]
- NEDD8 [NCIt concept]
- NEDD8 Activating Enzyme [NCIt concept]
- NEDD8 Activating Enzyme E1 Inhibitor TAS4464 [NCIt concept]
- NEDD8 Gene [NCIt concept]
- NEDD8 wt Allele [NCIt concept]
- NEDD8-Activating Enzyme E1 Catalytic Subunit [NCIt concept]
- NEDD8-Activating Enzyme E1 Regulatory Subunit [NCIt concept]
- NEFL Gene [NCIt concept]
- NEFL wt Allele [NCIt concept]
- NEIL1 Gene [NCIt concept]
- NEIL1 wt Allele [NCIt concept]
- NEIL3 Gene [NCIt concept]
- NEIL3 wt Allele [NCIt concept]
- NEK2 Gene [NCIt concept]
- NEK2 wt Allele [NCIt concept]
- NEK3 Gene [NCIt concept]
- NEK3 wt Allele [NCIt concept]
- NELFCD Gene [NCIt concept]
- NELFCD wt Allele [NCIt concept]
- NELL1 Gene [NCIt concept]
- NELL1 wt Allele [NCIt concept]
- NEO-201 Antigen Positive [NCIt concept]
- NES Gene [NCIt concept]
- NES wt Allele [NCIt concept]
- NEUROG1 Gene [NCIt concept]
- NEUROG1 wt Allele [NCIt concept]
- NF-AT [NCIt concept]
- NF-Kappa-B Inhibitor Alpha [NCIt concept]
- NF-kB [NCIt concept]
- NF1 Gene [NCIt concept]
- NF1 Gene Alteration Positive [NCIt concept]
- NF1 Gene Deletion [NCIt concept]
- NF1 Gene Frameshift Mutation [NCIt concept]
- NF1 Gene Inactivation [NCIt concept]
- NF1 Gene Mutation [NCIt concept]
- NF1 Gene Mutation Negative [NCIt concept]
- NF1 Gene Nonsense Mutation [NCIt concept]
- NF1 Gene Rearrangement [NCIt concept]
- NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- NF1 Positive [NCIt concept]
- NF1 wt Allele [NCIt concept]
- NF2 Gene [NCIt concept]
- NF2 Gene Deletion [NCIt concept]
- NF2 Gene Inactivation [NCIt concept]
- NF2 Gene Mutation [NCIt concept]
- NF2 Gene Rearrangement [NCIt concept]
- NF2 wt Allele [NCIt concept]
- NFATC2 Gene [NCIt concept]
- NFATC2 wt Allele [NCIt concept]
- NFE2L2 Gene [NCIt concept]
- NFE2L2 Gene Mutation [NCIt concept]
- NFE2L2 Gene Mutation Negative [NCIt concept]
- NFE2L2 wt Allele [NCIt concept]
- NFE2L2/KEAP1/CUL3 Mutant-targeting Agent MGY825 [NCIt concept]
- NFIB Gene [NCIt concept]
- NFIB wt Allele [NCIt concept]
- NFKB1 Gene [NCIt concept]
- NFKB1 wt Allele [NCIt concept]
- NFKB2 Gene [NCIt concept]
- NFKB2 Gene Rearrangement [NCIt concept]
- NFKB2 wt Allele [NCIt concept]
- NFKBIA Gene [NCIt concept]
- NFKBIA wt Allele [NCIt concept]
- NFYA Gene [NCIt concept]
- NFYA wt Allele [NCIt concept]
- NGF Gene [NCIt concept]
- NGF wt Allele [NCIt concept]
- NGFI-A-Binding Protein 2 [NCIt concept]
- NGFR Gene [NCIt concept]
- NGFR wt Allele [NCIt concept]
- NGFR-transduced Autologous T Lymphocytes [NCIt concept]
- NHEJ1 Gene [NCIt concept]
- NHEJ1 wt Allele [NCIt concept]
- NHP2 Gene [NCIt concept]
- NHP2 Gene Mutation [NCIt concept]
- NHP2 wt Allele [NCIt concept]
- NHS-POx-based Hemostatic Sealant Patch [NCIt concept]
- NID1 Gene [NCIt concept]
- NID1 wt Allele [NCIt concept]
- NID2 Gene [NCIt concept]
- NID2 wt Allele [NCIt concept]
- NIN Gene [NCIt concept]
- NIN wt Allele [NCIt concept]
- NIR Fluorochrome VM110 [NCIt concept]
- NK Cell-enriched Donor Lymphocytes [NCIt concept]
- NK Cell-priming Inert Tumor Cells [NCIt concept]
- NK-Cell Lymphoma, Unclassifiable [NCIt concept]
- NKAIN2 Gene [NCIt concept]
- NKAIN2 wt Allele [NCIt concept]
- NKG2-A/NKG2-B Type II Integral Membrane Protein [NCIt concept]
- NKG2-C Type II Integral Membrane Protein [NCIt concept]
- NKG2-D Type II Integral Membrane Protein [NCIt concept]
- NKX3-1 Gene [NCIt concept]
- NKX3-1 wt Allele [NCIt concept]
- NKp46/CD16-based CD123-targeted NK Cell Engager SAR443579 [NCIt concept]
- NKp46/CD16/CD20/IL-2-variant-specific NK Cell Engager IPH6501 [NCIt concept]
- NLGN3 Gene [NCIt concept]
- NLGN3 wt Allele [NCIt concept]
- NLGN4X Gene [NCIt concept]
- NLGN4X wt Allele [NCIt concept]
- NLR Family CARD Domain-Containing Protein 4 [NCIt concept]
- NLRC4 Gene [NCIt concept]
- NLRC4 Gene Mutation [NCIt concept]
- NLRC4 wt Allele [NCIt concept]
- NLRP1 Gene [NCIt concept]
- NLRP1 Gene Mutation [NCIt concept]
- NLRP1 wt Allele [NCIt concept]
- NLRP3 Agonist BMS-986299 [NCIt concept]
- NLRP3 Gene [NCIt concept]
- NLRP3 Inhibitor DFV890 [NCIt concept]
- NLRP3 wt Allele [NCIt concept]
- NLRP4 Antibody [NCIt concept]
- NLRP4 Gene [NCIt concept]
- NLRP4 wt Allele [NCIt concept]
- NME1 Gene [NCIt concept]
- NME1 wt Allele [NCIt concept]
- NMP22 Assay [NCIt concept]
- NNK Metabolite [NCIt concept]
- NNMT Gene [NCIt concept]
- NNMT wt Allele [NCIt concept]
- NOD2 Gene [NCIt concept]
- NOD2 wt Allele [NCIt concept]
- NODAL Gene [NCIt concept]
- NODAL wt Allele [NCIt concept]
- NOP10 Gene [NCIt concept]
- NOP10 Gene Mutation [NCIt concept]
- NOP10 wt Allele [NCIt concept]
- NOS2 Gene [NCIt concept]
- NOS2 Positive [NCIt concept]
- NOS2 wt Allele [NCIt concept]
- NOS3 Gene [NCIt concept]
- NOS3 Intron 4 VNTR [NCIt concept]
- NOS3 wt Allele [NCIt concept]
- NOTCH Family Gene Mutation [NCIt concept]
- NOTCH1 Gene [NCIt concept]
- NOTCH1 Gene Mutation [NCIt concept]
- NOTCH1 Gene Mutation Negative [NCIt concept]
- NOTCH1 Truncation Mutation [NCIt concept]
- NOTCH1 wt Allele [NCIt concept]
- NOTCH2 Gene [NCIt concept]
- NOTCH2 Gene Mutation [NCIt concept]
- NOTCH2 wt Allele [NCIt concept]
- NOTCH3 Gene [NCIt concept]
- NOTCH3 Gene Mutation [NCIt concept]
- NOTCH3 wt Allele [NCIt concept]
- NOTCH4 Gene [NCIt concept]
- NOTCH4 Gene Mutation [NCIt concept]
- NOTCH4 wt Allele [NCIt concept]
- NOX1 Gene [NCIt concept]
- NOX1 wt Allele [NCIt concept]
- NOX4 Gene [NCIt concept]
- NOX4 wt Allele [NCIt concept]
- NOXA BH3 Priming [NCIt concept]
- NPEPPS Gene [NCIt concept]
- NPEPPS wt Allele [NCIt concept]
- NPM1 Gene [NCIt concept]
- NPM1 Gene Alteration Positive [NCIt concept]
- NPM1 Gene Fusion Positive [NCIt concept]
- NPM1 Gene Mutation [NCIt concept]
- NPM1 wt Allele [NCIt concept]
- NPM1/ALK Fusion Gene [NCIt concept]
- NPM1/ALK Fusion Protein [NCIt concept]
- NPM1/MLF1 Fusion Gene [NCIt concept]
- NPM1/MLF1 Fusion Protein [NCIt concept]
- NPPB Gene [NCIt concept]
- NPPB Gene Product [NCIt concept]
- NPPB wt Allele [NCIt concept]
- NPRL3 Gene [NCIt concept]
- NPRL3 wt Allele [NCIt concept]
- NPY Gene [NCIt concept]
- NPY wt Allele [NCIt concept]
- NPY1R Gene [NCIt concept]
- NPY1R wt Allele [NCIt concept]
- NPY2R Gene [NCIt concept]
- NPY2R wt Allele [NCIt concept]
- NPY5R Gene [NCIt concept]
- NPY5R wt Allele [NCIt concept]
- NQO1 Gene [NCIt concept]
- NQO1 wt Allele [NCIt concept]
- NQO1*2 Allele [NCIt concept]
- NQO2 Gene [NCIt concept]
- NQO2 wt Allele [NCIt concept]
- NR0B1 Gene [NCIt concept]
- NR0B1 wt Allele [NCIt concept]
- NR0B2 Gene [NCIt concept]
- NR0B2 wt Allele [NCIt concept]
- NR1I2 Gene [NCIt concept]
- NR1I2 wt Allele [NCIt concept]
- NR1I3 Gene [NCIt concept]
- NR1I3 wt Allele [NCIt concept]
- NR3C1 Gene [NCIt concept]
- NR3C1 Positive [NCIt concept]
- NR3C1 wt Allele [NCIt concept]
- NR4A1 Gene [NCIt concept]
- NR4A1 wt Allele [NCIt concept]
- NR4A3 Gene [NCIt concept]
- NR4A3 wt Allele [NCIt concept]
- NRARP Gene [NCIt concept]
- NRARP wt Allele [NCIt concept]
- NRAS Exon 2 Mutation [NCIt concept]
- NRAS Exon 2 Mutation Negative [NCIt concept]
- NRAS Exon 3 Mutation [NCIt concept]
- NRAS Exon 3 Mutation Negative [NCIt concept]
- NRAS Exon 4 Mutation [NCIt concept]
- NRAS Exon 4 Mutation Negative [NCIt concept]
- NRAS Gene [NCIt concept]
- NRAS Gene Amplification [NCIt concept]
- NRAS Gene Mutation [NCIt concept]
- NRAS Gene Mutation Negative [NCIt concept]
- NRAS NM_002524.4:c.180_181delinsTA [NCIt concept]
- NRAS NM_002524.4:c.181C>A [NCIt concept]
- NRAS NM_002524.4:c.181C>G [NCIt concept]
- NRAS NM_002524.4:c.181_182delinsAG [NCIt concept]
- NRAS NM_002524.4:c.181_182delinsTT [NCIt concept]
- NRAS NM_002524.4:c.181_183delinsAAG [NCIt concept]
- NRAS NM_002524.4:c.182A>C [NCIt concept]
- NRAS NM_002524.4:c.182A>G [NCIt concept]
- NRAS NM_002524.4:c.182A>T [NCIt concept]
- NRAS NM_002524.4:c.182_183delinsGG [NCIt concept]
- NRAS NM_002524.4:c.182_183delinsTG [NCIt concept]
- NRAS NM_002524.4:c.183A>C [NCIt concept]
- NRAS NM_002524.4:c.183A>G [NCIt concept]
- NRAS NM_002524.4:c.183A>T [NCIt concept]
- NRAS NM_002524.4:c.34G>A [NCIt concept]
- NRAS NM_002524.4:c.34G>C [NCIt concept]
- NRAS NM_002524.4:c.34G>T [NCIt concept]
- NRAS NM_002524.4:c.35G>A [NCIt concept]
- NRAS NM_002524.4:c.35G>T [NCIt concept]
- NRAS NM_002524.5:c.35G>C [NCIt concept]
- NRAS NM_002524.5:c.38G>A [NCIt concept]
- NRAS NP_002515.1:p.G12A [NCIt concept]
- NRAS NP_002515.1:p.G12C [NCIt concept]
- NRAS NP_002515.1:p.G12D [NCIt concept]
- NRAS NP_002515.1:p.G12R [NCIt concept]
- NRAS NP_002515.1:p.G12S [NCIt concept]
- NRAS NP_002515.1:p.G12V [NCIt concept]
- NRAS NP_002515.1:p.G12X [NCIt concept]
- NRAS NP_002515.1:p.G13D [NCIt concept]
- NRAS NP_002515.1:p.G13X [NCIt concept]
- NRAS NP_002515.1:p.Q61E [NCIt concept]
- NRAS NP_002515.1:p.Q61H [NCIt concept]
- NRAS NP_002515.1:p.Q61K [NCIt concept]
- NRAS NP_002515.1:p.Q61L [NCIt concept]
- NRAS NP_002515.1:p.Q61P [NCIt concept]
- NRAS NP_002515.1:p.Q61R [NCIt concept]
- NRAS NP_002515.1:p.Q61X [NCIt concept]
- NRAS Negative [NCIt concept]
- NRAS Positive [NCIt concept]
- NRAS Protein Variant [NCIt concept]
- NRAS wt Allele [NCIt concept]
- NRG1 Gene [NCIt concept]
- NRG1 Gene Fusion Positive [NCIt concept]
- NRG1 Gene Rearrangement [NCIt concept]
- NRG1 wt Allele [NCIt concept]
- NRG2 Gene [NCIt concept]
- NRG2 wt Allele [NCIt concept]
- NRG3 Gene [NCIt concept]
- NRG3 wt Allele [NCIt concept]
- NRIP1 Gene [NCIt concept]
- NRIP1 wt Allele [NCIt concept]
- NRP1 Gene [NCIt concept]
- NRP1 wt Allele [NCIt concept]
- NRP2 Gene [NCIt concept]
- NRP2 wt Allele [NCIt concept]
- NRXN3 Gene [NCIt concept]
- NRXN3 wt Allele [NCIt concept]
- NSCLC-specific Marrow Infiltrating Lymphocytes [NCIt concept]
- NSD1 Gene [NCIt concept]
- NSD1 Gene Mutation [NCIt concept]
- NSD1 wt Allele [NCIt concept]
- NSD1/NUP98 Fusion Gene [NCIt concept]
- NSD1/NUP98 Fusion Protein [NCIt concept]
- NSD2 Gene [NCIt concept]
- NSD2 Gene Mutation [NCIt concept]
- NSD2 wt Allele [NCIt concept]
- NSD3 Gene [NCIt concept]
- NSD3 wt Allele [NCIt concept]
- NSMAF Gene [NCIt concept]
- NSMAF wt Allele [NCIt concept]
- NT-3 Growth Factor Receptor [NCIt concept]
- NT5C2 Gene [NCIt concept]
- NT5C2 wt Allele [NCIt concept]
- NT5E Gene [NCIt concept]
- NT5E wt Allele [NCIt concept]
- NTF3 Gene [NCIt concept]
- NTF3 wt Allele [NCIt concept]
- NTHL1 Gene [NCIt concept]
- NTHL1 Gene Mutation [NCIt concept]
- NTHL1 wt Allele [NCIt concept]
- NTN1 Gene [NCIt concept]
- NTN1 wt Allele [NCIt concept]
- NTRK Family Gene [NCIt concept]
- NTRK Family Gene Alteration Negative [NCIt concept]
- NTRK Family Gene Fusion Negative [NCIt concept]
- NTRK Family Gene Mutation [NCIt concept]
- NTRK Family Gene Mutation Negative [NCIt concept]
- NTRK Family Protein [NCIt concept]
- NTRK Gene Amplification [NCIt concept]
- NTRK Gene Fusion Positive [NCIt concept]
- NTRK Gene Rearrangement [NCIt concept]
- NTRK1 Fusion Negative [NCIt concept]
- NTRK1 Fusion Positive [NCIt concept]
- NTRK1 Gene [NCIt concept]
- NTRK1 Gene Alteration Positive [NCIt concept]
- NTRK1 Gene Amplification [NCIt concept]
- NTRK1 Gene Mutation [NCIt concept]
- NTRK1 Gene Product [NCIt concept]
- NTRK1 Gene Rearrangement [NCIt concept]
- NTRK1 Gene Translocation [NCIt concept]
- NTRK1 Overexpression Positive [NCIt concept]
- NTRK1 wt Allele [NCIt concept]
- NTRK1/TPM3 Fusion Gene [NCIt concept]
- NTRK2 Fusion Negative [NCIt concept]
- NTRK2 Fusion Positive [NCIt concept]
- NTRK2 Gene [NCIt concept]
- NTRK2 Gene Alteration Positive [NCIt concept]
- NTRK2 Gene Amplification [NCIt concept]
- NTRK2 Gene Mutation [NCIt concept]
- NTRK2 Gene Rearrangement [NCIt concept]
- NTRK2 Overexpression Positive [NCIt concept]
- NTRK2 wt Allele [NCIt concept]
- NTRK3 Fusion Negative [NCIt concept]
- NTRK3 Fusion Positive [NCIt concept]
- NTRK3 Gene [NCIt concept]
- NTRK3 Gene Alteration Positive [NCIt concept]
- NTRK3 Gene Amplification [NCIt concept]
- NTRK3 Gene Mutation [NCIt concept]
- NTRK3 Gene Rearrangement [NCIt concept]
- NTRK3 wt Allele [NCIt concept]
- NTS Gene [NCIt concept]
- NTS Gene Product [NCIt concept]
- NTS wt Allele [NCIt concept]
- NTSR1 Gene [NCIt concept]
- NTSR1 Positive [NCIt concept]
- NTSR1 wt Allele [NCIt concept]
- NUAK Family SNF1-Like Kinase 1 [NCIt concept]
- NUAK1 Gene [NCIt concept]
- NUAK1 wt Allele [NCIt concept]
- NUDT21 Gene [NCIt concept]
- NUDT21 wt Allele [NCIt concept]
- NUF2 Gene [NCIt concept]
- NUF2 wt Allele [NCIt concept]
- NUMA1 Gene [NCIt concept]
- NUMA1 wt Allele [NCIt concept]
- NUMA1/RARA Fusion Gene [NCIt concept]
- NUMA1/RARA Fusion Protein [NCIt concept]
- NUP107 Gene [NCIt concept]
- NUP107 wt Allele [NCIt concept]
- NUP214 Gene [NCIt concept]
- NUP214 Gene Alteration Positive [NCIt concept]
- NUP214 Gene Rearrangement [NCIt concept]
- NUP214 wt Allele [NCIt concept]
- NUP214/ABL1 239 kDa Fusion Protein [NCIt concept]
- NUP214/ABL1 310-333 kDa Fusion Protein [NCIt concept]
- NUP214/ABL1 Fusion Gene [NCIt concept]
- NUP214/ABL1 Fusion Gene Variant 1 [NCIt concept]
- NUP214/ABL1 Fusion Gene Variant 2 [NCIt concept]
- NUP98 Fusion Gene [NCIt concept]
- NUP98 Gene [NCIt concept]
- NUP98 Gene Alteration Positive [NCIt concept]
- NUP98 Gene Mutation [NCIt concept]
- NUP98 Gene Rearrangement [NCIt concept]
- NUP98 wt Allele [NCIt concept]
- NUP98/ADD3 Fusion Gene [NCIt concept]
- NUP98/ADD3 Fusion Protein [NCIt concept]
- NUP98/DDX10 Fusion Gene [NCIt concept]
- NUP98/DDX10 Fusion Protein [NCIt concept]
- NUP98/HOXA9 Fusion Gene [NCIt concept]
- NUP98/HOXA9 Fusion Protein [NCIt concept]
- NUP98/HOXC13 Fusion Gene [NCIt concept]
- NUP98/HOXC13 Fusion Protein [NCIt concept]
- NUP98/HOXD11 Fusion Gene [NCIt concept]
- NUP98/HOXD11 Fusion Protein [NCIt concept]
- NUP98/HOXD13 Fusion Gene [NCIt concept]
- NUP98/HOXD13 Fusion Protein [NCIt concept]
- NUP98/KDM5A Fusion Gene [NCIt concept]
- NUP98/KDM5A Fusion Protein [NCIt concept]
- NUP98/NSD1 Fusion Gene [NCIt concept]
- NUP98/NSD1 Fusion Protein [NCIt concept]
- NUP98/PHF23 Fusion Gene [NCIt concept]
- NUP98/PHF23 Fusion Protein [NCIt concept]
- NUP98/PRRX1 Fusion Gene [NCIt concept]
- NUP98/PRRX1 Fusion Protein [NCIt concept]
- NUP98/RAP1GDS1 Fusion Gene [NCIt concept]
- NUP98/RAP1GDS1 Fusion Protein [NCIt concept]
- NUP98/SETBP1 Fusion Gene [NCIt concept]
- NUP98/SETBP1 Fusion Protein [NCIt concept]
- NUP98/TOP1 Fusion Gene [NCIt concept]
- NUP98/TOP1 Fusion Protein [NCIt concept]
- NUP98/WHSC1L1 Fusion Gene [NCIt concept]
- NUP98/WHSC1L1 Fusion Protein [NCIt concept]
- NUSAP1 Gene [NCIt concept]
- NUSAP1 wt Allele [NCIt concept]
- NUT Family Member 1 [NCIt concept]
- NUT Family Member 2A [NCIt concept]
- NUT Family Member 2B [NCIt concept]
- NUT Family Member 2E [NCIt concept]
- NUTM1 Gene [NCIt concept]
- NUTM1 Gene Rearrangement [NCIt concept]
- NUTM1 Gene Translocation [NCIt concept]
- NUTM1 Positive [NCIt concept]
- NUTM1 wt Allele [NCIt concept]
- NUTM2A Gene [NCIt concept]
- NUTM2A wt Allele [NCIt concept]
- NUTM2A/CIC Fusion Gene [NCIt concept]
- NUTM2B Gene [NCIt concept]
- NUTM2B wt Allele [NCIt concept]
- NUTM2E Gene [NCIt concept]
- NUTM2E wt Allele [NCIt concept]
- NY-ESO-1 Overexpression Positive [NCIt concept]
- NY-ESO-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1 Protein Vaccine Plus Montanide ISA-51 VG [NCIt concept]
- NY-ESO-1 Reactive TCR Retroviral Vector Transduced Autologous PBL [NCIt concept]
- NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- NY-ESO-1-expressing Artificial Adjuvant Vector Cells ASP0739 [NCIt concept]
- NY-ESO-1-targeting Agent [NCIt concept]
- NY-ESO-1/GLA-SE Vaccine ID-G305 [NCIt concept]
- NY-ESO-1/LAGE-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1/MAGE-A4/PRAME/Survivin/SSX2-specific Autologous Cytotoxic T Lymphocytes [NCIt concept]
- Na(+)/H(+) Exchange Regulatory Cofactor NHE-RF3 [NCIt concept]
- Nab-paclitaxel [NCIt concept]
- Nab-paclitaxel/Danburstotug Complex AP160 [NCIt concept]
- Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 [NCIt concept]
- Nabiximols [NCIt concept]
- Nadofaragene Firadenovec [NCIt concept]
- Nafcillin [NCIt concept]
- Nagrestipen [NCIt concept]
- Naive Pregerminal Center B-Lymphocyte [NCIt concept]
- Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation [NCIt concept]
- Naive T-Lymphocyte [NCIt concept]
- Naltrexone Hydrochloride [NCIt concept]
- Naltrexone Hydrochloride/Bupropion Hydrochloride [NCIt concept]
- Nanatinostat [NCIt concept]
- NanoTherm Therapy [NCIt concept]
- Nanoparticle Albumin-Bound Docetaxel [NCIt concept]
- Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404 [NCIt concept]
- Nanoparticle Complex [NCIt concept]
- Nanoparticle Encapsulated AChR Epitopes CNP-106 [NCIt concept]
- Nanoparticle Formulation CPI-300 [NCIt concept]
- Nanoparticle Paclitaxel Ointment SOR007 [NCIt concept]
- Nanoparticle-based Paclitaxel Suspension [NCIt concept]
- Nanoplexed Poly I:C BO-112 [NCIt concept]
- Nanos Homolog 3 [NCIt concept]
- Nanoscale Coordination Polymer Nanoparticles CPI-100 [NCIt concept]
- Nanosomal Docetaxel Lipid Suspension [NCIt concept]
- Nanrilkefusp Alfa [NCIt concept]
- Napabucasin [NCIt concept]
- Naphthalimide Analogue UNBS5162 [NCIt concept]
- Naporafenib [NCIt concept]
- Naproxen [NCIt concept]
- Naproxen Sodium [NCIt concept]
- Naratuximab Emtansine [NCIt concept]
- Narazaciclib [NCIt concept]
- Narnatumab [NCIt concept]
- Narrow Band Imaging [NCIt concept]
- Narsoplimab [NCIt concept]
- Nasal Cavity Carcinoma [NCIt concept]
- Nasal Cavity Diffuse Large B-Cell Lymphoma [NCIt concept]
- Nasal Cavity and Paranasal Sinus Lethal Midline Granuloma [NCIt concept]
- Nasal Saline Irrigation Solution [NCIt concept]
- Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Nasal Vestibulitis [NCIt concept]
- Nasal Wash and Collection [NCIt concept]
- Nasaruplase Gamma [NCIt concept]
- Nascent Polypeptide-Associated Complex Subunit Alpha [NCIt concept]
- Nasopharyngeal Carcinoma [NCIt concept]
- Nasopharyngeal Differentiated Carcinoma [NCIt concept]
- Nasopharyngeal Disorder [NCIt concept]
- Nasopharyngeal Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Nasopharyngeal Low Grade Papillary Adenocarcinoma [NCIt concept]
- Nasopharyngeal Non-Keratinizing Carcinoma [NCIt concept]
- Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Nasopharyngeal Undifferentiated Carcinoma [NCIt concept]
- Nasopharyngoscopy [NCIt concept]
- Natalizumab [NCIt concept]
- Natriuretic Peptides B [NCIt concept]
- Natural Cytotoxicity Receptor Family [NCIt concept]
- Natural Cytotoxicity Triggering Receptor 1 [NCIt concept]
- Natural Cytotoxicity Triggering Receptor 2 [NCIt concept]
- Natural Cytotoxicity Triggering Receptor 3 [NCIt concept]
- Natural Cytotoxicity Triggering Receptor 3 Ligand 1 [NCIt concept]
- Natural Killer Cell [NCIt concept]
- Natural Killer Cell Receptor 2B4 [NCIt concept]
- Natural Killer Cell Therapy [NCIt concept]
- Natural Killer Cells ZRx101 [NCIt concept]
- Natural Killer T-Cell [NCIt concept]
- Nausea and Vomiting [NCIt concept]
- Nausea and Vomiting Therapy [NCIt concept]
- Navarixin [NCIt concept]
- Navicixizumab [NCIt concept]
- Navigated Transcranial Magnetic Stimulation [NCIt concept]
- Navigation [NCIt concept]
- Navigational Bronchoscopy [NCIt concept]
- Navitoclax [NCIt concept]
- Navoximod [NCIt concept]
- Navtemadlin [NCIt concept]
- Naxitamab [NCIt concept]
- Near Complete Response of Multiple Myeloma or Plasma Cell Leukemia [NCIt concept]
- Near Infrared Autofluorescence [NCIt concept]
- Near Infrared Imaging [NCIt concept]
- Near Infrared Imaging Agent HS-196 [NCIt concept]
- Near Infrared Imaging Agent IS-001 [NCIt concept]
- Near Infrared Spectroscopy [NCIt concept]
- Near-Infrared Fluorescence Endoscopy [NCIt concept]
- Near-Infrared Fluorescence Imaging [NCIt concept]
- Near-Infrared Fluorescence Imaging Probe [NCIt concept]
- Nebulizer Device [NCIt concept]
- Necdin [NCIt concept]
- Necitumumab [NCIt concept]
- Neck Dissection [NCIt concept]
- Neck Squamous Cell Carcinoma of Unknown Primary [NCIt concept]
- Necrobiotic Xanthogranuloma [NCIt concept]
- Necrotic [NCIt concept]
- Necrotic Process [NCIt concept]
- Nectin-1 [NCIt concept]
- Nectin-2 [NCIt concept]
- Nectin-4 [NCIt concept]
- Nectin-4-directed TLR8 Agonist SBT6290 [NCIt concept]
- Necuparanib [NCIt concept]
- Nedometinib [NCIt concept]
- Needle Biopsy [NCIt concept]
- Needle Biopsy of Prostate [NCIt concept]
- Neem Mouthrinse [NCIt concept]
- Negative Elongation Factor C/D [NCIt concept]
- Negative Pressure Wound Therapy [NCIt concept]
- Neihulizumab [NCIt concept]
- Nelarabine [NCIt concept]
- Nelfinavir [NCIt concept]
- Nelfinavir Mesylate [NCIt concept]
- Nelipepimut-S Plus GM-CSF Vaccine [NCIt concept]
- Nelistotug [NCIt concept]
- Nelitolimod [NCIt concept]
- Nelmastobart [NCIt concept]
- Nelson Syndrome [NCIt concept]
- Nemtabrutinib [NCIt concept]
- Nemvaleukin Alfa [NCIt concept]
- Nendratareotide Uzatansine [NCIt concept]
- Neoadjuvant Chemotherapy [NCIt concept]
- Neoadjuvant Radiation Therapy [NCIt concept]
- Neoadjuvant Therapy [NCIt concept]
- Neoantigen DNA-Based Pancreatic Cancer Vaccine [NCIt concept]
- Neoantigen Heat Shock Protein Vaccine rHSC-DIPGVax [NCIt concept]
- Neoantigen Peptide [NCIt concept]
- Neoantigen Peptide Vaccine [NCIt concept]
- Neoantigen Vaccine GEN-009 [NCIt concept]
- Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 [NCIt concept]
- Neoantigen-based Glioblastoma Vaccine [NCIt concept]
- Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine [NCIt concept]
- Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 [NCIt concept]
- Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 [NCIt concept]
- Neoantigen-loaded Autologous Dendritic Cell Vaccine [NCIt concept]
- Neoplasm [NCIt concept]
- Neoplasm Polygenic Risk Score [NCIt concept]
- Neoplasm Stage [NCIt concept]
- Neoplasm by Morphology [NCIt concept]
- Neoplasm by Site [NCIt concept]
- Neoplasm by Special Category [NCIt concept]
- Neoplasm of Uncertain Malignant Potential [NCIt concept]
- Neoplasm, Uncertain Whether Benign or Malignant [NCIt concept]
- Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present [NCIt concept]
- Neoplastic Cells with TFH Cell Phenotype Present [NCIt concept]
- Neoplastic Multinucleated Giant Cell [NCIt concept]
- Neoplastic Plasma Cells 1 Percent or Less of Peripheral Blood White Cells [NCIt concept]
- Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 10-59 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 10-60 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 20 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 20 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Neoplastic Plasma Cells 30 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 30 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 40 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 5 Percent or Less of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 5 Percent or More of Peripheral Blood White Cells [NCIt concept]
- Neoplastic Plasma Cells 6 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells 60 Percent or More of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells More than 20 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells More than 5 Percent of Peripheral Blood White Cells [NCIt concept]
- Neoplastic Plasma Cells Under 5 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Plasma Cells Under 5 Percent of Peripheral Blood White Cells [NCIt concept]
- Neoplastic Plasma Cells Under 50 Percent of Bone Marrow Nucleated Cells [NCIt concept]
- Neoplastic Syndrome [NCIt concept]
- Neopterin [NCIt concept]
- Neostigmine [NCIt concept]
- Neovascularization [NCIt concept]
- Nephrectomy [NCIt concept]
- Nephroureterectomy [NCIt concept]
- Neprilysin [NCIt concept]
- Neratinib [NCIt concept]
- Neratinib Maleate [NCIt concept]
- Nerve Conduction Velocity Test [NCIt concept]
- Nerve Grafting [NCIt concept]
- Nerve-Sparing Prostatectomy [NCIt concept]
- Nervous System Neoplasm [NCIt concept]
- Nesprin-2 [NCIt concept]
- Nestin [NCIt concept]
- Netazepide [NCIt concept]
- Netrin Receptor DCC [NCIt concept]
- Netrin-1 [NCIt concept]
- Netupitant [NCIt concept]
- Netupitant/Palonosetron Hydrochloride [NCIt concept]
- Neural Block [NCIt concept]
- Neural Cell Adhesion Molecule 1 [NCIt concept]
- Neural Cell Adhesion Molecule L1 [NCIt concept]
- Neural Stem Cells-expressing CRAd-S-pk7 [NCIt concept]
- Neuregulin-1 [NCIt concept]
- Neuregulin-2 [NCIt concept]
- Neuregulin-3 [NCIt concept]
- Neurexin-3 [NCIt concept]
- Neurexin-3-Beta [NCIt concept]
- NeuroBlate System [NCIt concept]
- Neuroblast [NCIt concept]
- Neuroblastoma [NCIt concept]
- Neuroblastoma-Amplified Sequence [NCIt concept]
- Neurocognitive Assessment [NCIt concept]
- Neurocutaneous Melanosis [NCIt concept]
- Neuroendocrine Carcinoma [NCIt concept]
- Neuroendocrine Carcinoma of Unknown Primary [NCIt concept]
- Neuroendocrine Convertase 1 [NCIt concept]
- Neuroendocrine Neoplasm [NCIt concept]
- Neuroendocrine Secretory Protein 55 [NCIt concept]
- Neuroendocrine Tumor [NCIt concept]
- Neurofeedback [NCIt concept]
- Neurofibromatosis [NCIt concept]
- Neurofibromatosis Type 1 [NCIt concept]
- Neurofibromatosis Type 2 [NCIt concept]
- Neurofibromin [NCIt concept]
- Neurofilament Light Polypeptide [NCIt concept]
- Neurogenic Locus Notch Homolog Protein 1 [NCIt concept]
- Neurogenic Locus Notch Homolog Protein 2 [NCIt concept]
- Neurogenic Locus Notch Homolog Protein 3 [NCIt concept]
- Neurogenic Locus Notch Homolog Protein 4 [NCIt concept]
- Neurogenin-1 [NCIt concept]
- Neuroimaging [NCIt concept]
- Neuroligin-3 [NCIt concept]
- Neuroligin-4, X-Linked [NCIt concept]
- Neurologic Examination [NCIt concept]
- Neuromedin N [NCIt concept]
- Neuromedin-C [NCIt concept]
- Neuromuscular Blockade [NCIt concept]
- Neuromuscular Electrical Stimulation [NCIt concept]
- Neuron Specific Enolase Measurement [NCIt concept]
- Neuronal Acetylcholine Receptor Subunit Alpha-3 [NCIt concept]
- Neuronal Acetylcholine Receptor Subunit Alpha-5 [NCIt concept]
- Neuronal Acetylcholine Receptor Subunit Beta-4 [NCIt concept]
- Neuronal Migration Protein Doublecortin [NCIt concept]
- Neuropathy [NCIt concept]
- Neuropathy Assessment [NCIt concept]
- Neuropeptide Y [NCIt concept]
- Neuropeptide Y Receptor Type 1 [NCIt concept]
- Neuropeptide Y Receptor Type 2 [NCIt concept]
- Neuropeptide Y Receptor Type 5 [NCIt concept]
- Neuropil [NCIt concept]
- Neuropilin-1 [NCIt concept]
- Neuropilin-2 [NCIt concept]
- Neuropsychological Assessment [NCIt concept]
- Neurotensin [NCIt concept]
- Neurotensin Receptor Type 1 [NCIt concept]
- Neurotensin/Neuromedin N [NCIt concept]
- Neurotization Procedure [NCIt concept]
- Neurotoxicity Syndrome [NCIt concept]
- Neurotrophin-3 [NCIt concept]
- Neutral Amino Acid Transporter A [NCIt concept]
- Neutral Amino Acid Transporter B(0) [NCIt concept]
- Neutral Ceramidase [NCIt concept]
- Neutralizing Anti-Drug Antibody [NCIt concept]
- Neutropenia [NCIt concept]
- Neutrophil [NCIt concept]
- Neutrophil Collagenase [NCIt concept]
- Neutrophil Count Greater than 0.5x10^9/L [NCIt concept]
- Neutrophil Cytosol Factor 1 [NCIt concept]
- Neutrophil Cytosol Factor 2 [NCIt concept]
- Neutrophil Cytosol Factor 4 [NCIt concept]
- Neutrophil Elastase [NCIt concept]
- Neutrophil Elastase Inhibitor [NCIt concept]
- Neutrophil Engraftment [NCIt concept]
- Neutrophil Extracellular Trap [NCIt concept]
- Neutrophil Gelatinase-Associated Lipocalin [NCIt concept]
- Neutrophil-Activating Peptide 2 [NCIt concept]
- Never Smoker [NCIt concept]
- Nevoid Basal Cell Carcinoma Syndrome [NCIt concept]
- Nevoid Melanoma [NCIt concept]
- Newly Diagnosed Carcinoma of Unknown Primary Origin [NCIt concept]
- Newly Diagnosed Childhood Ependymoma [NCIt concept]
- Next Generation Sequencing [NCIt concept]
- Nezastomig [NCIt concept]
- Nezulcitinib [NCIt concept]
- Niacin [NCIt concept]
- Niacinamide [NCIt concept]
- Nibrin [NCIt concept]
- Nibrozetone [NCIt concept]
- Niclosamide [NCIt concept]
- Nicotinamide N-Methyltransferase [NCIt concept]
- Nicotinamide Phosphoribosyltransferase [NCIt concept]
- Nicotinamide Riboside [NCIt concept]
- Nicotine [NCIt concept]
- Nicotine Dependence [NCIt concept]
- Nicotine Lozenge [NCIt concept]
- Nicotine Metabolite Ratio Measurement [NCIt concept]
- Nicotine Oral Pouch [NCIt concept]
- Nicotine Patch [NCIt concept]
- Nicotine Replacement [NCIt concept]
- Nicotine Replacement Agent [NCIt concept]
- Nicotinic Acetylcholine Receptor [NCIt concept]
- Nidanilimab [NCIt concept]
- Nidogen-1 [NCIt concept]
- Nidogen-2 [NCIt concept]
- Niemann-Pick Disease [NCIt concept]
- Nilotinib [NCIt concept]
- Nilotinib Hydrochloride Monohydrate [NCIt concept]
- Nilutamide [NCIt concept]
- Nimesulide-Hyaluronic Acid Conjugate CA102N [NCIt concept]
- Nimotuzumab [NCIt concept]
- Ninein [NCIt concept]
- Nineteen [NCIt concept]
- Nintedanib [NCIt concept]
- Nipocalimab [NCIt concept]
- Nipple Carcinoma [NCIt concept]
- Niraparib [NCIt concept]
- Nirogacestat [NCIt concept]
- Nirsevimab [NCIt concept]
- Nisevokitug [NCIt concept]
- Nitrate [NCIt concept]
- Nitrate Measurement [NCIt concept]
- Nitric Oxide [NCIt concept]
- Nitric Oxide Breath Test [NCIt concept]
- Nitric Oxide Signaling Pathway [NCIt concept]
- Nitric Oxide Synthase, Endothelial [NCIt concept]
- Nitric Oxide Synthase, Inducible [NCIt concept]
- Nitric Oxide Synthetase [NCIt concept]
- Nitrite [NCIt concept]
- Nitrogen Mustard Prodrug PR-104 [NCIt concept]
- Nitroglycerin [NCIt concept]
- Nitrosonornicotine [NCIt concept]
- Nitrous Oxide [NCIt concept]
- Nitroxoline [NCIt concept]
- Nivatrotamab [NCIt concept]
- Nivolumab [NCIt concept]
- Nivolumab and Recombinant Human Hyaluronidase [NCIt concept]
- Nivolumab/Relatlimab-rmbw [NCIt concept]
- No Evidence of Disease [NCIt concept]
- No Intervention Arm [NCIt concept]
- Nociceptin [NCIt concept]
- Nodal Homolog [NCIt concept]
- Nodal Marginal Zone Lymphoma [NCIt concept]
- Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Nogapendekin Alfa [NCIt concept]
- Nogapendekin Alfa Inbakicept [NCIt concept]
- Nomacopan [NCIt concept]
- Non-BRCA Gene Mutation [NCIt concept]
- Non-Cancer Diagnosis [NCIt concept]
- Non-Cogstate Baseline and Follow-up Measures [NCIt concept]
- Non-Cutaneous Melanoma [NCIt concept]
- Non-FDG-Positron Emission Tomography [NCIt concept]
- Non-Fucosylated Umbilical Cord Blood Regulatory T-cells [NCIt concept]
- Non-Functioning Pancreatic Neuroendocrine Tumor [NCIt concept]
- Non-Functioning Pancreatic Neuroendocrine Tumor G1 [NCIt concept]
- Non-Functioning Pituitary Neuroendocrine Tumor [NCIt concept]
- Non-Gaussian Water Diffusion Pattern [NCIt concept]
- Non-Hodgkin Lymphoma [NCIt concept]
- Non-Hodgkin Lymphoma During Pregnancy [NCIt concept]
- Non-Hodgkin Lymphoma in Remission [NCIt concept]
- Non-IgM Monoclonal Gammopathy of Undetermined Significance [NCIt concept]
- Non-Infectious Gastroenterocolitis [NCIt concept]
- Non-Invasive Automated Targeted Temperature Management [NCIt concept]
- Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade [NCIt concept]
- Non-Invasive Mechanical Ventilation [NCIt concept]
- Non-Lysosomal Glucosylceramidase [NCIt concept]
- Non-M3 Acute Myeloid Leukemia [NCIt concept]
- Non-Malignant [NCIt concept]
- Non-Malignant Neoplasm [NCIt concept]
- Non-Malignant Nodule [NCIt concept]
- Non-Metastatic Adrenal Gland Pheochromocytoma [NCIt concept]
- Non-Metastatic Gestational Trophoblastic Tumor [NCIt concept]
- Non-Muscle Invasive Bladder Carcinoma [NCIt concept]
- Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Non-Neoplastic Anorectal Disorder [NCIt concept]
- Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder [NCIt concept]
- Non-Neoplastic Optic Nerve Disorder [NCIt concept]
- Non-Receptor Tyrosine-Protein Kinase TYK2 [NCIt concept]
- Non-Recurrent Esophageal Carcinoma [NCIt concept]
- Non-Recurrent Lung Carcinoma [NCIt concept]
- Non-SF3B1 mRNA Splicing Gene Mutation [NCIt concept]
- Non-Synonymous KRAS Gene Mutation [NCIt concept]
- Non-Synonymous PTEN Gene Mutation [NCIt concept]
- Non-Synonymous RB1 Gene Mutation [NCIt concept]
- Non-Synonymous TP53 Gene Mutation [NCIt concept]
- Non-T Non-B CALLA Negative Adult Acute Lymphoblastic Leukemia [NCIt concept]
- Non-T Non-B CALLA Negative Childhood Acute Lymphoblastic Leukemia [NCIt concept]
- Non-T Non-B CALLA Positive Adult Acute Lymphoblastic Leukemia [NCIt concept]
- Non-T Non-B CALLA Positive Childhood Acute Lymphoblastic Leukemia [NCIt concept]
- Non-V600 BRAF Gene Mutation [NCIt concept]
- Non-Voltage-Dependent Calcium Channel [NCIt concept]
- Non-enzyme Inducing Antiepileptic Drug [NCIt concept]
- Non-esterified Fatty Acids Measurement [NCIt concept]
- Non-myeloablative TCR alpha/beta-depleted Haploidentical Hematopoietic Stem Cell Transplantation [NCIt concept]
- Non-synonymous ERBB2 Gene Mutation [NCIt concept]
- Non-synonymous FBXW7 Gene Mutation [NCIt concept]
- Non-synonymous FLT3 Gene Mutation [NCIt concept]
- Non-synonymous JAK Family Gene Mutation [NCIt concept]
- Non-synonymous KIT Gene Mutation [NCIt concept]
- Non-synonymous MAP2K Family Gene Mutation [NCIt concept]
- Non-synonymous MAPK Family Gene Mutation [NCIt concept]
- Non-synonymous PDGFR Family Gene Mutation [NCIt concept]
- Non-synonymous PKLR Gene Mutation [NCIt concept]
- Non-synonymous RAF Family Gene Mutation [NCIt concept]
- Non-synonymous RAS Family Gene Mutation [NCIt concept]
- Non-synonymous STAT Family Gene Mutation [NCIt concept]
- Non-synonymous VEGFR Family Gene Mutation [NCIt concept]
- Nongerminomatous Germ Cell Tumor [NCIt concept]
- Nonhomologous DNA End Joining [NCIt concept]
- Nonhomologous End-Joining Factor 1 [NCIt concept]
- Noninvasive [NCIt concept]
- Nonmelanomatous [NCIt concept]
- Nonmetastatic Castration-Resistant Prostate Carcinoma [NCIt concept]
- Nonmetastatic Castration-Sensitive Prostate Carcinoma [NCIt concept]
- Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [NCIt concept]
- Nonseminomatous [NCIt concept]
- Noraramtide [NCIt concept]
- Norepinephrine, DL- [NCIt concept]
- Norgestimate [NCIt concept]
- Norgestrel [NCIt concept]
- Normal Karyotype Intermediate Risk Acute Myeloid Leukemia [NCIt concept]
- Normofractionated Radiotherapy [NCIt concept]
- Nornicotine [NCIt concept]
- Noscapine Hydrochloride [NCIt concept]
- Nosocomial Pneumonia [NCIt concept]
- Notch Family [NCIt concept]
- Notch Signaling Inhibitor PF-06650808 [NCIt concept]
- Notch Signaling Pathway Inhibitor MK0752 [NCIt concept]
- Notch-Regulated Ankyrin Repeat-Containing Protein [NCIt concept]
- Notification [NCIt concept]
- NovoTTF-100A Device [NCIt concept]
- NovoTTF-100L [NCIt concept]
- NovoTTF-200A Device [NCIt concept]
- Nuclear Factor 1 B-Type [NCIt concept]
- Nuclear Factor Erythroid 2-Related Factor 2 [NCIt concept]
- Nuclear Factor NF-kappa-B p100 Subunit [NCIt concept]
- Nuclear Factor NF-kappa-B p105 Subunit [NCIt concept]
- Nuclear Factor NF-kappa-B p50 Subunit [NCIt concept]
- Nuclear Factor NF-kappa-B p52 Subunit [NCIt concept]
- Nuclear Factor of Activated T-Cells, Cytoplasmic 2 [NCIt concept]
- Nuclear Mitotic Apparatus Protein 1 [NCIt concept]
- Nuclear Pore Complex Protein Nup107 [NCIt concept]
- Nuclear Pore Complex Protein Nup214 [NCIt concept]
- Nuclear Pore Complex Protein Nup98 [NCIt concept]
- Nuclear Pore Complex Protein Nup98-Nup96 [NCIt concept]
- Nuclear Radiology Imaging Procedure [NCIt concept]
- Nuclear Receptor Coactivator 1 [NCIt concept]
- Nuclear Receptor Coactivator 2 [NCIt concept]
- Nuclear Receptor Coactivator 3 [NCIt concept]
- Nuclear Receptor Coactivator 4 [NCIt concept]
- Nuclear Receptor Corepressor 1 [NCIt concept]
- Nuclear Receptor ROR-Gamma [NCIt concept]
- Nuclear Receptor ROR-Gamma T [NCIt concept]
- Nuclear Receptor Subfamily 0 Group B Member 1 [NCIt concept]
- Nuclear Receptor Subfamily 0 Group B Member 2 [NCIt concept]
- Nuclear Receptor Subfamily 1 Group I Member 2 [NCIt concept]
- Nuclear Receptor Subfamily 1 Group I Member 3 [NCIt concept]
- Nuclear Receptor Subfamily 4 Group A Member 1 [NCIt concept]
- Nuclear Receptor Subfamily 4 Group A Member 3 [NCIt concept]
- Nuclear Receptor-Interacting Protein 1 [NCIt concept]
- Nuclear Transcription Factor Y Subunit Alpha [NCIt concept]
- Nuclease-Sensitive Element-Binding Protein 1 [NCIt concept]
- Nucleic Acid Sequencing [NCIt concept]
- Nucleolar Transcription Factor 1 [NCIt concept]
- Nucleolar and Spindle-Associated Protein 1 [NCIt concept]
- Nucleolin [NCIt concept]
- Nucleolysin TIA-1 Isoform p40 [NCIt concept]
- Nucleophosmin [NCIt concept]
- Nucleoprotein TPR [NCIt concept]
- Nucleoside Analog DFP-10917 [NCIt concept]
- Nucleoside Diphosphate Kinase A [NCIt concept]
- Nucleotide Analogue GS 9219 [NCIt concept]
- Nucleotide-Binding Oligomerization Domain-Containing Protein 2 [NCIt concept]
- Nucleus Accumbens-Associated Protein 2 [NCIt concept]
- Nulliparous [NCIt concept]
- Numidargistat [NCIt concept]
- Nutraceutical TBL-12 [NCIt concept]
- Nutrition Education [NCIt concept]
- Nutritional Assessment [NCIt concept]
- Nutritional Intervention [NCIt concept]
- Nutritional Research [NCIt concept]
- Nutritional Supplement Drink [NCIt concept]
- Nutritional Supplementation [NCIt concept]
- Nutritional Support [NCIt concept]
- Nuvisertib [NCIt concept]
- Nuvustotug [NCIt concept]
- Nuzefatide Pevedotin [NCIt concept]
- O6-Benzylguanine [NCIt concept]
- OAS2 Gene [NCIt concept]
- OAS2 wt Allele [NCIt concept]
- ODC1 Gene [NCIt concept]
- ODC1 wt Allele [NCIt concept]
- OFD1 Gene [NCIt concept]
- OFD1 wt Allele [NCIt concept]
- OGG1 Gene [NCIt concept]
- OGG1 wt Allele [NCIt concept]
- OLFM4 Gene [NCIt concept]
- OLFM4 wt Allele [NCIt concept]
- OLIG2 Gene [NCIt concept]
- OLIG2 wt Allele [NCIt concept]
- OMA1 Activator BTM-3566 [NCIt concept]
- OMD Gene [NCIt concept]
- OMD wt Allele [NCIt concept]
- OPCML Gene [NCIt concept]
- OPCML wt Allele [NCIt concept]
- OPHN1 Gene [NCIt concept]
- OPHN1 wt Allele [NCIt concept]
- OPRM1 Gene [NCIt concept]
- OPRM1 wt Allele [NCIt concept]
- ORAI1 Gene [NCIt concept]
- ORAI1 wt Allele [NCIt concept]
- ORM1 Gene [NCIt concept]
- ORM1 wt Allele [NCIt concept]
- OTX2 Gene [NCIt concept]
- OTX2 wt Allele [NCIt concept]
- OX-2 Membrane Glycoprotein [NCIt concept]
- OXT Gene [NCIt concept]
- OXT Gene Product [NCIt concept]
- OXT wt Allele [NCIt concept]
- Obatoclax Mesylate [NCIt concept]
- Obecabtagene Autoleucel [NCIt concept]
- Oberotatug Ravtansine [NCIt concept]
- Obese [NCIt concept]
- Obesity [NCIt concept]
- Obesity-Related Malignant Neoplasm [NCIt concept]
- Obexelimab [NCIt concept]
- Obinutuzumab [NCIt concept]
- Oblimersen Sodium [NCIt concept]
- Obrindatamab [NCIt concept]
- Obrixtamig [NCIt concept]
- Observer Assessment [NCIt concept]
- Ocaratuzumab [NCIt concept]
- Occult Lung Cancer AJCC v8 [NCIt concept]
- Occult Lung Carcinoma [NCIt concept]
- Occult Lung Non-Small Cell Carcinoma [NCIt concept]
- Occupational Therapy [NCIt concept]
- Ociperlimab [NCIt concept]
- Octreotide [NCIt concept]
- Octreotide Acetate [NCIt concept]
- Octreotide Depot Formulation CAM2029 [NCIt concept]
- Octreotide Long-acting Release Regimen [NCIt concept]
- Octreotide Pamoate [NCIt concept]
- Ocular Graft Versus Host Disease [NCIt concept]
- Ocular Melanoma [NCIt concept]
- Ocular Melanoma with Extraocular Extension [NCIt concept]
- Ocular Surface Squamous Neoplasia [NCIt concept]
- Oculus Rift Headset [NCIt concept]
- Odetiglucan [NCIt concept]
- Odontoameloblastoma [NCIt concept]
- Odontogenic Keratocyst [NCIt concept]
- Odontogenic Neoplasm [NCIt concept]
- Odronextamab [NCIt concept]
- Ofatumumab [NCIt concept]
- Ofranergene Obadenovec [NCIt concept]
- Ointment OQL011 [NCIt concept]
- Olanzapine [NCIt concept]
- Olaparib [NCIt concept]
- Olaratumab [NCIt concept]
- Old Burn Scar-Related Cutaneous Melanoma [NCIt concept]
- Oleandrin [NCIt concept]
- Oleclumab [NCIt concept]
- Olendalizumab [NCIt concept]
- Oleogel-S10 [NCIt concept]
- Olfactomedin-4 [NCIt concept]
- Olfactory Neuroblastoma [NCIt concept]
- Oligoastrocytoma [NCIt concept]
- Oligodendrocyte Marker O4 [NCIt concept]
- Oligodendrocyte Transcription Factor 2 [NCIt concept]
- Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted [NCIt concept]
- Oligofructose-Enriched Inulin [NCIt concept]
- Oligomeric Procyanidin Complex [NCIt concept]
- Oligometastasis [NCIt concept]
- Oligometastatic Breast Carcinoma [NCIt concept]
- Oligometastatic Colorectal Carcinoma [NCIt concept]
- Oligometastatic Cutaneous Melanoma [NCIt concept]
- Oligometastatic Esophageal Adenocarcinoma [NCIt concept]
- Oligometastatic Gastric Adenocarcinoma [NCIt concept]
- Oligometastatic Intrahepatic Cholangiocarcinoma [NCIt concept]
- Oligometastatic Lung Carcinoma [NCIt concept]
- Oligometastatic Malignant Solid Neoplasm [NCIt concept]
- Oligometastatic Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Oligometastatic Prostate Carcinoma [NCIt concept]
- Oligophrenin-1 [NCIt concept]
- Oligoprogression [NCIt concept]
- Olinciguat [NCIt concept]
- Olintatug Tesirine [NCIt concept]
- Olive Oil [NCIt concept]
- Olmutinib [NCIt concept]
- Olomorasib [NCIt concept]
- Olorofim [NCIt concept]
- Olutasidenib [NCIt concept]
- Olverembatinib [NCIt concept]
- Olvimulogene Nanivacirepvec [NCIt concept]
- Omacetaxine [NCIt concept]
- Omacetaxine Mepesuccinate [NCIt concept]
- Omaveloxolone [NCIt concept]
- Ombitasvir [NCIt concept]
- Ombrabulin [NCIt concept]
- Omega-3 Fatty Acid [NCIt concept]
- Omega-3-Acid Ethyl Esters [NCIt concept]
- Omega-6 Fatty Acid [NCIt concept]
- Omentum Gastrointestinal Stromal Tumor [NCIt concept]
- Omeprazole [NCIt concept]
- Omidubicel [NCIt concept]
- Omipalisib [NCIt concept]
- Ommaya Reservoir Tap [NCIt concept]
- Ompenaclid [NCIt concept]
- Onalespib [NCIt concept]
- Onalespib Lactate [NCIt concept]
- Onapristone [NCIt concept]
- Onartuzumab [NCIt concept]
- Onatasertib [NCIt concept]
- Oncocytic Neoplasm [NCIt concept]
- Oncocytic Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Oncocytic Variant of Chromophobe Renal Cell Carcinoma [NCIt concept]
- Oncogene H-Ras [NCIt concept]
- Oncogene K-Ras [NCIt concept]
- Oncogene N-RAS [NCIt concept]
- Oncolytic Adenovirus AdAPT-001 [NCIt concept]
- Oncolytic Adenovirus CAdVEC [NCIt concept]
- Oncolytic Adenovirus Expressing Interferon Beta/CD40 Ligand MEM-288 [NCIt concept]
- Oncolytic Adenovirus ICVB-1042 [NCIt concept]
- Oncolytic Bacterium [NCIt concept]
- Oncolytic HSV-1 C134 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody MVR-C5252 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-2 and IL-12 KB707 [NCIt concept]
- Oncolytic HSV-1 JNJ-87704916 [NCIt concept]
- Oncolytic HSV-1 NV1020 [NCIt concept]
- Oncolytic HSV-1 rQNestin34.5v.2 [NCIt concept]
- Oncolytic HSV-1 rRp450 [NCIt concept]
- Oncolytic HSV1716 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody/CD40L/4-1BBL RP3 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 ONCR-177 [NCIt concept]
- Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein [NCIt concept]
- Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter [NCIt concept]
- Oncolytic Newcastle Disease Virus MEDI5395 [NCIt concept]
- Oncolytic Newcastle Disease Virus Strain PV701 [NCIt concept]
- Oncolytic Poxvirus [NCIt concept]
- Oncolytic Type 2 Herpes Simplex Virus Expressing Anti-PD-L1/CD3 Bispecific Antibody BS-006 [NCIt concept]
- Oncolytic Type 2 Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor OH2 [NCIt concept]
- Oncolytic VSV-GP BI 1821736 [NCIt concept]
- Oncolytic Vaccinia Virus Expressing Leptin/IL-2 Fusion Protein ASP1012 [NCIt concept]
- Oncolytic Vaccinia Virus PF-07263689 [NCIt concept]
- Oncolytic Virus [NCIt concept]
- Oncolytic Virus ASP9801 [NCIt concept]
- Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody [NCIt concept]
- Oncotype DX Breast Cancer Assay [NCIt concept]
- Oncotype DX Breast Cancer Recurrence Score Less than or Equal to Eighteen [NCIt concept]
- Oncotype DX Breast Recurrence Score [NCIt concept]
- Oncotype DX Genomic Prostate Score [NCIt concept]
- Ondansetron [NCIt concept]
- Ondansetron Hydrochloride [NCIt concept]
- Online Adaptive Proton Stereotactic Body Radiation Therapy [NCIt concept]
- Online Mindfulness Meditation [NCIt concept]
- Ontorpacept [NCIt concept]
- Ontuxizumab [NCIt concept]
- Onvansertib [NCIt concept]
- Onvansertib Fumarate [NCIt concept]
- Onvatilimab [NCIt concept]
- Oophorectomy [NCIt concept]
- Opaganib [NCIt concept]
- Opebacan [NCIt concept]
- Opelconazole [NCIt concept]
- Open Distal Pancreatectomy [NCIt concept]
- Open Prostatectomy [NCIt concept]
- Operable Breast Carcinoma Finding [NCIt concept]
- Opevesostat [NCIt concept]
- Ophthalmic Ointment Dosage Form [NCIt concept]
- Ophthalmic Solution [NCIt concept]
- Ophthalmic Solution Dosage Form [NCIt concept]
- Ophthalmologic Complication [NCIt concept]
- Ophthalmoscopy [NCIt concept]
- Opiate Antagonist [NCIt concept]
- Opioid Dependence [NCIt concept]
- Opioid-Binding Protein/Cell Adhesion Molecule [NCIt concept]
- Oplunofusp [NCIt concept]
- Opnurasib [NCIt concept]
- Opolimogene Capmilisbac [NCIt concept]
- Oportuzumab Monatox [NCIt concept]
- Oprelvekin [NCIt concept]
- Oprozomib [NCIt concept]
- Optic Chiasm Neoplasm [NCIt concept]
- Optic Nerve Glioma [NCIt concept]
- Optic Tract Neoplasm [NCIt concept]
- Optical Biopsy [NCIt concept]
- Optical Coherence Tomography [NCIt concept]
- Optical Doppler Tomography [NCIt concept]
- Optical Frequency Domain Imaging Capsule Marking [NCIt concept]
- Optical Spectroscopy [NCIt concept]
- Opugotamig Olatansine [NCIt concept]
- Oral Aminolevulinic Acid Hydrochloride [NCIt concept]
- Oral Cavity Adenoid Cystic Carcinoma [NCIt concept]
- Oral Cavity Carcinoma [NCIt concept]
- Oral Cavity Mucoepidermoid Carcinoma [NCIt concept]
- Oral Cavity Mucosal Melanoma [NCIt concept]
- Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Oral Cavity Verrucous Carcinoma [NCIt concept]
- Oral Complication [NCIt concept]
- Oral Complication of Chemotherapy [NCIt concept]
- Oral Complication of Radiation Therapy [NCIt concept]
- Oral Cryotherapy [NCIt concept]
- Oral Examination [NCIt concept]
- Oral Hsp90 Inhibitor IPI-493 [NCIt concept]
- Oral Intraepithelial Neoplasia [NCIt concept]
- Oral Irinotecan Hydrochloride Formulation VAL-413 [NCIt concept]
- Oral Leukoplakia [NCIt concept]
- Oral Microbiome [NCIt concept]
- Oral Microencapsulated Diindolylmethane [NCIt concept]
- Oral Mucosal Deterging and Dental Prophylaxis [NCIt concept]
- Oral Mucositis WHO Grade I [NCIt concept]
- Oral Mucositis WHO Grade II [NCIt concept]
- Oral Sodium Phenylbutyrate [NCIt concept]
- Oral Topotecan Hydrochloride [NCIt concept]
- Oral-Facial-Digital Syndrome 1 Protein [NCIt concept]
- Orantinib [NCIt concept]
- Oraxol [NCIt concept]
- Orbit Radiation Therapy [NCIt concept]
- Orbital Squamous Cell Carcinoma [NCIt concept]
- Orchiectomy [NCIt concept]
- Ordastobart [NCIt concept]
- Ordesekimab [NCIt concept]
- Oregovomab [NCIt concept]
- Orelabrutinib [NCIt concept]
- Organ Transplantation [NCIt concept]
- Organic Anion Transporter Protein [NCIt concept]
- Organomegaly [NCIt concept]
- Orilanolimab [NCIt concept]
- Orludodstat [NCIt concept]
- Ornithine [NCIt concept]
- Ornithine Decarboxylase [NCIt concept]
- Oropharyngeal Adenoid Cystic Carcinoma [NCIt concept]
- Oropharyngeal Basaloid Squamous Cell Carcinoma [NCIt concept]
- Oropharyngeal Carcinoma [NCIt concept]
- Oropharyngeal Poorly Differentiated Carcinoma [NCIt concept]
- Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Oropharyngeal Undifferentiated Carcinoma [NCIt concept]
- Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma [NCIt concept]
- Orteronel [NCIt concept]
- Orthopedic Stabilization [NCIt concept]
- Orthopedic Surgical Procedure [NCIt concept]
- Orvacabtagene Autoleucel [NCIt concept]
- Osanetant [NCIt concept]
- Oseltamivir [NCIt concept]
- Oseltamivir Phosphate [NCIt concept]
- Osemitamab [NCIt concept]
- Osilodrostat [NCIt concept]
- Osimertinib [NCIt concept]
- Osimertinib Mesylate [NCIt concept]
- Osivelotor [NCIt concept]
- Osteoblast [NCIt concept]
- Osteoblastic Osteosarcoma [NCIt concept]
- Osteocalcin [NCIt concept]
- Osteoclast [NCIt concept]
- Osteolytic Lesions of Multiple Myeloma [NCIt concept]
- Osteomodulin [NCIt concept]
- Osteopathic Manipulative Therapy [NCIt concept]
- Osteopetrosis [NCIt concept]
- Osteopontin [NCIt concept]
- Osteoporosis [NCIt concept]
- Osteosarcoma [NCIt concept]
- Ostomy Skin Barrier [NCIt concept]
- Osugacestat [NCIt concept]
- Other Caregiver [NCIt concept]
- Other Investigational Agent [NCIt concept]
- Otlertuzumab [NCIt concept]
- Ototoxicity [NCIt concept]
- Outer Mitochondrial Transmembrane Helix Translocase [NCIt concept]
- Outreach [NCIt concept]
- Outreach and Inreach [NCIt concept]
- Ovarian Ablation Patient [NCIt concept]
- Ovarian Adenocarcinoma [NCIt concept]
- Ovarian Adenosarcoma [NCIt concept]
- Ovarian Brenner Tumor [NCIt concept]
- Ovarian Cancer Peptide Vaccine [NCIt concept]
- Ovarian Carcinoma [NCIt concept]
- Ovarian Carcinosarcoma [NCIt concept]
- Ovarian Choriocarcinoma [NCIt concept]
- Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Ovarian Clear Cell Cystadenocarcinoma [NCIt concept]
- Ovarian Dysgerminoma [NCIt concept]
- Ovarian Embryonal Carcinoma [NCIt concept]
- Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Ovarian Endometrioid Stromal and Related Neoplasms [NCIt concept]
- Ovarian Failure [NCIt concept]
- Ovarian Germ Cell Tumor [NCIt concept]
- Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Ovarian Mixed Germ Cell Tumor [NCIt concept]
- Ovarian Monodermal and Highly Specialized Teratoma [NCIt concept]
- Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Ovarian Mucinous Cystadenocarcinoma [NCIt concept]
- Ovarian Neoplasm [NCIt concept]
- Ovarian Polyembryoma [NCIt concept]
- Ovarian Sarcoma [NCIt concept]
- Ovarian Seromucinous Carcinoma [NCIt concept]
- Ovarian Serous Adenocarcinoma [NCIt concept]
- Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Ovarian Signet Ring Cell Adenocarcinoma [NCIt concept]
- Ovarian Small Cell Carcinoma [NCIt concept]
- Ovarian Squamous Cell Carcinoma [NCIt concept]
- Ovarian Teratoma [NCIt concept]
- Ovarian Transitional Cell Carcinoma [NCIt concept]
- Ovarian Undifferentiated Carcinoma [NCIt concept]
- Ovarian Yolk Sac Tumor [NCIt concept]
- Oxacillin [NCIt concept]
- Oxaliplatin [NCIt concept]
- Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome [NCIt concept]
- Oxcarbazepine [NCIt concept]
- Oxidative DNA Damage [NCIt concept]
- Oxidative Phosphorylation Inhibitor IACS-010759 [NCIt concept]
- Oxidized RyR1 Measurement [NCIt concept]
- Oxiglutatione [NCIt concept]
- OxyChip [NCIt concept]
- Oxybutynin Chloride [NCIt concept]
- Oxycodone [NCIt concept]
- Oxycodone Hydrochloride [NCIt concept]
- Oxygen 15-labeled Carbon Monoxide [NCIt concept]
- Oxygen 15-labeled Oxygen [NCIt concept]
- Oxygen Radical [NCIt concept]
- Oxygen Saturation Measurement [NCIt concept]
- Oxygen Therapy [NCIt concept]
- Oxygenated Hemoglobin [NCIt concept]
- Oxylipin [NCIt concept]
- Oxylipin Metabolomic Profile [NCIt concept]
- Oxymorphone [NCIt concept]
- Oxyquinoline Sulfate/Sodium Lauryl Sulfate Vaginal Gel [NCIt concept]
- Oxytocin [NCIt concept]
- Oxytocin-Neurophysin 1 [NCIt concept]
- Ozekibart [NCIt concept]
- Ozuriftamab Vedotin [NCIt concept]
- P-Selectin [NCIt concept]
- P-Selectin Glycoprotein Ligand 1 [NCIt concept]
- P-cadherin Inhibitor PCA062 [NCIt concept]
- P-cadherin-targeting Agent PF-06671008 [NCIt concept]
- P-p68 Inhibitor RX-5902 [NCIt concept]
- P2RY8 Gene [NCIt concept]
- P2RY8 wt Allele [NCIt concept]
- P2RY8/CRLF2 Fusion Gene [NCIt concept]
- P2Y Purinoceptor 8 [NCIt concept]
- PA2024 Antibody [NCIt concept]
- PA2G4 Gene [NCIt concept]
- PA2G4 wt Allele [NCIt concept]
- PACS1 Gene [NCIt concept]
- PACS1 wt Allele [NCIt concept]
- PADRE 965.10 [NCIt concept]
- PADRE-CMV Fusion Peptide Vaccine [NCIt concept]
- PAFAH1B2 Gene [NCIt concept]
- PAFAH1B2 wt Allele [NCIt concept]
- PAGR1 Gene [NCIt concept]
- PAGR1 wt Allele [NCIt concept]
- PAI-1 Inhibitor ACT001 [NCIt concept]
- PAK1 Gene [NCIt concept]
- PAK1 wt Allele [NCIt concept]
- PAK3 Gene [NCIt concept]
- PAK3 wt Allele [NCIt concept]
- PAK4 Gene [NCIt concept]
- PAK4 Inhibitor PF-03758309 [NCIt concept]
- PAK4 wt Allele [NCIt concept]
- PALB2 Biallelic Inactivation [NCIt concept]
- PALB2 Gene [NCIt concept]
- PALB2 Gene Mutation [NCIt concept]
- PALB2 Gene Mutation Negative [NCIt concept]
- PALB2 Protein Variant [NCIt concept]
- PALB2 wt Allele [NCIt concept]
- PALLD Gene [NCIt concept]
- PALLD wt Allele [NCIt concept]
- PALMD Gene [NCIt concept]
- PALMD wt Allele [NCIt concept]
- PAM50 Gene Expression Signature [NCIt concept]
- PARG Gene [NCIt concept]
- PARG Inhibitor ETX-19477 [NCIt concept]
- PARG Inhibitor IDE161 [NCIt concept]
- PARG wt Allele [NCIt concept]
- PARK7 Gene [NCIt concept]
- PARK7 wt Allele [NCIt concept]
- PARN Gene [NCIt concept]
- PARN Gene Mutation [NCIt concept]
- PARN wt Allele [NCIt concept]
- PARP Inhibitor CEP-9722 [NCIt concept]
- PARP Inhibitor E7016 [NCIt concept]
- PARP Inhibitor NMS-03305293 [NCIt concept]
- PARP/Microtubule Polymerization Inhibitor AMXI-5001 [NCIt concept]
- PARP/Tankyrase Inhibitor 2X-121 [NCIt concept]
- PARP1 Gene [NCIt concept]
- PARP1 Gene Mutation [NCIt concept]
- PARP1 Gene Product [NCIt concept]
- PARP1 Inhibitor GS-0201 [NCIt concept]
- PARP1 Inhibitor HRS-1167 [NCIt concept]
- PARP1 Inhibitor IMP1734 [NCIt concept]
- PARP1 Inhibitor SNV1521 [NCIt concept]
- PARP1 wt Allele [NCIt concept]
- PARP2 Gene [NCIt concept]
- PARP2 Gene Mutation [NCIt concept]
- PARP2 wt Allele [NCIt concept]
- PARP3 Gene [NCIt concept]
- PARP3 wt Allele [NCIt concept]
- PASD1 Antibody [NCIt concept]
- PASD1 Gene [NCIt concept]
- PASD1 wt Allele [NCIt concept]
- PATZ1 Gene [NCIt concept]
- PATZ1 wt Allele [NCIt concept]
- PATZ1/UQCRH Fusion Gene [NCIt concept]
- PAWR Gene [NCIt concept]
- PAWR wt Allele [NCIt concept]
- PAX-Interacting Protein 1 [NCIt concept]
- PAX/FOXO1 Fusion Gene [NCIt concept]
- PAX1 Gene [NCIt concept]
- PAX1 wt Allele [NCIt concept]
- PAX2 Gene [NCIt concept]
- PAX2 wt Allele [NCIt concept]
- PAX3 Gene [NCIt concept]
- PAX3 wt Allele [NCIt concept]
- PAX3/FOXO1 Fusion Gene [NCIt concept]
- PAX3/FOXO1 Fusion Protein [NCIt concept]
- PAX7 Gene [NCIt concept]
- PAX7 wt Allele [NCIt concept]
- PAX7/FOXO1 Fusion Gene [NCIt concept]
- PAX7/FOXO1 Fusion Protein [NCIt concept]
- PAX8 Gene [NCIt concept]
- PAX8 wt Allele [NCIt concept]
- PAX8/PPARG Fusion Gene [NCIt concept]
- PAX8/PPARG Fusion Protein [NCIt concept]
- PAXIP1 Gene [NCIt concept]
- PAXIP1 wt Allele [NCIt concept]
- PAXIP1-Associated Glutamate-Rich Protein 1 [NCIt concept]
- PBK Gene [NCIt concept]
- PBK wt Allele [NCIt concept]
- PBRM1 Gene [NCIt concept]
- PBRM1 Gene Mutation [NCIt concept]
- PBRM1 wt Allele [NCIt concept]
- PBTL CD19CAR-28/CD137/zeta [NCIt concept]
- PBX1 Gene [NCIt concept]
- PBX1 wt Allele [NCIt concept]
- PBXIP1 Gene [NCIt concept]
- PBXIP1 wt Allele [NCIt concept]
- PCA3 Gene [NCIt concept]
- PCA3 Score Greater than 35 [NCIt concept]
- PCA3 wt Allele [NCIt concept]
- PCDH7 Gene [NCIt concept]
- PCDH7 wt Allele [NCIt concept]
- PCLO Gene [NCIt concept]
- PCLO wt Allele [NCIt concept]
- PCM1 Gene [NCIt concept]
- PCM1 wt Allele [NCIt concept]
- PCM1-JAK2 Fusion Protein Expression [NCIt concept]
- PCM1/JAK2 Fusion Gene [NCIt concept]
- PCM1/JAK2 Fusion Protein [NCIt concept]
- PCM1/RET Fusion Gene [NCIt concept]
- PCM1/RET Fusion Protein [NCIt concept]
- PCNA Gene [NCIt concept]
- PCNA Gene Mutation [NCIt concept]
- PCNA Inhibitor AOH1996 [NCIt concept]
- PCNA wt Allele [NCIt concept]
- PCSK1 Gene [NCIt concept]
- PCSK1 wt Allele [NCIt concept]
- PCSK7 Gene [NCIt concept]
- PCSK7 wt Allele [NCIt concept]
- PCYT1A Gene [NCIt concept]
- PCYT1A wt Allele [NCIt concept]
- PD-1 Ligand Inhibitor [NCIt concept]
- PD-1 Targeted IL-15 Mutein Fusion Protein PF-07209960 [NCIt concept]
- PD-1 targeted IL-2Rb/g Agonist ANV600 [NCIt concept]
- PD-1-positive B-cell Peptide Antigen/MVF IMU-201/Montanide Vaccine [NCIt concept]
- PD-L1 Combined Positive Score [NCIt concept]
- PD-L1 Combined Positive Score Greater than 10 [NCIt concept]
- PD-L1 Combined Positive Score Greater than or Equal to 1 [NCIt concept]
- PD-L1 Combined Positive Score Greater than or Equal to 10 [NCIt concept]
- PD-L1 Combined Positive Score Greater than or Equal to 20 [NCIt concept]
- PD-L1 Combined Positive Score Greater than or Equal to 5 [NCIt concept]
- PD-L1 Combined Positive Score Less than 20 [NCIt concept]
- PD-L1 Combined Positive Score Less than 5 [NCIt concept]
- PD-L1 Expression 1-49 Percent [NCIt concept]
- PD-L1 Expression Greater than 50 Percent [NCIt concept]
- PD-L1 Expression Greater than or Equal to 1 Percent [NCIt concept]
- PD-L1 Expression Greater than or Equal to 50 Percent [NCIt concept]
- PD-L1 Expression Less than 1 Percent [NCIt concept]
- PD-L1 Expression Less than 50 Percent [NCIt concept]
- PD-L1 Expression Less than or Equal to 50 Percent [NCIt concept]
- PD-L1 Expression Positive in Myeloid-Derived Suppressor Cells [NCIt concept]
- PD-L1 Inhibitor [NCIt concept]
- PD-L1 Inhibitor AN4005 [NCIt concept]
- PD-L1 Inhibitor INCB086550 [NCIt concept]
- PD-L1 Inhibitor INCB099280 [NCIt concept]
- PD-L1 Inhibitor INCB099318 [NCIt concept]
- PD-L1 Overexpression [NCIt concept]
- PD-L1 Positive [NCIt concept]
- PD-L1 Tumor Proportion Score [NCIt concept]
- PD-L1 Tumor Proportion Score 1-49 [NCIt concept]
- PD-L1 Tumor Proportion Score Equal to 1 [NCIt concept]
- PD-L1 Tumor Proportion Score Greater than 1 [NCIt concept]
- PD-L1 Tumor Proportion Score Greater than or Equal to 1 [NCIt concept]
- PD-L1 Tumor Proportion Score Greater than or Equal to 5 [NCIt concept]
- PD-L1 Tumor Proportion Score Greater than or Equal to 50 [NCIt concept]
- PD-L1 Tumor Proportion Score Less than 1 [NCIt concept]
- PD-L1 Tumor Proportion Score Less than 49 [NCIt concept]
- PD-L1 Tumor Proportion Score Less than 50 [NCIt concept]
- PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480 [NCIt concept]
- PD-L1/IDO Peptide Vaccine IO102-103 [NCIt concept]
- PD-L1/PD-L2/VISTA Antagonist CA-170 [NCIt concept]
- PD-L2 Inhibitor [NCIt concept]
- PD1 Inhibitor [NCIt concept]
- PDCD1 Gene [NCIt concept]
- PDCD1 Positive [NCIt concept]
- PDCD1 Positive T-Lymphocytes [NCIt concept]
- PDCD1 wt Allele [NCIt concept]
- PDCD1LG2 Gene [NCIt concept]
- PDCD1LG2 wt Allele [NCIt concept]
- PDCD4 Gene [NCIt concept]
- PDCD4 wt Allele [NCIt concept]
- PDE2A Gene [NCIt concept]
- PDE2A wt Allele [NCIt concept]
- PDE3A Gene [NCIt concept]
- PDE3A Positive [NCIt concept]
- PDE3A wt Allele [NCIt concept]
- PDE4DIP Gene [NCIt concept]
- PDE4DIP wt Allele [NCIt concept]
- PDE5A Gene [NCIt concept]
- PDE5A wt Allele [NCIt concept]
- PDE8B Gene [NCIt concept]
- PDE8B wt Allele [NCIt concept]
- PDGFA Gene [NCIt concept]
- PDGFA Gene Amplification [NCIt concept]
- PDGFA Gene Fusion Positive [NCIt concept]
- PDGFA Gene Mutation [NCIt concept]
- PDGFA wt Allele [NCIt concept]
- PDGFB Gene [NCIt concept]
- PDGFB Gene Amplification [NCIt concept]
- PDGFB Gene Fusion Positive [NCIt concept]
- PDGFB Gene Mutation [NCIt concept]
- PDGFB wt Allele [NCIt concept]
- PDGFC Gene [NCIt concept]
- PDGFC wt Allele [NCIt concept]
- PDGFR Antibody [NCIt concept]
- PDGFR Family Gene Mutation [NCIt concept]
- PDGFR Gene Amplification [NCIt concept]
- PDGFR Positive [NCIt concept]
- PDGFR Protein Overexpression [NCIt concept]
- PDGFR-AA [NCIt concept]
- PDGFR-BB [NCIt concept]
- PDGFRA Antibody [NCIt concept]
- PDGFRA D842V Negative [NCIt concept]
- PDGFRA Exon 12 Mutation [NCIt concept]
- PDGFRA Exon 14 Mutation [NCIt concept]
- PDGFRA Exon 18 Mutation [NCIt concept]
- PDGFRA Gene [NCIt concept]
- PDGFRA Gene Amplification [NCIt concept]
- PDGFRA Gene Fusion Positive [NCIt concept]
- PDGFRA Gene Mutation [NCIt concept]
- PDGFRA Gene Mutation Negative [NCIt concept]
- PDGFRA Gene Rearrangement [NCIt concept]
- PDGFRA NM_006206.4:c.2525A>T [NCIt concept]
- PDGFRA NP_006197.1:p.D842V [NCIt concept]
- PDGFRA Positive [NCIt concept]
- PDGFRA Protein Variant [NCIt concept]
- PDGFRA wt Allele [NCIt concept]
- PDGFRB Gene [NCIt concept]
- PDGFRB Gene Amplification [NCIt concept]
- PDGFRB Gene Fusion Positive [NCIt concept]
- PDGFRB Gene Mutation [NCIt concept]
- PDGFRB Gene Rearrangement [NCIt concept]
- PDGFRB NP_002600.1:p.T681I [NCIt concept]
- PDGFRB Positive [NCIt concept]
- PDGFRB Protein Variant [NCIt concept]
- PDGFRB wt Allele [NCIt concept]
- PDGFRB/MYO18A Fusion Gene [NCIt concept]
- PDIA3 Gene [NCIt concept]
- PDIA3 wt Allele [NCIt concept]
- PDIA6 Gene [NCIt concept]
- PDIA6 wt Allele [NCIt concept]
- PDK1 Gene [NCIt concept]
- PDK1 wt Allele [NCIt concept]
- PDK2 Gene [NCIt concept]
- PDK2 wt Allele [NCIt concept]
- PDK3 Gene [NCIt concept]
- PDK3 wt Allele [NCIt concept]
- PDK4 Gene [NCIt concept]
- PDK4 wt Allele [NCIt concept]
- PDLIM2 Gene [NCIt concept]
- PDLIM2 wt Allele [NCIt concept]
- PDLIM3 Gene [NCIt concept]
- PDLIM3 wt Allele [NCIt concept]
- PDLIM4 Gene [NCIt concept]
- PDLIM4 wt Allele [NCIt concept]
- PDPN Gene [NCIt concept]
- PDPN wt Allele [NCIt concept]
- PDS5B Gene [NCIt concept]
- PDS5B Gene Mutation [NCIt concept]
- PDS5B wt Allele [NCIt concept]
- PDZ and LIM Domain Protein 2 [NCIt concept]
- PDZ and LIM Domain Protein 3 [NCIt concept]
- PDZ and LIM Domain Protein 4 [NCIt concept]
- PDZK1 Gene [NCIt concept]
- PDZK1 wt Allele [NCIt concept]
- PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1 [NCIt concept]
- PEA15 Gene [NCIt concept]
- PEA15 wt Allele [NCIt concept]
- PECAM1 Gene [NCIt concept]
- PECAM1 wt Allele [NCIt concept]
- PEG Hydrogel Spacing [NCIt concept]
- PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector IMNN-001 [NCIt concept]
- PELO Gene [NCIt concept]
- PELO wt Allele [NCIt concept]
- PELP1 Gene [NCIt concept]
- PELP1 wt Allele [NCIt concept]
- PEMT Gene [NCIt concept]
- PEMT wt Allele [NCIt concept]
- PENK Gene [NCIt concept]
- PENK Gene Product [NCIt concept]
- PENK wt Allele [NCIt concept]
- PEOX-based Polymer Encapsulated Paclitaxel FID-007 [NCIt concept]
- PEOX-based Polymer Encapsulated SN-38 FID-022 [NCIt concept]
- PEP-3-KLH Conjugate Vaccine [NCIt concept]
- PEP-CMV Vaccine [NCIt concept]
- PER1 Gene [NCIt concept]
- PER1 wt Allele [NCIt concept]
- PERK Inhibitor HC-5404-FU [NCIt concept]
- PERK Inhibitor NMS-03597812 [NCIt concept]
- PET/CT Patient [NCIt concept]
- PEX5-Related Protein [NCIt concept]
- PEX5L Gene [NCIt concept]
- PEX5L wt Allele [NCIt concept]
- PF4 Gene [NCIt concept]
- PF4 wt Allele [NCIt concept]
- PFKM Gene [NCIt concept]
- PFKM wt Allele [NCIt concept]
- PGBD5 Gene [NCIt concept]
- PGBD5 wt Allele [NCIt concept]
- PGF Gene [NCIt concept]
- PGF Gene Product [NCIt concept]
- PGF wt Allele [NCIt concept]
- PGK1 Gene [NCIt concept]
- PGK1 wt Allele [NCIt concept]
- PGLA/PEG Copolymer-Based Paclitaxel [NCIt concept]
- PGP Gene [NCIt concept]
- PGP wt Allele [NCIt concept]
- PGR Gene [NCIt concept]
- PGR Gene Product [NCIt concept]
- PGR wt Allele [NCIt concept]
- PGRMC1 Gene [NCIt concept]
- PGRMC1 wt Allele [NCIt concept]
- PH Domain Leucine-Rich Repeat-Containing Protein Phosphatase 1 [NCIt concept]
- PH Domain Leucine-Rich Repeat-Containing Protein Phosphatase 2 [NCIt concept]
- PH20 Hyaluronidase-expressing Adenovirus VCN-01 [NCIt concept]
- PHB1 Gene [NCIt concept]
- PHB1 wt Allele [NCIt concept]
- PHD Finger Protein 23 [NCIt concept]
- PHD Finger Protein 6 [NCIt concept]
- PHF23 Gene [NCIt concept]
- PHF23 wt Allele [NCIt concept]
- PHF6 Gene [NCIt concept]
- PHF6 Gene Mutation [NCIt concept]
- PHF6 wt Allele [NCIt concept]
- PHLPP1 Gene [NCIt concept]
- PHLPP1 wt Allele [NCIt concept]
- PHLPP2 Gene [NCIt concept]
- PHLPP2 wt Allele [NCIt concept]
- PHOX2B Gene [NCIt concept]
- PHOX2B Gene Mutation [NCIt concept]
- PHOX2B wt Allele [NCIt concept]
- PI3 Gene [NCIt concept]
- PI3 wt Allele [NCIt concept]
- PI3K Alpha Inhibitor [NCIt concept]
- PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate [NCIt concept]
- PI3K Alteration Positive [NCIt concept]
- PI3K Gene Mutation [NCIt concept]
- PI3K Inhibitor BGT226 [NCIt concept]
- PI3K Inhibitor GSK1059615 [NCIt concept]
- PI3K Inhibitor ZSTK474 [NCIt concept]
- PI3K p110beta/delta Inhibitor CVL237 [NCIt concept]
- PI3K-alpha Inhibitor TOS-358 [NCIt concept]
- PI3K-beta Inhibitor GSK2636771 [NCIt concept]
- PI3K-beta Inhibitor SAR260301 [NCIt concept]
- PI3K-delta Inhibitor AMG 319 [NCIt concept]
- PI3K-gamma Inhibitor ZX-4081 [NCIt concept]
- PI3K/MTOR Pathway Mutation [NCIt concept]
- PI3K/mTOR Inhibitor CLL442 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor DS-7423 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor PF-04691502 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor VS-5584 [NCIt concept]
- PI3Kalpha Inhibitor AZD8835 [NCIt concept]
- PI3Kbeta Inhibitor AZD8186 [NCIt concept]
- PI3Kdelta Inhibitor GS-9901 [NCIt concept]
- PI3Kdelta/gamma Inhibitor ZX-101A [NCIt concept]
- PIAS1 Gene [NCIt concept]
- PIAS1 wt Allele [NCIt concept]
- PICALM Gene [NCIt concept]
- PICALM wt Allele [NCIt concept]
- PICALM/MLLT10 Fusion Gene [NCIt concept]
- PICALM/MLLT10 Fusion Protein [NCIt concept]
- PIERCE2 Gene [NCIt concept]
- PIERCE2 wt Allele [NCIt concept]
- PIGA Gene [NCIt concept]
- PIGA Gene Mutation [NCIt concept]
- PIGA wt Allele [NCIt concept]
- PIGF Gene [NCIt concept]
- PIGF wt Allele [NCIt concept]
- PIK3AP1 Gene [NCIt concept]
- PIK3AP1 Gene Mutation [NCIt concept]
- PIK3AP1 wt Allele [NCIt concept]
- PIK3C2B Gene [NCIt concept]
- PIK3C2B Gene Amplification [NCIt concept]
- PIK3C2B Gene Mutation [NCIt concept]
- PIK3C2B wt Allele [NCIt concept]
- PIK3C2G Gene [NCIt concept]
- PIK3C2G Gene Mutation [NCIt concept]
- PIK3C2G wt Allele [NCIt concept]
- PIK3C3 Gene [NCIt concept]
- PIK3C3 Gene Mutation [NCIt concept]
- PIK3C3 wt Allele [NCIt concept]
- PIK3CA Gene [NCIt concept]
- PIK3CA Gene Alteration Positive [NCIt concept]
- PIK3CA Gene Amplification [NCIt concept]
- PIK3CA Gene Mutation [NCIt concept]
- PIK3CA Gene Mutation Negative [NCIt concept]
- PIK3CA Gene Rearrangement [NCIt concept]
- PIK3CA NM_006218.1:c.1258T>C [NCIt concept]
- PIK3CA NM_006218.1:c.1624G>A [NCIt concept]
- PIK3CA NM_006218.1:c.1624G>C [NCIt concept]
- PIK3CA NM_006218.1:c.1625A>G [NCIt concept]
- PIK3CA NM_006218.1:c.1625A>T [NCIt concept]
- PIK3CA NM_006218.1:c.1633G>A [NCIt concept]
- PIK3CA NM_006218.1:c.1633G>C [NCIt concept]
- PIK3CA NM_006218.1:c.1634A>C [NCIt concept]
- PIK3CA NM_006218.1:c.1634A>G [NCIt concept]
- PIK3CA NM_006218.1:c.1634A>T [NCIt concept]
- PIK3CA NM_006218.1:c.1635G>C [NCIt concept]
- PIK3CA NM_006218.1:c.1635G>T [NCIt concept]
- PIK3CA NM_006218.1:c.3139C>T [NCIt concept]
- PIK3CA NM_006218.1:c.3140A>G [NCIt concept]
- PIK3CA NM_006218.1:c.3140A>T [NCIt concept]
- PIK3CA NM_006218.1:c.3141T>G [NCIt concept]
- PIK3CA NM_006218.4:c.1035T>A [NCIt concept]
- PIK3CA NM_006218.4:c.263G>A [NCIt concept]
- PIK3CA NM_006218.4:c.3129G>A [NCIt concept]
- PIK3CA NM_006218.4:c.3129G>C [NCIt concept]
- PIK3CA NM_006218.4:c.3129G>T [NCIt concept]
- PIK3CA NM_006218.4:c.3145G>C [NCIt concept]
- PIK3CA NP_006209.2:p.C420R [NCIt concept]
- PIK3CA NP_006209.2:p.E542G [NCIt concept]
- PIK3CA NP_006209.2:p.E542K [NCIt concept]
- PIK3CA NP_006209.2:p.E542Q [NCIt concept]
- PIK3CA NP_006209.2:p.E542V [NCIt concept]
- PIK3CA NP_006209.2:p.E542X [NCIt concept]
- PIK3CA NP_006209.2:p.E545A [NCIt concept]
- PIK3CA NP_006209.2:p.E545D [NCIt concept]
- PIK3CA NP_006209.2:p.E545G [NCIt concept]
- PIK3CA NP_006209.2:p.E545K [NCIt concept]
- PIK3CA NP_006209.2:p.E545Q [NCIt concept]
- PIK3CA NP_006209.2:p.E545V [NCIt concept]
- PIK3CA NP_006209.2:p.E545X [NCIt concept]
- PIK3CA NP_006209.2:p.G1049R [NCIt concept]
- PIK3CA NP_006209.2:p.H1047L [NCIt concept]
- PIK3CA NP_006209.2:p.H1047Q [NCIt concept]
- PIK3CA NP_006209.2:p.H1047R [NCIt concept]
- PIK3CA NP_006209.2:p.H1047T [NCIt concept]
- PIK3CA NP_006209.2:p.H1047X [NCIt concept]
- PIK3CA NP_006209.2:p.H1047Y [NCIt concept]
- PIK3CA NP_006209.2:p.M1043I [NCIt concept]
- PIK3CA NP_006209.2:p.N345K [NCIt concept]
- PIK3CA NP_006209.2:p.Q546X [NCIt concept]
- PIK3CA NP_006209.2:p.R88Q [NCIt concept]
- PIK3CA Protein Variant [NCIt concept]
- PIK3CA wt Allele [NCIt concept]
- PIK3CA-Related Overgrowth Spectrum [NCIt concept]
- PIK3CB Gene [NCIt concept]
- PIK3CB Gene Amplification [NCIt concept]
- PIK3CB Gene Mutation [NCIt concept]
- PIK3CB wt Allele [NCIt concept]
- PIK3CD Gene [NCIt concept]
- PIK3CD Gene Mutation [NCIt concept]
- PIK3CD wt Allele [NCIt concept]
- PIK3CG Gene [NCIt concept]
- PIK3CG Gene Mutation [NCIt concept]
- PIK3CG wt Allele [NCIt concept]
- PIK3R1 Gene [NCIt concept]
- PIK3R1 Gene Mutation [NCIt concept]
- PIK3R1 wt Allele [NCIt concept]
- PIK3R2 Gene [NCIt concept]
- PIK3R2 Gene Mutation [NCIt concept]
- PIK3R2 wt Allele [NCIt concept]
- PIK3R2/USP8 Fusion Gene [NCIt concept]
- PIK3R2/USP8 Fusion Protein [NCIt concept]
- PIK3R3 Gene [NCIt concept]
- PIK3R3 Gene Mutation [NCIt concept]
- PIK3R3 wt Allele [NCIt concept]
- PIK3R5 Gene [NCIt concept]
- PIK3R5 Gene Mutation [NCIt concept]
- PIK3R5 wt Allele [NCIt concept]
- PIKFYVE Gene [NCIt concept]
- PIKFYVE wt Allele [NCIt concept]
- PIM Kinase Inhibitor LGH447 [NCIt concept]
- PIM Kinase Inhibitor SGI-1776 [NCIt concept]
- PIM1 Gene [NCIt concept]
- PIM1 wt Allele [NCIt concept]
- PIM2 Gene [NCIt concept]
- PIM2 wt Allele [NCIt concept]
- PIM3 Gene [NCIt concept]
- PIM3 wt Allele [NCIt concept]
- PIN1 Gene [NCIt concept]
- PIN1 wt Allele [NCIt concept]
- PIN2/TERF1-Interacting Telomerase Inhibitor 1 [NCIt concept]
- PINX1 Gene [NCIt concept]
- PINX1 wt Allele [NCIt concept]
- PIP4K2A Gene [NCIt concept]
- PIP4K2A wt Allele [NCIt concept]
- PITX2 Gene [NCIt concept]
- PITX2 wt Allele [NCIt concept]
- PKC-beta Inhibitor MS-553 [NCIt concept]
- PKD1L1 Gene [NCIt concept]
- PKD1L1 wt Allele [NCIt concept]
- PKLR Gene [NCIt concept]
- PKLR Gene Mutation [NCIt concept]
- PKLR NM_000298.5:c.1436G>A [NCIt concept]
- PKLR NP_000289.1:p.R479H [NCIt concept]
- PKLR Protein Variant [NCIt concept]
- PKLR wt Allele [NCIt concept]
- PKM Gene [NCIt concept]
- PKM wt Allele [NCIt concept]
- PKMYT1 Gene [NCIt concept]
- PKMYT1 Inhibitor [NCIt concept]
- PKMYT1 Inhibitor XL495 [NCIt concept]
- PKMYT1 wt Allele [NCIt concept]
- PLA2G1B Gene [NCIt concept]
- PLA2G1B wt Allele [NCIt concept]
- PLA2G2A Gene [NCIt concept]
- PLA2G2A wt Allele [NCIt concept]
- PLA2G7 Gene [NCIt concept]
- PLA2G7 wt Allele [NCIt concept]
- PLA2R1 Gene [NCIt concept]
- PLA2R1 wt Allele [NCIt concept]
- PLAG1 Gene [NCIt concept]
- PLAG1 wt Allele [NCIt concept]
- PLAGL1 Gene [NCIt concept]
- PLAGL1 wt Allele [NCIt concept]
- PLAGL2 Gene [NCIt concept]
- PLAGL2 wt Allele [NCIt concept]
- PLAT Gene [NCIt concept]
- PLAT wt Allele [NCIt concept]
- PLAU Gene [NCIt concept]
- PLAU wt Allele [NCIt concept]
- PLAUR Gene [NCIt concept]
- PLAUR wt Allele [NCIt concept]
- PLCB4 Gene [NCIt concept]
- PLCB4 Gene Mutation [NCIt concept]
- PLCB4 wt Allele [NCIt concept]
- PLCG1 Gene [NCIt concept]
- PLCG1 wt Allele [NCIt concept]
- PLCG2 Gene [NCIt concept]
- PLCG2 Gene Mutation [NCIt concept]
- PLCG2 wt Allele [NCIt concept]
- PLEC Gene [NCIt concept]
- PLEC wt Allele [NCIt concept]
- PLED-based MnSOD Mimetic [NCIt concept]
- PLG Gene [NCIt concept]
- PLG wt Allele [NCIt concept]
- PLIN2 Gene [NCIt concept]
- PLIN2 wt Allele [NCIt concept]
- PLK1 Gene [NCIt concept]
- PLK1 Inhibitor TAK-960 [NCIt concept]
- PLK1 wt Allele [NCIt concept]
- PLK4 Inhibitor [NCIt concept]
- PLK4 Inhibitor RP-1664 [NCIt concept]
- PLOD2 Gene [NCIt concept]
- PLOD2 wt Allele [NCIt concept]
- PLPP3 Gene [NCIt concept]
- PLPP3 wt Allele [NCIt concept]
- PLVAP Gene [NCIt concept]
- PLVAP wt Allele [NCIt concept]
- PLXDC1 Gene [NCIt concept]
- PLXDC1 wt Allele [NCIt concept]
- PLXNC1 Gene [NCIt concept]
- PLXNC1 wt Allele [NCIt concept]
- PLXND1 Gene [NCIt concept]
- PLXND1 wt Allele [NCIt concept]
- PLZ4-coated Paclitaxel-loaded Micelle Formulation [NCIt concept]
- PMAIP1 Gene [NCIt concept]
- PMAIP1 wt Allele [NCIt concept]
- PMEL Antibody [NCIt concept]
- PMEL Gene [NCIt concept]
- PMEL Positive [NCIt concept]
- PMEL wt Allele [NCIt concept]
- PML Gene [NCIt concept]
- PML wt Allele [NCIt concept]
- PML/RARA Fusion Gene [NCIt concept]
- PML/RARA Fusion Positive [NCIt concept]
- PML/RARA Fusion Protein [NCIt concept]
- PMS1 Gene [NCIt concept]
- PMS1 Gene Mutation [NCIt concept]
- PMS1 Protein Homolog 1 [NCIt concept]
- PMS1 wt Allele [NCIt concept]
- PMS2 Gene [NCIt concept]
- PMS2 Gene Mutation [NCIt concept]
- PMS2 Loss of Nuclear Expression [NCIt concept]
- PMS2 Negative [NCIt concept]
- PMS2 Nuclear Expression Intact [NCIt concept]
- PMS2 Protein Variant [NCIt concept]
- PMS2 wt Allele [NCIt concept]
- PNOC Gene [NCIt concept]
- PNOC Gene Product [NCIt concept]
- PNOC wt Allele [NCIt concept]
- PODXL Gene [NCIt concept]
- PODXL wt Allele [NCIt concept]
- POEMS Syndrome [NCIt concept]
- POLD1 Gene [NCIt concept]
- POLD1 Gene Mutation [NCIt concept]
- POLD1 wt Allele [NCIt concept]
- POLD3 Gene [NCIt concept]
- POLD3 wt Allele [NCIt concept]
- POLE Exonuclease Domain Mutation [NCIt concept]
- POLE Gene [NCIt concept]
- POLE Gene Mutation [NCIt concept]
- POLE Gene Mutation Negative [NCIt concept]
- POLE wt Allele [NCIt concept]
- POLH Gene [NCIt concept]
- POLH wt Allele [NCIt concept]
- POLI Gene [NCIt concept]
- POLI wt Allele [NCIt concept]
- POLK Gene [NCIt concept]
- POLK wt Allele [NCIt concept]
- POLQ Gene [NCIt concept]
- POLQ Gene Mutation [NCIt concept]
- POLQ wt Allele [NCIt concept]
- POLR2L Gene [NCIt concept]
- POLR2L wt Allele [NCIt concept]
- POMC Gene [NCIt concept]
- POMC Gene Product [NCIt concept]
- POMC wt Allele [NCIt concept]
- PON1 Gene [NCIt concept]
- PON1 wt Allele [NCIt concept]
- PON2 Gene [NCIt concept]
- PON2 wt Allele [NCIt concept]
- PORCN Gene [NCIt concept]
- PORCN wt Allele [NCIt concept]
- POSTN Gene [NCIt concept]
- POSTN wt Allele [NCIt concept]
- POT1 Gene [NCIt concept]
- POT1 Gene Mutation [NCIt concept]
- POT1 wt Allele [NCIt concept]
- POU Domain Class 2-Associating Factor 1 [NCIt concept]
- POU Domain, Class 5, Transcription Factor 1 [NCIt concept]
- POU2AF1 Gene [NCIt concept]
- POU2AF1 wt Allele [NCIt concept]
- POU5F1 Gene [NCIt concept]
- POU5F1 wt Allele [NCIt concept]
- POU5F1B Gene [NCIt concept]
- POU5F1B wt Allele [NCIt concept]
- POZ-, AT Hook-, and Zinc Finger-Containing Protein 1 [NCIt concept]
- PPAR Gamma Inhibitor [NCIt concept]
- PPAR Gamma Inhibitor FX-909 [NCIt concept]
- PPARA Gene [NCIt concept]
- PPARA wt Allele [NCIt concept]
- PPARD Gene [NCIt concept]
- PPARD wt Allele [NCIt concept]
- PPARG Gene [NCIt concept]
- PPARG wt Allele [NCIt concept]
- PPARGC1A Gene [NCIt concept]
- PPARGC1A Gene Product [NCIt concept]
- PPARGC1A wt Allele [NCIt concept]
- PPARGC1B Gene [NCIt concept]
- PPARGC1B wt Allele [NCIt concept]
- PPBP Gene [NCIt concept]
- PPBP Gene Product [NCIt concept]
- PPBP wt Allele [NCIt concept]
- PPE-Expressing Replication-Defective HSV-1 Vector NP2 [NCIt concept]
- PPFIBP1 Gene [NCIt concept]
- PPFIBP1 wt Allele [NCIt concept]
- PPIB Gene [NCIt concept]
- PPIB wt Allele [NCIt concept]
- PPID Gene [NCIt concept]
- PPID wt Allele [NCIt concept]
- PPM1D Gene [NCIt concept]
- PPM1D Gene Amplification [NCIt concept]
- PPM1D Gene Mutation [NCIt concept]
- PPM1D wt Allele [NCIt concept]
- PPP1CB Gene [NCIt concept]
- PPP1CB Gene Mutation [NCIt concept]
- PPP1CB wt Allele [NCIt concept]
- PPP1R15A Gene [NCIt concept]
- PPP1R15A wt Allele [NCIt concept]
- PPP2R1A Gene [NCIt concept]
- PPP2R1A Gene Mutation [NCIt concept]
- PPP2R1A Gene Mutation Negative [NCIt concept]
- PPP2R1A wt Allele [NCIt concept]
- PPP2R2A Gene [NCIt concept]
- PPP2R2A Gene Mutation [NCIt concept]
- PPP2R2A wt Allele [NCIt concept]
- PPT1 Gene [NCIt concept]
- PPT1 wt Allele [NCIt concept]
- PPY Gene [NCIt concept]
- PPY wt Allele [NCIt concept]
- PR Domain Zinc Finger Protein 1 [NCIt concept]
- PR1 Leukemia Peptide Vaccine [NCIt concept]
- PRAME Gene [NCIt concept]
- PRAME Positive [NCIt concept]
- PRAME wt Allele [NCIt concept]
- PRAME-targeting TCR-engineered NK Cells [NCIt concept]
- PRC2 Inhibitor ORIC-944 [NCIt concept]
- PRC2 Loss of Function Gene Mutation [NCIt concept]
- PRCC Gene [NCIt concept]
- PRCC wt Allele [NCIt concept]
- PRCC/TFE3 Fusion Gene [NCIt concept]
- PRCC/TFE3 Fusion Protein [NCIt concept]
- PRDM1 Gene [NCIt concept]
- PRDM1 wt Allele [NCIt concept]
- PRDM16 Gene [NCIt concept]
- PRDM16 wt Allele [NCIt concept]
- PRDX4 Gene [NCIt concept]
- PRDX4 wt Allele [NCIt concept]
- PRETEXT I Hepatoblastoma [NCIt concept]
- PRETEXT II Hepatoblastoma [NCIt concept]
- PRETEXT III Hepatoblastoma [NCIt concept]
- PRETEXT IV Hepatoblastoma [NCIt concept]
- PRF1 Gene [NCIt concept]
- PRF1 Gene Mutation [NCIt concept]
- PRF1 wt Allele [NCIt concept]
- PRICKLE1 Gene [NCIt concept]
- PRICKLE1 wt Allele [NCIt concept]
- PRKAA1 Gene [NCIt concept]
- PRKAA1 wt Allele [NCIt concept]
- PRKACA Gene [NCIt concept]
- PRKACA wt Allele [NCIt concept]
- PRKAR1A Gene [NCIt concept]
- PRKAR1A wt Allele [NCIt concept]
- PRKAR1A/RARA Fusion Gene [NCIt concept]
- PRKAR1A/RARA Fusion Protein [NCIt concept]
- PRKAR1A/RET Fusion Gene [NCIt concept]
- PRKAR1A/RET Fusion Protein [NCIt concept]
- PRKAR2A Gene [NCIt concept]
- PRKAR2A wt Allele [NCIt concept]
- PRKC Apoptosis WT1 Regulator Protein [NCIt concept]
- PRKCA Gene [NCIt concept]
- PRKCA wt Allele [NCIt concept]
- PRKCB Gene [NCIt concept]
- PRKCB wt Allele [NCIt concept]
- PRKCE Gene [NCIt concept]
- PRKCE wt Allele [NCIt concept]
- PRKCG Gene [NCIt concept]
- PRKCG wt Allele [NCIt concept]
- PRKCI Gene [NCIt concept]
- PRKCI wt Allele [NCIt concept]
- PRKD1 Gene [NCIt concept]
- PRKD1 wt Allele [NCIt concept]
- PRKD2 Gene [NCIt concept]
- PRKD2 wt Allele [NCIt concept]
- PRKDC Gene [NCIt concept]
- PRKDC Gene Mutation [NCIt concept]
- PRKDC wt Allele [NCIt concept]
- PRL Gene [NCIt concept]
- PRL wt Allele [NCIt concept]
- PRLR Gene [NCIt concept]
- PRLR Positive [NCIt concept]
- PRLR wt Allele [NCIt concept]
- PRMT1 Gene [NCIt concept]
- PRMT1 Inhibitor [NCIt concept]
- PRMT1 Inhibitor GSK3368715 [NCIt concept]
- PRMT1 wt Allele [NCIt concept]
- PRMT5 Gene [NCIt concept]
- PRMT5 Inhibitor AZD3470 [NCIt concept]
- PRMT5 Inhibitor BGB-58067 [NCIt concept]
- PRMT5 Inhibitor PRT811 [NCIt concept]
- PRMT5 Inhibitor SKL27969 [NCIt concept]
- PRMT5 Inhibitor TNG456 [NCIt concept]
- PRMT5 wt Allele [NCIt concept]
- PRMT5-MTA Inhibitor MRTX1719 [NCIt concept]
- PROCR Gene [NCIt concept]
- PROCR wt Allele [NCIt concept]
- PROCR/PDGFRA/ZEB1 Positive Cells [NCIt concept]
- PROKR2 Gene [NCIt concept]
- PROKR2 wt Allele [NCIt concept]
- PROM1 Gene [NCIt concept]
- PROM1 wt Allele [NCIt concept]
- PROS1 Gene [NCIt concept]
- PROS1 wt Allele [NCIt concept]
- PROX1 Gene [NCIt concept]
- PROX1 wt Allele [NCIt concept]
- PRRX1 Gene [NCIt concept]
- PRRX1 wt Allele [NCIt concept]
- PRSS1 Gene [NCIt concept]
- PRSS1 Gene Mutation [NCIt concept]
- PRSS1 Protein Variant [NCIt concept]
- PRSS1 wt Allele [NCIt concept]
- PRSS2 Gene [NCIt concept]
- PRSS2 Gene Mutation [NCIt concept]
- PRSS2 wt Allele [NCIt concept]
- PRTN3 Gene [NCIt concept]
- PRTN3 wt Allele [NCIt concept]
- PRUNE2 Gene [NCIt concept]
- PRUNE2 wt Allele [NCIt concept]
- PSA 50 Percent or Greater than Nadir [NCIt concept]
- PSA Antibody [NCIt concept]
- PSA Decline Greater than 30 Percent [NCIt concept]
- PSA Decline Greater than 50 Percent [NCIt concept]
- PSA Decline Greater than 75 Percent [NCIt concept]
- PSA Decline Greater than 90 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 25 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 30 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 50 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 90 Percent [NCIt concept]
- PSA Density Less than 0.15 [NCIt concept]
- PSA Density Less than 0.2 [NCIt concept]
- PSA Density Less than 0.3 [NCIt concept]
- PSA Doubling Time [NCIt concept]
- PSA Doubling Time Greater than 3 Months [NCIt concept]
- PSA Doubling Time Greater than 6 Months [NCIt concept]
- PSA Doubling Time Greater than or Equal to 10 Months [NCIt concept]
- PSA Doubling Time Greater than or Equal to 4 Months [NCIt concept]
- PSA Doubling Time Less than 12 Months [NCIt concept]
- PSA Doubling Time Less than 15 Months [NCIt concept]
- PSA Doubling Time Less than or Equal to 10 Months [NCIt concept]
- PSA Doubling Time Less than or Equal to 12 Months [NCIt concept]
- PSA Doubling Time Less than or Equal to 6 Months [NCIt concept]
- PSA Failure [NCIt concept]
- PSA Level [NCIt concept]
- PSA Level 0.05 to 0.7 [NCIt concept]
- PSA Level 0.1 to 0.7 [NCIt concept]
- PSA Level 0.1 to Fifty [NCIt concept]
- PSA Level 0.2 to Fifty [NCIt concept]
- PSA Level 0.2 to Four [NCIt concept]
- PSA Level 0.2 to Ten [NCIt concept]
- PSA Level 0.2 to Two [NCIt concept]
- PSA Level 0.5 to Fifty [NCIt concept]
- PSA Level 0.5 to Ten [NCIt concept]
- PSA Level Equal to Nadir Plus 2 ng/mL [NCIt concept]
- PSA Level Five to Ten [NCIt concept]
- PSA Level Four to Ten [NCIt concept]
- PSA Level Greater than 0.03 [NCIt concept]
- PSA Level Greater than 0.1 [NCIt concept]
- PSA Level Greater than 0.15 [NCIt concept]
- PSA Level Greater than 0.2 [NCIt concept]
- PSA Level Greater than 0.3 [NCIt concept]
- PSA Level Greater than 0.4 [NCIt concept]
- PSA Level Greater than 0.5 [NCIt concept]
- PSA Level Greater than 2.5 [NCIt concept]
- PSA Level Greater than Fifteen [NCIt concept]
- PSA Level Greater than Fifty [NCIt concept]
- PSA Level Greater than Five [NCIt concept]
- PSA Level Greater than Four [NCIt concept]
- PSA Level Greater than One [NCIt concept]
- PSA Level Greater than One Hundred [NCIt concept]
- PSA Level Greater than One Hundred Fifty [NCIt concept]
- PSA Level Greater than Ten [NCIt concept]
- PSA Level Greater than Twenty [NCIt concept]
- PSA Level Greater than Two [NCIt concept]
- PSA Level Greater than Zero [NCIt concept]
- PSA Level Greater than or Equal to 0.01 [NCIt concept]
- PSA Level Greater than or Equal to 0.05 [NCIt concept]
- PSA Level Greater than or Equal to 0.1 [NCIt concept]
- PSA Level Greater than or Equal to 0.2 [NCIt concept]
- PSA Level Greater than or Equal to 0.4 [NCIt concept]
- PSA Level Greater than or Equal to 0.5 [NCIt concept]
- PSA Level Greater than or Equal to 0.7 [NCIt concept]
- PSA Level Greater than or Equal to 0.8 [NCIt concept]
- PSA Level Greater than or Equal to Eight [NCIt concept]
- PSA Level Greater than or Equal to Fifteen [NCIt concept]
- PSA Level Greater than or Equal to Fifty [NCIt concept]
- PSA Level Greater than or Equal to Five [NCIt concept]
- PSA Level Greater than or Equal to Forty [NCIt concept]
- PSA Level Greater than or Equal to Four [NCIt concept]
- PSA Level Greater than or Equal to One [NCIt concept]
- PSA Level Greater than or Equal to Ten [NCIt concept]
- PSA Level Greater than or Equal to Three [NCIt concept]
- PSA Level Greater than or Equal to Twenty [NCIt concept]
- PSA Level Greater than or Equal to Twenty-Five [NCIt concept]
- PSA Level Greater than or Equal to Two [NCIt concept]
- PSA Level Less than 0.01 [NCIt concept]
- PSA Level Less than 0.02 [NCIt concept]
- PSA Level Less than 0.1 [NCIt concept]
- PSA Level Less than 0.2 [NCIt concept]
- PSA Level Less than 0.4 [NCIt concept]
- PSA Level Less than 0.5 [NCIt concept]
- PSA Level Less than 0.7 [NCIt concept]
- PSA Level Less than Fifteen [NCIt concept]
- PSA Level Less than Fifty [NCIt concept]
- PSA Level Less than Five [NCIt concept]
- PSA Level Less than Forty [NCIt concept]
- PSA Level Less than Four [NCIt concept]
- PSA Level Less than One [NCIt concept]
- PSA Level Less than One Hundred [NCIt concept]
- PSA Level Less than One Hundred Fifty [NCIt concept]
- PSA Level Less than Ten [NCIt concept]
- PSA Level Less than Thirty [NCIt concept]
- PSA Level Less than Twenty [NCIt concept]
- PSA Level Less than Twenty Five [NCIt concept]
- PSA Level Less than Two [NCIt concept]
- PSA Level Less than or Equal to 0.2 [NCIt concept]
- PSA Level Less than or Equal to 0.5 [NCIt concept]
- PSA Level Less than or Equal to Eighty [NCIt concept]
- PSA Level Less than or Equal to Eleven [NCIt concept]
- PSA Level Less than or Equal to Fifteen [NCIt concept]
- PSA Level Less than or Equal to Fifty [NCIt concept]
- PSA Level Less than or Equal to Five [NCIt concept]
- PSA Level Less than or Equal to Four [NCIt concept]
- PSA Level Less than or Equal to One Hundred [NCIt concept]
- PSA Level Less than or Equal to One Hundred Fifty [NCIt concept]
- PSA Level Less than or Equal to Ten [NCIt concept]
- PSA Level Less than or Equal to Thirty [NCIt concept]
- PSA Level Less than or Equal to Twenty [NCIt concept]
- PSA Level Less than or Equal to Two [NCIt concept]
- PSA Level Ten to Fifteen [NCIt concept]
- PSA Level Ten to Fifty [NCIt concept]
- PSA Level Ten to Twenty [NCIt concept]
- PSA Level Twenty to One Hundred Fifty [NCIt concept]
- PSA Level Twenty to One Hundred Fifty or Greater [NCIt concept]
- PSA Level Two to Forty [NCIt concept]
- PSA Level Two to Ten [NCIt concept]
- PSA Level Zero to Forty Four [NCIt concept]
- PSA Level Zero to Two [NCIt concept]
- PSA Nadir Greater than or Equal to 0.5 ng/mL [NCIt concept]
- PSA Nadir Less than 0.2 ng/mL [NCIt concept]
- PSA Nadir Less than 0.5 ng/mL [NCIt concept]
- PSA Nadir Less than or Equal to 0.2 ng/mL [NCIt concept]
- PSA Progression [NCIt concept]
- PSA Prostate Cancer Vaccine [NCIt concept]
- PSA/IL-2/GM-CSF Vaccine [NCIt concept]
- PSA/PSMA DNA Plasmid INO-5150 [NCIt concept]
- PSA/PSMA/PSCA-encoding DNA Plasmid Vaccine PF-06755990 [NCIt concept]
- PSA:154-163(155L) Peptide Vaccine [NCIt concept]
- PSAP Gene [NCIt concept]
- PSAP Gene Mutation [NCIt concept]
- PSAP wt Allele [NCIt concept]
- PSCA Antibody [NCIt concept]
- PSCA Gene [NCIt concept]
- PSCA Positive [NCIt concept]
- PSCA wt Allele [NCIt concept]
- PSENEN Gene [NCIt concept]
- PSENEN wt Allele [NCIt concept]
- PSMA PET-CT Scan [NCIt concept]
- PSMA SUVmean Less than 10 [NCIt concept]
- PSMA-Positive Extracellular Vesicles High [NCIt concept]
- PSMA-Positive Extracellular Vesicles Low [NCIt concept]
- PSMA-targeted Docetaxel Nanoparticles BIND-014 [NCIt concept]
- PSMA-targeted Radioligand Therapy [NCIt concept]
- PSMA-targeted Tubulysin B-containing Conjugate EC1169 [NCIt concept]
- PSMA-targeting Agent [NCIt concept]
- PSMA-targeting Agent-Technetium Tc99m EC0652 [NCIt concept]
- PSMA-targeting Fluorescent Imaging Agent IS-002 [NCIt concept]
- PSMA-targeting Fluorescent Imaging Agent MDX1201-A488 [NCIt concept]
- PSMA-targeting T-cell Redirecting Agent JNJ-80038114 [NCIt concept]
- PSMA/CD3 Tri-specific T-cell Activating Construct HPN424 [NCIt concept]
- PSMA/TARP Peptide Vaccine [NCIt concept]
- PSMA5 Gene [NCIt concept]
- PSMA5 wt Allele [NCIt concept]
- PSMB10 Gene [NCIt concept]
- PSMB10 wt Allele [NCIt concept]
- PSMB5 Gene [NCIt concept]
- PSMB5 wt Allele [NCIt concept]
- PSMB8 Gene [NCIt concept]
- PSMB8 wt Allele [NCIt concept]
- PSMB9 Gene [NCIt concept]
- PSMB9 wt Allele [NCIt concept]
- PSMD10 Gene [NCIt concept]
- PSMD10 wt Allele [NCIt concept]
- PSMD4 Gene [NCIt concept]
- PSMD4 wt Allele [NCIt concept]
- PSMG2 Gene [NCIt concept]
- PSMG2 wt Allele [NCIt concept]
- PTBP3 Gene [NCIt concept]
- PTBP3 wt Allele [NCIt concept]
- PTCH1 Gene [NCIt concept]
- PTCH1 Gene Deletion [NCIt concept]
- PTCH1 Gene Mutation [NCIt concept]
- PTCH1 NM_000264.5:c.2532G>C [NCIt concept]
- PTCH1 NM_000264.5:c.2532G>T [NCIt concept]
- PTCH1 NP_000255.2:p.W844C [NCIt concept]
- PTCH1 wt Allele [NCIt concept]
- PTEN Alteration Positive [NCIt concept]
- PTEN Deficiency [NCIt concept]
- PTEN Gene [NCIt concept]
- PTEN Gene Alteration Positive [NCIt concept]
- PTEN Gene Deletion [NCIt concept]
- PTEN Gene Frameshift Mutation [NCIt concept]
- PTEN Gene Inactivation [NCIt concept]
- PTEN Gene Mutation [NCIt concept]
- PTEN Gene Mutation Negative [NCIt concept]
- PTEN Gene Nonsense Mutation [NCIt concept]
- PTEN Negative [NCIt concept]
- PTEN Positive [NCIt concept]
- PTEN wt Allele [NCIt concept]
- PTGER4 Gene [NCIt concept]
- PTGER4 wt Allele [NCIt concept]
- PTGES Gene [NCIt concept]
- PTGES wt Allele [NCIt concept]
- PTGES2 Gene [NCIt concept]
- PTGES2 wt Allele [NCIt concept]
- PTGIS Gene [NCIt concept]
- PTGIS wt Allele [NCIt concept]
- PTGR1 Gene [NCIt concept]
- PTGR1 wt Allele [NCIt concept]
- PTGS1 Gene [NCIt concept]
- PTGS1 wt Allele [NCIt concept]
- PTGS2 Gene [NCIt concept]
- PTGS2 c.-765G/C Polymorphism Profile [NCIt concept]
- PTGS2 wt Allele [NCIt concept]
- PTH Gene [NCIt concept]
- PTH wt Allele [NCIt concept]
- PTK2 Gene [NCIt concept]
- PTK2 wt Allele [NCIt concept]
- PTK2B Gene [NCIt concept]
- PTK2B wt Allele [NCIt concept]
- PTK7 Gene [NCIt concept]
- PTK7 Positive [NCIt concept]
- PTK7 wt Allele [NCIt concept]
- PTP4A3 Gene [NCIt concept]
- PTP4A3 wt Allele [NCIt concept]
- PTPN1 Gene [NCIt concept]
- PTPN1 wt Allele [NCIt concept]
- PTPN11 Gene [NCIt concept]
- PTPN11 Gene Mutation [NCIt concept]
- PTPN11 wt Allele [NCIt concept]
- PTPN12 Gene [NCIt concept]
- PTPN12 wt Allele [NCIt concept]
- PTPN13 Gene [NCIt concept]
- PTPN13 wt Allele [NCIt concept]
- PTPN2 Gene [NCIt concept]
- PTPN2 wt Allele [NCIt concept]
- PTPN2/1 Inhibitor ABBV-CLS-579 [NCIt concept]
- PTPN21 Gene [NCIt concept]
- PTPN21 wt Allele [NCIt concept]
- PTPN6 Gene [NCIt concept]
- PTPN6 wt Allele [NCIt concept]
- PTPRB Gene [NCIt concept]
- PTPRB wt Allele [NCIt concept]
- PTPRC Gene [NCIt concept]
- PTPRC Gene Product [NCIt concept]
- PTPRC Positive [NCIt concept]
- PTPRC wt Allele [NCIt concept]
- PTPRD Gene [NCIt concept]
- PTPRD wt Allele [NCIt concept]
- PTPRN Autoantibody [NCIt concept]
- PTPRN Gene [NCIt concept]
- PTPRN wt Allele [NCIt concept]
- PTPRO Gene [NCIt concept]
- PTPRO wt Allele [NCIt concept]
- PTTG1 Gene [NCIt concept]
- PTTG1 Positive [NCIt concept]
- PTTG1 wt Allele [NCIt concept]
- PTX3 Gene [NCIt concept]
- PTX3 wt Allele [NCIt concept]
- PVA Microporous Hydrospheres/Doxorubicin Hydrochloride [NCIt concept]
- PVR Gene [NCIt concept]
- PVR Positive [NCIt concept]
- PVR wt Allele [NCIt concept]
- PVT1 Gene [NCIt concept]
- PVT1 wt Allele [NCIt concept]
- PWWP Domain-Containing Protein 2A [NCIt concept]
- PWWP2A Gene [NCIt concept]
- PWWP2A wt Allele [NCIt concept]
- PXN Gene [NCIt concept]
- PXN wt Allele [NCIt concept]
- PYCARD Gene [NCIt concept]
- PYCARD wt Allele [NCIt concept]
- PYY Gene [NCIt concept]
- PYY wt Allele [NCIt concept]
- Pacanalotamab [NCIt concept]
- Packed Red Blood Cell Transfusion [NCIt concept]
- Paclitaxel [NCIt concept]
- Paclitaxel Injection Concentrate for Nanodispersion [NCIt concept]
- Paclitaxel Poliglumex [NCIt concept]
- Paclitaxel Trevatide [NCIt concept]
- Paclitaxel-Eluting Film PTM-101 [NCIt concept]
- Paclitaxel-loaded Tumor Penetrating Microparticles [NCIt concept]
- Pacmilimab [NCIt concept]
- Pacritinib [NCIt concept]
- Padeliporfin [NCIt concept]
- Padnarsertib [NCIt concept]
- Pafolacianine [NCIt concept]
- Pafolacianine Sodium [NCIt concept]
- Pain [NCIt concept]
- Pain Assessment [NCIt concept]
- Pain Buddy [NCIt concept]
- Pain Therapy [NCIt concept]
- Paired Box Protein Pax-1 [NCIt concept]
- Paired Box Protein Pax-2 [NCIt concept]
- Paired Box Protein Pax-3 [NCIt concept]
- Paired Box Protein Pax-7 [NCIt concept]
- Paired Box Protein Pax-8 [NCIt concept]
- Paired Mesoderm Homeobox Protein 1 [NCIt concept]
- Paired Mesoderm Homeobox Protein 2B [NCIt concept]
- Paired-Like Homeodomain Transcription Factor LEUTX [NCIt concept]
- Palazestrant [NCIt concept]
- Palbociclib [NCIt concept]
- Palbociclib Isethionate [NCIt concept]
- Palifermin [NCIt concept]
- Palifosfamide [NCIt concept]
- Palifosfamide Tromethamine [NCIt concept]
- Palladin [NCIt concept]
- Palladium Pd-103 [NCIt concept]
- Palliative Care Nursing [NCIt concept]
- Palliative Radiation Therapy [NCIt concept]
- Palliative Surgery [NCIt concept]
- Palliative Therapy [NCIt concept]
- Palmar-Plantar Erythrodysthesia [NCIt concept]
- Palmdelphin [NCIt concept]
- Palmidrol [NCIt concept]
- Palmitic Acid [NCIt concept]
- Palmitoyl-Protein Thioesterase 1 [NCIt concept]
- Palonosetron [NCIt concept]
- Palonosetron Hydrochloride [NCIt concept]
- Paltimatrectinib [NCIt concept]
- Paltusotine [NCIt concept]
- Palupiprant [NCIt concept]
- Pamidronate Disodium [NCIt concept]
- Pamiparib [NCIt concept]
- Pamlectabart Tismanitin [NCIt concept]
- Pamrevlumab [NCIt concept]
- Pamvatamig [NCIt concept]
- Pan Cytokeratin Staining Method [NCIt concept]
- Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514 [NCIt concept]
- Pan-AKT Inhibitor LY2503029 [NCIt concept]
- Pan-AKT Kinase Inhibitor GSK690693 [NCIt concept]
- Pan-DDR DNA Decoy-cholesterol Conjugate VIO-01 [NCIt concept]
- Pan-ErbB Inhibitor [NCIt concept]
- Pan-FGFR Inhibitor LY2874455 [NCIt concept]
- Pan-KRAS Inhibitor [NCIt concept]
- Pan-KRAS Inhibitor BGB-53038 [NCIt concept]
- Pan-KRAS Inhibitor BI 1701963 [NCIt concept]
- Pan-KRAS Inhibitor JAB-23E73 [NCIt concept]
- Pan-KRAS Inhibitor LY4066434 [NCIt concept]
- Pan-KRAS Inhibitor PF-07934040 [NCIt concept]
- Pan-KRAS Inhibitor PF-07985045 [NCIt concept]
- Pan-KRAS Inhibitor YL-17231 [NCIt concept]
- Pan-Mutant-IDH1 Inhibitor Bay-1436032 [NCIt concept]
- Pan-RAF Inhibitor LY3009120 [NCIt concept]
- Pan-RAF/MEK Molecular Glue NST-628 [NCIt concept]
- Pan-TEAD Inhibitor ISM6331 [NCIt concept]
- Pan-TRK Inhibitor ONO-7579 [NCIt concept]
- Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981 [NCIt concept]
- Pan-mutant-selective PI3K-alpha Inhibitor RLY-2608 [NCIt concept]
- Pan-mutant-selective PI3K-alpha Inhibitor RLY-5836 [NCIt concept]
- Pan-variant KIT Inhibitor THE-630 [NCIt concept]
- Pancreastatin [NCIt concept]
- Pancreatectomy [NCIt concept]
- Pancreatic Acinar Cell Carcinoma [NCIt concept]
- Pancreatic Adenocarcinoma [NCIt concept]
- Pancreatic Adenosquamous Carcinoma [NCIt concept]
- Pancreatic Alpha Cell Adenoma [NCIt concept]
- Pancreatic Beta Cell Adenoma [NCIt concept]
- Pancreatic Carcinoma [NCIt concept]
- Pancreatic Cyst [NCIt concept]
- Pancreatic Cystic Lesion [NCIt concept]
- Pancreatic Cystic Neoplasm [NCIt concept]
- Pancreatic Delta Cell Adenoma [NCIt concept]
- Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Pancreatic Elastase [NCIt concept]
- Pancreatic Elastase Measurement [NCIt concept]
- Pancreatic Gastrin-Producing Neuroendocrine Tumor [NCIt concept]
- Pancreatic Glucagonoma [NCIt concept]
- Pancreatic Hormone [NCIt concept]
- Pancreatic Icosapeptide [NCIt concept]
- Pancreatic Insulin-Producing Neuroendocrine Tumor [NCIt concept]
- Pancreatic Insulinoma [NCIt concept]
- Pancreatic Intraductal Papillary-Mucinous Neoplasm [NCIt concept]
- Pancreatic Leiomyosarcoma [NCIt concept]
- Pancreatic Mucinous-Cystic Neoplasm [NCIt concept]
- Pancreatic Neoplasm [NCIt concept]
- Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Pancreatic Neuroendocrine Tumor [NCIt concept]
- Pancreatic Polypeptide Tumor [NCIt concept]
- Pancreatic Prohormone [NCIt concept]
- Pancreatic Secretory Trypsin Inhibitor [NCIt concept]
- Pancreatic Somatostatinoma [NCIt concept]
- Pancreatic Squamous Cell Carcinoma [NCIt concept]
- Pancreatic Stellate Cell [NCIt concept]
- Pancreatic Surgical Procedure [NCIt concept]
- Pancreaticoduodenectomy [NCIt concept]
- Pancreaticoduodenectomy Patient [NCIt concept]
- Pancreatitis [NCIt concept]
- Pancreatobiliary Carcinoma [NCIt concept]
- Pancrelipase [NCIt concept]
- Panendoscopy [NCIt concept]
- Panitumumab [NCIt concept]
- Panitumumab-IRDye800 [NCIt concept]
- Panobinostat [NCIt concept]
- Panobinostat Lactate [NCIt concept]
- Panobinostat Nanoparticle Formulation MTX110 [NCIt concept]
- Panulisib [NCIt concept]
- Pap Smear [NCIt concept]
- Papaverine [NCIt concept]
- Papaverine Hydrochloride [NCIt concept]
- Papette Brush Collection [NCIt concept]
- Papillary [NCIt concept]
- Papillary Carcinoma [NCIt concept]
- Papillary Renal Cell Carcinoma [NCIt concept]
- Papillary Squamous Cell Carcinoma [NCIt concept]
- Papillomavirus Protein E2 [NCIt concept]
- Papillomavirus Transforming Protein E6 [NCIt concept]
- Papillomavirus Transforming Protein E7 [NCIt concept]
- Papovavirus Infection [NCIt concept]
- Papulopustular Rash [NCIt concept]
- Para Aminohippurate Clearance Measurement [NCIt concept]
- Paracentesis [NCIt concept]
- Paraganglioma [NCIt concept]
- Parainfluenza Virus [NCIt concept]
- Parainfluenza Virus Infection [NCIt concept]
- Parainfluenza Virus Positive [NCIt concept]
- Paranasal Sinus Carcinoma [NCIt concept]
- Paranasal Sinus Diffuse Large B-Cell Lymphoma [NCIt concept]
- Paraneoplastic Antibody [NCIt concept]
- Paraneoplastic Antibody Positive [NCIt concept]
- Paratesticular Biphasic Mesothelioma [NCIt concept]
- Paratesticular Epithelioid Mesothelioma [NCIt concept]
- Paratesticular Malignant Mesothelioma [NCIt concept]
- Paratesticular Sarcomatoid Mesothelioma [NCIt concept]
- Parathyroid Gland Carcinoma [NCIt concept]
- Parathyroid Gland Chief Cell Adenoma [NCIt concept]
- Parathyroid Gland Clear Cell Adenoma [NCIt concept]
- Parathyroid Gland Mixed Cell Type Adenoma [NCIt concept]
- Parathyroid Hormone [NCIt concept]
- Parathyroidectomy [NCIt concept]
- Paravertebral Block [NCIt concept]
- Paricalcitol [NCIt concept]
- Paritaprevir [NCIt concept]
- Parotid Duct-Sparing Radiation Therapy [NCIt concept]
- Parotid Gland Carcinoma [NCIt concept]
- Parotid-Sparing Whole-Brain Radiation Therapy [NCIt concept]
- Paroxysmal Nocturnal Hemoglobinuria [NCIt concept]
- Parsaclisib [NCIt concept]
- Parsatuzumab [NCIt concept]
- Partial Brain Radiation Therapy [NCIt concept]
- Partial Breast Irradiation [NCIt concept]
- Partial Laryngopharyngectomy [NCIt concept]
- Partial Nephrectomy [NCIt concept]
- Partial Oncolysis [NCIt concept]
- Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 [NCIt concept]
- Partially HLA-matched AdV/CMV/EBV-specific Allogeneic T-Lymphocytes [NCIt concept]
- Partially HLA-matched AdV/CMV/EBV/BKV-specific Allogeneic T-lymphocytes [NCIt concept]
- Partially HLA-matched Adenovirus-specific T Lymphocytes [NCIt concept]
- Partner and Localizer of BRCA2 [NCIt concept]
- Partner-Assisted Coping Skills Training [NCIt concept]
- Pasifolate Exatecan [NCIt concept]
- Pasireotide [NCIt concept]
- Passive Smoke Exposure [NCIt concept]
- Pastoral Counselor [NCIt concept]
- Patent Blue V Dye [NCIt concept]
- Pathologic Complete Response [NCIt concept]
- Pathologic Examination [NCIt concept]
- Pathologic Stage 0 Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage 0 Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage I Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage I Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IA Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IB Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage II Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage II Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIA Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IIB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIB Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IIC Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage III Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage III Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIA Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIB Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIC Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IIID Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IV Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IV Gastric Cancer AJCC v8 [NCIt concept]
- Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Patidegib [NCIt concept]
- Patidegib Topical Gel [NCIt concept]
- Patient Derived Xenograft [NCIt concept]
- Patient Education [NCIt concept]
- Patient Monitoring [NCIt concept]
- Patient Monitoring System [NCIt concept]
- Patient Navigation [NCIt concept]
- Patient Navigator [NCIt concept]
- Patient Observation [NCIt concept]
- Patient Outcomes Registry [NCIt concept]
- Patient Registry Study [NCIt concept]
- Patient Self-Report [NCIt concept]
- Patient-Controlled Epidural Analgesia [NCIt concept]
- Patient-derived WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes [NCIt concept]
- Patritumab [NCIt concept]
- Patritumab Deruxtecan [NCIt concept]
- Patupilone [NCIt concept]
- Pavunalimab [NCIt concept]
- Pavurutamab [NCIt concept]
- Paxalisib [NCIt concept]
- Paxillin [NCIt concept]
- Pazopanib Hydrochloride [NCIt concept]
- Peak Cough Flow [NCIt concept]
- Peak Oxygen Consumption [NCIt concept]
- Pearson Syndrome [NCIt concept]
- Pectoral Nerve Block [NCIt concept]
- Pediatric Nutritional Supplement Drink [NCIt concept]
- Pedometer [NCIt concept]
- Pegargiminase [NCIt concept]
- Pegaspargase [NCIt concept]
- Pegcetacoplan [NCIt concept]
- Pegdinetanib [NCIt concept]
- Pegenzileukin [NCIt concept]
- Pegfilgrastim [NCIt concept]
- Peginterferon Alfa-2a [NCIt concept]
- Peginterferon Alfa-2b [NCIt concept]
- Peginterferon Alfa-2b Regimen [NCIt concept]
- Pegloprastide [NCIt concept]
- Pegloticase [NCIt concept]
- Pegsitacianine [NCIt concept]
- Pegtarazimod [NCIt concept]
- Pegtomarginase [NCIt concept]
- Pegulicianine Acetate [NCIt concept]
- Pegvisomant [NCIt concept]
- Pegvorhyaluronidase Alfa [NCIt concept]
- Pegylated CD25/CD122-selective Interleukin-2 Mutein STK-012 [NCIt concept]
- Pegylated Deoxycytidine Analogue DFP-14927 [NCIt concept]
- Pegylated Interferon Alfa [NCIt concept]
- Pegylated Liposomal Doxorubicin Hydrochloride [NCIt concept]
- Pegylated Liposomal Irinotecan [NCIt concept]
- Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010 [NCIt concept]
- Pegylated Orthogonal IL-2 STK-009 [NCIt concept]
- Pegylated SN-38 Conjugate PLX038 [NCIt concept]
- Pegylated TOP1 Inhibitor PEEL-224 [NCIt concept]
- Pegylated Topoisomerase Inhibitor [NCIt concept]
- Pegzilarginase [NCIt concept]
- Pelabresib [NCIt concept]
- Pelabresib Anhydrous [NCIt concept]
- Pelareorep [NCIt concept]
- Pelcitoclax [NCIt concept]
- Pelitinib [NCIt concept]
- Peluntamig [NCIt concept]
- Pelvic Examination [NCIt concept]
- Pelvic Fascia-Sparing Radical Prostatectomy [NCIt concept]
- Pelvic Floor Disorder [NCIt concept]
- Pelvic Hemorrhage [NCIt concept]
- Pelvic Lymphadenectomy Patient [NCIt concept]
- Pelvic Mass [NCIt concept]
- Pelvic Radiation Therapy [NCIt concept]
- Pelvic Rhabdomyosarcoma [NCIt concept]
- Pelvic Sarcoma [NCIt concept]
- Pelvic Soft Tissue Sarcoma [NCIt concept]
- Pelvic Undifferentiated High Grade Pleomorphic Sarcoma [NCIt concept]
- Pembrolizumab [NCIt concept]
- Pemetrexed [NCIt concept]
- Pemetrexed Disodium [NCIt concept]
- Pemlimogene Merolisbac [NCIt concept]
- Pemrametostat [NCIt concept]
- Pencil Beam Scanning [NCIt concept]
- Penile Basal Cell Carcinoma [NCIt concept]
- Penile Carcinoma [NCIt concept]
- Penile Paget Disease [NCIt concept]
- Penile Prosthesis Implantation [NCIt concept]
- Penile Squamous Cell Carcinoma [NCIt concept]
- Penpulimab [NCIt concept]
- Pentamidine [NCIt concept]
- Pentavalent KLH Conjugate Vaccine [NCIt concept]
- Pentetate Calcium [NCIt concept]
- Pentosan Polysulfate Sodium [NCIt concept]
- Pentostatin [NCIt concept]
- Pentoxifylline [NCIt concept]
- Pentraxin-Related Protein PTX3 [NCIt concept]
- Pepinemab [NCIt concept]
- Peposertib [NCIt concept]
- Peppermint Oil [NCIt concept]
- Peppermint Oil-containing Enteric-coated Microspheres [NCIt concept]
- Peptide Receptor Radionuclide Therapy [NCIt concept]
- Peptide YY [NCIt concept]
- Peptidyl-Prolyl Cis-Trans Isomerase B [NCIt concept]
- Peptidyl-Prolyl Cis-Trans Isomerase D [NCIt concept]
- Peptidyl-Prolyl Cis-Trans Isomerase FKBP1A [NCIt concept]
- Peptidyl-Prolyl Cis-Trans Isomerase FKBP5 [NCIt concept]
- Peptidyl-Prolyl Cis-Trans Isomerase FKBP8 [NCIt concept]
- Peptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 1 [NCIt concept]
- Peramivir [NCIt concept]
- Perampanel [NCIt concept]
- Percent Free Prostate-Specific Antigen Less than 25 [NCIt concept]
- Percutaneous Biopsy of Kidney [NCIt concept]
- Percutaneous Breast Biopsy [NCIt concept]
- Percutaneous Cryosurgery [NCIt concept]
- Percutaneous Hepatic Perfusion [NCIt concept]
- Percutaneous Local Ablation [NCIt concept]
- Percutaneous Neuromodulation Therapy [NCIt concept]
- Perenostobart [NCIt concept]
- Perflenapent Emulsion [NCIt concept]
- Perflubutane Microbubble [NCIt concept]
- Perflutren [NCIt concept]
- Perflutren Lipid Microspheres [NCIt concept]
- Perforin-1 [NCIt concept]
- Perfusion Magnetic Resonance Imaging [NCIt concept]
- Perfusion-Weighted Magnetic Resonance Imaging [NCIt concept]
- Periampullary Adenocarcinoma [NCIt concept]
- Pericardial Radiation Therapy [NCIt concept]
- Pericentriolar Material 1 Protein [NCIt concept]
- Pericyte [NCIt concept]
- Pericyte Coverage Measurement [NCIt concept]
- Perifosine [NCIt concept]
- Perilipin-2 [NCIt concept]
- Perillyl Alcohol [NCIt concept]
- Period Circadian Protein Homolog 1 [NCIt concept]
- Perioperative/Postoperative Complications [NCIt concept]
- Periorbital Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Periostin [NCIt concept]
- Peripheral Blood Lymphocyte Therapy [NCIt concept]
- Peripheral Blood Mononuclear Cell [NCIt concept]
- Peripheral Blood Stem Cell [NCIt concept]
- Peripheral Blood Stem Cell Transplantation [NCIt concept]
- Peripheral Lymph Node Addressin [NCIt concept]
- Peripheral Nerve Stimulation [NCIt concept]
- Peripheral Nervous System Neoplasm [NCIt concept]
- Peripheral Neuroblastoma [NCIt concept]
- Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Peripheral Primitive Neuroectodermal Tumor of Kidney [NCIt concept]
- Peripheral Pulmonary Nodule [NCIt concept]
- Peripheral T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Peripheral Vascular Intervention [NCIt concept]
- Peristomal Skin [NCIt concept]
- Peritoneal Biphasic Mesothelioma [NCIt concept]
- Peritoneal Carcinomatosis [NCIt concept]
- Peritoneal Epithelioid Mesothelioma [NCIt concept]
- Peritoneal Gastrointestinal Stromal Tumor [NCIt concept]
- Peritoneal Lavage [NCIt concept]
- Peritoneal Malignant Mesothelioma [NCIt concept]
- Peritoneal Sarcomatoid Mesothelioma [NCIt concept]
- Peritoneal Surface Disease Finding [NCIt concept]
- Peritoneoscopy [NCIt concept]
- Peritumoral Brain Edema [NCIt concept]
- Perometer [NCIt concept]
- Peroxiredoxin-4 [NCIt concept]
- Peroxisomal Acyl-Coenzyme A Oxidase 2 [NCIt concept]
- Peroxisomal Disorder [NCIt concept]
- Peroxisomal Multifunctional Enzyme Type 2 [NCIt concept]
- Peroxisome Proliferator-Activated Receptor Alpha [NCIt concept]
- Peroxisome Proliferator-Activated Receptor Delta [NCIt concept]
- Peroxisome Proliferator-Activated Receptor Gamma [NCIt concept]
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha [NCIt concept]
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha Isoform 4 [NCIt concept]
- Persistent [NCIt concept]
- Persistent Neuroblastic Cells [NCIt concept]
- Personal History of Uterine Cancer [NCIt concept]
- Personalized Medicine [NCIt concept]
- Personalized Neoantigen Cancer Vaccine VB10.NEO [NCIt concept]
- Personalized Neoantigen DNA Vaccine GNOS-PV01 [NCIt concept]
- Personalized Neoantigen DNA Vaccine GNOS-PVO2 [NCIt concept]
- Personalized Neoantigen Follicular Lymphoma Vaccine [NCIt concept]
- Personalized Neoantigen Ovarian Cancer Vaccine [NCIt concept]
- Personalized Neoantigen Upper Gastrointestinal Tract Cancer Vaccine [NCIt concept]
- Personalized Peptide Cancer Vaccine NEO-PV-01 [NCIt concept]
- Personalized Peptide Cancer Vaccine mBTCvax [NCIt concept]
- Personalized Polyepitope Plasmid DNA Breast Cancer Vaccine [NCIt concept]
- Personalized Synthetic Long Peptide Breast Cancer Vaccine [NCIt concept]
- Personalized Synthetic Long Peptide Vaccine [NCIt concept]
- Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy [NCIt concept]
- Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC [NCIt concept]
- Pertuzumab [NCIt concept]
- Pertuzumab Zuvotolimod [NCIt concept]
- Petadeferitrin [NCIt concept]
- Petosemtamab [NCIt concept]
- Petrolatum [NCIt concept]
- Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment [NCIt concept]
- Pevonedistat [NCIt concept]
- Pexastimogene Devacirepvec [NCIt concept]
- Pexidartinib [NCIt concept]
- Pexidartinib Hydrochloride [NCIt concept]
- Pexmetinib [NCIt concept]
- Ph Unknown [NCIt concept]
- Pharmacist [NCIt concept]
- Pharmacogenetic Test [NCIt concept]
- Pharmacogenomic Study [NCIt concept]
- Pharmacogenomic Test [NCIt concept]
- Pharmacogenomics [NCIt concept]
- Pharmacologic Management [NCIt concept]
- Pharmacological Ascorbate [NCIt concept]
- Pharmacological Study [NCIt concept]
- Pharmacotherapy [NCIt concept]
- Pharmacotherapy Discontinuation [NCIt concept]
- Pharyngeal Adenoid Cystic Carcinoma [NCIt concept]
- Pharyngeal Carcinoma [NCIt concept]
- Pharyngeal Squamous Cell Carcinoma [NCIt concept]
- Phellodendron amurense Bark Extract [NCIt concept]
- Phenanthrene Tetraol [NCIt concept]
- Phenazopyridine [NCIt concept]
- Phenelzine Sulfate [NCIt concept]
- Phenethyl Isothiocyanate [NCIt concept]
- Phenformin [NCIt concept]
- Phenformin Hydrochloride [NCIt concept]
- Phentolamine Mesylate [NCIt concept]
- Phenylalanine [NCIt concept]
- Phenylglyoxylic Acid [NCIt concept]
- Pheresis [NCIt concept]
- Philadelphia Chromosome [NCIt concept]
- Philadelphia Chromosome Negative [NCIt concept]
- Philadelphia Chromosome Positive [NCIt concept]
- Phlebitis [NCIt concept]
- Phlebotomy [NCIt concept]
- Phorbol-12-Myristate-13-Acetate-Induced Protein 1 [NCIt concept]
- Phosphate Measurement [NCIt concept]
- Phosphatidylcholine Translocator ABCB4 [NCIt concept]
- Phosphatidylcholine-Bound Silybin [NCIt concept]
- Phosphatidylcholine:Ceramide Cholinephosphotransferase 1 [NCIt concept]
- Phosphatidylcholine:Ceramide Cholinephosphotransferase 2 [NCIt concept]
- Phosphatidylethanolamine N-Methyltransferase [NCIt concept]
- Phosphatidylinositide 3-Kinase Inhibitor [NCIt concept]
- Phosphatidylinositol 3,4,5-Trisphosphate 3-Phosphatase and Dual-Specificity Protein Phosphatase PTEN [NCIt concept]
- Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase 1 [NCIt concept]
- Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase 1 Isoform 3 [NCIt concept]
- Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase 2 [NCIt concept]
- Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 [NCIt concept]
- Phosphatidylinositol 3-Kinase Regulatory Subunit Alpha [NCIt concept]
- Phosphatidylinositol 3-Kinase Regulatory Subunit Beta [NCIt concept]
- Phosphatidylinositol 3-Kinase Regulatory Subunit Gamma [NCIt concept]
- Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Isoform [NCIt concept]
- Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Isoform [NCIt concept]
- Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta Isoform [NCIt concept]
- Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma Isoform [NCIt concept]
- Phosphatidylinositol 4-Phosphate 3-Kinase C2 Domain-Containing Subunit Beta [NCIt concept]
- Phosphatidylinositol 4-Phosphate 3-Kinase C2 Domain-Containing Subunit Gamma [NCIt concept]
- Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Alpha [NCIt concept]
- Phosphatidylinositol N-Acetylglucosaminyltransferase Subunit A [NCIt concept]
- Phosphatidylinositol-4,5-Bisphosphate 3-Kinase [NCIt concept]
- Phosphatidylinositol-Binding Clathrin Assembly Protein [NCIt concept]
- Phosphatidylinositol-Glycan Biosynthesis Class F Protein [NCIt concept]
- Phosphaturic Mesenchymal Tumor [NCIt concept]
- Phosphodiesterase Type 4 [NCIt concept]
- Phosphofructokinase [NCIt concept]
- Phosphofurin Acidic Cluster Sorting Protein 1 [NCIt concept]
- Phosphoglycerate Kinase [NCIt concept]
- Phosphoglycerate Kinase 1 [NCIt concept]
- Phosphoglycerate Mutase Family [NCIt concept]
- Phosphoglycolate Phosphatase [NCIt concept]
- Phosphoinositide 3-Kinase Adapter Protein 1 [NCIt concept]
- Phosphoinositide 3-Kinase Regulatory Subunit 5 [NCIt concept]
- Phospholipase A2 [NCIt concept]
- Phospholipase A2, Membrane Associated [NCIt concept]
- Phospholipase C Gamma [NCIt concept]
- Phospholipid Phosphatase 3 [NCIt concept]
- Phospholipid-Transporting ATPase ABCA1 [NCIt concept]
- Phospholipid-Transporting ATPase ID [NCIt concept]
- Phosphoprotein [NCIt concept]
- Phosphoprotein Profile [NCIt concept]
- Phosphorylated 40S Ribosomal Protein S6 [NCIt concept]
- Phosphorylated EIF4E [NCIt concept]
- Phosphorylated Epidermal Growth Factor Receptor [NCIt concept]
- Phosphorylated Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 [NCIt concept]
- Phosphorylated Histone H2AX [NCIt concept]
- Phosphorylated Histone H3 Positive [NCIt concept]
- Phosphorylated Proline-Rich AKT1 Substrate 1 [NCIt concept]
- Phosphorylated Proto-Oncogene Tyrosine-Protein Kinase Src [NCIt concept]
- Phosphorylated RAC Serine/Threonine Kinase Family Protein [NCIt concept]
- Phosphorylated STAT3 Measurement [NCIt concept]
- Phosphorylated Serine-Protein Kinase ATM [NCIt concept]
- Phosphorylated Serine/Threonine-Protein Kinase Chk2 [NCIt concept]
- Phosphorylated Signal Transducer and Activator of Transcription 3 Positive [NCIt concept]
- Phosphorylated-FAK Y397 [NCIt concept]
- Phosphorylated-STAT1 Y701 [NCIt concept]
- Phosphorylated-STAT3 Y705 [NCIt concept]
- Phosphorylethanolamine [NCIt concept]
- Phosphoserine [NCIt concept]
- Photoacoustic Imaging [NCIt concept]
- Photobiomodulation Therapy [NCIt concept]
- Photodynamic Bone Stabilization System [NCIt concept]
- Photodynamic Compound TLD-1433 [NCIt concept]
- Photodynamic Therapy [NCIt concept]
- Photoimmunotherapy [NCIt concept]
- Photon Beam Craniospinal Irradiation [NCIt concept]
- Photon Beam Radiation Therapy [NCIt concept]
- Photon Counting Computed Tomography [NCIt concept]
- Photoplethysmography [NCIt concept]
- Phototherapy [NCIt concept]
- Photovaporization of the Prostate [NCIt concept]
- Photovoice [NCIt concept]
- Phthalate [NCIt concept]
- Phyllodes Tumor [NCIt concept]
- Physical Activity [NCIt concept]
- Physical Activity Measurement [NCIt concept]
- Physical Examination [NCIt concept]
- Physical Medical Procedure [NCIt concept]
- Physical Performance Testing [NCIt concept]
- Physical Therapy [NCIt concept]
- Physician [NCIt concept]
- Physician Assistant [NCIt concept]
- Physiologic Testing [NCIt concept]
- Physiological Support [NCIt concept]
- Phytocannabinoid [NCIt concept]
- Phytochlorin Sodium-Polyvinylpyrrolidone Complex [NCIt concept]
- Phytoene [NCIt concept]
- Phytofluene [NCIt concept]
- Phytohemagglutinin [NCIt concept]
- Phytohemagglutinin Skin Test [NCIt concept]
- Picoplatin [NCIt concept]
- Pictilisib Bismesylate [NCIt concept]
- Pidilizumab [NCIt concept]
- Piercer of Microtubule Wall 2 Protein [NCIt concept]
- Piezoelectric Breast Palpation [NCIt concept]
- Piezoelectric Elastic Modulus Scanner [NCIt concept]
- Pifusertib [NCIt concept]
- PiggyBac Transposable Element-Derived Protein 5 [NCIt concept]
- Pigment Epithelium-Derived Factor [NCIt concept]
- Pilaralisib [NCIt concept]
- Pill count [NCIt concept]
- Pilocarpine Hydrochloride [NCIt concept]
- Pilocytic [NCIt concept]
- Pimasertib [NCIt concept]
- Pimasertib Hydrochloride [NCIt concept]
- Pimicotinib [NCIt concept]
- Pimitespib [NCIt concept]
- Pimivalimab [NCIt concept]
- Pimozide [NCIt concept]
- Pinatuzumab Vedotin [NCIt concept]
- Pineal Region Neoplasm [NCIt concept]
- Pineoblastoma [NCIt concept]
- Pinometostat [NCIt concept]
- Pioglitazone [NCIt concept]
- Pioglitazone Hydrochloride [NCIt concept]
- Piper methysticum [NCIt concept]
- Piperacillin [NCIt concept]
- Piperacillin-Tazobactam [NCIt concept]
- Piperine Extract (Standardized) [NCIt concept]
- Pirotinib [NCIt concept]
- Pirtobrutinib [NCIt concept]
- Pituitary Gland Acidophil Adenoma [NCIt concept]
- Pituitary Gland Basophil Adenoma [NCIt concept]
- Pituitary Gland Blastoma [NCIt concept]
- Pituitary Gland Chromophobe Adenoma [NCIt concept]
- Pituitary Gland Neoplasm [NCIt concept]
- Pituitary Homeobox 2 [NCIt concept]
- Pituitary Neuroendocrine Tumor [NCIt concept]
- Pivekimab Sunirine [NCIt concept]
- Pixantrone [NCIt concept]
- Pixantrone Dimaleate [NCIt concept]
- Pixatimod [NCIt concept]
- Placebo [NCIt concept]
- Placebo Administration [NCIt concept]
- Placebo Control [NCIt concept]
- Placement of Surgical Mesh [NCIt concept]
- Placenta Growth Factor [NCIt concept]
- Placenta Growth Factor Isoform 1 [NCIt concept]
- Pladienolide Derivative E7107 [NCIt concept]
- Plamotamab [NCIt concept]
- Plan [NCIt concept]
- Planar Imaging [NCIt concept]
- Plaque Radiotherapy [NCIt concept]
- Plasma Cell [NCIt concept]
- Plasma Cell Labeling Index [NCIt concept]
- Plasma Cell Leukemia [NCIt concept]
- Plasma Cell Neoplasm [NCIt concept]
- Plasma Glucose Measurement [NCIt concept]
- Plasma Kallikrein [NCIt concept]
- Plasma Membrane [NCIt concept]
- Plasma Membrane Calcium-Transporting ATPase 3 [NCIt concept]
- Plasma Tumor DNA [NCIt concept]
- Plasmablast [NCIt concept]
- Plasmablastic Lymphoma [NCIt concept]
- Plasmacytoid Dendritic Cell [NCIt concept]
- Plasmacytoma [NCIt concept]
- Plasmalemma Vesicle-Associated Protein [NCIt concept]
- Plasmapheresis [NCIt concept]
- Plasmin-Antiplasmin Complex [NCIt concept]
- Plasminogen [NCIt concept]
- Plasminogen Activator Inhibitor 1 [NCIt concept]
- Plasmodium [NCIt concept]
- Plastin-2 [NCIt concept]
- Platelet [NCIt concept]
- Platelet Aggregation Process [NCIt concept]
- Platelet Basic Protein [NCIt concept]
- Platelet Count Greater Than or Equal to 150x10^9/L [NCIt concept]
- Platelet Count Greater than 20000 [NCIt concept]
- Platelet Count Greater than 300x10^9/L [NCIt concept]
- Platelet Count Greater than or Equal to 100000 [NCIt concept]
- Platelet Count Greater than or Equal to 20000 per Cubic Millimeter [NCIt concept]
- Platelet Count Greater than or Equal to 30000 [NCIt concept]
- Platelet Count Greater than or Equal to 30000 and Less than 50000 [NCIt concept]
- Platelet Count Greater than or Equal to 50000 [NCIt concept]
- Platelet Count Less Than 150x10^9/L [NCIt concept]
- Platelet Count Less than 30000 [NCIt concept]
- Platelet Endothelial Cell Adhesion Molecule [NCIt concept]
- Platelet Engraftment [NCIt concept]
- Platelet Factor 4 [NCIt concept]
- Platelet Glycoprotein 4 [NCIt concept]
- Platelet Membrane Glycoprotein 1b Alpha Chain [NCIt concept]
- Platelet Refractoriness [NCIt concept]
- Platelet Transfusion [NCIt concept]
- Platelet-Activating Factor Acetylhydrolase [NCIt concept]
- Platelet-Activating Factor Acetylhydrolase IB Subunit Alpha2 [NCIt concept]
- Platelet-Derived Growth Factor C [NCIt concept]
- Platelet-Derived Growth Factor Receptor [NCIt concept]
- Platelet-Derived Growth Factor Receptor Alpha [NCIt concept]
- Platelet-Derived Growth Factor Receptor Beta [NCIt concept]
- Platelet-Derived Growth Factor Subunit A [NCIt concept]
- Platelet-Derived Growth Factor Subunit B [NCIt concept]
- Platelet-Derived Growth Factor-AA [NCIt concept]
- Platelet-Derived Growth Factor-AB [NCIt concept]
- Platelet-Derived Growth Factor-BB [NCIt concept]
- Platelet-Derived Microparticle [NCIt concept]
- Platelet-rich Plasma [NCIt concept]
- Platelets Product [NCIt concept]
- Platinum Compound [NCIt concept]
- Platinum Doublet [NCIt concept]
- Platinum-Group Metal [NCIt concept]
- Platinum-Refractory Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Platinum-Refractory Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Platinum-Refractory Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Refractory Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Platinum-Refractory Ovarian Seromucinous Carcinoma [NCIt concept]
- Platinum-Refractory Ovarian Undifferentiated Carcinoma [NCIt concept]
- Platinum-Refractory Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Resistant Fallopian Tube Carcinoma [NCIt concept]
- Platinum-Resistant Fallopian Tube Endometrioid Adenocarcinoma [NCIt concept]
- Platinum-Resistant Head and Neck Carcinoma [NCIt concept]
- Platinum-Resistant Lung Small Cell Carcinoma [NCIt concept]
- Platinum-Resistant Malignant Female Reproductive System Neoplasm [NCIt concept]
- Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Platinum-Resistant Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Platinum-Resistant Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Platinum-Resistant Ovarian High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Resistant Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Platinum-Resistant Ovarian Seromucinous Carcinoma [NCIt concept]
- Platinum-Resistant Ovarian Undifferentiated Carcinoma [NCIt concept]
- Platinum-Resistant Primary Peritoneal Carcinoma [NCIt concept]
- Platinum-Resistant Primary Peritoneal Endometrioid Adenocarcinoma [NCIt concept]
- Platinum-Sensitive Endometrial Serous Adenocarcinoma [NCIt concept]
- Platinum-Sensitive Fallopian Tube Carcinoma [NCIt concept]
- Platinum-Sensitive Lung Small Cell Carcinoma [NCIt concept]
- Platinum-Sensitive Ovarian Carcinoma [NCIt concept]
- Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Platinum-Sensitive Primary Peritoneal Carcinoma [NCIt concept]
- Plecanatide [NCIt concept]
- Plectin [NCIt concept]
- Plectin-1 Targeting Agent PTP-01 [NCIt concept]
- Pleomorphic Liposarcoma [NCIt concept]
- Plerixafor [NCIt concept]
- Plethysmography [NCIt concept]
- Pleural Biphasic Mesothelioma [NCIt concept]
- Pleural Effusion [NCIt concept]
- Pleural Epithelioid Mesothelioma [NCIt concept]
- Pleural Leiomyosarcoma [NCIt concept]
- Pleural Malignant Mesothelioma [NCIt concept]
- Pleural Proximal-Type Epithelioid Sarcoma [NCIt concept]
- Pleural Sarcomatoid Mesothelioma [NCIt concept]
- Pleural Synovial Sarcoma [NCIt concept]
- Pleurectomy [NCIt concept]
- Pleurodesis [NCIt concept]
- Pleuropulmonary Blastoma [NCIt concept]
- Plexiform Neurofibroma [NCIt concept]
- Plexin Domain-Containing Protein 1 [NCIt concept]
- Plexin-C1 [NCIt concept]
- Plexin-D1 [NCIt concept]
- Plicamycin [NCIt concept]
- Plinabulin [NCIt concept]
- Plitidepsin [NCIt concept]
- Plixorafenib [NCIt concept]
- Plk1 Inhibitor BI 2536 [NCIt concept]
- Plocabulin [NCIt concept]
- Plogosertib [NCIt concept]
- Plozalizumab [NCIt concept]
- Pneumatic Compression Therapy with Reminders [NCIt concept]
- Pneumococcal 13-valent Conjugate Vaccine [NCIt concept]
- Pneumococcal 20-Valent Conjugate Vaccine [NCIt concept]
- Pneumococcal 21-Valent Conjugate Vaccine [NCIt concept]
- Pneumococcal 7-Valent Conjugate Vaccine [NCIt concept]
- Pneumococcal Conjugate Vaccine [NCIt concept]
- Pneumococcal Polyvalent Vaccine [NCIt concept]
- Pocenbrodib [NCIt concept]
- Podentamig [NCIt concept]
- Podocalyxin [NCIt concept]
- Podoplanin [NCIt concept]
- Pol Theta Inhibitor ART4215 [NCIt concept]
- Polarized Reflectance Spectroscopy [NCIt concept]
- Polatuzumab Vedotin [NCIt concept]
- Polfermetinib [NCIt concept]
- Poliglusam [NCIt concept]
- Polio Vaccination [NCIt concept]
- Poliovirus Receptor [NCIt concept]
- Poliovirus Receptor Antibody [NCIt concept]
- Poly (ADP-Ribose) Polymerase Inhibitor [NCIt concept]
- Poly ICLC [NCIt concept]
- Poly [ADP-Ribose] Polymerase 1 [NCIt concept]
- Poly [ADP-Ribose] Polymerase 1 p85 [NCIt concept]
- Poly [ADP-Ribose] Polymerase 2 [NCIt concept]
- Poly [ADP-Ribose] Polymerase Tankyrase-1 [NCIt concept]
- Poly [ADP-Ribose] Polymerase Tankyrase-2 [NCIt concept]
- Poly(A)-Specific Ribonuclease PARN [NCIt concept]
- Poly(ADP-Ribose) Glycohydrolase [NCIt concept]
- Poly-ADP-Ribosylation [NCIt concept]
- Polyacrylamide Gel Electrophoresis [NCIt concept]
- Polyamine Compound [NCIt concept]
- Polyamine Transport Inhibitor AMXT-1501 Dicaprate [NCIt concept]
- Polybrominated Diphenyl Ether [NCIt concept]
- Polycarbophil/Carbomer/Glycerin/Palm Oil Glyceride/Mineral Oil-containing Vaginal Moisturizer [NCIt concept]
- Polycomb Complex Protein BMI-1 [NCIt concept]
- Polycomb Protein EED [NCIt concept]
- Polycomb Protein SUZ12 [NCIt concept]
- Polycomb-Group Protein [NCIt concept]
- Polycyclic Aromatic Hydrocarbons [NCIt concept]
- Polycystic Kidney Disease Protein 1-Like 1 [NCIt concept]
- Polycythemia Vera [NCIt concept]
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase [NCIt concept]
- Polyethylene Glycol [NCIt concept]
- Polyethylene Glycol Hydrogel [NCIt concept]
- Polyethylene Glycol Polymer Surgical Sealant [NCIt concept]
- Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318 [NCIt concept]
- Polymerase Chain Reaction [NCIt concept]
- Polymerase Proofreading Associated Polyposis [NCIt concept]
- Polymeric Camptothecin Prodrug XMT-1001 [NCIt concept]
- Polymeric Nanoparticle-conjugated Camptothecin DAN-222 [NCIt concept]
- Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Polymorphism Analysis [NCIt concept]
- Polymorphonuclear Myeloid-Derived Suppressor Cell [NCIt concept]
- Polymorphous Low Grade Neuroepithelial Tumor of the Young [NCIt concept]
- Polymyxin B [NCIt concept]
- Polymyxin-B Immobilized Fiber PMX-20R [NCIt concept]
- Polyphenol [NCIt concept]
- Polypyrimidine Tract-Binding Protein 3 [NCIt concept]
- Polyribonucleotide 5'-Hydroxyl-Kinase Clp1 [NCIt concept]
- Polysaccharide-K [NCIt concept]
- Polysiloxane/Gadolinium Chelates-based Nanoparticles [NCIt concept]
- Polysomnography [NCIt concept]
- Polysomy 7 [NCIt concept]
- Polyspecific Direct Antiglobulin Test [NCIt concept]
- Polyubiquitin-B [NCIt concept]
- Polyubiquitin-C [NCIt concept]
- Polyunsaturated Fatty Acid [NCIt concept]
- Polyvalent Antigen-KLH Conjugate Vaccine [NCIt concept]
- Polyvalent Melanoma Vaccine [NCIt concept]
- Polyvinyl Alcohol [NCIt concept]
- Polzastobart [NCIt concept]
- Pomalidomide [NCIt concept]
- Pomegranate Juice [NCIt concept]
- Pomegranate Liquid Extract [NCIt concept]
- Pomegranate-Extract Pill [NCIt concept]
- Ponatinib Hydrochloride [NCIt concept]
- Ponesimod [NCIt concept]
- Ponsegromab [NCIt concept]
- Pooled Mutant KRAS-Targeted Long Peptide Vaccine [NCIt concept]
- Poor Performance Status [NCIt concept]
- Poor Prognosis Metastatic Gestational Trophoblastic Tumor [NCIt concept]
- Poorly Differentiated Neuroblastoma [NCIt concept]
- Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Population Pharmacokinetic Modeling [NCIt concept]
- Porcupine Inhibitor CGX1321 [NCIt concept]
- Porcupine Inhibitor ETC-159 [NCIt concept]
- Porcupine Inhibitor WNT974 [NCIt concept]
- Porfimer Sodium [NCIt concept]
- Porphyrin [NCIt concept]
- Portacath Placement [NCIt concept]
- Porustobart [NCIt concept]
- Posaconazole [NCIt concept]
- Poseltinib [NCIt concept]
- Positive Air Pressure Device [NCIt concept]
- Positive Antinuclear Antibody Test [NCIt concept]
- Positive EBV Test [NCIt concept]
- Positive History of COVID-19 [NCIt concept]
- Positive Para-Aortic Lymph Node [NCIt concept]
- Positive Pelvic Lymph Node [NCIt concept]
- Positive Transcription Elongation Factor B [NCIt concept]
- Positron Emission Mammography [NCIt concept]
- Positron Emission Tomography [NCIt concept]
- Positron Emission Tomography and Computed Tomography Scan [NCIt concept]
- Positron Emission Tomography and Magnetic Resonance Imaging [NCIt concept]
- Positron Emission Tomography with Radiolabeled Targeting Agent [NCIt concept]
- Posoleucel [NCIt concept]
- Post Mastectomy Recovery Jacket [NCIt concept]
- Post-Essential Thrombocythemia Myelofibrosis [NCIt concept]
- Post-Hepatitis Chronic Hepatopathy [NCIt concept]
- Post-Mastectomy Pain Syndrome [NCIt concept]
- Post-Translational Modification [NCIt concept]
- Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Post-Traumatic Stress Disorder [NCIt concept]
- Postcricoid Carcinoma [NCIt concept]
- Posterior Fossa Neoplasm [NCIt concept]
- Posterior Pharyngeal Wall Carcinoma [NCIt concept]
- Posterior Tongue Carcinoma [NCIt concept]
- Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8 [NCIt concept]
- Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Postpartum Mental or Behavioral Disorder [NCIt concept]
- Postsurgical Stage I Hepatoblastoma [NCIt concept]
- Postsurgical Stage II Hepatoblastoma [NCIt concept]
- Postsurgical Stage III Hepatoblastoma [NCIt concept]
- Postsurgical Stage IV Hepatoblastoma [NCIt concept]
- Potassium Iodide [NCIt concept]
- Potassium Measurement [NCIt concept]
- Potassium Voltage-Gated Channel Subfamily KQT Member 1 [NCIt concept]
- Povetacicept [NCIt concept]
- Povidone-Iodine [NCIt concept]
- Poziotinib [NCIt concept]
- Poziotinib Hydrochloride [NCIt concept]
- Pracinostat [NCIt concept]
- Pradusinstobart [NCIt concept]
- Pralatrexate [NCIt concept]
- Pralsetinib [NCIt concept]
- Pramlintide [NCIt concept]
- Prasterone [NCIt concept]
- Prasugrel [NCIt concept]
- Pravastatin [NCIt concept]
- Pravastatin Sodium [NCIt concept]
- Pre-B-Cell Leukemia Transcription Factor 1 [NCIt concept]
- Pre-B-Cell Leukemia Transcription Factor-Interacting Protein 1 [NCIt concept]
- Pre-Progastrin-Releasing Peptide [NCIt concept]
- Pre-existing Chronic Kidney Disease, Stage 3 [NCIt concept]
- Pre-mRNA 3'-End-Processing Factor FIP1 [NCIt concept]
- Prealbumin Measurement [NCIt concept]
- Prebiotic-based Vaginal Gel [NCIt concept]
- Precancerous Condition [NCIt concept]
- Precemtabart Tocentecan [NCIt concept]
- Prednisolone [NCIt concept]
- Prednisolone Acetate [NCIt concept]
- Prednisone [NCIt concept]
- Pregabalin [NCIt concept]
- Pregnancy [NCIt concept]
- Pregnanediol-3alpha-Glucuronide [NCIt concept]
- Pregnenolone [NCIt concept]
- Preinvasive Neoplasm of the Ampullary Region [NCIt concept]
- Prelamin-A/C [NCIt concept]
- Premalignant [NCIt concept]
- Prepronociceptin [NCIt concept]
- Presatovir [NCIt concept]
- Presence of ERBB2 Overexpressing Disseminated Tumor Cells [NCIt concept]
- Pressure Specified Sensory Device [NCIt concept]
- Pressure Stimulation Device [NCIt concept]
- Pretargeted Radioimmunotherapy [NCIt concept]
- Preventative Dietary Intervention [NCIt concept]
- Preventative Nutritional Supplementation [NCIt concept]
- Preventive Intervention [NCIt concept]
- Previously Treated Childhood Rhabdomyosarcoma [NCIt concept]
- Previously Treated Myelodysplastic Syndrome [NCIt concept]
- Prevotella [NCIt concept]
- Prexasertib [NCIt concept]
- Prexigebersen [NCIt concept]
- Prickle-Like Protein 1 [NCIt concept]
- Primary Biliary Cirrhosis [NCIt concept]
- Primary Brain Neoplasm [NCIt concept]
- Primary Central Nervous System B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Primary Central Nervous System Hodgkin Lymphoma [NCIt concept]
- Primary Central Nervous System Lymphoma [NCIt concept]
- Primary Central Nervous System Non-Hodgkin Lymphoma [NCIt concept]
- Primary Congenital Glaucoma [NCIt concept]
- Primary Cutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Primary Cutaneous B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other [NCIt concept]
- Primary Cutaneous Follicle Center Lymphoma [NCIt concept]
- Primary Cutaneous Gamma-Delta T-Cell Lymphoma [NCIt concept]
- Primary Cutaneous Lymphoma [NCIt concept]
- Primary Cutaneous Non-Hodgkin Lymphoma [NCIt concept]
- Primary Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Primary Debulking Surgery [NCIt concept]
- Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System [NCIt concept]
- Primary Effusion Lymphoma [NCIt concept]
- Primary Immune Thrombocytopenia [NCIt concept]
- Primary Intraocular Non-Hodgkin Lymphoma [NCIt concept]
- Primary Malignant Liver Neoplasm [NCIt concept]
- Primary Malignant Pelvic Neoplasm [NCIt concept]
- Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Primary Myelofibrosis [NCIt concept]
- Primary Myelofibrosis with CALR Mutation [NCIt concept]
- Primary Peritoneal Adenocarcinoma [NCIt concept]
- Primary Peritoneal Carcinoma [NCIt concept]
- Primary Peritoneal Carcinosarcoma [NCIt concept]
- Primary Peritoneal Clear Cell Adenocarcinoma [NCIt concept]
- Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Primary Peritoneal Low Grade Serous Adenocarcinoma [NCIt concept]
- Primary Peritoneal Mucinous Adenocarcinoma [NCIt concept]
- Primary Peritoneal Serous Adenocarcinoma [NCIt concept]
- Primary Peritoneal Serous Papillary Adenocarcinoma [NCIt concept]
- Primary Peritoneal Transitional Cell Carcinoma [NCIt concept]
- Primary Peritoneal Undifferentiated Carcinoma [NCIt concept]
- Primary Prostate Urothelial Carcinoma [NCIt concept]
- Primary Sclerosing Cholangitis [NCIt concept]
- Primary Systemic Amyloidosis [NCIt concept]
- Prime Cancer Vaccine MVA-BN-CV301 [NCIt concept]
- Primitive Neuroectodermal Tumor [NCIt concept]
- Principal Investigator [NCIt concept]
- Prior Anal Surgery [NCIt concept]
- Prior Platinum Therapy [NCIt concept]
- Prior Prostate Radiation Therapy [NCIt concept]
- Prior Radiation Therapy of Affected Breast [NCIt concept]
- Prior Radiation Therapy of Chest Wall [NCIt concept]
- Prior Radiation Therapy of Thoracic Region [NCIt concept]
- Prior Rectal Surgery [NCIt concept]
- Prior Systemic Chemotherapy for Current Cancer [NCIt concept]
- Prior Systemic Therapy for Current Cancer [NCIt concept]
- Prior Treatment of Current Cancer [NCIt concept]
- Pritelivir [NCIt concept]
- Prizloncabtagene Autoleucel [NCIt concept]
- Pro-Epidermal Growth Factor [NCIt concept]
- Pro-Interleukin-16 [NCIt concept]
- Pro-Neuregulin-1, Membrane-Bound Isoform [NCIt concept]
- Pro-Neuregulin-2, Membrane-Bound Isoform [NCIt concept]
- Pro-Neuregulin-3, Membrane-Bound Isoform [NCIt concept]
- Pro-Opiomelanocortin [NCIt concept]
- Proactive Therapy [NCIt concept]
- Probable ATP-Dependent RNA Helicase DDX10 [NCIt concept]
- Probable ATP-Dependent RNA Helicase DDX31 [NCIt concept]
- Probable ATP-Dependent RNA Helicase DDX41 [NCIt concept]
- Probable ATP-Dependent RNA Helicase DDX5 [NCIt concept]
- Probable E3 Ubiquitin-Protein Ligase DTX2 [NCIt concept]
- Probable G-Protein Coupled Receptor 101 [NCIt concept]
- Probable Global Transcription Activator SNF2L2 [NCIt concept]
- Probable Polyprenol Reductase [NCIt concept]
- Probable Ubiquitin Carboxyl-Terminal Hydrolase FAF-X [NCIt concept]
- Probiotic [NCIt concept]
- Probiotic Acidophilus [NCIt concept]
- Problem-Solving Skills Training [NCIt concept]
- Procalcitonin [NCIt concept]
- Procarbazine [NCIt concept]
- Procarbazine Hydrochloride [NCIt concept]
- Procaspase Activating Compound-1 VO-100 [NCIt concept]
- Prochlorperazine [NCIt concept]
- Procollagen Type I C-Terminal Peptide [NCIt concept]
- Procollagen Type I N-Terminal Peptide [NCIt concept]
- Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 2 [NCIt concept]
- Procollagen-Proline Dioxygenase [NCIt concept]
- Proctoscopy [NCIt concept]
- Proctoscopy with Biopsy [NCIt concept]
- Proenkephalin-A [NCIt concept]
- Proflavine Hemisulfate [NCIt concept]
- Progenitor Cell Engraftment [NCIt concept]
- Progesterone [NCIt concept]
- Progesterone Antagonist [NCIt concept]
- Progesterone Receptor [NCIt concept]
- Progesterone Receptor Isoform A [NCIt concept]
- Progesterone Receptor Negative [NCIt concept]
- Progesterone Receptor Positive [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry 1-10 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry 1-9 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry Greater than or Equal to 1 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry Less than 1 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry Less than 10 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry Less than 20 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry Less than or Equal to 10 Percent [NCIt concept]
- Progesterone Receptor Positive by Immunohistochemistry Less than or Equal to 9 Percent [NCIt concept]
- Progesterone Receptor Status [NCIt concept]
- Progesterone Receptor-Positive Breast Carcinoma [NCIt concept]
- Progesterone Receptor-Positive Malignant Neoplasm [NCIt concept]
- Proglumide [NCIt concept]
- Prognostic Liver Secretome Signature [NCIt concept]
- Prognostic Stage 0 Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage I Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IA Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IB Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage II Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IIA Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IIB Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage III Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IIIA Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IIIB Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IIIC Breast Cancer AJCC v8 [NCIt concept]
- Prognostic Stage IV Breast Cancer AJCC v8 [NCIt concept]
- Programmed Cell Death 1 Ligand 1 [NCIt concept]
- Programmed Cell Death 1 Ligand 2 [NCIt concept]
- Programmed Cell Death Protein 1 [NCIt concept]
- Programmed Cell Death Protein 4 [NCIt concept]
- Programmed Death Ligand 1 Measurement [NCIt concept]
- Progranulin [NCIt concept]
- Progressive Childhood Medulloblastoma [NCIt concept]
- Progressive Glioblastoma [NCIt concept]
- Progressive Hairy Cell Leukemia Initial Treatment [NCIt concept]
- Progressive Thyroid Gland Carcinoma [NCIt concept]
- Prohibitin 1 [NCIt concept]
- Prohibitin-Targeting Peptide 1 [NCIt concept]
- Proinsulin [NCIt concept]
- Prokineticin Receptor 2 [NCIt concept]
- Prolactin [NCIt concept]
- Prolactin Receptor [NCIt concept]
- Prolaris Prostate Cancer Testing [NCIt concept]
- Proliferating Cell Nuclear Antigen [NCIt concept]
- Proliferation-Associated Protein 2G4 [NCIt concept]
- Proliferative Verrucous Leukoplakia [NCIt concept]
- Proline-, Glutamic Acid- and Leucine-Rich Protein 1 [NCIt concept]
- Proline-Rich AKT1 Substrate 1 [NCIt concept]
- Proline-Rich Protein PRCC [NCIt concept]
- Prolonged Grief Disorder [NCIt concept]
- Prolow-Density Lipoprotein Receptor-Related Protein 1 [NCIt concept]
- Prolyl Endopeptidase FAP [NCIt concept]
- Prolymphocytic Leukemia [NCIt concept]
- Prominent Schwannian Stroma Present [NCIt concept]
- Prominin-1 [NCIt concept]
- Promoter [NCIt concept]
- Promoter-specific Methylation Profile [NCIt concept]
- Promoting Resilience in Stress Management [NCIt concept]
- Properdin [NCIt concept]
- Prophylactic Cranial Irradiation [NCIt concept]
- Prophylactic Mastectomy Patient [NCIt concept]
- Propofol [NCIt concept]
- Propranolol Hydrochloride [NCIt concept]
- Proprioception Assessment [NCIt concept]
- Proprotein Convertase Subtilisin/Kexin Type 7 [NCIt concept]
- Proprotein Convertase Subtilisin/Kexin Type 9 [NCIt concept]
- Propylene Glycol [NCIt concept]
- Prosaposin [NCIt concept]
- Prostacyclin Synthase [NCIt concept]
- Prostaglandin [NCIt concept]
- Prostaglandin D2 [NCIt concept]
- Prostaglandin E [NCIt concept]
- Prostaglandin E Synthase [NCIt concept]
- Prostaglandin E Synthase 2 [NCIt concept]
- Prostaglandin E2 [NCIt concept]
- Prostaglandin E2 Metabolite [NCIt concept]
- Prostaglandin E2 Receptor EP4 Subtype [NCIt concept]
- Prostaglandin E3 [NCIt concept]
- Prostaglandin F2alpha [NCIt concept]
- Prostaglandin G/H Synthase 1 [NCIt concept]
- Prostaglandin G/H Synthase 2 [NCIt concept]
- Prostaglandin I2 Metabolite [NCIt concept]
- Prostaglandin Reductase 1 [NCIt concept]
- Prostate Ablation [NCIt concept]
- Prostate Adenocarcinoma [NCIt concept]
- Prostate Adenocarcinoma without Neuroendocrine Differentiation [NCIt concept]
- Prostate Alveolar Rhabdomyosarcoma [NCIt concept]
- Prostate Brachytherapy [NCIt concept]
- Prostate Cancer Antigen 3 [NCIt concept]
- Prostate Carcinoma [NCIt concept]
- Prostate Carcinoma Metastatic in the Pelvic Cavity [NCIt concept]
- Prostate Cryotherapy [NCIt concept]
- Prostate Disorder [NCIt concept]
- Prostate Health Cocktail Dietary Supplement [NCIt concept]
- Prostate Health Index [NCIt concept]
- Prostate Mechanical Imager [NCIt concept]
- Prostate Neoplasm [NCIt concept]
- Prostate Radiation Therapy [NCIt concept]
- Prostate Specific Antigen Density [NCIt concept]
- Prostate Specific Antigen Measurement [NCIt concept]
- Prostate Stem Cell Antigen [NCIt concept]
- Prostate-Specific Antigen [NCIt concept]
- Prostate-Specific Membrane Antigen Uptake Finding by Positron Emission Tomography [NCIt concept]
- Prostatectomy [NCIt concept]
- Prostatic Acid Phosphatase [NCIt concept]
- Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 [NCIt concept]
- Prosthetics Intervention [NCIt concept]
- Protachykinin-1 [NCIt concept]
- Protease Inhibitor Formulation LB1148 [NCIt concept]
- Protease-Activated Receptor 1 [NCIt concept]
- Protease-activated Anti-EGFR/Anti-CD3 Bispecific Antibody Prodrug CX-904 [NCIt concept]
- Protease-activated Interferon Alpha-2b Prodrug CX-801 [NCIt concept]
- Proteasome Assembly Chaperone 2 [NCIt concept]
- Proteasome Subunit Alpha Type-5 [NCIt concept]
- Proteasome Subunit Beta Type-10 [NCIt concept]
- Proteasome Subunit Beta Type-5 [NCIt concept]
- Proteasome Subunit Beta Type-8 [NCIt concept]
- Proteasome Subunit Beta Type-9 [NCIt concept]
- Protectin [NCIt concept]
- Protection of Telomeres Protein 1 [NCIt concept]
- Protective Face Mask [NCIt concept]
- Protein AF-10 [NCIt concept]
- Protein AF-9 [NCIt concept]
- Protein AF1q [NCIt concept]
- Protein ALEX [NCIt concept]
- Protein Analysis [NCIt concept]
- Protein Arginine Methyltransferase 5 Inhibitor PF-06939999 [NCIt concept]
- Protein Arginine Methyltransferase 5 Inhibitor PRT543 [NCIt concept]
- Protein Arginine N-Methyltransferase 1 [NCIt concept]
- Protein Arginine N-Methyltransferase 5 [NCIt concept]
- Protein Artemis [NCIt concept]
- Protein Atonal Homolog 1 [NCIt concept]
- Protein BTG1 [NCIt concept]
- Protein Bicaudal C Homolog 1 [NCIt concept]
- Protein C-ets-1 [NCIt concept]
- Protein C-ets-2 [NCIt concept]
- Protein CBFA2T1 [NCIt concept]
- Protein CBFA2T2 [NCIt concept]
- Protein CBFA2T3 [NCIt concept]
- Protein Capicua Homolog [NCIt concept]
- Protein Carbonyl Content [NCIt concept]
- Protein Cereblon [NCIt concept]
- Protein Cripto [NCIt concept]
- Protein CutA [NCIt concept]
- Protein DEK [NCIt concept]
- Protein DJ-1 [NCIt concept]
- Protein Delta Homolog 1 [NCIt concept]
- Protein Disulfide-Isomerase A3 [NCIt concept]
- Protein Disulfide-Isomerase A6 [NCIt concept]
- Protein Disulfide-Isomerase Family [NCIt concept]
- Protein Dr1 [NCIt concept]
- Protein E6, Human Papillomavirus Type 16 [NCIt concept]
- Protein E6, Human Papillomavirus Type 18 [NCIt concept]
- Protein E7, Human Papillomavirus Type 16 [NCIt concept]
- Protein E7, Human Papillomavirus Type 18 [NCIt concept]
- Protein E7, Human Papillomavirus Type 52 [NCIt concept]
- Protein ECT2 [NCIt concept]
- Protein EMSY [NCIt concept]
- Protein ENL [NCIt concept]
- Protein Enabled Homolog [NCIt concept]
- Protein Expression [NCIt concept]
- Protein Expression Analysis [NCIt concept]
- Protein FAM3C [NCIt concept]
- Protein FAN [NCIt concept]
- Protein FEV [NCIt concept]
- Protein GREB1 [NCIt concept]
- Protein HIRA [NCIt concept]
- Protein Hook Homolog 3 [NCIt concept]
- Protein Interaction Domain Inhibitor Therapy [NCIt concept]
- Protein Jagged-1 [NCIt concept]
- Protein Jagged-2 [NCIt concept]
- Protein Kinase A [NCIt concept]
- Protein Kinase B [NCIt concept]
- Protein Kinase C [NCIt concept]
- Protein Kinase C Alpha Type [NCIt concept]
- Protein Kinase C Beta Type [NCIt concept]
- Protein Kinase C Epsilon Type [NCIt concept]
- Protein Kinase C Gamma Type [NCIt concept]
- Protein Kinase C Inhibitor [NCIt concept]
- Protein Kinase C Iota Type [NCIt concept]
- Protein Kinase C-Binding Protein 1 [NCIt concept]
- Protein Kinase C-Binding Protein NELL1 [NCIt concept]
- Protein Kinase Inhibitor [NCIt concept]
- Protein L-Myc [NCIt concept]
- Protein LSM14 Homolog A [NCIt concept]
- Protein Lyl-1 [NCIt concept]
- Protein MCM10 Homolog [NCIt concept]
- Protein Max [NCIt concept]
- Protein Mdm4 [NCIt concept]
- Protein Mono-ADP-Ribosyltransferase PARP3 [NCIt concept]
- Protein NDRG1 [NCIt concept]
- Protein NDRG2 [NCIt concept]
- Protein NDRG4 [NCIt concept]
- Protein O-Mannosyl-Transferase TMTC1 [NCIt concept]
- Protein PML [NCIt concept]
- Protein PTHB1 [NCIt concept]
- Protein Patched Homolog 1 [NCIt concept]
- Protein Pelota Homolog [NCIt concept]
- Protein Phosphatase 1 Regulatory Subunit 15A [NCIt concept]
- Protein Phosphatase 1D [NCIt concept]
- Protein Phosphatase EYA1 [NCIt concept]
- Protein Phosphatase Slingshot Homolog 2 [NCIt concept]
- Protein Piccolo [NCIt concept]
- Protein Polybromo-1 [NCIt concept]
- Protein Prune Homolog 2 [NCIt concept]
- Protein Quaking [NCIt concept]
- Protein Reprimo [NCIt concept]
- Protein S100-A10 [NCIt concept]
- Protein S100-A4 [NCIt concept]
- Protein S100-B [NCIt concept]
- Protein S100-Z [NCIt concept]
- Protein SET [NCIt concept]
- Protein SSX1 [NCIt concept]
- Protein SSX2 [NCIt concept]
- Protein SSX4 [NCIt concept]
- Protein SSXT [NCIt concept]
- Protein Sel-1 Homolog 1 [NCIt concept]
- Protein Shroom2 [NCIt concept]
- Protein Shroom3 [NCIt concept]
- Protein Smoothened [NCIt concept]
- Protein Sprouty Homolog 1 [NCIt concept]
- Protein Sprouty Homolog 2 [NCIt concept]
- Protein Sprouty Homolog 4 [NCIt concept]
- Protein Stabilized Liposomal Docetaxel Nanoparticles [NCIt concept]
- Protein TFG [NCIt concept]
- Protein Tob2 [NCIt concept]
- Protein Transport Protein Sec16A [NCIt concept]
- Protein Transport Protein Sec31A [NCIt concept]
- Protein Tyrosine Phosphatase Type IVA [NCIt concept]
- Protein Tyrosine Phosphatase Type IVA 3 [NCIt concept]
- Protein Unc-13 Homolog D [NCIt concept]
- Protein Wnt-10b [NCIt concept]
- Protein Wnt-10b Activity Measurement [NCIt concept]
- Protein Wnt-11 [NCIt concept]
- Protein Wnt-16 [NCIt concept]
- Protein Wnt-5b [NCIt concept]
- Protein or Enzyme Type Measurement [NCIt concept]
- Protein-Lysine 6-Oxidase [NCIt concept]
- Protein-Serine O-Palmitoleoyltransferase Porcupine [NCIt concept]
- Protein-Tyrosine Kinase 2-Beta [NCIt concept]
- Protein-engineered Interleukin-2 XTX202 [NCIt concept]
- Proteomic Profile [NCIt concept]
- Proteomic Profiling [NCIt concept]
- Proteus Sensor Patch [NCIt concept]
- Prothrombin [NCIt concept]
- Proto-Oncogene FRAT1 Protein [NCIt concept]
- Proto-Oncogene Tyrosine-Protein Kinase ROS [NCIt concept]
- Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret [NCIt concept]
- Proto-Oncogene Tyrosine-Protein Kinase Src [NCIt concept]
- Proto-Oncogene c-Fos [NCIt concept]
- Protocadherin Fat 1 [NCIt concept]
- Protocadherin Fat 4 [NCIt concept]
- Protocadherin-7 [NCIt concept]
- Proton Beam Craniospinal Irradiation [NCIt concept]
- Proton Beam Radiation Therapy [NCIt concept]
- Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging [NCIt concept]
- Proton Pencil Beam Scanning Spatially-Fractionated Radiotherapy [NCIt concept]
- Proton Pump Inhibitor [NCIt concept]
- Proton-Coupled Amino Acid Transporter 1 [NCIt concept]
- Proton-Coupled Folate Transporter [NCIt concept]
- Protoporphyrin IX [NCIt concept]
- Protransforming Growth Factor Alpha [NCIt concept]
- Proximal Gastric Adenocarcinoma [NCIt concept]
- Proximal Urethral Carcinoma [NCIt concept]
- Prulacabtagene Leucel [NCIt concept]
- Psammocarcinoma [NCIt concept]
- Pseudomyxoma Peritonei [NCIt concept]
- Pseudoporphyria [NCIt concept]
- Psilocybine [NCIt concept]
- Psychoeducational Assessment [NCIt concept]
- Psychological Assessment [NCIt concept]
- Psychological Impact of Cancer [NCIt concept]
- Psychomotor Assessment [NCIt concept]
- Psychosocial Assessment [NCIt concept]
- Psychosocial Assessment and Care [NCIt concept]
- Psychosocial Care [NCIt concept]
- Psychosocial Support for Caregiver [NCIt concept]
- Psychotherapy [NCIt concept]
- Pterostilbene [NCIt concept]
- Pudexacianinium Chloride [NCIt concept]
- Puffing Topography Monitor [NCIt concept]
- Pulmonary Artery-First Surgical Technique [NCIt concept]
- Pulmonary Complication [NCIt concept]
- Pulmonary Complications Management [NCIt concept]
- Pulmonary Embolism [NCIt concept]
- Pulmonary Function Test [NCIt concept]
- Pulmonary Nodule [NCIt concept]
- Pulmonary Vein-First Surgical Technique [NCIt concept]
- Pulrodemstat [NCIt concept]
- Pulse Oximetry [NCIt concept]
- Pulse Wave Velocity [NCIt concept]
- Pulsed Electromagnetic Fields Therapy [NCIt concept]
- Pulsed-Dose Rate Brachytherapy [NCIt concept]
- Punch Biopsy [NCIt concept]
- Purchase [NCIt concept]
- Puromycin-Sensitive Aminopeptidase [NCIt concept]
- Purple Grape Juice [NCIt concept]
- Putative Endoplasmin-Like Protein [NCIt concept]
- Putative Inactive Neutral Ceramidase B [NCIt concept]
- Putative Insulin-Like Growth Factor 2 Antisense Gene Protein [NCIt concept]
- Putative Macrophage-Stimulating 1-Like Protein [NCIt concept]
- Putative Neutral Ceramidase C [NCIt concept]
- Putative POU Domain, Class 5, Transcription Factor 1B [NCIt concept]
- Putative Polycomb Group Protein ASXL1 [NCIt concept]
- Putative Transcription Activator ORF50 [NCIt concept]
- Putative Tyrosine-Protein Phosphatase TPTE [NCIt concept]
- Putrescine [NCIt concept]
- Puxitatug Samrotecan [NCIt concept]
- Pvt1 Oncogene Long Non-Coding RNA [NCIt concept]
- Pyloroplasty [NCIt concept]
- Pyrazoloacridine [NCIt concept]
- Pyridinoline [NCIt concept]
- Pyridoxine Hydrochloride [NCIt concept]
- Pyriform Fossa Carcinoma [NCIt concept]
- Pyrimethamine [NCIt concept]
- Pyrotinib [NCIt concept]
- Pyruvate [NCIt concept]
- Pyruvate Dehydrogenase Kinase [NCIt concept]
- Pyruvate Kinase [NCIt concept]
- Pyruvate Kinase M2 Isoform Activator TP-1454 [NCIt concept]
- Pyruvate Kinase Measurement [NCIt concept]
- Pyruvate Kinase PKLR [NCIt concept]
- Pyruvate Kinase PKLR Isoform L-Type [NCIt concept]
- Pyruvate Kinase PKM [NCIt concept]
- Pyruvate Kinase PKM Isoform M2 Dimer [NCIt concept]
- Pyrvinium Pamoate [NCIt concept]
- Q-space Trajectory Imaging [NCIt concept]
- QKI Gene [NCIt concept]
- QKI wt Allele [NCIt concept]
- QS21 [NCIt concept]
- QSOX1 Gene [NCIt concept]
- QSOX1 wt Allele [NCIt concept]
- QTcF Prolongation [NCIt concept]
- Qigong [NCIt concept]
- Quadratus Lumborum Block [NCIt concept]
- Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine [NCIt concept]
- Quadrivalent Inactivated Influenza Vaccine [NCIt concept]
- Quality-of-Life Assessment [NCIt concept]
- Quantifiable Measurable Residual Disease Positivity [NCIt concept]
- Quantitative Computed Tomography [NCIt concept]
- Quantitative Lipid/Lipoprotein Particle Nuclear Magnetic Resonance Spectroscopy [NCIt concept]
- Quantitative Oblique Back-Illumination Microscopy [NCIt concept]
- Quantitative Reverse Transcriptase PCR [NCIt concept]
- Quantitative Sensory Testing [NCIt concept]
- Quantitative Ultrasound Spectroscopy [NCIt concept]
- Quaratusugene Ozeplasmid [NCIt concept]
- Quarfloxin [NCIt concept]
- Quavonlimab [NCIt concept]
- Quemliclustat [NCIt concept]
- Quercetin [NCIt concept]
- Quercetin/Rye Flower Pollen/Bromelain/Papain Supplement [NCIt concept]
- Questionnaire Administration [NCIt concept]
- Quinacrine Hydrochloride [NCIt concept]
- Quinolinic Acid [NCIt concept]
- Quinolonyl-oxazolidinone Antibiotic DNV3837 [NCIt concept]
- Quisinostat [NCIt concept]
- Quit2Heal [NCIt concept]
- QuitBot Smoking Cessation Program [NCIt concept]
- QuitGuide [NCIt concept]
- Quitline Program [NCIt concept]
- Quizartinib [NCIt concept]
- Quizartinib Dihydrochloride [NCIt concept]
- R-(-)-Gossypol Acetic Acid [NCIt concept]
- R-1,3-Butanediol-based Supplement [NCIt concept]
- R-CHOP Regimen [NCIt concept]
- R-CVP Regimen [NCIt concept]
- R-Spondin-2 [NCIt concept]
- R-Spondin-3 [NCIt concept]
- RAB23 Gene [NCIt concept]
- RAB23 wt Allele [NCIt concept]
- RAB27A Gene [NCIt concept]
- RAB27A Gene Mutation [NCIt concept]
- RAB27A wt Allele [NCIt concept]
- RAB40B Gene [NCIt concept]
- RAB40B wt Allele [NCIt concept]
- RAB5C Gene [NCIt concept]
- RAB5C wt Allele [NCIt concept]
- RABEP1 Gene [NCIt concept]
- RABEP1 wt Allele [NCIt concept]
- RABEP1/PDGFRB Fusion Gene [NCIt concept]
- RABEP1/PDGFRB Fusion Protein [NCIt concept]
- RAC-Alpha Serine/Threonine Kinase [NCIt concept]
- RAC-Beta Serine/Threonine Kinase [NCIt concept]
- RAC-Gamma Serine/Threonine Kinase [NCIt concept]
- RAC1 Gene [NCIt concept]
- RAC1 wt Allele [NCIt concept]
- RAC2 Gene [NCIt concept]
- RAC2 Gene Mutation [NCIt concept]
- RAC2 wt Allele [NCIt concept]
- RAC3 Gene [NCIt concept]
- RAC3 wt Allele [NCIt concept]
- RAD17 Gene [NCIt concept]
- RAD17 wt Allele [NCIt concept]
- RAD18 Gene [NCIt concept]
- RAD18 wt Allele [NCIt concept]
- RAD21 Gene [NCIt concept]
- RAD21 Gene Mutation [NCIt concept]
- RAD21 wt Allele [NCIt concept]
- RAD23A Gene [NCIt concept]
- RAD23A wt Allele [NCIt concept]
- RAD23B Gene [NCIt concept]
- RAD23B wt Allele [NCIt concept]
- RAD50 Gene [NCIt concept]
- RAD50 Gene Mutation [NCIt concept]
- RAD50 wt Allele [NCIt concept]
- RAD51 Gene [NCIt concept]
- RAD51 Gene Mutation [NCIt concept]
- RAD51 Gene Mutation Negative [NCIt concept]
- RAD51 Low [NCIt concept]
- RAD51 Negative [NCIt concept]
- RAD51 wt Allele [NCIt concept]
- RAD51B Gene [NCIt concept]
- RAD51B Gene Mutation [NCIt concept]
- RAD51B wt Allele [NCIt concept]
- RAD51B/HMGA2 Fusion Gene [NCIt concept]
- RAD51B/HMGA2 Fusion Protein [NCIt concept]
- RAD51C Gene [NCIt concept]
- RAD51C Gene Mutation [NCIt concept]
- RAD51C wt Allele [NCIt concept]
- RAD51D Gene [NCIt concept]
- RAD51D Gene Mutation [NCIt concept]
- RAD51D wt Allele [NCIt concept]
- RAD52 Gene [NCIt concept]
- RAD52 Gene Mutation [NCIt concept]
- RAD52 wt Allele [NCIt concept]
- RAD54B Gene [NCIt concept]
- RAD54B Gene Mutation [NCIt concept]
- RAD54B wt Allele [NCIt concept]
- RAD54L Gene [NCIt concept]
- RAD54L Gene Mutation [NCIt concept]
- RAD54L wt Allele [NCIt concept]
- RAD9A Gene [NCIt concept]
- RAD9A wt Allele [NCIt concept]
- RAD9B Gene [NCIt concept]
- RAD9B wt Allele [NCIt concept]
- RAET1L Gene [NCIt concept]
- RAET1L wt Allele [NCIt concept]
- RAF Family Gene Mutation [NCIt concept]
- RAF Inhibitor BDTX-4933 [NCIt concept]
- RAF Inhibitor DCC-3084 [NCIt concept]
- RAF Kinase Inhibitor XL281 [NCIt concept]
- RAF Proto-Oncogene Serine/Threonine-Protein Kinase [NCIt concept]
- RAF Wild Type [NCIt concept]
- RAF1 Fusion Positive [NCIt concept]
- RAF1 Gene [NCIt concept]
- RAF1 Gene Amplification [NCIt concept]
- RAF1 Gene Mutation [NCIt concept]
- RAF1 wt Allele [NCIt concept]
- RAG1 Gene [NCIt concept]
- RAG1 Gene Mutation [NCIt concept]
- RAG1 wt Allele [NCIt concept]
- RAG2 Gene [NCIt concept]
- RAG2 Gene Mutation [NCIt concept]
- RAG2 wt Allele [NCIt concept]
- RALA Gene [NCIt concept]
- RALA wt Allele [NCIt concept]
- RALB Gene [NCIt concept]
- RALB wt Allele [NCIt concept]
- RAMP2 Gene [NCIt concept]
- RAMP2 wt Allele [NCIt concept]
- RANBP17 Gene [NCIt concept]
- RANBP17 wt Allele [NCIt concept]
- RANBP2 Gene [NCIt concept]
- RANBP2 wt Allele [NCIt concept]
- RAP1GDS1 Gene [NCIt concept]
- RAP1GDS1 wt Allele [NCIt concept]
- RARA Gene [NCIt concept]
- RARA Gene Product [NCIt concept]
- RARA Gene Translocation [NCIt concept]
- RARA Positive [NCIt concept]
- RARA wt Allele [NCIt concept]
- RARA/PML Fusion Gene [NCIt concept]
- RARA/ZBTB16 Fusion Gene [NCIt concept]
- RARA/ZBTB16 Fusion Protein [NCIt concept]
- RARB Gene [NCIt concept]
- RARB wt Allele [NCIt concept]
- RARalpha Agonist IRX5183 [NCIt concept]
- RAS Family Gene [NCIt concept]
- RAS Family Gene Alteration Positive [NCIt concept]
- RAS Family Gene Mutation [NCIt concept]
- RAS Family Oncogene [NCIt concept]
- RAS Family Transcriptional Profile [NCIt concept]
- RAS Peptide Cancer Vaccine TG01 [NCIt concept]
- RAS Superfamily Protein [NCIt concept]
- RAS Wild Type [NCIt concept]
- RAS/BRAF/NF1 Triple Wild Type [NCIt concept]
- RAS/PI3K-alpha Interaction Inhibitor BBO-10203 [NCIt concept]
- RASA1 Gene [NCIt concept]
- RASA1 Gene Mutation [NCIt concept]
- RASA1 wt Allele [NCIt concept]
- RASA2 Gene [NCIt concept]
- RASA2 Gene Mutation [NCIt concept]
- RASA2 wt Allele [NCIt concept]
- RASGRF1 Gene [NCIt concept]
- RASGRF1 wt Allele [NCIt concept]
- RASSF1 Gene [NCIt concept]
- RASSF1 wt Allele [NCIt concept]
- RASSF5 Gene [NCIt concept]
- RASSF5 wt Allele [NCIt concept]
- RASopathy [NCIt concept]
- RB1 Gene [NCIt concept]
- RB1 Gene Alteration Positive [NCIt concept]
- RB1 Gene Deletion [NCIt concept]
- RB1 Gene Frameshift Mutation [NCIt concept]
- RB1 Gene Inactivation [NCIt concept]
- RB1 Gene Mutation [NCIt concept]
- RB1 Gene Mutation Negative [NCIt concept]
- RB1 Gene Nonsense Mutation [NCIt concept]
- RB1 Negative [NCIt concept]
- RB1 Positive [NCIt concept]
- RB1 wt Allele [NCIt concept]
- RBBP4 Gene [NCIt concept]
- RBBP4 wt Allele [NCIt concept]
- RBL1 Gene [NCIt concept]
- RBL1 wt Allele [NCIt concept]
- RBL2 Gene [NCIt concept]
- RBL2 wt Allele [NCIt concept]
- RBM14 Gene [NCIt concept]
- RBM14 wt Allele [NCIt concept]
- RBM15 Gene [NCIt concept]
- RBM15 wt Allele [NCIt concept]
- RBM15/MKL1 Fusion Gene [NCIt concept]
- RBM15/MKL1 Fusion Protein [NCIt concept]
- RBM39 Degrader [NCIt concept]
- RBM39 Degrader REC-1245 [NCIt concept]
- RBM4 Gene [NCIt concept]
- RBM4 wt Allele [NCIt concept]
- RBMS1 Gene [NCIt concept]
- RBMS1 wt Allele [NCIt concept]
- RBP4 Gene [NCIt concept]
- RBP4 wt Allele [NCIt concept]
- RBPJ Gene [NCIt concept]
- RBPJ wt Allele [NCIt concept]
- RE1-Silencing Transcription Factor [NCIt concept]
- RECQL Gene [NCIt concept]
- RECQL Gene Mutation [NCIt concept]
- RECQL wt Allele [NCIt concept]
- RECQL4 Gene [NCIt concept]
- RECQL4 Gene Mutation [NCIt concept]
- RECQL4 wt Allele [NCIt concept]
- REG3A Gene [NCIt concept]
- REG3A wt Allele [NCIt concept]
- RELA Fusion Positive [NCIt concept]
- RELA Gene [NCIt concept]
- RELA wt Allele [NCIt concept]
- RELB Gene [NCIt concept]
- RELB wt Allele [NCIt concept]
- REN Gene [NCIt concept]
- REN wt Allele [NCIt concept]
- RESOLVE Multishot Diffusion Weighted Echoplanar Imaging [NCIt concept]
- REST Gene [NCIt concept]
- REST wt Allele [NCIt concept]
- REST-003 ncRNA [NCIt concept]
- RET Fusion Positive [NCIt concept]
- RET Gene [NCIt concept]
- RET Gene Alteration Negative [NCIt concept]
- RET Gene Alteration Positive [NCIt concept]
- RET Gene Amplification [NCIt concept]
- RET Gene Fusion Negative [NCIt concept]
- RET Gene Mutation [NCIt concept]
- RET Gene Mutation Negative [NCIt concept]
- RET Gene Translocation [NCIt concept]
- RET Inhibitor LOXO-260 [NCIt concept]
- RET Overexpression Positive [NCIt concept]
- RET Positive [NCIt concept]
- RET wt Allele [NCIt concept]
- RET/NCOA4 Fusion Gene [NCIt concept]
- RET/PTC Rearrangement [NCIt concept]
- RET/TRIM24 Fusion Gene [NCIt concept]
- RET/TRIM33 Fusion Gene [NCIt concept]
- RETN Gene [NCIt concept]
- RETN wt Allele [NCIt concept]
- REV1 Gene [NCIt concept]
- REV1 wt Allele [NCIt concept]
- REVITALIZE [NCIt concept]
- RFC1 Gene [NCIt concept]
- RFC1 Gene Mutation [NCIt concept]
- RFC1 wt Allele [NCIt concept]
- RFC2 Gene [NCIt concept]
- RFC2 Gene Mutation [NCIt concept]
- RFC2 wt Allele [NCIt concept]
- RFC3 Gene [NCIt concept]
- RFC3 Gene Mutation [NCIt concept]
- RFC3 wt Allele [NCIt concept]
- RFC4 Gene [NCIt concept]
- RFC4 Gene Mutation [NCIt concept]
- RFC4 wt Allele [NCIt concept]
- RFC5 Gene [NCIt concept]
- RFC5 Gene Mutation [NCIt concept]
- RFC5 wt Allele [NCIt concept]
- RFLNA Gene [NCIt concept]
- RFLNA wt Allele [NCIt concept]
- RFT5-dgA Immunotoxin IMTOX25 [NCIt concept]
- RGD-modified COX-2 Promoter-controlled Conditionally Replicative Adenovirus RGDCRAdCox2F [NCIt concept]
- RGL4 Gene [NCIt concept]
- RGL4 wt Allele [NCIt concept]
- RGS1 Gene [NCIt concept]
- RGS1 wt Allele [NCIt concept]
- RGS22 Gene [NCIt concept]
- RGS22 wt Allele [NCIt concept]
- RGS5 Gene [NCIt concept]
- RGS5 wt Allele [NCIt concept]
- RHEB Gene [NCIt concept]
- RHEB Gene Rearrangement [NCIt concept]
- RHEB wt Allele [NCIt concept]
- RHO Gene [NCIt concept]
- RHO wt Allele [NCIt concept]
- RHOA Gene [NCIt concept]
- RHOA wt Allele [NCIt concept]
- RHOB Gene [NCIt concept]
- RHOB wt Allele [NCIt concept]
- RHOH Gene [NCIt concept]
- RHOH wt Allele [NCIt concept]
- RHOU Gene [NCIt concept]
- RHOU wt Allele [NCIt concept]
- RICTOR Gene [NCIt concept]
- RICTOR wt Allele [NCIt concept]
- RIF1 Gene [NCIt concept]
- RIF1 wt Allele [NCIt concept]
- RIGI Gene [NCIt concept]
- RIGI wt Allele [NCIt concept]
- RIPK1 Gene [NCIt concept]
- RIPK1 Inhibitor GSK3145095 [NCIt concept]
- RIPK1 wt Allele [NCIt concept]
- RIT1 Gene [NCIt concept]
- RIT1 Gene Mutation [NCIt concept]
- RIT1 wt Allele [NCIt concept]
- RLF Gene [NCIt concept]
- RLF wt Allele [NCIt concept]
- RNA Analysis [NCIt concept]
- RNA Electroporated CD19CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes [NCIt concept]
- RNA Polymerase II [NCIt concept]
- RNA Polymerase II Elongation Factor ELL [NCIt concept]
- RNA Sequence [NCIt concept]
- RNA Transcription Modulator AU-409 [NCIt concept]
- RNA-Binding Motif, Single-Stranded-Interacting Protein 1 [NCIt concept]
- RNA-Binding Protein 14 [NCIt concept]
- RNA-Binding Protein 15 [NCIt concept]
- RNA-Binding Protein 4 [NCIt concept]
- RNA-Binding Protein EWS [NCIt concept]
- RNA-Binding Protein FUS [NCIt concept]
- RNA-Binding Protein Musashi Homolog 2 [NCIt concept]
- RNA-lipoplex Cancer Vaccine BNT116 [NCIt concept]
- RNASEL Gene [NCIt concept]
- RNASEL wt Allele [NCIt concept]
- RNF130 Gene [NCIt concept]
- RNF130 wt Allele [NCIt concept]
- RNF213 Gene [NCIt concept]
- RNF213 wt Allele [NCIt concept]
- RNF213/ALK Fusion Gene [NCIt concept]
- RNF213/ALK Fusion Protein [NCIt concept]
- RNF216 Gene [NCIt concept]
- RNF216 wt Allele [NCIt concept]
- RNF217-AS1 Gene [NCIt concept]
- RNF217-AS1 wt Allele [NCIt concept]
- RNF43 Gene [NCIt concept]
- RNF43 Gene Mutation [NCIt concept]
- RNF43 wt Allele [NCIt concept]
- RNR Inhibitor BBI-825 [NCIt concept]
- RNR Inhibitor COH29 [NCIt concept]
- RNR Subunits Interaction Inhibitor TAS1553 [NCIt concept]
- RNase-Fc Fusion Protein RSLV-132 [NCIt concept]
- ROBO2 Gene [NCIt concept]
- ROBO2 wt Allele [NCIt concept]
- ROBO3 Gene [NCIt concept]
- ROBO3 wt Allele [NCIt concept]
- ROBO4 Gene [NCIt concept]
- ROBO4 wt Allele [NCIt concept]
- ROCK2 Gene [NCIt concept]
- ROCK2 wt Allele [NCIt concept]
- ROPN1 Gene [NCIt concept]
- ROPN1 Positive [NCIt concept]
- ROPN1 wt Allele [NCIt concept]
- ROR1 Antibody [NCIt concept]
- ROR1 Gene [NCIt concept]
- ROR1 Positive [NCIt concept]
- ROR1 wt Allele [NCIt concept]
- ROR1-targeting Agent [NCIt concept]
- ROR2 Gene [NCIt concept]
- ROR2 wt Allele [NCIt concept]
- RORC Gene [NCIt concept]
- RORC Gene Product [NCIt concept]
- RORC wt Allele [NCIt concept]
- ROS1 Driver Mutation Negative [NCIt concept]
- ROS1 Fusion Negative [NCIt concept]
- ROS1 Fusion Positive [NCIt concept]
- ROS1 Gene [NCIt concept]
- ROS1 Gene Alteration Negative [NCIt concept]
- ROS1 Gene Alteration Positive [NCIt concept]
- ROS1 Gene Amplification [NCIt concept]
- ROS1 Gene Fusion Negative [NCIt concept]
- ROS1 Gene Fusion Positive [NCIt concept]
- ROS1 Gene Inversion [NCIt concept]
- ROS1 Gene Mutation [NCIt concept]
- ROS1 Gene Mutation Negative [NCIt concept]
- ROS1 Gene Rearrangement [NCIt concept]
- ROS1 Gene Rearrangement Negative [NCIt concept]
- ROS1 Gene Translocation [NCIt concept]
- ROS1 Inhibitor [NCIt concept]
- ROS1 Negative [NCIt concept]
- ROS1 Positive [NCIt concept]
- ROS1 wt Allele [NCIt concept]
- ROS1/NTRK Inhibitor ANS03 [NCIt concept]
- RPA1 Gene [NCIt concept]
- RPA1 Gene Mutation [NCIt concept]
- RPA1 wt Allele [NCIt concept]
- RPA2 Gene [NCIt concept]
- RPA2 Gene Mutation [NCIt concept]
- RPA2 wt Allele [NCIt concept]
- RPA3 Gene [NCIt concept]
- RPA3 Gene Mutation [NCIt concept]
- RPA3 wt Allele [NCIt concept]
- RPL13A Gene [NCIt concept]
- RPL13A wt Allele [NCIt concept]
- RPL22 Gene [NCIt concept]
- RPL22 wt Allele [NCIt concept]
- RPL5 Gene [NCIt concept]
- RPL5 wt Allele [NCIt concept]
- RPLP0 Gene [NCIt concept]
- RPLP0 wt Allele [NCIt concept]
- RPN1 Gene [NCIt concept]
- RPN1 wt Allele [NCIt concept]
- RPP40 Gene [NCIt concept]
- RPP40 wt Allele [NCIt concept]
- RPRM Gene [NCIt concept]
- RPRM wt Allele [NCIt concept]
- RPS14 Gene [NCIt concept]
- RPS14 wt Allele [NCIt concept]
- RPS2 Gene [NCIt concept]
- RPS2 wt Allele [NCIt concept]
- RPS20 Gene [NCIt concept]
- RPS20 Gene Mutation [NCIt concept]
- RPS20 wt Allele [NCIt concept]
- RPS6 Gene [NCIt concept]
- RPS6 wt Allele [NCIt concept]
- RPS6KA1 Gene [NCIt concept]
- RPS6KA1 wt Allele [NCIt concept]
- RPS6KA3 Gene [NCIt concept]
- RPS6KA3 Positive [NCIt concept]
- RPS6KA3 wt Allele [NCIt concept]
- RPS6KA6 Gene [NCIt concept]
- RPS6KA6 wt Allele [NCIt concept]
- RPS6KB1 Gene [NCIt concept]
- RPS6KB1 wt Allele [NCIt concept]
- RPS6KB2 Gene [NCIt concept]
- RPS6KB2 wt Allele [NCIt concept]
- RPSA Gene [NCIt concept]
- RPSA wt Allele [NCIt concept]
- RPTOR Gene [NCIt concept]
- RPTOR wt Allele [NCIt concept]
- RRAD Gene [NCIt concept]
- RRAD wt Allele [NCIt concept]
- RRAS Gene [NCIt concept]
- RRAS Gene Mutation [NCIt concept]
- RRAS wt Allele [NCIt concept]
- RRAS2 Gene Mutation [NCIt concept]
- RRM1 Gene [NCIt concept]
- RRM1 wt Allele [NCIt concept]
- RRM2 Gene [NCIt concept]
- RRM2 wt Allele [NCIt concept]
- RRM2B Gene [NCIt concept]
- RRM2B wt Allele [NCIt concept]
- RRP15 Gene [NCIt concept]
- RRP15 wt Allele [NCIt concept]
- RRP15-Like Protein [NCIt concept]
- RSK1-4 Inhibitor PMD-026 [NCIt concept]
- RSPO Gene Fusion Positive [NCIt concept]
- RSPO2 Gene [NCIt concept]
- RSPO2 Gene Fusion Positive [NCIt concept]
- RSPO2 Gene Mutation [NCIt concept]
- RSPO2 wt Allele [NCIt concept]
- RSPO3 Gene [NCIt concept]
- RSPO3 Gene Fusion Positive [NCIt concept]
- RSPO3 Gene Mutation [NCIt concept]
- RSPO3 wt Allele [NCIt concept]
- RSVPreF3/AS01E RSV Vaccine [NCIt concept]
- RTEL1 Gene [NCIt concept]
- RTEL1 Gene Mutation [NCIt concept]
- RTEL1 wt Allele [NCIt concept]
- RUNX1 Gene [NCIt concept]
- RUNX1 Gene Mutation [NCIt concept]
- RUNX1 wt Allele [NCIt concept]
- RUNX1/MECOM Fusion Gene [NCIt concept]
- RUNX1/MECOM Fusion Protein [NCIt concept]
- RUNX1/RUNX1T1 Fusion Gene [NCIt concept]
- RUNX1/RUNX1T1 Fusion Positive [NCIt concept]
- RUNX1/RUNX1T1 Fusion Protein [NCIt concept]
- RUNX1/SH3D19 Fusion Gene [NCIt concept]
- RUNX1/SH3D19 Fusion Protein [NCIt concept]
- RUNX1/YTHDF2 Fusion Gene [NCIt concept]
- RUNX1/ZFPM2 Fusion Gene [NCIt concept]
- RUNX1/ZFPM2 Fusion Protein [NCIt concept]
- RUNX1/ZNF687 Fusion Gene [NCIt concept]
- RUNX1/ZNF687 Fusion Protein [NCIt concept]
- RUNX1T1 Gene [NCIt concept]
- RUNX1T1 wt Allele [NCIt concept]
- RUNX2 Gene [NCIt concept]
- RUNX2 wt Allele [NCIt concept]
- RUNX3 Gene [NCIt concept]
- RUNX3 wt Allele [NCIt concept]
- RWD Domain-Containing Protein 3 [NCIt concept]
- RWDD3 Gene [NCIt concept]
- RWDD3 wt Allele [NCIt concept]
- RXR-alpha Inhibitor [NCIt concept]
- RXR-alpha Variant-targeting Agent NM6603 [NCIt concept]
- RXRA Gene [NCIt concept]
- RXRA wt Allele [NCIt concept]
- RXRG Gene [NCIt concept]
- RXRG wt Allele [NCIt concept]
- RYR1 Gene [NCIt concept]
- RYR1 wt Allele [NCIt concept]
- Rab GTPase-Binding Effector Protein 1 [NCIt concept]
- Rabies Antibody [NCIt concept]
- Rabies Vaccine [NCIt concept]
- Rabies-Specific IgG Antibody [NCIt concept]
- Rabies-Specific IgM Antibody [NCIt concept]
- Rabusertib [NCIt concept]
- Racemetyrosine [NCIt concept]
- Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus [NCIt concept]
- Racial Melanosis [NCIt concept]
- Radgocitabine [NCIt concept]
- Radial Aplasia-Thrombocytopenia Syndrome [NCIt concept]
- Radial Probe Endobronchial Ultrasound [NCIt concept]
- Radiation Boost [NCIt concept]
- Radiation Dosimeter Device [NCIt concept]
- Radiation Dosimetry [NCIt concept]
- Radiation Enteritis [NCIt concept]
- Radiation Fibrosis [NCIt concept]
- Radiation Retinopathy [NCIt concept]
- Radiation Shielding [NCIt concept]
- Radiation Therapy [NCIt concept]
- Radiation Therapy Patient [NCIt concept]
- Radiation Therapy Recipient [NCIt concept]
- Radiation Therapy Treatment Planning and Simulation [NCIt concept]
- Radiation Toxicity [NCIt concept]
- Radiation to Greater than 25 Percent of Bone Marrow [NCIt concept]
- Radiation-Induced Dermatitis [NCIt concept]
- Radiation-Induced Disorder [NCIt concept]
- Radiation-Induced Pneumonitis [NCIt concept]
- Radiation-Induced Xerostomia [NCIt concept]
- Radical Cystectomy [NCIt concept]
- Radical Hysterectomy [NCIt concept]
- Radical Mastectomy [NCIt concept]
- Radical Nephrectomy [NCIt concept]
- Radical Prostatectomy [NCIt concept]
- Radical Prostatectomy Patient [NCIt concept]
- Radical Retropubic Prostatectomy [NCIt concept]
- Radio Beacon Transponder System [NCIt concept]
- Radio Frequency Energy Therapy [NCIt concept]
- Radioactive Iodine [NCIt concept]
- Radioactive Iodine Therapy [NCIt concept]
- Radioactive Sodium Iodide [NCIt concept]
- Radioembolization [NCIt concept]
- Radiofrequency Ablation [NCIt concept]
- Radiofrequency-Guided Localization [NCIt concept]
- Radiograph [NCIt concept]
- Radiographic Examination [NCIt concept]
- Radioimmunotherapy [NCIt concept]
- Radioisotope [NCIt concept]
- Radioligand Therapy [NCIt concept]
- Radiologic Examination [NCIt concept]
- Radiologic Imaging Procedure [NCIt concept]
- Radiology, Treatment Planning [NCIt concept]
- Radiomammography [NCIt concept]
- Radionuclide Imaging [NCIt concept]
- Radiopharmaceutical Compound [NCIt concept]
- Radioprotection [NCIt concept]
- Radiosensitivity Index [NCIt concept]
- Radiosurgery [NCIt concept]
- Radium Ra 223 Dichloride [NCIt concept]
- Radon Test Kit [NCIt concept]
- Raf Kinase Inhibitor [NCIt concept]
- Raf/KSR/Mek1 Trimer [NCIt concept]
- Ragifilimab [NCIt concept]
- Ragulator Complex Protein LAMTOR5 [NCIt concept]
- Ral-GDS-Related Protein [NCIt concept]
- Ralaniten Acetate [NCIt concept]
- Ralimetinib Mesylate [NCIt concept]
- Raloxifene [NCIt concept]
- Raloxifene Hydrochloride [NCIt concept]
- Raltegravir Potassium [NCIt concept]
- Raltitrexed [NCIt concept]
- Raludotatug Deruxtecan [NCIt concept]
- Ralzapastotug [NCIt concept]
- Ramipril [NCIt concept]
- Ramucirumab [NCIt concept]
- Ran-Binding Protein 17 [NCIt concept]
- Random Periareolar Fine-Needle Aspiration [NCIt concept]
- Ranibizumab [NCIt concept]
- Ranolazine [NCIt concept]
- Ranosidenib [NCIt concept]
- Rap1 GTPase-GDP Dissociation Stimulator 1 [NCIt concept]
- Rapamycin-Insensitive Companion of mTOR [NCIt concept]
- Rapamycin-Polarized Th1/Tc1 Autologous T Lymphocytes [NCIt concept]
- Rapcabtagene Autoleucel [NCIt concept]
- Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation [NCIt concept]
- Rare Childhood Malignant Neoplasm [NCIt concept]
- Rare Malignant Solid Neoplasm [NCIt concept]
- Ras Association Domain-Containing Protein 1 [NCIt concept]
- Ras Association Domain-Containing Protein 5 [NCIt concept]
- Ras GTPase-Activating Protein 1 [NCIt concept]
- Ras GTPase-Activating Protein 2 [NCIt concept]
- Ras Inhibitor LUNA18 [NCIt concept]
- Ras Inhibitor RSC-1255 [NCIt concept]
- Ras Signaling Pathway [NCIt concept]
- Ras-Related C3 Botulinum Toxin Substrate 1 [NCIt concept]
- Ras-Related C3 Botulinum Toxin Substrate 2 [NCIt concept]
- Ras-Related C3 Botulinum Toxin Substrate 3 [NCIt concept]
- Ras-Related Protein M-Ras [NCIt concept]
- Ras-Related Protein R-Ras [NCIt concept]
- Ras-Related Protein Rab-23 [NCIt concept]
- Ras-Related Protein Rab-27A [NCIt concept]
- Ras-Related Protein Rab-40B [NCIt concept]
- Ras-Related Protein Rab-5C [NCIt concept]
- Ras-Related Protein Ral-A [NCIt concept]
- Ras-Related Protein Ral-B [NCIt concept]
- Ras-Specific Guanine Nucleotide-Releasing Factor 1 [NCIt concept]
- Rasburicase [NCIt concept]
- Rasdegafusp Alfa [NCIt concept]
- Ravoxertinib [NCIt concept]
- Ravtansine [NCIt concept]
- Ravulizumab [NCIt concept]
- Reactive Therapy [NCIt concept]
- Real Time PCR [NCIt concept]
- Real-Time Contrast-Enhanced Ultrasonography [NCIt concept]
- Real-Time Position-Tracking Imaging [NCIt concept]
- Rearrangement of 10p12.3 [NCIt concept]
- Rearrangement of 11p15 [NCIt concept]
- Rearrangement of 12p13.2 [NCIt concept]
- Rebastinib [NCIt concept]
- Rebastinib Tosylate [NCIt concept]
- Rebimastat [NCIt concept]
- Recent Thymic Emigrant [NCIt concept]
- Receptor Activity-Modifying Protein 2 [NCIt concept]
- Receptor Antagonist Therapy [NCIt concept]
- Receptor Tyrosine Kinase [NCIt concept]
- Receptor Tyrosine Kinase Gene [NCIt concept]
- Receptor Tyrosine Kinase Gene Amplification [NCIt concept]
- Receptor Tyrosine Kinase Gene Mutation [NCIt concept]
- Receptor Tyrosine Kinase Gene Rearrangement [NCIt concept]
- Receptor Tyrosine Kinase Inhibitor R1530 [NCIt concept]
- Receptor Tyrosine-Protein Kinase ErbB-4 [NCIt concept]
- Receptor Tyrosine-Protein Kinase erbB-2 [NCIt concept]
- Receptor Tyrosine-Protein Kinase erbB-2 Carboxyl Terminal Fragment [NCIt concept]
- Receptor Tyrosine-Protein Kinase erbB-3 [NCIt concept]
- Receptor-Activated SMAD [NCIt concept]
- Receptor-Interacting Serine/Threonine-Protein Kinase 1 [NCIt concept]
- Receptor-Type Tyrosine-Protein Kinase FLT3 [NCIt concept]
- Receptor-Type Tyrosine-Protein Phosphatase Beta [NCIt concept]
- Receptor-Type Tyrosine-Protein Phosphatase C [NCIt concept]
- Receptor-Type Tyrosine-Protein Phosphatase Delta [NCIt concept]
- Receptor-Type Tyrosine-Protein Phosphatase O [NCIt concept]
- Receptor-Type Tyrosine-Protein Phosphatase-Like N [NCIt concept]
- Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand [NCIt concept]
- Recombinant Albumin-binding IL-12 SON-1010 [NCIt concept]
- Recombinant Anti-WT1 Immunotherapeutic GSK2302024A [NCIt concept]
- Recombinant Attenuated Salmonella typhimurium Expressing IL-2 [NCIt concept]
- Recombinant Bacterial Minicells VAX014 [NCIt concept]
- Recombinant EphB4-HSA Fusion Protein [NCIt concept]
- Recombinant Fowlpox GM-CSF Vaccine Adjuvant [NCIt concept]
- Recombinant Fowlpox-B7.1 Vaccine [NCIt concept]
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine [NCIt concept]
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine [NCIt concept]
- Recombinant Fowlpox-TRICOM Vaccine [NCIt concept]
- Recombinant Human Apolipoprotein(a) Kringle V MG1102 [NCIt concept]
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine [NCIt concept]
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine [NCIt concept]
- Recombinant Human Hyaluronidase [NCIt concept]
- Recombinant Human Hyaluronidase PH20 Antibody [NCIt concept]
- Recombinant Human Hyaluronidase and Pembrolizumab [NCIt concept]
- Recombinant Human Interleukin-15 [NCIt concept]
- Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Recombinant Human Papillomavirus Bivalent Vaccine [NCIt concept]
- Recombinant Human Papillomavirus Nonavalent Vaccine [NCIt concept]
- Recombinant Interferon Alfa [NCIt concept]
- Recombinant Interferon Alfa-2a [NCIt concept]
- Recombinant Interferon Alfa-2b [NCIt concept]
- Recombinant Interferon Beta [NCIt concept]
- Recombinant Interferon Gamma [NCIt concept]
- Recombinant Interleukin-2 [NCIt concept]
- Recombinant Interleukin-6 [NCIt concept]
- Recombinant Interleukin-7 [NCIt concept]
- Recombinant Luteinizing Hormone [NCIt concept]
- Recombinant MAGE-3.1 Antigen [NCIt concept]
- Recombinant Modified Vaccinia Ankara-5T4 Vaccine [NCIt concept]
- Recombinant Newcastle Disease Virus-encoding Interleukin-12 MEDI9253 [NCIt concept]
- Recombinant Newcastle Disease Virus-encoding Interleukin-12 V938 [NCIt concept]
- Recombinant Oxytocin [NCIt concept]
- Recombinant Parathyroid Hormone [NCIt concept]
- Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 [NCIt concept]
- Recombinant Super-compound Interferon [NCIt concept]
- Recombinant Thyrotropin Alfa [NCIt concept]
- Recombinant Tumor Necrosis Factor Family Protein [NCIt concept]
- Recombinant Vaccinia PSA Vaccine [NCIt concept]
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine [NCIt concept]
- Recombinant Vaccinia-MUC-1 Vaccine [NCIt concept]
- Recombinant Vaccinia-TRICOM Vaccine [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta and Tyrosinase Related Protein 1 [NCIt concept]
- Recombining Binding Protein Suppressor of Hairless [NCIt concept]
- Reconstructive Surgery [NCIt concept]
- Recreational Therapy [NCIt concept]
- Recruitment [NCIt concept]
- Rectal Adenocarcinoma [NCIt concept]
- Rectal Adenosquamous Carcinoma [NCIt concept]
- Rectal Carcinoma [NCIt concept]
- Rectal Catheter [NCIt concept]
- Rectal Epithelioid Cell Melanoma [NCIt concept]
- Rectal Mucinous Adenocarcinoma [NCIt concept]
- Rectal Neuroendocrine Tumor G2 [NCIt concept]
- Rectal Sarcomatoid Carcinoma [NCIt concept]
- Rectal Signet Ring Cell Adenocarcinoma [NCIt concept]
- Rectal Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Rectal Squamous Cell Carcinoma [NCIt concept]
- Rectal Surgery [NCIt concept]
- Rectal Undifferentiated Carcinoma [NCIt concept]
- Rectosigmoid Adenocarcinoma [NCIt concept]
- Rectosigmoid Carcinoma [NCIt concept]
- Recurrent AL Amyloidosis [NCIt concept]
- Recurrent ALK-Positive Large B-Cell Lymphoma [NCIt concept]
- Recurrent Abdominal Neuroendocrine Neoplasm [NCIt concept]
- Recurrent Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Recurrent Acral Lentiginous Melanoma [NCIt concept]
- Recurrent Acral Melanoma [NCIt concept]
- Recurrent Acute Bilineal Leukemia [NCIt concept]
- Recurrent Acute Biphenotypic Leukemia [NCIt concept]
- Recurrent Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Recurrent Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Recurrent Acute Myeloid Leukemia [NCIt concept]
- Recurrent Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Recurrent Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Recurrent Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Recurrent Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged [NCIt concept]
- Recurrent Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia [NCIt concept]
- Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia [NCIt concept]
- Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Recurrent Acute Pancreatitis [NCIt concept]
- Recurrent Acute Undifferentiated Leukemia [NCIt concept]
- Recurrent Adamantinomatous Craniopharyngioma [NCIt concept]
- Recurrent Adenocarcinoma [NCIt concept]
- Recurrent Adenoid Cystic Carcinoma [NCIt concept]
- Recurrent Adenovirus Infection [NCIt concept]
- Recurrent Adnexal Carcinoma [NCIt concept]
- Recurrent Adrenal Cortical Carcinoma [NCIt concept]
- Recurrent Adrenal Gland Pheochromocytoma [NCIt concept]
- Recurrent Adult Acute Lymphoblastic Leukemia [NCIt concept]
- Recurrent Adult Acute Myeloid Leukemia [NCIt concept]
- Recurrent Adult Brain Neoplasm [NCIt concept]
- Recurrent Adult Burkitt Lymphoma [NCIt concept]
- Recurrent Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Recurrent Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Recurrent Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Recurrent Adult Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Adult Hepatocellular Carcinoma [NCIt concept]
- Recurrent Adult Hodgkin Lymphoma [NCIt concept]
- Recurrent Adult Immunoblastic Lymphoma [NCIt concept]
- Recurrent Adult Liver Carcinoma [NCIt concept]
- Recurrent Adult Lymphoblastic Lymphoma [NCIt concept]
- Recurrent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Adult Soft Tissue Sarcoma [NCIt concept]
- Recurrent Adult Spinal Cord Neoplasm [NCIt concept]
- Recurrent Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Recurrent Advanced Hepatocellular Carcinoma [NCIt concept]
- Recurrent Advanced Malignant Solid Neoplasm [NCIt concept]
- Recurrent Advanced Phase Myeloproliferative Neoplasm [NCIt concept]
- Recurrent Aggressive Adult Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Aggressive NK-Cell Leukemia [NCIt concept]
- Recurrent Alveolar Rhabdomyosarcoma [NCIt concept]
- Recurrent Anal Canal Carcinoma [NCIt concept]
- Recurrent Anal Canal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Anal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Anaplastic (Malignant) Meningioma [NCIt concept]
- Recurrent Anaplastic Astrocytoma [NCIt concept]
- Recurrent Anaplastic Astrocytoma, IDH-Wildtype [NCIt concept]
- Recurrent Anaplastic Ependymoma [NCIt concept]
- Recurrent Anaplastic Ganglioglioma [NCIt concept]
- Recurrent Anaplastic Large Cell Lymphoma [NCIt concept]
- Recurrent Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Recurrent Anterior Pituitary Gland Neoplasm [NCIt concept]
- Recurrent Aplastic Anemia [NCIt concept]
- Recurrent Appendix Adenocarcinoma [NCIt concept]
- Recurrent Astrocytic Tumor [NCIt concept]
- Recurrent Astrocytoma [NCIt concept]
- Recurrent Astrocytoma, IDH-Mutant [NCIt concept]
- Recurrent Astrocytoma, IDH-Mutant, Grade 3 [NCIt concept]
- Recurrent Astrocytoma, IDH-Mutant, Grade 4 [NCIt concept]
- Recurrent Atypical Meningioma [NCIt concept]
- Recurrent Atypical Teratoid/Rhabdoid Tumor [NCIt concept]
- Recurrent B Acute Lymphoblastic Leukemia [NCIt concept]
- Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like [NCIt concept]
- Recurrent B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative [NCIt concept]
- Recurrent B Lymphoblastic Lymphoma [NCIt concept]
- Recurrent B-Cell Malignant Neoplasm [NCIt concept]
- Recurrent B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent B-Cell Prolymphocytic Leukemia [NCIt concept]
- Recurrent BRCA Hereditary Ovarian Carcinoma [NCIt concept]
- Recurrent Basal Cell Carcinoma [NCIt concept]
- Recurrent Bile Duct Carcinoma [NCIt concept]
- Recurrent Biliary Tract Carcinoma [NCIt concept]
- Recurrent Bladder Carcinoma [NCIt concept]
- Recurrent Bladder Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Bladder Urothelial Carcinoma [NCIt concept]
- Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm [NCIt concept]
- Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor [NCIt concept]
- Recurrent Brain Glioblastoma [NCIt concept]
- Recurrent Breast Adenocarcinoma [NCIt concept]
- Recurrent Breast Carcinoma [NCIt concept]
- Recurrent Breast Ductal Carcinoma In Situ [NCIt concept]
- Recurrent Breast Implant-Associated Anaplastic Large Cell Lymphoma [NCIt concept]
- Recurrent Breast Lymphoma [NCIt concept]
- Recurrent Breast Medullary Carcinoma [NCIt concept]
- Recurrent Breast Mixed Carcinoma [NCIt concept]
- Recurrent Breast Mucinous Carcinoma [NCIt concept]
- Recurrent Breast Papillary Carcinoma [NCIt concept]
- Recurrent Breast Tubular Carcinoma [NCIt concept]
- Recurrent Bronchogenic Carcinoma [NCIt concept]
- Recurrent Burkitt Leukemia [NCIt concept]
- Recurrent Burkitt Lymphoma [NCIt concept]
- Recurrent Carcinoma [NCIt concept]
- Recurrent Carcinoma of Unknown Primary [NCIt concept]
- Recurrent Castration-Sensitive Prostate Carcinoma [NCIt concept]
- Recurrent Central Nervous System Lymphoma [NCIt concept]
- Recurrent Central Nervous System Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Centroblastic Lymphoma [NCIt concept]
- Recurrent Cervical Adenocarcinoma [NCIt concept]
- Recurrent Cervical Adenosquamous Carcinoma [NCIt concept]
- Recurrent Cervical Carcinoma [NCIt concept]
- Recurrent Cervical Non-Squamous Cell Carcinoma [NCIt concept]
- Recurrent Cervical Squamous Cell Carcinoma [NCIt concept]
- Recurrent Childhood Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Recurrent Childhood Acute Lymphoblastic Leukemia [NCIt concept]
- Recurrent Childhood Acute Myeloid Leukemia [NCIt concept]
- Recurrent Childhood Anaplastic Astrocytoma [NCIt concept]
- Recurrent Childhood Anaplastic Astrocytoma, Not Otherwise Specified [NCIt concept]
- Recurrent Childhood Anaplastic Ependymoma [NCIt concept]
- Recurrent Childhood Anaplastic Large Cell Lymphoma [NCIt concept]
- Recurrent Childhood Anaplastic Oligoastrocytoma [NCIt concept]
- Recurrent Childhood Anaplastic Oligodendroglioma [NCIt concept]
- Recurrent Childhood Astrocytic Tumor [NCIt concept]
- Recurrent Childhood B Acute Lymphoblastic Leukemia [NCIt concept]
- Recurrent Childhood B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Childhood Brain Neoplasm [NCIt concept]
- Recurrent Childhood Brain Stem Glioma [NCIt concept]
- Recurrent Childhood Burkitt Lymphoma [NCIt concept]
- Recurrent Childhood Central Nervous System Embryonal Tumor [NCIt concept]
- Recurrent Childhood Central Nervous System Neoplasm [NCIt concept]
- Recurrent Childhood Cerebellar Astrocytoma [NCIt concept]
- Recurrent Childhood Cerebral Astrocytoma [NCIt concept]
- Recurrent Childhood Diffuse Astrocytoma [NCIt concept]
- Recurrent Childhood Diffuse Midline Glioma [NCIt concept]
- Recurrent Childhood Ependymoma [NCIt concept]
- Recurrent Childhood Fibrillary Astrocytoma [NCIt concept]
- Recurrent Childhood Fibrolamellar Carcinoma [NCIt concept]
- Recurrent Childhood Gemistocytic Astrocytoma [NCIt concept]
- Recurrent Childhood Giant Cell Glioblastoma [NCIt concept]
- Recurrent Childhood Glioblastoma [NCIt concept]
- Recurrent Childhood Gliomatosis Cerebri [NCIt concept]
- Recurrent Childhood Gliosarcoma [NCIt concept]
- Recurrent Childhood Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Childhood Hepatocellular Carcinoma [NCIt concept]
- Recurrent Childhood Hodgkin Lymphoma [NCIt concept]
- Recurrent Childhood Kidney Neoplasm [NCIt concept]
- Recurrent Childhood Large Cell Lymphoma [NCIt concept]
- Recurrent Childhood Leukemia [NCIt concept]
- Recurrent Childhood Low Grade Glioma [NCIt concept]
- Recurrent Childhood Lymphoblastic Lymphoma [NCIt concept]
- Recurrent Childhood Lymphoma [NCIt concept]
- Recurrent Childhood Malignant Germ Cell Tumor [NCIt concept]
- Recurrent Childhood Malignant Glioma [NCIt concept]
- Recurrent Childhood Malignant Liver Neoplasm [NCIt concept]
- Recurrent Childhood Malignant Neoplasm [NCIt concept]
- Recurrent Childhood Malignant Solid Neoplasm [NCIt concept]
- Recurrent Childhood Medulloblastoma [NCIt concept]
- Recurrent Childhood Mixed Phenotype Acute Leukemia [NCIt concept]
- Recurrent Childhood Myelodysplastic Syndrome [NCIt concept]
- Recurrent Childhood Neuroblastoma [NCIt concept]
- Recurrent Childhood Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Childhood Oligoastrocytoma [NCIt concept]
- Recurrent Childhood Oligodendroglioma [NCIt concept]
- Recurrent Childhood Optic Nerve Glioma [NCIt concept]
- Recurrent Childhood Osteosarcoma [NCIt concept]
- Recurrent Childhood Pilocytic Astrocytoma [NCIt concept]
- Recurrent Childhood Pilomyxoid Astrocytoma [NCIt concept]
- Recurrent Childhood Pineoblastoma [NCIt concept]
- Recurrent Childhood Pleomorphic Xanthoastrocytoma [NCIt concept]
- Recurrent Childhood Protoplasmic Astrocytoma [NCIt concept]
- Recurrent Childhood Rhabdomyosarcoma [NCIt concept]
- Recurrent Childhood Soft Tissue Sarcoma [NCIt concept]
- Recurrent Childhood Spinal Cord Neoplasm [NCIt concept]
- Recurrent Childhood Subependymal Giant Cell Astrocytoma [NCIt concept]
- Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified [NCIt concept]
- Recurrent Childhood T Acute Lymphoblastic Leukemia [NCIt concept]
- Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Recurrent Childhood Visual Pathway Glioma [NCIt concept]
- Recurrent Chordoma [NCIt concept]
- Recurrent Chronic Lymphocytic Leukemia [NCIt concept]
- Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Recurrent Chronic Myelomonocytic Leukemia [NCIt concept]
- Recurrent Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Recurrent Classic Hodgkin Lymphoma [NCIt concept]
- Recurrent Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Recurrent Colon Adenocarcinoma [NCIt concept]
- Recurrent Colon Carcinoma [NCIt concept]
- Recurrent Colorectal Carcinoma [NCIt concept]
- Recurrent Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Recurrent Combined Thymus Epithelial Neoplasm [NCIt concept]
- Recurrent Conjunctival Melanoma [NCIt concept]
- Recurrent Craniopharyngioma [NCIt concept]
- Recurrent Cutaneous Melanoma [NCIt concept]
- Recurrent Cutaneous Melanoma of the Extremity [NCIt concept]
- Recurrent Cytomegalovirus Infection [NCIt concept]
- Recurrent Dedifferentiated Chordoma [NCIt concept]
- Recurrent Dedifferentiated Liposarcoma [NCIt concept]
- Recurrent Desmoid Fibromatosis [NCIt concept]
- Recurrent Desmoplastic Small Round Cell Tumor [NCIt concept]
- Recurrent Diffuse Astrocytoma [NCIt concept]
- Recurrent Diffuse Glioma [NCIt concept]
- Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Recurrent Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Recurrent Diffuse Large B-Cell Lymphoma [NCIt concept]
- Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type [NCIt concept]
- Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation [NCIt concept]
- Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type [NCIt concept]
- Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Recurrent Diffuse Midline Glioma [NCIt concept]
- Recurrent Diffuse Midline Glioma, H3 K27-Altered [NCIt concept]
- Recurrent Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Recurrent Digestive System Carcinoma [NCIt concept]
- Recurrent Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Recurrent Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Recurrent Disease [NCIt concept]
- Recurrent Distal Cholangiocarcinoma [NCIt concept]
- Recurrent EBV Infection [NCIt concept]
- Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Recurrent EBV-Related Lymphoma [NCIt concept]
- Recurrent EBV-Related Lymphoproliferative Disease with Primary Immunodeficiency [NCIt concept]
- Recurrent Ectomesenchymoma [NCIt concept]
- Recurrent Endocrine Carcinoma [NCIt concept]
- Recurrent Endogenous Cushing Syndrome [NCIt concept]
- Recurrent Endometrial Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Adenosquamous Carcinoma [NCIt concept]
- Recurrent Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Dedifferentiated Carcinoma [NCIt concept]
- Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Mucinous Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Serous Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Squamous Cell Carcinoma [NCIt concept]
- Recurrent Endometrial Transitional Cell Carcinoma [NCIt concept]
- Recurrent Endometrial Undifferentiated Carcinoma [NCIt concept]
- Recurrent Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Recurrent Ependymoma [NCIt concept]
- Recurrent Epithelioid Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Recurrent Epithelioid Mesothelioma [NCIt concept]
- Recurrent Erdheim-Chester Disease [NCIt concept]
- Recurrent Esophageal Adenocarcinoma [NCIt concept]
- Recurrent Esophageal Anastomotic Stricture [NCIt concept]
- Recurrent Esophageal Carcinoma [NCIt concept]
- Recurrent Esophageal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Essential Thrombocythemia [NCIt concept]
- Recurrent Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Recurrent Extracranial Malignant Solid Neoplasm [NCIt concept]
- Recurrent Extragonadal Seminoma [NCIt concept]
- Recurrent Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Recurrent Extrahepatic Cholangiocarcinoma [NCIt concept]
- Recurrent Extramammary Paget Disease [NCIt concept]
- Recurrent Extranodal Diffuse Large B-cell Lymphoma [NCIt concept]
- Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Recurrent Extrapulmonary Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Extrapulmonary Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Extrarenal Rhabdoid Tumor [NCIt concept]
- Recurrent Extrarenal Rhabdoid Tumor of the Ovary [NCIt concept]
- Recurrent Fallopian Tube Carcinoma [NCIt concept]
- Recurrent Fallopian Tube Carcinosarcoma [NCIt concept]
- Recurrent Fallopian Tube Clear Cell Adenocarcinoma [NCIt concept]
- Recurrent Fallopian Tube Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Fallopian Tube Mucinous Adenocarcinoma [NCIt concept]
- Recurrent Fallopian Tube Transitional Cell Carcinoma [NCIt concept]
- Recurrent Fallopian Tube Undifferentiated Carcinoma [NCIt concept]
- Recurrent Fibroblastic Reticular Cell Sarcoma [NCIt concept]
- Recurrent Fibrolamellar Carcinoma [NCIt concept]
- Recurrent Fibrosarcoma [NCIt concept]
- Recurrent Follicular Helper T-Cell Lymphoma [NCIt concept]
- Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type [NCIt concept]
- Recurrent Follicular Helper T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Recurrent Follicular Lymphoma [NCIt concept]
- Recurrent Fungal Infection [NCIt concept]
- Recurrent Gallbladder Carcinoma [NCIt concept]
- Recurrent Gangliocytoma [NCIt concept]
- Recurrent Ganglioneuroblastoma [NCIt concept]
- Recurrent Gastric Adenocarcinoma [NCIt concept]
- Recurrent Gastric Carcinoma [NCIt concept]
- Recurrent Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Recurrent Gastroesophageal Junction Carcinoma [NCIt concept]
- Recurrent Gastrointestinal Stromal Tumor [NCIt concept]
- Recurrent Gestational Trophoblastic Tumor [NCIt concept]
- Recurrent Giant Cell Glioblastoma [NCIt concept]
- Recurrent Glioblastoma [NCIt concept]
- Recurrent Glioblastoma, IDH-Wildtype [NCIt concept]
- Recurrent Glioma [NCIt concept]
- Recurrent Gliomatosis Cerebri [NCIt concept]
- Recurrent Glioneuronal and Neuronal Tumors [NCIt concept]
- Recurrent Grade 1 Follicular Lymphoma [NCIt concept]
- Recurrent Grade 1 Meningioma [NCIt concept]
- Recurrent Grade 2 Follicular Lymphoma [NCIt concept]
- Recurrent Grade 3 Follicular Lymphoma [NCIt concept]
- Recurrent Grade 3a Follicular Lymphoma [NCIt concept]
- Recurrent Grade I Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Grade II Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Gray-Zone Lymphoma [NCIt concept]
- Recurrent HER2-Low Breast Carcinoma [NCIt concept]
- Recurrent HER2-Negative Breast Carcinoma [NCIt concept]
- Recurrent HER2-Positive Breast Carcinoma [NCIt concept]
- Recurrent HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Recurrent HIV-Related Lymphoproliferative Disorder [NCIt concept]
- Recurrent Hairy Cell Leukemia [NCIt concept]
- Recurrent Hairy Cell Leukemia Variant [NCIt concept]
- Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Recurrent Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Recurrent Hematologic Malignancy [NCIt concept]
- Recurrent Hemophagocytic Lymphohistiocytosis [NCIt concept]
- Recurrent Hepatoblastoma [NCIt concept]
- Recurrent Hepatocellular Carcinoma [NCIt concept]
- Recurrent Hereditary Thyroid Gland Medullary Carcinoma [NCIt concept]
- Recurrent High Grade B-Cell Lymphoma [NCIt concept]
- Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements [NCIt concept]
- Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements [NCIt concept]
- Recurrent High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements [NCIt concept]
- Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements [NCIt concept]
- Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Recurrent High Risk Chronic Myelomonocytic Leukemia [NCIt concept]
- Recurrent High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Recurrent Higher Risk Myelodysplastic Syndrome [NCIt concept]
- Recurrent Histiocytic Sarcoma [NCIt concept]
- Recurrent Histiocytic and Dendritic Cell Neoplasm [NCIt concept]
- Recurrent Hodgkin Lymphoma [NCIt concept]
- Recurrent Hormone Receptor-Negative Breast Carcinoma [NCIt concept]
- Recurrent Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Recurrent Human Papillomavirus-Related Malignant Neoplasm [NCIt concept]
- Recurrent Hypopharyngeal Carcinoma [NCIt concept]
- Recurrent Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Immunoblastic Lymphoma [NCIt concept]
- Recurrent Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Indolent B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Indolent Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Indolent T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Interdigitating Dendritic Cell Sarcoma [NCIt concept]
- Recurrent Intracranial Neoplasm [NCIt concept]
- Recurrent Intrahepatic Cholangiocarcinoma [NCIt concept]
- Recurrent Intravascular Large B-Cell Lymphoma [NCIt concept]
- Recurrent Kaposi Sarcoma [NCIt concept]
- Recurrent Kidney Medullary Carcinoma [NCIt concept]
- Recurrent Langerhans Cell Histiocytosis [NCIt concept]
- Recurrent Large B-Cell Lymphoma with IRF4 Rearrangement [NCIt concept]
- Recurrent Large Pleural Effusion [NCIt concept]
- Recurrent Laryngeal Carcinoma [NCIt concept]
- Recurrent Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Laryngeal Verrucous Carcinoma [NCIt concept]
- Recurrent Lip Basal Cell Carcinoma [NCIt concept]
- Recurrent Lip and Oral Cavity Carcinoma [NCIt concept]
- Recurrent Lip and Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Recurrent Liver Carcinoma [NCIt concept]
- Recurrent Low Grade Astrocytoma [NCIt concept]
- Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma [NCIt concept]
- Recurrent Lung Carcinoma [NCIt concept]
- Recurrent Lung Non-Small Cell Carcinoma [NCIt concept]
- Recurrent Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Recurrent Lung Small Cell Carcinoma [NCIt concept]
- Recurrent Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma [NCIt concept]
- Recurrent Lymphoma [NCIt concept]
- Recurrent Lymphoplasmacytic Lymphoma [NCIt concept]
- Recurrent Lymphoproliferative Disorder [NCIt concept]
- Recurrent MGMT-Methylated Glioblastoma [NCIt concept]
- Recurrent Malignant Abdominal Neoplasm [NCIt concept]
- Recurrent Malignant Bone Neoplasm [NCIt concept]
- Recurrent Malignant Brain Neoplasm [NCIt concept]
- Recurrent Malignant Breast Neoplasm [NCIt concept]
- Recurrent Malignant Choroid Plexus Neoplasm [NCIt concept]
- Recurrent Malignant Digestive System Neoplasm [NCIt concept]
- Recurrent Malignant Extragonadal Germ Cell Tumor [NCIt concept]
- Recurrent Malignant Extragonadal Nongerminomatous Germ Cell Tumor [NCIt concept]
- Recurrent Malignant Female Reproductive System Neoplasm [NCIt concept]
- Recurrent Malignant Genitourinary System Neoplasm [NCIt concept]
- Recurrent Malignant Germ Cell Tumor [NCIt concept]
- Recurrent Malignant Glioma [NCIt concept]
- Recurrent Malignant Head and Neck Mucosal Neoplasm [NCIt concept]
- Recurrent Malignant Male Reproductive System Neoplasm [NCIt concept]
- Recurrent Malignant Mastocytosis [NCIt concept]
- Recurrent Malignant Mesothelioma [NCIt concept]
- Recurrent Malignant Myoepithelioma [NCIt concept]
- Recurrent Malignant Neoplasm of Multiple Primary Sites [NCIt concept]
- Recurrent Malignant Neoplasm of Unknown Primary [NCIt concept]
- Recurrent Malignant Nongerminomatous Germ Cell Tumor [NCIt concept]
- Recurrent Malignant Oral Neoplasm [NCIt concept]
- Recurrent Malignant Ovarian Granulosa Cell Tumor [NCIt concept]
- Recurrent Malignant Pharyngeal Neoplasm [NCIt concept]
- Recurrent Malignant Retroperitoneal Neoplasm [NCIt concept]
- Recurrent Malignant Scrotal Neoplasm [NCIt concept]
- Recurrent Malignant Skin Neoplasm [NCIt concept]
- Recurrent Malignant Soft Tissue Neoplasm [NCIt concept]
- Recurrent Malignant Solid Neoplasm [NCIt concept]
- Recurrent Malignant Spermatic Cord Neoplasm [NCIt concept]
- Recurrent Malignant Supratentorial Neoplasm [NCIt concept]
- Recurrent Malignant Testicular Germ Cell Tumor [NCIt concept]
- Recurrent Malignant Thyroid Gland Neoplasm [NCIt concept]
- Recurrent Malignant Urinary System Neoplasm [NCIt concept]
- Recurrent Malignant Uterine Corpus Neoplasm [NCIt concept]
- Recurrent Mantle Cell Lymphoma [NCIt concept]
- Recurrent Marginal Zone Lymphoma [NCIt concept]
- Recurrent Mature T-Cell and NK-Cell Neoplasm [NCIt concept]
- Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Medulloblastoma, WNT-Activated [NCIt concept]
- Recurrent Melanoma [NCIt concept]
- Recurrent Meningioma [NCIt concept]
- Recurrent Merkel Cell Carcinoma [NCIt concept]
- Recurrent Mesonephric Adenocarcinoma [NCIt concept]
- Recurrent Metastatic Digestive System Carcinoma [NCIt concept]
- Recurrent Metastatic Gastric Carcinoma [NCIt concept]
- Recurrent Metastatic Lung Osteosarcoma [NCIt concept]
- Recurrent Metastatic Malignant Neoplasm [NCIt concept]
- Recurrent Metastatic Malignant Neoplasm in the Leptomeninges [NCIt concept]
- Recurrent Metastatic Melanoma [NCIt concept]
- Recurrent Metastatic Merkel Cell Carcinoma [NCIt concept]
- Recurrent Metastatic Skin Squamous Cell Carcinoma [NCIt concept]
- Recurrent Microsatellite Stable Colorectal Carcinoma [NCIt concept]
- Recurrent Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Recurrent Mixed Phenotype Acute Leukemia [NCIt concept]
- Recurrent Moderate-Severe Chronic Graft Versus Host Disease [NCIt concept]
- Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma [NCIt concept]
- Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Recurrent Mucosal Melanoma [NCIt concept]
- Recurrent Multicentric Castleman Disease [NCIt concept]
- Recurrent Multinodular and Vacuolated Neuronal Tumor [NCIt concept]
- Recurrent Multiple Myeloma [NCIt concept]
- Recurrent Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Recurrent Mycosis Fungoides [NCIt concept]
- Recurrent Mycosis Fungoides and Sezary Syndrome [NCIt concept]
- Recurrent Myelodysplastic Syndrome [NCIt concept]
- Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Recurrent Myelodysplastic/Myeloproliferative Neoplasm [NCIt concept]
- Recurrent Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Recurrent Myelofibrosis [NCIt concept]
- Recurrent Myeloproliferative Neoplasm [NCIt concept]
- Recurrent Myxofibrosarcoma [NCIt concept]
- Recurrent Myxoid Glioneuronal Tumor [NCIt concept]
- Recurrent NK-Cell Lymphoma, Unclassifiable [NCIt concept]
- Recurrent Nasal Cavity Squamous Cell Carcinoma [NCIt concept]
- Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Recurrent Nasopharyngeal Carcinoma [NCIt concept]
- Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Recurrent Nasopharyngeal Non-Keratinizing Carcinoma [NCIt concept]
- Recurrent Nasopharyngeal Undifferentiated Carcinoma [NCIt concept]
- Recurrent Neck Squamous Cell Carcinoma of Unknown Primary [NCIt concept]
- Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Recurrent Neuroblastoma [NCIt concept]
- Recurrent Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Neurofibromatosis Type 1 [NCIt concept]
- Recurrent Nodal Marginal Zone Lymphoma [NCIt concept]
- Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Recurrent Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Recurrent Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade [NCIt concept]
- Recurrent Non-Muscle Invasive Bladder Carcinoma [NCIt concept]
- Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma (NMIBC) with a Prior History of Low or Intermediate Risk NMIBC [NCIt concept]
- Recurrent Ocular Melanoma [NCIt concept]
- Recurrent Olfactory Neuroblastoma [NCIt concept]
- Recurrent Oligodendroglioma [NCIt concept]
- Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted [NCIt concept]
- Recurrent Oral Cavity Adenoid Cystic Carcinoma [NCIt concept]
- Recurrent Oral Cavity Mucoepidermoid Carcinoma [NCIt concept]
- Recurrent Oral Cavity Verrucous Carcinoma [NCIt concept]
- Recurrent Orbital Squamous Cell Carcinoma [NCIt concept]
- Recurrent Oropharyngeal Carcinoma [NCIt concept]
- Recurrent Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Oropharyngeal Undifferentiated Carcinoma [NCIt concept]
- Recurrent Osteosarcoma [NCIt concept]
- Recurrent Ovarian Carcinoma [NCIt concept]
- Recurrent Ovarian Carcinosarcoma [NCIt concept]
- Recurrent Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Germ Cell Tumor [NCIt concept]
- Recurrent Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Ovarian Seromucinous Carcinoma [NCIt concept]
- Recurrent Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Recurrent Ovarian Undifferentiated Carcinoma [NCIt concept]
- Recurrent Pancreatic Adenocarcinoma [NCIt concept]
- Recurrent Pancreatic Carcinoma [NCIt concept]
- Recurrent Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Paraganglioma [NCIt concept]
- Recurrent Paranasal Sinus Squamous Cell Carcinoma [NCIt concept]
- Recurrent Parathyroid Gland Carcinoma [NCIt concept]
- Recurrent Penile Carcinoma [NCIt concept]
- Recurrent Periorbital Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Recurrent Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Recurrent Pharyngeal Carcinoma [NCIt concept]
- Recurrent Pharyngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Pilocytic Astrocytoma [NCIt concept]
- Recurrent Pineal Parenchymal Cell Neoplasm [NCIt concept]
- Recurrent Plasmablastic Lymphoma [NCIt concept]
- Recurrent Platinum-Resistant Cervical Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Endometrial Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Fallopian Tube Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Primary Peritoneal Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Platinum-Sensitive Endometrial Carcinoma [NCIt concept]
- Recurrent Platinum-Sensitive Fallopian Tube Carcinoma [NCIt concept]
- Recurrent Platinum-Sensitive Ovarian Carcinoma [NCIt concept]
- Recurrent Platinum-Sensitive Primary Peritoneal Carcinoma [NCIt concept]
- Recurrent Polycythemia Vera [NCIt concept]
- Recurrent Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase [NCIt concept]
- Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Recurrent Polymorphous Low Grade Neuroepithelial Tumor of the Young [NCIt concept]
- Recurrent Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Recurrent Post-Essential Thrombocythemia Myelofibrosis [NCIt concept]
- Recurrent Primary Amyloidosis [NCIt concept]
- Recurrent Primary Bone Lymphoma [NCIt concept]
- Recurrent Primary Central Nervous System Lymphoma [NCIt concept]
- Recurrent Primary Central Nervous System Neoplasm [NCIt concept]
- Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma [NCIt concept]
- Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma [NCIt concept]
- Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type [NCIt concept]
- Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma [NCIt concept]
- Recurrent Primary Cutaneous Lymphoma [NCIt concept]
- Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Primary Effusion Lymphoma [NCIt concept]
- Recurrent Primary Malignant Central Nervous System Neoplasm [NCIt concept]
- Recurrent Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Recurrent Primary Myelofibrosis [NCIt concept]
- Recurrent Primary Peritoneal Carcinoma [NCIt concept]
- Recurrent Primary Peritoneal Carcinosarcoma [NCIt concept]
- Recurrent Primary Peritoneal Clear Cell Adenocarcinoma [NCIt concept]
- Recurrent Primary Peritoneal Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma [NCIt concept]
- Recurrent Primary Peritoneal Serous Adenocarcinoma [NCIt concept]
- Recurrent Primary Peritoneal Transitional Cell Carcinoma [NCIt concept]
- Recurrent Primary Peritoneal Undifferentiated Carcinoma [NCIt concept]
- Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma [NCIt concept]
- Recurrent Primary Vitreoretinal Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Progesterone Receptor-Positive Breast Carcinoma [NCIt concept]
- Recurrent Prostate Adenocarcinoma [NCIt concept]
- Recurrent Prostate Carcinoma [NCIt concept]
- Recurrent Prostate Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Pseudomyxoma Peritonei [NCIt concept]
- Recurrent Rectal Adenocarcinoma [NCIt concept]
- Recurrent Rectal Carcinoma [NCIt concept]
- Recurrent Rectosigmoid Carcinoma [NCIt concept]
- Recurrent Renal Cell Carcinoma [NCIt concept]
- Recurrent Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Recurrent Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Recurrent Respiratory Papillomatosis [NCIt concept]
- Recurrent Retinoblastoma [NCIt concept]
- Recurrent Rhabdoid Tumor [NCIt concept]
- Recurrent Rhabdoid Tumor of the Kidney [NCIt concept]
- Recurrent Rosai-Dorfman-Destombes Disease [NCIt concept]
- Recurrent Salivary Gland Adenocarcinoma, Not Otherwise Specified [NCIt concept]
- Recurrent Salivary Gland Carcinoma [NCIt concept]
- Recurrent Salivary Gland Mucoepidermoid Carcinoma [NCIt concept]
- Recurrent Salivary Gland Squamous Cell Carcinoma [NCIt concept]
- Recurrent Sarcoma of the Extremity [NCIt concept]
- Recurrent Schwannoma [NCIt concept]
- Recurrent Sclerodermatous Graft Versus Host Disease [NCIt concept]
- Recurrent Sebaceous Carcinoma [NCIt concept]
- Recurrent Secondary Acute Myeloid Leukemia [NCIt concept]
- Recurrent Secondary Diffuse Large B-Cell Lymphoma of the Central Nervous System [NCIt concept]
- Recurrent Severe Aplastic Anemia [NCIt concept]
- Recurrent Sezary Syndrome [NCIt concept]
- Recurrent Sinonasal Carcinoma [NCIt concept]
- Recurrent Sinonasal Inverted Papilloma [NCIt concept]
- Recurrent Sinonasal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Skin Carcinoma [NCIt concept]
- Recurrent Skull Base Squamous Cell Carcinoma [NCIt concept]
- Recurrent Small Cell Glioblastoma [NCIt concept]
- Recurrent Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Recurrent Small Intestinal Carcinoma [NCIt concept]
- Recurrent Small Lymphocytic Lymphoma [NCIt concept]
- Recurrent Soft Tissue Sarcoma [NCIt concept]
- Recurrent Soft Tissue Sarcoma of the Trunk and Extremities [NCIt concept]
- Recurrent Spindle Cell Sarcoma [NCIt concept]
- Recurrent Squamous Cell Carcinoma [NCIt concept]
- Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma [NCIt concept]
- Recurrent Supratentorial Glioblastoma [NCIt concept]
- Recurrent Systemic Anaplastic Large Cell Lymphoma [NCIt concept]
- Recurrent Systemic Anaplastic Large Cell Lymphoma, ALK-Positive [NCIt concept]
- Recurrent T Acute Lymphoblastic Leukemia [NCIt concept]
- Recurrent T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Recurrent T Lymphoblastic Lymphoma [NCIt concept]
- Recurrent T-Cell Large Granular Lymphocyte Leukemia [NCIt concept]
- Recurrent T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent T-Cell Prolymphocytic Leukemia [NCIt concept]
- Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma [NCIt concept]
- Recurrent T/NK-Cell Lymphoproliferative Disorder [NCIt concept]
- Recurrent Tectal Glioma [NCIt concept]
- Recurrent Testicular Lymphoma [NCIt concept]
- Recurrent Thymus Carcinoma [NCIt concept]
- Recurrent Thyroid Gland Carcinoma [NCIt concept]
- Recurrent Thyroid Gland Oncocytic Carcinoma [NCIt concept]
- Recurrent Tonsillar Squamous Cell Carcinoma [NCIt concept]
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Transformed Chronic Lymphocytic Leukemia [NCIt concept]
- Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Recurrent Transformed Mycosis Fungoides [NCIt concept]
- Recurrent Transformed Non-Hodgkin Lymphoma [NCIt concept]
- Recurrent Transplant-Related Kaposi Sarcoma [NCIt concept]
- Recurrent Triple-Negative Breast Carcinoma [NCIt concept]
- Recurrent Unresectable Colorectal Carcinoma [NCIt concept]
- Recurrent Unresectable Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Lung Non-Small Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Malignant Solid Neoplasm [NCIt concept]
- Recurrent Unresectable Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Renal Cell Carcinoma [NCIt concept]
- Recurrent Unresectable Triple-Negative Breast Carcinoma [NCIt concept]
- Recurrent Ureter Urothelial Carcinoma [NCIt concept]
- Recurrent Urethral Carcinoma [NCIt concept]
- Recurrent Urethral Urothelial Carcinoma [NCIt concept]
- Recurrent Urothelial Carcinoma [NCIt concept]
- Recurrent Uterine Corpus Carcinosarcoma [NCIt concept]
- Recurrent Uterine Corpus Sarcoma [NCIt concept]
- Recurrent Uveal Melanoma [NCIt concept]
- Recurrent Vaginal Carcinoma [NCIt concept]
- Recurrent Vaginal Squamous Cell Carcinoma [NCIt concept]
- Recurrent Very High Risk Myelodysplastic Syndrome [NCIt concept]
- Recurrent Visual Pathway Glioma [NCIt concept]
- Recurrent Vulvar Carcinoma [NCIt concept]
- Recurrent Vulvar Squamous Cell Carcinoma [NCIt concept]
- Recurrent Vulvovaginal Candidiasis [NCIt concept]
- Recurrent WHO Grade 2 Glioma [NCIt concept]
- Recurrent WHO Grade 3 Glioma [NCIt concept]
- Recurrent WHO Grade 4 Glioma [NCIt concept]
- Recurrent Waldenstrom Macroglobulinemia [NCIt concept]
- Red Blood Cell Exchange and Depletion Procedure [NCIt concept]
- Red Cell Fatty Acid Profile [NCIt concept]
- Red-light Photodynamic Therapy [NCIt concept]
- Reduced WAS Protein Expression [NCIt concept]
- Reduced-Intensity Transplant Conditioning Procedure [NCIt concept]
- Refametinib [NCIt concept]
- Referral [NCIt concept]
- Refilin-A [NCIt concept]
- Reflectance Confocal Microscopy [NCIt concept]
- Reflection Activities [NCIt concept]
- Reflexology [NCIt concept]
- Refractory AL Amyloidosis [NCIt concept]
- Refractory ALK-Positive Large B-Cell Lymphoma [NCIt concept]
- Refractory Abdominal Neuroendocrine Neoplasm [NCIt concept]
- Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Refractory Acute Bilineal Leukemia [NCIt concept]
- Refractory Acute Biphenotypic Leukemia [NCIt concept]
- Refractory Acute Graft Versus Host Disease [NCIt concept]
- Refractory Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Refractory Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Refractory Acute Monocytic Leukemia [NCIt concept]
- Refractory Acute Myeloid Leukemia [NCIt concept]
- Refractory Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Refractory Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Refractory Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Refractory Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged [NCIt concept]
- Refractory Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia [NCIt concept]
- Refractory Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Refractory Acute Myelomonocytic Leukemia [NCIt concept]
- Refractory Acute Undifferentiated Leukemia [NCIt concept]
- Refractory Adenocarcinoma [NCIt concept]
- Refractory Adenoid Cystic Carcinoma [NCIt concept]
- Refractory Adenovirus Infection [NCIt concept]
- Refractory Adnexal Carcinoma [NCIt concept]
- Refractory Adrenal Cortical Carcinoma [NCIt concept]
- Refractory Adrenal Gland Pheochromocytoma [NCIt concept]
- Refractory Adult Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Refractory Advanced Phase Myeloproliferative Neoplasm [NCIt concept]
- Refractory Aggressive B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Aggressive NK-Cell Leukemia [NCIt concept]
- Refractory Alveolar Rhabdomyosarcoma [NCIt concept]
- Refractory Alveolar Soft Part Sarcoma [NCIt concept]
- Refractory Ampulla of Vater Carcinoma [NCIt concept]
- Refractory Anal Canal Squamous Cell Carcinoma [NCIt concept]
- Refractory Anal Carcinoma [NCIt concept]
- Refractory Anal Squamous Cell Carcinoma [NCIt concept]
- Refractory Anaplastic Astrocytoma [NCIt concept]
- Refractory Anaplastic Ependymoma [NCIt concept]
- Refractory Anaplastic Ganglioglioma [NCIt concept]
- Refractory Anaplastic Large Cell Lymphoma [NCIt concept]
- Refractory Anaplastic Oligodendroglioma [NCIt concept]
- Refractory Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Refractory Anemia [NCIt concept]
- Refractory Anemia with Excess Blasts in Transformation [NCIt concept]
- Refractory Angiosarcoma [NCIt concept]
- Refractory Appendix Adenocarcinoma [NCIt concept]
- Refractory Atypical Chronic Myeloid Leukemia [NCIt concept]
- Refractory Atypical Teratoid/Rhabdoid Tumor [NCIt concept]
- Refractory B Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like [NCIt concept]
- Refractory B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative [NCIt concept]
- Refractory B Lymphoblastic Lymphoma [NCIt concept]
- Refractory B-Cell Malignant Neoplasm [NCIt concept]
- Refractory B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory B-Cell Prolymphocytic Leukemia [NCIt concept]
- Refractory Barrett Esophagus [NCIt concept]
- Refractory Basal Cell Carcinoma [NCIt concept]
- Refractory Bile Duct Carcinoma [NCIt concept]
- Refractory Bladder Carcinoma [NCIt concept]
- Refractory Bladder Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Refractory Bladder Urothelial Carcinoma [NCIt concept]
- Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm [NCIt concept]
- Refractory Breast Adenocarcinoma [NCIt concept]
- Refractory Breast Carcinoma [NCIt concept]
- Refractory Breast Implant-Associated Anaplastic Large Cell Lymphoma [NCIt concept]
- Refractory Breast Lymphoma [NCIt concept]
- Refractory Burkitt Leukemia [NCIt concept]
- Refractory Burkitt Lymphoma [NCIt concept]
- Refractory Carcinoma [NCIt concept]
- Refractory Central Nervous System Lymphoma [NCIt concept]
- Refractory Central Nervous System Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Centroblastic Lymphoma [NCIt concept]
- Refractory Cervical Adenocarcinoma [NCIt concept]
- Refractory Cervical Carcinoma [NCIt concept]
- Refractory Cervical Squamous Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Refractory Chemotherapy-Induced Nausea and Vomiting [NCIt concept]
- Refractory Childhood Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Refractory Childhood Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory Childhood Acute Myeloid Leukemia [NCIt concept]
- Refractory Childhood Anaplastic Astrocytoma [NCIt concept]
- Refractory Childhood Anaplastic Oligoastrocytoma [NCIt concept]
- Refractory Childhood Astrocytoma [NCIt concept]
- Refractory Childhood B Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory Childhood B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Childhood Brain Neoplasm [NCIt concept]
- Refractory Childhood Fibrillary Astrocytoma [NCIt concept]
- Refractory Childhood Fibrolamellar Carcinoma [NCIt concept]
- Refractory Childhood Glioblastoma [NCIt concept]
- Refractory Childhood Hodgkin Lymphoma [NCIt concept]
- Refractory Childhood Leukemia [NCIt concept]
- Refractory Childhood Lymphoblastic Lymphoma [NCIt concept]
- Refractory Childhood Lymphoma [NCIt concept]
- Refractory Childhood Malignant Germ Cell Tumor [NCIt concept]
- Refractory Childhood Malignant Neoplasm [NCIt concept]
- Refractory Childhood Malignant Solid Neoplasm [NCIt concept]
- Refractory Childhood Medulloblastoma [NCIt concept]
- Refractory Childhood Mixed Phenotype Acute Leukemia [NCIt concept]
- Refractory Childhood Myelodysplastic Syndrome [NCIt concept]
- Refractory Childhood Neuroblastoma [NCIt concept]
- Refractory Childhood Oligodendroglioma [NCIt concept]
- Refractory Childhood Osteosarcoma [NCIt concept]
- Refractory Childhood Pilomyxoid Astrocytoma [NCIt concept]
- Refractory Childhood Rhabdomyosarcoma [NCIt concept]
- Refractory Childhood Soft Tissue Sarcoma [NCIt concept]
- Refractory Childhood T Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory Cholangiocarcinoma [NCIt concept]
- Refractory Chromophobe Renal Cell Carcinoma [NCIt concept]
- Refractory Chronic Lymphocytic Leukemia [NCIt concept]
- Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [NCIt concept]
- Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Refractory Chronic Myelomonocytic Leukemia [NCIt concept]
- Refractory Classic Hodgkin Lymphoma [NCIt concept]
- Refractory Clear Cell Renal Cell Carcinoma [NCIt concept]
- Refractory Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Refractory Colon Adenocarcinoma [NCIt concept]
- Refractory Colon Carcinoma [NCIt concept]
- Refractory Colorectal Carcinoma [NCIt concept]
- Refractory Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Refractory Cutaneous Melanoma [NCIt concept]
- Refractory Cytomegalovirus Infection [NCIt concept]
- Refractory Dedifferentiated Chordoma [NCIt concept]
- Refractory Dedifferentiated Liposarcoma [NCIt concept]
- Refractory Desmoid Fibromatosis [NCIt concept]
- Refractory Desmoplastic Small Round Cell Tumor [NCIt concept]
- Refractory Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Refractory Diffuse Intrinsic Pontine Glioma [NCIt concept]
- Refractory Diffuse Large B-Cell Lymphoma [NCIt concept]
- Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type [NCIt concept]
- Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation [NCIt concept]
- Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type [NCIt concept]
- Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Refractory Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Refractory Digestive System Carcinoma [NCIt concept]
- Refractory Digestive System Neuroendocrine Carcinoma [NCIt concept]
- Refractory Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Refractory Distal Cholangiocarcinoma [NCIt concept]
- Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Refractory EBV-Related Lymphoma [NCIt concept]
- Refractory EBV-Related Lymphoproliferative Disease with Primary Immunodeficiency [NCIt concept]
- Refractory Endocrine Carcinoma [NCIt concept]
- Refractory Endometrial Adenocarcinoma [NCIt concept]
- Refractory Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Refractory Endometrial Dedifferentiated Carcinoma [NCIt concept]
- Refractory Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Refractory Endometrial Mucinous Adenocarcinoma [NCIt concept]
- Refractory Endometrial Serous Adenocarcinoma [NCIt concept]
- Refractory Endometrial Squamous Cell Carcinoma [NCIt concept]
- Refractory Endometrial Transitional Cell Carcinoma [NCIt concept]
- Refractory Endometrial Undifferentiated Carcinoma [NCIt concept]
- Refractory Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Refractory Epithelioid Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Refractory Epithelioid Sarcoma [NCIt concept]
- Refractory Erdheim-Chester Disease [NCIt concept]
- Refractory Erectile Dysfunction [NCIt concept]
- Refractory Esophageal Adenocarcinoma [NCIt concept]
- Refractory Esophageal Anastomotic Stricture [NCIt concept]
- Refractory Esophageal Squamous Cell Carcinoma [NCIt concept]
- Refractory Essential Thrombocythemia [NCIt concept]
- Refractory Ewing Sarcoma [NCIt concept]
- Refractory Extracranial Malignant Solid Neoplasm [NCIt concept]
- Refractory Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Refractory Extrahepatic Cholangiocarcinoma [NCIt concept]
- Refractory Extramammary Paget Disease [NCIt concept]
- Refractory Extranodal Diffuse Large B-cell Lymphoma [NCIt concept]
- Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Refractory Extrarenal Rhabdoid Tumor [NCIt concept]
- Refractory Extrarenal Rhabdoid Tumor of the Ovary [NCIt concept]
- Refractory Extraskeletal Myxoid Chondrosarcoma [NCIt concept]
- Refractory Fallopian Tube Carcinoma [NCIt concept]
- Refractory Fallopian Tube Carcinosarcoma [NCIt concept]
- Refractory Fallopian Tube Clear Cell Adenocarcinoma [NCIt concept]
- Refractory Fallopian Tube Endometrioid Adenocarcinoma [NCIt concept]
- Refractory Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Fallopian Tube Mucinous Adenocarcinoma [NCIt concept]
- Refractory Fallopian Tube Transitional Cell Carcinoma [NCIt concept]
- Refractory Fallopian Tube Undifferentiated Carcinoma [NCIt concept]
- Refractory Fibroblastic Reticular Cell Sarcoma [NCIt concept]
- Refractory Fibrolamellar Carcinoma [NCIt concept]
- Refractory Fibrosarcoma [NCIt concept]
- Refractory Follicular Helper T-Cell Lymphoma [NCIt concept]
- Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type [NCIt concept]
- Refractory Follicular Helper T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Refractory Follicular Lymphoma [NCIt concept]
- Refractory Fungal Infection [NCIt concept]
- Refractory Gallbladder Carcinoma [NCIt concept]
- Refractory Ganglioneuroblastoma [NCIt concept]
- Refractory Gastric Adenocarcinoma [NCIt concept]
- Refractory Gastric Carcinoma [NCIt concept]
- Refractory Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Refractory Gastroesophageal Junction Carcinoma [NCIt concept]
- Refractory Generalized Myasthenia Gravis [NCIt concept]
- Refractory Giant Cell Glioblastoma [NCIt concept]
- Refractory Glioblastoma [NCIt concept]
- Refractory Grade 1 Follicular Lymphoma [NCIt concept]
- Refractory Grade 2 Follicular Lymphoma [NCIt concept]
- Refractory Grade 3a Follicular Lymphoma [NCIt concept]
- Refractory Gray-Zone Lymphoma [NCIt concept]
- Refractory HER2-Negative Breast Carcinoma [NCIt concept]
- Refractory HER2-Positive Breast Carcinoma [NCIt concept]
- Refractory HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Refractory HIV-Related Lymphoproliferative Disorder [NCIt concept]
- Refractory Hairy Cell Leukemia [NCIt concept]
- Refractory Hairy Cell Leukemia Variant [NCIt concept]
- Refractory Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Refractory Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Refractory Hemophagocytic Lymphohistiocytosis [NCIt concept]
- Refractory Hepatoblastoma [NCIt concept]
- Refractory Hepatocellular Carcinoma [NCIt concept]
- Refractory High Grade B-Cell Lymphoma [NCIt concept]
- Refractory High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements [NCIt concept]
- Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements [NCIt concept]
- Refractory High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements [NCIt concept]
- Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements [NCIt concept]
- Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Refractory High Risk Acute Myeloid Leukemia [NCIt concept]
- Refractory High Risk Chronic Myelomonocytic Leukemia [NCIt concept]
- Refractory Higher Risk Myelodysplastic Syndrome [NCIt concept]
- Refractory Histiocytic Sarcoma [NCIt concept]
- Refractory Histiocytic and Dendritic Cell Neoplasm [NCIt concept]
- Refractory Hodgkin Lymphoma [NCIt concept]
- Refractory Hormone Receptor-Negative Breast Carcinoma [NCIt concept]
- Refractory Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Refractory Human Papillomavirus-Related Malignant Neoplasm [NCIt concept]
- Refractory Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Refractory Immunoblastic Lymphoma [NCIt concept]
- Refractory Indolent Adult Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Indolent B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Indolent Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Indolent T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Interdigitating Dendritic Cell Sarcoma [NCIt concept]
- Refractory Intermediate Risk Acute Myeloid Leukemia [NCIt concept]
- Refractory Intrahepatic Cholangiocarcinoma [NCIt concept]
- Refractory Intravascular Large B-Cell Lymphoma [NCIt concept]
- Refractory Invasive Pulmonary Aspergillosis [NCIt concept]
- Refractory Juvenile Myelomonocytic Leukemia [NCIt concept]
- Refractory Kaposi Sarcoma [NCIt concept]
- Refractory Kidney Medullary Carcinoma [NCIt concept]
- Refractory Langerhans Cell Histiocytosis [NCIt concept]
- Refractory Large B-Cell Lymphoma with IRF4 Rearrangement [NCIt concept]
- Refractory Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Refractory Leiomyosarcoma [NCIt concept]
- Refractory Leukemia [NCIt concept]
- Refractory Liposarcoma [NCIt concept]
- Refractory Liver Carcinoma [NCIt concept]
- Refractory Low Grade Astrocytoma [NCIt concept]
- Refractory Low Grade Fallopian Tube Serous Adenocarcinoma [NCIt concept]
- Refractory Low Grade Glioma [NCIt concept]
- Refractory Lung Adenocarcinoma [NCIt concept]
- Refractory Lung Non-Small Cell Carcinoma [NCIt concept]
- Refractory Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Refractory Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Refractory Lung Squamous Cell Carcinoma [NCIt concept]
- Refractory Lupus Glomerulonephritis [NCIt concept]
- Refractory Lymphoblastic Lymphoma [NCIt concept]
- Refractory Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma [NCIt concept]
- Refractory Lymphoma [NCIt concept]
- Refractory Lymphomatoid Granulomatosis [NCIt concept]
- Refractory Lymphoplasmacytic Lymphoma [NCIt concept]
- Refractory Malignant Bone Neoplasm [NCIt concept]
- Refractory Malignant Brain Neoplasm [NCIt concept]
- Refractory Malignant Extragonadal Germ Cell Tumor [NCIt concept]
- Refractory Malignant Female Reproductive System Neoplasm [NCIt concept]
- Refractory Malignant Gastrointestinal Stromal Tumor [NCIt concept]
- Refractory Malignant Glioma [NCIt concept]
- Refractory Malignant Glomus Tumor [NCIt concept]
- Refractory Malignant Leptomeningeal Neoplasm [NCIt concept]
- Refractory Malignant Male Reproductive System Neoplasm [NCIt concept]
- Refractory Malignant Mastocytosis [NCIt concept]
- Refractory Malignant Mesothelioma [NCIt concept]
- Refractory Malignant Myoepithelioma [NCIt concept]
- Refractory Malignant Neoplasm [NCIt concept]
- Refractory Malignant Neoplasm of Multiple Primary Sites [NCIt concept]
- Refractory Malignant Neoplasm of Unknown Primary [NCIt concept]
- Refractory Malignant Nongerminomatous Germ Cell Tumor [NCIt concept]
- Refractory Malignant Oral Neoplasm [NCIt concept]
- Refractory Malignant Ovarian Brenner Tumor [NCIt concept]
- Refractory Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Refractory Malignant Pharyngeal Neoplasm [NCIt concept]
- Refractory Malignant Phyllodes Tumor [NCIt concept]
- Refractory Malignant Skin Neoplasm [NCIt concept]
- Refractory Malignant Soft Tissue Neoplasm [NCIt concept]
- Refractory Malignant Solid Neoplasm [NCIt concept]
- Refractory Malignant Testicular Germ Cell Tumor [NCIt concept]
- Refractory Malignant Thymoma [NCIt concept]
- Refractory Malignant Thyroid Gland Neoplasm [NCIt concept]
- Refractory Malignant Urinary System Neoplasm [NCIt concept]
- Refractory Mantle Cell Lymphoma [NCIt concept]
- Refractory Marginal Zone Lymphoma [NCIt concept]
- Refractory Mature T-Cell and NK-Cell Neoplasm [NCIt concept]
- Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Medulloblastoma [NCIt concept]
- Refractory Medulloblastoma, WNT-Activated [NCIt concept]
- Refractory Melanoma [NCIt concept]
- Refractory Meningioma [NCIt concept]
- Refractory Merkel Cell Carcinoma [NCIt concept]
- Refractory Metastatic Colorectal Adenocarcinoma [NCIt concept]
- Refractory Metastatic Digestive System Carcinoma [NCIt concept]
- Refractory Metastatic Melanoma [NCIt concept]
- Refractory Metastatic Pancreatic Adenocarcinoma [NCIt concept]
- Refractory Microsatellite Stable Colorectal Carcinoma [NCIt concept]
- Refractory Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Refractory Mismatch Repair Proficient Colorectal Carcinoma [NCIt concept]
- Refractory Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Refractory Mixed Phenotype Acute Leukemia [NCIt concept]
- Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma [NCIt concept]
- Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Refractory Mucosal Melanoma [NCIt concept]
- Refractory Multiple Myeloma [NCIt concept]
- Refractory Mycosis Fungoides [NCIt concept]
- Refractory Mycosis Fungoides and Sezary Syndrome [NCIt concept]
- Refractory Myelodysplastic Syndrome [NCIt concept]
- Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Refractory Myelodysplastic/Myeloproliferative Neoplasm [NCIt concept]
- Refractory Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Refractory Myelofibrosis [NCIt concept]
- Refractory Myeloproliferative Neoplasm [NCIt concept]
- Refractory Myxoid Liposarcoma [NCIt concept]
- Refractory NK-Cell Lymphoma, Unclassifiable [NCIt concept]
- Refractory Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Refractory Nasopharyngeal Carcinoma [NCIt concept]
- Refractory Nasopharyngeal Non-Keratinizing Carcinoma [NCIt concept]
- Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Refractory Neuroblastoma [NCIt concept]
- Refractory Neuroendocrine Tumor [NCIt concept]
- Refractory Neurofibromatosis Type 1 [NCIt concept]
- Refractory Nodal Marginal Zone Lymphoma [NCIt concept]
- Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Refractory Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Refractory Non-Muscle Invasive Bladder Carcinoma [NCIt concept]
- Refractory Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Refractory Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Refractory Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Refractory Osteosarcoma [NCIt concept]
- Refractory Ovarian Carcinosarcoma [NCIt concept]
- Refractory Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Refractory Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Seromucinous Carcinoma [NCIt concept]
- Refractory Ovarian Serous Adenocarcinoma [NCIt concept]
- Refractory Ovarian Squamous Cell Carcinoma [NCIt concept]
- Refractory Ovarian Transitional Cell Carcinoma [NCIt concept]
- Refractory Ovarian Undifferentiated Carcinoma [NCIt concept]
- Refractory PEComa [NCIt concept]
- Refractory Pancreatic Adenocarcinoma [NCIt concept]
- Refractory Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Refractory Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Refractory Pancreatobiliary Carcinoma [NCIt concept]
- Refractory Paraganglioma [NCIt concept]
- Refractory Paranasal Sinus Squamous Cell Carcinoma [NCIt concept]
- Refractory Penile Carcinoma [NCIt concept]
- Refractory Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Refractory Plasma Cell Leukemia [NCIt concept]
- Refractory Plasmablastic Lymphoma [NCIt concept]
- Refractory Pleomorphic Liposarcoma [NCIt concept]
- Refractory Pleural Malignant Mesothelioma [NCIt concept]
- Refractory Polycythemia Vera [NCIt concept]
- Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase [NCIt concept]
- Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Refractory Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Refractory Post-Essential Thrombocythemia Myelofibrosis [NCIt concept]
- Refractory Primary Amyloidosis [NCIt concept]
- Refractory Primary Bone Lymphoma [NCIt concept]
- Refractory Primary Central Nervous System Lymphoma [NCIt concept]
- Refractory Primary Central Nervous System Neoplasm [NCIt concept]
- Refractory Primary Cutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma [NCIt concept]
- Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma [NCIt concept]
- Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type [NCIt concept]
- Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma [NCIt concept]
- Refractory Primary Cutaneous Lymphoma [NCIt concept]
- Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Primary Effusion Lymphoma [NCIt concept]
- Refractory Primary Malignant Central Nervous System Neoplasm [NCIt concept]
- Refractory Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Refractory Primary Myelofibrosis [NCIt concept]
- Refractory Primary Peritoneal Carcinoma [NCIt concept]
- Refractory Primary Peritoneal Carcinosarcoma [NCIt concept]
- Refractory Primary Peritoneal Clear Cell Adenocarcinoma [NCIt concept]
- Refractory Primary Peritoneal Endometrioid Adenocarcinoma [NCIt concept]
- Refractory Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma [NCIt concept]
- Refractory Primary Peritoneal Serous Adenocarcinoma [NCIt concept]
- Refractory Primary Peritoneal Transitional Cell Carcinoma [NCIt concept]
- Refractory Primary Peritoneal Undifferentiated Carcinoma [NCIt concept]
- Refractory Prostate Adenocarcinoma [NCIt concept]
- Refractory Prostate Carcinoma [NCIt concept]
- Refractory Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Refractory Pseudomyxoma Peritonei [NCIt concept]
- Refractory Rare Malignant Solid Neoplasm [NCIt concept]
- Refractory Rectal Adenocarcinoma [NCIt concept]
- Refractory Rectal Squamous Cell Carcinoma [NCIt concept]
- Refractory Renal Cell Carcinoma [NCIt concept]
- Refractory Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Refractory Rhabdoid Tumor [NCIt concept]
- Refractory Rhabdoid Tumor of the Kidney [NCIt concept]
- Refractory Rhabdomyosarcoma [NCIt concept]
- Refractory Rosai-Dorfman-Destombes Disease [NCIt concept]
- Refractory Round Cell Liposarcoma [NCIt concept]
- Refractory Salivary Gland Carcinoma [NCIt concept]
- Refractory Sclerodermatous Graft Versus Host Disease [NCIt concept]
- Refractory Sebaceous Carcinoma [NCIt concept]
- Refractory Secondary Acute Myeloid Leukemia [NCIt concept]
- Refractory Secondary Diffuse Large B-Cell Lymphoma of the Central Nervous System [NCIt concept]
- Refractory Secondary Hemophagocytic Lymphohistiocytosis [NCIt concept]
- Refractory Severe Aplastic Anemia [NCIt concept]
- Refractory Sezary Syndrome [NCIt concept]
- Refractory Skin Squamous Cell Carcinoma [NCIt concept]
- Refractory Small Intestinal Carcinoma [NCIt concept]
- Refractory Small Lymphocytic Lymphoma [NCIt concept]
- Refractory Soft Tissue Sarcoma [NCIt concept]
- Refractory Solitary Fibrous Tumor [NCIt concept]
- Refractory Spindle Cell Sarcoma [NCIt concept]
- Refractory Stage 0 Bladder Cancer AJCC v6 and v7 [NCIt concept]
- Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma [NCIt concept]
- Refractory Synovial Sarcoma [NCIt concept]
- Refractory Systemic Anaplastic Large Cell Lymphoma [NCIt concept]
- Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive [NCIt concept]
- Refractory T Acute Lymphoblastic Leukemia [NCIt concept]
- Refractory T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Refractory T-Cell Large Granular Lymphocyte Leukemia [NCIt concept]
- Refractory T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory T-Cell Prolymphocytic Leukemia [NCIt concept]
- Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma [NCIt concept]
- Refractory T/NK-Cell Lymphoproliferative Disorder [NCIt concept]
- Refractory Testicular Lymphoma [NCIt concept]
- Refractory Thymus Carcinoma [NCIt concept]
- Refractory Thyroid Gland Anaplastic Carcinoma [NCIt concept]
- Refractory Thyroid Gland Carcinoma [NCIt concept]
- Refractory Thyroid Gland Follicular Carcinoma [NCIt concept]
- Refractory Thyroid Gland Medullary Carcinoma [NCIt concept]
- Refractory Thyroid Gland Oncocytic Carcinoma [NCIt concept]
- Refractory Thyroid Gland Papillary Carcinoma [NCIt concept]
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Refractory Transformed Chronic Lymphocytic Leukemia [NCIt concept]
- Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Refractory Transformed Mycosis Fungoides [NCIt concept]
- Refractory Triple-Negative Breast Carcinoma [NCIt concept]
- Refractory Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Refractory Ureter Urothelial Carcinoma [NCIt concept]
- Refractory Urethral Urothelial Carcinoma [NCIt concept]
- Refractory Urothelial Carcinoma [NCIt concept]
- Refractory Uterine Corpus Carcinosarcoma [NCIt concept]
- Refractory Uveal Melanoma [NCIt concept]
- Refractory Vaginal Carcinoma [NCIt concept]
- Refractory Vaginal Squamous Cell Carcinoma [NCIt concept]
- Refractory Very High Risk Myelodysplastic Syndrome [NCIt concept]
- Refractory Visual Pathway Glioma [NCIt concept]
- Refractory Vulvar Carcinoma [NCIt concept]
- Refractory Vulvar Squamous Cell Carcinoma [NCIt concept]
- Refractory WHO Grade 1 Glioma [NCIt concept]
- Refractory WHO Grade 2 Glioma [NCIt concept]
- Refractory WHO Grade 3 Glioma [NCIt concept]
- Refractory WHO Grade 4 Glioma [NCIt concept]
- Refractory Waldenstrom Macroglobulinemia [NCIt concept]
- Refractory Wilms Tumor [NCIt concept]
- Refractory/Intolerant Non-Muscle Invasive Bladder Carcinoma (NMIBC) to BCG Treatment [NCIt concept]
- Refsum Disease [NCIt concept]
- Regenerating Islet-Derived Protein 3-Alpha [NCIt concept]
- Regenerative Peripheral Nerve Interface Surgery [NCIt concept]
- Regional Adrenal Gland Pheochromocytoma [NCIt concept]
- Regional Anesthesia Procedure [NCIt concept]
- Regional Chemotherapy [NCIt concept]
- Regional Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Regional Lymph Node Dissection [NCIt concept]
- Regional Neuroblastoma [NCIt concept]
- Regional Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Registry [NCIt concept]
- Regorafenib [NCIt concept]
- Regorafenib Anhydrous [NCIt concept]
- Regressing Cutaneous Melanoma [NCIt concept]
- Regulator of G-Protein Signaling 1 [NCIt concept]
- Regulator of G-Protein Signaling 22 [NCIt concept]
- Regulator of G-Protein Signaling 5 [NCIt concept]
- Regulator of Telomere Elongation Helicase 1 [NCIt concept]
- Regulatory B Cell [NCIt concept]
- Regulatory T-Cell to Effector T-Cell Ratio Measurement [NCIt concept]
- Regulatory T-Lymphocyte Count [NCIt concept]
- Regulatory-Associated Protein of mTOR [NCIt concept]
- Rehabilitation [NCIt concept]
- Reiki Therapy [NCIt concept]
- Relacorilant [NCIt concept]
- Relapsing-Remitting Multiple Sclerosis [NCIt concept]
- Related Donor Adenovirus-specific Cytotoxic T Cells [NCIt concept]
- Relatlimab [NCIt concept]
- Relaxation Technique [NCIt concept]
- Relaxation Therapy [NCIt concept]
- Releasing Hormone Agonist Therapy [NCIt concept]
- Releasing Hormone Antagonist Therapy [NCIt concept]
- Relugolix [NCIt concept]
- Remdesivir [NCIt concept]
- Remestemcel-L [NCIt concept]
- Remetinostat [NCIt concept]
- Remzistotug [NCIt concept]
- Renal AL Amyloidosis [NCIt concept]
- Renal Cell Carcinoma [NCIt concept]
- Renal Cell Carcinoma Associated with Neuroblastoma [NCIt concept]
- Renal Cell Carcinoma Peptides Vaccine IMA901 [NCIt concept]
- Renal Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Renal Complications Management [NCIt concept]
- Renal Failure [NCIt concept]
- Renal Function [NCIt concept]
- Renal Pelvis Adenocarcinoma [NCIt concept]
- Renal Pelvis Carcinoma [NCIt concept]
- Renal Pelvis Squamous Cell Carcinoma [NCIt concept]
- Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Renal Pelvis Urothelial Carcinoma, High Grade [NCIt concept]
- Renal Pelvis and Ureter Carcinoma [NCIt concept]
- Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Renal Toxicity [NCIt concept]
- Renin [NCIt concept]
- Renvistobart [NCIt concept]
- Reoviridae [NCIt concept]
- Reovirus Capsid Protein [NCIt concept]
- Reovirus RNA [NCIt concept]
- Reozalimab [NCIt concept]
- Repaglinide [NCIt concept]
- Reparixin [NCIt concept]
- Repetitive Transcranial Magnetic Stimulation [NCIt concept]
- Replication Competent Lentivirus [NCIt concept]
- Replication Competent Retrovirus [NCIt concept]
- Replication Factor C Subunit 1 [NCIt concept]
- Replication Factor C Subunit 2 [NCIt concept]
- Replication Factor C Subunit 3 [NCIt concept]
- Replication Factor C Subunit 4 [NCIt concept]
- Replication Factor C Subunit 5 [NCIt concept]
- Replication Protein A 14 kDa [NCIt concept]
- Replication Protein A 32 kDa Subunit [NCIt concept]
- Replication Protein A 70 kDa DNA-Binding Subunit [NCIt concept]
- Reporting [NCIt concept]
- Repository [NCIt concept]
- Repotrectinib [NCIt concept]
- Reproductive Endocrinologist [NCIt concept]
- Resectable Adenocarcinoma of Unknown Primary [NCIt concept]
- Resectable Adrenal Cortical Carcinoma [NCIt concept]
- Resectable Ampulla of Vater Adenocarcinoma [NCIt concept]
- Resectable Anaplastic Astrocytoma [NCIt concept]
- Resectable Anorectal Melanoma [NCIt concept]
- Resectable Appendix Carcinoma [NCIt concept]
- Resectable Astrocytoma [NCIt concept]
- Resectable Biliary Tract Carcinoma [NCIt concept]
- Resectable Bladder Urothelial Carcinoma [NCIt concept]
- Resectable Brain Neoplasm [NCIt concept]
- Resectable Breast Carcinoma [NCIt concept]
- Resectable Carcinoma [NCIt concept]
- Resectable Carcinoma of Unknown Primary [NCIt concept]
- Resectable Cervical Carcinoma [NCIt concept]
- Resectable Clear Cell Renal Cell Carcinoma [NCIt concept]
- Resectable Colon Adenocarcinoma [NCIt concept]
- Resectable Colon Carcinoma [NCIt concept]
- Resectable Colorectal Adenocarcinoma [NCIt concept]
- Resectable Colorectal Carcinoma [NCIt concept]
- Resectable Cutaneous Melanoma [NCIt concept]
- Resectable Dedifferentiated Liposarcoma [NCIt concept]
- Resectable Endometrial Carcinoma [NCIt concept]
- Resectable Esophageal Adenocarcinoma [NCIt concept]
- Resectable Esophageal Carcinoma [NCIt concept]
- Resectable Gallbladder Adenocarcinoma [NCIt concept]
- Resectable Gallbladder Carcinoma [NCIt concept]
- Resectable Gastric Adenocarcinoma [NCIt concept]
- Resectable Gastric Carcinoma [NCIt concept]
- Resectable Gastroesophageal Junction Adenocarcinoma [NCIt concept]
- Resectable Glioblastoma [NCIt concept]
- Resectable Glioma [NCIt concept]
- Resectable Head and Neck Carcinoma [NCIt concept]
- Resectable Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Resectable Head and Neck Squamous Cell Carcinoma [NCIt concept]
- Resectable Hepatoblastoma [NCIt concept]
- Resectable Hepatocellular Carcinoma [NCIt concept]
- Resectable Hilar Cholangiocarcinoma [NCIt concept]
- Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma [NCIt concept]
- Resectable Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Resectable Kidney Carcinoma [NCIt concept]
- Resectable Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Resectable Leiomyosarcoma [NCIt concept]
- Resectable Lip and Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Resectable Liposarcoma [NCIt concept]
- Resectable Liver Carcinoma [NCIt concept]
- Resectable Lung Adenocarcinoma [NCIt concept]
- Resectable Lung Non-Small Cell Carcinoma [NCIt concept]
- Resectable Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Resectable Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Resectable Lung Squamous Cell Carcinoma [NCIt concept]
- Resectable Malignant Bone Neoplasm [NCIt concept]
- Resectable Malignant Female Reproductive System Neoplasm [NCIt concept]
- Resectable Malignant Glioma [NCIt concept]
- Resectable Malignant Neoplasm [NCIt concept]
- Resectable Malignant Solid Neoplasm [NCIt concept]
- Resectable Merkel Cell Carcinoma [NCIt concept]
- Resectable Nasal Cavity Squamous Cell Carcinoma [NCIt concept]
- Resectable Neuroblastoma [NCIt concept]
- Resectable Oligodendroglioma [NCIt concept]
- Resectable Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Resectable Oropharyngeal Undifferentiated Carcinoma [NCIt concept]
- Resectable Osteosarcoma [NCIt concept]
- Resectable Ovarian Carcinoma [NCIt concept]
- Resectable Pancreatic Adenosquamous Carcinoma [NCIt concept]
- Resectable Pancreatic Carcinoma [NCIt concept]
- Resectable Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Resectable Paranasal Sinus Squamous Cell Carcinoma [NCIt concept]
- Resectable Periampullary Adenocarcinoma [NCIt concept]
- Resectable Platinum-Resistant Malignant Germ Cell Tumor [NCIt concept]
- Resectable Pleural Malignant Mesothelioma [NCIt concept]
- Resectable Sarcoma [NCIt concept]
- Resectable Sinonasal Mucosal Melanoma [NCIt concept]
- Resectable Skin Squamous Cell Carcinoma [NCIt concept]
- Resectable Small Intestinal Carcinoma [NCIt concept]
- Resectable Soft Tissue Sarcoma of the Trunk and Extremities [NCIt concept]
- Resectable Triple-Negative Breast Carcinoma [NCIt concept]
- Resectable Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Resection [NCIt concept]
- Resection of Rectum [NCIt concept]
- Reserve Cell Hyperplasia [NCIt concept]
- Resigratinib [NCIt concept]
- Resiquimod [NCIt concept]
- Resiquimod Hydrogel-based Sustained-release formulation [NCIt concept]
- Resiquimod Pegol [NCIt concept]
- Resiquimod Sulfate [NCIt concept]
- Resiquimod Topical Gel [NCIt concept]
- Resistance Training [NCIt concept]
- Resistant Starch [NCIt concept]
- Resistin [NCIt concept]
- Resolvin [NCIt concept]
- Resolvin D1 [NCIt concept]
- Resolvin D2 [NCIt concept]
- Resolvin E1 [NCIt concept]
- Respiratory Monitoring via Band [NCIt concept]
- Respiratory Muscle Training [NCIt concept]
- Respiratory Muscle Training Device [NCIt concept]
- Respiratory Syncytial Virus Infection [NCIt concept]
- Respiratory Syncytial Virus Positive [NCIt concept]
- Respiratory System Examination [NCIt concept]
- Respiratory Therapy [NCIt concept]
- Resting State Functional Connectivity Magnetic Resonance Imaging [NCIt concept]
- Restriction Spectrum Imaging [NCIt concept]
- Resveratrol [NCIt concept]
- Retaspimycin Hydrochloride [NCIt concept]
- Reteplase [NCIt concept]
- Reticular Fiber [NCIt concept]
- Reticulocyte [NCIt concept]
- Reticulocyte Count [NCIt concept]
- Retifanlimab [NCIt concept]
- Retinal Dehydrogenase 1 [NCIt concept]
- Retinal Dehydrogenase 2 [NCIt concept]
- Retinoblastoma [NCIt concept]
- Retinoblastoma-Associated Protein [NCIt concept]
- Retinoblastoma-Like Protein 1 [NCIt concept]
- Retinoblastoma-Like Protein 2 [NCIt concept]
- Retinoic Acid Receptor [NCIt concept]
- Retinoic Acid Receptor Alpha [NCIt concept]
- Retinoic Acid Receptor Alpha Isoform Alpha-2 [NCIt concept]
- Retinoic Acid Receptor Beta [NCIt concept]
- Retinoic Acid Receptor RXR-Alpha [NCIt concept]
- Retinoic Acid Receptor RXR-Gamma [NCIt concept]
- Retinoid 9cUAB30 [NCIt concept]
- Retinoid X Receptor [NCIt concept]
- Retinol Binding Protein Measurement [NCIt concept]
- Retinol-Binding Protein 4 [NCIt concept]
- Retroperitoneal Carcinoma [NCIt concept]
- Retroperitoneal Lymph Node Dissection [NCIt concept]
- Retroperitoneal Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Retroperitoneal Pain Syndrome [NCIt concept]
- Retroperitoneal Rhabdomyosarcoma [NCIt concept]
- Retroperitoneal Sarcoma [NCIt concept]
- Retroperitoneal Surgical Procedure [NCIt concept]
- Retrovector Encoding Mutant Anti-Cyclin G1 [NCIt concept]
- Rett Syndrome [NCIt concept]
- Revdofilimab [NCIt concept]
- Reverse Transcriptase-Polymerase Chain Reaction [NCIt concept]
- Revumenib [NCIt concept]
- Revumenib Citrate [NCIt concept]
- Rexinoid NRX 194204 [NCIt concept]
- Rezafungin [NCIt concept]
- Rezatapopt [NCIt concept]
- Rezorstobart [NCIt concept]
- Rhabdoid Tumor of the Kidney [NCIt concept]
- Rhenium Re 188 [NCIt concept]
- Rheumatoid Factor [NCIt concept]
- Rho GTPase-Activating Protein 26 [NCIt concept]
- Rho GTPase-Activating Protein 45 [NCIt concept]
- Rho Guanine Nucleotide Exchange Factor 12 [NCIt concept]
- Rho Guanine Nucleotide Exchange Factor 2 [NCIt concept]
- Rho-Associated Protein Kinase 2 [NCIt concept]
- Rho-Related GTP-Binding Protein RhoB [NCIt concept]
- Rho-Related GTP-Binding Protein RhoH [NCIt concept]
- Rho-Related GTP-Binding Protein RhoU [NCIt concept]
- Rhodopsin [NCIt concept]
- Rhombotin-1 [NCIt concept]
- Rhombotin-2 [NCIt concept]
- Ribavirin [NCIt concept]
- Ribaxamase [NCIt concept]
- Ribociclib [NCIt concept]
- Ribociclib Succinate [NCIt concept]
- Ribonuclease 3 [NCIt concept]
- Ribonuclease P Protein Subunit p40 [NCIt concept]
- Ribonuclease QBI-139 [NCIt concept]
- Ribonucleic Acid [NCIt concept]
- Ribonucleoside-Diphosphate Reductase Large Subunit [NCIt concept]
- Ribonucleoside-Diphosphate Reductase M2 [NCIt concept]
- Ribonucleoside-Diphosphate Reductase Subunit M2 B [NCIt concept]
- Ribonucleotide Reductase [NCIt concept]
- Ribosomal Protein S6 Kinase Alpha-1 [NCIt concept]
- Ribosomal Protein S6 Kinase Alpha-3 [NCIt concept]
- Ribosomal Protein S6 Kinase Alpha-6 [NCIt concept]
- Ribosomal Protein S6 Kinase Beta-1 [NCIt concept]
- Ribosomal Protein S6 Kinase Beta-2 [NCIt concept]
- Ribosome [NCIt concept]
- Ribosome Maturation Protein SBDS [NCIt concept]
- Ribosyldihydronicotinamide Dehydrogenase [Quinone] [NCIt concept]
- Richter Syndrome [NCIt concept]
- Ricolinostat [NCIt concept]
- Ridaforolimus [NCIt concept]
- Ridinilazole [NCIt concept]
- Rifampin [NCIt concept]
- Rifaximin [NCIt concept]
- Rigosertib [NCIt concept]
- Rigosertib Sodium [NCIt concept]
- Rilematovir [NCIt concept]
- Rilimogene Galvacirepvec [NCIt concept]
- Rilimogene Galvacirepvec/Rilimogene Glafolivec [NCIt concept]
- Rilimogene Glafolivec [NCIt concept]
- Rilogrotug [NCIt concept]
- Rilotumumab [NCIt concept]
- Riluzole [NCIt concept]
- Rilvegostomig [NCIt concept]
- Rimiducid [NCIt concept]
- Rinatabart Sesutecan [NCIt concept]
- Rindopepimut [NCIt concept]
- Rineterkib [NCIt concept]
- Rinse [NCIt concept]
- Rintatolimod [NCIt concept]
- Rintodestrant [NCIt concept]
- Ripretinib [NCIt concept]
- Risedronate Sodium [NCIt concept]
- Ritlecitinib [NCIt concept]
- Ritonavir [NCIt concept]
- Rituximab [NCIt concept]
- Rituximab and Hyaluronidase Human [NCIt concept]
- Rivaroxaban [NCIt concept]
- Riviciclib [NCIt concept]
- Rivipansel [NCIt concept]
- Rivoceranib [NCIt concept]
- Rivoceranib Mesylate [NCIt concept]
- Rivogenlecleucel [NCIt concept]
- Robatumumab [NCIt concept]
- Robertsonian Translocation [NCIt concept]
- Roblitinib [NCIt concept]
- Robot-Assisted Endoscopic Surgery [NCIt concept]
- Robot-Assisted Esophagectomy [NCIt concept]
- Robot-Assisted Laparoscopic Surgery [NCIt concept]
- Robot-Assisted Salvage Pelvic Lymph Node Dissection [NCIt concept]
- Robot-Assisted Surgery [NCIt concept]
- Robot-assisted Laparoscopic Partial Nephrectomy [NCIt concept]
- Robot-assisted Nipple Sparing Mastectomy [NCIt concept]
- Robot-assisted Salvage Pelvic Mass Resection [NCIt concept]
- Robotic Bariatric Sleeve Gastrectomy [NCIt concept]
- Robotic Bronchoscopy [NCIt concept]
- Robotic Hysterectomy [NCIt concept]
- Robotic Uterine Manipulator [NCIt concept]
- Robotic Water Ablation Therapy [NCIt concept]
- Robotic-Assisted Imaging [NCIt concept]
- Rocakinogene Sifuplasmid [NCIt concept]
- Rocapuldencel-T [NCIt concept]
- Rocbrutinib [NCIt concept]
- Rociletinib [NCIt concept]
- Rocuronium [NCIt concept]
- Rocuronium Bromide [NCIt concept]
- Roducitabine [NCIt concept]
- Roflumilast [NCIt concept]
- Rogaratinib [NCIt concept]
- Rogocekib [NCIt concept]
- Romidepsin [NCIt concept]
- Romiplostim [NCIt concept]
- Romyelocel-L [NCIt concept]
- Rondecabtagene Autoleucel [NCIt concept]
- Roniciclib [NCIt concept]
- Ropeginterferon Alfa-2B [NCIt concept]
- Ropidoxuridine [NCIt concept]
- Ropivacaine Hydrochloride [NCIt concept]
- Ropocamptide [NCIt concept]
- Ropporin-1A [NCIt concept]
- Rosacea [NCIt concept]
- Rose Bengal Solution PV-10 [NCIt concept]
- Rose Geranium in Sesame Oil Nasal Spray [NCIt concept]
- Rosiglitazone [NCIt concept]
- Rosiglitazone Maleate [NCIt concept]
- Rosmantuzumab [NCIt concept]
- Rosuvastatin [NCIt concept]
- Rosuvastatin Calcium [NCIt concept]
- Roundabout Homolog 2 [NCIt concept]
- Roundabout Homolog 3 [NCIt concept]
- Roundabout Homolog 4 [NCIt concept]
- Rous Sarcoma Virus Positive [NCIt concept]
- Rovalpituzumab Tesirine [NCIt concept]
- Roxadustat [NCIt concept]
- Roxithromycin [NCIt concept]
- Rubidium Chloride Rb-82 [NCIt concept]
- Rucaparib [NCIt concept]
- Rucaparib Camsylate [NCIt concept]
- Rucaparib Phosphate [NCIt concept]
- Rucosopasem Manganese [NCIt concept]
- Runt-Related Transcription Factor 1 [NCIt concept]
- Runt-Related Transcription Factor 2 [NCIt concept]
- Runt-Related Transcription Factor 3 [NCIt concept]
- Rupitasertib [NCIt concept]
- Rusfertide [NCIt concept]
- Ruthenium Ru-106 [NCIt concept]
- Ruthenium-based Small Molecule Therapeutic BOLD-100 [NCIt concept]
- Ruxolitinib [NCIt concept]
- Ruxolitinib Phosphate [NCIt concept]
- Ruxolitinib Phosphate Cream [NCIt concept]
- Ryanodine Receptor 1 [NCIt concept]
- S-Adenosyl-L-Methionine Disulfate P-Toluene-Sulfonate [NCIt concept]
- S-Adenosylmethionine Synthase Isoform Type-2 [NCIt concept]
- S-Methyl-5'-Thioadenosine Phosphorylase [NCIt concept]
- S-Methylmethionine-Homocysteine S-Methyltransferase BHMT2 [NCIt concept]
- S-Nitroso-Hemoglobin [NCIt concept]
- S-Nitrosylation [NCIt concept]
- S-Phase Fraction [NCIt concept]
- S-Phenyl-N-Acetylcysteine [NCIt concept]
- S-equol [NCIt concept]
- S-warfarin [NCIt concept]
- S100 Calcium Binding Protein [NCIt concept]
- S100A10 Gene [NCIt concept]
- S100A10 wt Allele [NCIt concept]
- S100A4 Gene [NCIt concept]
- S100A4 wt Allele [NCIt concept]
- S100B Gene [NCIt concept]
- S100B Positive [NCIt concept]
- S100B wt Allele [NCIt concept]
- S100Z Gene [NCIt concept]
- S100Z wt Allele [NCIt concept]
- S1PR1 Gene [NCIt concept]
- S1PR1 wt Allele [NCIt concept]
- S1PR2 Gene [NCIt concept]
- S1PR2 wt Allele [NCIt concept]
- S1PR3 Gene [NCIt concept]
- S1PR3 wt Allele [NCIt concept]
- S1PR4 Gene [NCIt concept]
- S1PR4 wt Allele [NCIt concept]
- S1PR5 Gene [NCIt concept]
- S1PR5 wt Allele [NCIt concept]
- SAE Battery [NCIt concept]
- SAM Pointed Domain-Containing Ets Transcription Factor [NCIt concept]
- SAMD9 Gene [NCIt concept]
- SAMD9 Gene Mutation [NCIt concept]
- SAMD9 wt Allele [NCIt concept]
- SAMD9L Gene [NCIt concept]
- SAMD9L Gene Mutation [NCIt concept]
- SAMD9L wt Allele [NCIt concept]
- SAP Domain-Containing Ribonucleoprotein [NCIt concept]
- SAR1B Gene [NCIt concept]
- SAR1B wt Allele [NCIt concept]
- SARNP Gene [NCIt concept]
- SARNP wt Allele [NCIt concept]
- SARS Coronavirus 2 [NCIt concept]
- SARS Coronavirus 2 Antibody [NCIt concept]
- SARS Coronavirus 2 IgM Antibody Positive [NCIt concept]
- SARS Coronavirus 2 Negative [NCIt concept]
- SARS Coronavirus 2 Positive [NCIt concept]
- SARS Coronavirus 2 RNA Positive [NCIt concept]
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes [NCIt concept]
- SARS-CoV-2 IgG Antibody [NCIt concept]
- SARS-CoV-2 Nucleoprotein [NCIt concept]
- SARS-CoV-2 Spike Glycoprotein [NCIt concept]
- SARS-CoV-2 Spike Protein Antibody Measurement [NCIt concept]
- SARS-CoV-2 Spike Protein Plasmid DNA Vaccine CORVax [NCIt concept]
- SART1 Gene [NCIt concept]
- SART1 wt Allele [NCIt concept]
- SAT1 Gene [NCIt concept]
- SAT1 wt Allele [NCIt concept]
- SB-AS15 Adjuvant [NCIt concept]
- SBDS Gene [NCIt concept]
- SBDS Gene Mutation [NCIt concept]
- SBDS wt Allele [NCIt concept]
- SCARB1 Gene [NCIt concept]
- SCARB1 wt Allele [NCIt concept]
- SCD Gene [NCIt concept]
- SCD wt Allele [NCIt concept]
- SCD1 Inhibitor MTI-301 [NCIt concept]
- SCGB1D2 Gene [NCIt concept]
- SCGB1D2 wt Allele [NCIt concept]
- SCGB2A2 Gene [NCIt concept]
- SCGB2A2 Positive [NCIt concept]
- SCGB2A2 wt Allele [NCIt concept]
- SCGB3A1 Gene [NCIt concept]
- SCGB3A1 wt Allele [NCIt concept]
- SCHIP1 Gene [NCIt concept]
- SCHIP1 wt Allele [NCIt concept]
- SCHLAP1 Gene [NCIt concept]
- SCHLAP1 wt Allele [NCIt concept]
- SCID-Repopulating Cell [NCIt concept]
- SCL-Interrupting Locus Protein [NCIt concept]
- SCN1A Gene [NCIt concept]
- SCN1A wt Allele [NCIt concept]
- SCN9A Gene [NCIt concept]
- SCN9A wt Allele [NCIt concept]
- SCUBE2 Gene [NCIt concept]
- SCUBE2 wt Allele [NCIt concept]
- SDC1 Gene [NCIt concept]
- SDC1 Negative [NCIt concept]
- SDC1 wt Allele [NCIt concept]
- SDC2 Gene [NCIt concept]
- SDC2 wt Allele [NCIt concept]
- SDC3 Gene [NCIt concept]
- SDC3 wt Allele [NCIt concept]
- SDC4 Gene [NCIt concept]
- SDC4 wt Allele [NCIt concept]
- SDH Complex Alteration Positive [NCIt concept]
- SDH Complex Gene Mutation [NCIt concept]
- SDHA Gene [NCIt concept]
- SDHA Gene Mutation [NCIt concept]
- SDHA NM_004168.3:c.1660C>T [NCIt concept]
- SDHA NP_004159.2:p.R554W [NCIt concept]
- SDHA Protein Variant [NCIt concept]
- SDHA wt Allele [NCIt concept]
- SDHAF2 Gene [NCIt concept]
- SDHAF2 Gene Mutation [NCIt concept]
- SDHAF2 wt Allele [NCIt concept]
- SDHB Gene [NCIt concept]
- SDHB Gene Mutation [NCIt concept]
- SDHB Negative [NCIt concept]
- SDHB wt Allele [NCIt concept]
- SDHC Gene [NCIt concept]
- SDHC Gene Mutation [NCIt concept]
- SDHC wt Allele [NCIt concept]
- SDHD Gene [NCIt concept]
- SDHD Gene Mutation [NCIt concept]
- SDHD wt Allele [NCIt concept]
- SEC14-Like Protein 1 [NCIt concept]
- SEC14L1 Gene [NCIt concept]
- SEC14L1 wt Allele [NCIt concept]
- SEC16A Gene [NCIt concept]
- SEC16A wt Allele [NCIt concept]
- SEC22B Gene [NCIt concept]
- SEC22B wt Allele [NCIt concept]
- SEC31A Gene [NCIt concept]
- SEC31A wt Allele [NCIt concept]
- SEER Sonorheometry Coagulation Monitoring [NCIt concept]
- SEL1L Gene [NCIt concept]
- SEL1L wt Allele [NCIt concept]
- SELE Gene [NCIt concept]
- SELE Positive [NCIt concept]
- SELE wt Allele [NCIt concept]
- SELENOF Gene [NCIt concept]
- SELENOF wt Allele [NCIt concept]
- SELENOP Gene [NCIt concept]
- SELENOP wt Allele [NCIt concept]
- SELL Gene [NCIt concept]
- SELL wt Allele [NCIt concept]
- SELP Gene [NCIt concept]
- SELP wt Allele [NCIt concept]
- SELPLG Gene [NCIt concept]
- SELPLG wt Allele [NCIt concept]
- SEM1 Gene [NCIt concept]
- SEM1 Gene Mutation [NCIt concept]
- SEM1 wt Allele [NCIt concept]
- SEMA3F Gene [NCIt concept]
- SEMA3F wt Allele [NCIt concept]
- SEMA4D Gene [NCIt concept]
- SEMA4D wt Allele [NCIt concept]
- SEMA6A Gene [NCIt concept]
- SEMA6A wt Allele [NCIt concept]
- SENP1 Gene [NCIt concept]
- SENP1 wt Allele [NCIt concept]
- SENP1/MESDC2 Fusion Gene [NCIt concept]
- SENP1/MESDC2 Fusion Protein [NCIt concept]
- SENP6 Gene [NCIt concept]
- SENP6 wt Allele [NCIt concept]
- SENP6/NKAIN2 Fusion Gene [NCIt concept]
- SEPTIN4 Gene [NCIt concept]
- SEPTIN4 wt Allele [NCIt concept]
- SEPTIN5 Gene [NCIt concept]
- SEPTIN5 wt Allele [NCIt concept]
- SEPTIN6 Gene [NCIt concept]
- SEPTIN6 wt Allele [NCIt concept]
- SEPTIN8 Gene [NCIt concept]
- SEPTIN8 wt Allele [NCIt concept]
- SEPTIN9 Gene [NCIt concept]
- SEPTIN9 wt Allele [NCIt concept]
- SERD ZN-c5 [NCIt concept]
- SERPINA1 Gene [NCIt concept]
- SERPINA1 wt Allele [NCIt concept]
- SERPINA3 Gene [NCIt concept]
- SERPINA3 wt Allele [NCIt concept]
- SERPINA7 Gene [NCIt concept]
- SERPINA7 wt Allele [NCIt concept]
- SERPINA9 Gene [NCIt concept]
- SERPINA9 wt Allele [NCIt concept]
- SERPINB9 Gene [NCIt concept]
- SERPINB9 wt Allele [NCIt concept]
- SERPINC1 Gene [NCIt concept]
- SERPINC1 wt Allele [NCIt concept]
- SERPIND1 Gene [NCIt concept]
- SERPIND1 wt Allele [NCIt concept]
- SERPINE1 Gene [NCIt concept]
- SERPINE1 wt Allele [NCIt concept]
- SERPINF1 Gene [NCIt concept]
- SERPINF1 wt Allele [NCIt concept]
- SERPINF2 Gene [NCIt concept]
- SERPINF2 wt Allele [NCIt concept]
- SESN3 Gene [NCIt concept]
- SESN3 wt Allele [NCIt concept]
- SET Gene [NCIt concept]
- SET wt Allele [NCIt concept]
- SET-Binding Protein [NCIt concept]
- SET/NUP214 Fusion Gene [NCIt concept]
- SET/NUP214 Fusion Protein [NCIt concept]
- SETBP1 Gene [NCIt concept]
- SETBP1 Gene Mutation [NCIt concept]
- SETBP1 wt Allele [NCIt concept]
- SETD2 Gene [NCIt concept]
- SETD2 Gene Mutation [NCIt concept]
- SETD2 wt Allele [NCIt concept]
- SETMAR Gene [NCIt concept]
- SETMAR wt Allele [NCIt concept]
- SEZ6 Gene [NCIt concept]
- SEZ6 wt Allele [NCIt concept]
- SF3B1 Gene [NCIt concept]
- SF3B1 Gene Mutation [NCIt concept]
- SF3B1 Gene Mutation Negative [NCIt concept]
- SF3B1 NP_036565.2:p.A774X [NCIt concept]
- SF3B1 NP_036565.2:p.D781X [NCIt concept]
- SF3B1 NP_036565.2:p.E622X [NCIt concept]
- SF3B1 NP_036565.2:p.G740X [NCIt concept]
- SF3B1 NP_036565.2:p.G742X [NCIt concept]
- SF3B1 NP_036565.2:p.H662X [NCIt concept]
- SF3B1 NP_036565.2:p.I704X [NCIt concept]
- SF3B1 NP_036565.2:p.K666X [NCIt concept]
- SF3B1 NP_036565.2:p.K700X [NCIt concept]
- SF3B1 NP_036565.2:p.K741X [NCIt concept]
- SF3B1 NP_036565.2:p.N626X [NCIt concept]
- SF3B1 NP_036565.2:p.R625X [NCIt concept]
- SF3B1 NP_036565.2:p.T663X [NCIt concept]
- SF3B1 NP_036565.2:p.V701X [NCIt concept]
- SF3B1 NP_036565.2:p.Y623X [NCIt concept]
- SF3B1 Protein Variant [NCIt concept]
- SF3B1 wt Allele [NCIt concept]
- SF3B3 Gene [NCIt concept]
- SF3B3 wt Allele [NCIt concept]
- SFN Gene [NCIt concept]
- SFN wt Allele [NCIt concept]
- SFPQ Gene [NCIt concept]
- SFPQ wt Allele [NCIt concept]
- SFPQ/TFE3 Fusion Gene [NCIt concept]
- SFPQ/TFE3 Fusion Protein [NCIt concept]
- SFRP1 Gene [NCIt concept]
- SFRP1 wt Allele [NCIt concept]
- SFRP2 Gene [NCIt concept]
- SFRP2 wt Allele [NCIt concept]
- SFRP4 Gene [NCIt concept]
- SFRP4 wt Allele [NCIt concept]
- SFRP5 Gene [NCIt concept]
- SFRP5 wt Allele [NCIt concept]
- SGLT2 Inhibitor [NCIt concept]
- SGMS1 Gene [NCIt concept]
- SGMS1 wt Allele [NCIt concept]
- SGMS2 Gene [NCIt concept]
- SGMS2 wt Allele [NCIt concept]
- SGPL1 Gene [NCIt concept]
- SGPL1 wt Allele [NCIt concept]
- SGPP1 Gene [NCIt concept]
- SGPP1 wt Allele [NCIt concept]
- SGPP2 Gene [NCIt concept]
- SGPP2 wt Allele [NCIt concept]
- SH2 Domain-Containing Protein 1A [NCIt concept]
- SH2 Domain-Containing Protein 1B [NCIt concept]
- SH2B Adapter Protein 3 [NCIt concept]
- SH2B3 Gene [NCIt concept]
- SH2B3 Gene Deletion [NCIt concept]
- SH2B3 wt Allele [NCIt concept]
- SH2D1A Gene [NCIt concept]
- SH2D1A Gene Mutation [NCIt concept]
- SH2D1A wt Allele [NCIt concept]
- SH2D1B Gene [NCIt concept]
- SH2D1B wt Allele [NCIt concept]
- SH3 Domain-Containing Protein 19 [NCIt concept]
- SH3D19 Gene [NCIt concept]
- SH3D19 wt Allele [NCIt concept]
- SH3GL1 Gene [NCIt concept]
- SH3GL1 wt Allele [NCIt concept]
- SHBG Gene [NCIt concept]
- SHBG wt Allele [NCIt concept]
- SHC-Transforming Protein 1 [NCIt concept]
- SHC1 Gene [NCIt concept]
- SHC1 wt Allele [NCIt concept]
- SHH Gene [NCIt concept]
- SHH Negative [NCIt concept]
- SHH Pathway Activation Negative [NCIt concept]
- SHH Positive [NCIt concept]
- SHH wt Allele [NCIt concept]
- SHMT1 Gene [NCIt concept]
- SHMT1 wt Allele [NCIt concept]
- SHOC2 Gene [NCIt concept]
- SHOC2 Gene Mutation [NCIt concept]
- SHOC2 wt Allele [NCIt concept]
- SHP2 Inhibitor BBP-398 [NCIt concept]
- SHP2 Inhibitor ERAS-601 [NCIt concept]
- SHP2 Inhibitor HBI-2376 [NCIt concept]
- SHP2 Inhibitor JAB-3312 [NCIt concept]
- SHP2 Inhibitor PF-07284892 [NCIt concept]
- SHROOM2 Gene [NCIt concept]
- SHROOM2 wt Allele [NCIt concept]
- SHROOM3 Gene [NCIt concept]
- SHROOM3 wt Allele [NCIt concept]
- SHTN1 Gene [NCIt concept]
- SHTN1 wt Allele [NCIt concept]
- SIGLEC15 Gene [NCIt concept]
- SIGLEC15 wt Allele [NCIt concept]
- SIGLEC9 Gene [NCIt concept]
- SIGLEC9 wt Allele [NCIt concept]
- SIGMAR1 Gene [NCIt concept]
- SIGMAR1 wt Allele [NCIt concept]
- SIK2 Gene [NCIt concept]
- SIK2 wt Allele [NCIt concept]
- SIRP-alpha-Fc Fusion Protein HCB101 [NCIt concept]
- SIRPA Gene [NCIt concept]
- SIRPA V2 Allele [NCIt concept]
- SIRPA V2/V2 Genotype Positive [NCIt concept]
- SIRPA wt Allele [NCIt concept]
- SIRPa-4-1BBL Fusion Protein DSP107 [NCIt concept]
- SIRPa-Fc-CD40L Fusion Protein SL-172154 [NCIt concept]
- SIRPa-targeting Agent [NCIt concept]
- SIRT1 Gene [NCIt concept]
- SIRT1 wt Allele [NCIt concept]
- SIRT2 Gene [NCIt concept]
- SIRT2 wt Allele [NCIt concept]
- SIX1 Gene [NCIt concept]
- SIX1 Gene Mutation [NCIt concept]
- SIX1 wt Allele [NCIt concept]
- SIX2 Gene [NCIt concept]
- SIX2 Gene Mutation [NCIt concept]
- SIX2 wt Allele [NCIt concept]
- SIX4 Gene [NCIt concept]
- SIX4 wt Allele [NCIt concept]
- SIX5 Gene [NCIt concept]
- SIX5 wt Allele [NCIt concept]
- SKAP1 Gene [NCIt concept]
- SKAP1 wt Allele [NCIt concept]
- SLAM Family Member 6 [NCIt concept]
- SLAM Family Member 7 [NCIt concept]
- SLAMF1 Gene [NCIt concept]
- SLAMF1 wt Allele [NCIt concept]
- SLAMF6 Gene [NCIt concept]
- SLAMF6 wt Allele [NCIt concept]
- SLAMF7 Gene [NCIt concept]
- SLAMF7 Positive [NCIt concept]
- SLAMF7 wt Allele [NCIt concept]
- SLC16A1 Gene [NCIt concept]
- SLC16A1 wt Allele [NCIt concept]
- SLC16A3 Gene [NCIt concept]
- SLC16A3 wt Allele [NCIt concept]
- SLC16A4 Gene [NCIt concept]
- SLC16A4 wt Allele [NCIt concept]
- SLC18A1 Gene [NCIt concept]
- SLC18A1 wt Allele [NCIt concept]
- SLC18A2 Gene [NCIt concept]
- SLC18A2 wt Allele [NCIt concept]
- SLC19A1 Gene [NCIt concept]
- SLC19A1 Gene Mutation [NCIt concept]
- SLC19A1 wt Allele [NCIt concept]
- SLC1A4 Gene [NCIt concept]
- SLC1A4 wt Allele [NCIt concept]
- SLC1A5 Gene [NCIt concept]
- SLC1A5 wt Allele [NCIt concept]
- SLC22A1 Gene [NCIt concept]
- SLC22A1 wt Allele [NCIt concept]
- SLC22A2 Gene [NCIt concept]
- SLC22A2 wt Allele [NCIt concept]
- SLC22A3 Gene [NCIt concept]
- SLC22A3 wt Allele [NCIt concept]
- SLC26A6 Gene [NCIt concept]
- SLC26A6 wt Allele [NCIt concept]
- SLC28A1 Gene [NCIt concept]
- SLC28A1 wt Allele [NCIt concept]
- SLC28A2 Gene [NCIt concept]
- SLC28A2 wt Allele [NCIt concept]
- SLC28A3 Gene [NCIt concept]
- SLC28A3 wt Allele [NCIt concept]
- SLC29A1 Gene [NCIt concept]
- SLC29A1 wt Allele [NCIt concept]
- SLC29A2 Gene [NCIt concept]
- SLC29A2 wt Allele [NCIt concept]
- SLC29A4 Gene [NCIt concept]
- SLC29A4 wt Allele [NCIt concept]
- SLC2A2 Gene [NCIt concept]
- SLC2A2 wt Allele [NCIt concept]
- SLC2A3 Gene [NCIt concept]
- SLC2A3 wt Allele [NCIt concept]
- SLC2A3P1 Gene [NCIt concept]
- SLC30A8 Autoantibody [NCIt concept]
- SLC30A8 Gene [NCIt concept]
- SLC30A8 wt Allele [NCIt concept]
- SLC31A1 Gene [NCIt concept]
- SLC31A1 wt Allele [NCIt concept]
- SLC34A2 Gene [NCIt concept]
- SLC34A2 wt Allele [NCIt concept]
- SLC35B2 Gene [NCIt concept]
- SLC35B2 wt Allele [NCIt concept]
- SLC36A1 Gene [NCIt concept]
- SLC36A1 wt Allele [NCIt concept]
- SLC37A4 Gene [NCIt concept]
- SLC37A4 Gene Mutation [NCIt concept]
- SLC37A4 Loss of Function Gene Mutation [NCIt concept]
- SLC37A4 wt Allele [NCIt concept]
- SLC38A3 Gene [NCIt concept]
- SLC38A3 wt Allele [NCIt concept]
- SLC39A6 Gene [NCIt concept]
- SLC39A6 Positive [NCIt concept]
- SLC39A6 wt Allele [NCIt concept]
- SLC3A2 Gene [NCIt concept]
- SLC3A2 wt Allele [NCIt concept]
- SLC43A1 Gene [NCIt concept]
- SLC43A1 wt Allele [NCIt concept]
- SLC43A2 Gene [NCIt concept]
- SLC43A2 wt Allele [NCIt concept]
- SLC44A1 Gene [NCIt concept]
- SLC44A1 wt Allele [NCIt concept]
- SLC44A4 Gene [NCIt concept]
- SLC44A4 wt Allele [NCIt concept]
- SLC45A2 Gene [NCIt concept]
- SLC45A2 Positive [NCIt concept]
- SLC45A2 wt Allele [NCIt concept]
- SLC45A3 Gene [NCIt concept]
- SLC45A3 wt Allele [NCIt concept]
- SLC46A1 Gene [NCIt concept]
- SLC46A1 wt Allele [NCIt concept]
- SLC47A1 Gene [NCIt concept]
- SLC47A1 wt Allele [NCIt concept]
- SLC47A2 Gene [NCIt concept]
- SLC47A2 wt Allele [NCIt concept]
- SLC4A1 Gene [NCIt concept]
- SLC4A1 wt Allele [NCIt concept]
- SLC4A3 Gene [NCIt concept]
- SLC4A3 wt Allele [NCIt concept]
- SLC5A1 Gene [NCIt concept]
- SLC5A1 wt Allele [NCIt concept]
- SLC5A2 Gene [NCIt concept]
- SLC5A2 wt Allele [NCIt concept]
- SLC5A5 Gene [NCIt concept]
- SLC5A5 Positive [NCIt concept]
- SLC5A5 wt Allele [NCIt concept]
- SLC5A8 Gene [NCIt concept]
- SLC5A8 wt Allele [NCIt concept]
- SLC6A2 Gene [NCIt concept]
- SLC6A2 wt Allele [NCIt concept]
- SLC6A3 Gene [NCIt concept]
- SLC6A3 wt Allele [NCIt concept]
- SLC6A4 Gene [NCIt concept]
- SLC6A4 wt Allele [NCIt concept]
- SLC6A8 Gene [NCIt concept]
- SLC6A8 Positive [NCIt concept]
- SLC6A8 wt Allele [NCIt concept]
- SLC7A11 Gene [NCIt concept]
- SLC7A5 Gene [NCIt concept]
- SLC7A5 wt Allele [NCIt concept]
- SLC7A6 Gene [NCIt concept]
- SLC7A6 wt Allele [NCIt concept]
- SLC7A7 Gene [NCIt concept]
- SLC7A7 wt Allele [NCIt concept]
- SLC7A8 Gene [NCIt concept]
- SLC7A8 wt Allele [NCIt concept]
- SLC8A1 Gene [NCIt concept]
- SLC8A1 wt Allele [NCIt concept]
- SLC9A1 Gene [NCIt concept]
- SLC9A1 wt Allele [NCIt concept]
- SLCO1B1 Gene [NCIt concept]
- SLCO1B1 wt Allele [NCIt concept]
- SLCO1B3 Gene [NCIt concept]
- SLCO1B3 Gene Positive [NCIt concept]
- SLCO1B3 wt Allele [NCIt concept]
- SLCO2B1 Gene [NCIt concept]
- SLCO2B1 wt Allele [NCIt concept]
- SLFN11 Gene [NCIt concept]
- SLFN11 Negative [NCIt concept]
- SLFN11 Positive [NCIt concept]
- SLFN11 wt Allele [NCIt concept]
- SLFN12 Gene [NCIt concept]
- SLFN12 Positive [NCIt concept]
- SLFN12 wt Allele [NCIt concept]
- SLIT and NTRK-Like Protein 6 [NCIt concept]
- SLIT-ROBO Rho GTPase-Activating Protein 3 [NCIt concept]
- SLIT1 Gene [NCIt concept]
- SLIT1 wt Allele [NCIt concept]
- SLIT2 Gene [NCIt concept]
- SLIT2 wt Allele [NCIt concept]
- SLIT3 Gene [NCIt concept]
- SLIT3 wt Allele [NCIt concept]
- SLITRK6 Gene [NCIt concept]
- SLITRK6 wt Allele [NCIt concept]
- SLPI Gene [NCIt concept]
- SLPI wt Allele [NCIt concept]
- SLX4 Gene [NCIt concept]
- SLX4 Gene Mutation [NCIt concept]
- SLX4 wt Allele [NCIt concept]
- SMAD1 Gene [NCIt concept]
- SMAD1 wt Allele [NCIt concept]
- SMAD2 Gene [NCIt concept]
- SMAD2 wt Allele [NCIt concept]
- SMAD3 Gene [NCIt concept]
- SMAD3 wt Allele [NCIt concept]
- SMAD4 Gene [NCIt concept]
- SMAD4 Gene Mutation [NCIt concept]
- SMAD4 wt Allele [NCIt concept]
- SMAD5 Gene [NCIt concept]
- SMAD5 wt Allele [NCIt concept]
- SMARCA2 Degrader PRT3789 [NCIt concept]
- SMARCA2 Degrader PRT7732 [NCIt concept]
- SMARCA2 Gene [NCIt concept]
- SMARCA2 Gene Inactivation [NCIt concept]
- SMARCA2 Gene Mutation [NCIt concept]
- SMARCA2 Inhibitor [NCIt concept]
- SMARCA2 Inhibitor LY4050784 [NCIt concept]
- SMARCA2 wt Allele [NCIt concept]
- SMARCA4 Deficient Tumor [NCIt concept]
- SMARCA4 Gene [NCIt concept]
- SMARCA4 Gene Inactivation [NCIt concept]
- SMARCA4 Gene Mutation [NCIt concept]
- SMARCA4 Inhibitor [NCIt concept]
- SMARCA4 Negative [NCIt concept]
- SMARCA4 wt Allele [NCIt concept]
- SMARCA5 Gene [NCIt concept]
- SMARCA5 wt Allele [NCIt concept]
- SMARCB1 Gene [NCIt concept]
- SMARCB1 Gene Inactivation [NCIt concept]
- SMARCB1 Gene Mutation [NCIt concept]
- SMARCB1 Negative [NCIt concept]
- SMARCB1 Positive [NCIt concept]
- SMARCB1 wt Allele [NCIt concept]
- SMC1A Gene [NCIt concept]
- SMC1A wt Allele [NCIt concept]
- SMC3 Gene [NCIt concept]
- SMC3 Gene Mutation [NCIt concept]
- SMC3 wt Allele [NCIt concept]
- SMG1 Gene [NCIt concept]
- SMG1 wt Allele [NCIt concept]
- SMN1 Gene [NCIt concept]
- SMN1 wt Allele [NCIt concept]
- SMN2 Gene [NCIt concept]
- SMN2 wt Allele [NCIt concept]
- SMO Gene [NCIt concept]
- SMO Gene Mutation [NCIt concept]
- SMO NM_005631.5:c.1222A>G [NCIt concept]
- SMO NM_005631.5:c.1234C>T [NCIt concept]
- SMO NM_005631.5:c.1552G>A [NCIt concept]
- SMO NM_005631.5:c.1553A>C [NCIt concept]
- SMO NM_005631.5:c.1573A>T [NCIt concept]
- SMO NM_005631.5:c.1598G>A [NCIt concept]
- SMO NM_005631.5:c.1921C>G [NCIt concept]
- SMO NM_005631.5:c.655A>G [NCIt concept]
- SMO NM_005631.5:c.662T>G [NCIt concept]
- SMO NM_005631.5:c.961G>A [NCIt concept]
- SMO NP_005622.1:p.E518A [NCIt concept]
- SMO NP_005622.1:p.E518K [NCIt concept]
- SMO NP_005622.1:p.I408V [NCIt concept]
- SMO NP_005622.1:p.L221R [NCIt concept]
- SMO NP_005622.1:p.L412F [NCIt concept]
- SMO NP_005622.1:p.M525L [NCIt concept]
- SMO NP_005622.1:p.N219D [NCIt concept]
- SMO NP_005622.1:p.P641A [NCIt concept]
- SMO NP_005622.1:p.S533N [NCIt concept]
- SMO NP_005622.1:p.V321M [NCIt concept]
- SMO wt Allele [NCIt concept]
- SMPD1 Gene [NCIt concept]
- SMPD1 wt Allele [NCIt concept]
- SMPD2 Gene [NCIt concept]
- SMPD2 wt Allele [NCIt concept]
- SMPD3 Gene [NCIt concept]
- SMPD3 wt Allele [NCIt concept]
- SMPD4 Gene [NCIt concept]
- SMPD4 wt Allele [NCIt concept]
- SNAI2 Gene [NCIt concept]
- SNAI2 wt Allele [NCIt concept]
- SNAP25 Gene [NCIt concept]
- SNAP25 wt Allele [NCIt concept]
- SNCAIP Gene [NCIt concept]
- SNCAIP wt Allele [NCIt concept]
- SNCG Gene [NCIt concept]
- SNCG wt Allele [NCIt concept]
- SNRPN Upstream Reading Frame Protein [NCIt concept]
- SNS01-T Nanoparticles [NCIt concept]
- SNURF Gene [NCIt concept]
- SNURF wt Allele [NCIt concept]
- SNX29 Gene [NCIt concept]
- SNX29 wt Allele [NCIt concept]
- SOCS1 Gene [NCIt concept]
- SOCS1 wt Allele [NCIt concept]
- SOCS2 Gene [NCIt concept]
- SOCS2 wt Allele [NCIt concept]
- SOCS3 Gene [NCIt concept]
- SOCS3 wt Allele [NCIt concept]
- SOD1 Gene [NCIt concept]
- SOD1 wt Allele [NCIt concept]
- SOD2 Gene [NCIt concept]
- SOD2 wt Allele [NCIt concept]
- SOD3 Gene [NCIt concept]
- SOD3 wt Allele [NCIt concept]
- SORT1 Gene [NCIt concept]
- SORT1 wt Allele [NCIt concept]
- SOS1 Gene [NCIt concept]
- SOS1 Gene Mutation [NCIt concept]
- SOS1 Inhibitor KQB198 [NCIt concept]
- SOS1 Inhibitor MRTX0902 [NCIt concept]
- SOS1 wt Allele [NCIt concept]
- SOST Gene [NCIt concept]
- SOST wt Allele [NCIt concept]
- SOX10 Gene [NCIt concept]
- SOX10 wt Allele [NCIt concept]
- SOX11 Gene [NCIt concept]
- SOX11 Positive [NCIt concept]
- SOX11 wt Allele [NCIt concept]
- SOX17 Gene [NCIt concept]
- SOX17 wt Allele [NCIt concept]
- SOX2 Gene [NCIt concept]
- SOX2 wt Allele [NCIt concept]
- SOX9 Gene [NCIt concept]
- SOX9 Gene Mutation [NCIt concept]
- SOX9 wt Allele [NCIt concept]
- SP1 Gene [NCIt concept]
- SP1 wt Allele [NCIt concept]
- SP3 Gene [NCIt concept]
- SP3 wt Allele [NCIt concept]
- SPA17 Gene [NCIt concept]
- SPA17 Positive [NCIt concept]
- SPA17 wt Allele [NCIt concept]
- SPAG11B Gene [NCIt concept]
- SPAG11B wt Allele [NCIt concept]
- SPANXB1 Gene [NCIt concept]
- SPANXB1 Positive [NCIt concept]
- SPANXB1 wt Allele [NCIt concept]
- SPARC-Like Protein 1 [NCIt concept]
- SPARCL1 Gene [NCIt concept]
- SPARCL1 wt Allele [NCIt concept]
- SPATA20 Gene [NCIt concept]
- SPATA20 wt Allele [NCIt concept]
- SPATS2-Like Protein [NCIt concept]
- SPATS2L Gene [NCIt concept]
- SPATS2L wt Allele [NCIt concept]
- SPDEF Gene [NCIt concept]
- SPDEF wt Allele [NCIt concept]
- SPECC1 Gene [NCIt concept]
- SPECC1 wt Allele [NCIt concept]
- SPECC1/PDGFRB Fusion Gene [NCIt concept]
- SPECC1/PDGFRB Fusion Protein [NCIt concept]
- SPHK1 Gene [NCIt concept]
- SPHK1 wt Allele [NCIt concept]
- SPHK2 Gene [NCIt concept]
- SPHK2 wt Allele [NCIt concept]
- SPHKAP Gene [NCIt concept]
- SPHKAP wt Allele [NCIt concept]
- SPI1 Gene [NCIt concept]
- SPI1 wt Allele [NCIt concept]
- SPIB Gene [NCIt concept]
- SPIB wt Allele [NCIt concept]
- SPINK1 Gene [NCIt concept]
- SPINK1 wt Allele [NCIt concept]
- SPINT1 Gene [NCIt concept]
- SPINT1 wt Allele [NCIt concept]
- SPN Gene [NCIt concept]
- SPN Positive [NCIt concept]
- SPN wt Allele [NCIt concept]
- SPOP Gene [NCIt concept]
- SPOP Gene Mutation [NCIt concept]
- SPOP wt Allele [NCIt concept]
- SPP1 Gene [NCIt concept]
- SPP1 wt Allele [NCIt concept]
- SPRED1 Gene [NCIt concept]
- SPRED1 Gene Mutation [NCIt concept]
- SPRED1 wt Allele [NCIt concept]
- SPRY1 Gene [NCIt concept]
- SPRY1 wt Allele [NCIt concept]
- SPRY2 Gene [NCIt concept]
- SPRY2 wt Allele [NCIt concept]
- SPRY4 Gene [NCIt concept]
- SPRY4 wt Allele [NCIt concept]
- SPTBN2 Gene [NCIt concept]
- SPTBN2 wt Allele [NCIt concept]
- SPTLC1 Gene [NCIt concept]
- SPTLC1 wt Allele [NCIt concept]
- SPY Elite Fluorescence Imaging [NCIt concept]
- SQSTM1 Gene [NCIt concept]
- SQSTM1 wt Allele [NCIt concept]
- SR Mitomycin Intravesical Solution [NCIt concept]
- SRC Family Tyrosine Kinase [NCIt concept]
- SRC Gene [NCIt concept]
- SRC Gene Mutation [NCIt concept]
- SRC Substrate Cortactin [NCIt concept]
- SRC wt Allele [NCIt concept]
- SRC/YES1 Kinase Inhibitor NXP900 [NCIt concept]
- SRD5A1 Gene [NCIt concept]
- SRD5A1 wt Allele [NCIt concept]
- SRD5A2 Gene [NCIt concept]
- SRD5A2 wt Allele [NCIt concept]
- SRD5A3 Gene [NCIt concept]
- SRD5A3 wt Allele [NCIt concept]
- SREBF1 Gene [NCIt concept]
- SREBF1 wt Allele [NCIt concept]
- SRGAP3 Gene [NCIt concept]
- SRGAP3 wt Allele [NCIt concept]
- SRGAP3/RAF1 Fusion Gene [NCIt concept]
- SRGAP3/RAF1 Fusion Protein [NCIt concept]
- SRSF1 Gene [NCIt concept]
- SRSF1 wt Allele [NCIt concept]
- SRSF2 Gene [NCIt concept]
- SRSF2 Gene Deletion [NCIt concept]
- SRSF2 Gene Mutation [NCIt concept]
- SRSF2 Gene Mutation Negative [NCIt concept]
- SRSF2 NP_003007.2:p.P95 Deletion [NCIt concept]
- SRSF2 NP_003007.2:p.P95X [NCIt concept]
- SRSF2 Protein Variant [NCIt concept]
- SRSF2 wt Allele [NCIt concept]
- SRSF3 Gene [NCIt concept]
- SRSF3 wt Allele [NCIt concept]
- SRXN1 Gene [NCIt concept]
- SRXN1 wt Allele [NCIt concept]
- SS1(dsFv)-PE38 Immunotoxin [NCIt concept]
- SS18 Gene [NCIt concept]
- SS18 Gene Mutation [NCIt concept]
- SS18 wt Allele [NCIt concept]
- SS18/SSX Rearrangement Positive [NCIt concept]
- SS18/SSX1 Fusion Gene [NCIt concept]
- SS18/SSX1 Fusion Protein [NCIt concept]
- SS18/SSX2 Fusion Gene [NCIt concept]
- SS18/SSX2 Fusion Protein [NCIt concept]
- SS18/SSX4 Fusion Gene [NCIt concept]
- SS18/SSX4 Fusion Protein [NCIt concept]
- SS18L1 Gene [NCIt concept]
- SS18L1 wt Allele [NCIt concept]
- SSBP1 Gene [NCIt concept]
- SSBP1 Gene Mutation [NCIt concept]
- SSBP1 wt Allele [NCIt concept]
- SSBP2 Gene [NCIt concept]
- SSBP2 wt Allele [NCIt concept]
- SSEA-4 Antigen [NCIt concept]
- SSH2 Gene [NCIt concept]
- SSH2 wt Allele [NCIt concept]
- SSRP1 Gene [NCIt concept]
- SSRP1 wt Allele [NCIt concept]
- SSTR1 Gene [NCIt concept]
- SSTR1 wt Allele [NCIt concept]
- SSTR2 Gene [NCIt concept]
- SSTR2 Gene Product [NCIt concept]
- SSTR2 wt Allele [NCIt concept]
- SSTR2-targeted Radioligand Therapy [NCIt concept]
- SSTR3 Gene [NCIt concept]
- SSTR3 wt Allele [NCIt concept]
- SSTR4 Gene [NCIt concept]
- SSTR4 wt Allele [NCIt concept]
- SSTR5 Gene [NCIt concept]
- SSTR5 wt Allele [NCIt concept]
- SSX1 Gene [NCIt concept]
- SSX1 wt Allele [NCIt concept]
- SSX2 Gene [NCIt concept]
- SSX2 Positive [NCIt concept]
- SSX2 wt Allele [NCIt concept]
- SSX2B Gene [NCIt concept]
- SSX2B wt Allele [NCIt concept]
- SSX4 Gene [NCIt concept]
- SSX4 wt Allele [NCIt concept]
- SSX4B Gene [NCIt concept]
- SSX4B wt Allele [NCIt concept]
- ST14 Gene [NCIt concept]
- ST14 wt Allele [NCIt concept]
- ST2 Gene [NCIt concept]
- ST7 Gene [NCIt concept]
- ST7 wt Allele [NCIt concept]
- STAB1 Gene [NCIt concept]
- STAB1 wt Allele [NCIt concept]
- STAG2 Gene [NCIt concept]
- STAG2 Gene Mutation [NCIt concept]
- STAG2 wt Allele [NCIt concept]
- STAT Family Gene Mutation [NCIt concept]
- STAT Inhibitor OPB-111077 [NCIt concept]
- STAT1 Gene [NCIt concept]
- STAT1 wt Allele [NCIt concept]
- STAT3 Degrader KT-333 [NCIt concept]
- STAT3 Gene [NCIt concept]
- STAT3 Gene Mutation [NCIt concept]
- STAT3 Inhibitor [NCIt concept]
- STAT3 Inhibitor C-188-9 [NCIt concept]
- STAT3 Inhibitor DSP-0337 [NCIt concept]
- STAT3 Inhibitor OPB-31121 [NCIt concept]
- STAT3 Inhibitor OPB-51602 [NCIt concept]
- STAT3 Inhibitor VVD-130850 [NCIt concept]
- STAT3 Inhibitor WP1066 [NCIt concept]
- STAT3 wt Allele [NCIt concept]
- STAT5 Protein Family [NCIt concept]
- STAT5B Gene [NCIt concept]
- STAT5B wt Allele [NCIt concept]
- STAT5B/RARA Fusion Gene [NCIt concept]
- STAT5B/RARA Fusion Protein [NCIt concept]
- STAT6 Gene [NCIt concept]
- STAT6 wt Allele [NCIt concept]
- STEAP1 Gene [NCIt concept]
- STEAP1 Positive [NCIt concept]
- STEAP1 wt Allele [NCIt concept]
- STEAP1-targeting Agent [NCIt concept]
- STEAP2 Gene [NCIt concept]
- STEAP2 wt Allele [NCIt concept]
- STEPS to Enhance Physical Activity [NCIt concept]
- STIL Gene [NCIt concept]
- STIL wt Allele [NCIt concept]
- STING Agonist [NCIt concept]
- STING Agonist BI 1387446 [NCIt concept]
- STING Agonist BI 1703880 [NCIt concept]
- STING Agonist BMS-986301 [NCIt concept]
- STING Agonist CRD3874 [NCIt concept]
- STING Agonist GSK3745417 [NCIt concept]
- STING Agonist IMSA101 [NCIt concept]
- STING Agonist MK-2118 [NCIt concept]
- STING Agonist PF-07820435 [NCIt concept]
- STING Agonist SB 11285 [NCIt concept]
- STING Agonist SNX281 [NCIt concept]
- STING Agonist-containing PTGFRN-expressing Exosomes CDK002 [NCIt concept]
- STING-expressing E. coli SYNB1891 [NCIt concept]
- STING1 Gene [NCIt concept]
- STING1 wt Allele [NCIt concept]
- STIP1 Gene [NCIt concept]
- STIP1 wt Allele [NCIt concept]
- STK11 Gene [NCIt concept]
- STK11 Gene Mutation [NCIt concept]
- STK11 Gene Rearrangement [NCIt concept]
- STK11 Protein Variant [NCIt concept]
- STK11 wt Allele [NCIt concept]
- STK33 Gene [NCIt concept]
- STK33 wt Allele [NCIt concept]
- STK35 Gene [NCIt concept]
- STK35 wt Allele [NCIt concept]
- STMN1 Gene [NCIt concept]
- STMN1 wt Allele [NCIt concept]
- STRA6 Gene [NCIt concept]
- STRA6 wt Allele [NCIt concept]
- STRA8 Gene [NCIt concept]
- STRA8 wt Allele [NCIt concept]
- STRN Gene [NCIt concept]
- STRN wt Allele [NCIt concept]
- STS Gene [NCIt concept]
- STS wt Allele [NCIt concept]
- STX11 Gene [NCIt concept]
- STX11 Gene Mutation [NCIt concept]
- STX11 wt Allele [NCIt concept]
- STXBP2 Gene [NCIt concept]
- STXBP2 Gene Mutation [NCIt concept]
- STXBP2 wt Allele [NCIt concept]
- SUFU Gene [NCIt concept]
- SUFU Gene Mutation [NCIt concept]
- SUFU wt Allele [NCIt concept]
- SULF2 Gene [NCIt concept]
- SULF2 wt Allele [NCIt concept]
- SULT1A1 Gene [NCIt concept]
- SULT1A1 wt Allele [NCIt concept]
- SULT1C2 Gene [NCIt concept]
- SULT1C2 wt Allele [NCIt concept]
- SULT1E1 Gene [NCIt concept]
- SULT1E1 wt Allele [NCIt concept]
- SUMF1 Gene [NCIt concept]
- SUMF1 wt Allele [NCIt concept]
- SUMO1 Gene [NCIt concept]
- SUMO1 wt Allele [NCIt concept]
- SUPT16H Gene [NCIt concept]
- SUPT16H wt Allele [NCIt concept]
- SUSD1 Gene [NCIt concept]
- SUSD1 wt Allele [NCIt concept]
- SUZ12 Gene [NCIt concept]
- SUZ12 wt Allele [NCIt concept]
- SV40 [NCIt concept]
- SVN53-67/M57-KLH Peptide Vaccine [NCIt concept]
- SWI/SNF Complex Antagonist Associated With Prostate Cancer 1 [NCIt concept]
- SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 5 [NCIt concept]
- SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily B Member 1 [NCIt concept]
- SYCP1 Gene [NCIt concept]
- SYCP1 wt Allele [NCIt concept]
- SYK Gene [NCIt concept]
- SYK wt Allele [NCIt concept]
- SYNE2 Gene [NCIt concept]
- SYNE2 wt Allele [NCIt concept]
- SYNPO Gene [NCIt concept]
- SYNPO wt Allele [NCIt concept]
- SYP Gene [NCIt concept]
- SYP wt Allele [NCIt concept]
- Sabatolimab [NCIt concept]
- Sabizabulin [NCIt concept]
- Sacituzumab Govitecan [NCIt concept]
- Sacituzumab Tirumotecan [NCIt concept]
- Sacral Nerve Stimulator [NCIt concept]
- Sacral Nerve Stimulator Battery [NCIt concept]
- Sacral Spine Neoplasm [NCIt concept]
- Safimaltib [NCIt concept]
- Safingol [NCIt concept]
- Safusidenib [NCIt concept]
- Sagopilone [NCIt concept]
- Saline [NCIt concept]
- Salirasib [NCIt concept]
- Saliva Collection [NCIt concept]
- Salivary Gland Acinic Cell Carcinoma [NCIt concept]
- Salivary Gland Adenocarcinoma [NCIt concept]
- Salivary Gland Adenoid Cystic Carcinoma [NCIt concept]
- Salivary Gland Carcinoma [NCIt concept]
- Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified [NCIt concept]
- Salivary Gland High Grade Carcinoma [NCIt concept]
- Salivary Gland High Grade Mucoepidermoid Carcinoma [NCIt concept]
- Salivary Gland Intermediate Grade Adenocarcinoma, Not Otherwise Specified [NCIt concept]
- Salivary Gland Low Grade Carcinoma [NCIt concept]
- Salivary Gland Low Grade Mucoepidermoid Carcinoma [NCIt concept]
- Salivary Gland Poorly Differentiated Squamous Cell Carcinoma [NCIt concept]
- Salivary Gland Squamous Cell Carcinoma [NCIt concept]
- Salivary Gland Undifferentiated Carcinoma [NCIt concept]
- Salpingectomy [NCIt concept]
- Salpingo-Oophorectomy [NCIt concept]
- Salsalate [NCIt concept]
- Salt-inducible Kinase Inhibitor GRN-300 [NCIt concept]
- Salvage Surgery [NCIt concept]
- Salvage Therapy [NCIt concept]
- Salvia hispanica Seed [NCIt concept]
- Sam68 Modulator CWP232291 [NCIt concept]
- Samalizumab [NCIt concept]
- Samarium Sm 153-DOTMP [NCIt concept]
- Samarium Sm-153 Lexidronam Pentasodium [NCIt concept]
- Samatatug Zovodotin [NCIt concept]
- Samotolisib [NCIt concept]
- Sampling [NCIt concept]
- Samrotamab Vedotin [NCIt concept]
- Sandhoff Disease [NCIt concept]
- Sapablursen [NCIt concept]
- Sapacitabine [NCIt concept]
- Sapanisertib [NCIt concept]
- Sapecmeran Autogene [NCIt concept]
- Saponin-Cholesterol-Phospholipid Adjuvant [NCIt concept]
- Saponin-based Immunoadjuvant OBI-821 [NCIt concept]
- Saposin-A [NCIt concept]
- Saposin-B [NCIt concept]
- Saposin-B-Val [NCIt concept]
- Saposin-C [NCIt concept]
- Saposin-D [NCIt concept]
- SarCNU [NCIt concept]
- Saracatinib [NCIt concept]
- Sarcoma [NCIt concept]
- Sarcoma of the Extremity [NCIt concept]
- Sarcomatoid Mesothelioma [NCIt concept]
- Sarcomatoid Renal Cell Carcinoma [NCIt concept]
- Sarcopenia [NCIt concept]
- Sarcosine [NCIt concept]
- Sargramostim [NCIt concept]
- Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine [NCIt concept]
- Sarilumab [NCIt concept]
- Saruparib [NCIt concept]
- Sasanlimab [NCIt concept]
- Satraplatin [NCIt concept]
- Satricabtagene Autoleucel [NCIt concept]
- Scanner Device [NCIt concept]
- Scavenger Receptor Class B Member 1 [NCIt concept]
- Scavenger Receptor Cysteine-Rich Type 1 Protein M130 [NCIt concept]
- Schlafen Family Member 11 [NCIt concept]
- Schlafen Family Member 12 [NCIt concept]
- Schuurs-Hoeijmakers Syndrome [NCIt concept]
- Schwannomin-Interacting Protein 1 [NCIt concept]
- Scientist [NCIt concept]
- Scintimammography [NCIt concept]
- Scl-70 Antibody [NCIt concept]
- Sclerostin [NCIt concept]
- Scopoletin [NCIt concept]
- Screening [NCIt concept]
- Screening Colonoscopy [NCIt concept]
- Screening Mammography [NCIt concept]
- Screening Method [NCIt concept]
- Screening Questionnaire Administration [NCIt concept]
- Screening Test [NCIt concept]
- Screening for Intestinal Tract Cancer [NCIt concept]
- Screening for Oral Cancer [NCIt concept]
- Scrotal Melanoma [NCIt concept]
- Scyllitol [NCIt concept]
- Seated Rowing [NCIt concept]
- Seattle Biopsy Protocol [NCIt concept]
- Sebaceous Carcinoma [NCIt concept]
- Sec61 Inhibitor KZR-261 [NCIt concept]
- Seclidemstat [NCIt concept]
- Secoisolariciresinol [NCIt concept]
- Second Primary Squamous Cell Carcinoma of the Head and Neck [NCIt concept]
- Second-Line Therapy [NCIt concept]
- Second-Look Surgery [NCIt concept]
- Secondary Acute Myeloid Leukemia [NCIt concept]
- Secondary Acute Myeloid Leukemia in Acquired Aplastic Anemia [NCIt concept]
- Secondary Central Nervous System Hodgkin Lymphoma [NCIt concept]
- Secondary Central Nervous System Lymphoma [NCIt concept]
- Secondary Central Nervous System Non-Hodgkin Lymphoma [NCIt concept]
- Secondary Diffuse Large B-Cell Lymphoma of the Central Nervous System [NCIt concept]
- Secondary Myelodysplastic Syndrome [NCIt concept]
- Secondary Myelofibrosis [NCIt concept]
- Secreted Frizzled-Related Protein 1 [NCIt concept]
- Secreted Frizzled-Related Protein 2 [NCIt concept]
- Secreted Frizzled-Related Protein 4 [NCIt concept]
- Secreted Frizzled-Related Protein 5 [NCIt concept]
- Secretin [NCIt concept]
- Secretin Human [NCIt concept]
- Secretin-Enhanced Magnetic Resonance Imaging [NCIt concept]
- Secretoglobin Family 1D Member 2 [NCIt concept]
- Secretoglobin Family 3A Member 1 [NCIt concept]
- Secretory Phospholipase A2 Receptor [NCIt concept]
- Securin [NCIt concept]
- Sedentary Lifestyle [NCIt concept]
- Segment Polarity Protein Dishevelled Homolog DVL-1 [NCIt concept]
- Segmentectomy [NCIt concept]
- Seizure [NCIt concept]
- Seizure Protein 6 Homolog [NCIt concept]
- Selective Androgen Receptor Modulator LY2452473 [NCIt concept]
- Selective Estrogen Receptor Covalent Antagonist [NCIt concept]
- Selective Estrogen Receptor Degrader AZD9496 [NCIt concept]
- Selective Estrogen Receptor Degrader GDC-0927 [NCIt concept]
- Selective Estrogen Receptor Degrader LSZ102 [NCIt concept]
- Selective External Radiation Therapy [NCIt concept]
- Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352 [NCIt concept]
- Selective Internal Radiation Therapy [NCIt concept]
- Selenium [NCIt concept]
- Selenoprotein F [NCIt concept]
- Selenoprotein P [NCIt concept]
- Self-Examination [NCIt concept]
- Self-guided Deep Breathing [NCIt concept]
- Seliciclib [NCIt concept]
- Selicrelumab [NCIt concept]
- Selinexor [NCIt concept]
- Selitrectinib [NCIt concept]
- Selonsertib [NCIt concept]
- Selpercatinib [NCIt concept]
- Selumetinib [NCIt concept]
- Selumetinib Sulfate [NCIt concept]
- Semaglutide [NCIt concept]
- Semaphorin-3F [NCIt concept]
- Semaphorin-4D [NCIt concept]
- Semaphorin-6A [NCIt concept]
- Semaxanib [NCIt concept]
- Seminoma [NCIt concept]
- Semmes Weinstein Monofilament Examination [NCIt concept]
- Semuloparin [NCIt concept]
- Sendegobresib [NCIt concept]
- Seneca Valley Virus-001 [NCIt concept]
- Sensitizing ALK Gene Mutation [NCIt concept]
- Sensitizing ALK Gene Mutation Negative [NCIt concept]
- Sensitizing BRAF Gene Mutation [NCIt concept]
- Sensitizing EGFR Gene Mutation [NCIt concept]
- Sensitizing EGFR Mutation Negative [NCIt concept]
- Sensitizing MET Gene Mutation Negative [NCIt concept]
- Sensitizing ROS1 Fusion Positive [NCIt concept]
- Sensitizing ROS1 Gene Mutation [NCIt concept]
- Sensitizing ROS1 Gene Mutation Negative [NCIt concept]
- Sensor Device [NCIt concept]
- Sensory Organization Test [NCIt concept]
- Sentinel Lymph Node Biopsy [NCIt concept]
- Sentinel Lymph Node Mapping [NCIt concept]
- Sentrin-Specific Protease 1 [NCIt concept]
- Sentrin-Specific Protease 6 [NCIt concept]
- Sepantronium Bromide [NCIt concept]
- Septin-4 [NCIt concept]
- Septin-5 [NCIt concept]
- Septin-6 [NCIt concept]
- Septin-8 [NCIt concept]
- Septin-9 [NCIt concept]
- Sequestosome-1 [NCIt concept]
- Serabelisib [NCIt concept]
- Serial Liquid Biopsy [NCIt concept]
- Seribantumab [NCIt concept]
- Serine [NCIt concept]
- Serine Hydroxymethyltransferase, Cytosolic [NCIt concept]
- Serine Palmitoyltransferase 1 [NCIt concept]
- Serine-Protein Kinase ATM [NCIt concept]
- Serine/Arginine-Rich Splicing Factor 1 [NCIt concept]
- Serine/Arginine-Rich Splicing Factor 2 [NCIt concept]
- Serine/Arginine-Rich Splicing Factor 3 [NCIt concept]
- Serine/Threonine Kinase Inhibitor CBP501 [NCIt concept]
- Serine/Threonine-Protein Kinase 33 [NCIt concept]
- Serine/Threonine-Protein Kinase 35 [NCIt concept]
- Serine/Threonine-Protein Kinase A-Raf [NCIt concept]
- Serine/Threonine-Protein Kinase ATR [NCIt concept]
- Serine/Threonine-Protein Kinase B-Raf [NCIt concept]
- Serine/Threonine-Protein Kinase Chk1 [NCIt concept]
- Serine/Threonine-Protein Kinase Chk2 [NCIt concept]
- Serine/Threonine-Protein Kinase D1 [NCIt concept]
- Serine/Threonine-Protein Kinase D2 [NCIt concept]
- Serine/Threonine-Protein Kinase DCLK1 [NCIt concept]
- Serine/Threonine-Protein Kinase LATS1 [NCIt concept]
- Serine/Threonine-Protein Kinase LATS2 [NCIt concept]
- Serine/Threonine-Protein Kinase MARK2 [NCIt concept]
- Serine/Threonine-Protein Kinase Nek2 [NCIt concept]
- Serine/Threonine-Protein Kinase Nek3 [NCIt concept]
- Serine/Threonine-Protein Kinase PAK 1 [NCIt concept]
- Serine/Threonine-Protein Kinase PAK 3 [NCIt concept]
- Serine/Threonine-Protein Kinase PAK 4 [NCIt concept]
- Serine/Threonine-Protein Kinase PLK1 [NCIt concept]
- Serine/Threonine-Protein Kinase Pim-1 [NCIt concept]
- Serine/Threonine-Protein Kinase Pim-2 [NCIt concept]
- Serine/Threonine-Protein Kinase Pim-3 [NCIt concept]
- Serine/Threonine-Protein Kinase Receptor R3 [NCIt concept]
- Serine/Threonine-Protein Kinase SIK2 [NCIt concept]
- Serine/Threonine-Protein Kinase SMG1 [NCIt concept]
- Serine/Threonine-Protein Kinase STK11 [NCIt concept]
- Serine/Threonine-Protein Kinase TAO3 [NCIt concept]
- Serine/Threonine-Protein Kinase ULK1 [NCIt concept]
- Serine/Threonine-Protein Kinase ULK2 [NCIt concept]
- Serine/Threonine-Protein Kinase WNK1 [NCIt concept]
- Serine/Threonine-Protein Kinase mTOR [NCIt concept]
- Serine/Threonine-Protein Kinase/Endoribonuclease IRE1 [NCIt concept]
- Serine/Threonine-Protein Phosphatase 2A 55 kDa Regulatory Subunit B Alpha Isoform [NCIt concept]
- Serine/Threonine-Protein Phosphatase 2A 65 kDa Regulatory Subunit A Alpha Isoform [NCIt concept]
- Serine/Threonine-Protein Phosphatase PP1-Beta Catalytic Subunit [NCIt concept]
- Serotonin [NCIt concept]
- Serotransferrin [NCIt concept]
- Serous [NCIt concept]
- Serpin A9 [NCIt concept]
- Serpin B9 [NCIt concept]
- Serplulimab [NCIt concept]
- Serratus Plane Block [NCIt concept]
- Sertraline [NCIt concept]
- Sertraline Hydrochloride [NCIt concept]
- Serum Amyloid A [NCIt concept]
- Serum CA125 Measurement [NCIt concept]
- Serum Free Immunoglobulin Light Chain [NCIt concept]
- Serum IgM Monoclonal Gammopathy of Less than 30g/L [NCIt concept]
- Serum Immunoglobulin Free Light Chain Ratio Abnormal [NCIt concept]
- Serum Magnesium Measurement [NCIt concept]
- Serum Paraoxonase/Arylesterase 1 [NCIt concept]
- Serum Paraoxonase/Arylesterase 2 [NCIt concept]
- Serum Protein [NCIt concept]
- Serum Protein Electrophoresis [NCIt concept]
- Serum Quantitative Immunoglobulins [NCIt concept]
- Serum Soluble CD163 Measurement [NCIt concept]
- Serum Soluble Interleukin-2 Receptor Subunit Alpha Measurement [NCIt concept]
- Serum-Ascites Albumin Gradient [NCIt concept]
- Serum-derived Bovine Immunoglobulin Protein Isolate [NCIt concept]
- Sestrin-3 [NCIt concept]
- Sevabertinib [NCIt concept]
- Seventeen [NCIt concept]
- Severe Acute Respiratory Distress Syndrome [NCIt concept]
- Severe Chronic Active EBV Infection [NCIt concept]
- Severe Combined Immunodeficiency [NCIt concept]
- Severe Congenital Neutropenia [NCIt concept]
- Severe Gastrointestinal Tract Acute Graft Versus Host Disease [NCIt concept]
- Severe Mosquito Bite Allergy [NCIt concept]
- Seviteronel [NCIt concept]
- Sex Hormone-Binding Globulin [NCIt concept]
- Sex Steroid Hormone [NCIt concept]
- Sexual Dysfunction [NCIt concept]
- Sexual Dysfunction and Infertility [NCIt concept]
- Sezary Cell Count [NCIt concept]
- Sezary Syndrome [NCIt concept]
- Sham Intervention [NCIt concept]
- Shared Neoantigen-Positive Malignant Solid Neoplasm [NCIt concept]
- Shark Cartilage Extract AE-941 [NCIt concept]
- Shave Biopsy [NCIt concept]
- Shave Excision [NCIt concept]
- Shear Wave Elastography [NCIt concept]
- Shootin-1 [NCIt concept]
- Short Chain Fatty Acid [NCIt concept]
- Short Chain Fatty Acid Measurement [NCIt concept]
- Short Course Chemoradiotherapy [NCIt concept]
- Short Tandem Repeat [NCIt concept]
- Short Tandem Repeat Profile [NCIt concept]
- Short Transient Receptor Potential Channel 6 [NCIt concept]
- Short-Term Fasting [NCIt concept]
- Shwachman-Diamond Syndrome [NCIt concept]
- Sialic Acid-Binding Ig-Like Lectin 15 [NCIt concept]
- Sialic Acid-Binding Ig-Like Lectin 9 [NCIt concept]
- Sialyl Tn Antigen [NCIt concept]
- Sialyl Tn-KLH Vaccine [NCIt concept]
- Sialyl-Tn Antigen Antibody [NCIt concept]
- Sickle Cell Disease [NCIt concept]
- Sickle Cell-Hemoglobin C Disease [NCIt concept]
- Siewert Classification [NCIt concept]
- Siewert Type I [NCIt concept]
- Siewert Type II [NCIt concept]
- Siewert Type III [NCIt concept]
- Sigma Intracellular Receptor 2 [NCIt concept]
- Sigma Non-Opioid Intracellular Receptor 1 [NCIt concept]
- Sigmoid Colon Adenoma [NCIt concept]
- Sigmoid Colon Carcinoma [NCIt concept]
- Sigmoid Colon Neuroendocrine Tumor G1 [NCIt concept]
- Sigmoid Colon Neuroendocrine Tumor G2 [NCIt concept]
- Sigmoid Colon Polyp [NCIt concept]
- Sigmoidoscopy [NCIt concept]
- Signal Peptide, CUB and EGF-Like Domain-Containing Protein 2 [NCIt concept]
- Signal Transducer CD24 [NCIt concept]
- Signal Transducer and Activator of Transcription [NCIt concept]
- Signal Transducer and Activator of Transcription 1-Alpha/Beta [NCIt concept]
- Signal Transducer and Activator of Transcription 3 [NCIt concept]
- Signal Transducer and Activator of Transcription 5B [NCIt concept]
- Signal Transducer and Activator of Transcription 6 [NCIt concept]
- Signal Transducer and Activator of Transcription Family Gene [NCIt concept]
- Signal Transduction Inhibitor [NCIt concept]
- Signaling Lymphocytic Activation Molecule [NCIt concept]
- Signet Ring Melanoma [NCIt concept]
- Sigvotatug Vedotin [NCIt concept]
- Silatecan AR-67 [NCIt concept]
- Sildenafil [NCIt concept]
- Sildenafil Citrate [NCIt concept]
- Silibinin [NCIt concept]
- Silicon Phthalocyanine 4 [NCIt concept]
- Silicone-based Film Forming Topical Gel [NCIt concept]
- Silmitasertib [NCIt concept]
- Silmitasertib Sodium [NCIt concept]
- Siltuximab [NCIt concept]
- Simethicone [NCIt concept]
- Simlukafusp Alfa [NCIt concept]
- Simotaxel [NCIt concept]
- Simtuzumab [NCIt concept]
- Simulated Altitude Intervention [NCIt concept]
- Simulated Forest Immersion Therapy [NCIt concept]
- Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy [NCIt concept]
- Simurosertib [NCIt concept]
- Simvastatin [NCIt concept]
- Sinecatechins [NCIt concept]
- Single Agent Therapy [NCIt concept]
- Single Nucleotide Polymorphism Profile [NCIt concept]
- Single Photon Emission Computed Tomography [NCIt concept]
- Single Protein Encapsulated Doxorubicin SPEDOX-6 [NCIt concept]
- Single-Stranded DNA Cytosine Deaminase [NCIt concept]
- Single-Stranded DNA-Binding Protein 2 [NCIt concept]
- Single-Stranded DNA-Binding Protein, Mitochondrial [NCIt concept]
- Singlet Oxygen [NCIt concept]
- Sinonasal Adenocarcinoma, Intestinal-Type [NCIt concept]
- Sinonasal Carcinoma [NCIt concept]
- Sinonasal Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Sinonasal Inverted Papilloma [NCIt concept]
- Sinonasal Poorly Differentiated Carcinoma [NCIt concept]
- Sinonasal Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Sinonasal Squamous Cell Carcinoma [NCIt concept]
- Sinonasal Tract and Oral Cavity [NCIt concept]
- Sinonasal Undifferentiated Carcinoma [NCIt concept]
- Sintilimab [NCIt concept]
- Sipavibart [NCIt concept]
- Sipuleucel-T [NCIt concept]
- Siremadlin [NCIt concept]
- Sirexatamab [NCIt concept]
- Sirolimus [NCIt concept]
- Sirolimus Albumin-bound Nanoparticles [NCIt concept]
- Sirolimus Topical Gel PTX-022 [NCIt concept]
- Sirpiglenastat [NCIt concept]
- Sirtratumab Vedotin [NCIt concept]
- Sister Chromatid Cohesion Protein PDS5 Homolog B [NCIt concept]
- Sisunatovir [NCIt concept]
- Sit to Stand Test [NCIt concept]
- Sit-Stand Workstation [NCIt concept]
- Sitagliptin [NCIt concept]
- Sitagliptin Phosphate [NCIt concept]
- Sitocabnagene Loxiveleucel [NCIt concept]
- Six-Twelve Leukemia [NCIt concept]
- Sizavaleucel [NCIt concept]
- Skin Adenosquamous Carcinoma [NCIt concept]
- Skin Angiosarcoma [NCIt concept]
- Skin Basal Cell Carcinoma [NCIt concept]
- Skin Biopsy [NCIt concept]
- Skin Carcinoma [NCIt concept]
- Skin Care Product [NCIt concept]
- Skin Disorder [NCIt concept]
- Skin Examination [NCIt concept]
- Skin Excision [NCIt concept]
- Skin Kaposi Sarcoma [NCIt concept]
- Skin Leiomyoma [NCIt concept]
- Skin Neoplasm [NCIt concept]
- Skin Neurofibroma [NCIt concept]
- Skin Prick Test [NCIt concept]
- Skin Reaction Secondary to Radiation Therapy [NCIt concept]
- Skin Squamous Cell Carcinoma [NCIt concept]
- Skin Squamous Cell Carcinoma In Situ [NCIt concept]
- Skin Staple [NCIt concept]
- Skin Swab [NCIt concept]
- Skin Test [NCIt concept]
- Skin Transplantation [NCIt concept]
- Skull Base Squamous Cell Carcinoma [NCIt concept]
- Sleep Diary [NCIt concept]
- Sleep Disorder [NCIt concept]
- Sleep Disorder Therapy [NCIt concept]
- Sleep Study [NCIt concept]
- Sleep-Disordered Breathing [NCIt concept]
- Sleeping Beauty Transposon Gene Therapy [NCIt concept]
- Sleeve Lobectomy [NCIt concept]
- Slit Homolog 1 Protein [NCIt concept]
- Slit Homolog 2 Protein [NCIt concept]
- Slit Homolog 3 Protein [NCIt concept]
- Sly Syndrome [NCIt concept]
- Smac Mimetic BGB-24714 [NCIt concept]
- Smac Mimetic GDC-0152 [NCIt concept]
- Smac Mimetic LCL161 [NCIt concept]
- Small Cell Carcinoma, Fusiform Cell Type [NCIt concept]
- Small Cell Intermediate Cell Carcinoma [NCIt concept]
- Small Cell Lung Carcinoma Transformation [NCIt concept]
- Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Small Intestinal Adenocarcinoma [NCIt concept]
- Small Intestinal Adenosquamous Carcinoma [NCIt concept]
- Small Intestinal Carcinoma [NCIt concept]
- Small Intestinal Gastrointestinal Stromal Tumor [NCIt concept]
- Small Intestinal Leiomyosarcoma [NCIt concept]
- Small Intestinal Lymphoma [NCIt concept]
- Small Intestinal Medullary Carcinoma [NCIt concept]
- Small Intestinal Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma [NCIt concept]
- Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Small Intestinal Neuroendocrine Carcinoma [NCIt concept]
- Small Intestinal Squamous Cell Carcinoma [NCIt concept]
- Small Intestinal Undifferentiated Carcinoma [NCIt concept]
- Small Lymphocytic Lymphoma [NCIt concept]
- Small Size Posterior Uveal Melanoma [NCIt concept]
- Small Ubiquitin-Related Modifier 1 [NCIt concept]
- Smart Scale Weight and Health Monitoring [NCIt concept]
- SmartClip Soft Tissue Marker [NCIt concept]
- SmartPill [NCIt concept]
- Smartphone [NCIt concept]
- Smoke-Free Home Program [NCIt concept]
- SmokefreeTXT Smoking Cessation Program [NCIt concept]
- Smokeless Tobacco [NCIt concept]
- Smokeless Tobacco Use [NCIt concept]
- Smoking [NCIt concept]
- Smoking Cessation Intervention [NCIt concept]
- Smoking Topography Research [NCIt concept]
- Smoldering Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Smoldering Multiple Myeloma [NCIt concept]
- Smoldering Systemic Mastocytosis [NCIt concept]
- Smoldering Waldenstrom Macroglobulinemia [NCIt concept]
- Smoothened Antagonist BMS-833923 [NCIt concept]
- Smoothened Antagonist LEQ506 [NCIt concept]
- Smoothened Antagonist TAK-441 [NCIt concept]
- Snuff Tobacco [NCIt concept]
- Social Networking [NCIt concept]
- Social Worker [NCIt concept]
- Sodium [NCIt concept]
- Sodium Bicarbonate [NCIt concept]
- Sodium Bicarbonate Solution [NCIt concept]
- Sodium Channel Protein Type 1 Subunit Alpha [NCIt concept]
- Sodium Channel Protein Type 9 Subunit Alpha [NCIt concept]
- Sodium Chloride [NCIt concept]
- Sodium Dichloroacetate [NCIt concept]
- Sodium Ferric Gluconate Complex [NCIt concept]
- Sodium Fluoride F-18 [NCIt concept]
- Sodium Hyaluronate Topical Hydrogel [NCIt concept]
- Sodium Hypochlorite [NCIt concept]
- Sodium Iodide I-131 [NCIt concept]
- Sodium Lauryl Sulfate/Citric Acid/Sodium Citrate-containing Surgical Irrigation Solution [NCIt concept]
- Sodium Metaarsenite [NCIt concept]
- Sodium Phenylbutyrate [NCIt concept]
- Sodium Selenite [NCIt concept]
- Sodium Stibogluconate [NCIt concept]
- Sodium Thiosulfate [NCIt concept]
- Sodium- and Chloride-Dependent Creatine Transporter 1 [NCIt concept]
- Sodium-Coupled Monocarboxylate Transporter 1 [NCIt concept]
- Sodium-Coupled Neutral Amino Acid Transporter 3 [NCIt concept]
- Sodium-Dependent Dopamine Transporter [NCIt concept]
- Sodium-Dependent Noradrenaline Transporter [NCIt concept]
- Sodium-Dependent Phosphate Transport Protein 2B [NCIt concept]
- Sodium-Dependent Serotonin Transporter [NCIt concept]
- Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108 [NCIt concept]
- Sodium/Calcium Exchanger 1 [NCIt concept]
- Sodium/Glucose Cotransporter 1 [NCIt concept]
- Sodium/Glucose Cotransporter 2 [NCIt concept]
- Sodium/Hydrogen Exchanger 1 [NCIt concept]
- Sodium/Iodide Cotransporter [NCIt concept]
- Sodium/Nucleoside Cotransporter 1 [NCIt concept]
- Sodium/Nucleoside Cotransporter 2 [NCIt concept]
- Sodium/Potassium-Transporting ATPase Subunit Alpha-1 [NCIt concept]
- Sodium/Potassium-Transporting ATPase Subunit Alpha-2 [NCIt concept]
- Sodium/Potassium-Transporting ATPase Subunit Alpha-3 [NCIt concept]
- Sodium/Potassium-Transporting ATPase Subunit Beta-1-Interacting Protein 2 [NCIt concept]
- Sofituzumab Vedotin [NCIt concept]
- Sofosbuvir [NCIt concept]
- Soft Palate Carcinoma [NCIt concept]
- Soft Tissue Neoplasm [NCIt concept]
- Soft Tissue Sarcoma [NCIt concept]
- Soft Tissue Sarcoma by AJCC v8 Stage [NCIt concept]
- Soft Tissue Sarcoma of the Trunk and Extremities [NCIt concept]
- Soft Tissue Sarcoma, Excluding Liposarcoma [NCIt concept]
- Solar Radiation-Related Cutaneous Melanoma [NCIt concept]
- Solar Simulated Light [NCIt concept]
- Solid Neoplasm [NCIt concept]
- Solid Organ Transplant Recipient [NCIt concept]
- Solid Organ Transplantation [NCIt concept]
- Solifenacin Succinate [NCIt concept]
- Solitary Plasmacytoma of Bone [NCIt concept]
- Solitary Pulmonary Nodule [NCIt concept]
- Soluble B Cell Maturation Antigen Measurement [NCIt concept]
- Soluble Calcium-Activated Nucleotidase 1 [NCIt concept]
- Soluble Epidermal Growth Factor Receptor [NCIt concept]
- Soluble Interleukin-6 Receptor Subunit Alpha [NCIt concept]
- Soluble Monocyte Differentiation Antigen CD14 [NCIt concept]
- Soluble Receptor Tyrosine-Protein Kinase erbB-2 [NCIt concept]
- Soluble Tumor Necrosis Factor Receptor Superfamily Member 1A [NCIt concept]
- Soluble Tumor Necrosis Factor Receptor Superfamily Member 8 [NCIt concept]
- Soluble Tumor Necrosis Factor Receptor Superfamily Member 9 [NCIt concept]
- Soluble Tumor Necrosis Factor Receptor Type II Measurement [NCIt concept]
- Soluble Tyrosine-Protein Kinase Receptor UFO [NCIt concept]
- Soluble Vascular Endothelial Growth Factor Receptor 2 [NCIt concept]
- Solute Carrier Family [NCIt concept]
- Solute Carrier Family 2, Facilitated Glucose Transporter Member 2 [NCIt concept]
- Solute Carrier Family 2, Facilitated Glucose Transporter Member 3 [NCIt concept]
- Solute Carrier Family 22 Member 1 [NCIt concept]
- Solute Carrier Family 22 Member 2 [NCIt concept]
- Solute Carrier Family 22 Member 3 [NCIt concept]
- Solute Carrier Family 26 Member 6 [NCIt concept]
- Solute Carrier Family 28 Member 3 [NCIt concept]
- Solute Carrier Family 45 Member 3 [NCIt concept]
- Solute Carrier Organic Anion Transporter Family Member 1B1 [NCIt concept]
- Solute Carrier Organic Anion Transporter Family Member 1B3 [NCIt concept]
- Solute Carrier Organic Anion Transporter Family Member 2B1 [NCIt concept]
- Somatic ATM Gene Mutation [NCIt concept]
- Somatic BRCA1 Gene Mutation [NCIt concept]
- Somatic BRCA2 Gene Mutation [NCIt concept]
- Somatic CHEK2 Gene Mutation [NCIt concept]
- Somatic Hypermutation [NCIt concept]
- Somatic KIT Gene Mutation [NCIt concept]
- Somatic PALB2 Gene Mutation [NCIt concept]
- Somatic UBA1 Gene Mutation [NCIt concept]
- Somatic Variation [NCIt concept]
- Somatic-to-Autonomic Nerve Grafting [NCIt concept]
- Somatostatin Analog Therapy [NCIt concept]
- Somatostatin Receptor [NCIt concept]
- Somatostatin Receptor 2 Positive [NCIt concept]
- Somatostatin Receptor Agonist [NCIt concept]
- Somatostatin Receptor Family Gene [NCIt concept]
- Somatostatin Receptor Positive [NCIt concept]
- Somatostatin Receptor Positron Emission Tomography [NCIt concept]
- Somatostatin Receptor Type 1 [NCIt concept]
- Somatostatin Receptor Type 2 [NCIt concept]
- Somatostatin Receptor Type 2b [NCIt concept]
- Somatostatin Receptor Type 3 [NCIt concept]
- Somatostatin Receptor Type 4 [NCIt concept]
- Somatostatin Receptor Type 5 [NCIt concept]
- Somatostatin-Producing Neuroendocrine Tumor [NCIt concept]
- Somatotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Somatotropin [NCIt concept]
- Somatropin [NCIt concept]
- Son of Sevenless Homolog 1 [NCIt concept]
- Sonesitatug Vedotin [NCIt concept]
- Sonic Hedgehog Pathway [NCIt concept]
- Sonic Hedgehog Protein [NCIt concept]
- Sonic Hedgehog/Patch Pathway Activated [NCIt concept]
- Sonication [NCIt concept]
- Sonidegib [NCIt concept]
- SonoCloud-9 [NCIt concept]
- Sonoelastography [NCIt concept]
- Sonolisib [NCIt concept]
- Sonrotoclax [NCIt concept]
- Sontuzumab [NCIt concept]
- Soquelitinib [NCIt concept]
- Sorafenib [NCIt concept]
- Sorafenib Tosylate [NCIt concept]
- Sortilin [NCIt concept]
- Sorting Nexin-29 [NCIt concept]
- Sotatercept [NCIt concept]
- Sotevtamab [NCIt concept]
- Sotigalimab [NCIt concept]
- Sotorasib [NCIt concept]
- Sotrastaurin Acetate [NCIt concept]
- Sovateltide [NCIt concept]
- Sovilnesib [NCIt concept]
- Sovipostobart [NCIt concept]
- Soy Isoflavones [NCIt concept]
- Soy Protein Isolate [NCIt concept]
- Spanlecortemlocel [NCIt concept]
- Spartalizumab [NCIt concept]
- Spatially-fractionated Radiation Therapy [NCIt concept]
- Spatula and Cytology Brush Collection [NCIt concept]
- Spebrutinib [NCIt concept]
- Special Diet Therapy [NCIt concept]
- Specimen Ultra-High-Field Magnetic Resonance Imaging [NCIt concept]
- Speckle-Type POZ Protein [NCIt concept]
- Spectrin Beta Chain, Non-Erythrocytic 2 [NCIt concept]
- Spectrophotometry [NCIt concept]
- Spectroscopy [NCIt concept]
- Sperm Protein Associated With the Nucleus on the X Chromosome B/F [NCIt concept]
- Sperm Surface Protein Sp17 [NCIt concept]
- Sperm-Associated Antigen 11B [NCIt concept]
- Spermatid Nuclear Transition Protein 1 [NCIt concept]
- Spermatogenesis-Associated Protein 20 [NCIt concept]
- Spermidine [NCIt concept]
- Spermine [NCIt concept]
- Spevatamig [NCIt concept]
- Spherical Nucleic Acid Nanoparticle NU-0129 [NCIt concept]
- Sphingolipid [NCIt concept]
- Sphingolipid Delta(4)-Desaturase DES1 [NCIt concept]
- Sphingolipid Delta(4)-Desaturase/C4-Hydroxylase DES2 [NCIt concept]
- Sphingolipidosis [NCIt concept]
- Sphingomyelin Phosphodiesterase [NCIt concept]
- Sphingomyelin Phosphodiesterase 2 [NCIt concept]
- Sphingomyelin Phosphodiesterase 3 [NCIt concept]
- Sphingomyelin Phosphodiesterase 4 [NCIt concept]
- Sphingosine 1-Phosphate [NCIt concept]
- Sphingosine 1-Phosphate Receptor 1 [NCIt concept]
- Sphingosine 1-Phosphate Receptor 2 [NCIt concept]
- Sphingosine 1-Phosphate Receptor 3 [NCIt concept]
- Sphingosine 1-Phosphate Receptor 4 [NCIt concept]
- Sphingosine 1-Phosphate Receptor 5 [NCIt concept]
- Sphingosine Kinase 1 [NCIt concept]
- Sphingosine Kinase 2 [NCIt concept]
- Sphingosine-1-Phosphate Lyase 1 [NCIt concept]
- Sphingosine-1-Phosphate Phosphatase 1 [NCIt concept]
- Sphingosine-1-Phosphate Phosphatase 2 [NCIt concept]
- Spinal Cord Compression [NCIt concept]
- Spinal Cord Neoplasm [NCIt concept]
- Spinal Cord Neurofibroma [NCIt concept]
- Spinal Cord Stimulation [NCIt concept]
- Spinal Hemangioblastoma [NCIt concept]
- Spindle Cell Rhabdomyosarcoma [NCIt concept]
- Spindle Cell Sarcoma [NCIt concept]
- Spindle Cell/Sclerosing Rhabdomyosarcoma [NCIt concept]
- Spinocerebellar Ataxia Type 16 [NCIt concept]
- Spiritual Therapy [NCIt concept]
- Spirometry [NCIt concept]
- Spironolactone [NCIt concept]
- Splanchnic Vein Thrombosis [NCIt concept]
- Splenic Disorder [NCIt concept]
- Splenic Manifestation of Leukemia [NCIt concept]
- Splenic Marginal Zone Lymphoma [NCIt concept]
- Splenic Neoplasm [NCIt concept]
- Splenic Radiation Therapy [NCIt concept]
- Splenic Small Lymphocytic Lymphoma [NCIt concept]
- Splenic Thrombosis [NCIt concept]
- Spliceosome RNA Helicase DDX39B [NCIt concept]
- Splicing Factor 3B Subunit 1 [NCIt concept]
- Splicing Factor 3B Subunit 3 [NCIt concept]
- Splicing Factor Proline-and Glutamine-Rich [NCIt concept]
- Splicing Factor U2AF 35 kDa Subunit [NCIt concept]
- Splicing Factor U2AF 65 kDa Subunit [NCIt concept]
- Splicing Inhibitor H3B-8800 [NCIt concept]
- Sponge [NCIt concept]
- Sporadic Breast Carcinoma [NCIt concept]
- Sporadic Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Spread of Lymphoma [NCIt concept]
- Sprouty-Related, EVH1 Domain-Containing Protein 1 [NCIt concept]
- Spunoleucel [NCIt concept]
- Squamous Cell Carcinoma [NCIt concept]
- Squamous Cell Carcinoma of Unknown Primary [NCIt concept]
- Squamous Dysplasia [NCIt concept]
- Squeezed Red Blood Cells Expressing HPV16 Epitopes SQZ-AAC-HPV [NCIt concept]
- Src Kinase-Associated Phosphoprotein 1 [NCIt concept]
- Src/tubulin Inhibitor KX2-361 [NCIt concept]
- St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8 [NCIt concept]
- St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8 [NCIt concept]
- Stabilin-1 [NCIt concept]
- Stabilized Sulphur Hexafluoride Microbubble-Based Contrast Agent [NCIt concept]
- Staff [NCIt concept]
- Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage 0 Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage 0 Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Anal Cancer AJCC v8 [NCIt concept]
- Stage 0 Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage 0 Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage 0 Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Bladder Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Breast Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Cervical Cancer AJCC v6 [NCIt concept]
- Stage 0 Cervical Cancer AJCC v7 [NCIt concept]
- Stage 0 Chronic Lymphocytic Leukemia [NCIt concept]
- Stage 0 Colon Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Colon Cancer AJCC v8 [NCIt concept]
- Stage 0 Colorectal Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Colorectal Cancer AJCC v8 [NCIt concept]
- Stage 0 Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage 0 Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage 0 Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage 0 Esophageal Cancer AJCC v6 [NCIt concept]
- Stage 0 Esophageal Cancer AJCC v7 [NCIt concept]
- Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage 0 Fallopian Tube Cancer AJCC v7 [NCIt concept]
- Stage 0 Gallbladder Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage 0 Gastric Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Stage 0 Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage 0 Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage 0 Laryngeal Cancer AJCC v6, v7, and V8 [NCIt concept]
- Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Lip Basal Cell Carcinoma [NCIt concept]
- Stage 0 Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Low Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8 [NCIt concept]
- Stage 0 Lung Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Lung Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Lung Cancer AJCC v8 [NCIt concept]
- Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Lung Non-Small Cell Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Lung Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Penile Cancer AJCC v6 [NCIt concept]
- Stage 0 Penile Cancer AJCC v7 [NCIt concept]
- Stage 0 Penile Cancer AJCC v8 [NCIt concept]
- Stage 0 Pharyngeal Cancer [NCIt concept]
- Stage 0 Rectal Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Rectal Cancer AJCC v8 [NCIt concept]
- Stage 0 Rectosigmoid Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage 0 Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage 0 Sinonasal Cancer AJCC v6, v7, and v8 [NCIt concept]
- Stage 0 Skin Cancer [NCIt concept]
- Stage 0 Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage 0 Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage 0 Squamous Cell Carcinoma [NCIt concept]
- Stage 0 Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage 0 Testicular Cancer AJCC v8 [NCIt concept]
- Stage 0 Ureter Cancer AJCC v7 [NCIt concept]
- Stage 0 Urethral Cancer AJCC v7 [NCIt concept]
- Stage 0 Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage 0 Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage 0 Vaginal Cancer AJCC v6 [NCIt concept]
- Stage 0 Vaginal Cancer AJCC v7 [NCIt concept]
- Stage 0 Vulvar Cancer AJCC v6 [NCIt concept]
- Stage 0 Vulvar Cancer AJCC v7 [NCIt concept]
- Stage 0a Bladder Cancer AJCC v8 [NCIt concept]
- Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0a Penile Cancer AJCC v8 [NCIt concept]
- Stage 0a Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage 0a Renal Pelvis Cancer AJCC v8 [NCIt concept]
- Stage 0a Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 [NCIt concept]
- Stage 0a Ureter Cancer AJCC v7 [NCIt concept]
- Stage 0a Ureter Cancer AJCC v8 [NCIt concept]
- Stage 0a Urethral Cancer AJCC v7 [NCIt concept]
- Stage 0a Urethral Cancer AJCC v8 [NCIt concept]
- Stage 0is Bladder Cancer AJCC v8 [NCIt concept]
- Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0is Penile Cancer AJCC v8 [NCIt concept]
- Stage 0is Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage 0is Renal Pelvis Cancer AJCC v8 [NCIt concept]
- Stage 0is Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 [NCIt concept]
- Stage 0is Ureter Cancer AJCC v7 [NCIt concept]
- Stage 0is Ureter Cancer AJCC v8 [NCIt concept]
- Stage 0is Urethral Cancer AJCC v7 [NCIt concept]
- Stage 0is Urethral Cancer AJCC v8 [NCIt concept]
- Stage 1 Neuroblastoma [NCIt concept]
- Stage 2 Neuroblastoma [NCIt concept]
- Stage 2A Neuroblastoma [NCIt concept]
- Stage 2B Neuroblastoma [NCIt concept]
- Stage 3 Neuroblastoma [NCIt concept]
- Stage 4 Neuroblastoma [NCIt concept]
- Stage 4S Neuroblastoma [NCIt concept]
- Stage A Prostate Cancer [NCIt concept]
- Stage B Prostate Cancer [NCIt concept]
- Stage C Prostate Cancer [NCIt concept]
- Stage D Prostate Cancer [NCIt concept]
- Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Acral Lentiginous Melanoma AJCC v7 [NCIt concept]
- Stage I Adrenal Cortical Carcinoma AJCC v7 [NCIt concept]
- Stage I Adrenal Cortical Carcinoma AJCC v8 [NCIt concept]
- Stage I Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Stage I Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Stage I Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Stage I Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage I Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage I Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage I Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Anal Cancer AJCC v8 [NCIt concept]
- Stage I Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage I Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage I Appendix Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage I Appendix Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Bladder Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Bladder Cancer AJCC v8 [NCIt concept]
- Stage I Bladder Cancer with Carcinoma In Situ [NCIt concept]
- Stage I Bladder Cancer without Carcinoma In Situ [NCIt concept]
- Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Bone Cancer AJCC v7 [NCIt concept]
- Stage I Bone Cancer AJCC v8 [NCIt concept]
- Stage I Bone Sarcoma AJCC v7 [NCIt concept]
- Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor [NCIt concept]
- Stage I Breast Cancer AJCC v6 [NCIt concept]
- Stage I Breast Cancer AJCC v7 [NCIt concept]
- Stage I Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Cervical Cancer AJCC v8 [NCIt concept]
- Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Childhood Large Cell Lymphoma [NCIt concept]
- Stage I Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage I Chronic Lymphocytic Leukemia [NCIt concept]
- Stage I Colon Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Colon Cancer AJCC v8 [NCIt concept]
- Stage I Colon Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Colorectal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Colorectal Cancer AJCC v8 [NCIt concept]
- Stage I Colorectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Cutaneous Melanoma AJCC v6 [NCIt concept]
- Stage I Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage I Cutaneous Merkel Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 [NCIt concept]
- Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 [NCIt concept]
- Stage I Differentiated Thyroid Gland Carcinoma AJCC v7 [NCIt concept]
- Stage I Differentiated Thyroid Gland Carcinoma AJCC v8 [NCIt concept]
- Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 [NCIt concept]
- Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 [NCIt concept]
- Stage I Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage I Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage I Duodenal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage I Esophageal Cancer AJCC v6 [NCIt concept]
- Stage I Esophageal Cancer AJCC v7 [NCIt concept]
- Stage I Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Extragonadal Non-Seminomatous Germ Cell Tumor [NCIt concept]
- Stage I Extragonadal Seminoma [NCIt concept]
- Stage I Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage I Gallbladder Cancer AJCC v6 [NCIt concept]
- Stage I Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage I Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage I Gastric Cancer AJCC v6 [NCIt concept]
- Stage I Gastric Cancer AJCC v7 [NCIt concept]
- Stage I Gastric Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage I Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Stage I Hepatocellular Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage I Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage I Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage I Hypopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage I Hypopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage I Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage I Hypopharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Ileal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage I Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage I Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage I Jejunal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Kidney Wilms Tumor [NCIt concept]
- Stage I Laryngeal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Lentigo Maligna Melanoma AJCC v7 [NCIt concept]
- Stage I Lip Basal Cell Carcinoma [NCIt concept]
- Stage I Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Liver Cancer [NCIt concept]
- Stage I Low-CSD Melanoma AJCC v7 [NCIt concept]
- Stage I Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage I Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage I Lung Cancer AJCC v6 [NCIt concept]
- Stage I Lung Cancer AJCC v7 [NCIt concept]
- Stage I Lung Cancer AJCC v8 [NCIt concept]
- Stage I Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Lung Non-Small Cell Cancer AJCC v7 [NCIt concept]
- Stage I Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage I Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage I Mixed Cell Type Kidney Wilms Tumor [NCIt concept]
- Stage I Mycosis Fungoides AJCC v7 [NCIt concept]
- Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage I Nasal Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Nasopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage I Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage I Nasopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Oral Cavity Verrucous Carcinoma [NCIt concept]
- Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage I Oropharyngeal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Osteosarcoma AJCC v7 [NCIt concept]
- Stage I Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Cancer AJCC v8 [NCIt concept]
- Stage I Ovarian Choriocarcinoma [NCIt concept]
- Stage I Ovarian Dysgerminoma AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Polyembryoma AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Teratoma AJCC v6 and v7 [NCIt concept]
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage I Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage I Pancreatic Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Paranasal Sinus Cancer [NCIt concept]
- Stage I Penile Cancer AJCC v6 [NCIt concept]
- Stage I Penile Cancer AJCC v7 [NCIt concept]
- Stage I Penile Cancer AJCC v8 [NCIt concept]
- Stage I Pharyngeal Cancer [NCIt concept]
- Stage I Pleural Malignant Mesothelioma AJCC v7 [NCIt concept]
- Stage I Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage I Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage I Prostate Cancer AJCC v6 [NCIt concept]
- Stage I Prostate Cancer AJCC v7 [NCIt concept]
- Stage I Prostate Cancer AJCC v8 [NCIt concept]
- Stage I Rectal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Rectal Cancer AJCC v8 [NCIt concept]
- Stage I Rectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage I Rectosigmoid Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Renal Cell Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Renal Cell Cancer AJCC v8 [NCIt concept]
- Stage I Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage I Renal Pelvis Cancer AJCC v8 [NCIt concept]
- Stage I Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage I Renal Pelvis and Ureter Cancer AJCC v8 [NCIt concept]
- Stage I Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage I Sinonasal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage I Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Skin Cancer [NCIt concept]
- Stage I Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage I Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage I Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage I Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 and v7 [NCIt concept]
- Stage I T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Stage I Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Cancer AJCC v8 [NCIt concept]
- Stage I Testicular Choriocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Immature Teratoma AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Mixed Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Seminoma AJCC v6 and v7 [NCIt concept]
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage I Thymoma AJCC v8 [NCIt concept]
- Stage I Thymus Epithelial Neoplasm AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage I Thyroid Gland Follicular Carcinoma AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage I Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage I Thyroid Gland Papillary Carcinoma AJCC v8 [NCIt concept]
- Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 [NCIt concept]
- Stage I Ureter Cancer AJCC v7 [NCIt concept]
- Stage I Ureter Cancer AJCC v8 [NCIt concept]
- Stage I Urethral Cancer AJCC v7 [NCIt concept]
- Stage I Urethral Cancer AJCC v8 [NCIt concept]
- Stage I Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage I Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage I Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage I Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage I Uveal Melanoma AJCC v7 [NCIt concept]
- Stage I Vaginal Cancer AJCC v6 and v7 [NCIt concept]
- Stage I Vaginal Cancer AJCC v8 [NCIt concept]
- Stage I Vulvar Cancer AJCC v6 [NCIt concept]
- Stage I Vulvar Cancer AJCC v7 [NCIt concept]
- Stage I Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IA Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IA Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage IA Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IA Bone Cancer AJCC v7 [NCIt concept]
- Stage IA Bone Cancer AJCC v8 [NCIt concept]
- Stage IA Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IA Breast Cancer AJCC v7 [NCIt concept]
- Stage IA Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Cervical Cancer AJCC v8 [NCIt concept]
- Stage IA Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage IA Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage IA Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IA Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IA Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IA Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IA Gastric Cancer AJCC v7 [NCIt concept]
- Stage IA Gastric Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IA Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IA Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IA Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IA Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IA Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IA Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IA Lung Cancer AJCC v7 [NCIt concept]
- Stage IA Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IA Lung Non-Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IA Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IA Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IA Mycosis Fungoides AJCC v7 [NCIt concept]
- Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IA Osteosarcoma AJCC v7 [NCIt concept]
- Stage IA Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IA Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage IA Pleural Malignant Mesothelioma AJCC v7 [NCIt concept]
- Stage IA Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage IA Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage IA Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage IA Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Testicular Cancer AJCC v8 [NCIt concept]
- Stage IA Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IA Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IA Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IA Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IA Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IA Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IA Vulvar Carcinoma AJCC v6 [NCIt concept]
- Stage IA1 Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA1 Cervical Cancer AJCC v8 [NCIt concept]
- Stage IA1 Lung Cancer AJCC v8 [NCIt concept]
- Stage IA2 Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA2 Cervical Cancer AJCC v8 [NCIt concept]
- Stage IA2 Lung Cancer AJCC v8 [NCIt concept]
- Stage IA3 Lung Cancer AJCC v8 [NCIt concept]
- Stage IB Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IB Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage IB Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IB Bone Cancer AJCC v7 [NCIt concept]
- Stage IB Bone Cancer AJCC v8 [NCIt concept]
- Stage IB Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IB Breast Cancer AJCC v7 [NCIt concept]
- Stage IB Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Cervical Cancer AJCC v8 [NCIt concept]
- Stage IB Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage IB Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage IB Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IB Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IB Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IB Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IB Gastric Cancer AJCC v7 [NCIt concept]
- Stage IB Gastric Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IB Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IB Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IB Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IB Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IB Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IB Lung Cancer AJCC v7 [NCIt concept]
- Stage IB Lung Cancer AJCC v8 [NCIt concept]
- Stage IB Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IB Lung Non-Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IB Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IB Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IB Mycosis Fungoides AJCC v7 [NCIt concept]
- Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IB Osteosarcoma AJCC v7 [NCIt concept]
- Stage IB Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IB Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage IB Pleural Malignant Mesothelioma AJCC v7 [NCIt concept]
- Stage IB Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage IB Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage IB Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage IB Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Testicular Cancer AJCC v8 [NCIt concept]
- Stage IB Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IB Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IB Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IB Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IB Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IB Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IB Vulvar Carcinoma AJCC v6 [NCIt concept]
- Stage IB1 Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB1 Cervical Cancer AJCC v8 [NCIt concept]
- Stage IB2 Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB2 Cervical Cancer AJCC v8 [NCIt concept]
- Stage IC Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IC Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IC Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IC Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IC Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IC Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IC Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Acral Lentiginous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage II Adrenal Cortical Carcinoma AJCC v7 [NCIt concept]
- Stage II Adrenal Cortical Carcinoma AJCC v8 [NCIt concept]
- Stage II Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Stage II Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Stage II Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Stage II Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage II Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage II Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage II Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Anal Cancer AJCC v8 [NCIt concept]
- Stage II Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage II Appendix Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage II Appendix Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Bladder Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Bladder Cancer AJCC v8 [NCIt concept]
- Stage II Bladder Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Bone Cancer AJCC v7 [NCIt concept]
- Stage II Bone Cancer AJCC v8 [NCIt concept]
- Stage II Bone Sarcoma AJCC v7 [NCIt concept]
- Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor [NCIt concept]
- Stage II Breast Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Cervical Cancer AJCC v6 [NCIt concept]
- Stage II Cervical Cancer AJCC v7 [NCIt concept]
- Stage II Cervical Cancer AJCC v8 [NCIt concept]
- Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Childhood Large Cell Lymphoma [NCIt concept]
- Stage II Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage II Chronic Lymphocytic Leukemia [NCIt concept]
- Stage II Colon Cancer AJCC v6 [NCIt concept]
- Stage II Colon Cancer AJCC v7 [NCIt concept]
- Stage II Colon Cancer AJCC v8 [NCIt concept]
- Stage II Colorectal Cancer AJCC v6 [NCIt concept]
- Stage II Colorectal Cancer AJCC v7 [NCIt concept]
- Stage II Colorectal Cancer AJCC v8 [NCIt concept]
- Stage II Contiguous Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Stage II Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage II Cutaneous Merkel Cell Carcinoma AJCC v7 [NCIt concept]
- Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 [NCIt concept]
- Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 [NCIt concept]
- Stage II Differentiated Thyroid Gland Carcinoma AJCC v7 [NCIt concept]
- Stage II Differentiated Thyroid Gland Carcinoma AJCC v8 [NCIt concept]
- Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 [NCIt concept]
- Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 [NCIt concept]
- Stage II Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage II Duodenal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage II Esophageal Cancer AJCC v6 [NCIt concept]
- Stage II Esophageal Cancer AJCC v7 [NCIt concept]
- Stage II Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage II Extragonadal Non-Seminomatous Germ Cell Tumor [NCIt concept]
- Stage II Extragonadal Seminoma [NCIt concept]
- Stage II Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage II Gallbladder Cancer AJCC v6 [NCIt concept]
- Stage II Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage II Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage II Gastric Cancer AJCC v6 [NCIt concept]
- Stage II Gastric Cancer AJCC v7 [NCIt concept]
- Stage II Gastric Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage II Gastric Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage II Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Stage II Hepatocellular Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage II Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage II Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage II Hypopharyngeal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Ileal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage II Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage II Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage II Jejunal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Kidney Wilms Tumor [NCIt concept]
- Stage II Laryngeal Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Lentigo Maligna Melanoma AJCC v6 and v7 [NCIt concept]
- Stage II Lip Basal Cell Carcinoma [NCIt concept]
- Stage II Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Liver Cancer [NCIt concept]
- Stage II Low-CSD Melanoma AJCC v7 [NCIt concept]
- Stage II Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage II Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage II Lung Cancer AJCC v6 [NCIt concept]
- Stage II Lung Cancer AJCC v7 [NCIt concept]
- Stage II Lung Cancer AJCC v8 [NCIt concept]
- Stage II Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage II Lung Non-Small Cell Cancer AJCC v7 [NCIt concept]
- Stage II Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage II Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage II Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage II Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage II Mixed Cell Type Kidney Wilms Tumor [NCIt concept]
- Stage II Mycosis Fungoides AJCC v7 [NCIt concept]
- Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage II Nasal Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Nasopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage II Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage II Nasopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Stage II Oral Cavity Adenoid Cystic Carcinoma [NCIt concept]
- Stage II Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Oral Cavity Mucoepidermoid Carcinoma [NCIt concept]
- Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Oral Cavity Verrucous Carcinoma [NCIt concept]
- Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage II Oropharyngeal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Osteosarcoma AJCC v7 [NCIt concept]
- Stage II Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Cancer AJCC v8 [NCIt concept]
- Stage II Ovarian Choriocarcinoma [NCIt concept]
- Stage II Ovarian Dysgerminoma AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Polyembryoma AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Teratoma AJCC v6 and v7 [NCIt concept]
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage II Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage II Pancreatic Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage II Paranasal Sinus Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Penile Cancer AJCC v6 [NCIt concept]
- Stage II Penile Cancer AJCC v7 [NCIt concept]
- Stage II Penile Cancer AJCC v8 [NCIt concept]
- Stage II Pharyngeal Cancer [NCIt concept]
- Stage II Pleural Malignant Mesothelioma AJCC v7 [NCIt concept]
- Stage II Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage II Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage II Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage II Prostate Cancer AJCC v6 [NCIt concept]
- Stage II Prostate Cancer AJCC v7 [NCIt concept]
- Stage II Prostate Cancer AJCC v8 [NCIt concept]
- Stage II Rectal Cancer AJCC v6 [NCIt concept]
- Stage II Rectal Cancer AJCC v7 [NCIt concept]
- Stage II Rectal Cancer AJCC v8 [NCIt concept]
- Stage II Rectosigmoid Cancer AJCC v6 [NCIt concept]
- Stage II Rectosigmoid Cancer AJCC v7 [NCIt concept]
- Stage II Renal Cell Cancer AJCC v6 [NCIt concept]
- Stage II Renal Cell Cancer AJCC v7 [NCIt concept]
- Stage II Renal Cell Cancer AJCC v8 [NCIt concept]
- Stage II Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage II Renal Pelvis Cancer AJCC v8 [NCIt concept]
- Stage II Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage II Renal Pelvis and Ureter Cancer AJCC v8 [NCIt concept]
- Stage II Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage II Sinonasal Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage II Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Skin Cancer [NCIt concept]
- Stage II Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage II Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage II Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage II Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage II T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Stage II Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Cancer AJCC v8 [NCIt concept]
- Stage II Testicular Choriocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Immature Teratoma AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Mixed Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Seminoma AJCC v6 and v7 [NCIt concept]
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage II Thymoma AJCC v8 [NCIt concept]
- Stage II Thymus Epithelial Neoplasm AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage II Thyroid Gland Follicular Carcinoma AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage II Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage II Thyroid Gland Papillary Carcinoma AJCC v8 [NCIt concept]
- Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 [NCIt concept]
- Stage II Ureter Cancer AJCC v7 [NCIt concept]
- Stage II Ureter Cancer AJCC v8 [NCIt concept]
- Stage II Urethral Cancer AJCC v7 [NCIt concept]
- Stage II Urethral Cancer AJCC v8 [NCIt concept]
- Stage II Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage II Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage II Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage II Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage II Uveal Melanoma AJCC v7 [NCIt concept]
- Stage II Vaginal Cancer AJCC v6 and v7 [NCIt concept]
- Stage II Vaginal Cancer AJCC v8 [NCIt concept]
- Stage II Vulvar Cancer AJCC v6 [NCIt concept]
- Stage II Vulvar Cancer AJCC v7 [NCIt concept]
- Stage II Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IIA Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IIA Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage IIA Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IIA Anal Cancer AJCC v8 [NCIt concept]
- Stage IIA Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IIA Bone Cancer AJCC v7 [NCIt concept]
- Stage IIA Bone Cancer AJCC v8 [NCIt concept]
- Stage IIA Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IIA Breast Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIA Cervical Cancer AJCC v6 [NCIt concept]
- Stage IIA Cervical Cancer AJCC v7 [NCIt concept]
- Stage IIA Cervical Cancer AJCC v8 [NCIt concept]
- Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage IIA Colon Cancer AJCC v7 [NCIt concept]
- Stage IIA Colon Cancer AJCC v8 [NCIt concept]
- Stage IIA Colon Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIA Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IIA Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IIA Colorectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIA Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage IIA Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage IIA Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage IIA Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IIA Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIA Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIA Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIA Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IIA Gastric Cancer AJCC v7 [NCIt concept]
- Stage IIA Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IIA Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIA Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Lung Cancer AJCC v7 [NCIt concept]
- Stage IIA Lung Cancer AJCC v8 [NCIt concept]
- Stage IIA Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IIA Osteosarcoma AJCC v7 [NCIt concept]
- Stage IIA Ovarian Cancer AJCC V6 and v7 [NCIt concept]
- Stage IIA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IIA Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIA Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage IIA Penile Cancer AJCC v8 [NCIt concept]
- Stage IIA Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IIA Prostate Cancer AJCC v7 [NCIt concept]
- Stage IIA Prostate Cancer AJCC v8 [NCIt concept]
- Stage IIA Rectal Cancer AJCC v7 [NCIt concept]
- Stage IIA Rectal Cancer AJCC v8 [NCIt concept]
- Stage IIA Rectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIA Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage IIA Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage IIA Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IIA Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIA Testicular Cancer AJCC v8 [NCIt concept]
- Stage IIA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage IIA Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IIA Uveal Melanoma AJCC v7 [NCIt concept]
- Stage IIA Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IIA1 Cervical Cancer AJCC v7 [NCIt concept]
- Stage IIA1 Cervical Cancer AJCC v8 [NCIt concept]
- Stage IIA2 Cervical Cancer AJCC v7 [NCIt concept]
- Stage IIA2 Cervical Cancer AJCC v8 [NCIt concept]
- Stage IIB Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IIB Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage IIB Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IIB Anal Cancer AJCC v8 [NCIt concept]
- Stage IIB Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IIB Bone Cancer AJCC v7 [NCIt concept]
- Stage IIB Bone Cancer AJCC v8 [NCIt concept]
- Stage IIB Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IIB Breast Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Cervical Cancer AJCC v8 [NCIt concept]
- Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage IIB Colon Cancer AJCC v7 [NCIt concept]
- Stage IIB Colon Cancer AJCC v8 [NCIt concept]
- Stage IIB Colon Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIB Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IIB Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IIB Colorectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIB Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage IIB Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage IIB Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage IIB Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IIB Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIB Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIB Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IIB Gastric Cancer AJCC v7 [NCIt concept]
- Stage IIB Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IIB Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIB Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Lung Cancer AJCC v7 [NCIt concept]
- Stage IIB Lung Cancer AJCC v8 [NCIt concept]
- Stage IIB Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IIB Osteosarcoma AJCC v7 [NCIt concept]
- Stage IIB Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IIB Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage IIB Penile Cancer AJCC v8 [NCIt concept]
- Stage IIB Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IIB Prostate Cancer AJCC v7 [NCIt concept]
- Stage IIB Prostate Cancer AJCC v8 [NCIt concept]
- Stage IIB Rectal Cancer AJCC v7 [NCIt concept]
- Stage IIB Rectal Cancer AJCC v8 [NCIt concept]
- Stage IIB Rectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIB Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage IIB Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage IIB Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IIB Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Testicular Cancer AJCC v8 [NCIt concept]
- Stage IIB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage IIB Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IIB Uveal Melanoma AJCC v7 [NCIt concept]
- Stage IIB Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IIC Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IIC Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IIC Colon Cancer AJCC v7 [NCIt concept]
- Stage IIC Colon Cancer AJCC v8 [NCIt concept]
- Stage IIC Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IIC Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IIC Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage IIC Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIC Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IIC Prostate Cancer AJCC v8 [NCIt concept]
- Stage IIC Rectal Cancer AJCC v7 [NCIt concept]
- Stage IIC Rectal Cancer AJCC v8 [NCIt concept]
- Stage IIC Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIC Testicular Cancer AJCC v8 [NCIt concept]
- Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Acral Lentiginous Melanoma AJCC v7 [NCIt concept]
- Stage III Adrenal Cortical Carcinoma AJCC v7 [NCIt concept]
- Stage III Adrenal Cortical Carcinoma AJCC v8 [NCIt concept]
- Stage III Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Stage III Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Stage III Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Stage III Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage III Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage III Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage III Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Anal Cancer AJCC v8 [NCIt concept]
- Stage III Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage III Appendix Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage III Appendix Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Bladder Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Bladder Cancer AJCC v8 [NCIt concept]
- Stage III Bladder Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Bone Cancer AJCC v7 [NCIt concept]
- Stage III Bone Cancer AJCC v8 [NCIt concept]
- Stage III Bone Sarcoma AJCC v7 [NCIt concept]
- Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor [NCIt concept]
- Stage III Breast Cancer AJCC v6 [NCIt concept]
- Stage III Breast Cancer AJCC v7 [NCIt concept]
- Stage III Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Cervical Cancer AJCC v8 [NCIt concept]
- Stage III Childhood Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage III Childhood Large Cell Lymphoma [NCIt concept]
- Stage III Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage III Chronic Lymphocytic Leukemia [NCIt concept]
- Stage III Colon Cancer AJCC v6 [NCIt concept]
- Stage III Colon Cancer AJCC v7 [NCIt concept]
- Stage III Colon Cancer AJCC v8 [NCIt concept]
- Stage III Colorectal Cancer AJCC v6 [NCIt concept]
- Stage III Colorectal Cancer AJCC v7 [NCIt concept]
- Stage III Colorectal Cancer AJCC v8 [NCIt concept]
- Stage III Cutaneous Melanoma AJCC v6 [NCIt concept]
- Stage III Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage III Cutaneous Merkel Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 [NCIt concept]
- Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 [NCIt concept]
- Stage III Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage III Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage III Duodenal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage III Esophageal Cancer AJCC v6 [NCIt concept]
- Stage III Esophageal Cancer AJCC v7 [NCIt concept]
- Stage III Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Extragonadal Non-Seminomatous Germ Cell Tumor [NCIt concept]
- Stage III Extragonadal Seminoma [NCIt concept]
- Stage III Fallopian Tube Cancer AJCC v6 [NCIt concept]
- Stage III Fallopian Tube Cancer AJCC v7 [NCIt concept]
- Stage III Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage III Gallbladder Cancer AJCC v6 [NCIt concept]
- Stage III Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage III Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage III Gastric Cancer AJCC v6 [NCIt concept]
- Stage III Gastric Cancer AJCC v7 [NCIt concept]
- Stage III Gastric Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage III Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Stage III Head and Neck Mucosal Melanoma AJCC v7 [NCIt concept]
- Stage III Hepatocellular Carcinoma AJCC v6 [NCIt concept]
- Stage III Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage III Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage III Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage III Hypopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage III Hypopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage III Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Ileal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage III Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage III Jejunal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Kidney Wilms Tumor [NCIt concept]
- Stage III Laryngeal Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Lentigo Maligna Melanoma AJCC v7 [NCIt concept]
- Stage III Lip Basal Cell Carcinoma [NCIt concept]
- Stage III Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Liver Cancer [NCIt concept]
- Stage III Low-CSD Melanoma AJCC v7 [NCIt concept]
- Stage III Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage III Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage III Lung Cancer AJCC v6 [NCIt concept]
- Stage III Lung Cancer AJCC v7 [NCIt concept]
- Stage III Lung Cancer AJCC v8 [NCIt concept]
- Stage III Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Lung Non-Small Cell Cancer AJCC v7 [NCIt concept]
- Stage III Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage III Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage III Mixed Cell Type Kidney Wilms Tumor [NCIt concept]
- Stage III Mycosis Fungoides AJCC v7 [NCIt concept]
- Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage III Nasal Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Nasopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage III Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage III Nasopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Oral Cavity Verrucous Carcinoma [NCIt concept]
- Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage III Oropharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage III Oropharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage III Osteosarcoma AJCC v7 [NCIt concept]
- Stage III Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Cancer AJCC v8 [NCIt concept]
- Stage III Ovarian Choriocarcinoma [NCIt concept]
- Stage III Ovarian Dysgerminoma AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Polyembryoma AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Teratoma AJCC v6 and v7 [NCIt concept]
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage III Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage III Pancreatic Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage III Paranasal Sinus Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Penile Cancer AJCC v6 [NCIt concept]
- Stage III Penile Cancer AJCC v7 [NCIt concept]
- Stage III Penile Cancer AJCC v8 [NCIt concept]
- Stage III Pharyngeal Cancer [NCIt concept]
- Stage III Pleural Malignant Mesothelioma AJCC v7 [NCIt concept]
- Stage III Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage III Primary Peritoneal Cancer AJCC v7 [NCIt concept]
- Stage III Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage III Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage III Prostate Cancer AJCC v6 [NCIt concept]
- Stage III Prostate Cancer AJCC v7 [NCIt concept]
- Stage III Prostate Cancer AJCC v8 [NCIt concept]
- Stage III Rectal Cancer AJCC v6 [NCIt concept]
- Stage III Rectal Cancer AJCC v7 [NCIt concept]
- Stage III Rectal Cancer AJCC v8 [NCIt concept]
- Stage III Rectosigmoid Cancer AJCC v6 [NCIt concept]
- Stage III Rectosigmoid Cancer AJCC v7 [NCIt concept]
- Stage III Renal Cell Cancer AJCC v6 [NCIt concept]
- Stage III Renal Cell Cancer AJCC v7 [NCIt concept]
- Stage III Renal Cell Cancer AJCC v8 [NCIt concept]
- Stage III Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage III Renal Pelvis Cancer AJCC v8 [NCIt concept]
- Stage III Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage III Renal Pelvis and Ureter Cancer AJCC v8 [NCIt concept]
- Stage III Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage III Sinonasal Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Skin Cancer [NCIt concept]
- Stage III Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage III Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage III Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage III T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Stage III Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Cancer AJCC v8 [NCIt concept]
- Stage III Testicular Choriocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Immature Teratoma AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Mixed Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Seminoma AJCC v6 and v7 [NCIt concept]
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage III Thymoma AJCC v8 [NCIt concept]
- Stage III Thymus Epithelial Neoplasm AJCC v8 [NCIt concept]
- Stage III Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage III Thyroid Gland Follicular Carcinoma AJCC v8 [NCIt concept]
- Stage III Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage III Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage III Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage III Thyroid Gland Papillary Carcinoma AJCC v8 [NCIt concept]
- Stage III Ureter Cancer AJCC v7 [NCIt concept]
- Stage III Ureter Cancer AJCC v8 [NCIt concept]
- Stage III Urethral Cancer AJCC v7 [NCIt concept]
- Stage III Urethral Cancer AJCC v8 [NCIt concept]
- Stage III Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage III Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage III Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage III Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage III Uveal Melanoma AJCC v7 [NCIt concept]
- Stage III Vaginal Cancer AJCC v6 and v7 [NCIt concept]
- Stage III Vaginal Cancer AJCC v8 [NCIt concept]
- Stage III Vulvar Cancer AJCC v6 [NCIt concept]
- Stage III Vulvar Cancer AJCC v7 [NCIt concept]
- Stage III Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IIIA Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage IIIA Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IIIA Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIA Anal Cancer AJCC v8 [NCIt concept]
- Stage IIIA Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IIIA Bladder Cancer AJCC v8 [NCIt concept]
- Stage IIIA Breast Cancer AJCC v7 [NCIt concept]
- Stage IIIA Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIA Cervical Cancer AJCC v8 [NCIt concept]
- Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage IIIA Colon Cancer AJCC v7 [NCIt concept]
- Stage IIIA Colon Cancer AJCC v8 [NCIt concept]
- Stage IIIA Colon Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIIA Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IIIA Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIIA Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage IIIA Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IIIA Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIIA Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Fallopian Tube Cancer AJCC v7 [NCIt concept]
- Stage IIIA Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIIA Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage IIIA Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IIIA Gastric Cancer AJCC v7 [NCIt concept]
- Stage IIIA Gastric Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IIIA Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IIIA Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IIIA Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IIIA Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIA Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIIA Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Lung Cancer AJCC v7 [NCIt concept]
- Stage IIIA Lung Cancer AJCC v8 [NCIt concept]
- Stage IIIA Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Lung Non-Small Cell Cancer AJCC v7 [NCIt concept]
- Stage IIIA Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IIIA Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IIIA Penile Cancer AJCC v8 [NCIt concept]
- Stage IIIA Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage IIIA Primary Peritoneal Cancer AJCC v7 [NCIt concept]
- Stage IIIA Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IIIA Prostate Cancer AJCC v8 [NCIt concept]
- Stage IIIA Rectal Cancer AJCC v7 [NCIt concept]
- Stage IIIA Rectal Cancer AJCC v8 [NCIt concept]
- Stage IIIA Rectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIIA Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage IIIA Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage IIIA Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIA Testicular Cancer AJCC v8 [NCIt concept]
- Stage IIIA Thymoma AJCC v8 [NCIt concept]
- Stage IIIA Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IIIA Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IIIA Uveal Melanoma AJCC v7 [NCIt concept]
- Stage IIIA Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IIIA Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IIIA1 Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIIA1 Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIA2 Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIIA2 Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIB Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage IIIB Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IIIB Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIB Anal Cancer AJCC v8 [NCIt concept]
- Stage IIIB Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IIIB Bladder Cancer AJCC v8 [NCIt concept]
- Stage IIIB Breast Cancer AJCC v7 [NCIt concept]
- Stage IIIB Breast Inflammatory Carcinoma [NCIt concept]
- Stage IIIB Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIB Cervical Cancer AJCC v8 [NCIt concept]
- Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage IIIB Colon Cancer AJCC v7 [NCIt concept]
- Stage IIIB Colon Cancer AJCC v8 [NCIt concept]
- Stage IIIB Colon Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIIB Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IIIB Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIIB Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage IIIB Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IIIB Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIIB Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Fallopian Tube Cancer AJCC v7 [NCIt concept]
- Stage IIIB Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIIB Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage IIIB Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IIIB Gastric Cancer AJCC v7 [NCIt concept]
- Stage IIIB Gastric Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IIIB Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IIIB Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IIIB Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IIIB Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIB Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIIB Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Lung Cancer AJCC v7 [NCIt concept]
- Stage IIIB Lung Cancer AJCC v8 [NCIt concept]
- Stage IIIB Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Lung Non-Small Cell Cancer AJCC v7 [NCIt concept]
- Stage IIIB Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7 [NCIt concept]
- Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7 [NCIt concept]
- Stage IIIB Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IIIB Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IIIB Penile Cancer AJCC v8 [NCIt concept]
- Stage IIIB Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage IIIB Primary Peritoneal Cancer AJCC v7 [NCIt concept]
- Stage IIIB Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IIIB Prostate Cancer AJCC v8 [NCIt concept]
- Stage IIIB Rectal Cancer AJCC v7 [NCIt concept]
- Stage IIIB Rectal Cancer AJCC v8 [NCIt concept]
- Stage IIIB Rectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IIIB Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage IIIB Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage IIIB Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIB Testicular Cancer AJCC v8 [NCIt concept]
- Stage IIIB Thymoma AJCC v8 [NCIt concept]
- Stage IIIB Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IIIB Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IIIB Uveal Melanoma AJCC v7 [NCIt concept]
- Stage IIIB Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IIIB Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IIIC Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage IIIC Anal Cancer AJCC v8 [NCIt concept]
- Stage IIIC Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IIIC Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IIIC Breast Cancer AJCC v6 [NCIt concept]
- Stage IIIC Breast Cancer AJCC v7 [NCIt concept]
- Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage IIIC Colon Cancer AJCC v7 [NCIt concept]
- Stage IIIC Colon Cancer AJCC v8 [NCIt concept]
- Stage IIIC Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IIIC Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IIIC Cutaneous Melanoma AJCC v7 [NCIt concept]
- Stage IIIC Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IIIC Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IIIC Fallopian Tube Cancer AJCC v7 [NCIt concept]
- Stage IIIC Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IIIC Gastric Cancer AJCC v7 [NCIt concept]
- Stage IIIC Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IIIC Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IIIC Lung Cancer AJCC v8 [NCIt concept]
- Stage IIIC Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIC Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IIIC Primary Peritoneal Cancer AJCC v7 [NCIt concept]
- Stage IIIC Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IIIC Prostate Cancer AJCC v8 [NCIt concept]
- Stage IIIC Rectal Cancer AJCC v7 [NCIt concept]
- Stage IIIC Rectal Cancer AJCC v8 [NCIt concept]
- Stage IIIC Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIC Testicular Cancer AJCC v8 [NCIt concept]
- Stage IIIC Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IIIC Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IIIC Uveal Melanoma AJCC v7 [NCIt concept]
- Stage IIIC Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IIIC Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IIIC1 Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IIIC1 Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IIIC2 Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IIIC2 Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IIIa Penile Cancer AJCC v7 [NCIt concept]
- Stage IIIb Penile Cancer AJCC v7 [NCIt concept]
- Stage IS Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IS Testicular Cancer AJCC v8 [NCIt concept]
- Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Acral Lentiginous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage IV Adrenal Cortical Carcinoma AJCC v7 [NCIt concept]
- Stage IV Adrenal Cortical Carcinoma AJCC v8 [NCIt concept]
- Stage IV Adult Diffuse Large Cell Lymphoma [NCIt concept]
- Stage IV Adult Diffuse Mixed Cell Lymphoma [NCIt concept]
- Stage IV Adult Diffuse Small Cleaved Cell Lymphoma [NCIt concept]
- Stage IV Adult Liver Cancer AJCC v7 [NCIt concept]
- Stage IV Adult Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IV Ampulla of Vater Cancer AJCC v7 [NCIt concept]
- Stage IV Ampulla of Vater Cancer AJCC v8 [NCIt concept]
- Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Anal Canal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Anal Cancer AJCC v8 [NCIt concept]
- Stage IV Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IV Appendix Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage IV Appendix Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Bladder Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IV Bladder Cancer AJCC v6 [NCIt concept]
- Stage IV Bladder Cancer AJCC v7 [NCIt concept]
- Stage IV Bladder Cancer AJCC v8 [NCIt concept]
- Stage IV Bladder Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Bladder Urothelial Carcinoma AJCC v7 [NCIt concept]
- Stage IV Bone Cancer AJCC v7 [NCIt concept]
- Stage IV Bone Cancer AJCC v8 [NCIt concept]
- Stage IV Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor [NCIt concept]
- Stage IV Breast Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Breast Inflammatory Carcinoma [NCIt concept]
- Stage IV Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Cervical Cancer AJCC v8 [NCIt concept]
- Stage IV Childhood Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IV Childhood Large Cell Lymphoma [NCIt concept]
- Stage IV Choroidal and Ciliary Body Melanoma AJCC v8 [NCIt concept]
- Stage IV Chronic Lymphocytic Leukemia [NCIt concept]
- Stage IV Colon Cancer AJCC v6 [NCIt concept]
- Stage IV Colon Cancer AJCC v7 [NCIt concept]
- Stage IV Colon Cancer AJCC v8 [NCIt concept]
- Stage IV Colon Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Colorectal Cancer AJCC v6 [NCIt concept]
- Stage IV Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IV Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IV Colorectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 [NCIt concept]
- Stage IV Digestive System Neuroendocrine Tumor AJCC v7 [NCIt concept]
- Stage IV Distal Bile Duct Cancer AJCC v7 [NCIt concept]
- Stage IV Distal Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IV Duodenal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Esophageal Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IV Esophageal Cancer AJCC v6 [NCIt concept]
- Stage IV Esophageal Cancer AJCC v7 [NCIt concept]
- Stage IV Esophageal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor [NCIt concept]
- Stage IV Extragonadal Seminoma [NCIt concept]
- Stage IV Extrahepatic Bile Duct Cancer [NCIt concept]
- Stage IV Fallopian Tube Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IV Gallbladder Cancer AJCC v6 [NCIt concept]
- Stage IV Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage IV Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IV Gastric Cancer AJCC v6 [NCIt concept]
- Stage IV Gastric Cancer AJCC v7 [NCIt concept]
- Stage IV Gastric Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IV Gastric Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IV Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 [NCIt concept]
- Stage IV Hepatocellular Carcinoma AJCC v6 [NCIt concept]
- Stage IV Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IV Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IV Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IV Hypopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage IV Hypopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IV Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Ileal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Intrahepatic Bile Duct Cancer AJCC v8 [NCIt concept]
- Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IV Jejunal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Kidney Wilms Tumor [NCIt concept]
- Stage IV Laryngeal Cancer AJCC v6 [NCIt concept]
- Stage IV Laryngeal Cancer AJCC v7 [NCIt concept]
- Stage IV Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Laryngeal Verrucous Carcinoma AJCC v7 [NCIt concept]
- Stage IV Lentigo Maligna Melanoma AJCC v6 and v7 [NCIt concept]
- Stage IV Lip Basal Cell Carcinoma [NCIt concept]
- Stage IV Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IV Liver Cancer [NCIt concept]
- Stage IV Low-CSD Melanoma AJCC v7 [NCIt concept]
- Stage IV Lung Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IV Lung Adenosquamous Carcinoma AJCC v7 [NCIt concept]
- Stage IV Lung Cancer AJCC v6 [NCIt concept]
- Stage IV Lung Cancer AJCC v7 [NCIt concept]
- Stage IV Lung Cancer AJCC v8 [NCIt concept]
- Stage IV Lung Large Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Lung Non-Small Cell Cancer AJCC v7 [NCIt concept]
- Stage IV Lung Small Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Lung Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage IV Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage IV Major Salivary Gland Carcinoma with Metastasis [NCIt concept]
- Stage IV Major Salivary Gland Carcinoma without Metastasis [NCIt concept]
- Stage IV Mixed Cell Type Kidney Wilms Tumor [NCIt concept]
- Stage IV Mycosis Fungoides AJCC v7 [NCIt concept]
- Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IV Nasal Cavity Cancer [NCIt concept]
- Stage IV Nasopharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage IV Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IV Nasopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IV Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage IV Oropharyngeal Carcinoma AJCC v6 [NCIt concept]
- Stage IV Oropharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage IV Osteosarcoma AJCC v7 [NCIt concept]
- Stage IV Ovarian Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IV Ovarian Choriocarcinoma [NCIt concept]
- Stage IV Ovarian Dysgerminoma AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Polyembryoma AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Teratoma AJCC v6 and v7 [NCIt concept]
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7 [NCIt concept]
- Stage IV Pancreatic Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Pancreatic Cancer AJCC v8 [NCIt concept]
- Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Paranasal Sinus Cancer AJCC v7 [NCIt concept]
- Stage IV Penile Cancer AJCC v6 [NCIt concept]
- Stage IV Penile Cancer AJCC v7 [NCIt concept]
- Stage IV Penile Cancer AJCC v8 [NCIt concept]
- Stage IV Pharyngeal Cancer [NCIt concept]
- Stage IV Pleural Malignant Mesothelioma AJCC v7 [NCIt concept]
- Stage IV Pleural Malignant Mesothelioma AJCC v8 [NCIt concept]
- Stage IV Primary Peritoneal Cancer AJCC v7 [NCIt concept]
- Stage IV Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IV Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IV Prostate Cancer AJCC v6 [NCIt concept]
- Stage IV Prostate Cancer AJCC v7 [NCIt concept]
- Stage IV Prostate Cancer AJCC v8 [NCIt concept]
- Stage IV Rectal Cancer AJCC v6 [NCIt concept]
- Stage IV Rectal Cancer AJCC v7 [NCIt concept]
- Stage IV Rectal Cancer AJCC v8 [NCIt concept]
- Stage IV Rectal Neuroendocrine Tumor AJCC v8 [NCIt concept]
- Stage IV Rectosigmoid Cancer AJCC v6 [NCIt concept]
- Stage IV Rectosigmoid Cancer AJCC v7 [NCIt concept]
- Stage IV Renal Cell Cancer AJCC v6 [NCIt concept]
- Stage IV Renal Cell Cancer AJCC v7 [NCIt concept]
- Stage IV Renal Cell Cancer AJCC v8 [NCIt concept]
- Stage IV Renal Pelvis Cancer AJCC v7 [NCIt concept]
- Stage IV Renal Pelvis Cancer AJCC v8 [NCIt concept]
- Stage IV Renal Pelvis and Ureter Cancer AJCC v7 [NCIt concept]
- Stage IV Renal Pelvis and Ureter Cancer AJCC v8 [NCIt concept]
- Stage IV Retroperitoneal Sarcoma AJCC v8 [NCIt concept]
- Stage IV Sinonasal Cancer AJCC v6 [NCIt concept]
- Stage IV Sinonasal Cancer AJCC v7 [NCIt concept]
- Stage IV Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Skin Cancer [NCIt concept]
- Stage IV Small Intestinal Adenocarcinoma AJCC v8 [NCIt concept]
- Stage IV Small Intestinal Cancer AJCC v7 [NCIt concept]
- Stage IV Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 [NCIt concept]
- Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 [NCIt concept]
- Stage IV Soft Tissue Sarcoma AJCC v7 [NCIt concept]
- Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 [NCIt concept]
- Stage IV T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Stage IV Thymoma AJCC v8 [NCIt concept]
- Stage IV Thymus Epithelial Neoplasm AJCC v8 [NCIt concept]
- Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage IV Thyroid Gland Follicular Carcinoma AJCC v8 [NCIt concept]
- Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage IV Thyroid Gland Papillary Carcinoma AJCC v8 [NCIt concept]
- Stage IV Ureter Cancer AJCC v7 [NCIt concept]
- Stage IV Ureter Cancer AJCC v8 [NCIt concept]
- Stage IV Urethral Cancer AJCC v7 [NCIt concept]
- Stage IV Urethral Cancer AJCC v8 [NCIt concept]
- Stage IV Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v6 [NCIt concept]
- Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IV Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IV Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IV Uveal Melanoma AJCC v7 [NCIt concept]
- Stage IV Vaginal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IV Vulvar Cancer AJCC v6 [NCIt concept]
- Stage IV Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IV Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IVA Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Bladder Cancer AJCC v8 [NCIt concept]
- Stage IVA Bone Cancer AJCC v7 [NCIt concept]
- Stage IVA Bone Cancer AJCC v8 [NCIt concept]
- Stage IVA Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IVA Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVA Cervical Cancer AJCC v8 [NCIt concept]
- Stage IVA Colon Cancer AJCC v7 [NCIt concept]
- Stage IVA Colon Cancer AJCC v8 [NCIt concept]
- Stage IVA Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IVA Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IVA Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage IVA Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IVA Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IVA Head and Neck Mucosal Melanoma AJCC v7 [NCIt concept]
- Stage IVA Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVA Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IVA Hypopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVA Laryngeal Cancer AJCC v7 [NCIt concept]
- Stage IVA Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Lip Basal Cell Carcinoma [NCIt concept]
- Stage IVA Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVA Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVA Liver Cancer [NCIt concept]
- Stage IVA Lung Cancer AJCC v8 [NCIt concept]
- Stage IVA Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage IVA Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IVA Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Nasopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVA Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Oropharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Osteosarcoma AJCC v7 [NCIt concept]
- Stage IVA Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IVA Paranasal Sinus Cancer AJCC v7 [NCIt concept]
- Stage IVA Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IVA Prostate Cancer AJCC v8 [NCIt concept]
- Stage IVA Rectal Cancer AJCC v7 [NCIt concept]
- Stage IVA Rectal Cancer AJCC v8 [NCIt concept]
- Stage IVA Sinonasal Cancer AJCC v7 [NCIt concept]
- Stage IVA Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Thymoma AJCC v8 [NCIt concept]
- Stage IVA Thymus Epithelial Neoplasm AJCC v8 [NCIt concept]
- Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8 [NCIt concept]
- Stage IVA Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IVA Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IVA Vaginal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVA Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IVA Vulvar Cancer AJCC v6 [NCIt concept]
- Stage IVA Vulvar Cancer AJCC v7 [NCIt concept]
- Stage IVA Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IVB Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Bladder Cancer AJCC v8 [NCIt concept]
- Stage IVB Bone Cancer AJCC v7 [NCIt concept]
- Stage IVB Bone Cancer AJCC v8 [NCIt concept]
- Stage IVB Bone Sarcoma AJCC v7 [NCIt concept]
- Stage IVB Cervical Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVB Cervical Cancer AJCC v8 [NCIt concept]
- Stage IVB Colon Cancer AJCC v7 [NCIt concept]
- Stage IVB Colon Cancer AJCC v8 [NCIt concept]
- Stage IVB Colorectal Cancer AJCC v7 [NCIt concept]
- Stage IVB Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Fallopian Tube Cancer AJCC v8 [NCIt concept]
- Stage IVB Gallbladder Cancer AJCC v7 [NCIt concept]
- Stage IVB Gallbladder Cancer AJCC v8 [NCIt concept]
- Stage IVB Gestational Trophoblastic Tumor AJCC v7 [NCIt concept]
- Stage IVB Head and Neck Mucosal Melanoma AJCC v7 [NCIt concept]
- Stage IVB Hepatocellular Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Hepatocellular Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Hilar Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVB Hilar Cholangiocarcinoma AJCC v8 [NCIt concept]
- Stage IVB Hypopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 [NCIt concept]
- Stage IVB Laryngeal Cancer AJCC v7 [NCIt concept]
- Stage IVB Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Laryngeal Verrucous Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Lip Basal Cell Carcinoma [NCIt concept]
- Stage IVB Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVB Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVB Liver Cancer [NCIt concept]
- Stage IVB Lung Cancer AJCC v8 [NCIt concept]
- Stage IVB Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage IVB Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7 [NCIt concept]
- Stage IVB Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Nasopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVB Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Oropharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Osteosarcoma AJCC v7 [NCIt concept]
- Stage IVB Ovarian Cancer AJCC v8 [NCIt concept]
- Stage IVB Paranasal Sinus Cancer AJCC v7 [NCIt concept]
- Stage IVB Primary Peritoneal Cancer AJCC v8 [NCIt concept]
- Stage IVB Prostate Cancer AJCC v8 [NCIt concept]
- Stage IVB Rectal Cancer AJCC v7 [NCIt concept]
- Stage IVB Rectal Cancer AJCC v8 [NCIt concept]
- Stage IVB Sinonasal Cancer AJCC v7 [NCIt concept]
- Stage IVB Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Thymoma AJCC v8 [NCIt concept]
- Stage IVB Thymus Epithelial Neoplasm AJCC v8 [NCIt concept]
- Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8 [NCIt concept]
- Stage IVB Uterine Corpus Adenosarcoma AJCC v8 [NCIt concept]
- Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 [NCIt concept]
- Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage [NCIt concept]
- Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 [NCIt concept]
- Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8 [NCIt concept]
- Stage IVB Uterine Sarcoma AJCC v7 [NCIt concept]
- Stage IVB Vaginal Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVB Vaginal Cancer AJCC v8 [NCIt concept]
- Stage IVB Vulvar Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVB Vulvar Cancer AJCC v8 [NCIt concept]
- Stage IVC Appendix Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Appendix Carcinoma AJCC v8 [NCIt concept]
- Stage IVC Colon Cancer AJCC v8 [NCIt concept]
- Stage IVC Colorectal Cancer AJCC v8 [NCIt concept]
- Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Head and Neck Mucosal Melanoma AJCC v7 [NCIt concept]
- Stage IVC Hypopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Hypopharyngeal Carcinoma AJCC v8 [NCIt concept]
- Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Laryngeal Cancer AJCC v7 [NCIt concept]
- Stage IVC Laryngeal Cancer AJCC v8 [NCIt concept]
- Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Laryngeal Verrucous Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Lip Basal Cell Carcinoma [NCIt concept]
- Stage IVC Lip Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVC Lip and Oral Cavity Cancer AJCC v8 [NCIt concept]
- Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVC Major Salivary Gland Cancer AJCC v7 [NCIt concept]
- Stage IVC Major Salivary Gland Cancer AJCC v8 [NCIt concept]
- Stage IVC Nasopharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVC Oral Cavity Cancer AJCC v6 and v7 [NCIt concept]
- Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 [NCIt concept]
- Stage IVC Oropharyngeal Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Paranasal Sinus Cancer AJCC v7 [NCIt concept]
- Stage IVC Rectal Cancer AJCC v8 [NCIt concept]
- Stage IVC Sinonasal Cancer AJCC v7 [NCIt concept]
- Stage IVC Sinonasal Cancer AJCC v8 [NCIt concept]
- Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 [NCIt concept]
- Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 [NCIt concept]
- Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8 [NCIt concept]
- Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 [NCIt concept]
- Stage V Kidney Wilms Tumor [NCIt concept]
- Stage V Mixed Cell Type Kidney Wilms Tumor [NCIt concept]
- Staining Method [NCIt concept]
- Standard Diet [NCIt concept]
- Standard Follow-Up Care [NCIt concept]
- Staphylococcus Aureus [NCIt concept]
- Stathmin [NCIt concept]
- Stationary Digital Chest Tomosynthesis [NCIt concept]
- Stationary Digital Tomosynthesis [NCIt concept]
- Status [NCIt concept]
- Stearoyl-CoA Desaturase [NCIt concept]
- Stem Cell [NCIt concept]
- Stem Cell Growth Factor Beta [NCIt concept]
- Stem Cell Isolation [NCIt concept]
- Stem Cell Mobilization Therapy [NCIt concept]
- Stent Device [NCIt concept]
- Stenting [NCIt concept]
- Stepped Palliative Care [NCIt concept]
- Stereotactic Ablative Radiotherapy [NCIt concept]
- Stereotactic Accelerated Partial Breast Irradiation [NCIt concept]
- Stereotactic Biopsy [NCIt concept]
- Stereotactic Body Radiation Therapy [NCIt concept]
- Stereotactic Implantation [NCIt concept]
- Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy [NCIt concept]
- Stereotactic Radiosurgery [NCIt concept]
- Sterile Alpha Motif Domain-Containing Protein 9 [NCIt concept]
- Sterile Alpha Motif Domain-Containing Protein 9-Like [NCIt concept]
- Sterile Distilled Water [NCIt concept]
- Steroid 17-Alpha-Hydroxylase/17,20 Lyase [NCIt concept]
- Steroid 5 Alpha-Reductase [NCIt concept]
- Steroid Compound [NCIt concept]
- Steroid Resistant Acute Graft Versus Host Disease [NCIt concept]
- Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host Disease [NCIt concept]
- Steroid Therapy [NCIt concept]
- Steroid-Dependent Gastrointestinal Tract Acute Graft Versus Host Disease [NCIt concept]
- Steroid-Refractory Pneumonitis [NCIt concept]
- Sterol 26-Hydroxylase, Mitochondrial [NCIt concept]
- Sterol Regulatory Element-Binding Protein 1 [NCIt concept]
- Steryl-Sulfatase [NCIt concept]
- Stimulated By Retinoic Acid Gene 6 Protein Homolog [NCIt concept]
- Stimulated by Retinoic Acid Gene 8 Protein [NCIt concept]
- Stimulator of Interferon Genes Protein [NCIt concept]
- Strata Immune Signature Positive [NCIt concept]
- Streptococcus mutans [NCIt concept]
- Streptococcus pneumoniae IgG Antibody Measurement [NCIt concept]
- Stress Cardiac Magnetic Resonance Imaging [NCIt concept]
- Stress Management Therapy [NCIt concept]
- Stress-Induced-Phosphoprotein 1 [NCIt concept]
- Stretching [NCIt concept]
- Striatin [NCIt concept]
- Stromal Cell [NCIt concept]
- Stromal Cell-Derived Factor 1 [NCIt concept]
- Stromal Predominant Kidney Wilms Tumor [NCIt concept]
- Stromelysin-1 [NCIt concept]
- Stromelysin-2 [NCIt concept]
- Strontium Chloride Sr-89 [NCIt concept]
- Structural Brain Imaging [NCIt concept]
- Structural Maintenance of Chromosomes Protein 1A [NCIt concept]
- Structural Maintenance of Chromosomes Protein 3 [NCIt concept]
- Structure-Specific Endonuclease Subunit SLX4 [NCIt concept]
- Student [NCIt concept]
- Study Control [NCIt concept]
- Study Subject [NCIt concept]
- Study of High Risk Factors [NCIt concept]
- Study of Socioeconomic and Demographic Variables [NCIt concept]
- Sturlimogene Erparepvec [NCIt concept]
- Subasumstat [NCIt concept]
- Subcutaneous Hormonal Therapy [NCIt concept]
- Subcutaneous Mastectomy [NCIt concept]
- Subcutaneous Panniculitis-Like T-Cell Lymphoma [NCIt concept]
- Subependymal Giant Cell Astrocytoma [NCIt concept]
- Subglottic Carcinoma [NCIt concept]
- Subject [NCIt concept]
- Sublingual Gland Carcinoma [NCIt concept]
- Submandibular Gland Carcinoma [NCIt concept]
- Submandibular Gland Transfer [NCIt concept]
- Submicron Particle Paclitaxel Sterile Suspension [NCIt concept]
- Substance Abuse [NCIt concept]
- Substance P [NCIt concept]
- Substance P-Saporin [NCIt concept]
- Substance-P Receptor [NCIt concept]
- Subtotal Gastrectomy [NCIt concept]
- Succimer [NCIt concept]
- Succinate Dehydrogenase [NCIt concept]
- Succinate Dehydrogenase Assembly Factor 2, Mitochondrial [NCIt concept]
- Succinate Dehydrogenase Cytochrome b560 Subunit, Mitochondrial [NCIt concept]
- Succinate Dehydrogenase Deficiency [NCIt concept]
- Succinate Dehydrogenase [Ubiquinone] Cytochrome B Small Subunit, Mitochondrial [NCIt concept]
- Succinate Dehydrogenase [Ubiquinone] Flavoprotein Subunit, Mitochondrial [NCIt concept]
- Succinate Dehydrogenase [Ubiquinone] Iron-Sulfur Subunit, Mitochondrial [NCIt concept]
- Succinate Dehydrogenase-Deficient Renal Cell Carcinoma [NCIt concept]
- Sucrose [NCIt concept]
- Sudocetaxel Zendusortide [NCIt concept]
- Sugammadex [NCIt concept]
- Sugemalimab [NCIt concept]
- Sulanemadlin [NCIt concept]
- Sulfasalazine [NCIt concept]
- Sulfatase-Modifying Factor 1 [NCIt concept]
- Sulfated DHEA Measurement [NCIt concept]
- Sulfatinib [NCIt concept]
- Sulfhydryl Oxidase 1 [NCIt concept]
- Sulfiredoxin-1 [NCIt concept]
- Sulforaphane [NCIt concept]
- Sulfotransferase 1A1 [NCIt concept]
- Sulfotransferase 1C2 [NCIt concept]
- Sulfur Hexafluoride [NCIt concept]
- Sulfur Hexafluoride Lipid Microspheres [NCIt concept]
- Sulindac [NCIt concept]
- Sunitinib [NCIt concept]
- Sunitinib Malate [NCIt concept]
- Sunscreen [NCIt concept]
- Sunvozertinib [NCIt concept]
- Super Enhancer Inhibitor GZ17-6.02 [NCIt concept]
- Superoxide Dismutase [Cu-Zn] [NCIt concept]
- Superoxide Dismutase [Mn], Mitochondrial [NCIt concept]
- Superparamagnetic Iron Oxide Magnetic Resonance Imaging [NCIt concept]
- Supersaturated Calcium Phosphate Rinse [NCIt concept]
- Support Education Activity [NCIt concept]
- Support Group Therapy [NCIt concept]
- Support for Caregiver [NCIt concept]
- Supportive Care [NCIt concept]
- Suppressive Monocyte [NCIt concept]
- Suppressor of Cytokine Signaling 1 [NCIt concept]
- Suppressor of Cytokine Signaling 2 [NCIt concept]
- Suppressor of Cytokine Signaling 3 [NCIt concept]
- Suppressor of Fused Homolog [NCIt concept]
- Suppressor of Tumorigenicity 14 Protein [NCIt concept]
- Suppressor of Tumorigenicity 7 Protein [NCIt concept]
- Supra-pharmacologic Dexamethasone Sodium Phosphate AVM0703 [NCIt concept]
- Supraglottic Carcinoma [NCIt concept]
- Suprasellar Germ Cell Tumor [NCIt concept]
- Supratentorial Gliosarcoma [NCIt concept]
- Suramin [NCIt concept]
- Suratadenoturev [NCIt concept]
- Surefire Antireflux Microcatheter [NCIt concept]
- Surface Guided Radiation Therapy [NCIt concept]
- Surface Immunoglobulin-Positive Cells Present [NCIt concept]
- Surface-Enhanced Laser Desorption/Ionization-Time of Flight Mass Spectrometry [NCIt concept]
- Surface-engineered Lentiviral Particles-expressing Cocal Glycoprotein/Anti-CD3 scFv Containing Transgene Encoding for Anti-CD19 CAR/Rapamycin Activated Cytokine Receptor System UB-VV111 [NCIt concept]
- Surgeon [NCIt concept]
- Surgical Castration [NCIt concept]
- Surgical Clip [NCIt concept]
- Surgical Implantation [NCIt concept]
- Surgical Mesh Implant [NCIt concept]
- Surgical Procedure [NCIt concept]
- Surgical Stapler [NCIt concept]
- Surgical Wound Closure [NCIt concept]
- Surgical Wound Drain [NCIt concept]
- Surovatamig [NCIt concept]
- Survey Administration [NCIt concept]
- Survival Motor Neuron Protein [NCIt concept]
- Survivin Antigen [NCIt concept]
- Survivin Positive [NCIt concept]
- Survivin mRNA Antagonist EZN-3042 [NCIt concept]
- Survivin-expressing CVD908ssb-TXSVN Vaccine [NCIt concept]
- Survivorship Care Plan [NCIt concept]
- Surzebiclimab [NCIt concept]
- Susceptibility Weighted Imaging [NCIt concept]
- Sushi Domain-Containing Protein 1 [NCIt concept]
- Sustained-Exposure Dexamethasone Formulation OTO-104 [NCIt concept]
- Sustained-release Lipid Inhaled Cisplatin [NCIt concept]
- Sustained-release Mitomycin C Hydrogel Formulation UGN-101 [NCIt concept]
- Sustained-release Mitomycin C Hydrogel Formulation UGN-103 [NCIt concept]
- Sutetinib Maleate [NCIt concept]
- Sutimlimab [NCIt concept]
- Suture Device [NCIt concept]
- Suvorexant [NCIt concept]
- Swallowable Sponge Cell Sampling Device [NCIt concept]
- Swallowing Therapy [NCIt concept]
- Symmetric Dimethylarginine [NCIt concept]
- Symptomatic COVID-19 Infection Laboratory-Confirmed [NCIt concept]
- Synaptic Vesicular Amine Transporter [NCIt concept]
- Synaptonemal Complex Protein 1 [NCIt concept]
- Synaptophysin [NCIt concept]
- Synaptophysin-Positive Neoplastic Cells Present [NCIt concept]
- Synaptopodin [NCIt concept]
- Synaptosomal-Associated Protein 25 [NCIt concept]
- Synbiotic Supplement [NCIt concept]
- Syndecan-1 [NCIt concept]
- Syndecan-2 [NCIt concept]
- Syndecan-3 [NCIt concept]
- Syndecan-4 [NCIt concept]
- Syngeneic Bone Marrow Transplantation [NCIt concept]
- Synovial Sarcoma [NCIt concept]
- Synphilin-1 [NCIt concept]
- Syntaxin-11 [NCIt concept]
- Syntaxin-Binding Protein 2 [NCIt concept]
- Synthetic Alkaloid PM00104 [NCIt concept]
- Synthetic Brain Tumor Peptides-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Poly ICLC Vaccine [NCIt concept]
- Synthetic Hypericin [NCIt concept]
- Synthetic Long E6/E7 Peptides Vaccine HPV-01 [NCIt concept]
- Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b [NCIt concept]
- Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 [NCIt concept]
- Synthetic Peptides E-PRA And E-PSM Vaccine [NCIt concept]
- Synthetic Plumbagin PCUR-101 [NCIt concept]
- Synthetic Tumor-Associated Peptide Vaccine Therapy [NCIt concept]
- Synthetic hTERT DNA Vaccine INO-1400 [NCIt concept]
- Synthetic hTERT DNA Vaccine INO-1401 [NCIt concept]
- System Support Mapping [NCIt concept]
- Systematic Light Exposure [NCIt concept]
- Systematic Programmed Illumination [NCIt concept]
- Systemic Chemoimmunotherapy [NCIt concept]
- Systemic Chemotherapy [NCIt concept]
- Systemic Corticosteroid Therapy [NCIt concept]
- Systemic Lupus Erythematosus [NCIt concept]
- Systemic Mast Cell Activation [NCIt concept]
- Systemic Mastocytosis [NCIt concept]
- Systemic Scleroderma [NCIt concept]
- Systemic Therapy [NCIt concept]
- T Acute Lymphoblastic Leukemia [NCIt concept]
- T Cell-Depleted Donor Lymphocyte Infusion [NCIt concept]
- T Cell-Depleted Hematopoietic Stem Cell Transplantation [NCIt concept]
- T Helper 17 Cell [NCIt concept]
- T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- T Lymphoblastic Lymphoma [NCIt concept]
- T-Box Transcription Factor T [NCIt concept]
- T-Box Transcription Factor TBX21 [NCIt concept]
- T-Box Transcription Factor TBX3 [NCIt concept]
- T-Cell Activation [NCIt concept]
- T-Cell Acute Lymphocytic Leukemia Protein 1 [NCIt concept]
- T-Cell Antigen CD7 [NCIt concept]
- T-Cell Chemokine [NCIt concept]
- T-Cell Chronic Lymphocytic Leukemia [NCIt concept]
- T-Cell Depletion Therapy [NCIt concept]
- T-Cell Differentiation Antigen CD6 [NCIt concept]
- T-Cell Immunoreceptor with Ig and ITIM Domains [NCIt concept]
- T-Cell Large Granular Lymphocyte [NCIt concept]
- T-Cell Large Granular Lymphocyte Leukemia [NCIt concept]
- T-Cell Leukemia Homeobox Protein 1 [NCIt concept]
- T-Cell Leukemia Homeobox Protein 3 [NCIt concept]
- T-Cell Leukemia/Lymphoma 6 Long Non-Coding RNA [NCIt concept]
- T-Cell Leukemia/Lymphoma Protein 1A [NCIt concept]
- T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- T-Cell Prolymphocytic Leukemia [NCIt concept]
- T-Cell Receptor [NCIt concept]
- T-Cell Receptor Alpha Chain [NCIt concept]
- T-Cell Receptor Alpha Locus [NCIt concept]
- T-Cell Receptor Alpha-Beta [NCIt concept]
- T-Cell Receptor Beta Chain [NCIt concept]
- T-Cell Receptor Beta Locus [NCIt concept]
- T-Cell Receptor Delta Chain [NCIt concept]
- T-Cell Receptor Delta Locus [NCIt concept]
- T-Cell Receptor Excision Circle [NCIt concept]
- T-Cell Receptor Gamma Chain [NCIt concept]
- T-Cell Receptor Gamma Chain Alternative Reading Frame Protein Isoform 1 [NCIt concept]
- T-Cell Receptor Gamma Locus [NCIt concept]
- T-Cell Receptor Gamma-Delta [NCIt concept]
- T-Cell Receptor Gene [NCIt concept]
- T-Cell Receptor Gene Rearrangement [NCIt concept]
- T-Cell Receptor Profile [NCIt concept]
- T-Cell Surface Antigen CD2 [NCIt concept]
- T-Cell Surface Glycoprotein CD1a [NCIt concept]
- T-Cell Surface Glycoprotein CD1c [NCIt concept]
- T-Cell Surface Glycoprotein CD3 Delta Chain [NCIt concept]
- T-Cell Surface Glycoprotein CD3 Epsilon Chain [NCIt concept]
- T-Cell Surface Glycoprotein CD3 Gamma Chain [NCIt concept]
- T-Cell Surface Glycoprotein CD3 Zeta Chain [NCIt concept]
- T-Cell Surface Glycoprotein CD4 [NCIt concept]
- T-Cell Surface Glycoprotein CD5 [NCIt concept]
- T-Cell Surface Glycoprotein CD8 [NCIt concept]
- T-Cell Surface Glycoprotein CD8 Alpha Chain [NCIt concept]
- T-Cell Surface Glycoprotein CD8 Beta Chain [NCIt concept]
- T-Cell Surface Protein Tactile [NCIt concept]
- T-Cell-Specific Surface Glycoprotein CD28 [NCIt concept]
- T-Cell/Histiocyte-Rich Large B-Cell Lymphoma [NCIt concept]
- T-Lymphocyte [NCIt concept]
- T-Lymphocyte Activation Antigen CD80 [NCIt concept]
- T-Lymphocyte Activation Antigen CD86 [NCIt concept]
- T-cell Engaging Antibody [NCIt concept]
- T-cell Engaging Bispecific Antibody [NCIt concept]
- T-cell Membrane-anchored Tumor-targeted IL-12-modified Tumor Infiltrating Lymphocytes [NCIt concept]
- T-cell Receptor-engineered T-cells [NCIt concept]
- T-type Calcium Channel Blocker ABT-639 [NCIt concept]
- T1 Rho Magnetic Resonance Imaging [NCIt concept]
- T4N5 Liposomal Lotion [NCIt concept]
- TAC1 Gene [NCIt concept]
- TAC1 wt Allele [NCIt concept]
- TACC1 Gene [NCIt concept]
- TACC1 wt Allele [NCIt concept]
- TACC3 Gene [NCIt concept]
- TACC3 Protein-Protein Interaction Inhibitor AO-252 [NCIt concept]
- TACC3 wt Allele [NCIt concept]
- TACR1 Gene [NCIt concept]
- TACR1 wt Allele [NCIt concept]
- TACSTD2 Expression by Immunohistochemistry 1+ [NCIt concept]
- TACSTD2 Expression by Immunohistochemistry 2+ [NCIt concept]
- TACSTD2 Expression by Immunohistochemistry 3+ [NCIt concept]
- TACSTD2 Expression by Immunohistochemistry Greater than or Equal to +1 [NCIt concept]
- TACSTD2 Gene [NCIt concept]
- TACSTD2 Positive [NCIt concept]
- TACSTD2 Status by Immunohistochemistry [NCIt concept]
- TACSTD2 wt Allele [NCIt concept]
- TADA2A Gene [NCIt concept]
- TADA2A wt Allele [NCIt concept]
- TAEK-VAC-HerBy Vaccine [NCIt concept]
- TAF1 Gene [NCIt concept]
- TAF1 Gene Mutation [NCIt concept]
- TAF1 wt Allele [NCIt concept]
- TAF15 Gene [NCIt concept]
- TAF15 wt Allele [NCIt concept]
- TAF15/NR4A3 Fusion Gene [NCIt concept]
- TAF15/NR4A3 Fusion Protein [NCIt concept]
- TAF2 Gene [NCIt concept]
- TAF2 wt Allele [NCIt concept]
- TAFIa Inhibitor DS-1040b [NCIt concept]
- TAG-72 Antigen [NCIt concept]
- TAGLN Gene [NCIt concept]
- TAGLN wt Allele [NCIt concept]
- TAL1 Gene [NCIt concept]
- TAL1 wt Allele [NCIt concept]
- TAM/c-Met Inhibitor RXDX-106 [NCIt concept]
- TAOK3 Gene [NCIt concept]
- TAOK3 wt Allele [NCIt concept]
- TAP1 Gene [NCIt concept]
- TAP1 wt Allele [NCIt concept]
- TAP2 Gene [NCIt concept]
- TAP2 wt Allele [NCIt concept]
- TAPBP Gene [NCIt concept]
- TAPBP wt Allele [NCIt concept]
- TAR DNA-Binding Protein 43 [NCIt concept]
- TARDBP Gene [NCIt concept]
- TARDBP wt Allele [NCIt concept]
- TARP Antibody [NCIt concept]
- TARP Gene [NCIt concept]
- TARP wt Allele [NCIt concept]
- TATA-Binding Protein-Associated Factor 2N [NCIt concept]
- TBCEL Gene [NCIt concept]
- TBCEL wt Allele [NCIt concept]
- TBL1X Gene [NCIt concept]
- TBL1X wt Allele [NCIt concept]
- TBL1Y Gene [NCIt concept]
- TBL1Y wt Allele [NCIt concept]
- TBL2 Gene [NCIt concept]
- TBL2 wt Allele [NCIt concept]
- TBX21 Gene [NCIt concept]
- TBX21 wt Allele [NCIt concept]
- TBX3 Gene [NCIt concept]
- TBX3 Gene Mutation [NCIt concept]
- TBX3 wt Allele [NCIt concept]
- TBXA2R Gene [NCIt concept]
- TBXA2R wt Allele [NCIt concept]
- TBXT Gene [NCIt concept]
- TBXT wt Allele [NCIt concept]
- TC22 Allele [NCIt concept]
- TCDD-Inducible Poly [ADP-Ribose] Polymerase [NCIt concept]
- TCEA1 Gene [NCIt concept]
- TCEA1 wt Allele [NCIt concept]
- TCEA1/PLAG1 Fusion Gene [NCIt concept]
- TCERG1L Gene [NCIt concept]
- TCERG1L wt Allele [NCIt concept]
- TCF12 Gene [NCIt concept]
- TCF12 wt Allele [NCIt concept]
- TCF12/NR4A3 Fusion Gene [NCIt concept]
- TCF12/NR4A3 Fusion Protein [NCIt concept]
- TCF3 Fusion Partner [NCIt concept]
- TCF3 Gene [NCIt concept]
- TCF3 wt Allele [NCIt concept]
- TCF3/HLF Fusion Gene [NCIt concept]
- TCF3/HLF Fusion Protein [NCIt concept]
- TCF3/PBX1 Fusion Gene [NCIt concept]
- TCF3/PBX1 Fusion Protein [NCIt concept]
- TCF3/TFPT Fusion Gene [NCIt concept]
- TCF4 Gene [NCIt concept]
- TCF4 wt Allele [NCIt concept]
- TCF7 Gene [NCIt concept]
- TCF7 wt Allele [NCIt concept]
- TCF7L2 Gene [NCIt concept]
- TCF7L2 Gene Mutation [NCIt concept]
- TCF7L2 wt Allele [NCIt concept]
- TCIRG1 Gene [NCIt concept]
- TCIRG1 Gene Mutation [NCIt concept]
- TCIRG1 wt Allele [NCIt concept]
- TCL1A Gene [NCIt concept]
- TCL1A wt Allele [NCIt concept]
- TCL6 Gene [NCIt concept]
- TCL6 wt Allele [NCIt concept]
- TCR Alpha-Beta Positive [NCIt concept]
- TCR Gamma-Delta Positive [NCIt concept]
- TCR alpha/beta/CD19-depleted Allogeneic Hematopoietic Progenitor Cells [NCIt concept]
- TCR-specific, alpha Fetoprotein-enhanced Autologous T Lymphocytes [NCIt concept]
- TDG Gene [NCIt concept]
- TDG wt Allele [NCIt concept]
- TDO2 Gene [NCIt concept]
- TDO2 wt Allele [NCIt concept]
- TDP1 Gene [NCIt concept]
- TDP1 wt Allele [NCIt concept]
- TEAD Inhibitor [NCIt concept]
- TEAD Inhibitor BGC515 [NCIt concept]
- TEAD Inhibitor IK-930 [NCIt concept]
- TEAD Inhibitor SW-682 [NCIt concept]
- TEAD Inhibitor VT3989 [NCIt concept]
- TEAD Transcription Factor Family [NCIt concept]
- TECTA Gene [NCIt concept]
- TECTA wt Allele [NCIt concept]
- TEK Gene [NCIt concept]
- TEK Gene Amplification [NCIt concept]
- TEK Gene Mutation [NCIt concept]
- TEK Overexpression Positive [NCIt concept]
- TEK wt Allele [NCIt concept]
- TERC Gene [NCIt concept]
- TERC Gene Mutation [NCIt concept]
- TERC wt Allele [NCIt concept]
- TERF1-Interacting Nuclear Factor 2 [NCIt concept]
- TERF2 Gene [NCIt concept]
- TERF2 wt Allele [NCIt concept]
- TERT Gene [NCIt concept]
- TERT Gene Mutation [NCIt concept]
- TERT wt Allele [NCIt concept]
- TET1 Gene [NCIt concept]
- TET1 wt Allele [NCIt concept]
- TET2 Gene [NCIt concept]
- TET2 Gene Mutation [NCIt concept]
- TET2 Negative [NCIt concept]
- TET2 wt Allele [NCIt concept]
- TF Gene [NCIt concept]
- TF wt Allele [NCIt concept]
- TFAP2E Gene [NCIt concept]
- TFAP2E wt Allele [NCIt concept]
- TFE3 Gene [NCIt concept]
- TFE3 Gene Rearrangement [NCIt concept]
- TFE3 Gene Translocation [NCIt concept]
- TFE3 Positive [NCIt concept]
- TFE3 wt Allele [NCIt concept]
- TFE3-Rearranged Renal Cell Carcinoma [NCIt concept]
- TFE3/ASPSCR1 Fusion Gene [NCIt concept]
- TFE3/PRCC Fusion Gene [NCIt concept]
- TFE3/PRCC Fusion Protein [NCIt concept]
- TFEB Gene [NCIt concept]
- TFEB Gene Translocation [NCIt concept]
- TFEB wt Allele [NCIt concept]
- TFF1 Gene [NCIt concept]
- TFF1 wt Allele [NCIt concept]
- TFF2 Gene [NCIt concept]
- TFF2 wt Allele [NCIt concept]
- TFF3 Gene [NCIt concept]
- TFF3 wt Allele [NCIt concept]
- TFG Gene [NCIt concept]
- TFG wt Allele [NCIt concept]
- TFG/NR4A3 Fusion Gene [NCIt concept]
- TFG/NR4A3 Fusion Protein [NCIt concept]
- TFG/NTRK1 Fusion Gene [NCIt concept]
- TFG/NTRK1 Fusion Protein [NCIt concept]
- TFIIH Basal Transcription Factor Complex Helicase XPB Subunit [NCIt concept]
- TFPI Gene [NCIt concept]
- TFPI wt Allele [NCIt concept]
- TFPI2 Gene [NCIt concept]
- TFPI2 wt Allele [NCIt concept]
- TFPT Gene [NCIt concept]
- TFPT wt Allele [NCIt concept]
- TFRC Gene [NCIt concept]
- TFRC wt Allele [NCIt concept]
- TG Gene [NCIt concept]
- TG wt Allele [NCIt concept]
- TG3 Antibody [NCIt concept]
- TGF-Beta Receptor Type-1 [NCIt concept]
- TGF-Beta Receptor Type-2 [NCIt concept]
- TGF-Beta Responsive Gene Signature [NCIt concept]
- TGF-beta Receptor 1 Inhibitor PF-06952229 [NCIt concept]
- TGF-beta-Resistant LMP-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- TGF-beta-targeting Agent [NCIt concept]
- TGFA Gene [NCIt concept]
- TGFA Gene Product [NCIt concept]
- TGFA wt Allele [NCIt concept]
- TGFB1 Gene [NCIt concept]
- TGFB1 wt Allele [NCIt concept]
- TGFB1I1 Gene [NCIt concept]
- TGFB1I1 wt Allele [NCIt concept]
- TGFB2 Gene [NCIt concept]
- TGFB2 wt Allele [NCIt concept]
- TGFB3 Gene [NCIt concept]
- TGFB3 wt Allele [NCIt concept]
- TGFBI Gene [NCIt concept]
- TGFBI wt Allele [NCIt concept]
- TGFBR1 Gene [NCIt concept]
- TGFBR1 wt Allele [NCIt concept]
- TGFBR2 Gene [NCIt concept]
- TGFBR2 wt Allele [NCIt concept]
- TGFBR3 Gene [NCIt concept]
- TGFBR3 wt Allele [NCIt concept]
- TGFbeta Inhibitor LY3200882 [NCIt concept]
- TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein BMS-986416 [NCIt concept]
- TH Gene [NCIt concept]
- TH wt Allele [NCIt concept]
- THBD Gene [NCIt concept]
- THBD Positive [NCIt concept]
- THBD wt Allele [NCIt concept]
- THBS1 Gene [NCIt concept]
- THBS1 wt Allele [NCIt concept]
- THBS2 Gene [NCIt concept]
- THBS2 wt Allele [NCIt concept]
- THPO Gene [NCIt concept]
- THPO wt Allele [NCIt concept]
- THRAP3 Gene [NCIt concept]
- THRAP3 wt Allele [NCIt concept]
- THRSP Gene [NCIt concept]
- THRSP wt Allele [NCIt concept]
- THY1 Gene [NCIt concept]
- THY1 wt Allele [NCIt concept]
- TIA1 Gene [NCIt concept]
- TIA1 wt Allele [NCIt concept]
- TIE1 Gene [NCIt concept]
- TIE1 wt Allele [NCIt concept]
- TIGIT Gene [NCIt concept]
- TIGIT wt Allele [NCIt concept]
- TIGIT-targeting Agent [NCIt concept]
- TIL 1383I T Cell Receptor-Transduced Autologous T Cells [NCIt concept]
- TIMP1 Gene [NCIt concept]
- TIMP1 wt Allele [NCIt concept]
- TIMP3 Gene [NCIt concept]
- TIMP3 wt Allele [NCIt concept]
- TIMP4 Gene [NCIt concept]
- TIMP4 wt Allele [NCIt concept]
- TINF2 Gene [NCIt concept]
- TINF2 Gene Mutation [NCIt concept]
- TINF2 wt Allele [NCIt concept]
- TIPARP Gene [NCIt concept]
- TIPARP wt Allele [NCIt concept]
- TJP1 Gene [NCIt concept]
- TJP1 wt Allele [NCIt concept]
- TK1 Gene [NCIt concept]
- TK1 wt Allele [NCIt concept]
- TLE1 Gene [NCIt concept]
- TLE1 wt Allele [NCIt concept]
- TLR 2/6/9 Agonist PUL-042 [NCIt concept]
- TLR Agonist Decoy20 [NCIt concept]
- TLR1 Gene [NCIt concept]
- TLR1 wt Allele [NCIt concept]
- TLR2 Gene [NCIt concept]
- TLR2 wt Allele [NCIt concept]
- TLR4 Agonist G100 [NCIt concept]
- TLR4 Gene [NCIt concept]
- TLR4 wt Allele [NCIt concept]
- TLR5 Gene [NCIt concept]
- TLR5 wt Allele [NCIt concept]
- TLR6 Gene [NCIt concept]
- TLR6 wt Allele [NCIt concept]
- TLR7 Agonist ANA773 Tosylate [NCIt concept]
- TLR7 Agonist LHC165 [NCIt concept]
- TLR7 Gene [NCIt concept]
- TLR7 agonist BNT411 [NCIt concept]
- TLR7 wt Allele [NCIt concept]
- TLR8 Agonist DN1508052 [NCIt concept]
- TLR8 Gene [NCIt concept]
- TLR8 wt Allele [NCIt concept]
- TLR9 Agonist DUK-CPG-001 [NCIt concept]
- TLR9 Agonist EMD 1201081 [NCIt concept]
- TLR9 Agonist IMO-2055 [NCIt concept]
- TLR9 Gene [NCIt concept]
- TLR9 wt Allele [NCIt concept]
- TLX1 Gene [NCIt concept]
- TLX1 wt Allele [NCIt concept]
- TLX3 Gene [NCIt concept]
- TLX3 wt Allele [NCIt concept]
- TMCC1 Gene [NCIt concept]
- TMCC1 wt Allele [NCIt concept]
- TMEM127 Gene [NCIt concept]
- TMEM127 Gene Mutation [NCIt concept]
- TMEM127 wt Allele [NCIt concept]
- TMEM204 Gene [NCIt concept]
- TMEM204 wt Allele [NCIt concept]
- TMEM37 Gene [NCIt concept]
- TMEM37 wt Allele [NCIt concept]
- TMEM97 Gene [NCIt concept]
- TMEM97 wt Allele [NCIt concept]
- TMOD3 Gene [NCIt concept]
- TMOD3 wt Allele [NCIt concept]
- TMOD3/CYP19A1 Fusion Gene [NCIt concept]
- TMPO Gene [NCIt concept]
- TMPO wt Allele [NCIt concept]
- TMPRSS2 Gene [NCIt concept]
- TMPRSS2 wt Allele [NCIt concept]
- TMPRSS2/ERG Fusion Gene [NCIt concept]
- TMPRSS2/ETS Family Fusion Gene [NCIt concept]
- TMPRSS2/ETV1 Fusion Gene [NCIt concept]
- TMPRSS2/ETV4 Fusion Gene [NCIt concept]
- TMPRSS2/ETV5 Fusion Gene [NCIt concept]
- TMPRSS6 RNAi SLN124 [NCIt concept]
- TMTC1 Gene [NCIt concept]
- TMTC1 wt Allele [NCIt concept]
- TNF Gene [NCIt concept]
- TNF Receptor Family Gene [NCIt concept]
- TNF Receptor Family Protein [NCIt concept]
- TNF Receptor-Associated Factor 1 [NCIt concept]
- TNF Receptor-Associated Factor 3 [NCIt concept]
- TNF Receptor-Associated Factor 6 [NCIt concept]
- TNF Repeat [NCIt concept]
- TNF wt Allele [NCIt concept]
- TNFAIP1 Gene [NCIt concept]
- TNFAIP1 wt Allele [NCIt concept]
- TNFAIP2 Gene [NCIt concept]
- TNFAIP2 wt Allele [NCIt concept]
- TNFAIP3 Gene [NCIt concept]
- TNFAIP3 Gene Mutation [NCIt concept]
- TNFAIP3 wt Allele [NCIt concept]
- TNFRSF10A Gene [NCIt concept]
- TNFRSF10A wt Allele [NCIt concept]
- TNFRSF10B Gene [NCIt concept]
- TNFRSF10B wt Allele [NCIt concept]
- TNFRSF10C Gene [NCIt concept]
- TNFRSF10C wt Allele [NCIt concept]
- TNFRSF11A Gene [NCIt concept]
- TNFRSF11A wt Allele [NCIt concept]
- TNFRSF11B Gene [NCIt concept]
- TNFRSF11B wt Allele [NCIt concept]
- TNFRSF13B Gene [NCIt concept]
- TNFRSF13B wt Allele [NCIt concept]
- TNFRSF13C Gene [NCIt concept]
- TNFRSF13C Positive [NCIt concept]
- TNFRSF13C wt Allele [NCIt concept]
- TNFRSF14 Gene [NCIt concept]
- TNFRSF14 wt Allele [NCIt concept]
- TNFRSF17 Gene [NCIt concept]
- TNFRSF17 Positive [NCIt concept]
- TNFRSF17 wt Allele [NCIt concept]
- TNFRSF18 Gene [NCIt concept]
- TNFRSF18 Positive [NCIt concept]
- TNFRSF18 wt Allele [NCIt concept]
- TNFRSF1A Gene [NCIt concept]
- TNFRSF1A wt Allele [NCIt concept]
- TNFRSF1B Gene [NCIt concept]
- TNFRSF1B wt Allele [NCIt concept]
- TNFRSF21 Gene [NCIt concept]
- TNFRSF21 wt Allele [NCIt concept]
- TNFRSF4 Gene [NCIt concept]
- TNFRSF4 wt Allele [NCIt concept]
- TNFRSF8 Expression Less than 10 Percent by Immunohistochemistry [NCIt concept]
- TNFRSF8 Gene [NCIt concept]
- TNFRSF8 Low [NCIt concept]
- TNFRSF8 Negative [NCIt concept]
- TNFRSF8 Positive [NCIt concept]
- TNFRSF8 wt Allele [NCIt concept]
- TNFRSF9 Gene [NCIt concept]
- TNFRSF9 Positive [NCIt concept]
- TNFRSF9 wt Allele [NCIt concept]
- TNFSF11 Gene [NCIt concept]
- TNFSF11 wt Allele [NCIt concept]
- TNFSF13 Gene [NCIt concept]
- TNFSF13 wt Allele [NCIt concept]
- TNFSF13B Gene [NCIt concept]
- TNFSF13B wt Allele [NCIt concept]
- TNFSF4 Gene [NCIt concept]
- TNFSF4 wt Allele [NCIt concept]
- TNFSF8 Gene [NCIt concept]
- TNFSF8 wt Allele [NCIt concept]
- TNFSF9 Gene [NCIt concept]
- TNFSF9 Gene Mutation Negative [NCIt concept]
- TNFSF9 wt Allele [NCIt concept]
- TNFalpha/IL-2-encoding Oncolytic Adenovirus TILT-123 [NCIt concept]
- TNFd3 Repeat [NCIt concept]
- TNKS Gene [NCIt concept]
- TNKS wt Allele [NCIt concept]
- TNKS2 Gene [NCIt concept]
- TNKS2 wt Allele [NCIt concept]
- TNNI3 Gene [NCIt concept]
- TNNI3 wt Allele [NCIt concept]
- TNNT2 Gene [NCIt concept]
- TNNT2 wt Allele [NCIt concept]
- TNP1 Gene [NCIt concept]
- TNP1 wt Allele [NCIt concept]
- TOB2 Gene [NCIt concept]
- TOB2 wt Allele [NCIt concept]
- TOMM20 Gene [NCIt concept]
- TOMM20 wt Allele [NCIt concept]
- TOP1 Gene [NCIt concept]
- TOP1 wt Allele [NCIt concept]
- TOP2A Gene [NCIt concept]
- TOP2A wt Allele [NCIt concept]
- TOP2B Gene [NCIt concept]
- TOP2B wt Allele [NCIt concept]
- TOPBP1 Gene [NCIt concept]
- TOPBP1 wt Allele [NCIt concept]
- TOX Gene [NCIt concept]
- TOX wt Allele [NCIt concept]
- TP53 Antibody [NCIt concept]
- TP53 Gene [NCIt concept]
- TP53 Gene Alteration Positive [NCIt concept]
- TP53 Gene Amplification [NCIt concept]
- TP53 Gene Deletion [NCIt concept]
- TP53 Gene Frameshift Mutation [NCIt concept]
- TP53 Gene Inactivation [NCIt concept]
- TP53 Gene Mutation [NCIt concept]
- TP53 Gene Mutation Negative [NCIt concept]
- TP53 Gene Nonsense Mutation [NCIt concept]
- TP53 Mutation Carrier [NCIt concept]
- TP53 NM_000546.5:c.380C>A [NCIt concept]
- TP53 NM_000546.5:c.394A>G [NCIt concept]
- TP53 NM_000546.5:c.396G>C [NCIt concept]
- TP53 NM_000546.5:c.396G>T [NCIt concept]
- TP53 NM_000546.5:c.638G>T [NCIt concept]
- TP53 NM_000546.5:c.659A>G [NCIt concept]
- TP53 NM_000546.5:c.746G>T [NCIt concept]
- TP53 NP_000537.3:p.K132E [NCIt concept]
- TP53 NP_000537.3:p.K132N [NCIt concept]
- TP53 NP_000537.3:p.R175H [NCIt concept]
- TP53 NP_000537.3:p.R213L [NCIt concept]
- TP53 NP_000537.3:p.R248W [NCIt concept]
- TP53 NP_000537.3:p.R249M [NCIt concept]
- TP53 NP_000537.3:p.S127Y [NCIt concept]
- TP53 NP_000537.3:p.Y220C [NCIt concept]
- TP53 Negative [NCIt concept]
- TP53 Overexpression Positive [NCIt concept]
- TP53 Positive [NCIt concept]
- TP53 wt Allele [NCIt concept]
- TP53*1 Allele [NCIt concept]
- TP53-Binding Protein 1 [NCIt concept]
- TP53AIP1 Gene [NCIt concept]
- TP53AIP1 wt Allele [NCIt concept]
- TP53BP1 Gene [NCIt concept]
- TP53BP1 wt Allele [NCIt concept]
- TP53INP1 Gene [NCIt concept]
- TP53INP1 wt Allele [NCIt concept]
- TP63 Gene [NCIt concept]
- TP63 Gene Product [NCIt concept]
- TP63 wt Allele [NCIt concept]
- TPH1 Gene [NCIt concept]
- TPH1 wt Allele [NCIt concept]
- TPI1 Gene [NCIt concept]
- TPI1 wt Allele [NCIt concept]
- TPM3 Gene [NCIt concept]
- TPM3 Gene Product [NCIt concept]
- TPM3 wt Allele [NCIt concept]
- TPM3/NTRK1 Fusion Gene [NCIt concept]
- TPM3/NTRK1 Fusion Protein [NCIt concept]
- TPM4 Gene [NCIt concept]
- TPM4 wt Allele [NCIt concept]
- TPO Gene [NCIt concept]
- TPO Receptor Agonist ONO-7746 [NCIt concept]
- TPO wt Allele [NCIt concept]
- TPR Gene [NCIt concept]
- TPR wt Allele [NCIt concept]
- TPR/MET Fusion Gene [NCIt concept]
- TPR/MET Fusion Protein [NCIt concept]
- TPR/NTRK1 Fusion Gene TRKT1 [NCIt concept]
- TPR/NTRK1 Fusion Gene TRKT2 [NCIt concept]
- TPR/NTRK1 Fusion Protein TRKT1 [NCIt concept]
- TPR/NTRK1 Fusion Protein TRKT2 [NCIt concept]
- TPSB2 Gene [NCIt concept]
- TPSB2 wt Allele [NCIt concept]
- TPT1 Gene [NCIt concept]
- TPT1 wt Allele [NCIt concept]
- TPTE Gene [NCIt concept]
- TPTE wt Allele [NCIt concept]
- TPX2 Gene [NCIt concept]
- TPX2 wt Allele [NCIt concept]
- TRA-1-60 Antigen [NCIt concept]
- TRA-1-81 Antigen [NCIt concept]
- TRAC Locus Integrated Anti-CD19 19(T2)28z1xx CAR-T Cells [NCIt concept]
- TRAF1 Gene [NCIt concept]
- TRAF1 wt Allele [NCIt concept]
- TRAF1-C5 Locus [NCIt concept]
- TRAF3 Gene [NCIt concept]
- TRAF3 Gene Mutation [NCIt concept]
- TRAF3 wt Allele [NCIt concept]
- TRAF6 Gene [NCIt concept]
- TRAF6 wt Allele [NCIt concept]
- TRAF7 Gene [NCIt concept]
- TRAF7 wt Allele [NCIt concept]
- TRAP1 Gene [NCIt concept]
- TRAP1 wt Allele [NCIt concept]
- TRDMT1 Gene [NCIt concept]
- TRDMT1 wt Allele [NCIt concept]
- TREM1 Gene [NCIt concept]
- TREM1 wt Allele [NCIt concept]
- TREM2 Gene [NCIt concept]
- TREM2 Positive [NCIt concept]
- TREM2 wt Allele [NCIt concept]
- TREML1 Gene [NCIt concept]
- TREML1 wt Allele [NCIt concept]
- TREX1 Gene [NCIt concept]
- TREX1 wt Allele [NCIt concept]
- TRIB2 Gene [NCIt concept]
- TRIB2 wt Allele [NCIt concept]
- TRIM16 Gene [NCIt concept]
- TRIM16 wt Allele [NCIt concept]
- TRIM21 Gene [NCIt concept]
- TRIM21 wt Allele [NCIt concept]
- TRIM24 Gene [NCIt concept]
- TRIM24 wt Allele [NCIt concept]
- TRIM24/RET Fusion Gene [NCIt concept]
- TRIM24/RET Fusion Protein [NCIt concept]
- TRIM28 Gene [NCIt concept]
- TRIM28 wt Allele [NCIt concept]
- TRIM33 Gene [NCIt concept]
- TRIM33 wt Allele [NCIt concept]
- TRIM33/RET Fusion Gene [NCIt concept]
- TRIM33/RET Fusion Protein [NCIt concept]
- TRIM63 Gene [NCIt concept]
- TRIM63 wt Allele [NCIt concept]
- TRIP11 Gene [NCIt concept]
- TRIP11 wt Allele [NCIt concept]
- TRIP11/PDGFRB Fusion Gene [NCIt concept]
- TRIP11/PDGFRB Fusion Protein [NCIt concept]
- TRK Inhibitor [NCIt concept]
- TRK Receptor Family Alteration Positive [NCIt concept]
- TRK Receptor Family Fusion Negative [NCIt concept]
- TRK Receptor Family Fusion Positive [NCIt concept]
- TROP2-targeting Agent [NCIt concept]
- TRP2 mRNA-electroporated Autologous Langerhans-type Dendritic Cell Vaccine [NCIt concept]
- TRPA1 Gene [NCIt concept]
- TRPA1 wt Allele [NCIt concept]
- TRPC2 Gene [NCIt concept]
- TRPC6 Gene [NCIt concept]
- TRPC6 wt Allele [NCIt concept]
- TRPM6 Gene [NCIt concept]
- TRPM6 wt Allele [NCIt concept]
- TRPM7 Gene [NCIt concept]
- TRPM7 wt Allele [NCIt concept]
- TRPM7/CYP19A1 Fusion Gene [NCIt concept]
- TRPV6 Gene [NCIt concept]
- TRPV6 wt Allele [NCIt concept]
- TSC1 Gene [NCIt concept]
- TSC1 Gene Inactivation [NCIt concept]
- TSC1 Gene Mutation [NCIt concept]
- TSC1 Gene Rearrangement [NCIt concept]
- TSC1 wt Allele [NCIt concept]
- TSC2 Gene [NCIt concept]
- TSC2 Gene Inactivation [NCIt concept]
- TSC2 Gene Mutation [NCIt concept]
- TSC2 Gene Rearrangement [NCIt concept]
- TSC2 wt Allele [NCIt concept]
- TSC22 Domain Family Protein 3 [NCIt concept]
- TSC22D3 Gene [NCIt concept]
- TSC22D3 wt Allele [NCIt concept]
- TSGA10 Antibody [NCIt concept]
- TSGA10 Gene [NCIt concept]
- TSGA10 wt Allele [NCIt concept]
- TSHB Gene [NCIt concept]
- TSHB wt Allele [NCIt concept]
- TSHR Gene [NCIt concept]
- TSHR wt Allele [NCIt concept]
- TSLP Gene [NCIt concept]
- TSLP wt Allele [NCIt concept]
- TSP-1 Activator VT1021 [NCIt concept]
- TSP-1 Mimetic ABT-510 [NCIt concept]
- TSPAN8 Gene [NCIt concept]
- TSPAN8 wt Allele [NCIt concept]
- TSPO Gene [NCIt concept]
- TSPO wt Allele [NCIt concept]
- TTF1 Gene [NCIt concept]
- TTF1 wt Allele [NCIt concept]
- TTK/PLK1 Inhibitor BAL0891 [NCIt concept]
- TTL Gene [NCIt concept]
- TTL wt Allele [NCIt concept]
- TTR Gene [NCIt concept]
- TTR Gene Mutation [NCIt concept]
- TTR Gene Mutation Negative [NCIt concept]
- TTR wt Allele [NCIt concept]
- TUBA1B Antibody [NCIt concept]
- TUBA1B Gene [NCIt concept]
- TUBA1B wt Allele [NCIt concept]
- TUBA3C Gene [NCIt concept]
- TUBA3C wt Allele [NCIt concept]
- TUBB Gene [NCIt concept]
- TUBB wt Allele [NCIt concept]
- TUBB3 Gene [NCIt concept]
- TUBB3 wt Allele [NCIt concept]
- TWIST1 Gene [NCIt concept]
- TWIST1 wt Allele [NCIt concept]
- TWIST2 Gene [NCIt concept]
- TWIST2 wt Allele [NCIt concept]
- TXN Gene [NCIt concept]
- TXN wt Allele [NCIt concept]
- TXNIP Gene [NCIt concept]
- TXNIP wt Allele [NCIt concept]
- TXNRD1 Gene [NCIt concept]
- TXNRD1 wt Allele [NCIt concept]
- TXNRD2 Gene [NCIt concept]
- TXNRD2 wt Allele [NCIt concept]
- TYK2 Fusion Positive [NCIt concept]
- TYK2 Gene [NCIt concept]
- TYK2 Gene Mutation [NCIt concept]
- TYK2 wt Allele [NCIt concept]
- TYMP Gene [NCIt concept]
- TYMP wt Allele [NCIt concept]
- TYMS Gene [NCIt concept]
- TYMS wt Allele [NCIt concept]
- TYR Gene [NCIt concept]
- TYR wt Allele [NCIt concept]
- TYRO3 Gene [NCIt concept]
- TYRO3 wt Allele [NCIt concept]
- TYRP1 Gene [NCIt concept]
- TYRP1 Positive [NCIt concept]
- TYRP1 wt Allele [NCIt concept]
- Tabalumab [NCIt concept]
- Tabelecleucel [NCIt concept]
- Tacaciclib [NCIt concept]
- Tacaribe Complex Virus [NCIt concept]
- Tacrolimus [NCIt concept]
- Tadalafil [NCIt concept]
- Tafamidis Meglumine [NCIt concept]
- Tafasitamab [NCIt concept]
- Tagmokitug [NCIt concept]
- Tagraxofusp-erzs [NCIt concept]
- Tai Chi [NCIt concept]
- Tailored Intervention [NCIt concept]
- Talabostat [NCIt concept]
- Talacotuzumab [NCIt concept]
- Talactoferrin Alfa [NCIt concept]
- Taladegib [NCIt concept]
- Talaporfin Sodium [NCIt concept]
- Talazoparib [NCIt concept]
- Talazoparib Tosylate [NCIt concept]
- Talc Poudrage [NCIt concept]
- Talfirastide [NCIt concept]
- Talimogene Laherparepvec [NCIt concept]
- Talotrexin Ammonium [NCIt concept]
- Talquetamab [NCIt concept]
- Tambiciclib [NCIt concept]
- Tamibarotene [NCIt concept]
- Taminadenant [NCIt concept]
- Tamoxifen [NCIt concept]
- Tamoxifen Citrate [NCIt concept]
- Tamrintamab Pamozirine [NCIt concept]
- Tandem Hematopoietic Stem Cell Transplantation [NCIt concept]
- Tandutinib [NCIt concept]
- Tanespimycin [NCIt concept]
- Tanezumab [NCIt concept]
- Taniraleucel [NCIt concept]
- TapCloud [NCIt concept]
- Tapasin [NCIt concept]
- Tapentadol Hydrochloride [NCIt concept]
- Tapotoclax [NCIt concept]
- Tarextumab [NCIt concept]
- Target of Rapamycin Complex 2 Subunit MAPKAP1 [NCIt concept]
- Targeted Alpha Therapy Agent [NCIt concept]
- Targeted Fusion Protein Therapy [NCIt concept]
- Targeted Molecular Therapy [NCIt concept]
- Targeted Muscle Reinnervation [NCIt concept]
- Targeted Prostate Biopsy [NCIt concept]
- Targeted Therapy [NCIt concept]
- Targeting Protein for Xklp2 [NCIt concept]
- Tariquidar [NCIt concept]
- Tarlatamab [NCIt concept]
- Tarloxotinib [NCIt concept]
- Tarloxotinib Bromide [NCIt concept]
- Tartrate-Resistant Acid Phosphatase Type 5 [NCIt concept]
- Tartrate-Resistant Acid Phosphatase Type 5b [NCIt concept]
- Tasadenoturev [NCIt concept]
- Tasadenoturev-infected Allogeneic Bone Marrow-derived Mesenchymal Stem Cells [NCIt concept]
- Taselisib [NCIt concept]
- Tasisulam Sodium [NCIt concept]
- Task Functional Magnetic Resonance Imaging [NCIt concept]
- Tasquinimod [NCIt concept]
- Taurine [NCIt concept]
- Tavokinogene Telseplasmid [NCIt concept]
- Tavolimab [NCIt concept]
- Taxane Analogue TPI 287 [NCIt concept]
- Tay-Sachs Disease [NCIt concept]
- Tazarotene [NCIt concept]
- Tazemetostat [NCIt concept]
- Tazemetostat Hydrobromide [NCIt concept]
- Tazobactam [NCIt concept]
- TdT-Mediated dUTP Nick End Labeling Assay [NCIt concept]
- Tebapivat [NCIt concept]
- Tebentafusp [NCIt concept]
- Tebotelimab [NCIt concept]
- Tecaginlimab [NCIt concept]
- Technetium TC-99m [NCIt concept]
- Technetium Tc 94m Sestamibi [NCIt concept]
- Technetium Tc 99 Hydrazinonicotinamide-Tricine-linked Interleukin-2 [NCIt concept]
- Technetium Tc 99m Trofolastat [NCIt concept]
- Technetium Tc 99m-labeled Tilmanocept [NCIt concept]
- Technetium Tc-99m Albumin Aggregated [NCIt concept]
- Technetium Tc-99m DTPA [NCIt concept]
- Technetium Tc-99m Ethylenedicysteine-Deoxyglucose [NCIt concept]
- Technetium Tc-99m Mebrofenin [NCIt concept]
- Technetium Tc-99m Medronate [NCIt concept]
- Technetium Tc-99m Sulfur Colloid [NCIt concept]
- Technology Provider [NCIt concept]
- Teclistamab [NCIt concept]
- Tecotabart [NCIt concept]
- Tecotabart Vedotin [NCIt concept]
- Tecovirimat [NCIt concept]
- Tectal Glioma [NCIt concept]
- Tegafur-gimeracil-oteracil Potassium [NCIt concept]
- Tegavivint [NCIt concept]
- Teglarinad Chloride [NCIt concept]
- Tegtociclib [NCIt concept]
- Telaglenastat [NCIt concept]
- Telaglenastat Hydrochloride [NCIt concept]
- Telangiectatic Osteosarcoma [NCIt concept]
- Telaprevir [NCIt concept]
- Telapristone Acetate [NCIt concept]
- Telatinib Mesylate [NCIt concept]
- Telavancin [NCIt concept]
- Telavancin Hydrochloride [NCIt concept]
- Telemedicine [NCIt concept]
- Telephone-Based Intervention [NCIt concept]
- Telisotuzumab [NCIt concept]
- Telisotuzumab Adizutecan [NCIt concept]
- Telisotuzumab Vedotin [NCIt concept]
- Telmisartan [NCIt concept]
- Telomerase [NCIt concept]
- Telomerase Cajal Body Protein 1 [NCIt concept]
- Telomerase RNA Component [NCIt concept]
- Telomere Length [NCIt concept]
- Telomere Maintenance Gene [NCIt concept]
- Telomere Reverse Transcriptase [NCIt concept]
- Telomere Syndrome [NCIt concept]
- Telomere-Associated Protein RIF1 [NCIt concept]
- Telomeric Allelic Imbalance Region [NCIt concept]
- Telomeric Repeat-Binding Factor 2 [NCIt concept]
- Telomeric Repeat-Containing RNA [NCIt concept]
- Telotristat Ethyl [NCIt concept]
- Telotristat Etiprate [NCIt concept]
- Telratolimod [NCIt concept]
- Temoporfin [NCIt concept]
- Temozolomide [NCIt concept]
- Temozolomide Perillyl Alcohol Conjugate NEO212 [NCIt concept]
- Template-based Focal Cryotherapy [NCIt concept]
- Temporal Lobe Epilepsy [NCIt concept]
- Temporally-Feathered Intensity-Modulated Radiation Therapy [NCIt concept]
- Temporally-modulated Pulsed Radiation Therapy [NCIt concept]
- Temsirolimus [NCIt concept]
- Temuterkib [NCIt concept]
- Tenalisib [NCIt concept]
- Tenascin Family [NCIt concept]
- Teniposide [NCIt concept]
- Tenofovir [NCIt concept]
- Tenofovir Alafenamide [NCIt concept]
- Tenofovir Anhydrous [NCIt concept]
- Tenofovir Disoproxil Fumarate [NCIt concept]
- Tepoditamab [NCIt concept]
- Tepotinib [NCIt concept]
- Tepotinib Hydrochloride [NCIt concept]
- Teprotumumab [NCIt concept]
- Terameprocol [NCIt concept]
- Teratoma [NCIt concept]
- Tergenpumatucel-L [NCIt concept]
- Tersolisib [NCIt concept]
- Tesetaxel [NCIt concept]
- Tesevatinib [NCIt concept]
- Tesidolumab [NCIt concept]
- Testicular Choriocarcinoma [NCIt concept]
- Testicular Diffuse Large B-Cell Lymphoma [NCIt concept]
- Testicular Disorder [NCIt concept]
- Testicular Embryonal Carcinoma [NCIt concept]
- Testicular Follicular Lymphoma [NCIt concept]
- Testicular Germ Cell Neoplasia In Situ [NCIt concept]
- Testicular Germ Cell Tumor [NCIt concept]
- Testicular Immature Teratoma [NCIt concept]
- Testicular Lymphoma [NCIt concept]
- Testicular Mature Teratoma [NCIt concept]
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma [NCIt concept]
- Testicular Mixed Choriocarcinoma and Seminoma [NCIt concept]
- Testicular Mixed Choriocarcinoma and Teratoma [NCIt concept]
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor [NCIt concept]
- Testicular Mixed Embryonal Carcinoma and Seminoma [NCIt concept]
- Testicular Mixed Embryonal Carcinoma and Teratoma [NCIt concept]
- Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma [NCIt concept]
- Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor [NCIt concept]
- Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma [NCIt concept]
- Testicular Mixed Germ Cell Tumor [NCIt concept]
- Testicular Mixed Yolk Sac Tumor and Teratoma [NCIt concept]
- Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma [NCIt concept]
- Testicular Neoplasm [NCIt concept]
- Testicular Non-Seminomatous Germ Cell Tumor [NCIt concept]
- Testicular Polyembryoma [NCIt concept]
- Testicular Seminoma [NCIt concept]
- Testicular Teratoma [NCIt concept]
- Testicular Yolk Sac Tumor [NCIt concept]
- Testimonial [NCIt concept]
- Testis-Specific Gene 10 Protein [NCIt concept]
- Testosterone [NCIt concept]
- Testosterone 17-Beta-Dehydrogenase 3 [NCIt concept]
- Testosterone Cypionate [NCIt concept]
- Testosterone Enanthate [NCIt concept]
- Testosterone Gel [NCIt concept]
- Testosterone Greater than 100 ng/dL [NCIt concept]
- Testosterone Greater than 120 ng/dL [NCIt concept]
- Testosterone Greater than 150 ng/dL [NCIt concept]
- Testosterone Greater than 175 ng/dL [NCIt concept]
- Testosterone Greater than 20 ng/dL [NCIt concept]
- Testosterone Greater than 200 ng/dL [NCIt concept]
- Testosterone Greater than 50 ng/dL [NCIt concept]
- Testosterone Greater than 75 ng/dL [NCIt concept]
- Testosterone Greater than or Equal to 100 ng/dL [NCIt concept]
- Testosterone Greater than or Equal to 125 ng/dL [NCIt concept]
- Testosterone Greater than or Equal to 150 ng/dL [NCIt concept]
- Testosterone Greater than or Equal to 200 ng/dL [NCIt concept]
- Testosterone Greater than or Equal to 300 ng/dL [NCIt concept]
- Testosterone Greater than or Equal to 50 ng/dL [NCIt concept]
- Testosterone Less than 100 ng/dL [NCIt concept]
- Testosterone Less than 20 ng/dL [NCIt concept]
- Testosterone Less than 200 ng/dL [NCIt concept]
- Testosterone Less than 300 ng/dL [NCIt concept]
- Testosterone Less than 348 ng/dL [NCIt concept]
- Testosterone Less than 50 ng/dL [NCIt concept]
- Testosterone Less than or Equal to 100 ng/dL [NCIt concept]
- Testosterone Less than or Equal to 50 ng/dL [NCIt concept]
- Testosterone Level Greater than 50 ng/dL Below Normal Range [NCIt concept]
- Testosterone Measurement [NCIt concept]
- Testosterone Nasal Gel [NCIt concept]
- Testosterone Suppression Finding [NCIt concept]
- Testosterone Vaginal Cream [NCIt concept]
- Tetanus Peptide Melanoma Vaccine [NCIt concept]
- Tetanus Toxoid Helper Peptide [NCIt concept]
- Tetanus Toxoid Vaccine [NCIt concept]
- Tetanus and Diphtheria Toxoids Adsorbed [NCIt concept]
- Tetanus-CMV Fusion Peptide Vaccine [NCIt concept]
- Tether Containing UBX Domain For GLUT4 [NCIt concept]
- Tethered Capsule Endomicroscopy [NCIt concept]
- Tethered Capsule Endoscope [NCIt concept]
- Tetracycline Hydrochloride [NCIt concept]
- Tetradecanoylphorbol Acetate [NCIt concept]
- Tetrahydrobiopterin [NCIt concept]
- Tetrahydrocannabinol Positive [NCIt concept]
- Tetrahydrouridine [NCIt concept]
- Tetraspanin-8 [NCIt concept]
- Tetrathiomolybdate [NCIt concept]
- Tetravalent RNA-lipoplex Cancer Vaccine BNT111 [NCIt concept]
- Tetrodotoxin [NCIt concept]
- Texas Education Agency Tobacco Prevention Program [NCIt concept]
- Text Message [NCIt concept]
- Text Message-Based Navigation Intervention [NCIt concept]
- Texting Smoking Cessation Program [NCIt concept]
- Tezemlimogene Daxadenorepvec [NCIt concept]
- Th1 Cell/Th2 Cell Ratio Measurement [NCIt concept]
- Thalamic Germinoma [NCIt concept]
- Thalidomide [NCIt concept]
- Thallium [NCIt concept]
- Theophylline [NCIt concept]
- TheraBionic P1 Device [NCIt concept]
- Therapeutic Allogeneic Cytotoxic T-Lymphocytes [NCIt concept]
- Therapeutic Allogeneic Hematopoietic Stem Cells [NCIt concept]
- Therapeutic Allogeneic Lymphocytes [NCIt concept]
- Therapeutic Autologous Dendritic Cells [NCIt concept]
- Therapeutic Autologous Hematopoietic Stem Cells [NCIt concept]
- Therapeutic Autologous Lymphocytes [NCIt concept]
- Therapeutic Autologous Platelet-rich Plasma [NCIt concept]
- Therapeutic Bacterial Strain CJRB-101 [NCIt concept]
- Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 [NCIt concept]
- Therapeutic Bronchoscopy [NCIt concept]
- Therapeutic Cancer Vaccine ATP128 [NCIt concept]
- Therapeutic Cancer Vaccine ATP150 [NCIt concept]
- Therapeutic Cancer Vaccine ATP152 [NCIt concept]
- Therapeutic Conventional Surgery [NCIt concept]
- Therapeutic Corticosteroid [NCIt concept]
- Therapeutic Dietary Intervention [NCIt concept]
- Therapeutic Effector T-Lymphocytes [NCIt concept]
- Therapeutic Endoscopic Surgery [NCIt concept]
- Therapeutic Epinephrine [NCIt concept]
- Therapeutic Estradiol [NCIt concept]
- Therapeutic Ex Vivo-expanded Allogeneic gamma delta T-cells TCB-202 [NCIt concept]
- Therapeutic Exchange Plasma [NCIt concept]
- Therapeutic Hormone [NCIt concept]
- Therapeutic Hydrocortisone [NCIt concept]
- Therapeutic Immune Globulin [NCIt concept]
- Therapeutic Insulin [NCIt concept]
- Therapeutic Laparoscopic Surgery [NCIt concept]
- Therapeutic Laparoscopy [NCIt concept]
- Therapeutic Lymphadenectomy [NCIt concept]
- Therapeutic Melatonin [NCIt concept]
- Therapeutic Nutritional Supplementation [NCIt concept]
- Therapeutic Procedure [NCIt concept]
- Therapeutic Surgical Procedure [NCIt concept]
- Therapeutic Testosterone [NCIt concept]
- Therapeutic Thoracoscopic Surgery [NCIt concept]
- Therapeutic Thoracoscopy [NCIt concept]
- Therapeutic Touch [NCIt concept]
- Therapeutic Tumor Infiltrating Lymphocytes [NCIt concept]
- Therapeutic Videothoracoscopy [NCIt concept]
- Therapy Evaluation [NCIt concept]
- Therapy-Related Toxicity [NCIt concept]
- Thermal Ablation Therapy [NCIt concept]
- Thermoacoustic Computed Tomography [NCIt concept]
- Thermotherapy [NCIt concept]
- Thiamine [NCIt concept]
- Thiarabine [NCIt concept]
- Thickness [NCIt concept]
- Thioguanine [NCIt concept]
- Thioredoxin [NCIt concept]
- Thioredoxin Reductase 1, Cytoplasmic [NCIt concept]
- Thioredoxin Reductase 2, Mitochondrial [NCIt concept]
- Thioredoxin-1 Inhibitor PX-12 [NCIt concept]
- Thioredoxin-Interacting Protein [NCIt concept]
- Thioridazine Hydrochloride [NCIt concept]
- Thiotepa [NCIt concept]
- Thioureidobutyronitrile [NCIt concept]
- Third-Party Logistics Provider [NCIt concept]
- Thomsen-Friedenreich Antigen Antibody [NCIt concept]
- Thoracentesis [NCIt concept]
- Thoracic Epidural Analgesia [NCIt concept]
- Thoracic Radiation Therapy [NCIt concept]
- Thoracic Spine Neoplasm [NCIt concept]
- Thoracic Surgical Procedure [NCIt concept]
- Thoracoscopic Surgery [NCIt concept]
- Thoracoscopy [NCIt concept]
- Thoracotomy [NCIt concept]
- Thorium Th 227 Anetumab Corixetan [NCIt concept]
- Thorium Th 227 Pelgifatamab Corixetan [NCIt concept]
- Thorium Th 227 Trastuzumab Corixetan [NCIt concept]
- Three Prime Repair Exonuclease 1 [NCIt concept]
- Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging [NCIt concept]
- Three-Dimensional Echo-Planar Spectroscopic Imaging [NCIt concept]
- Three-Dimensional Imaging [NCIt concept]
- Three-Dimensional Spoiled Gradient MRI [NCIt concept]
- Threonine [NCIt concept]
- Thrombectomy [NCIt concept]
- Thrombocytopenia [NCIt concept]
- Thrombocytopenic Purpura [NCIt concept]
- Thromboembolism [NCIt concept]
- Thromboembolism Prophylaxis [NCIt concept]
- Thrombomodulin [NCIt concept]
- Thrombomodulin Alfa [NCIt concept]
- Thrombopoietin [NCIt concept]
- Thrombopoietin Receptor [NCIt concept]
- Thrombospondin [NCIt concept]
- Thrombospondin-1 [NCIt concept]
- Thrombospondin-2 [NCIt concept]
- Thrombotic Thrombocytopenic Purpura [NCIt concept]
- Thromboxane [NCIt concept]
- Thromboxane A2 [NCIt concept]
- Thromboxane A2 Receptor [NCIt concept]
- Thromboxane B2 [NCIt concept]
- Thy-1 Membrane Glycoprotein [NCIt concept]
- Thymic Stromal Lymphopoietin [NCIt concept]
- Thymidine Kinase, Cytosolic [NCIt concept]
- Thymidine Phosphorylase [NCIt concept]
- Thymidylate Synthase [NCIt concept]
- Thymocyte Selection-Associated High Mobility Group Box Protein TOX [NCIt concept]
- Thymoma [NCIt concept]
- Thymoma Type A [NCIt concept]
- Thymoma Type AB [NCIt concept]
- Thymoma Type B [NCIt concept]
- Thymoma Type B1 [NCIt concept]
- Thymoma Type B2 [NCIt concept]
- Thymoma Type B3 [NCIt concept]
- Thymus Carcinoma [NCIt concept]
- Thymus Epithelial Neoplasm [NCIt concept]
- Thyroglobulin [NCIt concept]
- Thyroglobulin Antibody Negative [NCIt concept]
- Thyroglobulin Antibody Positive [NCIt concept]
- Thyroid Gland Adenocarcinoma [NCIt concept]
- Thyroid Gland Anaplastic Carcinoma [NCIt concept]
- Thyroid Gland Carcinoma [NCIt concept]
- Thyroid Gland Cribriform Morular Carcinoma [NCIt concept]
- Thyroid Gland Follicular Carcinoma [NCIt concept]
- Thyroid Gland Hyalinizing Trabecular Tumor [NCIt concept]
- Thyroid Gland Leiomyosarcoma [NCIt concept]
- Thyroid Gland Medullary Carcinoma [NCIt concept]
- Thyroid Gland Nodule [NCIt concept]
- Thyroid Gland Oncocytic Neoplasm [NCIt concept]
- Thyroid Gland Papillary Carcinoma [NCIt concept]
- Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma [NCIt concept]
- Thyroid Hormone Receptor-Associated Protein 3 [NCIt concept]
- Thyroid Hormone-Inducible Hepatic Protein [NCIt concept]
- Thyroid Lobectomy [NCIt concept]
- Thyroid Peroxidase [NCIt concept]
- Thyroid Receptor-Interacting Protein 11 [NCIt concept]
- Thyroid Stimulating Immunoglobulin [NCIt concept]
- Thyroid-Stimulating Hormone [NCIt concept]
- Thyroidectomy [NCIt concept]
- Thyrointegrin AlphaVBeta3 Antagonist fb-PMT [NCIt concept]
- Thyrotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Thyrotropin Receptor [NCIt concept]
- Thyrotropin Subunit Beta [NCIt concept]
- Thyroxine Suppression Therapy [NCIt concept]
- Thyroxine-Binding Globulin [NCIt concept]
- Ticagrelor [NCIt concept]
- Tidutamab [NCIt concept]
- Tifcemalimab [NCIt concept]
- Tigatuzumab [NCIt concept]
- Tight Junction Protein ZO-1 [NCIt concept]
- Tigozertinib [NCIt concept]
- Tilatamig Samrotecan [NCIt concept]
- Tilogotamab [NCIt concept]
- Tilsotolimod [NCIt concept]
- Tilsotolimod Sodium [NCIt concept]
- Timed Up and Go Functional Test [NCIt concept]
- Timolol Maleate [NCIt concept]
- Tin Sn 117m Pentetate [NCIt concept]
- Tinengotinib [NCIt concept]
- Tinlorafenib [NCIt concept]
- Tinodasertib [NCIt concept]
- Tinostamustine [NCIt concept]
- Tinurilimab [NCIt concept]
- Tinzaparin Sodium [NCIt concept]
- Tipapkinogene Sovacivec [NCIt concept]
- Tipifarnib [NCIt concept]
- Tirabrutinib [NCIt concept]
- Tiragolumab [NCIt concept]
- Tirapazamine [NCIt concept]
- Tirbanibulin [NCIt concept]
- Tisagenlecleucel [NCIt concept]
- Tislelizumab [NCIt concept]
- Tisotumab Vedotin [NCIt concept]
- Tissue Collection [NCIt concept]
- Tissue Expander-Implant Breast Reconstruction [NCIt concept]
- Tissue Factor [NCIt concept]
- Tissue Factor Pathway Inhibitor [NCIt concept]
- Tissue Factor Pathway Inhibitor 2 [NCIt concept]
- Tissue Factor-Derived Microparticle [NCIt concept]
- Tissue Flap Breast Reconstruction [NCIt concept]
- Tissue Oxygen Measurement [NCIt concept]
- Tissue Polypeptide Specific Antigen [NCIt concept]
- Tissue-Type Plasminogen Activator [NCIt concept]
- Titanium Dioxide/Zinc Oxide Sunscreen [NCIt concept]
- Tivantinib [NCIt concept]
- Tivozanib [NCIt concept]
- Tivozanib Hydrochloride [NCIt concept]
- Tivumecirnon [NCIt concept]
- Tixestobart [NCIt concept]
- Tizanidine Hydrochloride [NCIt concept]
- Tn Antigen [NCIt concept]
- Tn Antigen Antibody [NCIt concept]
- Tn Antigen-MUC1-32mer Antibody [NCIt concept]
- Tobacco Cessation Counseling [NCIt concept]
- Tobacco Use [NCIt concept]
- Tobacco Use Disorder [NCIt concept]
- Tobemstomig [NCIt concept]
- Tocilizumab [NCIt concept]
- Tocladesine [NCIt concept]
- Tocopherylhydroquinone [NCIt concept]
- Tocopherylquinone [NCIt concept]
- Tofacitinib Topical Cream [NCIt concept]
- Tolbutamide [NCIt concept]
- Tolcapone [NCIt concept]
- Tolinapant [NCIt concept]
- Toll-Like Receptor 1 [NCIt concept]
- Toll-Like Receptor 2 [NCIt concept]
- Toll-Like Receptor 4 [NCIt concept]
- Toll-Like Receptor 5 [NCIt concept]
- Toll-Like Receptor 6 [NCIt concept]
- Toll-Like Receptor 7 [NCIt concept]
- Toll-Like Receptor 8 [NCIt concept]
- Toll-Like Receptor 9 [NCIt concept]
- Toll-Like Receptor Family Gene [NCIt concept]
- Tolododekin Alfa [NCIt concept]
- Toluene [NCIt concept]
- Tolvaptan [NCIt concept]
- Tomaralimab [NCIt concept]
- Tomivosertib [NCIt concept]
- Tomographic Optical Breast Imaging [NCIt concept]
- Tomotherapy [NCIt concept]
- Tonation Breathing Technique [NCIt concept]
- Tongue Carcinoma [NCIt concept]
- Tonometry [NCIt concept]
- Tonsillar Carcinoma [NCIt concept]
- Tonsillar Diffuse Large B-Cell Lymphoma [NCIt concept]
- Tonsillar Mantle Cell Lymphoma [NCIt concept]
- Toothpaste [NCIt concept]
- Topical Calcitriol [NCIt concept]
- Topical Fibrinogen-depleted Human Standardized Platelet Lysate CAM-101 [NCIt concept]
- Topical Fluorouracil [NCIt concept]
- Topical Gel HT-001 [NCIt concept]
- Topical Imiquimod Regimen [NCIt concept]
- Topical Keratin [NCIt concept]
- Topical Keratinocyte Growth Factor Hair Serum [NCIt concept]
- Topical Menthol Cream [NCIt concept]
- Topical Phenylephrine Solution [NCIt concept]
- Topical Piperidine Nitroxide MTS-01 [NCIt concept]
- Topical Preparation [NCIt concept]
- Topical Steroid Therapy [NCIt concept]
- Topical VBP-926 Solution [NCIt concept]
- Topogram [NCIt concept]
- Topoisomerase I Inhibitor Genz-644282 [NCIt concept]
- Topoisomerase I Inhibitor LMP400 [NCIt concept]
- Topoisomerase I Inhibitor LMP776 [NCIt concept]
- Topoisomerase I Inhibitor-containing Antibody-drug Conjugate [NCIt concept]
- Topoisomerase I/II Inhibitor NEV-801 [NCIt concept]
- Topoisomerase II [NCIt concept]
- Topoisomerase-1 Inhibitor LMP744 [NCIt concept]
- Topoisomerase-I Inhibitor [NCIt concept]
- Topoisomerase-II-beta Inhibitor Racemic XK469 [NCIt concept]
- Topotecan [NCIt concept]
- Topotecan Hydrochloride [NCIt concept]
- Topotecan Hydrochloride Liposomes [NCIt concept]
- Topotecan Sustained-release Episcleral Plaque [NCIt concept]
- Toremifene Citrate [NCIt concept]
- Toripalimab [NCIt concept]
- Torque Teno Virus [NCIt concept]
- Torvutatug Samrotecan [NCIt concept]
- Tosedostat [NCIt concept]
- Tositumomab [NCIt concept]
- Tositumomab and Iodine I 131 Tositumomab [NCIt concept]
- Total [NCIt concept]
- Total Abdominal Hysterectomy [NCIt concept]
- Total Cortisol Equivalent Measurement [NCIt concept]
- Total Gastrectomy [NCIt concept]
- Total Gut Decontamination [NCIt concept]
- Total Human Interferon Gamma Serum Measurement [NCIt concept]
- Total Hysterectomy [NCIt concept]
- Total Iron Binding Capacity [NCIt concept]
- Total Laparoscopic Hysterectomy [NCIt concept]
- Total Laryngopharyngectomy [NCIt concept]
- Total Lymphoid Irradiation [NCIt concept]
- Total Marrow Irradiation [NCIt concept]
- Total Marrow and Lymphoid Irradiation [NCIt concept]
- Total Mastectomy [NCIt concept]
- Total Mesorectal Excision [NCIt concept]
- Total Nicotine Equivalent [NCIt concept]
- Total Nodal Irradiation [NCIt concept]
- Total Pancreatectomy [NCIt concept]
- Total Parenteral Nutrition [NCIt concept]
- Total Protein Measurement [NCIt concept]
- Total RNA Expression Profile [NCIt concept]
- Total Skin Electron Beam Radiation Therapy [NCIt concept]
- Total Thyroidectomy [NCIt concept]
- Total Tumor RNA-loaded Dendritic Cell Vaccine [NCIt concept]
- Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells [NCIt concept]
- Total-Body Irradiation [NCIt concept]
- Totrombopag [NCIt concept]
- Tovecimig [NCIt concept]
- Tovetumab [NCIt concept]
- Tovorafenib [NCIt concept]
- Tozadenant [NCIt concept]
- Tozasertib Lactate [NCIt concept]
- Tozinameran [NCIt concept]
- Tozuleristide [NCIt concept]
- Trabectedin [NCIt concept]
- Trabedersen [NCIt concept]
- TraceIT Tissue Spacer Implantation [NCIt concept]
- Tracheal Intubation [NCIt concept]
- Tracheal Papillomatosis [NCIt concept]
- Tracheoesophageal Speech [NCIt concept]
- Tracking [NCIt concept]
- Traditional Education [NCIt concept]
- Traditional Medicine [NCIt concept]
- Trametinib [NCIt concept]
- Trametinib Dimethyl Sulfoxide [NCIt concept]
- Trans Sodium Crocetinate [NCIt concept]
- Trans-Acting T-Cell-Specific Transcription Factor GATA-3 [NCIt concept]
- Trans-Activator Protein BZLF1 [NCIt concept]
- Trans-arterial Tirapazamine Embolization [NCIt concept]
- Transabdominal Ultrasound [NCIt concept]
- Transanal Endoscopic Surgery [NCIt concept]
- Transanal Excision [NCIt concept]
- Transanal Total Mesorectal Excision [NCIt concept]
- Transarterial Chemoembolization [NCIt concept]
- Transarterial Radioembolization [NCIt concept]
- Transbronchial Cryobiopsy Guided by Three-Dimensional Fluoroscopy [NCIt concept]
- Transbronchial Mediastinal Cryobiopsy [NCIt concept]
- Transbronchial Microwave Ablation [NCIt concept]
- Transbronchial Needle Aspiration [NCIt concept]
- Transcatheter Mitral Valve Repair [NCIt concept]
- Transcendental Meditation Therapy [NCIt concept]
- Transcobalamin [NCIt concept]
- Transcranial Direct Current Stimulation [NCIt concept]
- Transcranial Doppler Ultrasonography [NCIt concept]
- Transcranial Magnetic Stimulation [NCIt concept]
- Transcription Activator BRG1 [NCIt concept]
- Transcription Cofactor HES-6 [NCIt concept]
- Transcription Elongation [NCIt concept]
- Transcription Elongation Factor A Protein 1 [NCIt concept]
- Transcription Elongation Regulator 1-Like Protein [NCIt concept]
- Transcription Factor [NCIt concept]
- Transcription Factor 12 [NCIt concept]
- Transcription Factor 4 [NCIt concept]
- Transcription Factor 7 [NCIt concept]
- Transcription Factor 7-Like 2 [NCIt concept]
- Transcription Factor AP-1 [NCIt concept]
- Transcription Factor AP-2-Epsilon [NCIt concept]
- Transcription Factor COE1 [NCIt concept]
- Transcription Factor E2-Alpha [NCIt concept]
- Transcription Factor E2F1 [NCIt concept]
- Transcription Factor E2F3 [NCIt concept]
- Transcription Factor E2F6 [NCIt concept]
- Transcription Factor E3 [NCIt concept]
- Transcription Factor EB [NCIt concept]
- Transcription Factor ETV6 [NCIt concept]
- Transcription Factor GATA-4 [NCIt concept]
- Transcription Factor GATA-5 [NCIt concept]
- Transcription Factor GATA-6 [NCIt concept]
- Transcription Factor HES-1 [NCIt concept]
- Transcription Factor HES-2 [NCIt concept]
- Transcription Factor HES-3 [NCIt concept]
- Transcription Factor HES-4 [NCIt concept]
- Transcription Factor HES-5 [NCIt concept]
- Transcription Factor Jun-B [NCIt concept]
- Transcription Factor Jun-D [NCIt concept]
- Transcription Factor Maf [NCIt concept]
- Transcription Factor MafA [NCIt concept]
- Transcription Factor MafB [NCIt concept]
- Transcription Factor PU.1 [NCIt concept]
- Transcription Factor Protein SON-DP [NCIt concept]
- Transcription Factor RelB [NCIt concept]
- Transcription Factor SOX-10 [NCIt concept]
- Transcription Factor SOX-11 [NCIt concept]
- Transcription Factor SOX-17 [NCIt concept]
- Transcription Factor SOX-2 [NCIt concept]
- Transcription Factor SOX-9 [NCIt concept]
- Transcription Factor Sp1 [NCIt concept]
- Transcription Factor Sp3 [NCIt concept]
- Transcription Factor Spi-B [NCIt concept]
- Transcription Factor p65 [NCIt concept]
- Transcription Initiation Factor TFIID Subunit 1 [NCIt concept]
- Transcription Initiation Factor TFIID Subunit 2 [NCIt concept]
- Transcription Intermediary Factor 1-Alpha [NCIt concept]
- Transcription Regulator Protein BACH2 [NCIt concept]
- Transcription Termination Factor 1 [NCIt concept]
- Transcriptional Activator MN1 [NCIt concept]
- Transcriptional Activator Myb [NCIt concept]
- Transcriptional Adapter 2-Alpha [NCIt concept]
- Transcriptional Coactivator YAP1 [NCIt concept]
- Transcriptional Intermediary Factor 1-Beta [NCIt concept]
- Transcriptional Regulator ATRX [NCIt concept]
- Transcriptional Regulator ERG [NCIt concept]
- Transcriptional Repressor CTCF [NCIt concept]
- Transcriptional Repressor CTCFL [NCIt concept]
- Transcutaneous Acupoint Electrical Stimulation [NCIt concept]
- Transcutaneous Auricular Vagus Nerve Stimulation [NCIt concept]
- Transcutaneous Electrical Nerve Stimulation [NCIt concept]
- Transducin Beta-Like Protein 1 Family [NCIt concept]
- Transducin Beta-Like Protein 2 [NCIt concept]
- Transducin-Like Enhancer Protein 1 [NCIt concept]
- Transesophageal Echocardiography Test [NCIt concept]
- Transferrin Receptor [NCIt concept]
- Transferrin Receptor Protein 1 [NCIt concept]
- Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01 [NCIt concept]
- Transformed B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma [NCIt concept]
- Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed Non-Hodgkin Lymphoma [NCIt concept]
- Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma [NCIt concept]
- Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma [NCIt concept]
- Transforming Acidic Coiled-Coil-Containing Protein 1 [NCIt concept]
- Transforming Acidic Coiled-Coil-Containing Protein 3 [NCIt concept]
- Transforming Growth Factor Alpha [NCIt concept]
- Transforming Growth Factor Beta Receptor Type 3 [NCIt concept]
- Transforming Growth Factor Beta-1 [NCIt concept]
- Transforming Growth Factor Beta-1-Induced Transcript 1 Protein [NCIt concept]
- Transforming Growth Factor Beta-2 [NCIt concept]
- Transforming Growth Factor Beta-3 [NCIt concept]
- Transforming Growth Factor-Beta Superfamily [NCIt concept]
- Transforming Growth Factor-Beta-Induced Protein IG-H3 [NCIt concept]
- Transforming Protein RhoA [NCIt concept]
- Transfusion Dependent Alpha Thalassemia [NCIt concept]
- Transfusion Hemochromatosis [NCIt concept]
- Transgelin [NCIt concept]
- Transgenic Lymphocyte Immunization Vaccine [NCIt concept]
- Transglutaminase [NCIt concept]
- Transient Receptor Potential Cation Channel Subfamily A Member 1 [NCIt concept]
- Transient Receptor Potential Cation Channel Subfamily M Member 6 [NCIt concept]
- Transient Receptor Potential Cation Channel Subfamily M Member 7 [NCIt concept]
- Transient Receptor Potential Cation Channel Subfamily V Member 6 [NCIt concept]
- Transitional B-Lymphocyte Count [NCIt concept]
- Transitional Care Planning [NCIt concept]
- Translationally-Controlled Tumor Protein [NCIt concept]
- Translocation Breakpoint [NCIt concept]
- Translocator Protein [NCIt concept]
- Transmembrane Glycoprotein NMB [NCIt concept]
- Transmembrane Protease Serine 2 [NCIt concept]
- Transmembrane Protein 127 [NCIt concept]
- Transmembrane Protein 204 [NCIt concept]
- Transmembrane and Coiled-Coil Domains Protein 1 [NCIt concept]
- Transoral Robotic Surgery [NCIt concept]
- Transperineal Biopsy [NCIt concept]
- Transperineal MRI-guided Prostate Biopsy [NCIt concept]
- Transplant Conditioning [NCIt concept]
- Transplant-Related Hepatocellular Carcinoma [NCIt concept]
- Transplant-Related Lung Carcinoma [NCIt concept]
- Transplant-Related Renal Cell Carcinoma [NCIt concept]
- Transplant-Related Skin Squamous Cell Carcinoma [NCIt concept]
- Transplant-Related Squamous Cell Carcinoma [NCIt concept]
- Transplantation [NCIt concept]
- Transplanted Organ Complication [NCIt concept]
- Transportation [NCIt concept]
- Transrectal MRI-Guided Biopsy [NCIt concept]
- Transrectal MRI-Guided Prostate Biopsy [NCIt concept]
- Transrectal Prostate Biopsy [NCIt concept]
- Transrectal Ultrasonography Guided Biopsy [NCIt concept]
- Transrectal Ultrasound [NCIt concept]
- Transthoracic Needle Biopsy [NCIt concept]
- Transthyretin [NCIt concept]
- Transurethral Incision of the Prostate [NCIt concept]
- Transurethral Resection of Bladder Tumor [NCIt concept]
- Transurethral Vaporesection of the Prostate [NCIt concept]
- Transvaginal Ultrasound [NCIt concept]
- Transversus Abdominis Plane Block [NCIt concept]
- Transvesical Single Port Robotic Partial Prostatectomy [NCIt concept]
- Tranylcypromine [NCIt concept]
- Trastuzumab [NCIt concept]
- Trastuzumab Botidotin [NCIt concept]
- Trastuzumab Deruxtecan [NCIt concept]
- Trastuzumab Duocarmazine [NCIt concept]
- Trastuzumab Emtansine [NCIt concept]
- Trastuzumab Imbotolimod [NCIt concept]
- Trastuzumab Pamirtecan [NCIt concept]
- Trastuzumab Vedotin [NCIt concept]
- Trastuzumab/Hyaluronidase-oysk [NCIt concept]
- Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 [NCIt concept]
- Treatment Plan [NCIt concept]
- Treatment Planning [NCIt concept]
- Treatment-sensitive HIV Infection [NCIt concept]
- Trebananib [NCIt concept]
- Trefoil Factor 1 [NCIt concept]
- Trefoil Factor 2 [NCIt concept]
- Trefoil Factor 3 [NCIt concept]
- Treg Inhibitor GIM-531 [NCIt concept]
- Trem-Like Transcript 1 Protein [NCIt concept]
- Tremelimumab [NCIt concept]
- Tremtelectogene Empogeditemcel [NCIt concept]
- Treosulfan [NCIt concept]
- Tretinoin [NCIt concept]
- Triamcinolone [NCIt concept]
- Triapine [NCIt concept]
- Tribbles Homolog 2 [NCIt concept]
- Trichothiodystrophy [NCIt concept]
- Triciribine Phosphate [NCIt concept]
- Triclosan [NCIt concept]
- Trientine Hydrochloride [NCIt concept]
- Trier Social Stress Test [NCIt concept]
- Trifarotene [NCIt concept]
- Trifluridine [NCIt concept]
- Trifluridine and Tipiracil Hydrochloride [NCIt concept]
- Trifunctional Purine Biosynthetic Protein Adenosine-3 [NCIt concept]
- Triggering Receptor Expressed On Myeloid Cells 1 [NCIt concept]
- Triggering Receptor Expressed On Myeloid Cells 2 [NCIt concept]
- Triggering Receptors Expressed on Myeloid Cells Family Protein [NCIt concept]
- Triglycerides [NCIt concept]
- Triiodothyronine [NCIt concept]
- Trilaciclib [NCIt concept]
- Trimethoprim-Sulfamethoxazole [NCIt concept]
- Triosephosphate Isomerase [NCIt concept]
- Tripartite Motif-Containing Protein 16 [NCIt concept]
- Triple-Class Refractory Multiple Myeloma [NCIt concept]
- Triple-Negative Breast Cancer Finding [NCIt concept]
- Triple-Negative Breast Carcinoma [NCIt concept]
- Triptolide Analog [NCIt concept]
- Triptorelin [NCIt concept]
- Triptorelin Pamoate [NCIt concept]
- Tris-acryl Gelatin Microspheres [NCIt concept]
- Trisomy 12 [NCIt concept]
- Trisomy 21 [NCIt concept]
- Trisomy 21 Mosaicism [NCIt concept]
- Trisomy 8 [NCIt concept]
- Trivalent Influenza Vaccine [NCIt concept]
- TrkA Inhibitor VMD-928 [NCIt concept]
- Trophoblastic Tumor [NCIt concept]
- Tropisetron [NCIt concept]
- Tropomodulin-3 [NCIt concept]
- Tropomyosin Alpha-3 Chain [NCIt concept]
- Tropomyosin Alpha-3 Chain Isoform 2 [NCIt concept]
- Tropomyosin Alpha-3 Chain Isoform 3 [NCIt concept]
- Tropomyosin Alpha-4 Chain [NCIt concept]
- Troponin I [NCIt concept]
- Troponin I, Cardiac Muscle [NCIt concept]
- Troponin Measurement [NCIt concept]
- Troponin T, Cardiac Muscle [NCIt concept]
- Troriluzole [NCIt concept]
- Trotabresib [NCIt concept]
- Trovostobart [NCIt concept]
- Troxacitabine [NCIt concept]
- TruSight Oncology 500 Assay [NCIt concept]
- Truncated BID [NCIt concept]
- Truncated Glioma-Associated Oncogene Homolog 1 Protein [NCIt concept]
- Trypsin-1 [NCIt concept]
- Trypsin-2 [NCIt concept]
- Tryptase [NCIt concept]
- Tryptase Beta-2 [NCIt concept]
- Tryptophan [NCIt concept]
- Tryptophan 2,3-Dioxygenase [NCIt concept]
- Tryptophan 5-Hydroxylase 1 [NCIt concept]
- Tryptophan Metabolite [NCIt concept]
- Tuberin [NCIt concept]
- Tuberous Sclerosis [NCIt concept]
- Tubular [NCIt concept]
- Tubulin [NCIt concept]
- Tubulin Alpha-1B Chain [NCIt concept]
- Tubulin Alpha-3C/D Chain [NCIt concept]
- Tubulin Beta Chain [NCIt concept]
- Tubulin Beta-3 Chain [NCIt concept]
- Tubulin Inhibitor ALB 109564 Dihydrochloride [NCIt concept]
- Tubulin Inhibitor-containing Antibody-drug Conjugate [NCIt concept]
- Tubulin Polymerization Inhibitor AB8939 [NCIt concept]
- Tubulin-Specific Chaperone Cofactor E-Like Protein [NCIt concept]
- Tubulin-Tyrosine Ligase [NCIt concept]
- Tubulocystic Renal Cell Carcinoma [NCIt concept]
- Tucatinib [NCIt concept]
- Tucidinostat [NCIt concept]
- Tulmimetostat [NCIt concept]
- Tumor Antigen [NCIt concept]
- Tumor Antigen-reactive CD28+/CCR7+/CD27+/CD45RA- Cytotoxic T-lymphocyte [NCIt concept]
- Tumor Antigen-specific Antibody [NCIt concept]
- Tumor Board Review [NCIt concept]
- Tumor Cell Lysate Vaccine Therapy [NCIt concept]
- Tumor Cell Necrosis [NCIt concept]
- Tumor Cell-Derived Vaccine Therapy [NCIt concept]
- Tumor Cell-Encapsulating Diffusion Chamber Implantation [NCIt concept]
- Tumor DNA [NCIt concept]
- Tumor Debulking [NCIt concept]
- Tumor Infiltrating Lymphocyte [NCIt concept]
- Tumor Infiltrating Lymphocyte Therapy [NCIt concept]
- Tumor Infiltrating Macrophages [NCIt concept]
- Tumor Interstitial Fluid Pressure Measurement [NCIt concept]
- Tumor Lysis Syndrome [NCIt concept]
- Tumor Mass [NCIt concept]
- Tumor Mass of the Extremity [NCIt concept]
- Tumor Microenvironment of Metastasis Density [NCIt concept]
- Tumor Mutation Burden [NCIt concept]
- Tumor Mutation Burden Greater than or Equal to 10 Mutations per Megabase [NCIt concept]
- Tumor Mutation Burden Less than One Mutation per Megabase [NCIt concept]
- Tumor Necrosis Factor [NCIt concept]
- Tumor Necrosis Factor Alpha-Induced Protein 2 [NCIt concept]
- Tumor Necrosis Factor Alpha-Induced Protein 3 [NCIt concept]
- Tumor Necrosis Factor Family Protein [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 11 [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 13 [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 13B [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 4 [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 6 [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 8 [NCIt concept]
- Tumor Necrosis Factor Ligand Superfamily Member 9 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 10A [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 10B [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 10C [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 11A [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 11B [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 13B [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 13C [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 14 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 16 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 17 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 18 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 1A [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 1B [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 21 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 3 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 4 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 5 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 6 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 8 [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 9 [NCIt concept]
- Tumor Panel Sequencing [NCIt concept]
- Tumor Proliferation Gene Expression Signature [NCIt concept]
- Tumor Proportion Score [NCIt concept]
- Tumor Protein 63 [NCIt concept]
- Tumor Protein 63 Isoform 2 [NCIt concept]
- Tumor Protein p53-Inducible Nuclear Protein 1 [NCIt concept]
- Tumor RNA [NCIt concept]
- Tumor Suppressor ARF [NCIt concept]
- Tumor Treating Fields Therapy [NCIt concept]
- Tumor cDNA Expression Profile [NCIt concept]
- Tumor-Associated Calcium Signal Transducer 2 [NCIt concept]
- Tumor-Associated Macrophage [NCIt concept]
- Tumor-Associated Peptide Antigens Present [NCIt concept]
- Tumor-Cells Apoptosis Factor Hormone-Peptide [NCIt concept]
- Tumor-Infiltrating Immune Cell [NCIt concept]
- Tuparstobart [NCIt concept]
- Tusamitamab Ravtansine [NCIt concept]
- Tuspetinib [NCIt concept]
- Tuvusertib [NCIt concept]
- Tuxobertinib [NCIt concept]
- Twenty [NCIt concept]
- Twenty One [NCIt concept]
- Twist-Related Protein 1 [NCIt concept]
- Twist-Related Protein 2 [NCIt concept]
- Two-Dimensional Imaging [NCIt concept]
- Type 1 Helper Cell [NCIt concept]
- Type 1 Papillary Renal Cell Carcinoma [NCIt concept]
- Type 1 Regulatory T-Cell [NCIt concept]
- Type 2 Helper Cell [NCIt concept]
- Type 2 Papillary Renal Cell Carcinoma [NCIt concept]
- Type I Collagen [NCIt concept]
- Type I Endometrial Adenocarcinoma [NCIt concept]
- Type II Endometrial Adenocarcinoma [NCIt concept]
- Type II Hemipelvectomy Patient [NCIt concept]
- Type II JAK2 Inhibitor AJ1-11095 [NCIt concept]
- Type III Procollagen N-Terminal Peptide [NCIt concept]
- Type IV Hypersensitivity [NCIt concept]
- Type V Collagen Antibody [NCIt concept]
- Type-1 Angiotensin II Receptor-Associated Protein [NCIt concept]
- Type-Specific HPV Antibody [NCIt concept]
- Tyrosinase [NCIt concept]
- Tyrosinase Peptide [NCIt concept]
- Tyrosinase Positive [NCIt concept]
- Tyrosine 3-Monooxygenase [NCIt concept]
- Tyrosine Kinase Inhibitor [NCIt concept]
- Tyrosine Kinase Inhibitor XL228 [NCIt concept]
- Tyrosine Nitration [NCIt concept]
- Tyrosine Phosphorylated STAT5 [NCIt concept]
- Tyrosine-Protein Kinase ABL1 [NCIt concept]
- Tyrosine-Protein Kinase ABL2 [NCIt concept]
- Tyrosine-Protein Kinase BTK [NCIt concept]
- Tyrosine-Protein Kinase CSK [NCIt concept]
- Tyrosine-Protein Kinase Fgr [NCIt concept]
- Tyrosine-Protein Kinase Fyn [NCIt concept]
- Tyrosine-Protein Kinase Hck [NCIt concept]
- Tyrosine-Protein Kinase ITK/TSK [NCIt concept]
- Tyrosine-Protein Kinase JAK1 [NCIt concept]
- Tyrosine-Protein Kinase JAK2 [NCIt concept]
- Tyrosine-Protein Kinase JAK3 [NCIt concept]
- Tyrosine-Protein Kinase Lck [NCIt concept]
- Tyrosine-Protein Kinase Lyn [NCIt concept]
- Tyrosine-Protein Kinase Mer [NCIt concept]
- Tyrosine-Protein Kinase Receptor TYRO3 [NCIt concept]
- Tyrosine-Protein Kinase Receptor Tie-1 [NCIt concept]
- Tyrosine-Protein Kinase Receptor UFO [NCIt concept]
- Tyrosine-Protein Kinase SYK [NCIt concept]
- Tyrosine-Protein Kinase Transmembrane Receptor ROR2 [NCIt concept]
- Tyrosine-Protein Kinase Yes [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 1 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 11 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 12 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 13 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 2 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 21 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type 6 [NCIt concept]
- Tyrosine-Protein Phosphatase Non-Receptor Type Substrate 1 [NCIt concept]
- Tyrosyl-DNA Phosphodiesterase 1 [NCIt concept]
- U2 Small Nuclear Ribonucleoprotein Auxiliary Factor 35 kDa Subunit-Related Protein 2 [NCIt concept]
- U2AF1 Gene [NCIt concept]
- U2AF1 Gene Mutation [NCIt concept]
- U2AF1 Gene Mutation Negative [NCIt concept]
- U2AF1 NP_006749.1:p.Q157X [NCIt concept]
- U2AF1 NP_006749.1:p.R156X [NCIt concept]
- U2AF1 NP_006749.1:p.S34X [NCIt concept]
- U2AF1 Protein Variant [NCIt concept]
- U2AF1 wt Allele [NCIt concept]
- U2AF2 Gene [NCIt concept]
- U2AF2 Gene Mutation [NCIt concept]
- U2AF2 wt Allele [NCIt concept]
- U3 Small Nucleolar Ribonucleoprotein Protein IMP3 [NCIt concept]
- U4/U6.U5 Tri-SnRNP-Associated Protein 1 [NCIt concept]
- UAE Inhibitor TAK-243 [NCIt concept]
- UBA1 Gene [NCIt concept]
- UBA1 Gene Mutation [NCIt concept]
- UBA1 NP_003325.2:p.M41X [NCIt concept]
- UBA1 Protein Variant [NCIt concept]
- UBA1 wt Allele [NCIt concept]
- UBA3 Gene [NCIt concept]
- UBA3 wt Allele [NCIt concept]
- UBB Gene [NCIt concept]
- UBB wt Allele [NCIt concept]
- UBC Gene [NCIt concept]
- UBC wt Allele [NCIt concept]
- UBE2A Gene [NCIt concept]
- UBE2A wt Allele [NCIt concept]
- UBE2C Gene [NCIt concept]
- UBE2C wt Allele [NCIt concept]
- UBE2E Family [NCIt concept]
- UBE4B Gene [NCIt concept]
- UBE4B wt Allele [NCIt concept]
- UBQLN4 Gene [NCIt concept]
- UBQLN4 wt Allele [NCIt concept]
- UBR5 Gene [NCIt concept]
- UBR5 Gene Mutation [NCIt concept]
- UBR5 wt Allele [NCIt concept]
- UBTF Exon 13 Tandem Duplication [NCIt concept]
- UBTF Gene [NCIt concept]
- UBTF Tandem Duplication [NCIt concept]
- UBTF wt Allele [NCIt concept]
- UCHL1 Gene [NCIt concept]
- UCHL1 wt Allele [NCIt concept]
- UCHL5 Gene [NCIt concept]
- UCHL5 wt Allele [NCIt concept]
- UDP-Glucuronosyltransferase 1-1 [NCIt concept]
- UDP-Glucuronosyltransferase 1-4 [NCIt concept]
- UDP-Glucuronosyltransferase 1-6 [NCIt concept]
- UDP-Glucuronosyltransferase 1-7 [NCIt concept]
- UDP-Glucuronosyltransferase 1-9 [NCIt concept]
- UDP-Glucuronosyltransferase 2B15 [NCIt concept]
- UDP-Glucuronosyltransferase 2B17 [NCIt concept]
- UDP-Glucuronosyltransferase 2B7 [NCIt concept]
- UGCG Gene [NCIt concept]
- UGCG wt Allele [NCIt concept]
- UGT1A Locus [NCIt concept]
- UGT1A1 Gene [NCIt concept]
- UGT1A1 Gene Mutation [NCIt concept]
- UGT1A1 Gene Mutation Negative [NCIt concept]
- UGT1A1 Inhibitor [NCIt concept]
- UGT1A1 Polymorphism Positive [NCIt concept]
- UGT1A1 wt Allele [NCIt concept]
- UGT1A1*1/*28 Positive [NCIt concept]
- UGT1A1*1/*36 Positive [NCIt concept]
- UGT1A1*1/*37 Positive [NCIt concept]
- UGT1A1*28 Allele [NCIt concept]
- UGT1A1*28 Allele Negative [NCIt concept]
- UGT1A1*28/*37 Positive [NCIt concept]
- UGT1A1*36/*28 Positive [NCIt concept]
- UGT1A1*36/*37 Positive [NCIt concept]
- UGT1A1*6 Allele [NCIt concept]
- UGT1A1*6/*28 Positive [NCIt concept]
- UGT1A1*60 Allele [NCIt concept]
- UGT1A4 Gene [NCIt concept]
- UGT1A4 wt Allele [NCIt concept]
- UGT1A6 Gene [NCIt concept]
- UGT1A6 wt Allele [NCIt concept]
- UGT1A7 Gene [NCIt concept]
- UGT1A7 wt Allele [NCIt concept]
- UGT1A9 Gene [NCIt concept]
- UGT1A9 wt Allele [NCIt concept]
- UGT2B15 Gene [NCIt concept]
- UGT2B15 wt Allele [NCIt concept]
- UGT2B17 Gene [NCIt concept]
- UGT2B17 wt Allele [NCIt concept]
- UGT2B7 Gene [NCIt concept]
- UGT2B7 wt Allele [NCIt concept]
- UGT8 Gene [NCIt concept]
- UGT8 wt Allele [NCIt concept]
- UIMC1 Gene [NCIt concept]
- UIMC1 wt Allele [NCIt concept]
- UL16-Binding Protein 1 [NCIt concept]
- UL16-Binding Protein 2 [NCIt concept]
- UL16-Binding Protein 3 [NCIt concept]
- UL16-Binding Protein 6 [NCIt concept]
- ULBP1 Gene [NCIt concept]
- ULBP1 wt Allele [NCIt concept]
- ULBP2 Gene [NCIt concept]
- ULBP2 wt Allele [NCIt concept]
- ULBP3 Gene [NCIt concept]
- ULBP3 wt Allele [NCIt concept]
- ULK1 Gene [NCIt concept]
- ULK1 wt Allele [NCIt concept]
- ULK2 Gene [NCIt concept]
- ULK2 wt Allele [NCIt concept]
- UNC13D Gene [NCIt concept]
- UNC13D Gene Mutation [NCIt concept]
- UNC13D wt Allele [NCIt concept]
- UNG Gene [NCIt concept]
- UNG Gene Product [NCIt concept]
- UNG wt Allele [NCIt concept]
- UPF0606 Protein KIAA1549 [NCIt concept]
- UQCRH Gene [NCIt concept]
- UQCRH wt Allele [NCIt concept]
- UQCRH/EWSR1 Fusion Gene [NCIt concept]
- USH1G Gene [NCIt concept]
- USH1G wt Allele [NCIt concept]
- USP1 Gene [NCIt concept]
- USP1 Inhibitor ISM3091 [NCIt concept]
- USP1 Inhibitor TNG348 [NCIt concept]
- USP1 inhibitor KSQ-4279 [NCIt concept]
- USP1 wt Allele [NCIt concept]
- USP14 Gene [NCIt concept]
- USP14 wt Allele [NCIt concept]
- USP14/UCHL5 Inhibitor VLX1570 [NCIt concept]
- USP17L2 Gene [NCIt concept]
- USP17L2 wt Allele [NCIt concept]
- USP28 Gene [NCIt concept]
- USP28 wt Allele [NCIt concept]
- USP8 Gene [NCIt concept]
- USP8 wt Allele [NCIt concept]
- USP9X Gene [NCIt concept]
- USP9X wt Allele [NCIt concept]
- UTP23 Gene [NCIt concept]
- UTP23 wt Allele [NCIt concept]
- UV Excision Repair Protein RAD23 Homolog A [NCIt concept]
- UV Excision Repair Protein RAD23 Homolog B [NCIt concept]
- UV Light Therapy [NCIt concept]
- UV1 Telomerase Peptide Vaccine [NCIt concept]
- Ubamatamab [NCIt concept]
- Ubavitinib Tosylate [NCIt concept]
- Ubidecarenone Nanodispersion BPM31510n [NCIt concept]
- Ubiquilin-4 [NCIt concept]
- Ubiquitin [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase 1 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase 14 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase 17 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase 28 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase 8 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase BAP1 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase CYLD [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 [NCIt concept]
- Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L5 [NCIt concept]
- Ubiquitin Conjugation Factor E4 B [NCIt concept]
- Ubiquitin-Conjugating Enzyme E2 A [NCIt concept]
- Ubiquitin-Conjugating Enzyme E2 C [NCIt concept]
- Ubiquitin-Like Modifier-Activating Enzyme 1 [NCIt concept]
- Ubiquitin-Like Modifier-Activating Enzyme ATG7 [NCIt concept]
- Ubiquitin-Like Protein ISG15 [NCIt concept]
- Ublituximab [NCIt concept]
- Ucalolictide [NCIt concept]
- Ulevostinag [NCIt concept]
- Uliledlimab [NCIt concept]
- Ulimorelin Hydrochloride [NCIt concept]
- Ulixertinib [NCIt concept]
- Ulocuplumab [NCIt concept]
- Ultra High Sensitivity C-Reactive Protein Measurement [NCIt concept]
- Ultra-Low-Field MRI [NCIt concept]
- Ultrafast MRI [NCIt concept]
- Ultrahypofractionated Radiation Therapy [NCIt concept]
- Ultrasonographic Elastography [NCIt concept]
- Ultrasound [NCIt concept]
- Ultrasound Biomicroscopy [NCIt concept]
- Ultrasound Elasticity Imaging [NCIt concept]
- Ultrasound Imaging [NCIt concept]
- Ultrasound Microvessel Imaging [NCIt concept]
- Ultrasound Tomography [NCIt concept]
- Ultrasound-Guided Biopsy [NCIt concept]
- Ultrasound-Guided Fine-Needle Aspiration [NCIt concept]
- Ultrasound-Guided Near-Infrared Optical Tomography [NCIt concept]
- Ultrasound-Guided Prostate Biopsy [NCIt concept]
- Ultrasound-Guided Transbronchial Needle Aspiration [NCIt concept]
- Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy [NCIt concept]
- Ulviprubart [NCIt concept]
- Umbilical Cord Blood Transplantation [NCIt concept]
- Umbilical Cord Blood-Derived Lymphocyte Therapy [NCIt concept]
- Umbilical Cord Blood-Derived Mesenchymal Stem Cells [NCIt concept]
- Umbilical Cord Blood-derived CD16-expressing Natural Killer Cells AB-101 [NCIt concept]
- Umbralisib [NCIt concept]
- Umbralisib Tosylate [NCIt concept]
- Uncharacterized Histology [NCIt concept]
- Unconventional Myosin-Ig [NCIt concept]
- Unconventional Myosin-Va [NCIt concept]
- Unconventional Myosin-XVIIIa [NCIt concept]
- Underserved Population [NCIt concept]
- Undescribed Disease Entity Reported to CTRP [NCIt concept]
- Undetectable PSA [NCIt concept]
- Undifferentiated Carcinoma of Unknown Primary [NCIt concept]
- Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Undifferentiated Neuroblastoma [NCIt concept]
- Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Undifferentiated Retinoblastoma [NCIt concept]
- Undifferentiated Soft Tissue Sarcoma [NCIt concept]
- Unesbulin [NCIt concept]
- Unfavorable Intermediate Risk Prostate Carcinoma [NCIt concept]
- Unfolded Protein Response [NCIt concept]
- Unicentric Castleman Disease [NCIt concept]
- Uniformly-labeled [13C]fructose [NCIt concept]
- Uniformly-labeled [13C]glucose [NCIt concept]
- Uniformly-labeled [13C]glutamine [NCIt concept]
- Uniformly-labeled [13C]lactate [NCIt concept]
- Unilateral Breast Carcinoma [NCIt concept]
- Universal Donor Expanded TGF-beta-imprinted NK Cells [NCIt concept]
- University of Washington Quality of Life Scale, Version 4 [NCIt concept]
- Unmethylated MGMT Gene Promoter [NCIt concept]
- Unmutated Immunoglobulin Heavy Chain Variable Region Gene [NCIt concept]
- Unresectable Abdominal Neuroendocrine Neoplasm [NCIt concept]
- Unresectable Acral Lentiginous Melanoma [NCIt concept]
- Unresectable Acral Melanoma [NCIt concept]
- Unresectable Adenoid Cystic Carcinoma [NCIt concept]
- Unresectable Adrenal Gland Pheochromocytoma [NCIt concept]
- Unresectable Alveolar Soft Part Sarcoma [NCIt concept]
- Unresectable Ampulla of Vater Adenocarcinoma [NCIt concept]
- Unresectable Ampulla of Vater Carcinoma [NCIt concept]
- Unresectable Anal Canal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Anal Carcinoma [NCIt concept]
- Unresectable Anal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Anaplastic Astrocytoma [NCIt concept]
- Unresectable Angiosarcoma [NCIt concept]
- Unresectable Anorectal Melanoma [NCIt concept]
- Unresectable Appendix Adenocarcinoma [NCIt concept]
- Unresectable Astrocytic Tumor [NCIt concept]
- Unresectable Astrocytoma, IDH-Mutant [NCIt concept]
- Unresectable Bile Duct Carcinoma [NCIt concept]
- Unresectable Biliary Tract Carcinoma [NCIt concept]
- Unresectable Bladder Adenocarcinoma [NCIt concept]
- Unresectable Bladder Carcinoma [NCIt concept]
- Unresectable Bladder Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Bladder Squamous Cell Carcinoma [NCIt concept]
- Unresectable Bladder Urothelial Carcinoma [NCIt concept]
- Unresectable Bone Sarcoma [NCIt concept]
- Unresectable Breast Adenocarcinoma [NCIt concept]
- Unresectable Breast Carcinoma [NCIt concept]
- Unresectable Breast Inflammatory Carcinoma [NCIt concept]
- Unresectable Carcinoma [NCIt concept]
- Unresectable Castration-Resistant Prostate Carcinoma [NCIt concept]
- Unresectable Cervical Adenocarcinoma [NCIt concept]
- Unresectable Cervical Adenosquamous Carcinoma [NCIt concept]
- Unresectable Cervical Squamous Cell Carcinoma [NCIt concept]
- Unresectable Chordoma [NCIt concept]
- Unresectable Chromophobe Renal Cell Carcinoma [NCIt concept]
- Unresectable Clear Cell Renal Cell Carcinoma [NCIt concept]
- Unresectable Colon Carcinoma [NCIt concept]
- Unresectable Colorectal Adenocarcinoma [NCIt concept]
- Unresectable Colorectal Carcinoma [NCIt concept]
- Unresectable Craniopharyngioma [NCIt concept]
- Unresectable Cutaneous Melanoma [NCIt concept]
- Unresectable Dedifferentiated Liposarcoma [NCIt concept]
- Unresectable Desmoplastic Small Round Cell Tumor [NCIt concept]
- Unresectable Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Unresectable Diffuse Glioma [NCIt concept]
- Unresectable Diffuse Hemispheric Glioma, H3 G34-Mutant [NCIt concept]
- Unresectable Diffuse Midline Glioma [NCIt concept]
- Unresectable Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Unresectable Digestive System Adenocarcinoma [NCIt concept]
- Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Unresectable Digestive System Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Digestive System Neuroendocrine Neoplasm [NCIt concept]
- Unresectable Digestive System Neuroendocrine Tumor G1 [NCIt concept]
- Unresectable Digestive System Neuroendocrine Tumor G2 [NCIt concept]
- Unresectable Digestive System Neuroendocrine Tumor G3 [NCIt concept]
- Unresectable Distal Cholangiocarcinoma [NCIt concept]
- Unresectable Distal Esophagus Adenocarcinoma [NCIt concept]
- Unresectable Endometrial Carcinoma [NCIt concept]
- Unresectable Epithelioid Hemangioendothelioma [NCIt concept]
- Unresectable Epithelioid Sarcoma [NCIt concept]
- Unresectable Esophageal Adenocarcinoma [NCIt concept]
- Unresectable Esophageal Carcinoma [NCIt concept]
- Unresectable Esophageal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Estrogen Receptor-Positive Breast Carcinoma [NCIt concept]
- Unresectable Ewing Sarcoma [NCIt concept]
- Unresectable Extrahepatic Bile Duct Carcinoma [NCIt concept]
- Unresectable Extrahepatic Cholangiocarcinoma [NCIt concept]
- Unresectable Extrapulmonary Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Extrapulmonary Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Extrarenal Rhabdoid Tumor [NCIt concept]
- Unresectable Fallopian Tube Endometrioid Adenocarcinoma [NCIt concept]
- Unresectable Fallopian Tube High Grade Serous Adenocarcinoma [NCIt concept]
- Unresectable Fibrolamellar Carcinoma [NCIt concept]
- Unresectable Fibrosarcoma [NCIt concept]
- Unresectable Fumarate Hydratase-Deficient Renal Cell Carcinoma [NCIt concept]
- Unresectable Gallbladder Adenocarcinoma [NCIt concept]
- Unresectable Gallbladder Carcinoma [NCIt concept]
- Unresectable Gastric Carcinoma [NCIt concept]
- Unresectable Gastroesophageal Junction Carcinoma [NCIt concept]
- Unresectable Gastroesophageal Junction Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Genitourinary System Carcinoma [NCIt concept]
- Unresectable Glioblastoma [NCIt concept]
- Unresectable Glioma [NCIt concept]
- Unresectable Glioneuronal and Neuronal Tumors [NCIt concept]
- Unresectable HER2-Low Breast Carcinoma [NCIt concept]
- Unresectable HER2-Negative Breast Carcinoma [NCIt concept]
- Unresectable HER2-Positive Breast Carcinoma [NCIt concept]
- Unresectable Head and Neck Cutaneous Squamous Cell Carcinoma [NCIt concept]
- Unresectable Hepatoblastoma [NCIt concept]
- Unresectable Hepatocellular Carcinoma [NCIt concept]
- Unresectable Hereditary Thyroid Gland Medullary Carcinoma [NCIt concept]
- Unresectable Hilar Cholangiocarcinoma [NCIt concept]
- Unresectable Hormone Receptor-Negative Breast Carcinoma [NCIt concept]
- Unresectable Hormone Receptor-Positive Breast Carcinoma [NCIt concept]
- Unresectable Hypopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Intrahepatic Cholangiocarcinoma [NCIt concept]
- Unresectable Kidney Medullary Carcinoma [NCIt concept]
- Unresectable Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Laryngeal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Leiomyosarcoma [NCIt concept]
- Unresectable Liposarcoma [NCIt concept]
- Unresectable Liver Carcinoma [NCIt concept]
- Unresectable Lung Adenocarcinoma [NCIt concept]
- Unresectable Lung Carcinoma [NCIt concept]
- Unresectable Lung Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Lung Neuroendocrine Neoplasm [NCIt concept]
- Unresectable Lung Neuroendocrine Tumor [NCIt concept]
- Unresectable Lung Non-Small Cell Carcinoma [NCIt concept]
- Unresectable Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
- Unresectable Lung Non-Squamous Non-Small Cell Carcinoma [NCIt concept]
- Unresectable Lung Small Cell Carcinoma [NCIt concept]
- Unresectable Lymphoma [NCIt concept]
- Unresectable Malignant Digestive System Neoplasm [NCIt concept]
- Unresectable Malignant Extragonadal Germ Cell Tumor [NCIt concept]
- Unresectable Malignant Female Reproductive System Neoplasm [NCIt concept]
- Unresectable Malignant Gastric Neoplasm [NCIt concept]
- Unresectable Malignant Gastrointestinal Stromal Tumor [NCIt concept]
- Unresectable Malignant Glioma [NCIt concept]
- Unresectable Malignant Glomus Tumor [NCIt concept]
- Unresectable Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Unresectable Malignant Solid Neoplasm [NCIt concept]
- Unresectable Malignant Testicular Germ Cell Tumor [NCIt concept]
- Unresectable Malignant Thoracic Neoplasm [NCIt concept]
- Unresectable Melanoma [NCIt concept]
- Unresectable Meningioma [NCIt concept]
- Unresectable Merkel Cell Carcinoma [NCIt concept]
- Unresectable Metastasis [NCIt concept]
- Unresectable Microsatellite Stable Colorectal Carcinoma [NCIt concept]
- Unresectable Midgut Neuroendocrine Tumor [NCIt concept]
- Unresectable Mucosal Melanoma [NCIt concept]
- Unresectable Myxofibrosarcoma [NCIt concept]
- Unresectable Myxoid Liposarcoma [NCIt concept]
- Unresectable NUT Carcinoma [NCIt concept]
- Unresectable Nasal Cavity Squamous Cell Carcinoma [NCIt concept]
- Unresectable Nasopharyngeal Carcinoma [NCIt concept]
- Unresectable Nasopharyngeal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Neuroblastoma [NCIt concept]
- Unresectable Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Neuroendocrine Neoplasm [NCIt concept]
- Unresectable Neuroendocrine Tumor [NCIt concept]
- Unresectable Neuroendocrine Tumor G1 [NCIt concept]
- Unresectable Non-Sun Exposed Skin Melanoma [NCIt concept]
- Unresectable Oligodendroglioma [NCIt concept]
- Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted [NCIt concept]
- Unresectable Oral Cavity Squamous Cell Carcinoma [NCIt concept]
- Unresectable Oropharyngeal Squamous Cell Carcinoma [NCIt concept]
- Unresectable Oropharyngeal Undifferentiated Carcinoma [NCIt concept]
- Unresectable Osteosarcoma [NCIt concept]
- Unresectable Ovarian Carcinoma [NCIt concept]
- Unresectable Ovarian Clear Cell Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Endometrioid Adenocarcinoma [NCIt concept]
- Unresectable Ovarian High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Unresectable Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Low Grade Serous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Serous Adenocarcinoma [NCIt concept]
- Unresectable Ovarian Undifferentiated Carcinoma [NCIt concept]
- Unresectable Pancreatic Adenocarcinoma [NCIt concept]
- Unresectable Pancreatic Carcinoma [NCIt concept]
- Unresectable Pancreatic Ductal Adenocarcinoma [NCIt concept]
- Unresectable Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Pancreatic Neuroendocrine Neoplasm [NCIt concept]
- Unresectable Pancreatic Neuroendocrine Tumor [NCIt concept]
- Unresectable Pancreatic Neuroendocrine Tumor G3 [NCIt concept]
- Unresectable Papillary Renal Cell Carcinoma [NCIt concept]
- Unresectable Paraganglioma [NCIt concept]
- Unresectable Paranasal Sinus Squamous Cell Carcinoma [NCIt concept]
- Unresectable Paratesticular Biphasic Mesothelioma [NCIt concept]
- Unresectable Paratesticular Epithelioid Mesothelioma [NCIt concept]
- Unresectable Paratesticular Malignant Mesothelioma [NCIt concept]
- Unresectable Paratesticular Sarcomatoid Mesothelioma [NCIt concept]
- Unresectable Penile Squamous Cell Carcinoma [NCIt concept]
- Unresectable Periampullary Adenocarcinoma [NCIt concept]
- Unresectable Peritoneal Biphasic Mesothelioma [NCIt concept]
- Unresectable Peritoneal Epithelioid Mesothelioma [NCIt concept]
- Unresectable Peritoneal Malignant Mesothelioma [NCIt concept]
- Unresectable Peritoneal Sarcomatoid Mesothelioma [NCIt concept]
- Unresectable Pilocytic Astrocytoma [NCIt concept]
- Unresectable Platinum-Refractory Ovarian Carcinoma [NCIt concept]
- Unresectable Platinum-Resistant Fallopian Tube Carcinoma [NCIt concept]
- Unresectable Platinum-Resistant Ovarian Carcinoma [NCIt concept]
- Unresectable Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma [NCIt concept]
- Unresectable Platinum-Resistant Primary Peritoneal Carcinoma [NCIt concept]
- Unresectable Pleomorphic Liposarcoma [NCIt concept]
- Unresectable Pleural Biphasic Mesothelioma [NCIt concept]
- Unresectable Pleural Epithelioid Mesothelioma [NCIt concept]
- Unresectable Pleural Malignant Mesothelioma [NCIt concept]
- Unresectable Pleural Sarcomatoid Mesothelioma [NCIt concept]
- Unresectable Plexiform Neurofibroma [NCIt concept]
- Unresectable Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Unresectable Primary Central Chondrosarcoma [NCIt concept]
- Unresectable Primary Central Nervous System Neoplasm [NCIt concept]
- Unresectable Primary Peritoneal Endometrioid Adenocarcinoma [NCIt concept]
- Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma [NCIt concept]
- Unresectable Primary Peritoneal Serous Adenocarcinoma [NCIt concept]
- Unresectable Prostate Carcinoma [NCIt concept]
- Unresectable Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Pseudomyxoma Peritonei [NCIt concept]
- Unresectable Rectal Carcinoma [NCIt concept]
- Unresectable Renal Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Unresectable Renal Pelvis Urothelial Carcinoma [NCIt concept]
- Unresectable Renal Pelvis and Ureter Urothelial Carcinoma [NCIt concept]
- Unresectable Rhabdoid Tumor [NCIt concept]
- Unresectable Rhabdoid Tumor of the Kidney [NCIt concept]
- Unresectable Rhabdomyosarcoma [NCIt concept]
- Unresectable Round Cell Liposarcoma [NCIt concept]
- Unresectable Salivary Gland Carcinoma [NCIt concept]
- Unresectable Salivary Gland Squamous Cell Carcinoma [NCIt concept]
- Unresectable Sarcomatoid Renal Cell Carcinoma [NCIt concept]
- Unresectable Sinonasal Mucosal Melanoma [NCIt concept]
- Unresectable Skin Squamous Cell Carcinoma [NCIt concept]
- Unresectable Small Intestinal Adenocarcinoma [NCIt concept]
- Unresectable Small Intestinal Carcinoma [NCIt concept]
- Unresectable Soft Tissue Leiomyosarcoma [NCIt concept]
- Unresectable Soft Tissue Sarcoma [NCIt concept]
- Unresectable Solid Neoplasm [NCIt concept]
- Unresectable Succinate Dehydrogenase-Deficient Renal Cell Carcinoma [NCIt concept]
- Unresectable Synovial Sarcoma [NCIt concept]
- Unresectable Thymus Carcinoma [NCIt concept]
- Unresectable Thymus Neuroendocrine Neoplasm [NCIt concept]
- Unresectable Thyroid Gland Anaplastic Carcinoma [NCIt concept]
- Unresectable Thyroid Gland Carcinoma [NCIt concept]
- Unresectable Thyroid Gland Follicular Carcinoma [NCIt concept]
- Unresectable Thyroid Gland Medullary Carcinoma [NCIt concept]
- Unresectable Thyroid Gland Oncocytic Carcinoma [NCIt concept]
- Unresectable Thyroid Gland Papillary Carcinoma [NCIt concept]
- Unresectable Transitional Cell Carcinoma [NCIt concept]
- Unresectable Triple-Negative Breast Carcinoma [NCIt concept]
- Unresectable Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Unresectable Ureter Urothelial Carcinoma [NCIt concept]
- Unresectable Urethral Urothelial Carcinoma [NCIt concept]
- Unresectable Urothelial Carcinoma [NCIt concept]
- Unresectable Uterine Corpus Leiomyosarcoma [NCIt concept]
- Unresectable Uterine Corpus Sarcoma [NCIt concept]
- Unresectable Uveal Melanoma [NCIt concept]
- Unresectable Vaginal Carcinoma [NCIt concept]
- Unresectable Vulvar Squamous Cell Carcinoma [NCIt concept]
- Unresectable or Metastatic Non-Clear Cell Renal Cell Carcinoma, Excluding Chromophobe Renal Cell Carcinoma [NCIt concept]
- Unsaturated Iron Binding Capacity Measurement [NCIt concept]
- Unspecified Atypical Cells Present [NCIt concept]
- Untreated Adult Acute Lymphoblastic Leukemia [NCIt concept]
- Untreated Adult Acute Myeloid Leukemia [NCIt concept]
- Untreated Adult Rhabdomyosarcoma [NCIt concept]
- Untreated Childhood Acute Lymphoblastic Leukemia [NCIt concept]
- Untreated Childhood Anaplastic Astrocytoma [NCIt concept]
- Untreated Childhood Anaplastic Oligoastrocytoma [NCIt concept]
- Untreated Childhood Anaplastic Oligodendroglioma [NCIt concept]
- Untreated Childhood Brain Stem Glioma [NCIt concept]
- Untreated Childhood Cerebellar Astrocytoma [NCIt concept]
- Untreated Childhood Cerebral Astrocytoma [NCIt concept]
- Untreated Childhood Diffuse Astrocytoma [NCIt concept]
- Untreated Childhood Fibrillary Astrocytoma [NCIt concept]
- Untreated Childhood Gemistocytic Astrocytoma [NCIt concept]
- Untreated Childhood Giant Cell Glioblastoma [NCIt concept]
- Untreated Childhood Glioblastoma [NCIt concept]
- Untreated Childhood Gliomatosis Cerebri [NCIt concept]
- Untreated Childhood Gliosarcoma [NCIt concept]
- Untreated Childhood High Grade Astrocytic Tumor [NCIt concept]
- Untreated Childhood Low Grade Astrocytic Tumor [NCIt concept]
- Untreated Childhood Medulloblastoma [NCIt concept]
- Untreated Childhood Myeloid Neoplasm [NCIt concept]
- Untreated Childhood Oligoastrocytoma [NCIt concept]
- Untreated Childhood Oligodendroglioma [NCIt concept]
- Untreated Childhood Pilocytic Astrocytoma [NCIt concept]
- Untreated Childhood Pilomyxoid Astrocytoma [NCIt concept]
- Untreated Childhood Pineoblastoma [NCIt concept]
- Untreated Childhood Pleomorphic Xanthoastrocytoma [NCIt concept]
- Untreated Childhood Protoplasmic Astrocytoma [NCIt concept]
- Untreated Childhood Rhabdomyosarcoma [NCIt concept]
- Untreated Childhood Subependymal Giant Cell Astrocytoma [NCIt concept]
- Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor [NCIt concept]
- Untreated Childhood Visual Pathway Glioma [NCIt concept]
- Untreated Diffuse Large B-Cell Lymphoma Activated B-Cell Type [NCIt concept]
- Untreated Hairy Cell Leukemia [NCIt concept]
- Untreated Hematopoietic and Lymphoid Cell Neoplasm [NCIt concept]
- Untreated Metastatic Squamous Cell Carcinoma to Neck with Occult Primary [NCIt concept]
- Untreated Prolymphocytic Leukemia [NCIt concept]
- Unventilated Cigarette [NCIt concept]
- Upamostat [NCIt concept]
- Upinitatug [NCIt concept]
- Upinitatug Rilsodotin [NCIt concept]
- Upper Aerodigestive Invasive Malignancy [NCIt concept]
- Upper Alveolar Ridge Squamous Cell Carcinoma [NCIt concept]
- Uprevstobart [NCIt concept]
- Uproleselan [NCIt concept]
- Uprosertib [NCIt concept]
- Urabrelimab [NCIt concept]
- Urachal Carcinoma [NCIt concept]
- Uracil-DNA Glycosylase [NCIt concept]
- Uracil-DNA Glycosylase Isoform 1 [NCIt concept]
- Urea C-13 [NCIt concept]
- Urea/Lactic Acid-Based Cream [NCIt concept]
- Urelumab [NCIt concept]
- Ureter Carcinoma [NCIt concept]
- Ureter Urothelial Carcinoma [NCIt concept]
- Ureter Urothelial Carcinoma, High Grade [NCIt concept]
- Ureteroscopy [NCIt concept]
- Urethra Disorder [NCIt concept]
- Urethral Adenocarcinoma [NCIt concept]
- Urethral Carcinoma [NCIt concept]
- Urethral Catheter [NCIt concept]
- Urethral Sling Implantation [NCIt concept]
- Urethral Squamous Cell Carcinoma [NCIt concept]
- Urethral Stricture Surgery [NCIt concept]
- Urethral Undifferentiated Carcinoma [NCIt concept]
- Urethral Urothelial Carcinoma [NCIt concept]
- Urethroplasty [NCIt concept]
- Uric Acid [NCIt concept]
- Uridine [NCIt concept]
- Urinalysis [NCIt concept]
- Urinary Complication [NCIt concept]
- Urinary Diversion [NCIt concept]
- Urinary Incontinence [NCIt concept]
- Urinary Microbiome [NCIt concept]
- Urinary System Neoplasm [NCIt concept]
- Urinary Tract Toxicity [NCIt concept]
- Urine Albumin [NCIt concept]
- Urine Protein Electrophoresis [NCIt concept]
- Urokinase Plasminogen Activator Surface Receptor [NCIt concept]
- Urokinase-Derived Peptide A6 [NCIt concept]
- Urokinase-Type Plasminogen Activator [NCIt concept]
- Urolithin [NCIt concept]
- Urolithin A Supplement [NCIt concept]
- Urologic Surgical Procedure [NCIt concept]
- Urostomy Status [NCIt concept]
- Urothelial Carcinoma, High Grade [NCIt concept]
- Ursodiol [NCIt concept]
- Ursolic Acid [NCIt concept]
- Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis [NCIt concept]
- Used Individual or Group Counseling to Quit Cigarette Smoking [NCIt concept]
- Usher Syndrome Type-1G Protein [NCIt concept]
- Ustekinumab [NCIt concept]
- Utatrectinib [NCIt concept]
- Uterine Carcinosarcoma [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma cM1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pM1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN1a TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN1mi TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN2 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN2a TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN2mi TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT1a TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT1b TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT2 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT3 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT3a TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT3b TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT4 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinosarcoma [NCIt concept]
- Uterine Corpus Choriocarcinoma [NCIt concept]
- Uterine Corpus Leiomyoma [NCIt concept]
- Uterine Corpus Leiomyosarcoma [NCIt concept]
- Uterine Corpus Neoplasm [NCIt concept]
- Uterine Corpus Sarcoma [NCIt concept]
- Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential [NCIt concept]
- Uterine Size-Date Discrepancy [NCIt concept]
- Utidelone [NCIt concept]
- Utomilumab [NCIt concept]
- Uveal Epithelioid Cell Melanoma [NCIt concept]
- Uveal Intermediate Cell Type Melanoma [NCIt concept]
- Uveal Melanoma [NCIt concept]
- Uveal Melanoma Clinical Distant Metastasis TNM Finding v8 [NCIt concept]
- Uveal Melanoma Metastatic in the Liver [NCIt concept]
- Uveal Melanoma Pathologic Distant Metastasis TNM Finding v8 [NCIt concept]
- Uveal Mixed Epithelioid and Spindle Cell Melanoma [NCIt concept]
- Uveal Necrotic Melanoma [NCIt concept]
- Uveal Spindle Cell Melanoma [NCIt concept]
- Uveal Spindle Cell Type A Melanoma [NCIt concept]
- Uveal Spindle Cell Type B Melanoma [NCIt concept]
- Uzansertib [NCIt concept]
- Uzatresgene Autoleucel [NCIt concept]
- V(D)J Recombination-Activating Protein 1 [NCIt concept]
- V(D)J Recombination-Activating Protein 2 [NCIt concept]
- V-Set Domain-Containing T-Cell Activation Inhibitor 1 [NCIt concept]
- V-Set and Immunoglobulin Domain-Containing Protein 4 [NCIt concept]
- V-Type Immunoglobulin Domain-Containing Suppressor of T-Cell Activation [NCIt concept]
- V-Type Proton ATPase 116 kDa Subunit A 3 [NCIt concept]
- V-Type Proton ATPase Subunit S1 [NCIt concept]
- VASP Gene [NCIt concept]
- VASP wt Allele [NCIt concept]
- VAV2 Gene [NCIt concept]
- VAV2 wt Allele [NCIt concept]
- VCAM1 Gene [NCIt concept]
- VCAM1 wt Allele [NCIt concept]
- VCL-CB01 Vaccine [NCIt concept]
- VDAC2 Gene [NCIt concept]
- VDAC2 wt Allele [NCIt concept]
- VDR Gene [NCIt concept]
- VDR wt Allele [NCIt concept]
- VEGF-targeting Agent [NCIt concept]
- VEGF/HGF-targeting DARPin MP0250 [NCIt concept]
- VEGF:VEGFR Complex [NCIt concept]
- VEGFA Gene [NCIt concept]
- VEGFA Gene Product [NCIt concept]
- VEGFA wt Allele [NCIt concept]
- VEGFB Gene [NCIt concept]
- VEGFB wt Allele [NCIt concept]
- VEGFC Gene [NCIt concept]
- VEGFC wt Allele [NCIt concept]
- VEGFD Gene [NCIt concept]
- VEGFD wt Allele [NCIt concept]
- VEGFR Family Gene Mutation [NCIt concept]
- VEGFR Tyrosine Kinase Inhibitor [NCIt concept]
- VEGFR-targeting Agent [NCIt concept]
- VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 [NCIt concept]
- VEGFR2 Tyrosine Kinase Inhibitor PF-00337210 [NCIt concept]
- VEXAS Syndrome [NCIt concept]
- VHL Alteration Positive [NCIt concept]
- VHL Gene [NCIt concept]
- VHL Gene Amplification [NCIt concept]
- VHL Gene Mutation [NCIt concept]
- VHL wt Allele [NCIt concept]
- VIP Gene [NCIt concept]
- VIP Peptides [NCIt concept]
- VIP wt Allele [NCIt concept]
- VIPR1 Gene [NCIt concept]
- VIPR1 wt Allele [NCIt concept]
- VIPR2 Gene [NCIt concept]
- VIPR2 wt Allele [NCIt concept]
- VISTA-targeting Agent [NCIt concept]
- VLDL-C Oxidation [NCIt concept]
- VPS18 Gene [NCIt concept]
- VPS18 wt Allele [NCIt concept]
- VRP-encapsulated saRNA Encoding IL-12 VLPONC-01 [NCIt concept]
- VSIG4 Gene [NCIt concept]
- VSIG4 wt Allele [NCIt concept]
- VSIR Gene [NCIt concept]
- VSIR wt Allele [NCIt concept]
- VSV-GP BI 1831169 [NCIt concept]
- VSV-GP-based Cancer Vaccine VSV-GP128 [NCIt concept]
- VSV-GP-based Cancer Vaccine VSV-GP154 [NCIt concept]
- VT30 Topical Gel [NCIt concept]
- VTCN1 Gene [NCIt concept]
- VTCN1 Immunohistochemistry Assay [NCIt concept]
- VTCN1 Positive [NCIt concept]
- VTCN1 wt Allele [NCIt concept]
- VTN Gene [NCIt concept]
- VTN wt Allele [NCIt concept]
- VWF Gene [NCIt concept]
- VWF wt Allele [NCIt concept]
- Vabametkib [NCIt concept]
- Vaccine [NCIt concept]
- Vaccine Provider [NCIt concept]
- Vaccine Therapy [NCIt concept]
- Vaccinia Virus DD-CDSR [NCIt concept]
- Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules [NCIt concept]
- Vacuolar Protein Sorting-Associated Protein 18 [NCIt concept]
- Vacuum Erection Device [NCIt concept]
- Vacuum-Assisted Biopsy [NCIt concept]
- Vadastuximab Talirine [NCIt concept]
- Vadimezan [NCIt concept]
- Vaginal Adenocarcinoma [NCIt concept]
- Vaginal Adenoid Basal Carcinoma [NCIt concept]
- Vaginal Adenoid Cystic Carcinoma [NCIt concept]
- Vaginal Adenosquamous Carcinoma [NCIt concept]
- Vaginal Carcinoma [NCIt concept]
- Vaginal Clear Cell Adenocarcinoma [NCIt concept]
- Vaginal Dilator [NCIt concept]
- Vaginal Moisturizer [NCIt concept]
- Vaginal Neuroendocrine Carcinoma [NCIt concept]
- Vaginal Radiation Therapy [NCIt concept]
- Vaginal Squamous Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Vaginal Undifferentiated Carcinoma [NCIt concept]
- Valacyclovir [NCIt concept]
- Valemetostat [NCIt concept]
- Valemetostat Tosylate [NCIt concept]
- Valerian [NCIt concept]
- Valganciclovir [NCIt concept]
- Valine [NCIt concept]
- Valproic Acid [NCIt concept]
- Valproic Acid-Expanded Umbilical Cord Blood-derived CD34-positive Cells [NCIt concept]
- Valrubicin [NCIt concept]
- Valspodar [NCIt concept]
- Vancomycin [NCIt concept]
- Vandetanib [NCIt concept]
- Vandortuzumab Vedotin [NCIt concept]
- Vanillylmandelic Acid [NCIt concept]
- Vantictumab [NCIt concept]
- Vanucizumab [NCIt concept]
- Vaping [NCIt concept]
- Vapocoolant Analgesia [NCIt concept]
- Varegacestat [NCIt concept]
- Varenicline [NCIt concept]
- Varenicline Tartrate [NCIt concept]
- Variant Allele Frequency [NCIt concept]
- Variant Pathogenic/Likely Pathogenic [NCIt concept]
- Variant of Unknown Significance [NCIt concept]
- Varicella Zoster Virus [NCIt concept]
- Varicella-Zoster Virus Antibody [NCIt concept]
- Varicella-Zoster Virus Envelope Glycoprotein E Antibody [NCIt concept]
- Varicella-Zoster Virus Strain Oka/Merck Live Antigen [NCIt concept]
- Varlilumab [NCIt concept]
- Varlitinib [NCIt concept]
- Vascular Access Device Complications [NCIt concept]
- Vascular Cell Adhesion Protein 1 [NCIt concept]
- Vascular Disrupting Agent BNC105P [NCIt concept]
- Vascular Endothelial Growth Factor A [NCIt concept]
- Vascular Endothelial Growth Factor A 165 Isoform [NCIt concept]
- Vascular Endothelial Growth Factor B [NCIt concept]
- Vascular Endothelial Growth Factor C [NCIt concept]
- Vascular Endothelial Growth Factor D [NCIt concept]
- Vascular Endothelial Growth Factor Family [NCIt concept]
- Vascular Endothelial Growth Factor Receptor [NCIt concept]
- Vascular Endothelial Growth Factor Receptor 1 [NCIt concept]
- Vascular Endothelial Growth Factor Receptor 2 [NCIt concept]
- Vascular Endothelial Growth Factor Receptor 3 [NCIt concept]
- Vascular-Targeted Photodynamic Therapy [NCIt concept]
- Vascularized Lymph Node Transfer [NCIt concept]
- Vasculin-Like Protein 1 [NCIt concept]
- Vasoactive Intestinal Peptide [NCIt concept]
- Vasoactive Intestinal Polypeptide Receptor 1 [NCIt concept]
- Vasoactive Intestinal Polypeptide Receptor 2 [NCIt concept]
- Vasodilator-Stimulated Phosphoprotein [NCIt concept]
- Vasopressin V2 Receptor [NCIt concept]
- Vatalanib [NCIt concept]
- Vebreltinib [NCIt concept]
- Vecabrutinib [NCIt concept]
- Vecuronium [NCIt concept]
- Vedolizumab [NCIt concept]
- Veillonella [NCIt concept]
- Veledimex [NCIt concept]
- Veliparib [NCIt concept]
- Velpatasvir [NCIt concept]
- Veltuzumab [NCIt concept]
- Vemurafenib [NCIt concept]
- Venadaparib [NCIt concept]
- Venetoclax [NCIt concept]
- Venlafaxine [NCIt concept]
- Venlafaxine Hydrochloride [NCIt concept]
- Venlafaxine Hydrochloride Extended Release [NCIt concept]
- Veno-Occlusive Disease [NCIt concept]
- Ventilated Cigarette [NCIt concept]
- Ventriculoperitoneal Shunt Placement [NCIt concept]
- Vepafestinib [NCIt concept]
- Vepdegestrant [NCIt concept]
- Vepoloxamer [NCIt concept]
- Vepsitamab [NCIt concept]
- Verapamil [NCIt concept]
- Verapamil Hydrochloride [NCIt concept]
- Verbal Support [NCIt concept]
- VeriStrat [NCIt concept]
- Vericiguat [NCIt concept]
- Verpasep Caltespen [NCIt concept]
- Vertebroplasty [NCIt concept]
- Vertiginous Syndrome [NCIt concept]
- Verubulin Hydrochloride [NCIt concept]
- Very High Risk Chronic Myelogenous Leukemia, BCR-ABL1 Positive [NCIt concept]
- Very High Risk Myelodysplastic Syndrome [NCIt concept]
- Very High Risk Prostate Carcinoma [NCIt concept]
- Very Light Exercise [NCIt concept]
- Very Low Nicotine Content Cigarette [NCIt concept]
- Verzistobart [NCIt concept]
- Vesencumab [NCIt concept]
- Vesicle-Trafficking Protein SEC22b [NCIt concept]
- Vesicopexy [NCIt concept]
- Vesicular Stomatitis Virus-based Therapeutic Agent [NCIt concept]
- Vestibular Schwannoma [NCIt concept]
- Vevoctadekin [NCIt concept]
- Vevorisertib [NCIt concept]
- Vibecotamab [NCIt concept]
- Vibostolimab [NCIt concept]
- Vibostolimab/Pembrolizumab MK-7684A [NCIt concept]
- Vibrator Device [NCIt concept]
- Video Recording [NCIt concept]
- Video-Assisted Surgery [NCIt concept]
- Video-Assisted Thoracic Surgery [NCIt concept]
- Video-Based 3-Dimensional Surface Imaging [NCIt concept]
- Videocapsule Endoscopy [NCIt concept]
- Videostroboscopy [NCIt concept]
- Videotelephony [NCIt concept]
- Videothoracoscopy [NCIt concept]
- Vidoflufolastat (18F) [NCIt concept]
- Vidutolimod [NCIt concept]
- Vilamakitug [NCIt concept]
- Vilaprisan [NCIt concept]
- Vilastobart [NCIt concept]
- Villous [NCIt concept]
- Vimseltinib [NCIt concept]
- Vinblastine [NCIt concept]
- Vinblastine Sulfate [NCIt concept]
- Vinca-Domain Binding Agent [NCIt concept]
- Vincristine [NCIt concept]
- Vincristine Liposomal [NCIt concept]
- Vincristine Sulfate [NCIt concept]
- Vincristine Sulfate Liposome [NCIt concept]
- Vinflunine [NCIt concept]
- Vinorelbine [NCIt concept]
- Vinorelbine Tartrate [NCIt concept]
- Vinorelbine Tartrate Emulsion [NCIt concept]
- Vintafolide [NCIt concept]
- Viral G-Protein Coupled Receptor [NCIt concept]
- Viral Infection [NCIt concept]
- Viral Interleukin-6 Homolog [NCIt concept]
- Viral Protease p15 [NCIt concept]
- Viral RNA [NCIt concept]
- Viral Vector [NCIt concept]
- Viral Vector-based Cancer Vaccine VAC85135 [NCIt concept]
- Virgin Coconut Oil Mouth Rinse [NCIt concept]
- Virtual Avatar Interaction Program [NCIt concept]
- Virtual Patient Encounter [NCIt concept]
- Virtual Reality [NCIt concept]
- Virtual Reality Device [NCIt concept]
- Virtual Technology Intervention [NCIt concept]
- Virus-Related Hemophagocytic Lymphohistiocytosis [NCIt concept]
- Virus-based Gene Therapy Agent [NCIt concept]
- Visilizumab [NCIt concept]
- Vision Assessment [NCIt concept]
- Vislarafusp Alfa [NCIt concept]
- Vismodegib [NCIt concept]
- Vistusertib [NCIt concept]
- Vital Signs Measurement [NCIt concept]
- Vitamin A Compound [NCIt concept]
- Vitamin B Complex [NCIt concept]
- Vitamin B12 Measurement [NCIt concept]
- Vitamin B6 [NCIt concept]
- Vitamin C [NCIt concept]
- Vitamin D 1 Alpha-Hydroxylase Deficiency [NCIt concept]
- Vitamin D Deficiency [NCIt concept]
- Vitamin D Measurement [NCIt concept]
- Vitamin D3 Deficiency [NCIt concept]
- Vitamin D3 Receptor [NCIt concept]
- Vitamin E Compound [NCIt concept]
- Vitamin K [NCIt concept]
- Vitamin K-Dependent Protein S [NCIt concept]
- Vitespen [NCIt concept]
- Vitrectomy [NCIt concept]
- Vitreoretinal Disorder [NCIt concept]
- Vitronectin [NCIt concept]
- Vixtimotamab [NCIt concept]
- Vobramitamab Duocarmazine [NCIt concept]
- Vocimagene Amiretrorepvec [NCIt concept]
- Vociprotafib [NCIt concept]
- Vodobatinib [NCIt concept]
- Vodudeutentan Sodium [NCIt concept]
- Vofatamab [NCIt concept]
- Volagidemab [NCIt concept]
- Volasertib [NCIt concept]
- Volrustomig [NCIt concept]
- Voltage-Dependent Anion-Selective Channel Protein 2 [NCIt concept]
- Voltage-Dependent Calcium Channel Gamma-Like Subunit [NCIt concept]
- Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D [NCIt concept]
- Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1G [NCIt concept]
- Volume Measurement [NCIt concept]
- Volume Modulated Arc Therapy [NCIt concept]
- Volumetric Biopsy Specimen Imaging [NCIt concept]
- Volumetric Contrast-Enhanced Ultrasound Imaging [NCIt concept]
- Volumetric Laser Endomicroscopy [NCIt concept]
- Von Hippel Lindau Syndrome [NCIt concept]
- Von Hippel Lindau Syndrome-Associated Central Nervous System Hemangioblastoma [NCIt concept]
- Von Hippel Lindau Syndrome-Associated Clear Cell Renal Cell Carcinoma [NCIt concept]
- Von Hippel Lindau Syndrome-Associated Pancreatic Neuroendocrine Tumor [NCIt concept]
- Von Hippel-Lindau Disease Tumor Suppressor [NCIt concept]
- Vonlerolizumab [NCIt concept]
- Vopikitug [NCIt concept]
- Vopratelimab [NCIt concept]
- Vorasidenib [NCIt concept]
- Voriconazole [NCIt concept]
- Vorinostat [NCIt concept]
- Vorolanib [NCIt concept]
- Vorsetzumab Mafodotin [NCIt concept]
- Voruciclib [NCIt concept]
- Vosaroxin [NCIt concept]
- Vosilasarm [NCIt concept]
- Voucher [NCIt concept]
- Voxalatamab [NCIt concept]
- Voxelotor [NCIt concept]
- Voxilaprevir [NCIt concept]
- Voxtalisib [NCIt concept]
- Vudalimab [NCIt concept]
- Vulvar Adenocarcinoma [NCIt concept]
- Vulvar Basal Cell Carcinoma [NCIt concept]
- Vulvar Biopsy Patient [NCIt concept]
- Vulvar Carcinoma [NCIt concept]
- Vulvar Intraepithelial Neoplasia [NCIt concept]
- Vulvar Neuroendocrine Carcinoma [NCIt concept]
- Vulvar Paget Disease [NCIt concept]
- Vulvar Squamous Cell Carcinoma [NCIt concept]
- Vulvovaginal Atrophy [NCIt concept]
- Vusolimogene Oderparepvec [NCIt concept]
- WAP Four-Disulfide Core Domain Protein 1 [NCIt concept]
- WAP Four-Disulfide Core Domain Protein 2 [NCIt concept]
- WAS Gene [NCIt concept]
- WAS wt Allele [NCIt concept]
- WASH Complex Subunit Strumpellin [NCIt concept]
- WASHC5 Gene [NCIt concept]
- WASHC5 wt Allele [NCIt concept]
- WD Repeat and Coiled-Coil-Containing Protein [NCIt concept]
- WD Repeat and FYVE Domain-Containing Protein 2 [NCIt concept]
- WDCP Gene [NCIt concept]
- WDCP wt Allele [NCIt concept]
- WDFY2 Gene [NCIt concept]
- WDFY2 wt Allele [NCIt concept]
- WDHA Syndrome [NCIt concept]
- WEE1 Gene [NCIt concept]
- WEE1 wt Allele [NCIt concept]
- WFDC1 Gene [NCIt concept]
- WFDC1 wt Allele [NCIt concept]
- WFDC2 Gene [NCIt concept]
- WFDC2 wt Allele [NCIt concept]
- WHO Grade 2 Glioma [NCIt concept]
- WHO Grade 3 Glioma [NCIt concept]
- WIF1 Gene [NCIt concept]
- WIF1 wt Allele [NCIt concept]
- WNK1 Gene [NCIt concept]
- WNK1 wt Allele [NCIt concept]
- WNT Family Gene [NCIt concept]
- WNT Pathway Activated [NCIt concept]
- WNT Pathway Activation Negative [NCIt concept]
- WNT11 Gene [NCIt concept]
- WNT11 wt Allele [NCIt concept]
- WNT16 Gene [NCIt concept]
- WNT16 wt Allele [NCIt concept]
- WNT5B Gene [NCIt concept]
- WNT5B wt Allele [NCIt concept]
- WRAP53 Gene [NCIt concept]
- WRAP53 Gene Mutation [NCIt concept]
- WRAP53 wt Allele [NCIt concept]
- WRN Gene [NCIt concept]
- WRN Gene Mutation [NCIt concept]
- WRN Inhibitor GSK4418959 [NCIt concept]
- WRN Inhibitor HRO761 [NCIt concept]
- WRN Inhibitor RO7589831 [NCIt concept]
- WRN wt Allele [NCIt concept]
- WRNIP1 Gene [NCIt concept]
- WRNIP1 wt Allele [NCIt concept]
- WT1 124-138 Peptide Vaccine [NCIt concept]
- WT1 126-134 Peptide Vaccine [NCIt concept]
- WT1 235-243 Peptide Vaccine [NCIt concept]
- WT1 247-261 Peptide Vaccine [NCIt concept]
- WT1 Analog Peptide Vaccine [NCIt concept]
- WT1 Gene [NCIt concept]
- WT1 Gene Mutation [NCIt concept]
- WT1 Negative [NCIt concept]
- WT1 Peptide Vaccine WT2725 [NCIt concept]
- WT1 Peptide-loaded Allogeneic Dendritic Cell Vaccine [NCIt concept]
- WT1 Positive [NCIt concept]
- WT1 Protein-derived Peptide Vaccine DSP-7888 [NCIt concept]
- WT1 wt Allele [NCIt concept]
- WT1-A10/AS01B Immunotherapeutic GSK2130579A [NCIt concept]
- WT1-AS Gene [NCIt concept]
- WT1-AS wt Allele [NCIt concept]
- WT1-Sensitized Allogeneic T-Lymphocytes [NCIt concept]
- WT1-loaded Artificial Adjuvant Vector Cell Immunotherapeutic ASP7517 [NCIt concept]
- WT1-targeted IL-2-based Fusion Protein CUE-102 [NCIt concept]
- WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes [NCIt concept]
- WT1/PRAME/Survivin-specific T-cells MANA-312 [NCIt concept]
- WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401 [NCIt concept]
- WW Domain-Containing Transcription Regulator Protein 1 [NCIt concept]
- WWP1 Gene [NCIt concept]
- WWP1 wt Allele [NCIt concept]
- WWTR1 Gene [NCIt concept]
- WWTR1 wt Allele [NCIt concept]
- WWTR1/CAMTA1 Fusion Gene [NCIt concept]
- W_pro1 Cancer Vaccine [NCIt concept]
- Waiting List [NCIt concept]
- Waldenstrom Macroglobulinemia [NCIt concept]
- Walking School Bus Program [NCIt concept]
- Warfarin [NCIt concept]
- Warfarin Sodium [NCIt concept]
- Warm Antibody Autoimmune Hemolytic Anemia [NCIt concept]
- Warm Ischemia Procedure [NCIt concept]
- Warthin-Like Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Water O-15 [NCIt concept]
- Water Vapor Ablation [NCIt concept]
- Watercress [NCIt concept]
- Wedge Excision [NCIt concept]
- Wee1 Inhibitor [NCIt concept]
- Wee1 Inhibitor APR-1051 [NCIt concept]
- Wee1 Kinase Inhibitor IMP7068 [NCIt concept]
- Wee1-Like Protein Kinase [NCIt concept]
- Wee1/Myt1 Inhibitor SGR-3515 [NCIt concept]
- Wee1/PKMYT1 Inhibitor ACR-2316 [NCIt concept]
- Weight Change [NCIt concept]
- Werner Syndrome ATP-Dependent Helicase [NCIt concept]
- Werner Syndrome Helicase Inhibitor [NCIt concept]
- Western Blotting [NCIt concept]
- Whipple Procedure [NCIt concept]
- White Button Mushroom Extract [NCIt concept]
- White Grape Juice [NCIt concept]
- White Light Endoscopy [NCIt concept]
- White Wine [NCIt concept]
- Whole Abdominopelvic Intensity-Modulated Radiotherapy [NCIt concept]
- Whole Body Magnetic Resonance Imaging [NCIt concept]
- Whole Body Scan [NCIt concept]
- Whole Body Vibration [NCIt concept]
- Whole Breast Irradiation [NCIt concept]
- Whole Exome Sequencing [NCIt concept]
- Whole Food, Plant-based Diet [NCIt concept]
- Whole Genome Association Study [NCIt concept]
- Whole Genome Sequencing [NCIt concept]
- Whole Transcriptome Sequencing [NCIt concept]
- Whole-Body Scintigraphy [NCIt concept]
- Whole-Brain Radiotherapy [NCIt concept]
- Whole-liver Irradiation [NCIt concept]
- Wide Area Transepithelial Sampling [NCIt concept]
- Wide Local Excision [NCIt concept]
- Wilms Tumor [NCIt concept]
- Wilms Tumor Protein [NCIt concept]
- Wilms Tumor-Associated Antisense RNA [NCIt concept]
- Wire-Guided Localization [NCIt concept]
- Wire-free Radar Localization of Tumor [NCIt concept]
- Wireless Synchronized Cardiac Function Monitoring Device [NCIt concept]
- Wiskott-Aldrich Syndrome [NCIt concept]
- Wistar Rabies Virus Strain PM-1503-3M Vaccine [NCIt concept]
- Wnt Family Gene Alteration Positive [NCIt concept]
- Wnt Inhibitory Factor 1 [NCIt concept]
- Wnt Negative [NCIt concept]
- Wnt Positive [NCIt concept]
- Wnt Signaling Inhibitor APL-5125 [NCIt concept]
- Wnt Signaling Inhibitor SM04755 [NCIt concept]
- Wnt Signaling Pathway Inhibitor [NCIt concept]
- Wnt Signaling Pathway Inhibitor SM08502 [NCIt concept]
- Wolman Disease [NCIt concept]
- Worksheet [NCIt concept]
- Workshop [NCIt concept]
- Wound Care Management [NCIt concept]
- Write [NCIt concept]
- X-Box Binding Protein 1 [NCIt concept]
- X-Chromosome Inactivation [NCIt concept]
- X-Linked Lymphoproliferative Syndrome [NCIt concept]
- X-Linked Protoporphyria [NCIt concept]
- X-Ray Cross Complementing Group [NCIt concept]
- X-Ray Imaging [NCIt concept]
- X-Ray Phase-Contrast Imaging [NCIt concept]
- X-Ray Psoralen Activated Cancer Therapy [NCIt concept]
- X-Ray Repair Cross-Complementing Protein 5 [NCIt concept]
- X-Ray Repair Cross-Complementing Protein 6 [NCIt concept]
- X-ray Angiography [NCIt concept]
- X-ray Therapy [NCIt concept]
- XAGE1 Family Gene [NCIt concept]
- XBP1 Gene [NCIt concept]
- XBP1 wt Allele [NCIt concept]
- XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 [NCIt concept]
- XCL1 Gene [NCIt concept]
- XCL1 wt Allele [NCIt concept]
- XDH Gene [NCIt concept]
- XDH wt Allele [NCIt concept]
- XELOX Regimen [NCIt concept]
- XIAP Antisense Oligonucleotide AEG35156 [NCIt concept]
- XIAP Gene [NCIt concept]
- XIAP Gene Mutation [NCIt concept]
- XIAP wt Allele [NCIt concept]
- XK Gene [NCIt concept]
- XK Gene Mutation [NCIt concept]
- XK wt Allele [NCIt concept]
- XPA Gene [NCIt concept]
- XPA wt Allele [NCIt concept]
- XPC Gene [NCIt concept]
- XPC wt Allele [NCIt concept]
- XPO1 Gene [NCIt concept]
- XPO1 Gene Mutation [NCIt concept]
- XPO1 Inhibitor [NCIt concept]
- XPO1 NM_003400.4:c.1711G>A [NCIt concept]
- XPO1 NP_003391.1:p.E571K [NCIt concept]
- XPO1 Protein Variant [NCIt concept]
- XPO1 wt Allele [NCIt concept]
- XRCC Family Gene Mutation [NCIt concept]
- XRCC1 Gene [NCIt concept]
- XRCC1 wt Allele [NCIt concept]
- XRCC2 Gene [NCIt concept]
- XRCC2 Gene Mutation [NCIt concept]
- XRCC2 wt Allele [NCIt concept]
- XRCC3 Gene [NCIt concept]
- XRCC3 Gene Mutation [NCIt concept]
- XRCC3 wt Allele [NCIt concept]
- XRCC4 Gene [NCIt concept]
- XRCC4 wt Allele [NCIt concept]
- XRCC5 Gene [NCIt concept]
- XRCC5 wt Allele [NCIt concept]
- XRCC6 Gene [NCIt concept]
- XRCC6 Gene Mutation [NCIt concept]
- XRCC6 wt Allele [NCIt concept]
- XRN2 Gene [NCIt concept]
- XRN2 wt Allele [NCIt concept]
- Xaliproden Hydrochloride [NCIt concept]
- Xaluritamig [NCIt concept]
- Xanthine Dehydrogenase/Oxidase [NCIt concept]
- Xenotropic Murine Leukemia Virus-related Virus [NCIt concept]
- Xentuzumab [NCIt concept]
- Xerna TME Panel [NCIt concept]
- Xeroderma Pigmentosum [NCIt concept]
- Xeroderma Pigmentosum-Cockayne Syndrome Complex [NCIt concept]
- Xerostomia [NCIt concept]
- Xevinapant [NCIt concept]
- Xirestomig [NCIt concept]
- Xp11.2 Translocation [NCIt concept]
- Xylene [NCIt concept]
- Xylitol [NCIt concept]
- Xylitol-containing Oral Wipe [NCIt concept]
- Y+L Amino Acid Transporter 1 [NCIt concept]
- Y+L Amino Acid Transporter 2 [NCIt concept]
- Y593-Phosphorylated DDX5 [NCIt concept]
- YAP/TEAD Interaction Inhibitor IAG933 [NCIt concept]
- YAP1 Antisense Oligonucleotide ION537 [NCIt concept]
- YAP1 Gene [NCIt concept]
- YAP1 or WWTR1 Fusion Gene Positive [NCIt concept]
- YAP1 wt Allele [NCIt concept]
- YAP1/TFE3 Fusion Gene [NCIt concept]
- YAP1/TFE3 Fusion Protein [NCIt concept]
- YBX1 Gene [NCIt concept]
- YBX1 wt Allele [NCIt concept]
- YES Portal [NCIt concept]
- YES1 Gene [NCIt concept]
- YES1 Gene Mutation [NCIt concept]
- YES1 wt Allele [NCIt concept]
- YTH Domain Family Protein 2 [NCIt concept]
- YTHDF2 Gene [NCIt concept]
- YTHDF2 wt Allele [NCIt concept]
- YWHAE Gene [NCIt concept]
- YWHAE wt Allele [NCIt concept]
- YWHAZ Gene [NCIt concept]
- YWHAZ wt Allele [NCIt concept]
- Yeast-derived Beta-glucan Supplement [NCIt concept]
- Yoga [NCIt concept]
- Yolk Sac Tumor [NCIt concept]
- Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12 [NCIt concept]
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 [NCIt concept]
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 [NCIt concept]
- Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101 [NCIt concept]
- Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 [NCIt concept]
- Yttrium Y 90 Basiliximab [NCIt concept]
- Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Yttrium Y 90 Daclizumab [NCIt concept]
- Yttrium Y 90 Glass Microspheres [NCIt concept]
- Yttrium Y 90 Resin Microspheres [NCIt concept]
- Yttrium Y 90-Edotreotide [NCIt concept]
- Yttrium Y-90 Clivatuzumab Tetraxetan [NCIt concept]
- Yttrium Y-90 Epratuzumab Tetraxetan [NCIt concept]
- Yttrium Y-90 Ibritumomab Tiuxetan [NCIt concept]
- Yttrium-90 Microsphere Radioembolization [NCIt concept]
- Yttrium-90 Polycarbonate Brachytherapy Plaque [NCIt concept]
- ZBTB16 Gene [NCIt concept]
- ZBTB16 wt Allele [NCIt concept]
- ZBTB16/RARA Fusion Gene [NCIt concept]
- ZBTB16/RARA Fusion Protein [NCIt concept]
- ZC3H7B Gene [NCIt concept]
- ZC3H7B wt Allele [NCIt concept]
- ZC3H7B/BCOR Fusion Gene [NCIt concept]
- ZC3H7B/BCOR Fusion Protein [NCIt concept]
- ZCCHC8 Gene [NCIt concept]
- ZCCHC8 wt Allele [NCIt concept]
- ZEB1 Gene [NCIt concept]
- ZEB1 wt Allele [NCIt concept]
- ZEB2 Gene [NCIt concept]
- ZEB2 wt Allele [NCIt concept]
- ZFPM1 Gene [NCIt concept]
- ZFPM1 wt Allele [NCIt concept]
- ZFPM2 Gene [NCIt concept]
- ZFPM2 wt Allele [NCIt concept]
- ZFPM2/RUNX1 Fusion Gene [NCIt concept]
- ZGLP1 Gene [NCIt concept]
- ZGLP1 wt Allele [NCIt concept]
- ZMYM2 Gene [NCIt concept]
- ZMYM2 wt Allele [NCIt concept]
- ZMYM2/FGFR1 Fusion Gene [NCIt concept]
- ZMYM2/FGFR1 Fusion Protein [NCIt concept]
- ZMYM3 Gene [NCIt concept]
- ZMYM3 wt Allele [NCIt concept]
- ZMYND10 Gene [NCIt concept]
- ZMYND10 wt Allele [NCIt concept]
- ZMYND8 Gene [NCIt concept]
- ZMYND8 wt Allele [NCIt concept]
- ZNF217 Gene [NCIt concept]
- ZNF217 wt Allele [NCIt concept]
- ZNF331 Gene [NCIt concept]
- ZNF331 wt Allele [NCIt concept]
- ZNF384 Gene [NCIt concept]
- ZNF384 wt Allele [NCIt concept]
- ZNF423 Gene [NCIt concept]
- ZNF423 wt Allele [NCIt concept]
- ZNF521 Gene [NCIt concept]
- ZNF521 wt Allele [NCIt concept]
- ZNF532 Gene [NCIt concept]
- ZNF532 wt Allele [NCIt concept]
- ZNF532/NUTM1 Fusion Gene [NCIt concept]
- ZNF532/NUTM1 Fusion Protein [NCIt concept]
- ZNF687 Gene [NCIt concept]
- ZNF687 wt Allele [NCIt concept]
- ZNF700 Gene [NCIt concept]
- ZNF700 wt Allele [NCIt concept]
- ZNF793 Gene [NCIt concept]
- ZNF793 wt Allele [NCIt concept]
- ZNRF3 Gene [NCIt concept]
- ZNRF3 Gene Mutation [NCIt concept]
- ZNRF3 wt Allele [NCIt concept]
- ZRSR2 Gene [NCIt concept]
- ZRSR2 Gene Frameshift Mutation [NCIt concept]
- ZRSR2 Gene Mutation [NCIt concept]
- ZRSR2 Gene Mutation Negative [NCIt concept]
- ZRSR2 Gene Nonsense Mutation [NCIt concept]
- ZRSR2 wt Allele [NCIt concept]
- ZSCAN30 Gene [NCIt concept]
- ZSCAN30 wt Allele [NCIt concept]
- Zafirlukast [NCIt concept]
- Zalifrelimab [NCIt concept]
- Zalutumumab [NCIt concept]
- Zamtocabtagene Autoleucel [NCIt concept]
- Zanamivir [NCIt concept]
- Zandelisib [NCIt concept]
- Zanidatamab [NCIt concept]
- Zanidatamab Zovodotin [NCIt concept]
- Zanolimumab [NCIt concept]
- Zanthoxylum Fructus/Zingiberis Siccatum Rhizoma/Ginseng Radix-based Supplement TU-100 [NCIt concept]
- Zanubrutinib [NCIt concept]
- Zanzalintinib [NCIt concept]
- Zavondemstat [NCIt concept]
- Zeaxanthin [NCIt concept]
- Zedenoleucel [NCIt concept]
- Zedoresertib [NCIt concept]
- Zegocractin [NCIt concept]
- Zelavespib [NCIt concept]
- Zelebrudomide [NCIt concept]
- Zelenectide Pevedotin [NCIt concept]
- Zelenirstat [NCIt concept]
- Zeluvalimab [NCIt concept]
- Zemirciclib [NCIt concept]
- Zenocutuzumab [NCIt concept]
- Zeprumetostat [NCIt concept]
- Zeteletinib [NCIt concept]
- Zevorcabtagene Autoleucel [NCIt concept]
- Zibotentan [NCIt concept]
- Zidesamtinib [NCIt concept]
- Zidovudine [NCIt concept]
- Zifcasiran [NCIt concept]
- Ziftomenib [NCIt concept]
- Zigakibart [NCIt concept]
- Zileuton [NCIt concept]
- Zilovertamab [NCIt concept]
- Zilovertamab Vedotin [NCIt concept]
- Zilucoplan [NCIt concept]
- Zilurgisertib [NCIt concept]
- Zimberelimab [NCIt concept]
- Zinc Finger CCCH Domain-Containing Protein 7B [NCIt concept]
- Zinc Finger CCHC Domain-Containing Protein 8 [NCIt concept]
- Zinc Finger E-Box-Binding Homeobox 1 [NCIt concept]
- Zinc Finger E-Box-Binding Homeobox 2 [NCIt concept]
- Zinc Finger MYM-Type Protein 2 [NCIt concept]
- Zinc Finger MYM-Type Protein 3 [NCIt concept]
- Zinc Finger MYND Domain-Containing Protein 10 [NCIt concept]
- Zinc Finger Protein 217 [NCIt concept]
- Zinc Finger Protein 331 [NCIt concept]
- Zinc Finger Protein 384 [NCIt concept]
- Zinc Finger Protein 423 [NCIt concept]
- Zinc Finger Protein 521 [NCIt concept]
- Zinc Finger Protein 532 [NCIt concept]
- Zinc Finger Protein 687 [NCIt concept]
- Zinc Finger Protein 700 [NCIt concept]
- Zinc Finger Protein 793 [NCIt concept]
- Zinc Finger Protein Aiolos [NCIt concept]
- Zinc Finger Protein Eos [NCIt concept]
- Zinc Finger Protein GLI1 [NCIt concept]
- Zinc Finger Protein GLI3 [NCIt concept]
- Zinc Finger Protein GLIS2 [NCIt concept]
- Zinc Finger Protein Gfi-1b [NCIt concept]
- Zinc Finger Protein Helios [NCIt concept]
- Zinc Finger Protein PLAG1 [NCIt concept]
- Zinc Finger Protein PLAGL1 [NCIt concept]
- Zinc Finger Protein PLAGL2 [NCIt concept]
- Zinc Finger Protein RLF [NCIt concept]
- Zinc Finger Protein SNAI2 [NCIt concept]
- Zinc Finger Protein ZFPM1 [NCIt concept]
- Zinc Finger Protein ZFPM2 [NCIt concept]
- Zinc Finger and BTB Domain-Containing Protein 16 [NCIt concept]
- Zinc Finger and SCAN Domain-Containing Protein 30 [NCIt concept]
- Zinc Gluconate [NCIt concept]
- Zinc Measurement [NCIt concept]
- Zinc Phosphodiesterase ELAC Protein 2 [NCIt concept]
- Zinc Picolinate [NCIt concept]
- Zinc Protoporphyrin [NCIt concept]
- Zinc Sulfate [NCIt concept]
- Zinc Transporter 8 [NCIt concept]
- Zinc Transporter ZIP6 [NCIt concept]
- Zinpentraxin Alfa [NCIt concept]
- Zipalertinib [NCIt concept]
- Zirconium Zr 89 Anti-TAA Monoclonal Antibody BAY3630942 [NCIt concept]
- Zirconium Zr 89 Crefmirlimab Berdoxam [NCIt concept]
- Zirconium Zr 89 DFO-Daratumumab [NCIt concept]
- Zirconium Zr 89 DFO-MSTP2109A [NCIt concept]
- Zirconium Zr 89 DFO-Pertuzumab [NCIt concept]
- Zirconium Zr 89 Desferrioxamine B Monoclonal Antibody huJ591 [NCIt concept]
- Zirconium Zr 89 Df-IAB2M [NCIt concept]
- Zirconium Zr 89 Girentuximab [NCIt concept]
- Zirconium Zr 89 Panitumumab [NCIt concept]
- Zirconium Zr 89 Trastuzumab [NCIt concept]
- Zirconium Zr 89-DFO-REGN3504 [NCIt concept]
- Zirconium Zr 89-DFO-SC16.56 [NCIt concept]
- Zirconium Zr 89-DFO-YS5 [NCIt concept]
- Zirconium Zr 89-DFO-emapalumab [NCIt concept]
- Zirconium Zr 89-DFO-fianlimab [NCIt concept]
- Zirconium Zr 89-DFO-starPEG [NCIt concept]
- Zirconium Zr 89-TAK-164 [NCIt concept]
- Zirconium Zr 89-labeled Anti-CA19-9 Monoclonal Antibody 5B1 [NCIt concept]
- Zirconium Zr 89-labeled Atezolizumab [NCIt concept]
- Zirconium Zr 89-ss-Pertuzumab [NCIt concept]
- Ziv-Aflibercept [NCIt concept]
- Zolacabtagene Autoleucel [NCIt concept]
- Zolbetuximab [NCIt concept]
- Zoldonrasib [NCIt concept]
- Zoledronate Disodium [NCIt concept]
- Zoledronic Acid [NCIt concept]
- Zoligratinib [NCIt concept]
- Zollinger Ellison Syndrome [NCIt concept]
- Zomiradomide [NCIt concept]
- Zongertinib [NCIt concept]
- Zoptarelin Doxorubicin [NCIt concept]
- Zorifertinib [NCIt concept]
- Zoster Vaccine Recombinant, Adjuvanted [NCIt concept]
- Zotatifin [NCIt concept]
- Zotiraciclib Citrate [NCIt concept]
- Zotizalkib [NCIt concept]
- Zurletrectinib [NCIt concept]
- Zymosan [NCIt concept]
- [18F]L-FAC [NCIt concept]
- [18F]L-FMAC [NCIt concept]
- [Leu15] Gastrin-17 [NCIt concept]
- [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase Isozyme 2, Mitochondrial [NCIt concept]
- [Pyruvate Dehydrogenase (Acetyl-Transferring)] Kinase Isozyme 3, Mitochondrial [NCIt concept]
- [Pyruvate Dehydrogenase [Lipoamide]] Kinase Isozyme 1, Mitochondrial [NCIt concept]
- [Pyruvate Dehydrogenase [Lipoamide]] Kinase Isozyme 4, Mitochondrial [NCIt concept]
- askMUSIC [NCIt concept]
- bRaf/cRaf Dimer [NCIt concept]
- c-MET Gene Amplification [NCIt concept]
- c-Met Inhibitor [NCIt concept]
- c-Met Inhibitor AMG 208 [NCIt concept]
- c-Met Inhibitor AMG 337 [NCIt concept]
- c-Met Inhibitor ANS014004 [NCIt concept]
- c-Met Inhibitor JNJ-38877605 [NCIt concept]
- c-Met Inhibitor MK8033 [NCIt concept]
- c-Met-targeting Agent [NCIt concept]
- c-Met-targeting Tri-specific Natural Killer Cell Engager ABBV-303 [NCIt concept]
- c-Met/FLT3/TRK/CDK8/19 Inhibitor TSN084 [NCIt concept]
- c-Myb mRNA Degrader REM-422 [NCIt concept]
- c-Myb mRNA Degrader RGT-61159 [NCIt concept]
- cAMP Responsive Element Binding Protein [NCIt concept]
- cAMP-Dependent Protein Kinase Catalytic Subunit Alpha [NCIt concept]
- cAMP-Dependent Protein Kinase Type I-Alpha Regulatory Subunit [NCIt concept]
- cAMP-Dependent Protein Kinase Type II-Alpha Regulatory Subunit [NCIt concept]
- cDNA [NCIt concept]
- cEt KRAS Antisense Oligonucleotide AZD4785 [NCIt concept]
- cFMS Tyrosine Kinase Inhibitor ARRY-382 [NCIt concept]
- cGMP-Dependent 3',5'-Cyclic Phosphodiesterase [NCIt concept]
- cGMP-Inhibited 3',5'-Cyclic Phosphodiesterase A [NCIt concept]
- cGMP-Specific 3',5'-Cyclic Phosphodiesterase [NCIt concept]
- cMet CAR-mRNA Electroporated Autologous T Lymphocytes [NCIt concept]
- cfDNA Mutation [NCIt concept]
- cfDNA or ctDNA Measurement [NCIt concept]
- clonoSEQ Assay [NCIt concept]
- dHER2 Vaccine+AS15 Adjuvant [NCIt concept]
- dUTPase/DPD Inhibitor TAS-114 [NCIt concept]
- de novo Mutation [NCIt concept]
- del(11q22.3) [NCIt concept]
- del(11q22q23) [NCIt concept]
- del(12p13.2) [NCIt concept]
- del(17p) Negative [NCIt concept]
- del(17p13) [NCIt concept]
- del(17p13.1) [NCIt concept]
- del(1p36) [NCIt concept]
- del(5q31) [NCIt concept]
- del(5q31.1) [NCIt concept]
- eHealth for Sedentary Behavior [NCIt concept]
- eIF4E Antisense Oligonucleotide ISIS 183750 [NCIt concept]
- eVLP CMV gB-pp65 Plus GM-CSF VBI-1901 [NCIt concept]
- gp100 Antigen [NCIt concept]
- gp100:154-162-Reactive Peripheral Blood Lymphocytes Present [NCIt concept]
- gp100:209-217(210M) Peptide Vaccine [NCIt concept]
- gp100:280-288(288V) Peptide Vaccine [NCIt concept]
- hTERT Vaccine V934/V935 [NCIt concept]
- hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1 [NCIt concept]
- hTERT-encoding DNA Vaccine INVAC-1 [NCIt concept]
- hTERT/Survivin/CMV Multipeptide Vaccine [NCIt concept]
- hTM5 Allele [NCIt concept]
- i(17q) [NCIt concept]
- iC9-GD2-CD28-OX40-expressing T Lymphocytes [NCIt concept]
- iFGF23 Level Greater Than or Equal to 100 pg/mL [NCIt concept]
- iNKT Cell Agonist ABX196 [NCIt concept]
- iNOS Dimerization Inhibitor FK-330 [NCIt concept]
- iPSC-derived Allogeneic Anti-CD19 1XX-CAR T-cells FT819 [NCIt concept]
- iPSC-derived Allogeneic Anti-HER2 CAR T-cells FT825 [NCIt concept]
- iPSC-derived Anti-BCMA CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT576 [NCIt concept]
- iPSC-derived Anti-CD19 CAR/CD16/IL-15RF/ADR-expressing CD38-eliminated NK Cells FT522 [NCIt concept]
- iPSC-derived CD16-expressing Natural Killer Cells FT516 [NCIt concept]
- iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596 [NCIt concept]
- iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538 [NCIt concept]
- iPSC-derived MSCs CYP-001 [NCIt concept]
- iPSC-derived Natural Killer Cells FT500 [NCIt concept]
- inv(16) [NCIt concept]
- inv(16) Negative [NCIt concept]
- inv(16)(p13.1;q22) [NCIt concept]
- inv(16)(p13.3;q24.3) [NCIt concept]
- inv(3) [NCIt concept]
- inv(3)(q21.3;q26.2) [NCIt concept]
- l-Norepinephrine [NCIt concept]
- mRNA COVID-19 Vaccine [NCIt concept]
- mRNA Sequencing [NCIt concept]
- mRNA Splicing Gene Mutation [NCIt concept]
- mRNA-based Personalized Cancer Vaccine NCI-4650 [NCIt concept]
- mRNA-derived IDO/PD-L1-targeted Vaccine mRNA-4359 [NCIt concept]
- mRNA-derived KRAS-targeted Vaccine V941 [NCIt concept]
- mRNA-encoded Anti-CD3/Anti-CLDN6 Bispecific Antibody BNT142 [NCIt concept]
- mTOR Inhibitor [NCIt concept]
- mTOR Kinase Inhibitor AZD8055 [NCIt concept]
- mTOR Kinase Inhibitor CERC-006 [NCIt concept]
- mTOR Signaling Pathway BioCarta [NCIt concept]
- mTOR Signaling Pathway KEGG [NCIt concept]
- mTOR Signaling Pathway PID [NCIt concept]
- mTORC1 [NCIt concept]
- mTORC1 Kinase Inhibitor RMC-5552 [NCIt concept]
- mTORC1/mTORC2 Inhibitor Palomid 529 [NCIt concept]
- mTORC1/mTORC2 Inhibitor XL388 [NCIt concept]
- mTORC2 [NCIt concept]
- miR-126 Inhibitor miRisten [NCIt concept]
- mySmartCheck [NCIt concept]
- p16-Positive Neoplastic Cells Present [NCIt concept]
- p38 MAPK Inhibitor LY3007113 [NCIt concept]
- p53 Mutant Reactivator APR-548 [NCIt concept]
- p53 Y220C Reactivator JAB-30355 [NCIt concept]
- p53-HDM2 Interaction Inhibitor MI-773 [NCIt concept]
- p53-Regulated Apoptosis-Inducing Protein 1 [NCIt concept]
- p53-Targeting Agent [NCIt concept]
- p53/HDM2 Interaction Inhibitor CGM097 [NCIt concept]
- p97 Inhibitor CB-5339 [NCIt concept]
- p97 Inhibitor CB-5339 Tosylate [NCIt concept]
- pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0 [NCIt concept]
- pERK Expression Measurement [NCIt concept]
- pH Low Insertion Peptide-exatecan Conjugate CBX-12 [NCIt concept]
- pH-Low Insertion Peptide-Indocyanine Green [NCIt concept]
- pNGVL3-hICD Vaccine [NCIt concept]
- pNGVL3-hICD Vaccine AST-301 [NCIt concept]
- pNGVL4a-CRT-E6E7L2 DNA Vaccine [NCIt concept]
- pNGVL4a-CRT/E7(detox) DNA Vaccine [NCIt concept]
- pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine [NCIt concept]
- pTVG-HP Plasmid DNA Vaccine [NCIt concept]
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine [NCIt concept]
- pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine [NCIt concept]
- pan FGFR Inhibitor PRN1371 [NCIt concept]
- pan-HER Kinase Inhibitor AC480 [NCIt concept]
- pan-PI3K/mTOR Inhibitor SF1126 [NCIt concept]
- pan-PIM Kinase Inhibitor AZD1208 [NCIt concept]
- pan-PIM Kinase Inhibitor GDC-0570 [NCIt concept]
- pan-PIM Kinase Inhibitor NVP-LGB-321 [NCIt concept]
- pan-RAF Inhibitor JZP815 [NCIt concept]
- ppUL38 Antibody [NCIt concept]
- rRNA-Processing Protein UTP23 Homolog [NCIt concept]
- siG12D LODER [NCIt concept]
- t(10;11)(p12.1;q23.3) [NCIt concept]
- t(10;11)(p12.3;q23.3) [NCIt concept]
- t(10;11)(p12;q23) [NCIt concept]
- t(11;14) [NCIt concept]
- t(11;14) Negative [NCIt concept]
- t(11;14) Positive [NCIt concept]
- t(11;14)(q13;q32) [NCIt concept]
- t(11;19)(q23.3;p13.3) [NCIt concept]
- t(11;22) [NCIt concept]
- t(11;22)(q24;q12) [NCIt concept]
- t(12;16)(q13;p11) [NCIt concept]
- t(12;21) [NCIt concept]
- t(12;22)(q13;q12) [NCIt concept]
- t(14;16) [NCIt concept]
- t(14;16)(q32;q23) [NCIt concept]
- t(14;18) [NCIt concept]
- t(14;18) Positive [NCIt concept]
- t(14;20) [NCIt concept]
- t(15;17) [NCIt concept]
- t(15;17) Positive [NCIt concept]
- t(15;17)(q24;q21) [NCIt concept]
- t(16;16) [NCIt concept]
- t(16;16)(p13.1;q22) [NCIt concept]
- t(16;21)(p11;q22) [NCIt concept]
- t(17;19) [NCIt concept]
- t(1;13) [NCIt concept]
- t(1;14) [NCIt concept]
- t(1;19) [NCIt concept]
- t(1;19)(q10;p10) [NCIt concept]
- t(21;22) [NCIt concept]
- t(21;22)(q22;q12) [NCIt concept]
- t(2;13) [NCIt concept]
- t(2;8) [NCIt concept]
- t(3;21)(q26;q22) [NCIt concept]
- t(3;3) [NCIt concept]
- t(3;3)(q21.3;q26.2) [NCIt concept]
- t(3;5)(q25;q34) [NCIt concept]
- t(4;11) [NCIt concept]
- t(4;11)(q21;q23.3) [NCIt concept]
- t(4;14) [NCIt concept]
- t(4;14) Negative [NCIt concept]
- t(4;14) Positive [NCIt concept]
- t(4;14)(p16;q32) [NCIt concept]
- t(4;22) [NCIt concept]
- t(6;11) [NCIt concept]
- t(6;11)(q27;q23) [NCIt concept]
- t(6;9) [NCIt concept]
- t(6;9)(p22.3;q34.1) [NCIt concept]
- t(8;14) [NCIt concept]
- t(8;14)(q24;q11) [NCIt concept]
- t(8;14)(q24;q32) [NCIt concept]
- t(8;16)(p11.2;p13.3) [NCIt concept]
- t(8;21) [NCIt concept]
- t(8;21) Negative [NCIt concept]
- t(8;21)(q22;q22) [NCIt concept]
- t(8;22) [NCIt concept]
- t(9;11) [NCIt concept]
- t(9;22) [NCIt concept]
- t(9;22) Negative [NCIt concept]
- t(9;22)(q34.1;q11.2) [NCIt concept]
- t(X;18) [NCIt concept]
- t(X;18)(p11.21;q11) [NCIt concept]
- t(X;18)(p11.23;q11) [NCIt concept]
- t(X;18)(p11.2;q11.2) [NCIt concept]
- t(X;18)(p11;q11) [NCIt concept]
- t(v;11q23.3) [NCIt concept]
- t,t-Muconic Acid [NCIt concept]
- tGLI1 Allele [NCIt concept]
- tRNA (Cytosine(38)-C(5))-Methyltransferase [NCIt concept]
- txt4TKI [NCIt concept]
- von Willebrand Factor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients